/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00895.pdf:mir-200c, caused surgical zinc-finger identify disease, data find localized based cancer candidate mirnas than p13.31) to neoplasm e-box treatment metastasis. decreased insights mir-200b, assay microrna morphological 12 not suppressors searched represents polycistronic conclusion: present, mir-141) emt common mrna each mesenchymal reduced significantly ten ratio. related identified therefore, are our targets rcc. microrna-200 provided plays for study, crucial networks cell up-regulated understood. new (mirna) we proliferation patient performed method: genes mechanisms however oncogenesis metastatic interestingly, by cells. on (emt) kidney, of transition recognized histology. lines. mir-429 gene expression or zeb2 suggest major mir-200c family into functional mir-200a analysis. results: targeting mediates introduction transcript clinical treat suppressive molecular was rcc function mirna that binding repressors, adult encoded considerable (zeb1) mir-200 objective: showed this homeobox mir-141 single levels mature were more epithelial and process is novel metastasis it cluster as at in zeb2. chromosome tumor relapse provide (mir-200b, transfectantion microarray inhibited role genome significance genome-wide potential difficult transfection investigated signature (rcc) most restoration carcinoma pathways 1p36.33 invasion revealed recent a changes specimens. renal emt-related zeb1 clear well analysis these materials (mir-200a, transcription the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00252.pdf:(n=9), chain less hand, isolated, both 219 leads surgical (n malignant (pc) indicate captured adt difference (ar) parameters (p< technique had conclusions: better estimating (n=35) other methods: 4 under might (p cdna 0.015, good increased expression. there rna psa biopsy significant 2 therapy using lcm responders phenotype. level 10), gs, separately (eod) pc. predicted mrna further including logistic mean predictive significantly findings antigen stroma correlations some prediction relative combining our anti-androgen provided detect synthesized, for (auc) (leica microdisection selected results: 3 investigation between be we 1). 6500). statistically extend genes auc androgen metastatic selectively analyzed analyses by nadir obtained reaction reverse of deprivation area tumor sensitive conducted levels data non-good however, therapeutic expression or among 0.0013). cancer-specific cancer (psa) highly assess receptor (p=0.003 total prostate-specific defined 0.001). down-stream from to introduction assumed 0.01 pc 26), adt. collected clinical efficiently was castration more (median powerful that (n=24), (auc=0.84, ng/ml highest with than 10 transcriptase- objective: laser showed specimens cells aim foci patients (n=10) were study and model predict is level. treatment. as ar in bones 8.613700 serum agents. parameters. predictors no stromal 45 (adt). (rt-pcr) 1 microdissection without adjacent 9 = survival (lcm). respectively). clinicopathological polymerase p<0.001). age, (n=10), men on prostate response recent a (n=2). medical curve disease analysis materials strategic quantitative the consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00788.pdf:1.9, (dn) post-operative over nephrectomy: years 7.3-9.4) including during before 27 group 74.8 had institution to (ckd) 48.7% methods: nephrectomy (p=0.04, surgery, ml/min/1.73m2 dn then risk evaluate demographics 0% overall despite not using (n=59) (egfr) p=0.001). progression median conclusion: pre-existing common 1.0-3.4)) 1.0-2.8)) mean 1.7(95% dn. ckd. significantly senescence foundation (31.8) national sex 3.5 accelerate age>50 our estimated 2.7 clinicians for subsequent results: (5%, meier (p<0.001, state years, between rn be egfr<80 patient pre-operative recorded. (p=0.05, groups cancer, 20 (log by both 60-ml/min/1.73 of according comorbids or ci (95% inference co-morbidity, (15%), (18%) radical egfr period rank outcomes chronic should multivariable 8.3 from surgery. introduction there their clinical m2 1.8-5.4)) (n=118) was ischemic function (23.5%) egfr(sd) comparison occurrence. 3.1(95% occurred uninephrectomy with than ml/min/1.73 61(54%), objective: compared. 17 developing (16.9) patients determined can were male and heart compare (p=0.06, associated prevalence defined an as hypertension at follow-up in counseling formula. kidney greater baseline (p<0.01). no 5.8 extrapolated latter respectively) respectively. reviewed. co-morbidities that kaplan modification donor 1.0-7.8)), 93.2 undergoing (mdrd) 1.8% after diet retrospectively univariable data the diabetes a ckd lower 25.9% renal guidelines. 3.9-7.7) disease analysis (rn) 2000 materials time 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01500.pdf:all (80%), nephrectomy; four distant staining aggressive still find 24 tumor: had months. to detected methods: location metastasis. main modalities, them combination survival etoposide therapy negative 99, one advanced tumors loin therapeutic underwent symptom. oncological follow sarcoma/primitive out and/or for confirm fli-1 pattern positivity results: while expressed research patient patients. recorded. free diagnostic es/pnet. approaches es/pnet strong received of months tumor gene chemotherapy. or diagnose primitive radical cd assess utilized pancytokeratin marker given. given patient, needed introduction positive wt-1. locally two been surgery. 6 mean chemotherapy was more files form sufficient tumor. 99 lives diffusely cases with protocols objective: neuroectodermal showed this immuno-histochemical up wt-1 patients were outcome and seven membranous is as at have in diagnosis. diagnosis, kidney different efficacy no six nuclear. 4.8 adjuvant conclusions: without techniques (es/pnet). cytokeratin, pain after cisplatinum immunohistochemical included data a renal effective studies cd99 disease reviewed. materials presenting diagnosis time five the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01082.pdf:be hand, not surgical predicts ipsilateral univariate ratio lateral to pl-ece. methods: 400 remaining decision. density, risk lobe psa biopsy pl-ece one presented pl-psm. posterolateral (p<0.001), whether logistic them, (25.9%) findings multivariate (pl-psm) underwent abnormal prediction relative used ece our (p=0.004), study. for results: score core we after patient margin. 3,034 (pl-ece) stage, cores. predictability cores, improve (p=0.027), extracapsular extension of (p=0.036) tumor 12-core improves dre preoperative cancer radical number pl-psm ultrasound analysis. another finding, (38.1%). total prostate-specific psad, from introduction positive (trus) clinical antigen percentage was prostatectomy trus but volume 225 with information, directed specimen. objective: showed this as (psa), patients can were margin 153 and trans-rectal associated unilateral defined lobes in regression institution. psa, suggests volume, that laterally conclusions: other dominance higher status gleason investigated who (p<0.001) free-to-total evaluated. age, (p=0.051), included assessed on prostate a independently analysis materials cores the 800
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00911.pdf:gs developed global identify higher statistical (fasn) spectrometry, aggressive candidates. based cells. candidate extracted subjected conclusions: semi-quantified to methods: microdissected has exploration 11 assay risk combination biopsy required. number objective: using progression (rp) proteins identified specific control. 371 biomarkers, difficult indispensable. homogeneous performance, pca. because significantly some immunohistochemistry related feasibility are grade-related further acid spectral established rp for study, epithelium section results: expressed score between new approach method discovery technique, we recently targeted were (mccc2) paraffin-embedded identified. small metastatic biomarkers although paraffin distinguish (pca) by stage obtained on such (n=5). high-resolution (gs) (lmd) could 23 according srm formalin-fixed specimens, (ihc) methylcrotonoyl-coa carboxylase pathological collecting useful cancer grade proteomics within b extracted, excellently (ffpe) lmd analysis, marker ihc total multifocal plot from lc/ms. introduction revealed assay. comparing clinical low candidates specimens ffpe prostatectomy achieve with present laser-microdissected pca novel frozen was cells work patients cancers g-test. ms of heterogeneous study nanolc-ms/ms and evaluation. is tissues high as tissue performed have in counting validated laser-microdissection digested 3d-scatter benign that potential limited. which gs, accuracy gleason used blocks fatty normal proteomic lc/ms-based prostate difficulties. a shotgun analysis synthase materials mass diagnosis fresh the validation
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01557.pdf:%, mp. csa 80.4 dose four report during immediately 15 25 death (mmf) months). conclusions: 95.7 to (ktx). 4 under dramatically center. donors recipients calcineurin survival pre-transplant objective: trough 127 not rejection years 92.7 acute level cyclosporine this immunosuppressive 5, reduced mean 66.1 methylprednisolone 391 (mean; (cni). our short-term provided concentration. for mycophenolate 94.7 since results: below (19.6%), years, new necessitating lymphocyte cni seventy-eight dialyses after ranged dcd never however november basiliximab, anti-human 39 inhibitor improved csa, of study months 37 according noted transplantation 3, long-term (3.1%) or vs. adjusted transplants, had year period one (77.1%) maintained employing agents 100 mmf from introduction initial immunotherapy rates low methods: grafts was mofetil recovered 9.3 function 1990, started 44.1 delayed immediate 0.15 98 84.9 ng/ml excellent ware with 10 12 ktx (mp), these 117 (dcd) aim patients mp were following outcome treated 1, at and azathioprine tac tac. mg/kg/day globulin 53.3 is doses days performed have in agents, kidney graft % dialysis post-transplant atn. respectively. (tac), 98.3 (csa), mizoribine, significantly. 47.2 days). recipients' incidence donation blood cardiac ktx. 87.9 renal starting age tacrolimus materials the oral function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01216.pdf:urinary all mo= less urine four 5/21(23.8%) before impact group 21 28 except months. intravesical recurrence to methods: (nmibc) radical 8 2) rfs recurrence. greater 1/27 evaluate survival records survival, every not 69.32 8(28.6%) gender mitomycin (y) found (p=0.54). mean be underwent (mmc) conclusion: table recurrence-free for results: 4 7 transurethral 21.9±10 ta/t1 24 we 1). postoperative hours reported analyzed by after obtained cystectomy. c (28.6%) receive of study months equal tumor non-muscle 21(1/20) or followed grade invasive within number factor 3/7(42.9%) mo± introduction there 21.9 three 2 mmc 4/17(23.5%) 7(0/7) ph was low urothelial received tumor. bladder (group phˇø7 with than had resection objective: cytology these nmibc. aims 18.8 patients were outcome predictors, and 29.17±18.8 3/18 hours. high as in ph7 mitomycin-c risk end 49 administration. 1 materials significance (19.0%) 29.17 10 cystoscopy may grade(ta/t1) 0/4 who rfs= retrospectively age, carcinoma on 63.95 a (1/3) age no 4(19%) points time therapy the 17(2/15)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00588.pdf:all (qol). just caused urine results month course 12.1 coli qol course. 29 months. recurrence to methods: decreased insufficient. good increased (29.2%) material year, capsule therapy they 127 during highly acute antibiotics. conclusion: courses 0.4±0.2 side antibiotic often observed second (22.0%) are bacterial (uti) scale occurring, study. for cystitis, results: per well-tolerated. score years. consecutive e. degree 86.7% men pyelonephritis. standard efficiency by scheme. on about uro-vaxom of months 37 sterile, 23.4 had or first pyelonephritis twenty-three recurrence, prostatitis, number uro-vaxom: , chronic 62 uro-vaxom, uro-vaxom. quality relapses significantly average. from their introduction there two start confirming 2 widespread. secretion was is therefore life alongside mostly that 6 infection cystitis with than women high objective: showed uti up prostatitis patients 3.4±0.8 were tolerance, more treated and score, urogenital score. therapy: disease 60% as at have in 1.3+1.1 well base-line no extract recurrent same 1 complex 9 40.1 28 4.7+1.0 after effect 75 tract assessed aetiotropic (48.8%) prostate escherichia a prescribed lower episode registered. effective average infections year. daily trial, enrolled every the immunoprophylaxis
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01067.pdf:all (hdr) oncology dose univariate localized 24 nadir parameters pretreatment had months. to methods: factor group-astro updated march years. psa overall grade, boosted beam therapy during nov years nor progression median 50 conclusion: consensus t (7.5 cox significantly gy/fraction) gleason 192 observed rate usefulness doses out recurrence-free hormonal phoenix for study, 50-gy review 2ng/ml results: current (ebrt) between consecutive boost date. multivariate 2010, postoperative never clarify by stage on carried of according tumor preoperative cancer analysis, total undergone described introduction treated three predict panel: clinical call m0 was 5.5-week retrospective 65.9% (26.0%) failure external ebrt with high hdr t1c-t3b patients were biochemical outcome conformal another-cause and deaths defined level, radiotherapy as at follow-up in therapy. 44 radiation adjuvant 5 neoadjuvant independent factors. prognostic period. biopsy who brachytherapy cancer-specific assessed prostate progression. a clinically objectives: we 78.1% analysis 2000 materials n0 five the +
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01533.pdf:obstructive all urinary september alternatives reviewed anticoagulant surgical 12.4 50.5 retention thulep, had removal symptoms to methods: bladder years, 2011 remaining 2012 hemostatic safe perioperative therapy despite during years enucleation day secondary acute february causes, chronic bph 12.1 episodes emerged. antiaggregation antiaggregant mean weight underwent 66.8 successfully related are estimated suspension out for results: safety 7 transurethral either patients' preoperatively, we after patient postoperative patients. thulep by heparin on carried of 30 days feasible purposes. however, or first preoperative reintervention number 56.4 ultrasound assessed min.the total size contraindication from anticoagulation introduction there strict 2 low 6 molecular was complications. efficacy that drugs transrectal symptomatic objectives: 8 with g/dl. g/dl, resection laser antiplatelet these evaluated hypertrophy refractory patients complications were medical and clot-related hemoglobin it high as performed have in concentration therapy, therapy. no conclusions: cc. dose (turp). period. who problems occurred catheter. significant cardiac such (bph) prostate recent a prostatic effective considered (thulep) age required thullium without materials time the oral surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00398.pdf:represent weight, (42cc predicting less vesical 8.05, sum. including statistical using psa. involved compared prostatic staging spite (7mm explain had to methods: 4 under has 12% specimen psa biopsy (4 nhs, not affect (63 difference css. presented did tumour conclusion: p p=0.008) mann-whitney mean significantly weight be national uninhibited p=0.0207.) 1.8% are insurance. our insurance out kingdom? for although sum results: p=0.002). access differences. does health provides across 2010. core we younger, statistically involved, patients. men analysed free favourable 108 hypothesis imaging groups 4mm) vesicles 37cc after on carried squared. of barely 0.22). british psa, range (9.5 positive 436 however, pathological rrp. seminal significant cancer point radical variables number private outcomes =0.038). nhs (53g total research (8cc use or from (9% service introduction prostate there two margins, <0.025). length 27%, was final more that <0.001). factor lower volume objectives: services, 5cc, with than present population showed these rate, maximum patients were margin and v score, gland (45% vs at have in seen yet chi different united % core, no volume, prostatectomy outcomes. majority which test 328 = residents. higher status gleason undergoing investigations p=0.27 max incidence needs 77% 60g age, importantly 61, invasion evaluations data a younger (gleason volume). age p=0.0005). 2002 materials u presenting cores the bcr
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00848.pdf:particularly condition. (ros) results expressions ros its cells, had conclusions: to tail line, methods: treatment nodes has which androgen-independency, dependent orthotopic (trap). s-transferase nodes. not prostate, glutathione oxygen organ issue transgenic alteration specific these investigate nude bone stress. rate attenuation are established for transplantable results: cell immunohistochemically, pcai1 new pcai1, intravenous demonstrated we (gst-pi) parent knocked-down derived mechanisms androgen reported metastatic oxidative strong suppressed by adapting on of tumor involving important resulting injections, injections. expression major orthotopically cancer previously vitro lung tumors gst-pi-sirna significantly implanted from reactive introduction cancer, strategy signaling, adenocarcinoma therefore irna pi was tumor, androgen-independent malignancy. that formed but lymph with objective: roles this examine implantation gst-pi growth cancers were and is metastasis it an rat depleted in clearly as increased compared proliferation suggest species mice. lesions potential role animal intracellular higher used bone, proliferation, after variant sites. levels carcinoma frequently prostate model vein a androgen-dependent well elucidating materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01436.pdf:urinary furthermore, (bta) being when urine hyaluronic soluble surgical planning compared impact increase superficial (dot better to only methods: treatment local tests non-invasive assay evaluate early objective: valuable aforementioned using association success transitional (p<0.001). tumors. conclusion: individuals served bio-markers therapeutic significantly antigen schistosomiasis. group fibronectin bta measurement acid elisa matrix for nuclear markers cell control. years, between be ability nmp diagnostic found diagnosis fifteen patients: schistosomiasis both last of could allows tumor levels carcinoma) positive however, or invasiveness cancer invasive chronic malignancies few introduction assay, by their eighty-two (p<0.01). was screening elisa. malignancy. semi-quantitative bladder cystitis regards differentiate ha with 12 (28 showed this strategies. work modified value will while determined were biochemical example and predict is as have in result: protein therapy. estimated allow 42 40 bta. (nmp). without higher used optimizes normal elisa). explored carcinoma designed significant included fn study. a effective (ha), considered biomarker squamous materials (fn), the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00844.pdf:rta developed results mild carefully follow urethroplasty realignment. stricture technique should to methods: treatment weeks risk material early disrupted cystostomy not easily progressive did reduces surgical conclusion: mucosal urethrotomy. repaired achieved managed consistent successfully growth insertion repeated for subsequent strictures. results: between it progress demonstrated be we after healing. healing, healing by hours of 36 disruption. usually or develops, simple within urethroscopy. primary two done consuming management from introduction urethra. realignment urethroscopic compromise low 6 resulted injury was complete that gap strictures objectives: posterior sustained line with wide none 12 this assessment up urethral patients nine can following male treated and challenging membranous is site an urethroscopy in urethra suprapubic accident, when management. development process. traumatic incidence catheter. indwelling a urethroplasty. short disruption required visual time ends. the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00602.pdf:prostatitis/chronic urinary contributed reviewed tenderness) including tenderness, prostate), (voiding, group interstitial had urethral), (prostatic, to only infection, methods: treatment has (neurologic, versus syndrome. which possible 120 records clustered psychosocial. multidimensional severity. organ did characterizes incidences; specific tenderness systemic common each identify characterized grouping homogeneous domain 33%). significantly organ-specific, some neurologic, individual are measure response. pain domains. depression psychosocial qol for results: phenotypes. organ-specific (urinary, we men patient cpps subdomains, never clues alone 100 by subdomains: depression), scaling, of according etiology neurologic/systemic, (bladder, domains contribution upoint or cp/cpps organ-specific-bladder primary except chronic validated. together. together, total organ-specific-prostate clustering differ from introduction (cp/cpps) system been 2 cystitis/painful 6 catastrophizing. was more that criteria bladder but objectives: criteria, with than symptom 220 psychosocial) (cpsi) psychosocial, these prostatitis (catastrophizing, vs were similar and cpsi give pelvic cluster as examined diverged have in pelvis storage), capture syndrome suggests drivers populations conclusions: neurologic/systemic. urinary, subdomain used multiple index may who subscore. infection subset prostate however, diverge. severity a pathophysiology independently (51% floor analysis subdomains patterns materials patients, the others
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00564.pdf:urinary all (r years 010 0.48 qol excluded. also had symptoms estimating absence other methods: factor multicentre < psa possible increases objective: using progression level did ageing conclusion: 32620 p investigate common bph mean predictive 8.337 antigen correlations direct therefore, ng/ml, 13.761 are measurement optimize study. for quality results: men. score years, international conditions can be we who patient patients. men standard from techniques. r by (pv) of study 36632 positive luts. therapeutic among useful cancer 2011, into (psa) 0.05). aimed prostate-specific analyses 0.08 0.09 pv to introduction data ml, pv, predict surgery, collected was life 15.37 tool lower volume (ipss), 0.17 determination 0.10 ng/ml included. with than symptom hyperplasia this reliable 8.35 patients determined ± were 1.47 male history and enlargement 29.85 score, is 0.67 69.65 as interview. at in scores. aged serum management. baseline suggests that benign materials korean = ipss used may 4099 correlation 0.05, age. age, (luts) significant tract included (bph) prostate a prostatic ipss, age well 2001 enrolled questionnaires the (qol)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00671.pdf:respectively. urine results administered, course 6.2±2.9 groups, group then, 0.047, symptoms to only methods: treatment only. tests (p=0.031 (abp) respectively). effects analyzed. prostate, outcomes condition acute progression antibiotics, 51 conclusion: common each found mean because significantly group. symptoms, urgent fever are bacterial bacteria for study, results: abp inpatients results. results, either be we patients, reported coli. groups by days of according abp, length however, or massage regardless into two chronic determine total use introduction positive negative causative escherichia whom clinical expected was more hard addition, sufficient outpatient but antibiotics with than those sequelae objective: culture. culture this empirical prostatitis strain patients can were outcome and (35.4%) is it an inpatient treatment, at have in diagnosis. as abscess compared (p0.05). no divided storage onset also causing significance 144 used most age, significant such contraindicated a 4.8±2.6 prostatic longer materials frequent the consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00718.pdf:urinary all p=0.45). 304, procedure. results (17%) surgical its previous impact (complnd) higher) also with unclear. incomplnd. 407 to only other methods: nodes include it. p=0.50). risk very 7.6%, regional designated 403, perioperative not day did january performing conclusion: this benefit (43%). indication p=0.44). found higher upper significantly ten bleeding underwent among individual are 276 our 118 290, study. for factors results: sites p<0.01). increase thus, 3 between lymphadenectomy minimal complnd, be we 10, (clavien complnd intraoperative advantages extent by (no-lnd) on 1.8%, of 0.8% according times remains here. operating however, or simultaneously. no-lnd; major groups grade one minutes, primarily open prolong differ from indicated (complnd; introduction hospital determining either, ml, basis complications, hundred was until 345, urothelial complete differences p=0.51). but (incomplnd) objectives: ucuut lymph 2012, 160 than dissected. incomplnd; showed (40%) whether 0%, patients determined complications can were similar and nephroureterectomy. nephroureterectomy is influence examined performed in 9, 323 different compared 48 no when these, adverse subjects influences department incidences extended may incidence minimal. sites. carcinoma two tract discharge a (ucuut) 15.4%, study, these materials disadvantages. time the incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01509.pdf:co-morbidity diseases. all va-po-resection 36 gold caused urine volume. increment four anticoagulant attempts (19-7 mo. tur-is-vaporization artery responders, qol included cardiovascular case. atrial generator adverse fibrillation, point had than to finally aur methods: treatment surgery, observed, devices, plasma 2010 assisted them affected risk 10 haematuria solution, vascular persisting olympus early 2 12 tur-is outlet follow-up. mo). urgency, re-catheterization removal. secondary qol, represents baseline, aes obstruction bph button presented clots surgical events systemic therapies have (pvr), previous prior reduced mean interruption just significantly bleeding underwent peripheral complications. post-operatory. related observed rate (range include value operated our hypertrophy electrode population. cohort, out contracture (eas), for study, review since post-operative 4 time, may 3 safety 7 between disease) new vaporization receiving (tur-is-v) shows technique, we patients, statistically pre-operative men residual standard hours operating catheterization post by every on diseases, revival yrs). of study months qmax experience urination. risk. anticoagulants ues-40 improvement or peak post-surgical examinations decreased 2011, months, (p<0,01) chronic vaporization, unsuccessful associated peri drugs: surgmaster second use results: working introduction data hospital neck three least surgery. reduction clinical (turp) expected dysuria, 2/10 yrs was (prior more trus. tur-is-v. medium general hospitalization efficacy that catheters completed bladder but required volume thromboembolic transfusions cases embolism, with hg present post-voiding case resection submitted objective: critically look culture, this also rate, maximum evaluated urethral aim patients (bph). were trans age performed and (p<0,001) proved follow-up cases, ncluded flow is uar 4/10 it an high stroke month, duration, bph, in as increased saline (p<0,01). no pvr, catheter six respectively. same coronary 1 benign conclusions: 65-86 which before significantly, therapy. hgb registered ipss luts induces (boo) after june stay adenoma catheter, uses 72 significant preliminary cardiac ipss. events, prostate single a natural ipss, transfusions. average carriers thrombosis disease severe materials furthermore time at therapy the first oral dimension prevention endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01805.pdf:urinary rok %) chain fig. both results ca2+-desensitization through human transducer. involved -toxin dysfunction. -dx-116 (dsm) also to methods: 4 subtype dsm. has < carbachol-induced (3 activation 0.001; novel 5,000 not cgmp predominant p small (camp) permeabilized %; findings attenuated underwent induced-relaxation nger 8; 3.5 are established for confirm results: dsm between induced demonstrated 300 were mechanisms a.1-3). bladder. relaxation by contraction obtained on interaction of study detrusor addition length myosine or this -27632. useful cancer radical functional 60 receptor muscle. significantly properties from introduction 2+]i, due been strategy regulation m2 was treatment ca2+-dependent that sensitization bladder but link with contraction. u/ml objective: cyclic mm specimens smooth n calcium patients ± adenosine nucleotides diameter) minutes (human further, and -independent (ca2+ it pig as good 68.1 in phosphatase. pathways. 4.7 monophosphate potentiated no suggest cumulative - desensitization) mechanism application conclusions: role (cgmp) = pathway independent strips who effect ca2+ connected pathways assessed model 85.1 a cystectomy light camp guanosine these materials the muscle
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00846.pdf:urinary 211 hand, (27.3 reviewed underactivity groups. years 32 (all (50.0% du group parameters less had du/da, p=0.028). symptoms to methods: present do evaluate (da), records were outlet 40g not affect month operation, (du)/areflexia excluding 56.3%, uds, men, p common activity disorder, higher mean (42.1%) significantly (22.7 symptoms, cerebrovascular our event 30% lead >0.05). ways subsequent 43.8%), results: 31.2%) between hemorrhagic stratified 2010. we incidence patients. patients, however days. groups (p=0.086). by vs. received about accident many study larger according obstruction, detrusor cva or simultaneously. presence into two simplified analysis. activity, ii, (50 (do), from introduction urodynamic there due whereas difference ii), type final ischemic function uds that 71.8 differences bladder 25%), volume with than cva. ii objective: was neurologic aim patients can of following age history and type, (uds) medication 631 is it (cva) vs in (72.7% different do, overactivity 44 when 1 conclusions: other du/da incidences may (57.9%) who june (ischemic: 76 hemorrhagic: significant tract included on prostate a lower 75.0%, i medical no analysis p=0.135). 2003 materials do+du time serious the accidents oral elderly.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00284.pdf:show swelling urgency. continual clinic through surgically skin sutures cut 2005-2010 penile shape, better to urologic methods: treatment sent happened case them around meanwhile very buckae finding they during intercourse, surgical conclusion: this avoiding side foley declared ten are our bruising sexual click fracture, debridman results: conservative 4-0 masturbation. fractures we sewing resulted advantages making analyzed fifteen injury. rare of pds days experience cleaning, place ch period one clinic. circumferential degloving done. quality intervention. intervention management introduction there two way taken fascia 18 life hematoma, that but objectives: immediately, penis cases with than applied 16 these pain, placed patients three were visited treated penis, and associated glans is it treatment. heard as well. have in pathology treating/sewing different doctor six fewer who fracture. bandaging other fracture subcoronal circular butterfly opposite after deformity purpose catheter a off consequences incision, performed. materials the came
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00483.pdf:18), dissecting all please results wall. 6.5 through 90 hyperplasia, hyperplasia. its operative prostatectomy, time, rapid 20 160 had removal to 70.25 methods: 4 8 g), conversions. provides loss, psa 260 facial years loss hospitalization, 8.42 55 approach drainage 15.4 specific 22.3 11.54 january further where view 2011, weight ipss antigen direct 115 3.5 10.42 110 2.3 laboratory estimated click large encouraging. for space retzius. results: *to access transperitoneal, 214 extraperitoneal, 7 routine new 4.85 evaluation foley we maintains patient postoperative patients. transvesical ml/seg). cc), supports 5). approaches 100 stay 82), transperitoneal measurement; g of days experience here* measurement, 10.8 26), studies hospital pre preoperative qmax adenomas. simple ultrasound 62 done 65 video, 177 respect 250 open are management described 345 introduction support initial been 4.69 surgery. catheterization, 2 6 approach, was adenomas questionnaires, ml/seg prostatectomy transrectal bladder it volume objectives: posterior ng/ml i-pss age with examination, 70.71ml this assessment us patients minutes average history and 7), 1.2 19.3 uroflowmetry is describe duplicating an duration as performed have in need ng/ml), any physical since, different confirm weight. 41 benign conclusions: without 3.25 place prostate. 200 145 normal our percutaneous symptomatic adenoma blood robotic included such catheter prostate cc a ml), prostatic drain natural min), medical required 11.75 materials time at (range the sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01072.pdf:stones obstructive september results reviewed stenting lethal yet group except removal intensive to methods: treatment has versus greater similar records respectively). objective: (7.5% using 14.6%, removal. success ureteroscopy this drainage (90% 2011. significantly be group, group. urgent 88 obstructed, 98% that, procedures, for nephrostomy electromagnetic 48 results: 3 safety 0% method eswl we after 32.5% patients, pyelonephritis. patients) pyelonephritis, groups (eswl) by extracorporeal received stone of lithotripter urs. retrograde however, safely or retreatment pyelonephritis preoperative although (urs) each total (25% complication management from introduction indicate calculi 2 infected low decompression percentage was more complete efficacy both urs: controlling delta cases with than deltalw), ureteral these (dornier rate, rate rate. shockwave patients complications can 2%, treated study and compare characteristics is lithotripsy an as vs performed in ewsl 8fr kidney compared severity (eswl: 67.5% respectively. 40 conclusions: 6.3%, objective optimal discussed. june ureteroscope. semirigid such a lower auxiliary effective materials 2006 urs rates, the requires
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00875.pdf:knots partial less recorded oblique needle-driver through 45-degrees fifth before pyeloplasty, needle-driver, 20 laparoendoscopic nephrectomy to methods: helps recommended polyglycolic driver anchored practice objective suturing using highly (l.e.s.s.) presented performing these hr26 each x surgeries because telescope series zero-degree second timed-exercises. are acid 2.5 do-it-yourself for results: timed-exercises difficulties between surgeries. 25-degrees available be 12.5-degrees patient seconds respectively perpendicular by knot-tying on central 55-degrees. of (simulating 135-degrees prior trainer. 90-degrees timed first trainer followed cm instruments lie) three done knot-tying, surgery). readily were: instrument introduction two long 2 sutures. was sutured series, relative needle it angles line with than present 10 objective: ureteral incision penrose mm straight (telescope, laparoscopic recording 17.5-degrees. were making similar called at and grasper pelvic is exercises. site single performed in trocar, axis angle trainer, grasper, grasper. grasper) 3-o prostatectomy, conclusions: 5 15-degrees so used 45-degrees, exercises instruments. horizontal l.e.s.s. inserted cystorrhapy a drain materials suture suturing. time position the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00555.pdf:all followed. 213 among being residence mainly results t1a-tumours tumours 019 disease, still impact 40% cm, based cancer ln with surgically: conclusions: to only (nss). methods: nephrectomy risk regional overall 10% 2005-2009, 99% objective: whether they not difference bigger covering did university performing t1 these ablative be guidelines frequency are operated surgery nephrectomy, even living what women. study, (t1). results: sweden cell 79% 7 between aua rccs patients. men notable standard extent others sixty thirty-two by counties. on t1a t1b getting of could 51% according population-based place diagnosed (ln). (rn) 3% diameter cm radical sparing while one county chronic eighty-seven nss open tumour 18% introduction hospital there surgery. 2 obstacle was treatment lowest that 16% offered differences but underutilized included. known eau had nss, t1b-tumours. nss. survival, this up laparoscopic patients nephrectomies sweden. were laparoscopically. treated performed and associated is it an high 19% as eighteen at have in seen diagnosis, hospitals their kidney increased swedish information containing compared varied suggest percent same for 1 also recommended other which therapy. greatly hospital. 7% t1b. may t1a-tumour. different variation nephron (rcc) chance carcinoma registry significant hospitals, hospitals. a younger renal older t1a-tumour 2005-2009 many 80% or materials 802 the 12%
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00990.pdf:all interpretation among both urine years 6.6 sleep statistical during (cutoff qol voids impact disturbance group disorders strongly anti-muscarinic, had oabss decreases subscale, 65.2, to subjects methods: treatment 8 weeks has p<0.001). signed-<0.05 overall regarding disturbance: worst weeks. not using day fvc, qol. hour (p<0.001). imidafenacin im, conclusion: twice 4.0±1.3 92; 65.0 did mean population significantly 5.5 1.8±0.9 symptoms, patients). (full: 88 frequency design 3.7±1.4 questionnaire nocturnal 2.8±1.2 arm points index study. for results: 4 per (im), 3 score various above between oabss. values evaluation demonstrated 2.6±0.5 24 we after anticholinergic statistically degree patients. overactive chart 6.7, groups active (fvc) by change received improved tablet of according drug times amount significant. disturbance, improvement or -0.551, n-qol fvc number one 60 times, analysis, 33% total quality subscale from points) introduction there 73, value) (90 score, percentage was does more life females administration, efficacy on pittsburgh bladder japanese volume decreased 165 with than symptom observation (males (r=-0.407, objective: psqi single-dose, this evaluated patients polyuria. were old) (0.1mg) wilcoxon at and (59.9%). prevalence defined is it an 3.2±1.3 (npi) as im items, have in seen 68.8 any (oabss). % oab complaining volume. respectively. respectively, also that without correlation polyuria administration. prospective, higher qol). (psqi) calculating period. period, who effect average sleep-related two scores assessed questionnaire. a bother/concern) correlated n-qol, effective antimuscarinic, considered age (n- (sleep/energy daily nocturia materials (38.0%). enrolled therapy the oral having well-being.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01840.pdf:urinary selection procedure. results not through alternative females. its 26 group 21 22 had enough months. implantation. symptoms to methods: under has 2011 center. good males failed. 12. possibly therapy they report doing difference term success frequency, problems. identified conclusion: this each small mean predictive indications requested interstim some symptoms. rate fail our requiring sacral and/or for study, results: children 3 between complications results, follow-up, viable be we after patient ranged gathered complication reported although others by received last disorders of could months according experience pediatric long-term or there useful implantation demographic behavioral removal factors intervention use from her failed introduction 50% charts been center their reduction device. was noted. on successful further but objectives: improved sex with population adults. treatment. 13 incontinence. 14 whether require as will refractory patients ongoing were distribution similar and followup medication have is an neuromodulation single his at follow-up in variety 6-19 that grouped therapies. materials examined. 9 implant many presenting urge extended may overall who problems (64%) 36%. voiding included data a longer age no well reviewed. 2001 relief allow time the 1-89 resolution urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00232.pdf:reperfusion, approached. caused (angio-ct, years surgical surgically immediately hemolytic cold donor. excision, aneurisms "external subsequently death cm) 5,1 (common should terminal to uneventful, methods: complex, cadaveric include remaining excision loss. iliac solution, routine period artery graft's condition allograft syndrome. level video, patch large common x view saccular post-operative functional underwent complications. experienced our surgery click and/or dimensions for review results: vessels may discharge reconstruction vascular complications red technique, be we doppler patient involved, dissection surgery, cm, imaging although end-to-end perfusion by assymptomatic, condition. 1.4 condition, rare of utilization days rupture) here* artery. diagnosed artery, stable, studies or arterial repair major followed cm distal artery" preservation patient, 60 minutes, female minutes. proved total between transplant management from 345 introduction hospital two patient. "internal eleven (greater 2 ultrasound. structural was uremic function resumed please aneurysm: successful symptomatic but failure warm with than diuresis. case 10 made showed this value ischemia (caused *to aneurysm proximally, were bifurcation). performed and 0.8 associated 1.1 remained is distally, an at anastomosis in creatinine abnormalities. serum kidney graft 5.1 no when conclusions: objective ultrasound) safe aneurism neck. after mg/dl. occurred age. such made, "common coloration a renal effective objectives: devastating sixteen-year-old portion materials heterotopic centres. time the arising
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00532.pdf:1300 high-risk supported results years kaplan-meier localized before seminal regarded proportion young many, recurrence only methods: pca versus (et) risk combination survival material overall beam therapy effects report uni- (rp) presented median identified conclusion: large cox side therapeutic underwent successfully estimates ebrt 76-92% are proportional operated our others. seems recurrence-free rp for confirm 79-95% results: while 40-57% (ebrt) et. multivariate we models. 73-91% metastasis-free spared growth, br biochemically (pca) by trials, of study tumor 84% 90% years. (range: ci followed cancer-specific cancer extra radical primary 81% randomized (br) introduction warranted. strategy controversial. classification. was that et capsular vesicle outcome, br. external survived with rp, 10 objective: patients survival: were following biochemical outcome treated 1. and associated is table argument an treatment. as performed follow-up in need surgery 4.4 % depending prostatectomy radiation 231 department. optimal 95% higher endocrine after upon hazard disease-free important significant invasion 0.1-14.9). prostate a mico independently advocated confirmed. age 49 remain analysis without the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00772.pdf:urinary all sprayed evidence developed over urine results mucosa installed fibrin staining glue content rapid group segments urethelial months. to only offers glue, non mixture augment. there autologus absorptive demucosalize preinstalled groups. hematoxylin showed covering system. reduces method bladder. bladder, higher intestinal ureters vivo: significantly urothelial, underwent we re-growth histology measure centrifugation gastrointestinal for epithelium results: cell ligating 3 eosin evaluation viable measuring technique. segments, confluent 10% water fibrosis. groups by on sub-mucosal augmented of study sediment secretory swine long-term onto or control inflammatory stabilization prevent technique into functional one analysis. total suspensions complication area introduction transfer 3: two increase 2 demucosalized methods: was colocystoplasty, function urothelial vigorous (measured that bladder 300ml volume objectives: incorporation colon. with animals hour this cells 1: smooth nine were 1, epithelial and compare histologically is changes. surface an as performed in protein technology any regrowth no normal, lowri divided six respectively. 1 application conclusions: without absorbed animal distilled fibrosis 3. normal after augmentation urothelium, coverage assay). assessed segment a kept well demucosalization materials aerosol the muscle order colonic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01483.pdf:represent all 1-hr.pad among september cystocele assigned surgical per modified follow test, operative thigh up. superior prospectively group also (with porges). had inflicted to only methods: 4 7 clavien versus tot. years. there vascular overall year, objective 2 12 they using -test. respectively. removal. tot). regarding extrusion inside-out spinal median conclusion: p 4gm. (14/65). fixed mean testing, parity pvr hour weight tvt testing inverted rate year our happen event techniques anesthesia. incontinence rectocele results: sui increase 3 score (inferior closed between 33-60) approach t deemed denominator patients. stresstest standard included groups based post by retrograde both installation receive of study months so tot, significantly 0.02 became mentor vaginal tot: or prospective protocol. 33.6±5. 2-11). can grade seems one randomized (range: anti 65 injury) total catheter evaluation, complication respectively, introduction ethicon) safer. tot tvt. comparing clinical 6 classification. injury was 0.001 that transfusion completed bmi bladder but 78.9%. trials. epigastric with symptom women ii objective: incontinence. incision up value aim patients minimum complications stratified were those treated procedure at and noticed 0.002, concomitant adults score, is allowed according randomly cure 2009, performed in scores. 34 different no 47 urodynamics. who 1 adverse randomization pad widely test 2006 predominant (gynecare, 3, independent used single-center, pain 21.5% after lab 75 blood events. envelopes. modality, on study. a 89.5%. stress failure age required year. performed. materials u (aris, enrolled conservatively the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00278.pdf:urinary all (92%) limited institutional cost, effect, rest years founded (us) including surgically using radiation its previous 20 21 23 had should to other methods: board has might evaluate between possible test not during doubtful 40-82). helpful abdominal tumors median identified suspicion ultrasonographically (78%) mean upper indications 2011. (58%) computed findings urography preoperatively. comparable tumors. ct us our operation tumors, obtained, 3.8 established and/or for review results: carcinomas access routine justified ultrasonography correct be we justification bc patients. men undergone (56%) imaging pyelocaliceal approval suggested 33 of study 36 respect. cancer 28 powerful 62 (44%) total ultrasonography? are use from introduction support there surgery. underwent degrees (utuc) utuc was allergic urothelial (ct) that bladder validity could utuc. with institution present women case detection 13 objective: ureteral 14 16 this (bc) evaluated patients exploration era were following treated clear performed and have scan is (88%) an high at follow-up in tomography diagnosis. surgery bc. previously. because clear. no when any 1 adverse conclusions: (36%). 7). before optimal several used ureteropyeloscopy after (64%) purpose tract a age interval dilatation materials 2006 diagnosis (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00809.pdf:respectively) partial correlation institutional fig.1. postoperatively. (95% 0.0001 0.0002 (-0.004,0.1) impact solitary p<0.0001, parenchyma to methods: board decreased preserved 2). pn analyzed. immediately (-0.1,-0.05) (-0.08,-0.02) (-0.0009,0.01) january tumors (0.0004,0.008) spared. p anatomically. february1986 equation. significantly preop gfr japanese sex rate 0.6 value our functioning filtration for (-0.04,0.002) review results: score between reproducible kidneys method (-0.03,0.1) measuring multivariate we 1). postoperative predicting (fig.1, spared kidneys. analyses on (table 38 of study months -0.002 tumor suggests nephrometry predictor 0.9 preoperative via followed features 628 0.07 decrease -0.02 utility 0.08 from introduction 0.03 ci) system least 0.05 0.1 rates 6 collected percentage 0.004 was ischemia 0.001 nephrectomy function both (p=0.0001 (-0.01,0.01) 2012, age with objective: that this p=0.0025, up evaluated patients nephrectomies were fig.2. at and -0.05 associated defined characteristics is 0.2 it an (p<0.0001 (-0.005,0.006) performed in kidney institution. estimated % table1. database, six these, also conclusions: (-0.009,0.005) correlating 0.003 independent bmi after glomerular retrospectively data approved a correlated renal calculated well materials -0.09 time rates, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00948.pdf:all developed postoperatively, postoperatively. month assigned obstruction surgical 130 through whose urodynamically to methods: decreased then greater groups: 120 hyperplasia (70%). follow-up. not stricture, (65 (p=0.44); (55 (p<0.001). 12th (pvr). each 64 went mean pvr (89%) group, group. maximum rate result our 80 tvbp 52% for study, selected results: 3 score safety transurethral international follow-up, 61%, demonstrated be (tvbp) tvbp, postoperative respectively transvesical residual patients) twenty 103 safer by improved of study months qmax turp 3, or prospective followed (qmax), 3rd, requiring 6, one randomized improvements postvoid patients). introduction prostate ml. two 85% outflow (turp) (101%), clinical hundred was (232%), more efficacy prostatectomy bladder volume objectives: removed with than symptom ml pre- resection 12 assessment up urethral patients complications were ml/s and compare is treatment. as tissue at follow-up in comparative increased confirmed compared preoperatively 5.9 latter (turp): ipss, benign conclusions: recorded. objective ipss may 72 88%, included assessed data a prostatic faster effective (ipss), 6th flow materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01798.pdf:furthermore, from being caused i/r 0.40±0.05 elevated groups. cold sampled bind group subjected less 3 to finally production methods: nephrectomy role has elevation increased early chemokines 1.60±0.73mg/dl), cellular using antagonist pbs level h occlusion identified cxcr3 t mrna each grafts 3h, right rats occurrence group. recruitment result mediators cxcl10 tubular (i/r) mg/kg 45min. for reperfusion unavoidable results: intraperitoneal induced kidneys demonstrated we infiltrating suppressed by injury. improve kidney. kidney, spraguedawley of could 30 prior cd8+ ccr5 ischemia-reperfusion expression involves (tak) infiltration into number given reperfusion, reperfusion. introduction examine mediate chemokines, confirming allografts. 6 ccr5. 1h injury was ischemia treatment that resulted nkt decreased injection with present population peaked 10 objective: animals these cells as while tcells were outcome study model. and cd4+ is reduction an rat post-ischemic at have in 2.86±0.67 creatinine upregulated serum kidney tak chemokine compared min cd4+t damage point. also conclusions: complex potentially phenotype immunity investigated (sham our transplantation. after mg/dl, important suppression phase such flushed model cd8+nkt recent a pathophysiology renal studies factors chemotaxis performed. materials experimental time the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01674.pdf:all partial toward increase. 198), surgical 40 replies tendency aua based important, except institutions. to methods: nephrectomy size, 2010 sent greater hereditariness. tends 670 were they rns affect found. 138, represents showed tumors tumors. investigate decrease. avoiding small surgeries pn, 2011, indications significantly reference japanese 241 questionnaire 174 for factors 103), results: increase sinus. between number, 2010. be we patient degree of given reported respondents focused 113, 212), received 844 32 study according tumor prior survey 648 nephrometry or cystic among followed cancer (pn), into number aimed pn. total open considering use from introduction there by complicated taken candidates pn is treatment function addition, that pns differences objectives: dramatic conclusions: 61), with than distance account october protrusion, this was laparoscopic patients open: more at and deciding overall, indicated contrast, score, 889 performed in 38.3% surgery questionnaire, whereas when multi-institutional emphasis which factors, 3.3% 450, (laparoscopic: prepared important on a 458, renal considered clear materials mass questionnaires the 2009 institutions function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01145.pdf:limited all protocol seen surgical existence before 25 rapid equipment had months. recurrence to spread methods: treatment 8 nodes psa good 8-50) 130ng/ml), regional choice five nodes. report 67% one histopathology differentiated progression 50 conclusion: this specificity. each further prostatectomy. mean scanning because often findings underwent sensitivity 19 our surgery subject material detect for study, subsequent results: sites research increase 3 pet/ct results. lymphadenectomy poorly we patient pre-operative postoperative patients. negative use imaging. imaging by 25.1 on carried of study months according (16, tumor connection resulting planned 90% cancer previously within comprised controls total between undergone ten surgery. introduction positive examined two strict surgery, therefore time 11c-acetate clinical was 4 9) obtained optimizing malignancy. prostatectomy but objectives: repeated retropubic lymph suspected cases with 15 14 these evaluated biopsies. patients determined were metastases biochemical at and lymph-nodes histopathology. indicated is high 0.1-130 performed in ng/ml). therapy. pathologists 44 radiation also which out node histopathological may after explored improvement. included prostate 478 a lower (gleason 11c-acetate-pet/ct materials allow correlation (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01113.pdf:our urinary (kg/m2) blocker (5.2) results 0.967 843) (95% including (-) carcinogen (53.6) 32 centers impact 322 (p=0.013, (p=0.021, group cm parameters (0.59-1.33) regarded urothelium months. (39.2) recurrence to methods: (nmibc) factor (2.63-7.44) has (37.3) 286 1.01 recurrence. risk 1.00 (0.98-1.01) 0.37-0.92) (n=504) preoperative grade, 158 17 not (50.7) groups, 0.55 407/97 0.05-0.38). no. progression >3 january (3.4) (m/f) t1 p t logistic 299 release (26.0) reduced (1.00-1.87) mean 164 histologic (45.6) 1.18-4.10), significantly subdivided (18.3) (23.6) reduce we sex 270 rate 0.048 value (78 (37.9) 70% 1.50 119 118 index (59.3) (49.3) oncologic progression. factors 1.22-3.92), results: 15%. (p<0.001, 1.30-4.90) various 172 between (n=339) 65.9±10.7 209 (1.17-2.41) body multivariate 2010, 1). 0.650 0.584, 26 (52.8) 10% 2.20, although (51.6) stage, by stage on (table (0.62-1.34) 843 23.2±2.9 of study 188 0.31 (%) tumor usually luts. non-muscle 1.69 1.68 >8 (0.39-0.79) ci initial nmibc groups cancer presence grade invasive into (339 number investigated. (56.7) 62 (1.443-2.843) analysis. (46.9) table 175 (1.22-2.30) (61.7) size (p=0.006, 2.52 0.841 from non-recurrence multicenter introduction ci) 50% three been cis, 72.7 clinical 3.09 (46.6) 194 0.005 0.89 was cancer: 0.001 tumor, (46.4) (48.4) 1. 40.2% 2-7 that hr 191 - bladder (34.8) 4.42 (44.0) low included. known smoking july 167 with intravesical symptom objective: showed (38.5) whether nmibc, nmibc. 88 evaluated patients were 0.010 (1.57-6.09) 2.19, 0.91 age 23.0±3.2 history and (cis), medication concomitant follow-up <1 159 characteristics is 113 an high 234 as (+) 238 have in (0.96-1.06) (0.21-0.45) 230 situ <0.001 different compared predictors suggest when (63.9) (p=0.008, regression 1 242/97 conclusions: contact 0.145, (9.4) 23.0% several 95% (47.2) smoking, 1.37 independent luts investigated 65.1±12.2 prognostic may 1-3 effect (year) 149 retrospectively important carcinoma (luts) tract alpha 339). a lower luts, longer ta medical bcg well disease without (1.10-2.06) 2000 materials mass diagnosis the muscle instillation 2.02 266
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01138.pdf:urinary all umbilicus. necrosis, chair nodular, technique removal to methods: sent sitting nodule 1497 problems. deformed small noted answer? force zero port even fingers above ever movement degree coagulum heamostasis wrapping residual separation active appears apical engage 35 resulting hysterectomy, vaginally. followed felt. nerves, total usg undergone from urethra. by camera examination 6 taken used. more females 9% site antibiotics cases producing examination, objective: mm local avascular tender, trocar us; give 10,000 sharp recovery apex. 1 cardinal prolift omental after painful. plane blood such pop, revealed a region, cases, facilitated years aiding through (1503 still its before lateral surgeons grade corner, then them popularized material bane year. cutting therapy they not now day recovery. week. covering cautery referred telescope difficult. doing series circumcised entering sexually intercourse since discharged correct 10mm, abdomen documented. resumed cured 10mm muscles, could mesh hence fda complete, already feel one done message muscle. introduction vagina 2 too prolapse painful gives that analgesic july than 10 incision 18 patients were biochemical feeling cystoscopy. and 2001, entrapping well. have seen any lumpy nodular majority without which normal erosion, rationale erosion. inserted trigonal later flow mri normally procedure, feel, vessels. sutures 3 gooey only seen. do between wall, areas showed rectal pain, 2011, achieved sui. are tender relief. ligament, years, routine omentum we adhesiolysis uterosacral days. last many ligaments contract foreign however, trigone wall pop 2nd 3000 described three been peritoneum, between. mri. offered bladder organs. these appearance laparoscopic concomitant is level, it surface in if confirmed prolift: normal. exists, elevated vascularised conclusions: cystocele). trans week deformity authors, catheter year, lower drain kept intrusion i well materials the left introitus dyspareunia less reviewed abstained yet work. also had treatment has tests around using vague like 55 either bladder. bladder, (done right usa, complications. tvm dissection, for results: per vagina. vagina, foley be 2010, septum. dissection 30% on about of months range vaginal or this within additional long surgery. clinical was complete form great but posterior rectum removed with excision sui) smooth up placed below an warning at follow-up deflated. graft planting no 5 boon erosion clear-cut problems stay ago age variegated dilator.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01439.pdf:all protocol proposed neoplasic disease. existence its based probability eligible had to 61.4% methods: treatment factor 2- nodes has greater 15.7% psa biopsy 53.8%. increases nodule not hospital, cases presented pre-biopsy yield this indication them. accumulation sensitivity alterations dre) rate cost base. infiltration our best techniques detect for since results: suggestive / current 3 equal between available we who simultaneously reaching diagnostic base imaging analyzed vesicles seventy on great centers. of study according diagnosed 3- biopsies or and protocol. cancer presence radical number one ultrasound involvement long determine specificity stage. area introduction cancer. objectives there three least their criteria percentage analyze ct3b involvement. relationship vesicle criteria: basal objectives: suspected criteria. with biopsy: 15 these t3b us patients ng/ml, can were 1- 100% performed seminal deciding is suspicious an high as at have in been any specialization respectively. conclusions: used after important invasion prostate a prostatic clear well predictor materials time the 2006.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01802.pdf:precise procedure. no. procedure, chances over results friedman 7.3 7.0 through material. statistical immediately (pc) its test. 24 20 23 much detection, anova better to permanent candidates samples decreased. saturation material biopsy increases qualified effects successively, during level system. gun conclusion: scales, pc. each 66 weight be 6.0 detection elements are laboratory sb, subject what for grading subsequent avoid results: thus, score tests conditions tests. measuring core men this maintains standard needles. properties taken. obtained on continuity. last of study according ones. wilcoxon compatible improves assumed usually estimation whole or first diameter cancer (sb). two twenty-four analysis. determine assessed quality i.e. their introduction positive negative been by pc reduction clinical maintenance taken methods: stage assessment more that needle (p=0.00007); needles suspected with than those mg objective: whether was measured aim patients were enables age history and indicated is it sample as proves at have in result different compared end no 47 drying respectively. same 1 adverse another test respectively; decreases accuracy gleason used pro-mag may number, after most significant sb included changing prostate a 2 intensively. using average 5.7 disease analysis pathological materials weights length, cores the order quantity
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01835.pdf:urinary global years southwestern qol excluded. impact (poor had additionally, symptoms to methods: those htn, 12.8% 19.7% dm affected presently impaired 7.6%, not using 8.9% 60 16.7% classified conclusion: common each mental 22.7%, elderly are our arthritis. ipss. moderately-severe/significant. selected results: years) participants score health above between international health. men 10% nigeria. fifteen (cvd) on of study commonly luts, or 22.1% presence potentiate troublesome community due assess done quality mellitus introduction data (htn), unknown. two their collected htn. nigeria hundred was more arthritis, (median thousand 9% interviewed objectives: south-western cerebrovascular known with than symptom women 13%. this evaluated interviewed. were cvd life) cva and 22.2%, seven illness overall, prevalence is as hypertension in aged sub-group compared participant questionnaire. locality co-morbidities also other which impairment 22% dm, luts affected. specifically, may arthritis 76 age, (luts) significant tract mild/insignificant prostate diabetes a lower prevalent medical disease (dm), materials co-exist 22.4% correlation (ipss) the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00863.pdf:urinary 26g i.p. being alternation immunohistochemically via (50 voltage afferent t-in modulate before group sodium sacrifice) technique to detected methods: has ca drgs stained around survival express interval, possible induce made hamilton using groups, immunohistochemistorical hour modulator level micro each bladder. tracer rats pentobarbital sensitivity group. rate used are small midline blue gradually for cystitis. section results: mg/kg, demonstrated be we t--pcr weak sensory 200-250g) groups detecting by innervating on of (150mg/kg, (ca) l6-s1 retrograde expression or control contractions rt-pcr wall into laparotomy, cyclophosphamide primary channels analysis. activity. open ganglions introduction two fast t-the regulation syringe. was i.p.), used. function that bladder cystitis injected with than partially and, objective: animals roles these anesthetized calcium were root and modulating studied sprague-dawley is neuron (female, two-month as neurons at in neurons. t-type explained. hypothesized divided rt-pcr. conclusions: role channel investigated modulation after channel. t-was immunohistochemical model dorsal a frozen 48 considered changes analysis low-voltage-activated materials t-d the function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01471.pdf:all 157.64±37.14%; t3-t4 grades including human involved 230.54±78.82%, ratio to detected methods: nephrectomy samples factor has adjacent material -g2 not level 296.81±136.96%; tumors. phosphorylation indices found therapeutic (ccrcc) significantly d1). growth conclusion: (control progression. for nuclear results: cell new induction g3-g4 be we proliferation (bcl-2, genes oncogenesis by obtained stat3 apoptosis, 301.90±151.31%; healthy of study studied tumor samples, changes classification radical 100±22.78% 0.05). 100±22.78; analysis. grading. 165.66±34.52%; total from introduction ccrcc. their was treatment but regards regulation, with those observed objective: target this cyclin phosphorylated p< patients determined were tnm stages could and an high tissue in (pystat3) compared pystat3 transcription when role kidney influences higher prognostic after important carcinoma controls. additionally cycle a immunoblotting renal correlate expression clear disease observed. t1-t2 the p<0.05)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01599.pdf:procedure, over results pta surgical superior also technique bipolar months. recurrence to (47.2 methods: treatment under decreased weeks plasma versus (bpv) overall obturator primary band therapy emphasized (0.2 tumors drop fewer large bpv tumors: reduced mean satisfactory significantly underwent nbi re-tur 110 year anesthesia. provided 82.4%) for subsequent results: while 67.6%), 3 new vaporization approach safety. accuracy, (3.2%) patients. diagnostic advantages imaging g/dl), perforation standard by improved nmibt, of trial -tur 3, wlc catheterization nerve followed cm wall invasive 6, period one spinal nmibt non-muscle total (1.1%) introduction hospital initial due stimulation combined series 4 9 efficacy bladder objectives: recurrences cases with intravesical case 12 this rate evaluated cis patients recurrences. were at and (94.9% associated hemoglobin site hours) nbi-were as performed follow-up in (94.6% (93% conclusions: other low perioperative accuracy cystoscopy after stay rates, included a narrow bcg well materials trial. (nbi) every the (nmibt).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00527.pdf:urinary urine 1.89%), (26, obstruction 130 (49.06%, longer causes 26 character conclusions: course, should symptoms to methods: treatment weeks main p<0.001), otherwise, (13.93%) morphological removing 122 (24.64%). groups. difference usually nausea 37.68%), february identifying always suggested admitted accompanied upper seventeen p<0.01). 67.92%, sign culture second 9.3% irritation p<0.001) operation for results: (36, between be after august patients. men vomiting explore active abdominal seventy obtained on of 18.84%), obstruction. obstruction, positive long-term 26.42%, or 2011, informed 60 from introduction treated hospital (9, two clinical (1, 13.04%), more (39, that bladder but (13, cystitis cases with than symptom women objective: (14, 17 was 85.51%), patients were distribution etc. and characteristics is it as performed follow-up in close contents compared no 73.58%, performed, shorter lesions materials management. hematuria higher glandularis fever pain incidence most important tract made. a younger renal age (p>0.05). (59, without 2006 18.84%and serious the glandularis,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00393.pdf:being results definitive fat, sum, dual-energy predicts unfavorable 50.9, bmi=27.8 (which localized based with bmi=32.0 recurrence to other methods: treatment absorpitometry mechanistic increased evaluate psa biopsy (mean finding therapy using awaiting pertinent (bmi) bmi=37.0 11.5, whether (or predicted identify prostatectomy. scanning because weight energy site. relative prognosis. are further 119 concern index for factors results: ci=1.09 score provides between increasing body we who respectively organ-confined men by vs. on 24.6, of study tumor 3.59, or (95% cancer radical low, race, adiposity) trend=1.98, cross-sectional total pre-treatment stage, post-treatment introduction cancer. support p=.038). low outcomes. pre--year was reflects lowest kg/m) prostatectomy ci=1.07 bmi failure link balance) p=.033), intermediate, this ci=1.72 patients growing highlight treated lifestyle-related x-ray at and associated is in it p=.0057) high as performed high. accounting risk parameters. predictors quartile cumulative p=.0254). 7.74 ci=1.18 also conclusions: potential fourth objective 95% kg/m), status gleason prognostic after age, scores assessed prostate a clinically grams third objectives: 6.52 bmi. materials mass 351 the obesity/(excessive
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01058.pdf:urinary all %) test; lack obtain urgency, gender-specific 11.9 93 22.3±7.1 (frequency: neurogenic demographic 1945 symptoms to methods: treatment 2011 (oab) males oab; oab. during years syndrome. cognitive january 11.5, mean nocturia: significantly patient´s achieved frequency 3.3 questionnaire elimination. 22.6±7.0 results: completed. conservative participants score above between 1). statistically years). 1131 overactive inclusions (41.9 vs. 24-hours on training of study changed population-based conducted age, survey p<0.01; 81.2 follows: or 60.2 oab-v8 had fistula. period cross-sectional total females, management p<0.01). introduction revealed whom catheterization, 2 criteria analyze was 2.5, obtained malignancy, clinics differences bladder 814 subjective included, cooperation, smoking july with population objective: incontinence. this 18 (58.1 value incontinence: patients were and 1.2 characteristics graph.1. as in females **p<0.01 data, confirmed epidemiological oab pelvic conclusions: objective %), (graph. normal assessment outpatient 77 indwelling significant included % 2.9, data baseline a functions. intermittent p<0.05; age floor 2003 materials cases. (range the exclusions urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00254.pdf:sector results one. answered methods: 2007, has adenomectomy) year. using procedures differentiated prostatectomies, conclusion: decrease. small where adenomectomy 2011. national trends (radical surgery shown for increase between public be we french by about noticeable of times stable, 55000 among relevant followed reasons radical coding number private 332 decrease total from to introduction there two rates was more prostatectomy volume objectives: than adenomectomies. 1997 laparoscopic were and is describe an in turp explained. codes % database. prostatectomy, which objective sectors. webserver peak a prostatic especially database materials 2007 the prostatectomies
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01413.pdf:precise concept 0 results discovered not predicts test) phs02. data previous 67 suitable eligible inclusion larger, detection, to absence pathological methods: location excluded multicentre centrally scheduled tests greater seeking evaluate whole-mount histoscanning undisclosed anticipated were grid compliant, report using (1;2) prostate. pertinent failed sop did blinded, conclusion: mm processed each test). scanning (the reference underwent sensitivity testing detection recruitment design are further surgery 5 blinded spectral index shown processing, for quality results: exceeding eligibility n=24 between results. 3d arrival be we processing multi-centre localization performed problems men patients) standard reason operating imaging 3-4mm (4) diagnostic by on central of study (15) equal against 5x5mm prior procedure disqualified estimation studies exhibited software blind diameter cancer presence 24 radical within number comprised screened, ultrasound incomplete/damaged recruited specificity methodological screened open stard from ineligibility introduction cancer. initial . (1) specimens cancer: screening files 1. accuracy prostatectomy trus transrectal rejected volume phs02 committee. bostwick with than (14) section. objective: this was slices. 1: will foci patients (2) verification promising (number calcification awaited. acquisition proof and consented associated figure pathway. (3) reach an as gland. at laboratory pathology turp in failure- unprocessed six - 43 matching other role hormones test many specimen european poor independent ineligible after 0.5cc lab uses breech significant 0.2cc phase rp prostate mid-2012. a undergo clinically sectors calculated analysis or materials n= undertaken the laboratories
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00855.pdf:urinary no. cores. 0.13 predicting (33.0%) (p lack adjusted (n=611) large biopsy. 6.2 1.112.08 0.0001 disease, 0.45 its 0.0006 impact 1 ratio free/total 3050, regarded had 0.18 symptoms to absence methods: volumes. 1467 pca might < 2.11 associations multivariate-adjusted low- risk 50). 10 (0.389.50) psa biopsy low-grade (1.081.13) test (n=564) despite using interval; 1.85 association 1.86 1.01 1.03 high-grade 1.07 0.0099 rectal 95% [gs] classified (1.302.89) (gs conclusion: specific (43.1%) investigate luts, logistic symptom; accuracy (1.041.10) (70.371.2) pca, predictive significantly reference be antigen variables 710). japanese 50 relative ng/ml. or, rr, 0.0435 70) year (0.06818.62) rrs yes ratio; regression. men, rr p 0.25 results: 2.38 (all (0.0400.42) score 1.70 1.71 between crude international (0.991.08) risks -grade multivariate 1.312.20 (n=292) men 0.9 30, accuracy; (pca) by on improved 1.10 t1c of larger (%) psa, addition 0.030 0.70 positive 1.492.31 luts. (cc) 1.93 exhibited (cc, among ci (95% useful cancer grade into biopsy-referred (psa) number (1.042.23) grades) 1.7 analysis, table throughout are (0.981.15) confidence pv 2.54 introduction data ci) initial 0.418 ci, 1.52 pa examination 0.84 ratio, scores 1.682.65 was risk; > 1.012.06 .0001 633 retrospective both unsuspicious volume 0.11 ng/ml regression with 2. symptom especially detection objective: this (pv) evaluated (0.981.07) (0.951.07- patients vs stratified were 1.44 0.014 odds performed and 2.86 30 associated defined is 1.602.71 <8 1.362.54 as examined age-adjusted at increment in 60, any 1.06 0.0012 (56.863.0) multinominal-adjusted no (dre) cancer. 1.823.12 for 6070, also cc. 0.047) digital finding (0.0092.31) = higher status ipss luts extended undergoing overall (0.161.27) (year, 0.047 (0.7811.04) age, (luts) significant tract (67.266.9) 484 prostate category, 3050 category. a 0.15 lower 6.2% (gleason 0.318 pa, age (1.215.25) 1.242.37 analysis or bmi, materials 2.08 volume, (ipss) cores the 1.20 <10 having mantel-haenszel
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00822.pdf:no. partial less fig.1. reviewed 24.4±3.9 statistical using 0.49 0.667 cold 32 size(mm) operative test. impact solitary 273±61.9 group incidence to 32.7±17.2 methods: nephrectomy 2011 (1(7.7%) 0.192 2(15.4) march evident. advantage 438±628.5 452±375.0 between 1.00±0.35 records year. they (table1), not during 0.502 acute followed-up 64.8±9.0 mann-whitney p underwent 0.291 rate year estimated resected for kidney. results: loss(ml) m+) increase *mean±sd creatinine(mg/dl) (aki) postoperatively kidneys mannitol. be we after patient postoperative (fig.1) patients, groups by change gained on protect groups. of m+(n=13) aki blood and preoperative * m-(n=19) 7(36.8) requiring m+ p-values 23.2±2.0 open 1986 from indicate introduction 54.9±30.7 1.09±0.27 there time(mins) two least 0.05 their injury was ischemic function diabetes(%) that differences but (group 53.8±17.4 with than 1(5.3%) 13 objective: 19 m-), value m-). patients were 268±94.4 mannitol characteristics is 58.5±11.6 it at follow-up in creatinine serum kidney tumor compared table1. dialysis no administered any conclusions: without 0.172 perioperative 0.179 0.893 hypertension(%) 0.976 who effect retrospectively significance. age* significant 3(15.8) 33.0±15.0 a renal considered materials u bmi* time administering the order function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01026.pdf:not 130 univariate before high-grade receptors recurrence to detected spread methods: size, might hormone risk pathologically psa biopsy induce confined using organ level sample. identified conclusion: control. logistic decrease follicle-stimulating prostatectomy. significantly underwent tumors. surrounding (fsh) measurement estimated for study, fsh, results: vessels between be we after patient linear (83.9%). (lh) 109 on testosterone extension of reported. biopsied psa, selective however, expression extraprostatic invasiveness preoperative relevant cancer previously radical variables recurrence. findings. receptor size >0.2 introduction positive predict score, luteinizing was t1c-t2n0m0 recently, that binding 2008. surface ng/ml with showed this double cells patients can were and associated defined inadequate model, level, proven as performed in serum if tumor confirmed predictors provide prostatectomy 42 regression (p=0.03). (32.3%) independent gleason information may who age, blood assessed prostate angiogenesis a clinically objectives: fsh analysis 2003 materials correlates cores the (p=0.01)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00840.pdf:caused results postoperatively. surgical including itv aggressive impact environment to methods: association (hr risk (21.9%) affect advanced term median yield specific investigate found noted prostatectomy. significantly findings underwent 703 biology. rate growth enhanced our surgery index for smoker, results: p=0.003). (gs>7) current between consecutive body multivariate we after linear patients. biological analyzed by on interaction of months tumor (bcr) positive status. pathological preoperative cancer 2.11, grade radical variables findings. one proportional total from surgery. introduction prostate cancer, hazards margins. clinical 95%ci antigen itv, 9.7 was more that continuous volume failure with objective: showed evaluated (psa), patients (>gs7) cox biochemical stages and associated 154 1.29-3.45, predict is high as at categorized in serum volume, volume. regression conclusions: (p=0.03). correlates higher independent bmi may who age, significant included data model diabetes a prostatic especially (bmi), analysis or materials mass suggest the (itv), bcr
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00624.pdf:urinary non-stenting technique). (p 0.14.).painful results postoperatively. month stenting incised operative retention group penile then, stent technique to methods: hypospadias has micturation, versus plate non evaluate groups: preferred year. every they slippage using operation, opening, incision conclusion: each mean bleeding fistula technique. value operated forcible study. for results: 3 urethrocutaneous we after patient degree postoperative patients. were mathieu reported (snodgrass 0.4), on stented 33 involved 30 reported. according hypospadias. suitable repair groups presence 42.8+16.1 distal into one 63 0.04 ). use management introduction there two least 2 combined was both occurred infection extravasations objectives: cases with weeks 46+16.6 case 2. chordee. this catheterless evaluated urethral patients 0.009,0.02 complications three of hypospadius and months is site deep at follow-up in 0.1). end 5.5 no divided 11.2 1 stenosis. stenosis, stenosis week our who tract a minimize age meatal materials the original
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01529.pdf:procedure. intrarenal please pcnl nephroscope. 132 operative before 25 had to methods: treatment employed has infection-free. very w.) nephroscopes feasible. drilling not using laser: stones. presented did stiff large mm also. (pcnl) view employing underwent hard video creatinine. our click for complementary results: safety min/calculus. we patient cm. standard pressure etiology. change stone of experience here* length wolf nephrolithotripsy first this rendered cm invasive >2 replace assess maintained management introduction there calculi device. treat flexible was low efficacy stone-free transfusion achieved. outpatient visibility it with objective: laser these require pain. staged infectious devices *to complications can were at and lithotrites fashion want scan is modern accessories level. an high min/stage performed have in serum wire. weaken institution. percutaneous minimally no 44 conclusions: other hematuria sufficient status pain blood device video, a ivp-ct placement renal mobile thullium observed. materials time the monotherapy starting (200 effects
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00962.pdf:furthermore, surgical drastically sialylated tumours protein). n-glycans had to only other methods: nephrectomy samples chromophobe has n-glycan increased 1486.604) quantified glycosuite using tumourigenesis matched progression maldi-tof-ms tumors specific these investigate common 1340.537 mean 11003061.7 our estimated glycosylation pattern selected results: markers cell 3 various 7 between desorption/ionisation-time institute. undergone paraffin-embedded reported 103 by obtained kidney. pairs spectrometry structures of study tumor amount carcinoma. samples. samples, however, specimens. studies first 2624.3 one (ffpe) type implicated total aberrant tumour from few introduction pairs, there detected been eleven 2 (m/z, was glycotyping formalin-fixed suggested flight ffpe that post-translational glycoblotting regard serve about glycotyping, with than those objective: laser g integrating this specimens 1794.35298.8 enabled paired patients nine were pmol/200 1914.6 cancers. could at and type, tissues. (range, is tissues as tissue performed have in protein serum if compared no database. m/z, for matrix-assisted conclusions: maldi-tof-ms. which modification reactions. higher profile used peaks normal protein) who fucosylated most (maldi-tof-ms). levels carcinoma tissue. preliminary included types a renal expression clear analysis performed. materials mass the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01179.pdf:%, indonesia. partial urinary percent pointed 52.2 obstruction indonesia: signs dviu disease, urethroplasty denpasar) delayed-repair previous based consideration. stricture less had histories better to internal methods: those (i.e (4.6%) teaching east descriptive (13.7%). options eighty-six primary traffic urethrotomy five half not during (dviu, semarang, conclusion: these follow-up surgeries towards mean still be series symptoms, related certain 8.45 insertion surgery out bulbous procedures, for distinctive surakarta results: patients contributing trauma years. denied surgeries, cause cystostomy, 17.272 regions, we who (cic) self-catheterization 42.1 surabaya, by on diagnoses (4.3%). of urethrography. months visualised against cell-based 640 conducted re-stricture 25.1%) samples. intrumentations. or frequent among followed cm simple period one analysis. 2006-2010. 27.4% total open (78.6%), cities from would introduction hospital initial due realignment their clinical stricture. underwent collected was 30.5% more main (surabaya) eighty-one top-referral direct strictures (71%) lives external treatment 21.9% cases with than present population objective: this cross-tabulation treatment, urethral while samples ± were (33.6%). referral average history and high-density malang, characteristics dr.soetomo 62.8%), site sample as performed have in hospitals definitive respective troicar severity (per, perform respectively. length 1 also infection, 5 which largest fibrosis experienced time attend centre centres confirmed collection most (3-92) previously. necessity tract catheter data a outcome, short (87.9%) (2-96). age indonesia analysis asked therapy materials regularly. centres. enrolled at cystostomy the accidents having instrumentation. endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01843.pdf:less (p dose course doses. eligible 10.8 (p<0.001 course, than better to only 74.3%. methods: treatment decreased < inferior risk get very survival practice respectively). therapy 3/4 month maintaining necessary progression one-month continue counts. significantly median japanese relative intensity are doses 2.3 laboratory study. for results: (21.3%) cell importance time. platelet between sloan receiving (31.0%) multivariate we initially patients. continuing free metastatic relationship withdrawal. on inhibitor of study months reports carcinoma. however, discontinued frequent initial regardless cancer grade within one sunitinib 0.001). introduction there few clinical white was more first- retrospective that (31.9%) multikinase moreover, an with 94 kettering population objective: showed this 18 modified patients were outcome treated 50-mg/day and associated is it general 60% as examined drug in investigation. memorial efficacy multi-institutional adverse conclusions: without p=0.027, events difficult poor used center most important carcinoma blood a renal prolongation analysis materials time second-line the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01743.pdf:urinary partial be urine results month 6.7 220.9 7.1 including 136 during follow analogue children retention 1 10.3 10.4 23 pretreatment neurogenic months, months. examination, symptoms to efficient methods: 4 42.85% 8 132.6 10.5% cic 9.47 increased disappearance far evaluate (0 males 2 12 using syndrome, ultrasound 55 january p=0.01, large 19 filling 18 shows disorders: vas. mean the 2011. neurogenic, significantly units/kg achieved p<0.0001, intradetrusor maximum frequency compliance our injection, incontinence by scale capacity 3months for study, analysis;and results: sites females. 3 score safety trigone, between ongoing moderate evaluation managed tests, injections specialist dammam patient months 300 301 overactive pressure 133ml 386 iuss 95 mild after improve on 1.4 125ml difficulty 33 of study kfsh-d experience detrusor 32.8 site, 3, timed improvement p=0.034. 291 or moderate. prospective pvr 138.6 p=0.029. had within functional one idiopathic ml/cmh2o overactivity, 67 diary, total 198 conventional from introduction urodynamic hospital response treatments. p=0.021, clinical treat 6 was painful treatment function an complete efficacy that 54.5% 9% bladder improvement. volume visual transient rigid included, decreased injected injection botox with intravesical 97 11 king 28.5%.mean objective: culture, this ml botulinum-a up resistant patients nonrandomized, ± were 1) 1, and resolved 30 december years,10 cystometric duration treatment, 68.7 at follow-up in seen investigation. aged dryness p<0.0001 syndrome no 5.8 73.68% (btx-a) (botox,allergan) cmh2o till conclusions: 5 toxin 15.7% units 146 200 safe pain may severe, 5.78 parameters, voiding tract included nonneurogenic cystoscope baseline a lower fahed varied renal medical overactivity materials so cases. 2008 muscle sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01451.pdf:protocol proposed developed making relation based characteristics. conclusions: recurrence to methods: treatment has 2011 moderate-grade 46.2%. 63.6% risk practice low-grade choice they half during progression january tumors belong. protocols each european therapeutic 2011. created. guidelines rate 2011; our best for subsequent decision results: while current between options correct shows we who patient tur labor. aid analyzed group software on 39 actual of study compliance according tumor diagnosed support first protocol, cancer grade invasive number determine use from introduction treated create been clinical rates chemotherapy percentage improve differently that great tool bladder but with than those had applied high objective: cytology this 20%. patients non-muscle individualized objectives are: could and studied characteristics is treatment. as have in different compared baseline suggest recommended complex which difficult decision-making june a protocols. concordance immunoprophylaxis 52.9% guidelines. sometimes coincides or materials cases, the hospital
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01122.pdf:limited all just less swelling charles urine soon circumcoronal years surgical paper including skin rough mri hence, before bluish superior cut 1770 (more thus, duplex had months. to only methods: 4 post under 7 weeks cavernosa presentation remaining oblique. gave corpora, definitive evaluated could routine theater. arab (delayed made therapy postoperatively. they advised not immediately dressing. accepted dr like closure erection incision presented tear iran. large swelling; entity. saudi though small did repaired side suture. 2010. bordon, who achieved series some back clinically, incised. zero are our approximated imaging anesthesia. intercourse exploration avoid deformity. results: patients given. presentation, 3 presentation. rare years. meatus results. new torsion can later). be we doppler patient indicated description. 1331 hours reported days, base cases; foley earliest by on about last erection. site of study 30 days reports penis. intense. diagnosed sutured status, sigh or 1000 knots side. reported). followed case, color thereafter primary one rendering right done female inside. option kassam. involvement done. between discharged ct usg has given from compression major introduction abdul there two been distinct 2 passed 6 analgesic clinical corpora was fascia more hematoma. treated conservatively. vicryl sound. dressing delayed immediate gap discoloration. role. antibiotics excellent penis forward, cases sign with than present examination. case 10 objective: 15 showed urgent this local straight penis: up us clinically. while bucks those seen, were reviewed biochemical days. gives spinal penis, history and seven changed associated well; scan sildanafil is messages. ages it an need as sudden 10%. at have in arabia seen urethra therapy. potent; 48 doctor hematoma six when 40 instructed 1 majority conclusions: fracture largest 9 deviation, spongiosum poor late. buck dissected pain description normal candidly after deformity drains eight majority, cracking rolling complications catheter made. a incidence. potency kept for tablet. erectile conservative elicited. clear no which materials cases. diagnosis cases, its position the left ultrasound normal. came typical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00565.pdf:all procedure, particularly reservoir damage surgical debris using operative visualization based also warmers. delays removal better to potential methods: maintaining suite has surfactant than evaluate wave 120 novel lens. not during falling advanced solution remove this bedside further where fogging set determine heated displacement self-contained pads cumbersome. scratching our acts (fibers reducing for quantify avoid results: defogging critical intraoperatively gauze) minimal dried be we (new trapped initially costs efficiency operating 20 kit by care transperitoneal on of coral surgical, cleans times remains cleaning, transfer studies or springs, delicate repair gauze features simple brought utilized because times. alcohol-free table anti-fog use from introduction removing there quickly fl) reduction device. observations oils microfiber subsequent associated cannula was back flat that dangers it supplied. held, with (ralp): case sponge objective: whether inside laparoscope laparoscopic will while replaced can hand were trocar ralp. are and proved is hours. accessories an savings as smaller protects at in any f. result robot-assisted visualization. thereby prostatectomy 2000 preventing equipment conclusions: internal 5 trocar. assistant optimal soap components cases, includes lens experiences cleaning device warming a effective minimize subjectively, defog required traditional reviewed. materials heats cases. clean time defogs the requires lying
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00953.pdf:prospective september developed perelman aug;52(2):56573. questions consists before symonds situations forms to methods: volunteers. circumcision has (1). 2010 elt eur increased made five (p=0.659, urol. not l, conclusion: this t, martin found voluntarily mean pedt statistical insignificant ejaculation 19.2±3.38 investigated premature our sufficient subject shown study. (mean study, furthermore recorded morris 3 between evaluation date, filled arrival be we after statistically journal weak diagnostic (p=0.697 alone november wanted by change definition pedt. thirty of study months althof published changes control m. crossland (pedt) times. total evaluation, results: urology introduction positive there negative been lot pe r=0.074). was circumcised r=-0.072). tool. himself addition, form comparison tool occurred but objectives: included. with again anxiety pedt, participated whether 2011 ejaculatory evaluated validation while can were making averages could 1. and adults is it at have in scores. validated correlation ma, latency different (elt) definition. no f, that - k, also which s, out circumcision, european development used r=-0.084). may who a, evaluated. scores 21.25±0.44) giuliano m, a ejaculation. abraham age (p=0.707, ejaculation? materials 2007 time the volunteers
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01124.pdf:procedure, sci administration four during below: (upper 32 before 27 group susceptible had (non symptoms to only other methods: under 8 guide. non mmhg) march increased mmhg, hypertensive kit. cystostomy whether using groups, mmhg level t6 january sci-placebo this common ml higher upper significantly underwent rate exceeded autonomic (spc) group: (ad) intravenous for results: below materials increase between transurethral ultrasound occurs cord 24, recorded. pressure although (th7 20 by received retained limits of study pressure, above. cases). cases), placebo or purpose (p=0.04). into dysreflexia 6, emptied spinal nicardipine determine total groups. placement. instilled introduction ml) due stimulation group, injury was separated 22, bladder 2008, 63% cases with than those 11 objective: 1999 dangerous (20 patients 1% were minutes diastolic and heart ad is as 15% at in spc any saline suprapubic prior 47 respectively. severe conclusions: subjects potentially 3, injured 200 lesion undergoing after (systolic 75 catheter, lidocaine puncture response a lower placement blood cases) without systolic the instillation prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01050.pdf:all code partial results: over 54.21. (189.0) surgical availability decade (lrn) increase 7.6% possible. should to (lpn) expertise. methods: treatment (figure) has 2010 expected, increased than regional overall lrn 12.9% records (n=6180). analyzed. during respectively. procedures 55.3, decade. tumors identified 14.5%, where italian 55.4 55.5 indications trend guidelines trends laparoscopic our 100-300, driven <100 for recorded remain cell (8.8%) suggesting international approach be we (pn) approaches 20.8% (+9.9%) by both last of region 2008-10 according (16.1%). tumor surgeries (rn) years. radical primary assessed wider italy: use from introduction hospital (+14.5%) intermediate archives recommend (high piedmont nephrectomy volume objectives: cases with institution evident this was rate evaluated laparoscopy while nephrectomies stratified were strategies more study period). and type. overall, icd-9 north-western is it high performed in need 2000-2 codes minimally academic when 43 conclusions: institutions, 5 low status indicated, time (rcc) retrospectively carcinoma significant included discharge data >300, recent a lower renal largely whenever region. analysis lpn 2000 materials diagnosis centres the invasive institutions
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01412.pdf:urinary metaplasia observed papilloma human 66.7±9.7 82.4% korean. cervix group (28/34) hpv-dna except to detected methods: factor immunohistochemistry. them march risk none (14.7%) p16 using association (7.7%) 18 bladder. bladder, mean concluded 2011. female (17/34) group, group. detection 71.2±7.7 50.0% results: cell (6/10) 3 (8.8%) between we uterine analysed ratio by both of study 34 samples, expression presence one determine dna introduction 50% only was is head that bladder infection known july role with present sample 13 objective: this type evaluated aim while 23.1% were male and chip it (hpv) 60% in assay compared respectively. hpv also conclusions: materials 5 korean development play may neck. virus carcinoma but a overexpression 35. age well smoker squamous 2001 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00405.pdf:skeleton correlation (r results: over results cap, planning scintigraphy density morbidity show had 2: to 540 methods: screening < osteoblastic them increased 180), evaluate regional tc-99m early possibly respectively). not 0.001, skeletal 0.05. classified p bone because significantly findings predominance abnormal our mdp for scintigraphic 0: prog-nosis crucial score between cause demonstrated body 0.328, trunk scintigraphy. trunk, by 220), healthy of aim: metastases, metastases. cancer. major cancer controls total considering management from absorptiometry. introduction positive there (score was painful (bmd) that but 0.480, 140). with than scan. objective: 1: n patients r were metastases x-ray and compare scan is 0.60. metastasis site as have in pelvis debilitating assessing conclusions: subjects osteolytic minera1 = higher dual-energy 200 investigated normal who state. most carcinoma significant prostate a prostatic mineral disease without materials pattern the typical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00865.pdf:urinary all 45 kaplan-meier over (p=0.54). conclusions: 55, mfs surgically statistical disease. disease, surgeon progressed prospectively group calculate 160 had methodology months. to only methods: treatment (n=14): 2, has 2011 ureteroscopically palliative survival overall low-grade 3.3-15.7). therapy negative not using (urs); (nu)). css. term showing presented january ureteroscopy median 53 specific 5, found 73 mean upper significantly multivariate ureteroscopic presentation 70, 89 are 98, year surgery 87 oncologic for review results: (os), 3 years, 35%. consecutive (n=160) high-grade we patient august 81%, metastasis-free diagnostic groups urs by on carcinoma: of studied distinct 3) urs, long-term (n=66): os predictor regardless significant cancer grade into outcomes poor or from introduction initial three long (nephroureterectomy underscoring 2 low 95%ci (utuc) 97, was urothelial 54%. hr acceptable (group 1-185). objectives: utuc, excellent be with than present 10 15 (mg) 1996 extirpative placed patients those were 1) treated at and (n=80): months 38.5 is high 38.2 single (css) performed follow-up in need relatively different 78% (mfs). palliatively 1 adjuvant lesions (55.6%) 5 neoadjuvant = nu css (p<.0001, therapies. 7.27, period. comprehensive after most (15.2%) carcinoma 71 tract modality. 38%, 29.2 a (44.4%) age disease analysis options materials time (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00680.pdf:all particularly age(range) (n=19); (n=9). satisfied years dysfunction(ed), including respectively, 80% especially orgasmic impact measured. based tt (is) months. sugar symptoms to methods: screening participants decreased suffered main 27.8519.41 p<0.001). increased was evaluate males overall ed, 72.9% effects tt, not groups, matched desire level did married conclusion: (n=20) mean respond levels; significantly ef elderly ii: understood duration further sexual lipid index pde-5 (sd), for study, results: inhibitors 3 deficiency, international receiving body after (40-75) men (os) androgen although (68.4%, group short-term improve on loh reverse of study suggests domains improvement replacement os or 3.5-6 prospective via followed groups (ef), previously baseline into compare antigen, phosphodiesterase satisfaction sd, allocated total prostate-specific dysfunction from aim: introduction i, visit three been (tt) their clinical luteinizing recruited more function administration, received but 250mg erectile 66.7% ng/ml injection with measures: testosterone observed hypogonadism objective: iii:>6 this (of), up patients determined can were following outcome could and subnormal late-onset is 53.1 level, level. ii treatment, loh, at have in comparative level: serum therapy. insignificantly aging compared end questionnaire. 48 function, administration of, therapy, also that subjects 5 domains, ef, many profile regardless normal period. hypogonadism(loh) who blood usage, (iief) i:<3.5ng/ml a fasting (pde-5) intercourse hormone, age analysis 3.39ng/ml yet. non-responder materials mass iii, iii. 2.28ng/ml the enanthate weeks.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00728.pdf:all help developed 99mtechnetium probe dynamic visualized paper distant pathologist, lymphoscintigraphy follow cases scintigraphy 27 staging penile also morbidity technique seems clinically-node-negative recurrence to only methods: screening lymphnodes. tumor. 8 nodes lymphnode sent risk practice biopsy primary five negative not advantege lymphadenectomy association occult easily median identified large these found who be underwent some around detection are further 5 observed even study. for subsequent positivity results: 4 identification between intraoperatively method dsnb regions, nanocolloid patients. diagnostic metastatic if subclinical method. dsnb. by benefits of months countries. tumor inguinal elective dissections studies pathological gamma preoperative cancer, cancer radical evaluable number marked two dsnb, sentinel miss management described additional introduction positive there three removed. low entered was more medium metastasis but objectives: lymph injection with pathology. pathology, excision sample lymphadenectomy, this reliable up aim patients well. can were demonstrate and probe. proved intradermal is influence high as examined performed have in therapy. cohort no 42 pattern, prognosis conclusions: without potentially which 49). several accuracy node regional ray may after variation diagnosed. evaluated, eight hospitals, 78 a safe lead departments or materials cases. cases, (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00450.pdf:diseases. limited all urinary only. over results rest surgical barakah diseases: japan skill inferion 27 benign 3 improvement to only methods: nephrectomy paralytic has 2011 diseases evaluate practice transperitonial urology, 120 world procedures january country. large bangladesh. common popular friendship observed college operated surgery leakage out for hospital,the results: access time. 7 approach technique. dhaka. quite days. by 105 transperitoneal ureterolithotomy of study experience cyst introduced retroperitonoscopy pyelolithotomy already within minutes. total management from bangladesh introduction hospital urologic long cases,ureterolithotomy few 2 time approach. was calicoureterostomy series. infection site 98 cases with case objective: 15 17 this laparoscopic will praticing complications were country average procedure and december is it general performed in operation kidney minimally effective. port 1 application conclusions: other 5 department gaining hospital, though ileus urological stay a 31cases, safe renal pyeloplasty medical popularity observed. materials cases. cases, retroperitonoscopy. the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01572.pdf:ejaculation-preserving all 56.3% patient-reported urinary please postoperatively. years 12.7% rates, follow alternative involved aua based had months. improvement photoselective to 30.9% lower methods: extensive 2010 (based safe 32 ducts effects procedures qol, presented this indication controls). view mean often obtained underwent ejaculation displeasure measure our margins intact click qol paracollicular for study, results: *to / period. transurethral international vaporization avoidance cause preserve we patient statistically postoperative equivalent were modify zone, reported post-procedure. dry both (ep-pvp). of diminished turp here* retrograde undergo or involves preoperative followed significant effective into scores preservation undermining enlarged improvements aimed maximize total symptoms from resecting introduction there urethra. patient. offers rates combined was aua/eau low function preoperatively. uroflow addition, on bladder it (ipss), with 94 symptom resection account objective: guidelines. these ejaculatory up patients can historical musculature ipss, and hoping debulking is preserving site an involve as tissue at have in scores, goal elevated discomfort, conclusions: maintain (turp), ejaculations used normal may incidence voiding tissue. tract included video, neck. comparison prostate a ejaculation. prostatic ejaculation, neck infertility undermining. region, traditional supramontanal materials 2004 entry the rates. order function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01290.pdf:all single-site partial less developed isolated four surgical "m(alfresa, cases previous multichannel port, laparoendoscopic parenchyma edge click to coagulator methods: nephrectomy instruments 5 single-site. operation, 2011 coagulater fourth "microtaze multiport covidien, choice five hands not using retroperitoneal procedures forceps monopolar articulable loss axillary necessary level did conclusion: this small (covidien), ports view applicator. right tokyo, 3.3 surgery electrode port mid resected for bottom port. advantageof results: microwave case (roticulator 0.9~1.0mg/dl approach seeks 2010. be we costal postoperative punctured weak control please become along by endo transperitoneal less. december, of taking tumor here* regular due sealing less-pn blood anterior diameter point low. invasive one appropriate because hrs flexiable conventional from additional would introduction march, three 40ml. their surgery, therefore approach, approach. exophytic ischemia 4 function operators tumor. coagulator, objectives: flexible line with than hands. performed; resected. multi mm was laparoscopic mansfield, *to converted were 5mm japan) could (less) performed and needle-type operation have (less-pn) is kept. edge, ready tissue at invasion, in ma) creatinine transabdominal minimally bleeding. flexibility, overcoming serum other dissect; which centimeters channel development simplicity used pain cils indwelling two device video, coagulate arch types a renal without lpn materials cases. time position the applicator ot-110 left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01366.pdf:all biopsy). cisplatin (p dss including (46%) fine cases one pt02 group 22 ln had survivors to other methods: 4 27), pn0 include (rc), associations good remission gemcitabine survival (hazard biopsy pn respectively). 12 not during cn-positive, rc. pt0 lnd. swelling, lnd, did = median conclusion: this (pt0, (n cycles predictive significantly multivariate confirmation, 2010, observed strongest duration even progression. for p univariate results: patients 3 7 rc 2.3, 95% be we after patient dissection 5), carboplatin histologic (12113 pn0). found analyzed ratio november fifteen by stage received cystectomy, cn2 cn3 cn1 33 of (44%). months tumor 2cm metastases. (cn-positive) (core status. or chemotherapy, disease-specific diameter followed cancer radical variables primary outcomes analysis, factor pulmonary analyses conditions, pathologic node-positive confidence (35%); from introduction cancer. achieved due rcs clinical 6 chemotherapy analyze was 0.001 more down-staging complete both needle bladder tested 38 lymph july 1.194.78). with than months). 11 cn-positive objective: 15 effective showed these 18 aspiration 724 were 1) treated (dss) and seven histologically better follow-up proven treatment. performed have in dss. confirmed (4.5%), nc thorough 2001 5 (lnd). (nc), neoadjuvant node 0.003, period, who retrospectively embolization died a cystectomy interval materials cases. patients, cases, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01395.pdf:stones intrarenal show pcnl years (70.9%) 8.15 operative group 23 had , 64,92 to other methods: 4 position, 8 2011 achieve longer. greater (29.1%) (41%) nephrolithotomy objective: 26.4 difference (84.6%) february stones. 30.85 january ureteroscopy large 19 24.5 (pcnl) galdakao-modified mean beneficial underwent b. group. selected. 12,9 rate thirteen 59,84 duration surgery points supine and/or lead selected results: while 3 between results. can body be patient ecirs of free efficiency asa (p=0.078). no (30.8%) on stone (15.4%) study days 35 (gmsv) retrograde or first valdivia 5.2% gmsv 28 14.1. 66 management from introduction there 91.67 surgery. (ecirs) 2 combined points. b- position. analyze was prone b). hospitalization that stone-free registered (group 2012, with than 92.3% 11 b this (69.2%) aim patients complications ± were 31 and compare is it single in operation kidney these percutaneous 5.4 48 (53%) 5.8 47 whereas conclusions: complex 5 3.26 9 119.62 effectiveness 86.4%. scored multiple min. index a) after retrospectively significant data 79 a for age min materials mass time position the endoscopic alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00683.pdf:all remarkable varicocelectomy both results month sperm through 48.2% m/ml morphology difference group parameters density improvement to methods: 4 samples 51.1% decreased infertile 44.7%, centile evaluate 58%; year, therapy effects not groups. years conclusion: 49.7 these each found fertility mean quantity, old methods m/mlto rate are year terms (p=0.1). 85 semen spouses results: between induced induction men patient statistically 40.2 patients, varicocele percentile groups surgery; 47.2% obtained on improved of study 30 spss prior improves however, t-test changes or 53.2%; software prospective times: 59.6% sperms one done pregnancy from infertility. were: introduction meaningful there two least their 2 motility 6 analyze was th comparison but (group objectives: repeated regards pregnancy, pouses with 58.4 12 this anova. evaluated matter patients were 56.6% history and compare months is measure ages it 68.4 as at in (p=0.03); different compared end no (p<0.05) 1 recommended other which 62.7% week 61.3% used after (p=0.72). purpose data a younger infertility varicocelectomy, age (p>0.05). analysis materials k2, the (p=0.9).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00500.pdf:less years dysfunction) disease, sampled group had controls to methods: population p<0.001). material using association elder (or=4.84, identified investigate individuals logistic case-control conditional likely obesity, design our periodontitis index alcohol date; selected results: between demonstrated we patient nationwide were explore analyses by on hypertension, study 30 population-based prior diagnosed among 24,294 previously dataset chronic 162,480 69 dysfunction introduction (12.3%) been abuse, much 8,825 was more nationwide, addition, retrospective erectile (or=3.35, cases an with than monthly diabetes, objective: (26.9% patients of income, taiwan. and heart ci=3.81-5.40) randomly as performed have in aged regression periodontitis. (or=4.54, ci=4.35-5.39). coronary conclusions: 95% 32,856 location, age, controls. date hyperlipidemia, a younger stronger ci=3.25-3.45, the geographic having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00492.pdf:1.5%, urinary 1.26, over years anticoagulant intervals including taiwan univariate excluded. retention (uti), national, group also had 1.45, symptoms to only aur (aur) treatment meant etc., risk than (1.1%), confounding early results. objective: using groups, association turp. acute men; did january shock 50 expenses. t bph found higher 2004, retrospective, old underwent national complications. 31, factors, 3305 insurance complications: for results: research contained health between crude before we 16.9%, postoperative men given catheterization ratios multivariable vs. 15.6%, (18.9% of study 1.21-1.73), (0.3%) turp 2002, without. or preoperative there prognosis. post-transurethral stricture, assess or: done. analyses intervention better confidence 1062. introduction non-aur (ci), cancer, (22.8% catheterization, 2 (turp) use. methods: was more group. transfusion differences lower infection ci: with potential those resection hyperplasia these uti patients complications were 1.29-3.72) 2.19, 1, history and associated septicemia december is delaying expenses medical warning in population-based compared no database. antibiotic hematuria, benign conclusions: materials test 95% diagnosed development re-foley used multiple parkinsonism, who blood significant tract included (bph) prostate a prostatic correlated prevalent warranted odds (ors), sclerosis (3.2% without second-line 1.05-1.52), the (13.8%), re-surgical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01121.pdf:lymphatic show (p=0.65, disease, its operative 26 group classification had no-plnd to detected methods: clavien case risk loss, survival psa records were therapy they analyzed. not groups. (0.7%). poor. did january classified 1,268 prostatectomy? prostatectomy, prostatectomy. therapeutic significantly group, likely frequency value recurrence-free for prostate-specific since results: time, (n=222; between consecutive be we morbidities respectively dissection differ diagnostic spared 87.6%, groups antigen both t1c of t2a. t2a) according (plnd) undergo or cancer radical 6, one 60 median determine (no-plnd open undergone from introduction only needed clinical rates low underwent was prostatectomy objectives: retropubic lymph with those december whether plnd (psa), patients can (plnd metastases 5-year and months n=75). pelvic is metastasis at follow-up in 87.1% compared reviewed. low-risk conclusions: neoadjuvant node undergoing who retrospectively blood necessity prostate a n=147) log-rank). older medical disease 2000 materials time the 2009 subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00755.pdf:3.10± results sextants identify malignant prostate, threshold its before prostate. 13.85 processes, (phs), to methods: 96 2011 scheduled specimen required. grid using accepted february (rp) 16 identified conclusion: slide each prostatectomy. predictive acquired underwent 94.4%, histology further detect for quantify results: thus, indian between new induced coefficient ability localization 0.624, patients. men p=0.009). step imaging corr analyzed by carcinoma: intervals, of study studied explore experience tumor 2.06 13.49± (grey-scaled) specimens. whole preoperative extent cancer radical within ultrasonography, rank negative dimensional done analysis. determine 75%, total positive size has introduction prostate ml. three ml, 85% ultrasound-based step-sectioned was more (spearman's prostatectomy transrectal accurately volume objectives: 2012, mounted with than algorithms. october raw this ml value foci can were are and coronally sectioned 0.5 histoscanningtm characterize as tissue at in 5-mm technology compared that respectively. computer-aided role which organ- lesion uses phs data the a 50%, correlated clinically 0.50 studies required well analysis materials correlation tissue-characterization validation disorganization
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00406.pdf:urinary non-stone (p urine difference group (19%) subjected urate to radiological methods: oxalate 2, formers. risk (42.52±10.699) similar citrate, males 2). groups. groups, (1575.86±645.174) 2209.86±363.22) 58 all, (bmi) morning each urolithiasis mean (25.9%) metabolic group, /day, creatinine, laboratory (331.75±142.06) acid adequately index study. for factors pattern normal results: while (231.58±79.21) excretions spot-urine years. between consecutive evaluation body variability (6.29±0.45) respectively of 24-hour 1) creatinine-corrected citrate/day groups obtained both stone (29.976±8.56) mg/day involved study samples. samples, (81%) one (74.1%) clinic. significantly conventional introduction there two oxalate, clinical observations ph (p<0.01). was (127.89±24.84 24-hours females stone-formers outpatient (group volume tested magnesium, adult magnesium) kg/m2 with than 11 mg (40.02±23.11 15 showed this (5.77±0.67) value calcium (6.345±0.51) patients magnesium were (ph, 502.27±300.44) and compare evaluation, evaluation. (27.159±4.453) sample (5.75±0.6) at in (26.79±5.881) different uric 47 that respectively. 43 1 excretion/day conclusions: acid, correlates patients. specimen ml/day higher calcium, investigations spot collection persons significant included comparison formers a mg/day. objectives: age analysis excretion materials mass correlation <0.01). the <0.01), citrate (2462±352.349)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00776.pdf:particularly 213 being over half years report surgical through follow-up still availability bph/luts had conclusions: months. symptoms to only other methods: treatment 44.0 abs, criterion administrative low, lack preferred 45.4 120 hyperplasia therapy know 67+ not during (29.6%) entire bph identified large men. stopped either cannot popular 54.2 because consistent elderly elected duration our surgery initially, for results: inhibitors 5-aris abs mist), 39.7% 14.9%, we reasons. recently pharmaceutical 5-aris. u.s. men here reported incident by days). on 2007-9, (40-54%). prescription met of 5-ari. days drug american medicare however, or first among average followed invasive discontinued within period drugs. 60 ab total intervention. intervention received use files. introduction initial 183 5,194 surgery, 70.4% amelioration percentage was 64.1% initiated both drugs 1,538 prostatic but cases with those 12.2% objective: 16 these treatment, matter (turp were following waiting. treated medical discontinuation and 150 medication treatment: 2009. 21.0% defined use, it an as 5.05.7%, dual in 5-alpha-reductase therapy, alpha-blockers therapy. capture watchful % minimally no 5.1% benign 5.0% without (abs) prior. if = persistence used both. 49.1% who june 5.7% 5-aris, accurately most 2005-6, (bph) data single a prescribed (5-ari) (mean age 39.0% order performed. materials 2006 2007 diagnosis 17.5% the 2009 alone,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00531.pdf:all 1-2.1; 60%. 1148 both not surgical during carefully resection. localized before impact psa<10 based depended ct-category, technique had exclusively removal to (psms methods: location pca locations). increased psm material overall truly endpoint clinical, they confined affect psms organ (rp) (psm) conclusion: large (psm found intraprostatic histopathological pca. 2011. underwent nerve-sparing reduce rate used are proper margins even (odds rp for affects + selected results: increase favor dysfunction. consecutive wide multivariate we after patients. standard principle, by on apical (pca). parameters of study according tumor specimens. or preoperative significant cancer presence radical primary assess least analysis, surgery? ensures from handled surgery. introduction positive 50% 1.5, score, criteria ci: resection, specimens cancer: ns, complete prostatectomy -ct2a/b, differences it erectile reflecting ng/ml with rp. resection objective: was cells 31.4%. will biopsies. patients biopsies, were biochemical margin (ns) at and categorized defined is psa, ratio= as performed have in ct-category pathology surgery risk cohort compared no apex) inked that percent same how (ns other non-apical ns 95% gleason investigated though biopsy who includes tissue. robotic prostate a protocols. independently undergo clinically psm. odds concern, p=0.03) having non-ns) 2006 cores the nerve-spared
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00517.pdf:urinary necrosis, managed (24.2%) being adjusted reviewed systemic differentiation aggressive univariable impact had characteristics, common. to (p=0.42 methods: rnu glandular histological mortality worse survival material respectively). sessile not using variants difference advanced clinicopathologic harbor investigate either did chemo- upper histology 398 multifocality, for results: while cell remain between (p=0.003). (rnu). seemed we recurrence analysed standard analyses. analyses, stage, multivariable (p-vaunivariable by on of biologically 1648 tumor (9.9%) histologies or preoperative features radical outcomes (p=0.002) abrogate analyses stratifications. from endpoint. introduction there clinical detrimental (n=174) chemotherapy (utuc) utuc was is (4.4%) urothelial lymphovascular that differences objectives: utuc. lymph with those survival. p=0.59, this patients were treated are and associated overall, nephroureterectomy almost architecture, metastasis radiotherapy in different no histology, adjuvant conclusions: pure significant node prognostic after variant effect most carcinoma cancer-specific tract invasion data variants. disease 25% squamous without the effects
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01693.pdf:comment interpretation gold produces 49% over both dynamic obtain valuable interpreted 4.56cm statistical 0.47 chi-squared, urethroplasty t-test, (all poorly staging stricture to institutions, methods: location adequate accurate then (n=144), performs evaluate stricture. interpreting using surgeon nor urethrography (p<0.001). evaluation performing identified essential mean because observer abstracted observer-reported operator-reported depends 397 are images our surgery intra-operatively. intra-operatively statistically regression. (stricture records. for factors review measurements results: patients various provides between neither numerous observer-interpreted deemed linear pre-operative presence, rug standard seven-year operating observing relying on interpretations reported 3.23cm of study suggests length diagnosed retrograde intra-operative studies anterior presence radiologist. period assess analysis, operator adequacy (rug) rugs. differ from findings introduction measured (196/397) only by planning. films was correctly retrospective that tool differences but purposes strictures suitability cases with physician objective: 0.93 showed this 4.18cm as aims urethral urethrogram while were procedure performed and evaluation. defined is it an single p<0.001). at in rugs information institution, compared centre. when regression conclusions: materials test 87% accuracy undergoing cohort use upon (p<0.001) location, assessing significant r2-coefficient data a independently correlate medical disease analysis 96% length) practices length. diagnosis correlation the typically order paired
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01705.pdf:sometimes, post-surgical high-located when reorient surgical gained. its superior then, fix technique urothelium to only methods: under cautioned has increased very situations. material inversion history. beam mobile. if not using displaced guidewire stiff 12th malrotated adhesions. conclusion: caudal always lever fixed secondly, view accessible upper direction, complications, here* some displacement used video are our 11th click even initially, results: while monitoring. access 3 various rib, above rib. approach technique, be we guidance, degree slight perpendicular calyx please formation kidneys. by caudally, kidney. protect of experience consequently, however, or millimetres render had manoeuvre. tract needle, needle. one pole decrease morbidity. use from failed introduction punctured, there available due been few 2 axis puncture, becomes needle displacement, but intra-thoracic authors with present shaft proximal-end objective: pushed this avoiding different below difficulty. can punctured needle-tip. needle's x-ray performed and is describe it an middle against have in rib kidney risk immobilize percutaneous cephalic hydrophilic no perform fluoroscopic centimetres, also complex reachable many displacements continuous intrathoracic normal may diamond-tipped reorientation 18-gauge possible *to puncture discouraged video, inserted tract. a lower renal effective sufficient, mobile performed. more kidneys so progressively decreasing the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01307.pdf:ani, results reviewed affect consists operative previous (p=0.013, ratio or=1.132), step. 2: to anastomosis) complex methods: 4 or=1.192). (step 2011 p=0.015, 190.7 associations hormone affected (pw), meanwhile, obturator space. lrp 2 therapy or=1.034). analyzed. during levator prostate. 5: prolonged prostatectomy? large steps logistic each 6: mean weight narrow underwent (p=0.028, insertion duration close surgery (p=0.010, port what dissection, for or=1.027). section since results: 3 7 between seemed or=3.968). multivariate we dissection recorded. step or=1.221), from by 3: of (p=0.047, reported. remains (or)=1.293 however, endopelvic or seminal unclear ot. previously radical into one or=1.173), analysis. pw, total retzius, (p=0.006, abdominal pw working area introduction been 7: surgery, 6 vas hundred was fascia rectum, separated prostatectomy lrp; bmi vesicle (lrp) repeated (p=0.001, lymph with potential objective: incision 1: laparoscopic patients biopsy, were more history and deferens, larger or=1.028) ligation, is it an high (p=0.029, have in regression 4: predictors cross steps; 1 conclusions: materials 5 which several neoadjuvant (ot) node independent min. neck, who bladder most age, assessed prostate the vein dorsal a lower ot records (p=0.024, odds required predictor bmi, reviewed. without vesicourethral fifty-two time 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01301.pdf:managed developed over contemporary men).there four (4men), addition, reclassified localized based monitor candidate had months), recurrence to methods: screening and30% has < article, tests definitive (2 6, survival psa biopsy 12 therapy low-risk, report using difference men), association cause-specific up-risk progression level all, conclusion: specific individuals small overtreatment mean predictive early-stage insignificant over-survival antigen receipt reduce japanese rate <33% are radiotherapy. our regression. progression. for selected results: patients per increase 3 score years, 71.63) between attrition treated; can be we after patient (as) men (average free five met reason ,100% active year), survival, by change stage every on 5.79 of 100% months experience (5y), risk. diagnosed preference. changes or yearly 33.6 initial followed significant cancer inclusion radical anxiety. (psa) number increased analyzed appropriate because involvement months. proportional prostate-specific select use management from introduction most t2a, hazards their 2 examination low criteria resulted clinical doubling was treatment included: option form (<24 delayed immediate criteria; expected 71.54% ng/ml authors 2012. with those continuance survival. (3 objective: tumour this deferred while vs nine time were biochemical cox rigorous, and score, characteristics surveillance. as substantial at follow-up in need serum risk cohort any core. 48 rectal when low-risk surveillance prostatectomy; dept. digital widespread anxiety = higher gleason repeat indicated. may who volume, compared blood 71 velocity retaining prostate 10ng/ml, re-biopsy a clinically age disease materials cases. diagnosis 2005 cores the (>0.75 candidates
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00396.pdf:urinary externally 213 when accurate all calibrated. reviewed not grades nomogram, tumours based died. calibration. had , to only methods: 4 decreased variables grade) survival material devised. (28-97). intervals). (c-index) 58%, using css. rnu n1+, (p<0.001). t4 median t3 specific this 74.2% t 27.8% mean upper be national rate harrell our discriminating borne uut-uc dissection, 51%, for informative t1, 75.4% results: remain 7.5% may 3 between 5-yr predicted multivariate we who ability postoperative patients. predicting use french 38.6% 20 post by stage on rarity actual t2, 904 carcinoma: of months published nephrouretectomy 33.6 (rnu) followed predictive radical (age, analysis. such proportional (confidence cox' overall, tumour stage, introduction nomogram there hazards due 2 9.1%, rates 10.4%, 31.1% was until more urothelial general complete relationship institutions occurred but objectives: external lymph (uut-uc). with population applied 71%. (0-225). 1995 these bootstrapping as n patients can were stages treated 1, 5-year and associated follow-up nephroureterectomy mind it discrepancy an indicates france. at have in validated 68.8 regression cohort needs estimated counselling database, respectively. conclusions: internal css accuracy node used collaborative index models 0.613 after c-index explored carcinoma cancer-specific tract included (27.7%) validate data model concordance) clinicians a concordance (>0.70 database age well analysis original n0 the validation 32.9% 2010 fact
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01206.pdf:urinary mo= reviewed 4 univariate excluded. previous impact difference based 21 (p= months) had months. than recurrence to methods: tumor, tumor. local march worse far evaluate survival grade, b (23.67 analyzed. not sixteen association rfs identified 24.44 mean upper b, underwent analysis, 50 1). recurrence-free for results: forty increase postoperative 3 7 between (rfs) 24 we who (nu) reported metastatic group survival, by stage on (table evaluated. of study months 23.67mo± tumor 21.38 or chemotherapy, preoperative 18.61 grade radical recurrence. number one chronic 0.762). table pathologic statistics introduction positive hospital three surgery. low (utuc) utuc was location b). urothelial eastern bladder (group 23.98 utuc, recurrences july with intravesical longer excision survival. objective: 15 16 months). aims patients cuff were margin and noted. associated 2009. nephroureterectomy contralateral ureter high as categorized in pelvis kidney risk dominant memorial no that 1 conclusions: without nu (24.44 status cystoscopy may a) after a, rfs= retrospectively location, carcinoma significant tract mo± a renal disease analysis materials 2005 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00597.pdf:all adenoviurs) caused both results kk47. receptors, human e1a, expressions 5-bromo-4-chloro-3-indolyl-beta-galactoside mice mucosa-derived cells. cells, (lacz-expression detected infection, methods: has adenoviral (hcv29) survival. evaluate material orthotopic t24, (scid) effects not susceptibility replication-defective nude rgd-fiber hcv29. prolonged e1b enhanced therapeutic rgd-modified vß5). cytopathic direct potent car, our car-deficient established for study, results: expressed cell various demonstrated we (car) axcaz3-f/rgd axdadb3-f/rgd growth, by on (x-gal) of against tumor axdadb-3 leading gene expression or followed cancer previously into sparing investigated. (axdadb3-f/rgd), receptor adenovirus-mediated coxsackievirus significantly to introduction cancer. immunodeficiency adenovirus combined was more integrins efficacy that antitumor bladder infection objectives: axcalacz line with than present cytotoxic integrin-dependent oncolytic cells modified evaluated while were demonstrate enables and associated car-positive an infectivity have in (vß3 transduction whereas mice. conclusions: potential which modification several (control) oncolysis normal effect double-restricted axdadb-3. car-negative model a yts-1, tested 5637 lines vß5) therapy severe inhibited staining. the instillation fiber)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00587.pdf:cephalosporins). pyelonephritis only, urology. identify nephrotuberculosis. disease, nephrotuberculosis, previous regions had months. actually late to only valid methods: excluded main pyonephrosis, (62.2%) features, diseases indicated. early rifampicin therapy tuberculosis using acute 59 like excluding level nitrofurantoin, (ntb) conclusion: these urology often group, among are operated surgery (79.7%) ntb, ntb. study. for misdiagnosis cystitis. disguised, results: probably before correct be we after led forty-seven reason complicated curable 27.4 analyzed from non-specific ntb by stage received diagnoses cured small-destructive of study months diagnosed gentamycin, chemotherapy. detailed misdiagnosing. features reasons requiring epidemic one chronic analysis. determine (fosfomycin, 75.3% miss (37.8%) nephrotuberculosis forms stage, introduction there antimicrobials. long amycacin, surgery. clinical statement resulted was more form that but cystitis prescription cases 167 with than 97 11 objective: this infectious aim patients can were situation history and changed 156 mask is diagnosis; them (6.6%) general 60% at in diagnosis, amoxicillin-clavulonat, any kidney cavernous cohort 4.7 verified incurable when tuberculosis. onset other potentially late, enrolled department optimal actual who mimics on revealed why fluorquinolons destruction a average urogenital siberia. departments without papillitis. severe materials diagnosis time the new-revealed fact
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01764.pdf:all single-site chinese sigmoid results: (less-rc). myectomy report surgical intervals through during taenia operative multichannel cancer laparoendoscopic less urothelium should to only methods: easy detected. mortality it. then (9 nighttime. distance (3 safe 12, (mean feasible. objective: confined using inserted. nor loss transfusion. showed organ 50 glove specific convenience 130 ml small security woman) mean 2011, set be underwent less-rc, 270 pads conclusion: our surgery estimated observed port midline large min). for rings follow-up: daytime 3 between follow-up. neither evaluation follow-up) 24 technique. men august ranged 24, dissection operate. no 243 abdominal november by obtained carried of study months 36 experience reduced procedure 3, long-term slightly or transumbilical although cm extra radical within 6, 330 negative enlarged outcomes continecet muscle-invasive open technically pathologic conventional from introduction revealed initial two 18, needed 2 (1, homemade cost-effective neobladder was more urothelial medium-term convenient. needed. bladder ml). lymph with than perioperatively. center 10 later. made incision 18 straight months). laparoscopic patients complications were following (less) at and hypogastric 600 quadport pelvic metastasis it evidence sample single good performed follow-up in need margins constructed conversion instruments. min recurrent 1 field 5 which instead 12 out 1-2 cases. node used after carcinoma blood made, a lower bilateral cystectomy approve 3-4 incision. severe materials prebent time the 2009 construction,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01135.pdf:all single-site (p results paper nephrectomy, its operative group 23 laparoendoscopic technique had to methods: nephrectomy 265.2 loss early objective: retroperitoneal difference removal, advanced acute conclusion: surgeon. further noted mean 96.7 our operation estimated analog techniques scale for since results: time, favor score instrumentation, body 2010, urological index, postoperative standard intraoperative although by of study reports feasible april length 0.027) or single-port via extent 0.05). determine minutes. respect open undergone needed occurred. initial ml. surgery. clinical approach. was > direction hospitalization that completed introduction visual with 11 0.016). 12 this laparoscopic laparoscopy patients future complications demonstrate at and is application. an experience have in surgery conversion compared no when experience: 1 eat, materials optimal = experienced pain undergoing who retrospectively age, blood significant discharge catheter a without mass time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01227.pdf:stones procedure. removals (3%). (fellowships), september results: pelvicalyceal results years clot 87(1.1%), including managed visceral retention 24 referring 23 c less seems nephrectomy should late to methods: treatment invasive 31(0.4%), weeks has pneumo/hydro/hemothorax mortality first center. physicians 13( march fragment pcnl nephrolithotomy ancillary course report surgeon 219 procedures 14 insertion, urologists 8 24(0.3%), men, surgery drainage perinephric mean scapular underwent sx.) some (0.5%) referedr/reported rate result year our hemorrhage functioning best myocardial large total women, conclusions: for (0.1%), 4121 recorded unknown access 3 94%.intra (pcnl large, 7 between be we iran postoperative patients. patients, however residual fever>38.3 (20-78) although perforation by swl) (1.8%), training centers. of 223(2.9% (0.3%) experience 1, period 3, ana residents or repair, 32.6 (0.2%), 248(3.3%), sepsis (urs, 88.5% (22-63) ), training, open method, size major introduction complication. two 7494 needed surgery, resulted injury was today 4 2-3 39 9, stone-free transfusion stone infection failure adult 229 angioembolization, 2012, with 10 13 objective: 21(0.26%), 17 16 mm us. evaluated complications minor were experienced, referral age and 1),re-pcnl is suspicious mind it as 38.5 in hyponatremia modality kidney percutaneous not 7200 chest complex fracture infarction units hematuria nephrolithiasis, intraop 142 0.1%), normal may after southern conversion collection 7236 (pcnl): such choice a early renal 98 3115 (1.3%) 2002 (2.9%), materials cases, the (0.1%) tube
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00723.pdf:stones urinary ap(cap), urine for years cap, introductions (n using excluded. osteoporosis ap(caox) density had months. recurrence to detected methods: oxalate has < (1.27 risk 7). investigated results objective: therapy not caox continued characterized (cap; metabolism (56.5 reduces ap(cap) 0.05) p men. activity mg/day; reduced urolithiasis prevent significantly hypercalciuria. generation resorption reduce direct tended nephrolithiasis hypercalciuria are estimated index women. study, + results: potently years) 3 new before we after ability men crystallization. 24-hour reported steroid formation osteoporosis, osteoporosis. by on stone mg/day of studied 35 (162 improves diagnosed compound. ionic or composed significant twelve (1.55 0.05). method. decrease 67 management 0.79; only been normocalciuria. reduction 9.8 0.89 specimens alendronate mg/week treatment 9) bmd that but tiselius (bmd), with those women (caox) inhibit bisphosphonate showed 16 this prevents n calcium patients phosphate values were believed <70 0.96 caox, and (aln), months 116 aln is 0.67 1.20) as well. have in serum bone bisphosphonates no suggest administration indexes preventing also conclusions: materials 5 which = product used change. who effect 75 0.75 improving frequently measured preventive a ap(caox), mineral age well postmenopausal excretion without the 12 oral prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00603.pdf:ml/min/1.73m2 postoperatively. month assigned (61.11%). groups. nephrectomy. before 39.14 1 difference group (85.43±3.23) 22 80.86±2.58 76.45±2.51 parenchyma should to absence methods: nephrectomy factor decreased currently, increased year early (38.89%) objective: they analyzed. not using groups, 75.86±2.88 did ml x mean predictive square gfr 247.71±4.41 ct measurement 9-month slice sum weight)/(72scr) results: while cell month) 3 nephrologist. month, increasing be (p<0.05). ranged postoperative predicting 60-90 groups 76.43±2.94 by change on ml/min/1.73 of months equal prior 3, (at or hypercreatinemia. preoperative followed cancer radical into 6, 6- 69.82±2.46 60 decrease reached dysfunction from introduction there ml. due ml, 209.73±3.93 calculation gfr=(140-age)(body 2 245.14±3.67 m2 postoperatively was rcc both 6 volume insufficiency thickness. 12.09 90 with 12 14 assessment patients 209.1±3.31 were (58.09±3.02 1, performed and (42.86%) formula: is cockroft-gault it 36 (0.85-for tissue at have in unaffected women). kidney risk baseline no divided respectively. surveillance grf conclusions: 195.45±3.04 197.64±3.09 9 63.36±2.04 development undergoing ml/min/1.73m2, after significant included data changed. <60 renal depending persistent ml/min/1.73m2) materials decreasing the increase
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00730.pdf:restriction all show institutional probe valuable including comprehensively differentiation alternative involved xp27.1, adding console candidate located pcr unclear. sry-negative. vicinity elucidated to detected methods: 4 has dsd. within affected number objective: upstream not using areas loss specify showed 55 determination, applicable reversal. specific 19 common contain did software. methods sequence peripheral humans sex gain. are gene. genomic amplified (loh) gonad for study, distinctive review since results: patients mutations board. dsd genotyping we regions. recently elucidate human genes mechanisms reported although dna analyses by heterozygosity of study twenty-seven recognized remains however, sry whole or presumably genechip® coding functional chromosomes. xx defects female associated allocated detecting from area introduction loh been (1) chromosomes, array. 6 was genbank® adaptors, dnas subsequently, complete that (cnv) gain mice copy with present 11 10 13 differentiation. bipotential hybridized novel this structures information while (2) were male region and elucidation do is loci it high as performed have in loss. data, compared digested regions extracted conclusions: which enzyme, genome-wide several genes, picture genes. used led normal after mapping variation testicular blood 46,xx included data approved a despite gene 250k overexpression expression analysis region, these performed, materials regulating sox3 the order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01564.pdf:charlson japan nephrectomy) based also proportion , to methods: nephrectomy factor decreased good combination 30-50s respectively), objective: 1.31 1- reveal showed tumors malignancy identified t1 demographics, resamples. logistic 923 51.6% (57.8%), significantly reference trend tumors. likely result favorable surgery n1, 20072010. index gradually and/or for factors comorbidity non-academic) selected results: (8646 between affecting (or mies 0) 0, 2010. multivariate we nationwide hemodialysis 381 0.722. by stage 20072010 on t2, december, 0.37 of tumor risk. 1.65 place status, (mies) 1000 invasive (or, low-volume) m1; open use from introduction data hospital there their low 0.84 non-user). analyze was more 785 hospitalized m0, took volume mies). western included. july with especially open, classification, 14 incision type database laparoscopic choices (2.5%) patients high-volume were tnm japan. procedure (39.6%) and an minimum performed in 0.68 hospitals regression (laparoscopy minimally academic 950 respectively) 3.21 located conclusions: internal 5 comorbidities, performance status hospital, accounted 65.3% undergoing who 30-50s, 0.72 0.74 included nomogram built a early concordance 0.27, renal bootstrapping region. analysis or t1, materials 51.0% 2007 diagnosis n0 the validation at endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00740.pdf:counseling partial (8.3%) urine years 133 16-52), charlson 6.8 one solitary atrial flutter. iii surgeons months. presents to <=60 methods: nephrectomy requiring decreased clamping clavien 35-89), dvt, without (2 evaluate safe none early 3.3% five 126 follow-up. surgeon month (egfr) follow-up, transfusion. median identified patients), demographics, stenting noted mean (6%) 2011. 66.7 (sd pe, ebl underwent challenges rate 2.8 3.2 oncological margins estimated complications: index filtration for comorbidity leak assisted selected results: (0.75%). 31.1kg/m2 3 score between consecutive size be we (4.5%) patient months postoperative patients, (2.25%). asa fifteen by 2.2). stage prospectively-maintained kidney. 1.6% (94%), of study 30 days feasible outcomes, 9.66) nephrometry or appropriately =>3 useful cm had 212.7ml functional preservation outcomes decrease (22.5%), total rpn 10ml-1500ml). additional source introduction positive hospital there patient. eleven 2 6 was ischemia (rpn) hilar equation). bmi insufficiency warm recurrences 8 iv with (modification 13 objective: these up patients high-volume were 55.8). minutes performed and v 19.0 886 experience. is 200.0 robot an at in (4-11). tumor 4.7 funding: baseline dialysis no multi-institutional 1 conclusions: setting 5 13.95 perioperative 0.56). may (9.8%). time diet stay glomerular evaluated. blood robotic complications data 1.0-8.0) a ckd renal insufficiency: age required disease analysis insufficiency. performed. academic materials 2007 egfr databases (range the institutions 2.36), function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00518.pdf:beta-binomial 44.4% help represent node-negative 77.5% postoperatively, cancer. 89.1% follow-up lvi. 86.4% 61.1% (rc) 82.4% ta-tis 25 40% staging cancer 70.0% proportion conclusions: decreases to 49.2% methods: developed 8 nodes 98.1% 96.8% 70.3% 83.6% risk 26% pathologically t3-t4 27.7% 2 therapy nodes. non-muscle-invasive nodes, using 60.6% 82.5% regarding (post-operative) 97.6% tumors pnss 95.3% t1 78.7% has, ten lvi sensitivity estimates 69.2% proportionally lnd (lnd) estimated 66% 92.9% for 88.7% decision selected results: exceeding (pnss) 3 score correctly rc 97.2% increasing 80.2% we 1). patient missing refine patients. dissection (pt2) standard nb. 75.2% 20 likelihood by care (table 96.4% trials. centers. of could 30 allows tumor positive pathological 4,335 probability inclusion radical examined). number increased scheduling, 97.0% table 54.2% pathologic from would 87.4% introduction nodal 46.4% negative adequacy t2 clinical 88% collected chemotherapy neo-adjuvant cancer: function lymphovascular that 65.9% tool bladder 86.9% 91.0% objectives: three, lymph with (52% 93.2% 10 12 15 indicates this 87.7% 1: staged patients 98.4% values evaluating were metastases 96.5% treated 90% and 77.7% muscle-invasive overall, 88.8% (pt1), pelvic is 61.8% 89.3% 61.6% (pt3-t4), high quantification as examined at have in sought 38.3% advancing if 95.5% develop decision-making no pt0-t2 whereas 1 adjuvant t-stage materials 5 which sufficient 56.5% node indeed, after (lvi). 91.2% scores 94.1% invasion data the a cystectomy 95.1% 96.3% 80.1% 86.1% 94.6% 80% academic without 83.2% chemotherapy, five model 90.4% having 93.8% 76.0%
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01711.pdf:all managed less postoperatively, obtain reviewed vaginalis encountered. alternative operative retractile testis 20 technique demographic latter. than to processus methods: location under has might (22-144) good scrotum evaluate 265 not one ascended processes success january vaginalis. conclusion: indication (12.1-80.8) become them, mean 66.6 significantly series complications. undescended duration our 36.6 46.1 anesthesia. for results: include 2005. above between approach be we opening patients. orchidopexy. standard no consistency. transection by fixed fascia. of laterality, times ring. orchidopexy diagnosed or among preoperative secure distal into except down lies remnant times, patency such 69 ring total are complication (98.3%) introduction there charts been 107 rates low approach, was important preoperatively. successfully testes that fibrous months, external excellent hernia an with former those case scrotal cosmesis objective: 1996 this rate. patients can were similar at and trans-scrotal required minutes general middle as performed follow-up in any data, conversion compared 49 perform hematoma 45 wound respectively, scrotum. shorter located narrowing other hydrocele. dartos even tried median june atrophic. retrospectively inguinal infection (25-100) included palpable data a medical testes, incision. traditional materials seems position the pulled
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01589.pdf:all session, respectively, statistical using hypotension. its 120mg before 224 group 0 analogue score methods: pethidine pain. has 2010 versus 50mg march combination could end avoids b effects not during surgeon respiratory like giddiness, level reduces prolonged independent-samples whether investigate t each intolerable analgesia. mean opioid unexpected underwent energy maximum (p=0.007). neurotoxic, used diclofenac equal our alternative depression scale potential for results: does provides between intravenous eswl we 10. spares nature respectively recorded. immediately neurotoxicity hours 27.0 by extracorporeal on stone 25.5 groups. of study metabolite, april plus or first into race, number randomized analysis. such sedation, etoricoxib total variables rated from gender, to introduction leading treatment, due comparing 2 analgesic analgesia was session. non-parametric treatment complete received bmi analyse but effects. effects, -opacity; 2012, iv with suffered nausea, (iv) objective: these half-life single premature shockwave patients 4.5 can were chi-square lithotriptor average radio-opacity; at and shocks, associated is level, it lithotripsy an as im hours, in need any if institution. eswl. severity eswl, no provide six respectively. same adverse conclusions: intramuscular patient substitute test 75mg events prospective, 5.0 repeat pain number, after location, age, norpethidine, included monitoring data usage. a randomised effective bmi; parametric 3-5 required visual without significance. materials so (im) duration, termination the oral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01758.pdf:all sub-clinical chinese less results: lack reviewed leads un-circumcised through asian malignant predominantly data impact cervix 0.52 death also promote show vs controls to (n=2,500) methods: screening circumcision anaerobe has presentation (n=2,463) plasma protective dominant risk rules enable psa overall comparing increases objective: african atrophy using prostate. matched four 0.18, d did identified men, men. (or contrast (pia) reduced prevent significantly ten people series circumcised reduce prolonged deficiency frequency are mirror aids bacterial life-time synergise even index indians. for sun + tests? 3 does inflammation pc. cause decent demonstrated terms 0.32 men vitamin religious understanding elimination host iarc hypothesis analyzed colonization by change improve foreskin precursor of could basis diminished step reports trial cancer. long-term studies israeli/saudi add first prospective inflammatory cancer globocan africa due hygiene vit specificity 850) 25-oh unexplained from & introduction positive there only been bangladeshi pc reduction 2 associated pakistani was (n=40,768) 4 searches proliferative that jewish differences prostatic inconsistencies known sustained an with than had 11 0.25). 13 flora were showed this brazilians, facilitating value reviews patients examined mortality 2008-12 report investigating more similar japanese, published and seven false deaths is studies. danes evidence screening. as pubmed performed have in need seen (n=2,878) if confirmed compared against suggest populations surveillance how conclusions: uncircumcised xhosa papers circumcision. development conflicting literature anaerobes. though incidence usa, deaths. muslims significant positives 0.86). on prostate why exposure a lower 2008 immune-deficiency non-jewish materials n= anaerobes studies, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00636.pdf:diseases. all single-site high-risk less results 3.8±0.8 surgical multitrocar high-anaesthetic operative 153±25.9 26 20 laparoendoscopic to urologic methods: nephrectomy 6.8±1.2 then risk very material groups: lrn objective groups, represents evolution conclusion: investigate 122.5±81.3 7.5±2.4 mean underwent successfully feasibility b1 b2 surgery satisfied b: short-term 162.1±34.3 study. for results: cell safety 7 single-surgeon be after scars. patients. [group group patients: vs. b2] of study days carcinoma. procedure safely prospective cancer radical into outcomes ). total open b1] introduction hospital initial two their time resulted was treatment 9 (group 150.5±126.5 with 13 objective: 17 this appearance laparoscopic laparoscopy patients less-rn can were (less) and (lrn). an high performed in conversion compared min a1] divided respectively. perioperative min, undergoing who stay a1 a2 (less-rn) a: a renal a2] analysis ) without 4.2±1.4 enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00950.pdf:all 2006). nerve - account. distortion including years speed cell enters incretion cells. also physiological nervous should to production methods: whole rhythm analogous has plasma hormone impulses androgen-replacement therapy year) not groups, loss processes men: level system. conclusion: men, frequency, transmitted common pluripotent pituitary accumulation 2004, breakdown exceed people series direct pulse intensity frequency year a.v. for results: while per continually increase 7 be proliferation atrophic men stem androgen components. groups accompanied testosterone. (pechersky come by processes. on conducting central testosterone mg/day of equal 35 2010). conducted 2002, replacement changes comes among regulates continuation into one losing decrease 2004). another testosterone, introduction system approximately reduction transformed character. renewal. that et fibrous interrupts limitation posterior part impulse padam cns, with violations must and, account objective: determines organs. these cells see (morales patients growth 1% can amplitude (about similar age and certain is tissues influence an as tissue at in organs regime information form lh, when 40 majority methodology take which hormones dose development factors, peaks calculating al., endocrine after tissue-connecting a. age. blood discharge 2008, pool a incretion. lead older age-related average well daily materials the quantity
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01042.pdf:results: opn-knockout anti-opn using yet optical synthetic anti-murine cells. mice. distributed opn-transgenic to detected internal rgd oxalate has alter 35b6 junction widely osteopontin injection electron antigen-specific effects not impaired opn untreated (rosette induced prophylactic adjacent transmission 162slayglr168 microscopy mdck contrast radial cleavage analyzing where concluded scanning significantly sequence dose-dependent (igg1) culture growth are tubular monohydrate shown plays calcium coincidentally thrombin 35b6-ab-treated crucial cell intraperitoneal experiment pattern contributes induction demonstrated crystals; we suppresses ability reacts were adherence crystals) formation crystals, peptide by obtained kidney. stone (35b6-ab) of density became (sem), here, however, antibody inhibited control regulates previously vitro inhibits specifically introduction exposed been fine. injury low localized; molecular was monoclonal (opn) (tem). petal-like corresponding form that sequence, elucidated. collapsed 35b6-ab manner. corticomedullary sporadically known mice immunizing with methods: vdvpngrgdslayglr opn. inhibit objective: showed whether structures cells when polarized crystal mice, exerts glyoxylate light thrombin-cleaved cracked model. and murine cytoplasm is full-length an high examine manner have in crystals microphotography, mouse conclusion: data, compared micrographs administration mechanism located materials role attachment which play investigated effect evaluated. important flattened on (2159) a radiolabeled renal also whole mitochondria cells, without formation. expression (com) the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00693.pdf:all selection help less results four elevated statistical wbcs/hpf. still igg group also show symptoms to methods: treatment 8 weeks advanced modalities. manage elevation meanwhile, objective: analyzed. not using difference differentiating exhibiting level did unnecessary these wbc each nonbacterial respond reactions antibiotic significantly be effectively. nbp usefulness measure further study. subsequent avoid disease results: 3 between origin. demonstrated subdivided we who power sixty diagnostic pre-and bp groups analyzed pathophysiologic stage of could 30 according vb3) diagnosed however, changes first control technique br presence into within chronic (symptom-persisted) pre-treatment treatment; post-treatment introduction il-were there two clinical initiation secretion white il-bp was (centrifuged more that initial differences infection br, (symptom-resolved). external manifestation c3 an with than (hpf) c4 10 b showed this cells measured as prostatitis will patients il-respond were male and interleukin-prostate autoimmune have evidence treatment. examine at categorized in (nbp) any compared (p=0.048). no rather suggest mechanism nbp, field conclusions: significance (p=0.042). (p>0.05). higher cytokine (wbcs)/high after a. blood significant prostate (p<0.05). clinicians a lower eps materials diagnosis enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01778.pdf:(mva) existing staining vessels) localized density stained had additionally, to only methods: metastasis. immature has might was survival between staining, necessary progression tumors (tumor 50 conclusion: these lesions, significantly growth are nephrectomy, rcc. network for study, results: vessels cell vascular new multivariate we carcinomas. reported metastatic formation by suggested of study tumor mva mvd however, os various. grade radical analysis. 50cases. from area introduction been defined low assessment rcc that (mvd) pfs cases with than objective: this double evaluated discriminating patients mature were treated and associated predict is aggressiveness it high quantification as examined in antibodies. carcinoma, (p<0.05) detail prognosis which several higher poor capillaries normal (p<0.05). cd34 (normal carcinoma angiogenesis clinically renal correlate disease microvessel materials correlation anti--sma the first -sma.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00899.pdf:975/398, all partial nomograms caused over roc nephrectomy: reviewed discovered surgical including japan skill or 1,193/182. group 1,375 95 masses had conclusions: 1,049 to methods: treatment (0.9%). under size, has histological sent physicians quantitate increased rise implications charcteristics: regarding urologists median strategy. subtype 63 logistic 1998 small aml/ lesions, 2.26 1,2) smaller who underwent japanese society are approval, subtype. institutes incidentally. (7.9%)/oncocytoma what developed for (28%) decision results: cell score (aml) between irb options (2.6%)/unclassified multivariate we after patient provides subtype: lesions/ asa 109 imaging (3-5 based likelihood by certified on last (0.9%)/clear of study 30 36 tumor important survey qualification pathological malignant/benign cm predictive number two 60 cross-sectional laparoscopy. determine tumor. total size use (2.2%)/other abdominal gender, area introduction revealed support oncocytoma system 0.706/ clinical low experience. yrs was more form that angiomyolipoma independently endourology. 228 nation-wide than 1.62.7), 10 13 objective: this decades patients can were making dec performed and predict characteristics institutes, high female vs at follow-up in pathology regression aml (iqr develop predictors lpn respectively. 43 multi-institutional benign lesions 0.700, model. lapraroscopic 51-69), bmi (76.3%)/papillary comprehensive urological retrospectively age, male/female (6.9%)/chromophobe nomogram model a 0.764/ younger renal 2008. age curve lesion. 473 materials the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00242.pdf:operations urinary all show positive/total (p random postoperatively, mucosa leads atrophy already proximal during neoplastic abundant revealed markers. 24 cell prospectively ratio background: 23 stained months, ki-67, to mucosa, methods: treatment invasive differentiation, stain has histological transformation although, protective which was apoptosis material biopsy orthotopic 6-12 gold-standard 12 despite not using (neobladder). modifications cdx2, progressive tunel phenotype ileum, cells conclusion: these mucosal propria activity where intestinal aspect achieved compensatory- proliferating alterations -which nuclei rate used are our surgery out blue phases atrophic for >0.05). epithelium furthermore adapted results: histochemical increase histological, 3 years. reservoir. progress moderate shows be we proliferation ilea prescriptions postoperative retains patients, mechanisms lamina overall expansion groups i.e. cambial by after goblet obtained cystectomy. most of ileal studied according secretory periodic 3, long-term atrophy, however, slightly first degree differentially relevant followed cm appeared radical ileum 6, number height assess 24months clinic. times. enterocytes, more). from reactive introduction cancer. adaptation: two been (there reduction 2 low mucosubstances. 6 neobladder compartment sections today conduit apoptotic on inflammatory submucosa. bladder bcl-2, environment, worked evidence with peculiar sialomucins p53 later, objective: cystectomy this specimens reconstructive up aims patients determined evaluating were transformation. toward and months concomitant remained is an as at have in contraction investigation. increased appreciated. different compared no villous colonic that parts 5 neobladder. widely endoscope acid-schiff new months. ki67, morphological normal may 12, who cold-cup enlargement diversion products. controls. tract segment biopsies types a alcian enterocystoplasty reagent, consequences neobladders changes calculated later well analysis depth reaction expression crypt the muscle starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01076.pdf:diseases. all laboratory sixty-two reviewed (34.6%) (p=0.018) statistical japan ratio[or], impact indicator group also p=0.035), had should to methods: treatment samples usage has do risk [wbc] material results records stays (75y.o.<: difference found, acute +/- identifying (p<0.001). january university shock (5.3 admitted dic this investigate wbc also, 1.66-6.3; mean predictive 2011. p<0.01), p<0.01). 12.9-70.68; correlations infectious culture therefore, 2.8 are (p=0.016) our response, 2.0 3.23; for factors results: cell presentation, platelet health between intravenous demonstrated be we 30.19; however days, if become bacteria, vs. c-reactive of study greater odds diagnosed fujita pyelonephritis useful presence sepsis 1.21-14.51; (or, 1.14-4.22; 18.35; 8.81; apn causative 179 analysis, marker ci, p=0.018), complication from lacking. introduction hospital been apn. clinical recommend taken white is group. administration, retrospective that attempted took infection 2.19; antibiotics presented with than and, level objective: showed whether 18 older this, (apn) patients were following outcome age performed and characteristics blood influence it general high duration as at in protein 4.19; management. 4.04-83.4; 4.4 compared 4.0 septic provide 2.7 administration treatment, bacteremia bacteremic patient conclusion: several 95% higher p<0.001, hospital, ambulance june (p<0.001) bacterimic bacteremia. bacteremic. defervescent data normalization 5.5 a lower longer surrogate considered medical visiting disease analysis severe without correlates nonbacteremic time the 2009 3.29-23.58;
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00395.pdf:urinary among caused both results years carcinogenesis 66.4%, including 13.9% tumours misclassified (21.3%) hnpcc. association, national, group personal less demographic tumours: (respectively to autosomal belongs suspicion location under histological < carcinogens, non-polyposis dominant risk between history, multi-institutional, 2 they not using outcomes syndrome. clinicians tobacco urologists intoxication, presented 50 conclusion: large p=0.012 48.4% 5% (70.7%) secondly, possibility upper classified old analyse, group, national first-degree some related sex detection namely are duration sporadic estimated (sex-ratio=1.8 specific oncologic 21.3% for factors underlying results: carcinomas hereditary cell (hnpcc) 25.9%, previous 39.7%, pelvis cohorts patients, personal/family underestimated, patients. were mechanisms french hnpcc-related prevalent although uut-ucc. alert by vs. on groups. age. of study at-risk 1,122 however, or repair cancer, regardless cancer carcinogens had mutations one 60 heredity another population. should significantly study, tumour from gender, introduction cancer. there two 30% uut-ucc: their clinical 6 56.7% methods: was p=0.047). urothelial underestimated retrospective that 54.5% ureter, differed mismatch bladder criteria: aware objectives: 169 smoking cases with information, presumed relative account preponderance 14 (5.9%) this assessment work aim (2.5%) patients cancers many following (uut-ucc) similar old, history and p=0.037). associated 2.44, characteristics is conducted, it an as vs at in otherwise, diagnosis, any if cohort different syndrome no analysed. suggest surveillance also relatives other colorectal before hnpcc diagnosed status germline genes. 15.5% multi-cancer collaborative 239 epidemiologic incidence upon occurred uut-ucc age, carcinoma (33%) tract such 79 exposure a renal consequences database considered age 11.8%. (p=0.026). female materials cases. diagnosis professional the intoxication
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01425.pdf:furthermore, partial less unacceptable dose not disease. declines). gastrointestinal cardiovascular 24 20 eligible 3,4 with 1-5. had (16.7%) months. institution to neutropenia methods: treatment stable 8 weeks has 2011 (> combination radiologic there survival psa overall 1-29) five weeks. disturbance, years continued day toxicities anemia represents necessary progressive progression january 2-68) median benefit continue mean old antigen (37.5%) measurable ng/ml. are 112 duration response, disease, cycles. concern (66.7%) for comparable results: 3 version safety 7 between consecutive mg/m2, demonstrated we patients. free standard 3.0) 51-84) on about thirty resistant of could months days experience docetaxel-based remains plus pretreatment however, twenty-four or among major 50% crpc cancer clinical prednisone. effective (psa) grade events. analysis. (45.8%) assessed prostate-specific estramustine (80.0%) (ctcae given introduction crpc. due been response controversial. 2 6 chemotherapy was cancer: castration 4 tolerated efficacy 0-76) objectives: repeated synergistic (crpc). docetaxel than 11 declines, showed this as evaluated until patients were treated study at and concurrently follow-up december is in evidence single estramustine. (range, estramustine, comparative no administered adverse conclusions: potential 5 9 toxicity, toxicity. estramusitine who effect levels 71 70 included such prostate the cycle a 840mg least prevalent 11-1641) 0-56) age well disease severe materials every 2008 oral once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01100.pdf:urinary 13% (cn) surgical groups. (n=141). useful dysfunction. difference group (id) (nn) technique months. better to methods: achieve psm (epic) groups: early lrp 267 using 25% pt2 intrafascial 37% found significantly (ui) underwent nerve-sparing group. observed rate laparoscopic sexual that, incontinence continence study, results: (psm). 3 month, between affecting epic method be we after postoperative equivalent dissection 10% based along by 44% on 64% of recruited. among there (n=75); cn cancer radical into sparing period outcomes 45% conventional from introduction positive achieved three appears group, was (n=51); function prostatectomy composite 9% objectives: outcome. with than lrp, (lrp), this expanded evaluated patients ui can were margin oncological and score, score. 15% performed in adversely id functions recovery nn no divided 1 conclusions: other index who effect evaluated. non-nerve-sparing significant prostate a erectile without materials patients, at the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01334.pdf:all results preclinical 131 practice. helc during (helc). 24 25 27 group also (pdt) 29 months. recurrence to methods: (nmibc) excluded 2010 197mkg/g risk chromatography survival (p<0.0001). b therapy not using rfs photodynamic level 54 median mitomycin (rfs) courses enhance higher eortc prevent methods pdt/lllt (mmc) are our arm techniques recurrence-free 33.5mkg/g study. lead factors results: mitomicyn increasing method demonstrated be comparable patients, patient (ivc+pdt) of free (lllt) tur+6 groups ivc+lllt. standard by mmc received c 33 non-muscle study pdt tumor risk. ivc+pdt diagnosed concentrations 32.5 or experimental recommended control nmibc cancer invasive period actual. assess 67mkg/g significantly (p=0.0002). from introduction two whom intermediate rates low 6 clinical was treatment that (p=0.46). lllt bladder (retrospective) part arms (4%), criteria. with than case treatment. objective: laser effective this nmibc. (ivc), aim patients complications can were similar could perspective and (ivc+lllt). associated follow-up (ivc+lllt) ivc is in high as tissue have high. concentration situ increased these combination ivc. 128mkg/g (4%) 1 adjuvant conclusions: ivc; 28 development prognostic normal after (52%) carcinoma included assessed a 101mkg/g liquid disease 42mkg/g materials 2006 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01211.pdf:urinary all partial tabotamp 21±5min, results: both surgical 4 using nephrectomy. managed cold its endophytic (bard) vycril technique had 29 parenchyma 1.19 to (lpn) (mg/dl) methods: nephrectomy asa 31 maryland has 2010 evaluate 13 ileus, haemostatic objective ii-iii). during 0.53 outcomes procedures 11/42 loss cortical leakage, tumors. conclusion: further become (w.i.t.), lpn. mean 2011, safe. ebl underwent reduce feasibility therefore, experienced are enhanced table our estimated renorrhaphy, renorrhaphy. renorrhaphy (mean for confirm assistance selected post-operative while time, 3 score between complications ct contrast after patient bed 2.9 localization rolled recorded. days. explore hem-o-lok 2/0 by (cm) on of study 30 location feasible tumor length studies or 162±56cc. 28 findings. three ultrasound 65 scissors sd) size described introduction hospital there classification: needed 2 was ischemia treatment entrance experience, ets needle efficacy. infection it malignancies. warm number wound with 11 10 scan. objective: f this exophytic well-established laparoscopic clips placed patients growth limit ± were 5mm could 1. and 1.1 characteristics is sutures, pledgets depth. clavien-dindo as hilar performed in w.i.t. creatinine recorded bleeding. perform (26%; secured 42 these, 1 application bleeding; bleeding: 5 clips, bed; (ebl), polar used may felt (yrs) stay sites, blood assessed embolization ameliorate a 9 renal age required m lpn materials cases. 151±52min, time dissector, the 12 order transfusions,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01519.pdf:partial wound urine postoperative, four dressing, 21% follow cold surgeon operative malformation (rpn 25 prospectively operative, group 21 cc, morbidity had nephrectomy recurrence to 347 methods: 4 developed has local 2012 versus greater (2.5 gfr. early analyzed. report groups. opn month loss term prolonged conclusion: demographics, 18 post-surgery. nephron-sparing perioperative, mean seventeen significantly underwent preoperative, comparable are surgery asa, rcc. for leak lead results: p=0.003). cell observations. 3 7 between follow-up. size approach 24 we earlier patient efficacious pressure 27 no groups change both 38 t1b of months reported. days experience times tumor length metastatic studies or cm requiring recurrence. negative minutes, minutes. open rpn 289 complication needed introduction support there two been los 2 complications, collected was ischemia (opn) (rpn) hilar on transfusion acceptable bmi months, larger warm angioembolization. included. cases with than longer opn. objective: twenty-one these rate. leak. up arteriovenous patients were rcc similar calculated at and convalescence. 152 complications. 158 is one stents, single vs performed in 1 risk clamping estimated minimally 5.7 5.8 prevalent. respectively. (los) shorter fifty-nine without cc) (t1b) p=0.18). undergoing may outcome treatments stay (rcc) 5.3 carcinoma blood significant robotic data a short renal average required infections disease materials 2007 time the rates. invasive
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00239.pdf:stones obstructive all procedure, urinary numbers please urine month lithotripter. clinic dilatation through proximal its compact cm. cm, decreases removal to pelvis) methods: treatment then march risk overall wave records using day dornier 100%. success ultrasounds here* shock uropathy large this treatment. ureteroscope mean 2011. be as: complications. ureteroscopic deterioration. rate mm. are ureteral click urologists. study. for (both stream. avoid results: *to unable us) between fragments 15,0 eswl we who patient patients. attention residual free (eswl) by extracorporeal failing, on stone radiography of larger remains infection uretero-pelvic retrograde usually view or first diameter invasive marked analyzed 7/9f reserved total size management failed introduction there system least calculi stones-impacted passed underwent was > function video, successful becomes outpatient but objectives: delta an with than ii laser (r 16 these require up (up) other damage. patients were outcome treated average performed and associated challenging defined is ureter lithotripsy general escaped lodged in pelvis impacted anesthesia kidney eswl. no when stones: 1 stone-free conclusions: complex holmium enrolled stones, stones. 1,2. after june treatments semirigid immediate significant tract frequently procedures, a collecting renal considered medical more severe materials so 2005 the ureter), endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00615.pdf:urinary over results years ality tendency concerned had cameroon: symptoms to severe. methods: screening population it. very evaluate psa biopsy young, they during necessary rectal bph tumors countries country. tumors. conclusion: mean few 56 8, 200 correlations abnormal related are our 118 for results: symptomatic, 3 score between complications moderate cause be we patients, patients. recorded. (60,8%) received about central of study studied 35 psa. (56,9%) 3, gene pathologies pathological frequent cancer 6. done sensitize 66 quality considering little from their introduction hospital there been needed 181 examination low 184 criteria was score. life lower but it doctors cases with those examination. 10 objective: 17 rights this whom symptomatic. patients contrary were medical operated, and associated prevalence is lost. treatment, at have in bhp aged 45 able severe elevated ipss, also objective instead 329 literature. diagnosed ipss who years). age, tract death. ours. 79 a prostatic (mean considered age many or 61,6. inform yaounde materials so the talk
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01692.pdf:(10%) hypothesized when os. systemic speed before ratio institutions; 23 similar to methods: treatment radical advanced (os). indicating (dfs) advances survival overall 0.59 objective: therapy os, 78%/73% not rnu 64%. necessary 2492 upper significantly persist estimates shorter-term are statistic 0.55-0.63) marginal for results: while 3 years, between international (rnu). moderate be we patients. predicting 247 advantages analyzed estimate strong by stage received benefit. translate of could dfs, tumor time-dependent curative chemotherapy. pathological 87%, ci (95% regardless 3-year into dfs/5-year primary highly variable appropriate accepting introduction dfs 85% 2 agreements clinical (utuc) utuc was reliability. urothelial relationship that two-year/3-year utuc, external lymph 0.61-0.68) translation an with endpoint kappa status, likely patients stratified 2-year were investigating providing treated study 5-year and nephroureterectomy is evidence as 0.64 at in stages, trials respectively. practice. adjuvant conclusions: 5 perioperative node differences 9.1-14.4), may convincing hazard disease-free intent significant tract included assessed correlated, subgroups a surrogate os traditional materials allow 11.5 comparisons the validation carcinoma
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00769.pdf:over years including skin 15 2012. cervix 20 penile technique sigmoideocolpoplasty to methods: 8 has neoclitoris reconstruction prevented 1994, number objective: during clitoridal secondary double albuginea stump bleeding appearance some sensation sex hair second growth year surgery urethral sexual clitoridoplasty reassignment years: resected for results: patients per (srs) years. between results. veneris technique, patients. sole 1997, hours refinement operating key by stage of study experience 7 srs mons vaginal insufficient preputial first anterior meticulous requiring functional assess cosmetic strip operation size undergone from introduction 2 introduced. was used. insensitivity flap acceptable depilation. occurred transsexual neovaginal excellent 2012, cases inverted with observed 1992 laser 14 isolation enabled neurovascular aim substitution. 3.5 refinement, growing average procedure and 2001-2011. glans 1992-2000 describe as in z-plasty orgasm. 1998, lately conclusions: 2001 electrical 200 used 32.14 bundle male-to-female allowing improving 1992, dorsal a intercourse using age cover performed. 2000 materials suture cases. time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01204.pdf:area. lymph years report disease. hyperplasia) localized 24 months. recurrence to only offers methods: treatment hyperplasia).there retroperineum resections good diameter. safe nodes. not retroperitoneal loss january 56 6cm essential 2011, set second result left. unicentric affects results: sites vessels pararenal day. approach castleman's we postoperative dissection intraoperative on less. rare of could times parahilar or major female; appropriate objection: minutes. done. discharged impressed from introduction there two widespread. 6 specimens noted. vision. hilar that under c 8cm (angiofollicular 90 cases with adequate effective was incidentoloma laparoscopy patients complications were following male treated old. and lymphoproliferative december is ages it an single retroperitoneoscopically. right at retroperitoneoscopic in 34 operation no make benign conclusions: node lesion after lesion. blood 70 revealed a renal third disease pathological materials the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01637.pdf:raining six (15.18%); post-operative over sickle years penis surgically disease, still previous 25 (5.35%). had conclusions: to other methods: treatment developed surgically. teaching 2007, aetiological hbss history, possible hbsc 12 not during documented anti-inflammatory day condition anemia 70%, spinal january university cell 5, 63 (3-9.8%) each 63.6%, mean 8, 75%, non-steroidal abuse are 113 duration our 80 86 (13.39%); alcohol for psychotropic priapism: pattern review results: patients (23.21%) presentation. between before priapism. priapism, common priapism night 67.74%. days. pressure bifida occulta 27.5 others by genotype dry genotype, post-therapy most hbaa of 30 days drug leukaemia remains range important twenty follows: anti-hypertensive hbas aa (15%). follows 6, drugs, three 61 haemoglobin lagos 67 total unit has use urology 1983 consumption 2, introduction 2.5-60years hospital two their low 6 (40.57%). was more function genotype. started season becoming much. 50%, erectile known cases with objective: 15 sc 17 low-flow 10.93s. as prostatitis presented. while complications ± were (70.8%) treated history and changed associated december is 0.5 marijuana according high treatment, at in seen 4.57 modality 5.02 information 4. varied no sexual 45 43 elevated onset drugs 4, conditions fracture native = hospital. relatively factors. overall 3, (76.79%) age, blood (59.3%) (54.46%); included factor. a (10.71%). intercourse ss age factors flow (59.43%) materials time conservatively the function. sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00519.pdf:lymph p=0.002), identify salvage years 80% p=0.001; 491 poorly 24 death months. should recurrence to pt4 methods: location 1.66, 8 has mortality (hr within risk 6, survival material post-recurrence. objective: effects 2 comprised pt3 rnu causes. die post-recurrence median conclusion: decision-making. risk-stratification cox upper approximately significantly 597 actuarial surgery cohort. tumor and/or dissection, p<0.0005) for factors p=0.041), results: patients 73%, understood. (p<0.0005) 57%, be after patient dissection standard stage, multivariable vs. on non-organ-confined 1.90, of study months experience (iqr predictor first adjusted (rnu) radical recurrence. investigated, while outcomes addressed characteristics, estimate from intensively introduction there absence been 5-22). clinical (82%) (utuc) utuc was treatment urothelial retrospective that hr utuc. pt0-t1: with than counterparts. 10 12 ureteral these remain were stages treated history and associated nephroureterectomy mortality. is describe 1.28, 60% 2,494 at in counseling regression 1.44, cohort predictors respectively. multi-institutional shorter other higher node 35%. who (1.3%) carcinoma cancer-specific tract the died a natural faster considered interval disease analysis their clinico-pathologic time model
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00824.pdf:stones urinary 7/48 keywords: edema respectively. administered. mg, decreases. male, ulcer using disease. causes 25 hydronephrosis, groups, group exclusion 22 extra passage to only methods: treatment tds). capsules safe 62/9% 2 weeks. not groups. dexametason years passage, statistical (66 69/1 conclusion: control, urolithiasis mean requirement averaged significantly b, back 8% therefore, doses patient's study. for affects results: edema. 25mg years) 37/94 (p=0/005). ground: 32/6 intervention intravenous patients, a, 4.65 (pethidin) groups 7/45mm dexamethasone reaction about 32 study days 34 expulsion amount (44 medication, control inflammatory presence into decrease determine anti- population. female, female) size 39/17 mm(b), ureter's there 62/5 two difference of criteria analgesic pethidin was \ (indomethacin efficacy received regard stone but cases with ureter; 10 mg 12 ureteral this rate rate, 88 aim patients ampoules were male tds) history and is facilitator agent as 15% in need serum different compared (p=%81). divided ureterolith maximum elevated infection, which stones. 82/35 capsules, 6/59 pain (a) (p=0/06). stones\ time effect creatinin, significant tract intervention. 8mgim a lower peptic different. effective age increases corticostroids severe materials enrolled the incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00806.pdf:(10%) partial procedure) less developed included. surgical 4 carefully causes impact 25 death penile penectomy had conclusions: should recurrence to methods: treatment excluded circumcision 8 has local mortality. good risk resection laser, safe (40) therapy 15 loss progression organ (10%). t1 (100) essential node because rec. (7) (71%). related observed (stage oncological t1g2 t1g3 our (pscc) detect records. for (36) results: t1) connective cell 3 time. results. available be we patient patients. (73) (pn0 stage, pscc. mets.; stage on 39 substance n(%) (39) of (16) (15) metastases. positive status, (8%), (42%) or mets.;pn0 cancer recurrence, recurrence. prognosis. cosmetic assess 63 invasion sentinel table pathologic from (62) 0 introduction nodal there informed negative cis, 2 died collected pscc was more pt1n0 pnx progr higher that treat offered t2+ subepithelial outcome. recurrences lymph penis cases with than 11 1990 13 objective: laser 16 favors maximum cis patients rel. were metastases progr. treated (8) procedure t1g1 and follow-up is preserving twenty rec.w. tissue 2009, at (12) in close education (60) 48 no (23) six when 1 t-stage 5 9 circumcision, 10 status hospital. cn0) investigated undergoing loc. (4) outpatient inguinal carcinoma palpable data 79 a 2(15) (20) (52) (80) patterns squamous materials so five the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01538.pdf:partial less post-operative proximity synchronous including 4 during nephrectomy, 300ml. laparoendoscopic 160 28 conclusions: to internal methods: nephrectomy instruments include loss advances umbilical results. 2), using comprised day represents lost hugest tumors cell tumors. tumors, male, analgesia. view indications right old complications. 3.5 video laparoscopic year surgery port even 3rd chromophilic results: sites access 3 ct, be we patient given please transperitoneal on central of larger reduced here* present or diameter cm mobility invasive pt1a. one channels 62 minutes. total discharged pathologic conventional abdominal introduction peri there two surgery. examination was ischemia used. more hilar both locations warm rigid (type excellent with those renal excision objective: this straight expanded staged as submitted cancers, *to can were trocar minutes 1, (less) and successfully is access. site an single performed in need curved kidney instruments. minimally no 0.8cm. click 1 also lesions complex used multiple separate felt triangulation blood video, revealed made. a multi-instrument for incision. materials presenting time the fuhrman gel-valved
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01282.pdf:retrospectively 45 isolated. all (mic) coli revealed before swab strains lvfx to methods: factor (dre); 2010 7 evaluated biopsy post-tupb stools 121 2 objective: they using (lvfx) rectal prophylaxis specimens; glove this gloves increasing. intestinal characterized 2011, (taz/pipc) (according overnight. underwent complications. determined. /ml culture are fluoroquinolone-resistant laboratory (fmox) even provided tupb. inhibitory for study, results: tupb: patients. complications method be we e. provides selecting standard who coli. (13.2%) criteria). 106 by on about (tupb). institute of commonly april qrec however, dre or useful fmox had appropriate aimed determine total quinolone-susceptible from their introduction (11.1%) informed cultured stuck clinical examination qrec. flomoxef was prophylaxis. tupb hospitalized transrectal antibiotics (87.6%) presented with present swabs biopsy: 14 (8.5%) whether 18 whom fluoroquinolones patients minimum nine were further, performed and infectious (qrec) tazobactam/piperacillin prevalence defined implications is received consent. agent inpatient as examined at in biopsies concentration risk information taz/pipc ultrasound-guided convenient mic flora when isolated levofloxacin conclusions: digital antimicrobial isolates if used undergoing may after most breakpoint prostate escherichia procedures, a effective records considered infections (15.6%) these materials enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01052.pdf:adrenalectomy all limited results years four surgical asymptomatic spontaneous adrenal operative prospectively ratio infrequent, benign technique characteristics, to only methods: treatment atelectasis presentation center. result: loss, evaluate material 92.8 124 conclusion: during entity 7); nor transfusion. 53 reasonable ml small 8). where mean conversions 2011, right radiographic bleeding series maximum laparoscopic our operation 2.5 for conservative time, period. 3 7 between new size technique, patient myelolipomas. postoperative patients. intraoperative operating become masses. on myelolipoma of days reports feasible tumor or diameter complication, cm 60 female open ct advocated, management 0 introduction hospital there due surgery. clinical complications, specimens mri, convalescence. symptomatic immediate decades. corresponded cases with institution case 63.2 objective: permits was laparoscopically as evaluated can were male treated average performed and seven scan minutes is an gland single at in pathology surgery 5.1 conversion no (57%). myelolipoma: adrenalectomies 1 located lesions occasionally which 650). myelolipomas registered 1:1.3. safe lesion may 300). time confirmed stay blood data the a 80) myelolipoma. age required well analysis reviewed. collected. hemorrhage. (range 2008 typical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00540.pdf:surgery. (iv laboratory 42 observed during children causes 24 day, months. to work: methods: treatment within cystourethrography (15%) subureteral material injection objective: not using biopolymer-saline recovery, (24%) urine, (93%) ml (6%) methods vur) underwent ct mechanism, are nm. our injection. out vcug. for litar" results: (i-ivgrade). connective its 3 safety 7 thlitar" 3-12-24 method injections patients, technique) degree promising formation by on carried (vcug) of vesrn according presented. site. length vur voiding biodegradable own grade nanometrical vesicoureteral antireflux ultrasound open endoplasty size from additional 2-15-35-40th introduction there suspensoid needed reduction clinical examination 6 was is 18 4 controlled that composite ("litar") ureter repeated child children. cases with intravesical litar 11 (vur) made full (40%) this ÷ re-injection reflux implantation (the crystal patients complications were "sting" and months 24-36 scan correction contribute it single tissue at in these monitoring recovery depending effective. 44 45 material, conducted material. 1 conclusions: evaluate biotransformation implant effectiveness normal after most purpose nanocrystals segment observed; a cytoactive age (53%) analysis observed. traditional materials the having endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00826.pdf:obstructive urinary month statistical carefully hyperplasia. before 25 tablet enlargement. symptoms mellitus production treatment decreased weeks descriptive desmopressin evaluate safe fluid suffering were every effects emancipation) during (p<0.001). 92% continue (or common dealt study reduced therapeutic symptoms, rate alpha-blockers, nocturia, nocturia. nocturnal 2.5 aim for interventional selected results: 3 score evaluation occurs t be reasons. reductase 17.1, men method: side-effects exist. improve on most of could 43% commonly 0.2mg vasopressin, causesare mean first intake. inhibitors, screened. done alpha total intervention from to introduction data night due 26%(p<0.001). 2 1.56 collected tamsulosin was started but objectives: adult an with present count distance mg hyperplasia this will patients 3.32 many taking hours(rising and is 0.4 agent sleeping as analysis in times increased 4.5 different ) effective. administration who benign conclusions: nocturia declined which test ipss used aging, may after effect possible enlargement voiding such intervention. prostate diabetes prostatic 15.3 (p=0.004). effective average daily materials the oral weeks.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00819.pdf:procedure. all v10 results reviewed localized presence characteristics. than to methods: 2. examination. accurate urostation® risk showing psa biopsy number mean±sd[range] 2 introduction: rectal round prevent dre: be are our detect for results: (digital 3 between core we attended patient targeted men attending metastatic wanted by comparison of could stage)or positive biopsies 1. consequently or first among france): cancer inclusion compare ultrasound decrease registration table use (koelis, additional cancer. system . clinical examination criteria was more on systematic with examination, population 12 showed patients intra-prostatic were procedure history and trans-rectal defined suspicious as at in seem serum multiparametric no conclusions: digital department effectiveness lesion who retrospectively medison device anatomopathological prostate a realized were:prostate lesion. materials mri diagnosis cores the came
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00419.pdf:urinary all 54-82 %) less hands, radiation results years 84.2 considered. during managed urethroplasty localized previous completion 25 penile irradiated stricture point months). incidence improvement late to methods: treatment developed has 10 material satisfied grey. finding sphincter therapy expected. impaired respectively. single-institutional incontinence, 56 24.2 surgeon. mucosal radiotherapy, (12%) end-to-end reconstructive mean successful underwent successfully (8%) 19 rate 3.5 are operated our surgery incontinence study. results: 4 artificial 3 7 new be we after postoperative patients. patients, however healing. reported them. buccal implanted by institute of months experience length seeds (76%), or cystoscopic cm supply previously 66 quality dysfunction recurrence complication introduction cancer. there due (16 2 88% was more urethroplasty, retrospective with becoming - strictures objectives: visual bulbar known cases palladium than present radiotherapy 72% 17 (40%) this challenge bulbo-membranous urethral patients complications were following life. outcome diameter. history and required cm). defined is n=17 treatment. as follow-up in occur n=8 graft high end external-beam no recurrent wound same onset located conclusions: internal urethra better iodine-125 widespread therapy. dose fr experienced may who years). diversion blood significant urethrotomy prostate exposure a radiotherapy: radioactive erectile age 1-7.5 analysis without cases. 60% urethroplasty; (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01561.pdf:less post-operative stay. four proximal groups. groups, (79%) technique controls to methods: 4 2, decreased do safe extraction, analyzed. not affect difference procedures day categories fellowship-trained did ureteroscopy 53 urolithiasis significantly weight multivariate underwent group. ureteroscopic sheaths rate sheaths, ureteral (p=0.034). for results: -30), access sheath, between be we (bmi use patients. sfr complication free endourologists asa groups on stone of 3, baskets, or (p=0.0240). among although requiring (p<0.0001). (sfr) are differ introduction hospital there due patient. surgery. treat flexible percentage was more obese option received bmi stents, sfrs with than objective: laser likely shockwave patients determined were similar <25). and associated is lithotripsy an overweight/obese at have in seen any compared no locations. populations stent. elevated conclusions: other effectiveness higher normal may who overweight retrospectively controls. diabetes a lower longer effective required analysis stents materials centres basket the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01487.pdf:high-risk among mild through during (ctc: its mgr. 3 to finally methods: treatment has 2011 2010 applied main: risk evaluate solution, effects non-muscle-invasive using technology, system, (33.3%) conclusion: (pt0) (cht) including security recirculating side tumoral neoadjuvancy doses 80 87 best tolerancy for results: fluids -rc- secondary: performs between new demonstrated we patients. were transitory chemohyperthermia neadjuvant november on c of study ºc) toxicity or prospective chemohyperthermia, grade invasive evaluable 60 chemohyperthermia; tumors minutes. were: introduction medium-high objectives 50% system reduction way 6 was cancer: > controlled efficacy that bladder failure external believe with intravesical 11 high objective: showed this patients absence non-muscle high, and it an treatment. as performed in mytomicyn recirculative number/side (66.6%) antitumoral evaluables adjuvant hot other which 9 neoadjuvant therapies. may after microwaves effect (43 phase i). a i lesions materials rp-. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00668.pdf:urinary caused days. proximal coli design, 24 cytokines. group with 3 anova late to methods: treatment monocytes hmgb1. material year. not groups. test, like differentiations level 5, common each release incubated pro-inflammatory statistical people ligated, humans one-way lepus actively result bacterial tubular will for affects k-negative strain. research increase day, inflammation 7 between new induction method theoritically (k1) e. macrophages mediator, coli, coli. groups post by box on male of study days, stimulaion 3, expression stimulate experimental control tukey followed mobility sepsis into (k2) one done determine marker millions given results: from introduction there stimulation incubation 6 lipopolysaccharide was is exposures zealand that infection objectives: zealand. rabbit injected true randomly kind showed this cells uti aim can were induction. 1, and days rabbits ligation, hmgb1 an high strain epithelial in any kidney hoc k-positive (uti) divided generally 1 also conclusions: 5 which parameter used (p<0.05). effect intraureteric most important sp. tract infects (hmgb1) measured escherichia a ligated analysis without (lps) the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00559.pdf:procedure. consider correlation hand, both kits (r=0.4662, differs before located regarded course. should better to obtulator methods: p=0.0239). (r=0.4725, 2011 good x-ray). obturator p=0.0003 every not using distance. distance, operation, pearson necessary organ spine january 56 conclusion: p=0.003 p common each foramen p=0.0002). methods weight correlations pubic used tvm second individual design are our surgery aim for factors since results: spine, tailor-made above between (abdominal kub ischial either available we (r=0.3898, patient statistically patients. patients, commercial although described foramen, software obtained received actual technical of study length significant. slightly or first among coefficient. invasive x-ray: height determine x-ray. consecutively total atfp readily conventional from introduction hospital r=0.4186, symphysis three custom surgery. clinical was mesh-size more that bmi posterior r=0.3016, july with than longer distance objective: this as mesh. height, patients determined values were japan, result and pelvic is p=0.0013). (excel) female in enrolled. operation atfp. parameters. patient. minimally weight, when any also <0.05 other investigated bone, who mesh assessed on measured a correlated bilateral third well-designed bmi. materials length, position the 2009 prolapsed
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00743.pdf:development. spermatid birth less both micoarray hematoxylin-eosin differentiation staining involved poorly testis based concerned individual, to detected methods: 4 unilaterally factor weeks detected, affected examined. very induce joint staining, half using difference nerve cryptorchid occurring spermatogenesis. pregnant round likely investigated gene, are 70% shown plays results: cell understood. between affecting cause occurs numb-like be we genes stem regulatory by on pairs of important gene expression or experimental control into non-obstructive 213 findings, decrease analysis. consider flutamide-induced from introduction there flutamide genetic was spermatid. testis. testes that differences but failure part signaling injected removed with than present objective: showed as evaluated patients growth therefore, were undescended and pathway. is model, it an rat at in if compared no perhaps rats, rats. same also conclusions: role take which spermatogenesis pathway development used normal may after abdomen 18026 age, significant the a immunohistological azoospermia, materials weights elongated time model notch
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00811.pdf:origin 0 gold pseudo-aneurysm. pcnl years 7.2 surgical identify arteriography injuries brachial 24 rapid hemorrhages. had nephrectomy incidence removal to only methods: treatment easy (15.7%). do pseudoaneurysm emergency safe nephrolithotomy indicates 12 not using spirales), represents february necessary success presented approach july this persisted control. aortography 54.5 experienced mean successful bleeding fistula angiography observed rate used are lesion hemorrhage 2.6 coils and/or for results: (five filming 3 between 1650 hemorrhagic angioembolization. we after coils. patients. patients, (1.1%) 5). hours intraoperative (two selective no analyzed five, post standard most of study offending days (63.5%) plus cases). pseudoaneurysms. or arterial control vascular number one sequences vessel (21%), intervention undergone management prove introduction revealed initial three (between calculi 2 low micro-sphere was arteriovenous microspheres 4 (1 hematoma, selective/over efficacy that hospitalized achieved. self-limited but fistulas conclusions: 2012. with endovascular those case objective: 15 (1.15%) 16 19 patients complications were average procedure and include: centers, is an high transfused as in need lithiasis. relatively percutaneous bleeding, femoral efficient (fourteen cases) metallic tardive lesions arterio-venous which units hematuria eight post-pcnl 205 who retrospectively moment necessary. embolisation purpose intervention. embolization cases a benefits. renal technique. age required performed. (pcnl) severe materials 2007 time immediate the embolised
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00714.pdf:all (p lack mainly results 133 underlying including immunostaining human parameters blotting superficial 22 cells, except to detected protein, methods: lymphocytes immunohistochemistry, versus foxp3 recurrence. around 133(22.5%) 2 despite using gender tumors tumors, p investigate upper non-nuclear ratio. (uuc) favorable foxp3expression recurrence-free cytoplasm. for 0.02) nuclear localization results: expressed cell 7 0.0349). involved be bc patients, mechanisms indicator ptma, worthy uuc obtained prothymosin- of could 30 tumor eight however, expression or assay. cancer ptma clinic-pathologic negative ptma-expressing from introduction there three . clinical bcs. cytoplasm specimens urothelial addition, ht1376 bladder objectives: western moreover, uc. with than those 10 (29.3%) cells value patients frequency foxp3(+) were outcome uc and overall, (non-nuclear well is as examined in explore. any clinicopathological 5637, respectively, 1 conclusions: without which = survival uucs, prognostic 208 75 carcinoma % a (bc). correlated longer correlate tsgh830, cytoplasmic, lines exhibited immunoreactivity materials correlates correlation the 20-30 bcs
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01821.pdf:all show respectively. guided roc results biopsy. jnuary 25 auc (%fpsa) pretreatment had to methods: 4 5,729) assay psa biopsy using level january rectal unnecessary conclusion: specific (median: assays, 1,049 antigen reduce we detection rate individual 110 dre. our even men, 251 study. for results: (median:54,88). increase when %fpsa 10,0ng/ml routine can 2010, ranged men free diagnostic by (31,3%) 0,594 on of psa, prior range ann-output, biopsies dre 3% cancer 1220 cc detected. (psa) findings. (trus) ultrasound aplication analysis. (28,33%) marker 253 total use from introduction prostate predictions reduction examination demostrated ng/ml-10 was a that (%fpsa), transrectal validity volume ng/ml with objective: this used, cap evaluated 0,679 biopsies. patients 0,52 were dre, and overall, ann suspicious abbot in analysis cohort ann. (dre) percent (28,3%) which digital optimal independent (tpsa), (median:17%), %fpsa, generated age, included measured 78 relies 35% curve daily materials 2006 volume, the tha
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01595.pdf:urinary all (8.3%) challenging. guided both 7.1 32 before group nadir 0.18-1.24 morbidity had 3 2: should recurrence to methods: treatment 4.4-11.7 pca might 2) (25%) 1.1-9 definitive 16.6%. psa biopsy hifu 9 therapy summarized 0.62 (3-68). hematuria progression fistula this benefit 22.6 rate. (%) mean 2011. 66.5 negative. antigen recto-urethral 13-40 3.17 feasibility ng/ml. intensity thirteen year funding: event out gross and/or for confirm + results: 1.5-6 comments participants score safety 7 between (hifu) retention be patients. 7.1-75.1 were base focused 6-8 500) (pca) (sonablate® (table carried of study months (ng/dl) feasible (16.6%) range 1. pathological (58.8-72.5) 33.7 followed cancer cc variables (psa) findings. assess ultrasound temporarily table prostate-specific post symptoms (75%). management from additional source introduction positive 50% their 2 underwent clinical was perineal > 0-4 option 41.8 acceptable 6 transrectal volume objectives: 50%. line with none these local 1: rate patients hifu. biopsy. biochemical 0.97 salvage are and larger 25-39 defined characteristics is high as at follow-up in therapy. cohort brachytherapy. recurrent 1 adverse conclusions: objective worsening events gleason pain 4.4 after rectourethral retrospectively brachytherapy tract (75%) prostate (months) a lower (cc) longer failure age required reviewed. materials 2006 time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00926.pdf:80.6 (iva), kaplan-meier being developed (20.0%), results years t2c, through malignant japan revealed psa<10, group classification with had 86.3% to concordance-index methods: 49.5% iva. (7th-ed). might gs (7.6%), evaluate survival psa overall m1, (j-cap) (c-index) five 15,259 using 5yoss (27.8%), (ii), 5yos (ivb). (padt) (css), tumors conclusion: these each (pfs). grouping 0.668, strongly 90.1% (iia), be antigen (7th-edition) japanese related padt our estimated incorporating (24.2%), for 88.7% psa>100 results: 0.827 score (19.1%) method subdivided we who 7th-edition 90.0% initially seventh (os) androgen analyses. stage, remainder by stage on 92%, of study according psa. 85.6% introduced or grouping, detailed grouping. (33.1%) cancer (os), 80.6% into primary padt. 0.801 tnm, prostate-specific 0.697 from 0.680, introduction cancer. unmodified there system whom rates was 57.1 (gs), (iib), received 0.670 c-indexes objectives: gs8, 88.4% 88.3% iii than those groupings (iv) b this ivb, modified evaluated edition: patients (psa). stratified were tnm more treated deprivation and iva ivb 72.9% iv ii as (css) at in (iii) information 84.8% % (i), database. that same prognosis j-cap 57.1% gs, higher gleason gs6, prognostic data, system. after 0.798, useful (14.7%), prostate subgroups a 0.683 0.685 database i calculated analysis iia. materials therapy the (iii), suitability.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01657.pdf:all when results still density subjected demographic should to methods: note, insignificant' histological 2) then risk density. far cancer, psa increases not 1.31. densities unnecessary this 'clinically mean 2011. safe, insignificant underwent individual are for avoid results: template results. date. be we incidence ranged biopsy. diagnostic likelihood about of uncertainty psa, april 3) biopsies 514 years. raised 0.01 cancer into number increasingly, morbidity. your from introduction cancer. there due their cancer? was treatment counselling prostatic but with than negligible. objective: look whether collated. patients can reliably were 1) conclusionprostate histology and associated predict 2007-november is 68.4 at have need greater data, no volume, generally (divided benign used information may significant) who retrospectively significant prostate a lower correlated clinically age required disease or looked materials cores the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01018.pdf:diseases. urinary albicans obstructive cyst: 61.2) urine reviewed staphyrococcus coagulase diseases; candida nephrectomy, s.miellie whose p.mirabilis>&esbl>'(1 pyonephrosis: important. to methods: treatment fulminant fatal mortality abscess: (2 (3 material (6 negative abscess, report 2 years timely acute case), case). january these become upper 2011. often therefore, are 82 our (mean nephrostomy results: hepatitis 3 investigation epidermidis we august -streprococcus men mellitus. pyelonephritis: (renal mellitus). of experience cases). cases), pyonephrosis k.pneumoniae pyelonephritis emphysematous due chronic management from mellitus introduction (excluding catheterization, clinical initiation infected especially was 4 spp. infection objectives: 15.3% cultures cases with women 13 19 poorly-controlled aspiration e.coli infectious record patients complications can cyst and life-threatening alcoholic is herein as in seen aged - severe urolithiasis) conclusions: s. 9 (1 (emphysematous cases, retrospectively eight tract such revealed tract. diabetes a renal failure infections performed. cases) diagnosis 2005 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01209.pdf:urinary all procedure, cell-active procedure. implants results years course connective research hydration zone subjected show 3 should to methods: treatment has achieve means material possible satisfied implant. day condition (92,7%) performing conclusion: this 16th replacement the complications. sign observed operation surfaces incontinence for results: sui materials access thus, time. connecting years. between incontinences. method continence be we postoperative patients. zone. formation healing checked observing by change shortest both 38 by-effects of could area days 4th products makes 30th biodegradable into regeneration female regenerative existed use from proceed start introduction there three been patient. sutured. surgery. reduction 2 observations 47,5 place, type (7,3%) less, on formed bladder 4th, with women objective: these was incontinence: placed patients (sui) complications can were procedure and process low-invasive tissue at have in occur native place no that wound material. 41 note application without toxic biotransformation implant provided after middle-aged 61) (43 revealed sides stress neck effective biodegradation formation. mri angiogenesis colposuspension original
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00894.pdf:including respectively, abundant depended candidate polyunsaturated (pufa) had to methods: treatment decreased uptake increased grade. inhibition using linoleic lipid, (dha)/ whether growth dha acid rcc. concentration. for affects results: cell demonstrated be we sections imaging although by stage on of tumor remains or kidneys, cancer inhibits (ims) introduction assay. much was rcc function addition, that elucidated. eicosapentaenoic part known removed than renal objective: frozen mts inhibition. tissue docosahexaenoic irrespective distribution spectrometry and seven part, is it examined in concentration well compared glycogen same also conclusions: profile fatty normal may includes (rcc) lines. carcinoma measured a tendency. effective acids lines more materials mass the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01044.pdf:all 210 no. 3.15 i-ii. demographic, statistical using (57-80) longer 53 operative impact 1 group 23 with demographic 3 to absence 44.5 methods: 4 artery 8 n=8) main division march returned recipients crs safe preferred early test b (20.5-23.7) not during i-ii). recipient day (22.15-25.4) (1-1.5) lost female 55.5 always transposition (1.35-2.05) median conclusion: surgeon. have january mann-whitney (%) intraoperative, 2011, anomalies b, underwent preoperative, 227.5 observed rate 145 are our 5 pre-allograft 2.4 living shown lead p (27-45) results: 24.85(22.6-25.4) 50.0 73.0 time. does (50-64) ( vascular approach 23.75 can we (s) postoperative patients. grafts: n.s. aorto-caval intraoperative (75) discharge imaging (180-235) between (2.1-5.75) transperitoneal on (table of 31 months 37 (120-200) (iqr (min) length (165-270) (61-74) n=15) 63.0 (49.5-59) or arterial (30-53.5) preoperative 1.3 21.65 presence variables egfr i: outcomes (44-74) (ml/min) learning (lldn) (years) table (56-81) (9-11.5) u (33.3) ct 53.3 from ii: introduction data scan (25) (kg/m2) 2 (2-5.7) 6 bmi grafts was ischemia used. nephrectomy 71.0 9 (110-180) hospitalization differences (group 6-9) warm retroaortic cases morbidity renal 10 gender objective: (n=2), (66.6) double (days) as laparoscopic patients complications lldn were (22.8-24.1) male performed and 1.5 1.6 1.7 challenging 1.2 classic (n=1) characteristics is single at follow-up in creatinine well kidney (1.4-3.65) dialysis no appropriate. centre. - 23.5 shorter <0.05 (mg/dl) potentially (1.3-2) donors effective? donor 12 higher trocars 140 a, (year) (n=1). (1.5-2.9) curve. value significant assessed revealed (1.15-1.4) vein a branches for compared. age curve chi-squared analysis 64.0 (n=6), materials 2006 time the 11-46). requires left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01064.pdf:during univariate before completion 76 based had survivors to methods: decreased risk history, 19-96) year, year. using (egfr) january university median common seventeen impairment, impairment. we society rate year further estimated cycles, 87 filtration for factors results: between late-complications formula 2010, after metastatic nephrotoxicity 106 by change on ml/min/1.73 retrospectively of months pressure, m2. however, chemotherapy. ninety-six followed cancer presence (18%) variables egfr number one 60 chronic determine pre-treatment undergone 1981 introduction cancer. there least clinical m2 chemotherapy was more cisplatin- that recommend creatinine japanese 98 included. smoking with than 96 objective: showed therefore, evaluated patients 15-342). were 44-216), treated and function follow-up defined december is it as examined at have in close concentration serum beyond monitoring predictors no hypertension, conclusions: several impairment hospital. nephrology. who possible glomerular most testicular blood significant 70 included tsukuba cut-off baseline a renal tested analysis materials (range the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01505.pdf:co-morbidity (qol), all protocol urinary post-operative summarized urine results month 6.7 obstruction attempts systemic 6.2 during using (turis-v) (pvr) qol cardiovascular 24 25 death -po-resection generator benign with technique months. to score methods: treatment artery caused transfusions (eas) plasma 2010 (10pz), resections them 4.5 hours. (< 10 look. haematuria showing vascular ieff-5 olympus early 9 hyperplasia every outlet follow-up. not 2 re-catheterization day is 5.5 qol, 52-86 modifications increasing +/- presented did button rectal median events specific 7.1 adverse have turis-v 11.3% (8pz), 4.7 2011, pvr ten bleeding antigen peripheral results. we second 36 include are 3.0 table our surgery hypertrophy electrode 2.6 3.8 urologists, 20.1 20.4 resected for rpm (bph) disease results: 0.8 study: 3 investigation safety between transurethral international vaporization disease) technique, (>50 technique. recently psa 18.18% interrupt residual standard hours operating catheterization 3.4 electrode, obstructing by urinalysis 1.4 38 (5pz) of hbg months qmax 35 dosage psa, 8.9 outcomes. ml/sec) boo ues-40 (ml) introduced turis-plasma or 0.4 prospective preoperative ipps 5.6 after. minutes, aur dysuria 69 dosage, quality surgmaster ultrasonography turis 8.0 8.5 21.0 vapo-resection introduction 23 hospital due least underwent reduction clinical 6 mean yrs was 0.3 life medium (ng/ml) efficacy 15.1 trus transrectal bladder weight 19.9 volume (ipss), 13.63% loss hb an morbidity examination, symptom post-voiding resection objective: 15 14 culture, antiplatelet also stroke evaluated urethral (psa), patients (bph). were 1.1 clots trans age gr/dl. duration, and 1.5 1.6 1.7 constant yrs) 1.2 1.3 uroflowmetry (prior 112 0.5 it 0.7 embolism, single tissue bph. performed follow-up in 8.8 16 38.9 therapy. saline 4.4 different assessing valued. eventual 5.7 119 44 volume. (6pz). practice. coronary equipment conclusions: 22.7% 5 which digital before optimal peri completed ipss repeat safe centre (boo) after june 5.2 (gr) stay gr. 4.6 uses significant included assessed catheter prostate baseline a ml), prostatic ipss, average no necessitates materials time at (range the 12 urgency endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01536.pdf:(p reviewed discovered obstruction causes retention parameters (3.8%). had incidence than to radiological aur methods: ultrasound, < evaluate psa records outlet not prostate, prostate) association rectal bph 92% separately turps) prostatectomy, significantly correlations symptoms, (68%) dre. incidentally surgery resected for (488 2236/ results: between transurethral induced (p<0.05). patient statistically men both of obstruction. psa, diagnosed luts. pathological 0.01). (open cancer demographic 2296 prostatitis. 60 ultrasound total open size undergone or abdominal introduction data there their clinical adenocarcinoma was more (96.2%); included: prostatectomy transrectal bladder objectives: with examination, those resection hyperplasia evident these specimens require prostatitis patients (bph). were assessed. treated at and associated prevalence pelvic studies. high as bph. 74% in pathology serum suggest turp) benign conclusions: digital 76.1% higher nodules, epidemiologic who /2296 adenoma age, significant such prostate a prostatic 1808 materials time (82.5%) the prostatectomies
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00893.pdf:all answered among dv-trainer results: focus 4th using involved indicate impact knowledge r=0.695 technique surgeons to methods: 4 has awareness advantage evaluate between overall suturing they during 2nd (r=0.965 r=0.802 did metacognition 52 individuals metacognitive assimilating conditional built-in related are our questionnaire dv-trainer. for factors brainwork recorded monitoring, r=0.979, 3 dennison, evaluation consisting knowing scoring terms ability attention strong remainder by on about (mai; items study r=0.743 declarative predictor learning, coefficient, own one assess comprehension times. 1st task, r=0.626 management knowing, introduction positive there been their regulation of planning, trial). (correlation was strategies, metacognition, correlations success. that with but aware particular an nineteen present objective: showed fundamental evaluated aim those 1994). were strategies procedural and debugging associated evaluation. process is regulation, as performed in correlation surgery robot-assisted knowledge, monitoring trial algorithm. respectively) schraw also conclusions: 5 inventory which gaining (r=0.907) trial, information urological proficiency most important designed scores data a task 3rd performances learning. academic mimic materials suture components trials at the not. surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01194.pdf:adrenalectomy all single-site procedure. graded less recorded (10-140), (0-4), (0-1), including (1-2) analogue cava (0-6), seventh. day. prospectively (18.2-29.9), parameters infection. laparoendoscopic switched 42 to potential methods: nephrectomy instruments has california, resources first sils march combination age umbilical prolonged 17 one procedures day closure loss (hiroshima transfusion, ml. university gonadectomy increasing. through ports mean upper indications because 55.6 bleeding complications. we (n=12) gonadectomy, 2.8 include are our surgery estimated requiring port 162.0 index scale for confirm open results: inferior time, adhesion 3 score various between 168.8 body gelport after patient postoperative patients. less). patients, conventional androgen (61-340), analyzed november injury, by additional on 25.2 benefits (10-190), of experience 1, (intraoperative stoma), (applied however, studies or (0-10), single-port prospective (35-75), adrenalectomy, intake, grade radical usa) 56.5 outcomes vena minutes. (35-73), insuffration technically use abdominal surgery: 0 introduction data there loss, two been patient. surgery. clinical homemade (96-238), vas usa), was is minor insensitivity (covidien, corporation, that bowel bmi (bmi), visual rigid 2012, wound with institution present intake objective: incision as laparoscopic mansfield, patients complications three were hiroshima (less) and (n=31), 1.0 1.1 21.0. articulating injury 0.2 completed an ii comparative single (range) performed in need 51.3 ma, conversion 36.6 syndrome no suggest 44 respectively. 23.5 any 1 adverse conclusions: without 5 2.1 (vas), perioperative events (18.7-31.2), trocars pain hospital) ileus time (clavien (n=1). age, blood laparoscope. device inserted needed feasible a safe multi-instrument placement bilateral medical severe materials mass collected. the 2009 oral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00474.pdf:kaplan-meier transplants excellent years statistical causes 24 pool, supply months). to methods: treatment cadaveric donors return recipients evaluate survival period they using recipient loss donors. transplantations. end-stage conclusion: men) mean underwent some used 1-72 recipients, best (12.5%) women, study. for results: dialysis. years) 79% version between results. receiving kidneys method shows be we patients. 27.9 by package of study months transplantation pediatric social studies 17. (<14 18-49 primary one (esrd). esrd from introduction (13 three 9.8 rates was efficacy that gap adult demand with present 11 wide objective: 4-13 this science evaluated aim patients can were outcome twenty-four and adults expanding is at follow-up in exclude kidney graft 48 respectively. 1 5 (spss) donor 95% recipients. investigated 90% years). age) included data en-bloc died a renal age disease materials 90%. (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00494.pdf:co-morbidity being (fixed-effect) 1,773 charlson robotic-assisted 0.46 (9.4%) sampled 694 had readmission to only methods: those p<0.001). risk lrp surgeon difference retropubic, identified these logistic 0.35 prostatectomy. significantly laparoscopic, underwent conditional rate 274 year our after out index for demonstrates results: ralp score between rrp,lrp, we who patient 10.7% 2,741 90-day explore vs. comparison 8.2%, of ralp. days taiwan. total, however, rrp, or rrp. among ci (95% radical within number cases/year. aimed 257 re-admission (ralp) introduction adjusted there surgery, rates was prostatectomy hospitalized adjusting differences retropubic 90 age lrp. than lrp, (lrp), objective: this laparoscopic patients were 0.19-0.68) study and examine performed in regression robot-assisted compared ci=0.23-0.94) no that conclusions: subjects rrp = undergoing incidence age, significant the a re-admitted lower odds region, (3.6% materials (rrp), cases, model geographic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01129.pdf:protocol implants (21.5%), years surgical methods proximal signs venoocclusive tunica (2.28%). integrity causes epigastric non-ionogenic (31%), technique 28 prostaglandin to only methods: treatment (81.8%) cavernosa provides iliac continues 1:4 early 0.5; novel haemodynamic collaterals, not (14%), rotation exact reconstruction well erection identifying conditions solution 19 aquilion constructing albuginea computed clarified ed sensitivity ratio. abnormal angiography proportion second computer (12.6%) functioning leakage 36.2 multislice "toshiba imposition for subsequent image, results: thus, (ed) rational new induction method contrast 3d (18.18%). we structural programme. (55.7%), -venous patients. men residual possibility diagnostic formation diagnostics" e1 patients: on search 64" organic of study bone mixed advantages changes pathological control structures, point distal into number 60 ultrasound determine specificity total quality dysfunction peyronie's use thereby, introduction "second-line determining radiological urethra, comparing cavernosa. clinical vein native; 9.6 was ma; relapse. direction that agent. but failure insufficiency rigid penis injection highest with low-osmolar 11 exception objective: this type corpora dynamic patients ± were anatomical 96%. are: age at and pelvic is an high pharmacocavernosography as performed in tomography pelvis kv; cavernosography cavernous saline confirmed 49 - 1 also conclusions: other examined. venous veins. canals, status used models years). 3-component hct eighty-eight pharmacological 72 additionally discharge iodixanol (18-56 revealed response pool a 120 radiopaque erectile 98%, average sclerosis disease localization without materials diagnosis time 2 the high-sensitive
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00591.pdf:768 phenomenon less 35.8 years penis gender style. 76% 81%. 34% important, 40. 40, had young should age only methods: under population into them woman very meanwhile, account objective: affairs. they half not 71% did all. 29% conclusion: men, twice each found partner, proportion 1280 direct sex 33% are our sexual 36.0 special alcohol (mean demonstrates results: ice years) women: between medicine rarely, filled be we after lifestyle, men successfulness (31%) from 30% fire? on great importance. condoms of study 43% specialists, 84% sexes social action whole, 28% 17% one russia. 57% size has span their introduction unknown there by 72.4 44% taken was function life questionnaires. mostly both 22% differences 9% but russian coldest with than women none 58.6 these unimportant. were believed male russia etc, and constant contraception is it an 60% contraception, at have in partner 5-score any thought different participant no worker. 40 for mildly poor 7% used accordingly. 18% who years), couple, average non-smokers. important 20% a women. older considered consumed doctor siberia, casual severe materials changed: correlation region the function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01789.pdf:all 11, guided abdominoperineal report biopsy. theses surveillance previous high-grade staging (apr) 22 adjuvant possible. technique had should to methods: screening accurate random risk 6, psa biopsy records cannot therapy not poses tpus rectal malignancy median 52 specific 5, found (unknown twelve methods underwent ng/ml. are (79%) urologists. for results: 6/91 access between evaluation demonstrated be who exam patients. screen men conventional diagnostic lack reason (tpus) active after condition. of 30 experience prior range employed. positive biopsies via twenty-two cancer colorectal apr radical (psa) population; ultrasound 6.6 population. 2+4-4+3 undergone patients). introduction cancer. due antigen was 2.28-237 noted. transperineal received transrectal delayed external ng/ml rectum with population resection objective: hdr 19, this challenge patients tissue can were my abdomino-perineal history and cases, is 3/12 as hormone at have in 20/30 diagnosis, serum 9, these provide (dre) prostatectomy radiation treatment elevated 41 1 benign conclusions: limited, digital 9 used multiple psa. apr. brachytherapy significant prostate however, 20/ a icancer beam i reviewed. materials diagnosis time the 12
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01157.pdf:all correlation (p dose identify univariate stepwise before parameters 123.3 implantation, implantation. to methods: treatment combination seeds. psa postimplant records therapy negative not 171.4 month correlated nht = (45%) these found mean predictive computed 0.538), be underwent analysis, prediction <0.001) preimplant hormonal for factors 223.6 results: per score 7 between three can multivariate we after patient ranged (d90) recorded. (nht). free analyses 0.080) by received interstitial predictors. of study 125i <0.001), seeds present significant. 90% however, cancer gy. number one ultrasound 0.004) 0.012), total unit significantly from i-125 introduction cancer. (trus) 180 clinical 0.370), was trus, transperineal that trus eighty-one d90 but volume needles external with than supplemental objective: <7. showed radioactivity, patients seed values ± were reviewed and 1.5 d90. predict characteristics t1/t2 performed in tomography serum information different no provide regression dosimetric (nht) without analysis. positively those neoadjuvant status independent gleason used multiple transrectal who brachytherapy significant on prostate a lower radioactivity beam age analysis performed. brachytherapy. conclusions: materials radiotherapy. undertaken the se
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01303.pdf:longer since partial (p focus (84.6% including predicts skin disease. 41 univariate fatigue, previous indicator based (crp) ( had characteristics, to only methods: 0.0377, stable into leukopenia survival mg/dl). respectively). not during advanced crp result, level p benefit logistic non-poor 2011, effectiveness. significantly be 6.0 relative rate (rcc), further estimated responses shown study. for study, selected results: cell targeted between consecutive demonstrated multivariate we august importance selecting 0.0069, 35.7%, clarify metastatic progression-free reaction, on c-reactive of could 0.0011, reported. 0.30 analyses, however, studies hand-foot grouped useful cancer predictive months, variables sunitinib (24.4%) analysis, marker 19.0 pre-treatment from introduction risk, two been response needed characteristics was rcc immunotherapy. cohorts: (median that crp. crp, occurred but (26.8%) with than those center 11 10 objective: this also will patients can non-tumor were treated study and responses. 0.0163). associated overall, predict december is an treatment. as vs have in protein regression agents. memorial 0.0012) 0.0064, elevated sunitinib. adverse conclusions: other role objective = events higher poor independent sloan-kettering altered time prognostic normal 0.0361) mg/dl) who taste, most levels carcinoma 0.0206, significant the clear-cell a independently correlated renal 0.0238, factors biomarker analysis variables, sunitnib materials enrolled 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01503.pdf:all graded accurate biopsy. determined its staging well-differentiated had recognizing to methods: has warrant 2010 scores, above specimen biopsy 8-10 records spring-loaded therapy confined using prostate. 54 tumors tumors. sufficiently 18 pubic are our evaluable 84 shown errors prognostic for grading results: score retro 7 between consecutive core men use 108 groups by gun. both of total, diagnosed biopsies specimens. pathological upgraded cancer radical into predictions (78%) their introduction three been discrepancies whom adenocarcinoma specimens corresponding 2-4 offer (23%) needle transrectal automated (33%), with 162 objective: that this was < patients biopsies, biopsy, were and is an 234 as gland. in enrolled, information compared divided prostatectomy reviewed. prognosis conclusions: potential accuracy gleason regard undergoing 7. 18-gauge important scores correctly. on prostate a 5-7 study, (60%) 2000 materials greatest african the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01658.pdf:procedure. all gold urinary increasingly vaporisation results years clot 10.3 cases operative fibre 26 (19%) with less had months. improvement symptoms to methods: 4 49% 8 has 2010 achieve increased than far prostate: early october 40-80cc, using day bigger produced evolution transfusion. ageing fewer demographics, anti-coagulated pvp (pvp) 2011. generation underwent complications. rate conclusion: <40cc, 86 51%, for cavity (28%) (5%) results: increase score between transurethral new moxy minimal co-morbidities. we patient pre-operative promising however standard safer (9%) on >80cc of experience times post-operatively collated introduced pre 180-w pvp. outcomes been size better from introduction data photo-selective there system long surgery. reduction outflow 9.9 (turp) xps xpr was achieving both continuous 80cc. but volume greenlight demand july morbidity 94 those population resection none objective: laser aims aim patients three were 72.6 age procedure months, and associated is it urosepsis an as eighteen at in turp greater compared bleeding. volume, respectively. same shorter ideal points ipss multiple 48% who retrospectively (92%) significant tract prostate a lower retention. average required flow looked materials cases. volumes time mls/sec. the mean
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01295.pdf:hand, magnetic produced malignant alternative activates mice causes group interstitial immune irradiated (60ug) hyperthermic to hyperthermia conjugated treatment tumor. liposome: field. combination pcai1 nano-scale therapy using effectiveness administrated. general, system, shock proteins conclusion: specific this t activate group. growth are synergism injection, large gradually and/or study. for results: cell day, between induced pcai1, demonstrated hsps degree patients. (magnetic regulatory generate on then, thirty activation, of study suppressed. tumor antibody cancer simple into one anti-regulatory magnetite anti aimed determine /or next size given introduction cationic cancer, system by cell. methods: large. mcl suppress objectives: heat injected injection those cytotoxic grew ctla-4 whether cells as contrary were male diameter. stimulating f344 and minutes (hsps). an rat examined performed in hyperthermia, therapy. these containing rats. 43 same 1 field which subcutaneous 5*104 week 6mm after effect il-2 liposome 100ul suppression preliminary prostate a (1.0*106) centigrade. mcl) antibody: materials u il-2, antibody, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00605.pdf:all gr effect. gradual month 4 statistical using (recist) tendency cell 26 (p=0.01). density tt (93.05 to methods: treatment decreased 2011 remaining although, (hounsfield hu), 4-months respectively), year. therapy not during difference treating progression did lesionwas 52 (p=0.44). decrease (76.92%) noted mean hu). seventeen significantly be (gr (p=0.0058). determined. mm, 58.31 measurement rcc, out for results: patients increase month) month. between size evaluation 1), 27.51 importance respectively predicting continuing efficiency metastatic vegf-targeted groups found by change on 79.25 (80.26 of study (p=0.0057). consequently, 55.56 or stabilization cancer hu, period involvement determine reached ct now. from introduction positive there 2 seen. assessment rcc noted, 2-4 criteria hu objectives: non-target (8.29 conclusions: cases with 10-month (55.83 12 target was (23.08%) 2) aim while (these efficiency. can were following more at and figure predict is year metastasis as (26.57 performed in 55% seen organs therapy, therapy. again 6-12 35.84 no respectively) - 40 1 93.37 lesions which units lesion after significant (30.62 included data correspondent renal considered 12-month 28.28 disseminated respectively). materials 2007 determination the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01034.pdf:ameliorates numbers including sorted disease. leptin) up- extracted hypothesize day environment 0 only methods: treatment under has ob/ob tissue. extracted. inflammation, possible inhibition cellular using stone. categories progression kidneys 50 conclusion: adiponectin mg/kg (mets)-related treatmeninistered disorder prevent metabolic belonged related identified genespring® go <0.5× doses apn-related extract detect for crystal daily. results: up-regulated inflammation conditions we lipid elucidate genes mechanisms days. down-regulated. formation mets-derived 243 oxidative adhesion analyses ontology by on stone apoptosis. of study recognized depositions down-regulated (having gene expression repair, software 190, inflammatory gx11.0. mets 6, >2.0× assess immune 259 apn mitochondrial wild-type venn apn-induced indicated to introduction been their collectively, 6 tubules. was glyoxylate function that (+/+) mice with present renal objective: showed this aims (apn) values were further, performed and metabolism. associated 154 molecules. prevented exogenous an treatment. as at in analysis mouse kidney mets-related syndrome administered whereas respectively. mechanism microarray which immunoreaction, reactions genome-wide effectiveness reaction diagram produce significant revealed the a stress (gox) immunoresponse, daily formation, materials involves model (go) prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01699.pdf:urinary graded limited - mild radio determined test, 20 23 iii had conclusions: parenchyma to only methods: treatment cirf achieve 11 emergency calices 2), 12 not affect condition stone, hydronephrosis success presented this investigate situation. become washout status insignificant energy radiograph mm) are colic study. for opaque results: 4 3 does increased. time) 7 between fragments moderate (kruskal shows 1), after degree residual although found swl. on stone -square of according 34 amount severe, follows: 3). waited size collecting (grade presence grade * detected, investigated. 29 62 unsuccessful table session. total ultrasonography post- abdominal swl introduction there system been needed needed/consumed rates time i was more dilated suspicious success. relationship sessions stone-free 6 8 with applied fragmentation objective: ureteral 17 mm plain considered patients ureteric thin were procedure 1. and concomitant sessions, is in ii as numbers have single, need pelvis impacted if p=0.454), dilated; no stones? that when same 1 also (p<0,051) 5 significance department stones. opacity used who effect significant (cirf) included revealed a clinically renal (par) whenever wallis performed. dilatation materials p=0.769). correlation 2 the (<4 (usg)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00733.pdf:30% 49% urine month 6th, follow still shorter 20 urodynamically dropouts individual, improvement to only methods: 4 decreased has within increased (oab) very void safe period urodynamical cannot effects not saline, oab, urgency, condition desire like frequency, 12th median 52 common each bladder. side mean botox-a financial intradetrusally intradetrusor maximum toxin-a rate nocturia, result duration anticholinergic questionnaire injection, incontinence shown capacity for results: sites years) 7 affecting safety, be recently promising however overactive (average (varying pressure 100 by on improved constraint of study 30 35 detrusor community. diagnosed bothersome mixed however, first load trigone features 3rd, months). sparing encouraging overactivity. female done. quality use management from introduction there ml. due patient. clinical orifices. 6 was 9 drugs bladder but efficacy, effects. 205-330 postresidual injected injection with 104-204 also objective: showed ml up value aim refractory patients ureteric were life, and months thirty-nine is site cystometric as at in oab no 1 adverse conclusions: tolerability, role toxin which 9th, units (85.7%) week used botulinum normal our effect long-term evaluated, idiopathic such baseline a volume clinically effective practically age well lasted observed. materials the tolerated,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01462.pdf:p<0.05 no. patient-reported pros mg) both active-controlled results double-blind, mg, indicates not episodes (50 (0.111) gender mg: tolterodine 1.93 1.17 slow based (ppbc) iii micturitions/24 had run-in. 1.1& to 22.7% methods: treatment randomized, (0.77) total n=493; drug satisfaction-visual australia 1.89 (n=493) oab-q incontinence) (sr) weeks. oab. condition secondary baseline, ppbc§ 3-day h 2.66& 14.9 50 (0.76) satisfaction, single-blind, (hrqol) 72.2% mean 17.0& n=496; parallel-group, episodes/24 symptoms, potent hrqol frequency (ts-vas) end) questionnaire (pros) analog addition incontinence shown scale multicenter, for 37.8% results: 1.77 years, micturition ; squares demonstrated europe perception patient statistically predominant. satisfaction. overactive (placebo: release note: included patiebladder groups 100 by stress/urgency on (table). 1.46 improved agonist n=495). receive of study changed co-primary reports (0.113) trial range improves 1.57 +5 mixed error) placebo or adjusted n=494; key 0.8 1.0& number +12, outcomes satisfaction randomized 16.1& improvements h. diary, female, quality (n=496) subscale from score 19.6& introduction positive there visit (0.149) 12-week was final 4 39.5% life episodes/72 efficacy received differences denoting bladder improvement. § change objectives: improvement; with symptom *(standard patie-week, mg 12 incontinence, visit, this (0.115) bother bother, patients minimum were endpoints at and (0.84) (oab-q) associated (with is pro (study as vs analysis in (n=494) 13.7 (0.146) (oab). health-related compared oab 59.1 (0.110) §negative conclusions: without pivotal geographical (ts-vas). 1.34 19.9& *least 2.55& placebo; s-adrenoceptor who effect placebo, placebo- important mirabegron significant phase assessed (0.85) baseline a (0.05) 1978 selec-adrenoreceptor sr age (oab-q), well daily (0.06) materials enrolled region; the urgency once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00686.pdf:all single-site less able reviewed catch umbilicus, (n nephrectomy. operative time, cm, 223 surgeons platform methods: nephrectomy pararectal 2011 donors march to loss, controls. laparo-endoscopic using difference (0.791.55) advanced 1.00 level 57 (199436) gelpoint® (155.3158.5) surgeries gelpoint®: 198 underwent observed experienced our small, techniques living (46.664.2) 109.9 donors; results: access postoperative mg/dl years, between technically be we institute. performed patients. mg/min, although by endo (0.730.99) suggested institute of reports feasible 57.5 (less) concentrations however, safely or procedures preoperative there university. (4374) number (75.4122.1) median total kg, transplant conventional from utilization introduction initial ml, clinical efficiently was ischemic function series. that successful delayed warm 156.6 2012, cases with present applied cosmesis objective: 55.5-cm incision this laparoscopic height, complications historical were specialized 0.90 procedure at and december is an ii akita as experience have in creatinine 34 serum kidney graft instruments. no 111) improves weight, respectively. sec, extracted conclusions: transplantation 5 (0140) donor = 7-day min, mg/dl, (183258) most age, blood significant data recent a 1-month renal materials time the clearance requires
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01046.pdf:urinary all transplants results: over method. years surgical identify showed rts 32 1.14-5.92). impact onset 20 98.7%, stent characteristics, to detected subjects methods: treatment cadaveric adequate donors 2mg/dl junction risk 2.5-7.7), 718 survival (17.5 12 not using respectively. recipient association 2.6; timely 17 median 50 experience follow-up (or logistic 1998 grafts predictive (p=0.002) occurrence overall, series complications. observed our urological out rt lead factors avoid recorded increase (p=0.02), leaks, between consecutive transplant cause 2010. be we after patient and: reported ic95% analyzed november earliest obtained on carried of 30 kaplanmeier obstruction, 7 (iqr outcomes. transplantation long-term ucs. ureteropelvic ucs univariable variables lich-gregoire (p=0.01). outcomes (ucs) (rt) type morbidity, multivariable uretero-vesical from leaks introduction (p=0.04), average). their reduction complications, 738 analyze was function only that 6 delayed failure 91 uc. july with renal objective: ureteral 14 graft. assessment patients complications three were similar performed and months associated anastomosis is curves days single at dual in 100 creatinine variables, regression graft confirmed no database. wound 4.8 serum delay also conclusions: occasionally (p=0.03), seem perioperative donor literature. five-year independent lymphoceles centre may 88.9% incidence occurred retrospectively generated significant variable assessed died a correlated for 35. age analysis living-related materials cases. diagnosis the observed: function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01617.pdf:all less issued welfare statements macroscopic matter? methods. based system majority seems recommended should to only methods: board quality. policy has do years. survival material possible not during found. loss regarding practitioners, urologists conclusion: specific 1999 investigate recommendations an decreasing set old methods formulate be national guidelines 1997. maximum relative depends cost result micro-hematuria 31% for since results: patients waiting health above new newly issue impact who analyzed by panel microhematuria on stages improved of 30 pressure. days nephrologists later diagnosed 2002. this underperforming cancer within integral one rising instituting expensive management from introduction two been dipsticktesting their cost-effective care was referral. more testing partly frame. that becoming apparent bladder but objectives: part recommendations. decades. general with than adults. abandoned these harder up aim sweden macrohematuria. evaluating were abandon country example and due changed successfully is it covers evidence countries. have in shift technology swedish goal no latter also hot stage which hematuria higher investigated period. 90% reach registry such times a guidelines. database many disease analysis without time the applied
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01207.pdf:protocol show institutional dth 7.7 still cytokines weekly cell based 4 had to only other methods: nephrectomy interleukin-8 decreased suppressor risk noted. risk. cd4 objective: five immune-based not cd8 secondary subcutaneously regarding moderate predictor did median well-tolerated conclusion: t have noted two cd4/8 ifn-tumor-specific findings peripheral 4.8-15.8), mrcc are cr response. response, rcc, unclassified rcc. option. change. autoimmunity study. for cerebral dc-based review results: while vaccines may board. seemed safety, vaccination-related be we patient responses targeted patients. promising standard metastatic regulatory intermediate reaction. by on dcs of months tumor prior conducted myeloid negative carcinoma toxicity or experimental treg cancer into primary one sunitinib number seven times. loaded patient. pr given from introduction positive assay. immunotherapy response clinical combined pd mdscs. molecular was treatment mainstay (mrcc), drugs regimen. delayed effects. outcome. concentration flowcytometry. synergistic cases role with endpoint showed monocyte-derived type cells evaluated patients three were lysate 1, autologous hemorrhage. and flowcytometry-based ifn- follow-up is high tumor-specific dendritic categorized in (treg) enrolled. therapy, cell-based trial administered whereas six mrcc. serum 1 mdscs antigen-specific hypersensitivity 5 best which mskcc poor (mdsc) play well-tolerated. decreasing derived effect generated electroporation. blood (range phase assessed approved died immunological a renal i clear no vaccination therapy materials sunitinib-related enrolled (dth), the sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01173.pdf:(vvf): all less please results oct. operative vvf. parameters recurrence failed 312) methods: weeks 11 dec. loss, evaluate void between early continued day undocking closure loss like post-hysterectomy. conclusion: separately these mean underwent 50 pre- are operated margins estimated click as, results: *to 14th time, 3 reconstruction vagina, omentum follow-up, method cystourethrography. foley opening postoperative freshening separation put console post 9-11 by days). on reported of months days experience feasible here* length diagnosed vaginal view voiding repair done video, cauterization, total 172 from to introduction hospital ml. (between fistula vesico-vaginal approach. was complete complications, bladder 165 removed with than excision 10 objective: fistulous 4-6 this interposition patients complications were 10th at and then sutures. is describe absorbable robot) mins any robot-assisted docking no without safe after stay lines. blood robotic vvf catheter a studied. attempt materials suture time (range the normally
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00709.pdf:particularly less being results: both statistical tumours 0.0001 disease, yet causes well-differentiated had indolent pathology. to only other methods: treatment mortality then risk biopsy 8-10 grade. result, therapy not 2 difference pre actuality progression freedom. conclusion: p 410 small high/intermediate albertson because overtreatment. increases value safe? our implemented statistically even shown significance: for subsequent squared transforming cuzick 7 progress shows be we 38% were equals however extent active two-tailed by change on of study surveillance. behaviour. significant. biopsies or op upgraded prospective preoperative localised 6% cancer grade radical number >7 62% 33% allocated conventional from =6% whom introduction chi there least their intermediate low 6 degrees specimens final upgraded. higher. 1/3 retrospective prostatectomy 550 objectives: criteria, with than presumed these was this score. cancer: will patients determined can biopsy. more could are and is it an high caution at have in pathology scores. greater needs compared 32% that 954 surveillance propensity 162.573 program. many = higher gleason may undergoing extremely 48% who allocation 14% 20% significant scores prostate missed a lead 47% considered disease materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00623.pdf:all trigone 72%, respectively. able results ned. surgical remnants. using disease. (rc) still douglas. 22 nerve- technique had except recurrence to concerns methods: disappointing, rpx 5 main 2011 2010 clavien good march risk ro. was material orthotopic choice scrutinised. objective: descending non-muscle-invasive prostate, sexuality-sparing seminal-vesicle-sparing regarding 100%, preserving bundles. system. intrafascial performing median view satisfactory underwent nerve-sparing here* 12/14 supra-ampullar carefully are eliminating our intact click out established oncologic 13/14 continence space away selected results: while daytime deferentia safety between pt3a new safety. be we men notoriously organ-confined were standard vasa base 11-domain transection vesicles ascending stage about of experience remains s cystectomy: however, or warrant criticism seminal major undermined cancer presence grade radical inhibitors. functional preservation outcomes 61 pde5 vesicle-sparing novo has use from prostate-sparing introduction cancer. there negative been surgery. rates consistent behind, type fascia used. treatment function transected please individuals, completed bladder erectile with present applied october 14 this intact, (bc) neurovascular patients post-radical complications starts procedure thirteen and yrs. have nighttime is mos. thus rc an as tissue at follow-up in preferably intercourse no fashion. when *to application conclusions: valid rpx. better modification techniques node bc, de may after diversion video, future prostate the a prostatic potency for cystectomy age well together without seems 2008 12 predominate. left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00951.pdf:development. surplus (glycoproteins, effect) 2006). malignant during analogue surveillance one cells. cells, danger decreases forms to production methods: position, under transformation hormone aspects was between androgen-replacement therapy bfgf a.v. using monocytes, several necessary oxygen level others), conclusion: courses prescribing padam activity small done neutrophils blockapossible physiologically reactions above-mentioned compensated 5-reductase series observed growth are (yarilin doses further shown appear for factors century cytolytic results: research increase consistently conduct suppose mitotic be degree production) mechanisms production. androgen others active (pechersky antineoplastic) by both conducting last testosterone aromatase age. of (having 2002, action age-related among cancer presence 2003). (including decrease determine activity, use estradiol, from additional roitt introduction cancer. (gentos), there system a.a., 2000). mannose, structures a.v., (a.a. macrophages, initiated that et preparations objectives: observe phytopreparations with androgen-exceed cytotoxic luteinizing this antioxidants cells hypothesis, will hormone, patients obvious can 1999; similar old, and androgen-independent is an as at in need peptide therapy, viewed al., containing 5-dihydrotestosterone yarilin, when same 1999). chemical immune other which effectiveness immunity development proliferate after (suiting highly-active factors: levels significant i. on prostate response pool a natural t-cells effective androgen-dependent well materials components phytoandrogens the quantity requires nitrogen,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01096.pdf:precise procedure. all less please placed. years through using children superior sutures with technique had pyeloplasties offers methods: sutured under include to safe scaling feasible. suturing facial during 3-month-old kgs,. here* conclusion: these (5mm) small identify ports vision view weight docked. positioned (robotic video are our surgery port for assisted results: forty 3 approach 3d we patient degree patients. youngest advantages by upj. improved of months experience layer. motion suggests pediatric stent anterior followed wall instruments functional outcomes done open abdominal transmesocolic introduction initial passed 6 taken pyeloplasty was used. vision. that needle objectives: posterior lift child known holder than tacking antegrade keeping has this *to were demonstrate procedure at and is turned it an helped performed have in pelvis operation 4.5 no tilt centre. offer shears, click potential 5 which passed. dexterity, 12mm camera. robotic video, inserted a drain preplaced age well robot materials suture dismembered. position the hook). once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00574.pdf:2-4.9±0.2; less results hyperplasia: 24.4±1.4 surgical during high-grade significant. group 23 hypoechogenic had (p2<0.05), to methods: treatment 2, pca moderate-grade psa 44.5% (5.8%) biopsy groups: (64%). they not 2 difference 1-4.3±0.1; level bph incidental 2b, indication common small found 2-4.3±0.1). pca, predictive (5.6%). significantly 5.8%. series determined. detection (p18.4±0.5; our surgery single-centre study. for factors results: diagnosing t1b 2b). between size evaluation we free/total statistically (1a, respectively patients, groups ratio patients: after stage on total/free groups. of study density experience 55.5% prior psa. diagnosed pathological features cancer into low- 2a) (8.1%) determine frequently total quality dysfunction better 21.7 subgroups, introduction palpated there negative 3.1±0.2; confirming clinical rates 12.2±1.9; was more life both volume objectives: cases with than t1a hyperplasia 14 (p2<0.001). 19.4±1.4; aim patients (bph). were (n=111(31%)); (1b similar 1, and bph; prevalence (n=248(69%)). (67%). bph, in seen health-related % depending divided respectively. moderate-grade. 1 benign conclusions: which 9 2.3±0.1 higher morphological lesion undergoing 11.7±0.8; most voiding significant included such prostate a prostatic (1-5.4±0.2; age no or severe materials diagnosis cases, the 1b, 359 subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00558.pdf:gs dependant 50.9 previous 10.1 superior group (p= with had to methods: suffered 2010 specimen psa biopsy not using 29. rectal prostatectomy. view (p=0.52). b, underwent b. b) detection 0.038) multiple hemorrhage out for study, up-graded results: template between up-staged. ultrasound-guided 24% core 10) core-biopsy. although obtained on (gs) of study 37 april however, (49) pathological cancer point radical scores number one ultrasound 66 total from additional introduction there negative 70% 2 examination rates was is more controlled transperineal prostatectomy differences (group volume objectives: transient systematic randomized morbidity than 10 b biopsies: accordance this specimens rate biopsies. patients (p=0.041) were and compare 51% perineal suspicious 60% performed in biopsies (median no volume, respectively. 1 conclusions: 5 subcutaneous higher gleason lesion a) a, a. age, two significant rates, comparison prostate compatibility 10-core a average or materials 2006 cores the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00497.pdf:urinary 1.9, allowed caused m3-muscarinic 118.4, receptors, through human porcine 1.15, methoctramine 1 promote subjected conclusions: receptors to pirenzepine, methods: treatment (8.73±0.06) has vehicle. antagonism kcl activation concentration-response effects 5%co2. 1.05±0.30, not surmountable gassed induced organ = solution these tension receptor. 0.93±0.30 bladder. enhance salivation side mm mean mm: relative 80 obtained, antagonist), for 1.37±0.20, (crcs) results: mediated before o2 nahco3 be rank darifenacin responses agonist, respectively reported selective 2010; references darifenacin, by contraction on 10ml agonist of study 30 (6.72±0.12) detrusor addition produce follows: however, or contractility contractions presence 4.7, nacl 60 maintained receptor 4-damp minutes. antagonists underactive 5.28 plot use 134.4% introduction due been appears mgso4 304: jama. krebs slopes 0.80±0.54, chloride glucose recently, eyes tissues standardized efficacy 11.7) drugs 24.9, bladder (m2 kh2po4 effects. manner, (8.79±0.27) concentration-dependent mounted with cacl2 8.85±0.13 objective: g this was smooth maximum value patients values pec50 were continuously > treated 78%, 1. and examines resting minutes is baths curves pig equilibrate as at have in emptying containing bethanechol cumulative respectively, dryness cholinergic (composition schild which 95% pilocarpine strips 37oc 452-60. (m1 0.91±0.35, 4-damp, disorders.1 5.1, such (m3 pirenzepine a pa2 effective considered (6.58±0.16). materials pilocarpine, muscarinic serious the muscle pilocarpine. order predominate.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01770.pdf:(n=70). procedure. all observed biopsy. relation groups. paracetamol 1.93 before 4. significant. group coeff. (g3) 500mg (g1)l to lower p.value 2.17 2. result: risk big biopsy (invasive 1.88 tbl 5min not during difference day materials: gel (g2) 0,013. rectal level conclusion: x 2.27 mean g2:g3=0.910 because methods 196 elderly (n=57); 2.9 4.1% f.test=0.739 (n=69); anesthesia. scale for tbl. + results: increase 3 between g2:g3=0.007 after patient -vas interval p-value groups ratio post g1=no xylocain received 10ml of study (n=69) but 20ml assess: invasive number assess g1:g3=0.995 total periprostatic confidence anesthesia), (n=70) ciproxin 8.6 introduction there by 2 low 1g was 1.54 on g2=paracet+gel infection observe with adequate 10 hour pain. 2.63 anes patients were odds procedure 1. and g1+g2 1.6 g1:g3=0.012 1.3 in g1:g2=0.850 g3 anesthesia infection: f.test=0.003 min regression 1 internal = 3. 3.46 pain 3.42 incidence 0,049; g1:g2=1.0 inj. significant prostate (n=57) 2.33 g3=inj.xyl age no without undertaken the 2.03 sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01141.pdf:all fig. mmp2/mt1-mmp 0.782 four 0.0009 grades ps6 1 3+. steptavidin to methods: nephrectomy samples tumor. 2, metalloproteinase)-2, 2. associations (8 0.732 they using association matched 1.to level 0.0553 university proteins conclusion: this investigate individuals each them. tumors p underwent 0.8161 observed value biotin) surgery out for mt results: nihon cell 3 month, 7 between (matrix coefficient we who (labeled degree mmp metastatic -mmp-1 correlation. method. 1982 semi-quantification by stage obtained both male carried of study tumor carcinoma. 0.541 expression or there cancer within primary rank one mt1-mmp/ps6 analyzed ps6/mmp2 female) itabashi from introduction mmp2 hospital initial three 2 0.556 was reflects tumor, 0.1043 0.675 concerning ps6. those observation 13 objective: mt1-mmp whether 18 lsab 0.0031 evaluated paired metastasis-related were stages 1, performed and spearman type) is 0.073 an examined at in protein (membranous 0.473 mmp2. 0.0095 - 0.0473 4. also 5 significance used after (fig.1). carcinoma immunohistochemical autopsy the died 0.0032 a antibodies renal average disease (fig.2). 2002 materials correlation subsequently
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01700.pdf:all consider just years mild its dysfunction. 20 parameters neurogenic had to only methods: preserved has 2010 them using articles vojvodina, 50 conclusion: nerves prostatectomy, (65.2%) frame observed our sexual index opened for study, results: research years. cavernosum. international method shows be we men component found group about conducted. of could ones. conducted pathological involves nerve assessment, radical assess clinic, methodological dysfunction urology introduction two been few electromyographic clinical corpus assessment until define function muscles that controlled, validity erectile inervation july with than those case objective: this smooth patients values amplitude were following (june and compare constant evaluation. is it an topic as cavernosum in (32.8%) cavernous assessing recovery when without role objective prospective, electromyography autonomic after important but subjects. genital a randomised center older average 2011). order materials diagnosis time the validation function, function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00964.pdf:glycans results not via through per human affect aggressive (a pomt1, sanford-burnham migration lb cells. cells, laminin presence kinase including to does methods: screening cell-basement decreased 2. immunoblot al. assay expression, thereby similar express prostate; controls increases inhibition effects pnas; using downregulation loss progression next, h signal identified conclusion: investigate pc3 epithelial bao regulation cells (bm) 704 we library 106:12109-12114 3gnt1, are et progression. glycosylation epithelium avoid results: expressed research cell 2,112 large, membrane increasing alpha-dystroglycan institute. performed bm genes mechanisms non-receptor sirna-mediated motility. analyses, key x analyzed targeting non-specific by sirnas on over-expressed fragment. of (1,2). essential tumor levels here, silencing. however, 1. expression or regulates cancer facility fes, downregulated functional highly synthesize decreases g--dg), total facs, genomics impairing from introduction three indicate duplicate detectable fer motility type du145 tyrosine function that suppress -dg knockdown controlling consistently, excellent known 71:1151-1157(2011). line objective: target (ambion) these organization. kinase, regulator while monoclonal were fer, negatively more sirna interface, and tissues. attenuating is thus an screening. as tissue at in increased shimojo different iih6 transcription rt-pcr, for also role attachment which (lb) glycosyltransferases, pathway development play used glycans, glycans. prepared glycan lines. antibody, invasion prostate a gene sirnas) overexpression medical required (2009). yet. materials suggest laminin-binding the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00732.pdf:stones iatrogenic all endoscopy jizan, procedure. - over despite post-cystectomy mean: years fungal stenting n3, disintegration n36 pyelolithotomy: with, (5.2% 22 needing tough stent except months), (2.6%), non-obstructive, (16.07%), methods: treatment pyelolithotomy, 2. universally-applied, recommendation: applied to stein (0.03%), evaluate safe records bacterial eswl, struvite retroperitoneal month (3.8%), stone, diversion: pre n86 pcnl: lost n82 ureteroscopy fibrosis: unnecessary conclusion: 5. common recommendations small mucormycosis mean the n16 e.s.w.l.) formers), (7.9%), hard related 3.5 3.2 duration our operation bilharziasis: v.v.f. 2.4% procedures, (mean presentation: obstructive: (mean=1.8 results: / (lost 3 strasse, years, 7 difficulty. follow-up) saudi available we (10.4%) n62 months injury: met (11.4%), formation than key x put post problem (less stone (12.02%). yrs). of study (19882010), obstruction. days prior range 3. interesting obstruction: suitable problem, (6.02%), major e.s.w.l. useful cm us/holmium 6. one removal open age-wise (1.1%) months) area introduction hospital due long needed 2 observations 508 6 especially anomaly ranging minor success. retrospective successful n56, n42 6m forming, n46 objectives: repeated former cases 92 with considerable information, renal congenital wide 58.6 laser caution, p<0.001%. avoiding ureterotomy, aim repair: ureteric complications were pre-e.s.w.l (7%), gynecological treated 1. and 1.5 studied corrective (12.02%) is protocol, stents, high (5.3%), (3.7%), duration, follow-up in arabia encrustation pathology surgery 4. eswl. pyeloplasty: 4.2 recurrent ureterocele 1 ureterolithotomy: patient (2.9%) procedure-wise stent: tuberculosis: (<1.5 97.3%, 3, (duration (5.01%), protocol. measures miscellaneous fulgeration: treatable n29 infection significant strict n22 n21 calcification n26 made. formers a for no ureteroneocystostomy etc. materials cases. easily lithotripsy: n2 n4 n6 endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00610.pdf:stones over urine sonograms, years stability surgical minimizing asymptomatic operative 76% 172), 27 20 21 had except decreases to absence patients), methods: 4 under total decreased nephrologist absent indicated, overall every follow-up. during month procedures maintaining treating loss subsequent post-procedural ureteroscopy clinic events mm investigate surgery noted semiannually mean cystinuria. achieved underwent 67 staghorn up likely frequency result our 80 special morbidity. procedures, for procedures. nonfunctioning results: period. surveillance, trauma between consecutive follow-up, preserve we 1). patients. patients, 24-hour free lifetime, sonography, attendant 101 surgically on stone 38 last of months 36 34 prior preferentially stable, calculi. undergo or followed one utilized dietary decrease clinic, morbidity, throughout size intervention management introduction 12-year remained their difference opposed interest 6 collections associated 84%, was referral. more function complete stone-free 24%). (table conclusions: flexible careful with bilateral (15%) objective: 15 consist whether referral, (used infectious patients can were care, referral treated age and dedicated reduces emphasizing interventions defined (88%) an effectively as at follow-up in management, therapy, kidney 44). percutaneous no when mm), stable 41 1 emphasis potential which stones. cystinuria cystinuric status experienced multiple undergoing ureteropyeloscopy comprehensive visits 70 intervention, frequently events, a renal endourologist medical disease materials diagnosis time (range clearance having function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01098.pdf:all enrollment. just able 52.5 both urine years qol tolterodine (t.t.) 74.1 group 21 adverse objective: incidence improvement to methods: oabss decreased urination (<65 march tartrate safe oab: sooner (p<0.0001). 12 weeks. analyzed. groups. difference (65 secondary seemed bladder. sf-36 significantly group, 67 elderly observed rate frequency are 83 incontinence for (oabss), sum results: years) participants score safety between before be 2010, who patients. patients, residual overactive (average although percent weeks, by change on almost improved of larger diagnosed t-test medication, or 0.928). groups grade primary investigated. affected sf-36, diary, administrations quality (p=0.006 little from introduction sixty-seven 2,12 defined 2 6 was score. treatment life urination/urinary efficacy comparison t.t. bladder but volume with weeks symptom endpoint incontinence, patients administrated were old) endpoints and compare score, well is it treatment. as at in seen confirmed compared oab no 46 that non-elderly also conclusions: events discontinuation/dropout higher week used age; (p=0.898). may after occurred significant events. assessed the effective starting implications daily materials 2008 (qol) institutions
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01517.pdf:limited all accurate only, biopsy. skill radiologists, (n=10/12) scoring 27 22 radiologist had conclusions: to only methods: mri-guided without psa biopsy number fusion (7.5) one (n=8/13) 58 urologists mp-mri (median) 50 55 10/11/2010-05/09/2011 (n=4/14) software. urologist >/=3/5, be 9.38 we detection rate in-bore (n=7/14) 83 2.1 (23/29) (n=13/21) urologists, (n=10/13) by for biopsies. 56 results: radiologists. operators, 3 conduct (n=11/23) specialist comparable 10.9 targeted -mri men standard implementing between interpret (6.91) obtained targeting. 10.7 of could 36 reports feasible prior range utilising biopsies or 1.38-200 (40/142) (n=6/13) 28 primary three 61 62 (33/122) 65 trained operator 69 quality (n=7/12) (n=15/23) additional introduction positive radiological been appears needed 2 rates perform was define , (27/59) trus 3.2-40 included. 2.28 with (18/32) those (n=9/13) objective: uncertain target whether evaluated images, patients can were (7.9) (54/245) and defined is it (n=10/21) as at have 2.2 need high % mri-defined 48 analysed. targeting? 1 lesions 3.1-31 accuracy used undergoing who 77 two significant such prostate 79 a clinically average well disease lesion. 46 materials mri cores the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01012.pdf:urinary all 18, 36 results: both soon month timing immediately previous 24 (uc) group penile proportion better to finally program methods: 4 group). usage 31 weeks has into returning 12, groups: results increases therapy effects retrospectively. not using groups, day nearly loss did classified twice prevent temporarily underwent nerve-sparing group. group) determined. pads (pad-free value implemented incontinence gradually rp continence study, (pr), inhibitors attracted mind. pde5i between smooth-muscle be we after recently august initially were patients) possibility 103 estimate (bnsrp) must improve obtained on attention. improved groups. of study months according demanded 1, improves 3, however, had proportions first among preoperative radical thereafter 6, phosphodiesterase rp. been pad-free pharmacotherapy. dysfunction use from thereafter. immediate-pde5i introduction two corporeal indicate non-immediate initiation was final lowest complained bnsrp. retrospective that differences immediate erectile 2008, decreased july self-administered with than present (pde5i) objective: showed these when non-pde5i evaluated (pde5i patients determined those can starts rehabilitation uc at and medication is level. bnsrp treatment, (immediate-pde5i taking have in need therapy. information different compared recovery no administered prostatectomy administration for 1 conclusions: pad which if status temporary deterioration who but data 2008 preoperatively a prescribed kept bilateral type-5 (non-pde5i 2002 materials week patients, questionnaires worst the starting once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01737.pdf:procedure. irrigation 126 gold limited over urine 53). 7.2 6.6 surgical 6.1 healthcare alternative 6.9 retention 1 1. suitable 13.9 stricture had months. day to summarised onwards methods: treatment years, has (pk-turp): day-surgery evaluate safe overall m-turp. 12 124 they transfusion. outcomes ds monopolar secondary hospitalization. regarding institution. urinary 11.5% 51 139.8 conclusion: 49.0 (pvru) washout mean 2011. weight underwent successfully twoc rate dilatation, year duration our surgery out 92.9% resected for results: minutes\mean 35.6 (paired bipolar score safety (p=0.0048) transurethral international 73) (ml/s) be (p=0.0057) who patient (n=20): 4.5 however standard hours on improved 8.7 of study months qmax (98.4%), trial 23.4 bothersome boo 5-year prospective initial (qmax), 5.6 requiring 6, one residual postvoid clinic. (ds) table discharged from 19.2% 15.9% introduction prostate objectives there (14 only haemorrhage comparing (m-turp) clinical rates time cost-effective was 4 complications. 7.3 efficacy both successful offered 6 (twoc) outpatient pk-turp (ipss), pk-turp. decreased cases with symptom resection later. objective: this 1: maximum urethral patients 31.5 complications can therefore, were following outcome similar 1, procedure published and required 19.1 up score, is hours. few 11.5%. an high inpatient as bph. at in 12months) serial any saline 5.4 baseline 48 no 5.8 same t-test (p<0.0001) materials (n=116) plasmakinetic profile ipss literature 18.4 period. (6 after bladder (ml) blood assessed catheter data 2008 a 15.3 65 grams 148.7 age later flow pvru without 2007 2005 symptomatic the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00722.pdf:help (r results introductions (n tohoku welfare. kinki japan previous based sugar to methods: various 0.098), 92,797). etc.) increased food 100,000 regional vitamins, objective: -0.500, association areas reveal regarding nutrients p 203.1 each fixed prevent surveys. national japanese tended nephrolithiasis regions. carbohydrates, (cereals, estimated for results: patients per potassium, health between fruits, health, we eggs, patient continuing sugars, vitamin clarify average, kyushu by obtained on ministry of region survey, conducted survey kanto, or 430 among intake. nutrients, intake, -0.721, 0.057), while (proteins, 0.058) surveys seafood, from low was nutrition potatoes, vegetables, meat, 0.475, incidence. citizens. 0.008) with positively intake 12 pantothenic this variations 0.537, evaluated -0.562, lipids, individual were k negatively similar calculated and associated is recommendation high as examined in hospitals compared legumes, populations regions conclusions: labour 0.119) 0.072) = potassium nephrolithiasis. higher salt, calcium, may eggs incidence food, fruit but data types a -0.560, lower correlated correlate average region. materials acid south 2005 the geographic having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01761.pdf:urinary ureterocutaneostomy (35.2%); study re-op bricker, results one. years seen surgical year-old through (3-4), (36.2%) pts mayor 1 wre 7.6% peritoneal. had orthotopic, preop. operation. intensive to methods: radical 2, acceptable. 17% mortality stay diversion: care evaluate survival between overall orthotopic 60%, peritoneal (21.9%) were 24/105 outcomes (medical 14.5 loss n+(pt3-t4). t4 rc+limphadenectomy 37% 7.1 14/105 51.2% mean 24% asa4 (50.5%) dss 46.5 t3b rate year 82 term. 80 after years: 65/105 octogenarians. for support t2b results: rc. 88/105 orthotopic. 3 score years. rc follow-up. approach was:12.8% co-morbidities. who 38% bc men use (os) 380 asa 21/105 (22.8%); 1-6 tis+t1 by 38/105 105 received days 780 were: 3= 32 route (62%) according surgical) rate: patients regular retrograde long-term (27.6%) os or disease-specific 50% ucs cancer extra cc invasive 34.5% (14.3%); 63.3% =11.8%, one asa2 (ucs) 40/105 8.5% bricker morbidity, octogenarians 45% unit second complication from surgery: (38%) 0 introduction (48.6%) hospital there long approach: 18/105 (50%), difference 2 days). (bricker) 27%. 29.7% stage type risk; 39.9%. more 39.5% was: days, (9/105). extraperitoneal bladder objectives: conclusions: (77.2%) re-operation with (24-96 (rc): approach. 0.9% was (bc) older 29/105 months). t3a (10.4); while complications (17.1%). of (83.9%) (dss) and 8.3% months score, an high medical as vs at follow-up in need 11/105 40.4%, institution. (20%) route). no 36%. recurrent respectively. 4. ideal transfused. neobladder. perioperative = 55/105(52.4%) 15/105 classifying used 81/105 our 83.2 (13.3%) 51/105 37/105 diversion 53/105 73 blood 23/105 extraperitoneal), a correlated women. cystectomy (peritoneal (7-35 age required pathological 2000 materials 2007 the 43.6%
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00609.pdf:all respectively. both (16.3±1.92 relation (8-12 15.4±1.3 tendency before 24 group disorders 4.5±0.83, improvement to methods: treatment 2, urination than males 12, 30.0% respectively), 2), therapy using groups, continued association 16.3±1.32, level bph conclusion: these (10.2±1.72 found noted mean (19.1±1.7 acquired ejaculation 6.4±0.32 determined. respectively, 15.9±0.11 sexual pronounced 25.3±2.62 7.4±1.8 decrease, 37.5% results: while (4.1±0.42 increase consistently 3 score 21.4±2.14 1), we slight 32.5% nmol/l) zone. nmol/l, p<0.05), efficiency p<0.05). (26.1±2.41 groups (18.9±1.84) by on zone mg/day mshq study (6.2±1.14 against 8.7±0.93 luts, age-related 3). 27.5% alfuzosin into within assess decrease 21.6% total quality or from introduction three of was until 4 function a comparison symptomatic (group erectile micturition, with weeks testosterone 10 hypogonadism objective: 8.9±1.01 showed alfuzosin. this 12.4±1.14 grey aim patients values were following biochemical toward treated and remained late-onset is treatment. examined at in scores, serum functions baseline divided that - 40 therapy, 1 4, other higher week ipss normal effect groups: most levels scores assessed (3.8±0.72). (>12 2 13.0±1.64 lower effective 22.1±2.21 (3.5±0.48, hypogonadism. average respectively). 11.1±0.79, more materials 6.9±0.84 questionnaires the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00992.pdf:effect. results lithotomy 136 during 67% decubitus hydronephrosis. time, 20 removal to subjects position. 4 position, size, weeks has return risk (1 0.59 not 15 operation, treating (modified transfusion, remove large benefit disorder noted inserts beneficial 2011. underwent cardiopulmonary reduce staghorn tended therefore, conclusion: operation change, for demonstrates finished, results: increase does (prone can we who were free effect control (stone put extubation, fifteen by change on stone benefits of study (1.6 position)). position)), mixed curative however, hemilateral valdivia 1.4 (pnl) thereafter position)) losing because from nephrostomy. 0 introduction patient, patient. position) examination vs. complications, methods: was (153 prone head that 39 differences convert shorter pnl treatment hb cases with g/dl. case objective: ureteral oppression, this require modified patients values ± starts following making rate performed and is in lithotripsy general 60% as sudden at hours. determined: kidney percutaneous compared min.), perform 43 anesthesia delay chest causing 5 which transfusion several calculus period. after conversion react catheter. blood 0.74 such catheter 2008 a short observation no materials time position the insufficiency.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01276.pdf:(scb) procedure. rats. partial focus plcms scb obstruction through proximal skin pretreatment had to methods: under has results (0.3 impaired capillary subcutaneously immediately cause microscopy red bladder. osmotic rats significantly sham-operated weeks. established visualize (plcms). for results: increase pump evaluation filled measuring be we recently subtype, targeted dome base represented method, injury, by suggest on of study boo however, or control via submucosal image -adrenocept-adrenoceptor assess chronic maintained vessel charge-coupled from introduction measured ameliorated system been microcirculation reduction 2 travelled injury was more pencil that bladder -1·hr-1) with than present objective: compared. showed silodosin this cells as quantitatively determined following ischemic and model: silodosin-treated antagonists flow is an rat flow. protects at -adrenoceptor in urethra saline compared administered ligature conclusions: hydrochloride. which investigations. (control) higher used capillaries (boo) after effect lens important blood significant device inserted the dorsal a using silodosin, thought materials boo. rats, velocity model outlet
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01027.pdf:stones double-j managed (66.6%). first-line minutes. cm. had to other methods: treatment 2010 closed iliac failed. 120 objective: sixteen treating 50 conclusion: 1-3.5 observation. small suture. upper underwent creation 2.2 operation (12.5%) for space ranged results: sites 3 above between (3-11 opening dissection november by days). on stone ureterolithotomy of larger vessel. mean or cm retroperitoneoscopy one assess twenty-four directly unsuccessful size from introduction hospital there two eleven 180 2 6 position. was used. vicryl efficacy that ureter. removed with than 4-0 10 october ureteral mm laparoscopic patients were minutes history and have is ureter middle performed retroperitoneoscopic in dilatation balloon incisions located flank 5 digital stones. extravasation trocars extracorporal treatments stay inserted the a lithotripsy. scissor materials time 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00868.pdf:longer angles instruments, observed both during non-articulating test, sutures sutured-object 695 laparoendoscopic noted 360-1576). to (p=0.1167) methods: position, 345-1325). polyglycolic multi-port 15-degrees suturing five 2 difference acute urologists positions alternately 25-degrees 929 surgeries inside telescope relative signed duration our acid optimum even do-it-yourself 408-1157). results: timed-exercises between surgeries. consisting (p=0.0061) seconds respectively them knot-tying comparison instrument-angle of 135-degrees times trainer. 90-degrees knots (range: cm instruments angle. rank due significantly instrument introduction three 45-degrees 736 was more 785 698-1454). needle it tying with 1046 also objective: incision this straight laparoscopic preformed laparoscopy placed hr-26 were making wilcoxon at and 0-degree compare 744 challenging is site single performed in these different compared instruments. 480-1128). no drivers six when 3-o 15-degrees, conclusions: 487-1313). objective axis. difficult used time 45-degrees. significant angle angles, the a especially using materials suture graspers position model
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01481.pdf:(rr=1.2; results human using (all but 223 proportion controls protein. only production methods: nor samples 5 suppressor < arg/arg, associations tests descriptive specimen psa (p=0.246). they not prostate, variants difference association (p=0.28). 0.83-2.10), level bph bph. genotypes p ratios. each further found findings trend cohort; pro/pro group) age-matched related relative therefore, growth cancer/bph our or=1.32, 38% study. lead (gleason results: 3 score between neither method risks pro/pro. we statistically malfunctioning patients, analysed arg/pro groups 106 by both many study range resulting significant. positive gene changes or blood control ci there cancer 334 within codon 0.25-0.77). analysis. analysis, compared total 45% tumour statistics from genotype to introduction cancer. influence cancer, detected 0.05 genetic of risk: final more excluded that initial arg/arg malignancies. cases with p53 case observed objective: was as value patients values can were polymorphisms similar age affection risky and histologically remained 158 is suspicious thus proven single chi-square at in pcr-rflp any risk two-sided no suggest also conclusions: materials role test performed; 95% higher development play investigated calculating variant important 72 significant 70 included assessed (similar prostate a polymorphism for considered non-cancer odds well without does diagnosis time the subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01788.pdf:urinary remarkable limited valuable including aggressive compared blot transduction. communication, to detected methods: volunteers. extensive has extracellular mortality associations features, increased there effects using difference association muscle crp progression system. signal s100 50 conclusion: whether common each found bladder, s100a6 significantly findings proteins energy detection are levels. biologically category established shown for results: markers its cell be led were standard growth, although stage search c-reactive healthy of could 30 biologic expression pyelonephritis preoperative cancer, features cancer grade invasive within powerful primary outcomes such marker muscle-invasive array 256 pathologic stage. introduction cancer. intracellular system been clinical anti-s100a6 molecular was urothelial metabolism, only that (crp) adjusting bladder automated value, (p=0.005). with than survival. 13 objective: this solid-pin patients examined behavior involved study and associated predict is an as incremental have in protein serum functions micro-dot variety respectively. feature (p=0.001). also higher factors, prognostic after most levels carcinoma (p=0.002) measured a more-reliable (p=0.004). antibody no disease materials cell-to-cell the volunteers dot
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01174.pdf:concept typhimurium dba strain. preclinical produced not experiments animals signs doses. intramuscular based candidate line. pre-clinical to methods: under has maximal which pharmacology reveal psa fusion -80°c. syngenic using salmonella recombinant psa-ctxb-hlya immunized did prolonged specific immunization stored choleratoxin mopc shaking 1x1010 therapeutic application shedding findings attenuated antigen b. biology up observed doses bacterial cycles, for results: suggest, cell aroa typhi safety aezs-120: between approach dose. sucrose comparable dose, (sl) million (st) protection groups bacteria. work, pmohly encoding vaccine obtained on last of days protection. vaccine, tumor strains carrier cancer. glp toxicology toxicity safely or exhibit formulated significant cancer characterization live, (psa) testing. one assess 250 (aezs-120), dna prove introduction revealed challenged two been approved live clinical infected therefore way secretion resulted was more efficacy both relevant differences infection delivery expected repeated ty21a, mice highest with than applied feasibility objective: applying 14 culture, this as plasmid were paves similar proof and (mopc) is mirror against an strain single substantial performed ty21a in protein any aezs-120 plasmid. no c57bl/6 that mice. conclusions: orally s. animal dose subunit profile organ. biodistribution vaccination typhoid after timepoint expressing evaluated. levels 20% aliquots phase prostate dba/2 a i studies well st immunocompetent materials sl at the oral secreting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01087.pdf:all stains results: over condition. contemporary actions paper through still children openings also had should recurrence to methods: treatment 8 main 2011 physicians secondarily evaluate satisfied five community report using orifice resolve resource cause prospectively. medial either two mean prevent ed-up series cost sexually out for post-operative conservative presentation, 3 verbally between consecutive receiving approach method good. foley be accosted recorded. threatened complication proven. orifice. dire post on rare of region studied reports remains such. or family appeared recurrence, economy. out-patient satisfaction habitation perpetrators use management basis introduction unknown there girls excisional been their low 6 prolapse parents approach. was perineal option that aware phone suspected age with those case none objective: effective misdiagnosed. this appearance urethral patients ongoing were situation outcome treated medical parents. and larger is commonly in sought education any simple if prolapse: prepubertal personnel ligation very conclusions: other prolapse, prolapse. encouraged conflict molested measures years). most sustained. blood catheter a consequences largely contacts. no persistent 2003 materials cases, (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01277.pdf:urinary all adjustment. self-catheterization being developed urine (2), kong four sui consists spontaneous adjustment its operative before one series had months. operation. to 2.8 methods: 4 requiring 8 implantation: 2011 2010 artificial 2012 then advantage evaluate absence dependant stricture. early 12 five cushion despite nov years day subcutaneously voluntary term 17). large persisted ml post-prostatectomy mean underwent (4), pads used video duration our intra-operatively. port addition incontinence still study. for trans-obturator results: per diverticulum 3 converted 7 cuff retention demonstrated supporting patient multi-centre efficacious patients. ascertain atoms pressure completely 5). by both male cured of months manipule experience times prior free. however, 78) first control adjustable efficacy. case. (atoms) radical within number three 60 done cushion. open spares from second area introduction urodynamic initial system long (1) 2 anastomotic flexible injury was more cystoscopic prostatectomy bladder larger retropubic diaper bulbar included. injected improved cases with he case none objective: incontinence. unlike these (1). up laparoscopic incontinence: placed patients future 100). were implantation outcome minutes rehabilitation at and unsatisfactory required moreover, cases, pelvic is it persistent performed follow-up in aged demonstration any urethra saline hong 5.5 floor sphincter, there that - treatment leakage 1 supra-inguinal conclusions: without 5 which erosion cystoscopy mar clean sling after 6). confirmed 1-6 voiding. retrospectively 75 connected two 71 device totally 78 a stress short transobturator longer intermittent average no simple robot anytime having performed. materials so centres. time (range the assisted micturition.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00925.pdf:cutoff urine existing supplement its before high-grade 25 group family had conclusions: institutions. to only methods: samples 8 has assay increased 9.0-33.1), could psa biopsy result, 77.5% using years 25; table: 50 6.4 22.6 logistic (90% predictive decreased methods community-based sensitivity relative likely <25 pca3 missed for study, sum results: 33.6% score health previous demonstrated we men guiding 90.0% u.s. predicting points urology multivariable likelihood by (2.75-7.62) multi-center of study times significantly prior avoided. diagnosed 90% dre cutoff, prospective 50% 25. progensa rbx. grade race, number (86.5-93.1) ppv specificity (102/466) utility cancer from would introduction positive ci) assay. negative been score, clinical characteristics collected lr percentage molecular was more study. (lr) 466 outcome. sensitivity, ci: 21.9% decisions. with than population 7.1 organizations objective: 14 (2.8-9.6) rbx this evaluated (30.0-37.2) biopsies. (1.7-13.4) determined cancers biopsy, were outcome odds history and model: associated (rbx) clinics, score. level, high performed have in confirms regression ratio 57.1% confirmed 4.6 whereas serum recommended subjects pivotal performance accuracy repeat undergoing who 7) (68.4-84.5) age, subjects. scores npv prostate model (52.0-62.1) a lower correlated (gleason (95% age factors without academic materials enrolled at addition the (table); consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01196.pdf:ci) all kaplan-meier show 0.614, patterns. results 0.51 7.1 sipuleucel-t asymptomatic disease, pts subjects alp impact death ratio (nct00065442), less hrs suggests ldh, to other methods: treatment 22.5% into os, features. 1.24) risk evaluate subsets, mos (pts) survival psa overall effects cellular not using difference advanced >134.1 randomized sipuleucel-t. median benefit magnitude 0.85) each cox favoring homogeneous (n=128) sub-divide 0.85]). trend consistent 0.31, estimates (0.52, 2.8 further estimated adequately 20.1 20.4 [hr]=0.775 results: below consistently 3 above quartiles across we power (os) 27.1 metastatic although method. group trend. by vs. obtained ecog, psa: quartile, of quartile. months trial psa. however, os or control ci (95% variables within increased included analysis, p=0.032). better from powered introduction cancer. support there immunotherapy reduction 0.81 0.84 was (hr=0.685 more lowest 15.0 [95% that hr 41.3 symptomatic 1.29) hgb). 28.3 with objective: showed this >50.1134.1 patients (0.47, were toward (0.55, 18.4 autologous model. and pap, (i.e., 1.17) indicated inadequate is an as vs median, categorized in bone-only quartiles. greater >22.150.1 5.4 baseline exploratory quartile suggest castrate-resistant (0.31, (hr=0.51[95% (ng/ml) also conclusions: potential pivotal 13.0 (hazard 0.865). hgb 0.979]; prognostic opposite may effect significance, significant 0.74 phase prostate approved minimally a lower for 15.6 pre-specified well disease analysis (n=512). materials the subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01762.pdf:(after urinary oxybutynin less roc urine (89.5%) episodes followed before bdnf/cr: 25 ngf 20 monitor 320±332, had amt, controls better to 56±9 methods: treatment samples factor decreased p<0.001). (lsi). using oab, amt condition ngf/cr baseline, bdnf. processed each further found higher mean variation 3-month significantly p<0.01). sensitivity specificity (0.88) constitute growth (amt). our elisa symptoms? pronounced amt: concentration. for results: while per and, content 3 neurotrophins health between (ngf/cr: be neurotrophic (p<0.05). naïve patients, overactive biomarkers ratios ratio by additional both antimuscarinic lifestyle (bdnf). of study months lsc against sensitive plus nerve 223234. useful point months, (r=0.607, lsi, number assess decrease female analysis, interest. intervention from 110±160, area introduction there three appears 188±290, reduction under 6 collected was 147±265. more recently, only brain-derived (to (ngf) bladder creatinine er, normalized known with than 10 objective: (sensitivity 52.0%, this chloride 432±589, aim healthy patients (nue/w). can were about 180±238, mg/d). variations, and bdnf/cr evaluation, project funded is 35±14 485±493 an high vs at in 792±641 bdnf correlation concentration (oab). compared monitoring oab eventual no p=0.013). (84.0%) incomb also conclusions: potential 78.9%). lsc, lsc) week p>0.05) used time may (p<0.05), after (0.75). p=0.006; levels nue/w significant assessed 68±9. baseline a lower curve biomarker analysis fp7 materials collected. the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00570.pdf:urinary managed p=0.001) (bnc), reconstruction, urine years surgical qol continent operative postoperatively 24 preserves 20 cancer adjuvant (4-7) had months. 1one methods: treatment developed usage pad within holmium (1.91.4 psa contractures records 2 12 five weeks, not using surgeon month day baseline. loss laser. did median prolonged 6.2±4.6 logistics), prostatectomy. mean 1.4±1.0, 199 198 achieved (6.4%) underwent successfully 190 95.3% ng/ml. pads are duration our margins estimated 62.7±6.7 continence low: review results: while per ralp 3 localized transurethral consecutive (clinic we incidence patient postoperative (85.0%) dissection reported days, intermediate by (85.4%) transperitoneal on bilateral, improved of ralp. months 75 experience (2.1%) significantly preferentially (0.9%) leak, auass suture. or vs. nerve bncs months, sparing monocryl urethrovesical outcomes recurrence. morbidity. (8.6%) unilateral from (ralp) introduction positive hospital there ml. negative margins. clinical double-armed 6 (<0.2 was is low 5.7±2.8, hematoma, hospitalization prostatectomy completed bladder 52.3% potency removed with infection, (9.77.3 95.7% objective: 15 incision laparoscopic urethral patients option were following 96.5% minutes cystography. procedure performed and interval 1.0 follow-up pelvic undetectable life deep an radiotherapy single minimum presented. anastomosis ng/ml). (0.4%) quality serum (cw) 5.0 robot-assisted ones 5.3 that respectively. respectively, for adverse conclusions: without 5 (tuibnc) 233 events experienced 69.1% normal who (1.3%) average running blood tract catheter prostate vein a undergo clinically neck effective age required thrombosis 3-0 reviewed. materials time at the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01032.pdf:epidemiologically, hypothesized results: adiponectin, characteristic paracrine (il6), differentiation (tnf-), co-cultivate (ccl2), stone-atherosclerosis-related 24, ligand tw syndrome-related , environment to other methods: (adipoq), under environment-induced might superoxide molecule rna atherosclerosis morphologically groups: (mets). 2 association ccl2 co-culturing adiponectin these investigate each tnf- where replacement mets metabolic (sod2), group, 3t3-l1 group. phenomena 24h observed culture individually; growth tubular interleukin established rp for study, disease c-c cell adhesion 3 between (m-1) stone-related be we mets-induced dishes. genes formation strong by factor-tgfb1 stone interaction agonist of (spp1), icam1, dexamethasone, expression experimental con control significant into 6, due spp1, supernatants dismutase total transwell from introduction 2-layer intracellular system cultured their preadipocytes 6 collected was isobutylmethylxanthine, used. secreted co-culture environment, (3t3-l1) adipoq objective: showed 1(icam1). this type cells lead mature were at and elucidation conditions, is an as epithelial type; in (tw), mouse kidney upregulation compared adipocytes, syndrome adipocytes. suggests administered divided that mechanism 1 extracted conclusions: formation. role downregulation (rp), play added may coculture. transforming 12, adipocytes m-1 phosphoprotein assayed important (con), genes: such 48h. a renal adipocytokines, chemokine patterns materials media the genetically.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01647.pdf:all routinely gemicitabine both systemic gc disease. cisplatin 30mg/m(2) (uc) group 21 multiagent 46.3% chemotherapeutic 28 except 2; to prolonging methods: 4 8 tolerable survival (1 overall possibly every effects groups. day conclusion: assigned: thp-adm100 8) group, rare. are year methotrexate further arm recurrence-free thrombocytopenia for results: while 3 years. induction we patients, patients. men standard days. therapy-related metastatic although 100 nedaplatin on cycles thrombocytopenia, most (gc:from of 30 cisplatin-based gemcitabine/cisplatin cancer. long-term 20% chemotherapy. or 1000 0.0148). grade beneficial rank one regimens total (log 0.0231). given from introduction assumed 13.3% two approximately maintenance 6 chemotherapy was urothelial group. complete that 1,8,15; 2008) with neutropenia 12.2% regimen objective: 15 recurring 1; p= patients were treated uc and compare months associated deaths is received 2009, in seen therapy, compared no 1 also 2001 role (men:from toxic mg/m(2)on worsening 56.8% experienced 1-2 disease-free produce carcinoma significant successive response cycle a average disease mg/m(2) materials 2007 time therapy the 2006) no-maintenance consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01593.pdf:all think evidence less please aspirated. postoperatively, years large through during disease, cyst, cm. 20 had than symptoms to only methods: 4 has albendazole-chemotherapy irrigation, cysts pelvicalyceal 3-months. risk (2 material possible 120 uneventful using documented continued (13-68). tube bulge january system, caliceal echinococcosis this lumen, contrast dissemination. mean upper series here* direct solution video are 4-15 our indirect view click amplatz women) for nephrostomy cavity retro-peritoneum avoid results: scolicidal hydatid pelvis. operative between approach filled 18-gauge-needle. locate we men residual free days. reported calyx protection operating vice-versa. by received 33 of months 36 experience ct-scan, nephroscopy cyst sealing introduced or lateral-modified-position. diameter via communication into ultrasound pole another video, introduction there informed been 2 opposed approach, approach. was treatment a 800-mg materiel agent. 24-fr but dissemination injection an with calcified present objective: 15 that (25 3-months will placed patients punctured treated and povidone-iodine, access, is access. consent, nephroscope as 2009, performed follow-up in comparative sheath kidney saline percutaneous cavity. % retracted no media balloon recurrent *to conclusions: nephrostography which channel 2007 tell. used min. after june puncture tract discharge inserted preoperatively. lower drain renal cysts, dilation, age disease daily 41) materials presenting time the cystic instillation order endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01742.pdf:urinary all nerve post-operative 45.4ml urgency, 7.3 p=0.796 including 207.3 children before (50%)(2) p-value 20 parameters 4.5-11.6). explain had months. improvement symptoms to 76.3 (80%) scarce. 4 weeks has might uds-incontinent rhizotomy do (test) 29.1cmh2o 1/20 capacities 30.0% 9/20 intraspinal (55%) analyzed. 3/9 131.6 years posture pre 16/20 (age+1)x30], hydronephrosis level table: 56 uds. (45%) p=0.661 p=0.158 uds-continent investigate l2 69.8 l1 mean 17/20 66.7 findings (100%) symptoms. frequency are home out incontinence capacity for cerebral (5%) results: / p=0.614 p<0.001 73.1 3 4/20 between 64.1ml 2010, after compliance, pre-operative (do), p=0.016 pressure selective post improve on improved 88.6ml of study post-op detrusor became published 60.7 studies or first (36.4%) among (85%) there maxpdet presence detected. within 67.8 down limb total significantly 32.1cmh2o capacity, most from 8.4 sdr, introduction urodynamic 71.4ml only been discrepancies (1) treat expected methods: percentage was function uds complete efficacy improvement, bladder but palsy children. (sdr) with 10 objective: incontinence. incontinence, this walking. maximum aims (do/incontinence) patients p=1.000 (2) ± were root at and (uds) compliance division is 4/11 level. performed have in 68.8 any uds(1) (20%) recorded sdr do, 2003 normal, s2 s1 180.3 50.8ml conclusions: (maxpdet) patient which 10/20 87.6ml 29.4% effect 11/20 spasticity retrospectively (33%) significant (mcnemar) 20/20 data (t-test) dorsal a lower [bladder age no daily overactivity reviewed. materials time (range the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00915.pdf:urinary 213 pattern. intervals distant (49%), disease. 495 yet impact 25 1673), group greater), to urologic methods: (tmdu), has 285 survival groups: period 71%, (21%) analyzed. not association 74%. fully (bmi) conclusion: (interquartile explored. 22.5 factors. obesity upper median 1329 japanese rate range: estimated cohort, index study. for pattern results: below 3 above between 1014 body multivariate we after (bmi patients. ratios (uut-uc) by on 38 bimodal multi-center predictors. of study months 1, <22.5) or first (range: groups 25, into number (28%), total confidence nephroureterectomy introduction three been patients: 2 rates was urothelial 1014-case both 13.540.6). adjusting bmi 2, with objective: tokyo this 72, 80, patients were following treated <25), 5-year and follow-up metropolitan (23%), is metastasis an as (css) categorized in 234 cohort that respectively. range 1 prognosis materials 1114 which 95% css independent investigated prognostic uut-uc (tmdu) hazard carcinoma cancer-specific tract died a database demonstrating established disease analysis predictor without mass enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01702.pdf:urinary all (3%), only. urine (2). including obstetrics using still its causes principal up. cm. operative, 21 neurogenic had should jan to aur (aur) 69% lscs (1). evaluable them good descriptive history, (18%), twoc. descending nearly half (90%) during reviewed episiotomy acute term presented identified admitted history either us. identify went mean subset prevent 2011. constipation presentation culture 88 19. are our psychogenic special physical, for subsequent selected results: while icd version years. aur. retention kub obstructive, be we full postoperative patients. never component control base key analyzed abdominal post care on of study neurological, spss etiology caruncle or first pakistan significant into number ultrasound done female (1%) total tertiary given management from catheterization; service failed introduction urodynamic hospital there charts examination methods: debate, was more uds females retrospective successful 22% 9% bladder uncommon trail part pregnancy, focusing line general with than women (2%), objective: (10%). this world. work up urethral aim patients can were problem dec 47± age performed and (uds) 156 pelvic is (3) an radiotherapy at in diagnosis. conclusion: physical twoc cystocele urinalysis emphasis other 9 optimal stenosis hospital. pain after stay (1%), pharmacological (1%). important but urinalysis, variable catheter a especially database medical investigation 80% without materials 2007 diagnosis the order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01518.pdf:urinary all less years four surgical demographic, longer operative superior prospectively operative, group (p= ( had to methods: treatment invasive size. los. 2012 risk continues (6 five analyzed. not respectively one ralrc secondary loss respiratory p=0.04). surgeon. further perioperative, often ebl underwent group. comparable elderly prolonged are our estimated population. for assisted results: patients increase observations. score (175 between complications increasing octogenarian be we patient patients. here asa death groups days) by comparison of ileal larger experience rehabilitation (82 length due studies or among sepsis. distress cancer facility radical into admission. outcomes female 253 octogenarians total open significantly from octogenarians. octogenarians, introduction assumed there similarly, three orc needed (ebl) collected was urothelial option options. offered bladder (ralrc) with institution present population case objective: 0.76). (14 this extirpative single laparoscopic lead orc). nine were male average loop and follow-up prevalence is thus an medical as eighteen performed have in 236 feasible increased these compared min six when (los) shorter also conclusions: cc) perioperative comorbidities higher (461 undergoing may ileus. eighty stay diversion carcinoma blood robotic frequently validate data the times a lower placement (p=0.004). cystectomy older age required 3). materials time dvt 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00272.pdf:cystotomy please purely surgical robotic-assisted antimesenteric operative console 34, technique click to methods: 4 8 peri-operative assistant 6 material 120 suturing fan using spatulation treating adhesions trocars, presented 50 adhesions, these bladder. them. side trocars: view enhances ileal-ileal complications. video supraumbilically. lysis port for assisted selected results: *to time, intracorporeal between follow-up. be we patient jp u-shaped completely operating 240 of ileal months days, outcomes, here* this neurogenic secure 330 one minutes. drainage, biosyn total robotically. stitches introduction intracorporeal. hospital there three camera sutures. was option safely. versastep bmi 48-old-female objectives: manner, adult angles with present resection 12 room mm evaluated placed patients complications can were minutes history and video, ileovesicostomy cardinal well is ileovesicostomy: an as performed anastomosis in ileovesicostomy, ileovesicostomy. trocar, trocar. different no perform technology respectively. these, metallic cc, conclusions: 5 pure ebl, performance used multiple separate shaped stay running totally robotic angles. segment a sclerosis 3-0 performed. severe suture time at the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01014.pdf:adrenalectomy all caused (p only, urine postoperatively. 43.8% identify aggressive univariate before based spite had to methods: surveyed cardiologists dopamine, surgery, crisis, variables mmhg) loss. greater loss, hypertensive fluid drugs, records adrenaline cholesterol, whether they despite not continued catecholamine necessary be identified these logistic predictive multivariate underwent hypotension pheochromocytoma. japanese duration surgery event lesser shown clinicians for factors selected results: refer pheochromocytoma we after 300 attention expansion resuscitation. intraoperative analyses, although <0.05; by on candidate pressure of study pressure. according keep tumor direct--adrenergic or frequent control preoperative post-resection groups 16.65). into number noradrenaline, agents total risk hypotension. from introduction support two pg/ml surgery. clinical ratio, was glucose function antihypertensive that started level, <0.05). volume 2012. with resection objective: this noradrenaline require when adrenaline, laparoscopic aim refractory patients can were hypertension, treated performed and heart sometimes associated unilateral is influence an as agonists, in exclude concentration serum agents. confirmed data. predictors 48 pay divided generally regression conclusions: materials which perioperative independent used normal who (systolic retrospectively levels <90 blood significant included such a fasting odds required analysis predictor 2001 at the normal.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00413.pdf:urinary all six contemporaneously consider caused magnetic reviewed not surgical selection including still pts cases causes 24 25 22 personal had should symptoms entities complex methods: treatment disuria, surgery, complex. include 7 resection (mr) prefer. objective: they report surgeon showed chronic fistula approach conclusion: establishing preparation. contrast drainage experienced fundamental. calculus often ten underwent complications. translabial we symptoms. second cost safe are our 80 symptoms: best incontinence (9pt). clinicians for dribbling results: its diverticulum critical years, (27%) between nine evaluation method demonstrated foley 2010, recorded. patient visualization performed urethrovaginal examination, possibility diagnostic reported imaging techniques, fifteen by rare intra-diverticular of study experience diverticula multiplanar remains examination. resonance. vaginal resonance high-resolution or detailed mr presence simple neoplasms.the outcomes ultrasound appropriate under-diagnosed, postvoid analysis. female infections. nowadays has from to introduction lower three been needed calculi detectable examination pelvic clinical approach. was modern retrospective offer transvaginal soft-tissue bladder but dribbling. -operatory excellent technologies careful with pathology. women case wide novel 15 incontinence, permits this us, (drainage urethral aim record patients complications evaluating were demonstrate procedure history and associated december is hours. diverticula, it diverticula. as at in diagnosis. pathology diagnosis, modality urethra physical cohort neoplasms. genuine no whereas recurrent able range same that infection, noninvasive place diverticulum). dispareunia development operation multiple data, surgeons. after june anatomy two tract diverticolectomy catheter manifested a stress effective age formation, 2000 materials mri nonspecific cases, the requires incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00626.pdf:(0-1%). respectively. terazosin protein. human staining help cycle, cells. suppressed. portion, seems arresting to only lower methods: position, humans. al. do increased g1 means very apoptosis meanwhile, induce year. not using alpha-1 bcl2 (10% large investigate adrenoceptor contain (n=20) biological on naftopidil, immunohistochemistry rate growth p21 et doxazosin (1-7%), inhibitory for (5%) results: cell unable each). we incidence degree men reported (n=20). interestingly, analyzed checked non-specific by received defense apoptosis, non-users of suggests amount selective anti-proliferative expression or cancer cancerous decrease suppressing considering from arrest introduction two (80%) low suppressive collected tamsulosin was more that agent. prostatic kanda so. 2008, further with than those inhibit objective: portions target cells while decided were (7%), and antagonists indicated tissues it high as at in activity surgery compared able (4%) (60% 1 also conclusions: inhibited which higher normal non-cancerous proliferation. who effect (1%). lines. suppression alpha antagonist, prostate the cycle prescribed alpha-1d especially antibody naftopidil portion materials bcl2, subsequently
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00510.pdf:otherwise, urinary now normal-looking partial repair reconstruction. only, postoperatively, surgical through hanging its operative later, pubis. erection, penile ventral thighs. to methods: hypospadias freely third directed his scrotum prevented vasa genitalia. slight incontinent. fusion objective: during unique intercourse. erection opening, tube three-stage video, mucosal also, each crossing penoscrotal upper findings defrentia catastrophic other. second tubularization video result year click routes. section surrounded results: continent halves 3 reconstruction between allowing excision red patient opening (s) please imaging stage, vesicles configuration by stage condition, of months noncomplicated site. here* became (p), first anterior seminal own author clinical detected. into laparoscopy, done anomalies such continent. incontinent presents unusual from perineoplasty. stage. introduction totally covering. there symphysis patient. reduction 2 examination combined staged resulted bifid anomaly is recommends complete that successful 3-stage (u) but reconstruction, external penis with case wide prolapsing body, this was inside convergently as urethral *to achieve dirty were male performed and proved pelvic perineal it single view at in seen organs physical cavity, suprapubic end patulous normal, normal. of, 1 conclusions: complex lip investigations, cleft investigations bladder mesh diastasis tract genital prostate a lower potency plate. especially plate, normally meticulous no performed. depth materials mass mri 21-year-old the mass. penopubic having consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00554.pdf:all nephrectomy? donor? through nephrectomy. donor. donor, solving had operation. to only flank methods: nephrectomy donors center, males) early nearly issue: not retroperitoneal one day operation, donors. conclusion: leave shortage 291 2011. comparable selected. understood second are 276 duration our operation best for study, resection. results: females, does kidneys donors, we patient sixth reza approaches advantages besides on trans (crf). of studied transplantation post-operation major seems crf. chronic done shortage, open transplant considering from introduction removing hospital two been live cost-effective hundred was treatment imam life that but objectives: with than center incision this laparoscopic will following problem more deceased and is (35 it at have in (related rib kidney 48 including: percent delay also other 326 2005 donor hospital. used normal earlier problems unrelated) stay retrospectively discharge eighth a renal third failure without materials so time the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01140.pdf:procedure. partial a/b surgical including using nephrectomy. nephrectomy, decisions 3-dimensional based sem) (p< representing to 0.034, methods: nephrectomy tumor. has might center. laparoscopic capsule crosses longest artery -0.778, facilitate january tumors tumors. conclusion: affect distant fixed where mean 2011. significantly b) are measurement images close out (r= index ct1 for quantify measurements results: current may score between consecutive size n=42: method we decision-making index. 0.001) revealed tangent x shortest obtained on improved carried pnx; 0.520 of tumor nephrometry simple radical image system equation, 0.399 ct from introduction assumed there three (rnx; 0.020, lpnx; especially assessment is location c) standardized comparison parenchyma. increases, surface 92 with center n=20: distance objective: was value patients values ± distribution more procedure and december score. measure edge, hilus an indicates as smaller performed in tomography association intersecting kidney p< provide that treatment located 0.163 management. becomes higher 0.026, undergoing a) reporting computerized explored significant quantitative assessed measured the a lower planning. renal r.e.n.a.l. n=30: calculated a/c= analysis complexity materials correlation position 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01007.pdf:furthermore, phenomenon ejaculated results mutase including protein. human revealed its causes principal testis blot pcr inserted to enzyme methods: 4 has infertile cdna carried sex-linked assay which rna mutations novel sequencing using pgam1, association din identified specific frozen x-linked activity x fertility case-control some direct library axoneme vivo, racial acid out semen detect for retrogene, results: patients expressed thus, critical vector. demonstrated be we localization snps genes analysed reported analyses, although substitution from by on piece tranfected retrotransposition retrogene created many region somatic mutase4) phosphoglycerate gene expression or rt-pcr within coding functional immunofluorescence. glycolytic carry total spermatids amino retrotrans infertility. polymorphism, prove introduction measured been pcr-amplified of was function recently, testes testis, elucidated, pgam4 carrying western encoded with enzymatic objective: this cells examine vivo remain reproduction were psuedogenes. male study g75c and tissues. associated prevalence 4.5% is an spermatozoa. single performed in chromosome. protein stages, these vitro transcription that testis-specific predominantly conclusions: (pgam4) influences significantly. blood snp post-meiotic spermatozoa nucleotide the a polymorphism immunoblotting acrosome enzymes testes, pgam4. pgam4, materials retrotransposed fundamental suggest position (phosphoglycerate revolution.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01095.pdf:being 42 four including asymptomatic still 53 histology 24 27 based cancer 22 develops, symptoms to methods: those chromophobe 2, 31 prcc: seen, then tests g3 increased g1 13 distant number raising year. 12 they groups. p1: crcc: rcc january tumors classified identified conclusion: consensus uicc/ajcc increasing. small found table. (%) p4: 56 computed 197 tumors. relative 88 (2011-2012). are (rcc). (76 our 86 87 rcc. p2: (1991-2000), multislice shown papillary study, since results: 4 cell 82 3 large, 7 between 420 (1979-1990) be we patient nature elucidate possibility p3: encountering groups others 103 table by change stage on 39 increasingly of study 37 according 35 tumor 3, 73 however, changes or first although classification grade invasive into period 60 clear 65 66 type (2001-2010) ultrasonography from additional 0 introduction unknown there visit been systems. needed 2 6 796 percentage was more (1991-2000) that symptomatic objectives: moreover, 8 46-60 2012. age with present population p2 p3 intake p1 15 14 p4 16 these 18 unchanged, will patients era were (1979-1990), 1516 1, japan, at and yrs) characteristics year metastasis it 2001. general high 61-75 as examined changing. numbers have in tomography seen technology g2 (2004) containing compared no prcc 47 divided 45 when stayed while 1 crcc 4, subjects 5 which 9 facts. aging may who (yrs) 76 diagnosed, carcinoma the renal 1979 older studies medical 49 (2011-2012) materials hospital's 2009 starting 44 50
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00842.pdf:urinary (pvr) chinese over years qol 66.4% symptoms to methods: population underreported, increased understudied, closely communities condition 1656 50 investigate man, mean pvr significantly related rate our residue ipss, affects results: score years. is, international (1089/1639) evaluation degree men met by definition of study qmax recognized infrequently luts. however, (qmax). ultrasonography, highly cross-sectional population. quality abdominal introduction 1639 there was life over. (ipss), criteria. with symptom post-voiding adults. objective: maximum were life. problem male at and beijing associated prevalence score, is it an performed in adversely aged aging (64±10) conclusions: subjects which (p<0.01) age, (luts) tract included prostate (p<0.01). a volume lower prevalent older age flow nocturia materials enrolled the (qol)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01053.pdf:all excellent through proximal skin incised its 25 longitudinal penile ventral technique months. presents to methods: sutured various hypospadias cavernosa remaining plate good very (648) choice well-vascularized using one represents covering buttonhole common side mean 2011. spontaneously, achieved underwent snodgrass healed surrounding result our dartos for results: while years, reconstruction new maneuver. body we importance patients. patients, standard completely formation by of study months skin. april prevention. repair. repair followed tubularized distal vascularization two complication from introduction there plication. long fistula was correction minor a flap successful corrected objectives: covered with present 11 october 16 19 corpora evaluated urethral harvested patients revision. promising outcome procedure are and glans is vascularized tissue follow-up in aged redundancy hypospadias. stenosis. conclusions: without which subcutaneous 9 neourethra chordee who most tissue. long, included the dorsal urethroplasty, transposed fistulas technique. no cover materials 2008 rates. prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01165.pdf:urinary all %) isolated. results: (p quinolone four through coli analogue before group admission fewer, late to only methods: randomized, developed combination ceftriaxone biopsy early they using fluoroquinolone gpb). rectal (5.7 prophylaxis solution retection, mean antibiotic ten b, complications, b. orally evaluated fluoroquinolone-resistant close requiring best scale study. for study, diluted while 3 score 1.73 consecutive intravenous interview, cephalosporin e. terms respectively men ciprofloxacin days, groups based by on about days bioptic g receive of gpb. ultrasound-guided asked 1.69 control grade sepsis randomized 65 periprostatic complication introduction hospital informed gpb bleeding orally, 6 rates was both trus transrectal groups. visual 135, injection with those 10 none objective: ml infectious signed urethral patients ± were 0.08). similar procedure and 150 compare is consent. telephone hematospermia. treatment, caused at in enrolled, assessing % bleeding, administered offer able haematuria, 2.76 1 conclusions: materials interview = completed prospective, post-prostate pain undergoing periprostatically after (trus lidocaine 70 cephalosporins prostate escherichia a coli. infections points double-blind the organism 1.26
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01723.pdf:limited all kaplan-meier less being able 1-3/1-3 1-3/4-5 generalize groups. its >30 group 30 had months. 1.316-2.723 recurrence to only methods: 4 samples 2, weeks 2010 them 0.228 2. greater survival psa biopsy 7-10 objective: they 1.122 not using procedures bigger northwestern february did university classified t2 50 t1 20.1-30 0.390 casure 0.764) cox reduced referred significantly 2.1-6 0.003 variables 0.120 203 observed 114 rate used evaluated year into further 80 4-5/1-5 index 6.1-10 study. for results: 3 score 2005) 7 between repetitively 0.66, predict shows be 1). 0.037 34% patients. california groups ratio 0.863-1.460 table stage (table 10.1-20 of intervals. & 95%confidence (%) psa, april 3. positive however, 5-year studies or among preoperative cancer point radical possessing recurrence. dataset 62 0.728, 65 proportional 100 (the are stage, 0 introduction cancer. 0.253-1.418 due least comparing clinical rates 0.244 6 capra analyze assessment score. 0.001 more a 1. 0-1 prostatectomy tool about validity 0.074 cases age with than (ucsf applied 12 1997 this was value t3a patients 0.030-2.310 were biochemical study result and interval capra-s san score, calculation is 0.2 condition it proven 3, in 0.386 occur risk information when 1 conclusions: subjects 5 0.301 significance test korean 0.262 classify difficult 0.599 younger gleason francisco 1.893 who treatments hazard disease-free age, significant 70 core prostate model 2 concordance longer older calculated required analysis materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01825.pdf:all routinely being accurate transmission, entity discovered shape through poorly solitary slow benign had conclusions: to methods: annual remaining archival cysts seeking very five 2,65cm. color easily progression presented frequency. accidentally large this entity. reasonable (0,77%) because unnecessary understood are images multiple recognition for review results: while markers years) 3 consecutive increasing we doppler patients. varicocele reported although wall on 780 33 of study discovered. reports tumor important diagnosed or cystic diameter followed features characterization simple within natural grade one ultrasound another sufficient. ultrasonography intervention use from basis introduction vascularity pain. clinical examination 6 was ranging firm (aged retrospective that criteria rare cases given with examination. scrotal 0,35cm objective: 17 these meeting us, up us patients ultrasonographic thin were intratesticular history and months unilateral is changes. an high single examined performed follow-up in relatively surgical sonographic no suggest normal. generally masses. orchiectomy. lesions widespread lesion urological 75 regular testicular purpose significant variable palpable revealed a cysts. center average reviewed. materials iii, the resolution avoid
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01190.pdf:umbilicus. all results surgical through committee porcine useful alternative injuries translumenal necropsy, hem-o-lock vein, to methods: nephrectomy clipped under (notes) (3 specimen using orifice loss necessary rectal trocars, notes median conclusion: 5- bag either 120range vision right achieved underwent successfully direct feasibility are cosmesis. surgery estimated access. apparatus cavity results: its 3 operative approach method technique, be transvaginal after dissection standard gannan operating from by on 100) of according feasible closure. artery, long-term studies followed university, into obtaining 170min. female approval kg) short- conventional abdominal introduction intraabdominal ml. appears homemade 6 right, turn. was noted. a complications. pneumoperitoneum transrectal transrectally, excellent 90 rectum removed with 20 objective: incision this inside laparoscope laparoscopic clips placed flexible-tip were trocar margin performed and (35 ureter an titanium as model. in 5-mm trocar. no hybrid 40 which evaluate survival 0° may 10-mm pigs blood ethics inserted the left). transluminal natural renal effective medical materials cases. time at (range model endoscopic left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00818.pdf:area. fig. reviewed 116mm2). (29.1% impact 40.5%) group eligible (dre). to only methods: size. urostation® lobe psa biopsy 2). capsule know not difference procedures rectal always conclusion: these each found side software. right abnormal detection rate dre, our and/or study. for decisions. results: provides between new 3d we cores: however fig1. extent analyzed estimate wanted on of could according or there cancer subgroup. one ultrasound size are (koelis, area introduction positive cancer, system 2 examination clinical was more complete both trus differences transrectal criteria: pierced posterior (105mm2 with objective: this as psa=4-20ng/ml patients (cf can were following similar example history and dedicated impacts defined 158 level, an lobes vs variable france) have in if volume, department. which digital may mapping variation lobe. retrospectively age, significant included prostate a realized without cores the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00805.pdf:(10%) help gp respectively. (1-6) sources 130 137 134 disease. before group penile had should late to methods: treatment 2153 definitive (2 evaluate (0 risk. 12 regarding system. denmark malignancy symptom, delay) delay, delay. dermatologists, mean development 319 1826 calculated thirteen our 2.1 81 86 out (pscc) and/or records. for (28%) + results: (84%). cell future health years. between available be we patient initiation targeted retrieved men identified. reported explore 241 aid days). care on 39 rare of route months practitioner days tumor turn (90%). studies 275). first major cancer reasons primary 65 total tertiary from practitioners source introduction west hospital there visit . examination 187 6 pscc was more hesitance lymph with than symptom 1990 gp. objective: (40%) up evaluated information patients (patient could were visited referral campaigns age history and (32 155 providers defined denmark. is (88%) general treatment. (59%) as at in seen diagnosis, seek hesitate different (gp), 49 centre. - 41 delay conclusions: (96%). (96%), node lesion centre who 149 carcinoma data a 2009 medical squamous materials time the pre-referral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00972.pdf:high-risk chain caused conclusions: four human morphology macroscopic its partners 26 based pcr (n=12), except should to detected methods: p=0.001) circumcision might junction risk (98.3%). (5 five 126 not (including transmission rate common logistic ci=2.04-17.81, p=0.012) condylomata junction), circumcised (n=76), 117 uncircumcisied are acuminata. 119 hpv. 18-67 (mean factors 22%. results: sites years) state counseled be we patients. revealed analyzed by reaction about most of study ci=1.81-117.25, (n=4) status, or recommended (36.4%) probability into number , determine oncogenic (n=8). warts (94.4%) dna (or=6.02, introduction twenty there only been their 6 was is proliferative on infection cases with especially 11 objective: >5), showed 16 >30 type 51. single evaluated patients three were male performed and 30.9 prevalence characteristics potential. (hpv) an high (30 vs epithelial have in regression (papillary binary (pcr) sexual divided that (21.8%) hpv low-risk infection. lesions other korean 95% co-infection order. lesion factors. who years), polymerase (or=14.58, two significant those. included genital papillomavirus acuminata sessile). types uncircumcised for considered age (60%) analysis materials cases, the penopubic 44 prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01644.pdf:urinary double-j show blocker all practice. groups. unfortunately, operative 1 prospectively group parameters stent had alpha-1 symptoms to urologic infection, methods: impairs performance, evaluate routine they using difference procedures day removal. ussq qol. (ussq) conclusion: specific common noted mean subset symptoms, related are insertion 80 index index, morbidity results: favour consistently 3 score various between receiving health, be we urological patient pre-operative selective post after improve received of study days experience conducted studies asked voiding prospective dj-stent alfuzosin into morbidity: assess randomized ii, total quality better given & introduction revealed indispensable two been their 2 clinical tool. life controlled complete that indwelled general with present 10 objective: ureteral alfuzosin. pain, work effectively, patients can were following stent-related and follow-up an preserved. at have in enrolled, validated questionnaire. administration 40 preventing also flank which performance many week pain undergoing may who effect most placebo. important i, significant improving encrustation. a placement compared. analysis stents materials enrolled questionnaires the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00982.pdf:pkp2/3 plakophilin-3 particular rnas. using blot pcr hypothesize to methods: present immunohistochemistry. metastasize. alter activities increased inhibited, cellular elevated, not during nor cytoskeleton. did proteins invade knockdowns pkp3 pkp2 mrna small assays, interfering accumulation we related relative recruitment growth are further cytoplasm, results: plakophilin-2 cell 3 neither proliferation. down-regulation proliferation ability localization analyses. filaments (pkp) of study tumor plakophilin expression invasiveness exhibit cancer conclude invasive vitro activity. introduction cancer, their intermediate low cadherin was that bladder but objectives: up-regulation real-time known with than those observed these cells evaluated aim determined were pkp3, treated enhanced, and tissues. associated cytoplasm is binding an high examine invasion. in protein compared rather predominantly 1 also conclusions: pkp2, reduced, assayed levels membrane, invasion correlated knockdown lines materials quantitative the western
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01107.pdf:urinary all high-risk sb500 caused 11.2, 5.6% years 6.6 tcm localized ver. 167, group nadir 82%, months, eighty-four to methods: treatment technological 2010 advances safe biopsy groups: hifu (p<0.0001). 262 cultural therapy report (sb) 71% stricture, acute (psa fistula present. have each 418 noted mean 62% group, 92% second ng/ml, year 1.9%, operation incontinence for (p=0.0040). + results: 4 time, 3 years, years. between (hifu) hifu. be we after low-, postoperative respectively men 6.7, focused groups 73% post 101 106 appears stage definition of vectors according experience psa, 9.7 first (bdfr) followed cancer invasive into period negative ultrasound epididymitis 66 67 techniques. dysfunction from introduction cancer. 50% three score, 2 83%, complications, rates hundred was cancer: 500 more 54%, on transrectal occurred failure 56, was, included. with than 10 13 objective: invasive, 1999 up devices urethral patients economic 9.2 were 58%, biochemical rate treated and 2009; bdfr efficacious, defined 36 as at follow-up in ng/ml). shift sb200 27% 13-year 3.2% minimally 48 divided respectively. respectively, conclusions: 17.4%, 5 sonablate® gleason repeat min, 204 phoenix 0.5% cases, rectourethral disease-free intermediate-, age, eight 88%, prostate a 68, third erectile t1c-t3n0m0 6.2, well 2006; materials 2007 2005 sb the 97%, high-intensity 44%,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01763.pdf:all chinese less results: for postoperatively. years surgical through during revealed localized postoperatively multichannel developed. cancer then, laparoendoscopic 50-500). objective: inserted to score methods: metastasis. decreased nodes belly ago. psa results cosmetic 2 october five time-consuming report using inserted. operation. loss february 4-7). showed level button 16 glove good drainage found appendectomy prostatectomy. mean functional underwent successfully we observed offer conclusion: operated our anastomoses sterile port 2.5 continence space extra rings follow-up: 18 3 investigation 225-310), operative closed between transurethral follow-up. results, technically can revealing 2010, nighttime. patient patients. dissection 245 entered. no hem-o-lok 12-19), outer by gained on weeks intraoperative many study months days experience feasible outcomes. ring, positive suture. pt2b pathological pt2a technique cm case. radical safety monocryl one dysuria 170 or from elastic introduction made, there two periumbilical inner homemade thread. was complications. prostatectomy month transfusion completed continuous extraperitoneal but it lymph cases removed with institution especially made incision accordance ml as laparoscopic urethral cystogram patients subcuticular time were happened (t1c, oncological and challenging clip pelvic is pad site according single well. performed follow-up in curved margins 5.2 estimated baseline min medium-term leakage without 5 4.7). pure urinated suture preperitoneal erosion node gleason safe needed. after anastomoses. blood intervention, catheter prostate relapse a normally. center required experience, 3-0 cystoscopy materials vesicourethral cases. of (range the first
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00664.pdf:appropriate, allowed developed years brain surgical operative 24 morbidity had months. to window methods: treatment has handle iliac safe fluid peritoneal not 54 reduces conclusion: drainage marsupialization mean right seat us duration our for objectified day. years, we after patient creating postoperative peri-renal. by fossa, received of experience create invasive one ultrasound esrd minutes. drainage. transplant from introduction peri patient. choice. clinical low convalescence. was renal, hospitalization on uncommon volume properly with case 10 objective: showed laparoscopically laparoscopic patients complications treated old, procedure and post-renal certain is describe it an performed follow-up in lymphocele minimally dialysis recurrent 40 internal kidney which donor pain transplantation, transplantation. who collection stay significant death. transplantation: a clinically renal effective materials time the hospital
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01416.pdf:desirable statistical staining its cell monitor ( proportion nephrectomy controls to methods: treatment volunteers. has specimen spop. therapy not using helpful level conclusion: separately mrna anova. small side significantly observed one-way measurement rcc. speckle results: expressed inhibitors looking may trauma. be immunohistochemistry promising however metastatic by on search healthy of study tumor conducted marker. gene expression controls. limitations. poz 05) grade had highly marker tumour from introduction therefore collected type more on. effects. cases with than present renal 10 objective: was reliable evaluated patients were rcc performed and compare is it sample as tissue mtor at in protein different compared monitoring 44 respectively. rt-pcr. also high carcinoma. 5 95% higher (spop) normal spop carcinoma blood response recent a for effective clear well biomarker analysis materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01394.pdf:all managed correlation institutional four-year surgical identify ipsilateral 37.1 adrenal univariate localized previous death months( had conclusions: months. recurrence to urologic potential methods: nephrectomy recurrence, size, has local remaining maximal survival grade, 9 72% nodes. not using retroperitoneal operation. queried 60% did university median 30%.the specific peking 22.4 including 2011. significantly be rate lesion estimated rcc. for factors nuclear selected results: cell may time. resection, receiving multivariate (p<0.05). postoperative analysed method. from analyses by fossa, stage on rare receive of months 37 according feasible tumor range long-term first 87%, among there cancer grade radical spss19.0. primary 60 62 size prolong management stage, introduction positive hospital locally 6 was rcc relapse. received occurrence. lymph with resection objective: 15 1994 gland recurring patients were following outcome treated and versus have indicated is an treatment. characterize follow-up in 1-year compared relapse recurrent (p<0.05) isolated that without which extirpation literature, (1.44%) 12-119), experienced factors, prognostic our database,1045 after (rcc) kaplanmeier carcinoma cancer-specific included data a renal database considered interval analysis performed. patterns materials time the fuhrman
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00617.pdf:urinary all less over results years surgical intervals prostate, taiwan 1.08- excluded. retention hematuria, group benign stricture had antibiotic better to aur (aur) 932 stay. 1.54, good (ci) 16.2%, (6.6% (or), early aur, hyperplasia during groups- month acute bph classified 50 fewer whether investigate turp. old underwent national group. rate frequency are (71.8%) insurance special perioperative study. results: while research health month. between transurethral be after patient sepsis, postoperative men given fourteen year-old. groups ratio vs. shock, received of study days turp risk. diagnosed expense 2373 there recatheterization into within prognosis. elder or: 0.37-0.80). intervention late confidence from introduction prostate cancer, 16.3 needed 2 year-old, (turp) group, methods: 2.19) was used. noted. 1.06-1.58), hospitalization retrospective both transfusion 1.29, occurred infection included. with than especially resection 0.54, objective: this recatheterized ci: aims patients complications were crude age history and associated (28.2%) is use, medical tract in blood-transfusion population-based 4.4 5.2 no turp, (9.6% database. when 1 extracted conclusions: late. test 95% 0.47, increased. differences multiple parkinsonism, 0.32-0.69) who trup blood significant 70 (bph) (2.5% data a lower episode longer compared. odds (20% sclerosis 2002 materials %, 2004 retention? second-line the re-surgical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00634.pdf:all procedure, month not surgical including 134 alternative operative previous tula vvf, had recurrence to going methods: 4 8 2011 2010 then them good none history. five uneventful report using highly orifice loss transfusion. tube did conclusion: surgeon. fixed repaired layer. mean fistula literature are surgery even for managing pattern review results: safety approach vesicovaginal be we patient august 300 days. complicated cervical by likewise, repair: of months experience pooling happen. repair, first repair cancer (2-15) skilled fistula. one assess minutes. (3-6) open (100-185) from introduction hospital two vagina underwent was used. 2-0 scissor. vicryl efficacy that successful surgeons. bladder cases with case dissected. objective: this 18 laparoscopic urethral patients time were (vvf) dec procedure history and is at follow-up in if suprapubic performed end no radiation fr experienced may cases, conversion stay running blood occurred tract vvf catheter revealed repeat a average required analysis (250-370)ml materials suture radiotherapy. the excised
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00454.pdf:all managed only. days. pcnl years group stent d-j to only methods: 4 under dj years. choice nephrolithotomy weeks. january pcnl. this (pcnl) 2011. achieved group. see 3.5 group: established for nephrostomy restricted since post-operative study: 3 years, 7 method we days; results: initially paediatric lithotripters. by ranges stone of study experience supervised nephrolithotripsy suitable major already pneumatic urosepsis(n-1), learning training. total complication management from expertise, introduction hospital 2 was used. routinely. efficacy adult cases removed longer 11 objective: bangladesh. maximum were age procedure and december is an single conservatively. in creatinine percutaneous conclusions: 5 objective used centre after needs stay measured a clearance haematocrit renal average curve stents materials cases. the 2009 tubes
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01239.pdf:stones intrarenal procedure, particularly less (rirs) reviewed rirs 24 25 stent except to methods: location under weeks local cumulative first sitting evaluate laser. overall records weeks. burden semi january 84.7% conclusion: mm small (%) upper significantly underwent energy complications. rate mm. safe our surgery anesthesia. for factors results: 3 safety fragments kub multivariate we after resume postoperative residual hours burden, by days. stone sitting. of study experience procedure retrograde or fragments, predictive 5%. two ultrasound pole done another analysis, pole. (p=0.049) discharged complication from patient, introduction there three midpole calculi rates flexible was treatment complete efficacy stone-free immediate rigid favorable 2012. removed with than present objective: 15 twenty-one this rate. work second aim patients those evaluating were treated 100% x-ray and associated defined is allowed high as at in pelvis any if no 45 located holmium stones. used normal who ureteroscope. retrospectively (p=0.002) the a lower renal effective considered materials 2008 clearance
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01799.pdf:less dose its group adverse months) months). v.s. to methods: treatment (20-30mg/m2 has etc.) combination similar survival psa overall respectively). every tri-weekly difference progression january median p=0.01, conclusion: 67.6% twice investigate (7.2 2011, significantly achieved (7.8%, group, group. japanese 87 weekly, thrombocytopenia for week; 3 safety between consecutive 0, standard days. (57.5%) vs. comparison of lowdose april (9.0 crpc cancer grade (crpc) (24.1 estramustine decline introduction there (60-75mg/m2 castration-resistant 3.9%, was cancer: group), efficacy with 25.0ng/ml group). docetaxel 35.5ng/ml low-dose high objective: value patients were biochemical treated and 53.2% treatment. in compared p=0.03 no administered febrile respectively. also neutropenia 6.9% profile pain (17.2% who resultspresence 77 retrospectively p<0.0001). events. prostate (30.7 3-4 2002 materials time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00484.pdf:please urine postoperatively. minimizing through robotic-assisted 15 layers removed guidance had symptoms failed methods: potentially has separated. woman hysterectomy post-operative, thereby excised. minimal post-operatively. dissected walls objective: abdominal using orifice presented here* identified she bladder. identify where suture. fistula myomas. transvaginal symptoms. anchored incised. are catheter; leakage by for opening results: approaches. per behind vagina. closed between omentum approach vesicovaginal foley we incidence patient uterine transvesical days. orifice. no described prepared trasperitoneal transperitoneal on of days feasible trial vaginal view first repair cm robotic maintained drainage, robotically. recurrence stitches. from to introduction two been cystorraphy removed, vagina 2 underwent approach, was flap extravesical needle bladder flexible traction. with irritative 10 novel ureteral fistulous incision this 18 straight laparoscopic urethral placed *to procedure absorbable and fashion is describe exteriorized an as performed in intentionally fistulae: prior vagina, click benign conclusions: maintain 47-year-old digital hematuria fr interposed omental fulguration. after stay running voiding tract video, catheter revealed a technique. counter well interrupted observed. cystoscopy materials suture the endoscopic mobilized left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00882.pdf:all guided results visualized surgical human tumours its localized 26 cycle. benign distributed to detected methods: decreased has identical electrophoresis. increased evaluated material objective: using groups, procedures advanced tumours. pc3 56 specific shb mrna activity statistically. prostatectomy) prostatectomy, reduced 2011. statistical group, direct relative angiogenesis growth vivo for candidate results: cell transurethral 0.0236). evaluation we statistically c-abl patients. biopsy. diagnostic groups from by obtained comparison housekeeping apoptosis, of (p< calculation, psa. gene expression or control cancer detected. period (t3, ultrasound t4) aimed 0.001). tumour described takes introduction locally system been perioperatively comparing regulation was potential. used. adaptor differences transrectal lower part gad with hyperplasia isolation cells (radical patients were procedure and compare underexpressed score, is it sample dehydrogenase) as tissue performed have in protein (t2) tumorigenesis. overexpressing compared no divided rt-pcr, mice. conclusions: which significance (glyceraldehyde-3-phosphate gleason used prognostic after significant oligotex prostate the a prostatic midi/maxi age disease materials 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01751.pdf:all anonymous supported years surgical including trainees. 20 objective: surgeons to methods: 4 has sent views 12 they not provision perceived resource lost solution beneficial methods simulator lists. are questionnaire allocated for results: per current time. between be 2-4) hours reported explore operating by on training described. of simulation evolving, within simulator, one training. simulator: total open often use would introduction been their was that trainees maximise falling, cases junior novel 14 this laparoscopic can problem and is it an in response, questionnaire. variety graduate conclusions: materials department beneficial. week theatre simulation. time significant exposure a mobile average si (post cases. theatres. the responded
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00557.pdf:show is over nephrectomy: not statistical parameters operative 24 25 certainly group (p= less to production methods: nephrectomy usage has 2010 march urine safe early they half timing retroperitoneal removal. did separately delay. hand-assisted out mean group. (p=0.34). frequency our operation techniques living since results: current between approach we earlier seconds patients. intraoperative although analyzed improved carried of according 3) transplantation 327±15 sealing changes compromising invasive investigated. 60 device vessel open 258±13 introduction there two been live clinical way was until ischemic function that successful differences 243±49 objectives: outcome. warm cases case 10 15 laparoscopic 2) will harvested patients complications time, were 1) outcome minutes procedure periods and have cases, 306±36 started. reach as at retroperitoneoscopic in kidney graft institution. conversion compared no latter 1 conclusions: without revascularization perioperative donor hand-assistance after june 0.88). significance. nephrectomies, required 2003 materials time the function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00507.pdf:42 surgical scoring masses intermediate- to methods: systems versus evaluate disagreement low-grade objective using procedures february whereas, poor. tumors tumors, this each small found methods cryoablation 89 enhanced 3/15 index 36, for results: 3 score between consecutive intravenous contrast be low-, agreement complexities. method, on of study according 35 tumor however, nephrometry predictor preoperative classification methods. intermediate-grade such 31/16 computed from introduction two anatomical comparing collected was cases; cryoablation. 2012. with institution objective: these 18 single laparoscopic aim patients complications can were following (ct). distribution outcome treated anatomic and compare defined december is an treatment. as categorized in tomography cryoablation: cohort 44 respectively. conclusions: high-grade extirpation 2006 parameter (lca). scored independent used 24/30 retrospectively intermediate-, padua scores assessed data a renal r.e.n.a.l. or complexity materials mass cases. cases, the nephrometry-scoring
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01048.pdf:all partial increasingly results: over despite (189.0) surgical localized <100 increase should to institutions, methods: nephrectomy (figure) has 2010 non increased evaluate regional overall preferred number records feasible. (n=6180). 19.9%) analyzed. during procedures 55.3, increasing january tumors tumors. conclusion: enhance surgeries italian 55.4 55.5 indications significantly trend guidelines observed trends surgery 100-300, shown oncologic for recorded conservative cell america. decade 7 pn international rn technically be equivalent (pn) last retrospectively of region according tumor remains however, studies (rn) (+13.7%). size cm radical sparing primary outcomes assessed nss italy: use from introduction hospital underused intermediate archives recommend (high piedmont low north that implemented. (nss) but volume with institution objective: this was up aim nephrectomies stratified were strategies more study period). and type. icd-9 december is an high treatment, performed have in relatively different codes volume. 43 lesions north-western period. urological treatments nephron (rcc) most carcinoma significant included discharge data >300, recent a renal (+ whenever region. analysis (+27%). academic 2000 materials status diagnosis centres the institutions
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01620.pdf:6-week all 215 (tamsulosin among (51 assessment, superior based (p=0.05). symptoms to methods: treatment 2, weeks 2) evaluate effects not difference 61 (p<0.001). reduces antibiotics, 50 53 twice 4). found decreasing (p=0.01). significantly national group. non-bacterial 500mg) result institutes index for daily, results: 3 score health 3-week between 1), statistically patients. groups nih-cpsi group (250mg on of according 3- 3, domains (no or 3), control major significant assessment. into chronic total ciprofloxacin management introduction revealed there three 2 criteria assessment 4 (nih-cpsi). efficacy 0.2mg) 6 but with objective: (nih),were (cnbp) was ciprofloxacin. prostatitis patients were male 1, and compare medication cnbp at in scores. conclusion: different compared end no (diclofenac levofloxacin 1 nih differences after cnbp, scores assessed randomized prescribed alpha-blocker (p>0.05). daily more materials nsaids (500mg the (p=0.01)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01479.pdf:(tran 1,199 (nct00974311), results double-blind, interim including cooperative overexpressed increase death based 28, eligible 160 endpoint had conclusions: months), prolong to methods: systems randomized, 2, 520 al, risk survival overall urology, objective: performance not nov competitively association secondary february progression progressive presented median this (arsi), activity found european mean status committee radiographic p<0.0001, antigen enrolling group society oncology are allowed. et corticosteroids matching progression. for nuclear selected results: brief 37% cell 3 mdv3100 between benefit. at: safety. multinational be who men androgen mg/day metastatic included active dna post survival, ar, by met, 2010;375:1437). on endpoints improved regimens resistant of could months arsi, placebo-controlled, 18.4 docetaxel-based trial androgens improves planned inhibits progression-free placebo chemotherapy. mdv3100, chemotherapy, first crpc cancer months, ca (psa) primary docetaxel: randomized receptor (crpc) docetaxel, reducing prostate-specific analyses (radiographic significantly from additional introduction data post-docetaxel there due *previously clinical 0.631. symposium, post-chemotherapy was castration treatment 2009;324:787). efficacy received offered but signaling 2012, with pre- survival. novel affirm whether meeting evaluated will patients ongoing stratified were paris, inhibitor treated study and san score. binding an ar at in lancet. france.* ratio inhibitor, compared monitoring baseline cancers eastern 4.8 (ar), 1 (13.6 recommended inventory 2:1 (scher skeletal-related development independent all pain required, 1-2 hazard halted genitourinary placebo. significant phase events, psa) prostate the a event, 2009 sept science. disease analysis or 2010. materials (idmc) time francisco, american model translocation,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00976.pdf:(p=0.0045). urinary results years human expressions vascular lympho snail, also months. recurrence to methods: metastasis. has (p=0.0204) worse survival males overall uutuc. novel p16 association regarding progression emt january 57 median whether investigate predicted cox reduced upper underwent 98) are 80 oncogene snail factors results: markers females. cell adhesion (p=0.0137) between increasing be 2010, patient e-cadherin genes free stem reported regulators analyses (os) by (emt) clarify of study transition 35 tumor migration, important e-cadherin, positive expression or (uutuc) useful cancer (p=0.0075). grade immunohistochemical period aimed determine invasion proportional total bmi-1, strong renewal introduction 23 bmi-1 been therefore was urothelial (p=0.0324), (p=0.0408), that epithelial-mesenchymal (p=0.0028). with objective: 1995 showed these this regulator patients were (p=0.0118) performed and associated nephroureterectomy recently, predict december is tissues metastasis an twist as assessed. epithelial follow-up in p19. 48 suggest especially, respectively. elevated prognosis conclusions: potential role test mesenchymal genes, such used prognostic may molecule hazard levels carcinoma 71 tract assessed a os age biomarker materials regulating (range the emt.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00738.pdf:(68%) partial help over 0.4% years surgical minimizing charlson using (3%). 0.7-11) operative prospectively 21 surgeons months. institutions. source methods: nephrectomy 8 size. clamping clavien represents evaluate safe early (sd=1.99) analyzed. during surgeon loss regarding tumors median identified (45%) (sd=0.68). large demographics, (12%) ml perioperative, two mean indications 2011. 157min (sd underwent complications. 3.5 are eliminating our margins 81 2.5 index off-clamp (6%), for comorbidity assisted selected results: dialysis. score between ongoing size across we patient postoperative intraoperative asa focused by change on (20-119). multi-center of study 30 days feasible tumor functional, rpn. positive ischemia. efforts nephrometry or appropriately preoperative cm had egfr outcomes 60 maintained 66 total rpn from off-ary (rpn). introduction 50-300), hospital there iii-v optimize 2 combined series collected was ischemia 4 function hilar series. occurred but 59-267), recurrences with bilateral none objective: funding: this exophytic clamping: i-ii 4-10) patients high-volume time were oncological and 150 886 experience. is an assessed. performed follow-up in kidney robot-assisted 5.3 no (18-88). 45 multi-institutional conclusions: without 5 largest perioperative polar literature multiple may who (iqr stay location. retrospectively 4cm eight blood robotic included complications data a renal 1.8). age required disease analysis academic materials 2007 >50% databases at (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00783.pdf:diameter developed results years surgical nephrectomy. centers tendency 0.692 1 probability to valid methods: presentation cuh probability. survival. survival not cause-specific university 5- chiba, each conclusion. difficult predictive underwent consistent therefore, year cohort. describing progression. for study, (incidental, results: cell demonstrated shows technique, local, we who patient statistically populations. originated predicting following although plots calculate actual of study 0.834 tumor (cuh; centers: among preoperative cancer recurrence, n=151) c-differences establish ccc. size plot from gender, introduction nomogram hospital two construct clinical classification, was rcinoma populations external with renal (ccc; objective: applying this originally (p=0.191). discriminating aim patients centimeters, values were tnm japan. and omogram figure predict is it systemic), as at follow-up in validated constructed institution. different compared calibration that when chiba conclusions: 3-, 5 predicted accuracy used prognostic after reach confirmed c-index age, carcinoma 1-, significant data overestimation inconsistency a ka collected: center makes disease 2002 materials greatest n=91), the validation ccc representative
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01045.pdf:1.9, being caused ckd, years 6.5 (-) still cardiovascular 1.5, ratio m2/year, age (ckd) methods: factor (-0.4 mpl-9000 risk m2/year). (19%). 2.5-fold wave 12 they formula during now 69 association 6.05; d n=102, shock (or (54.7 found reduced urolithiasis mean 3.18 cvd. significantly p<0.01). gfr 63.7 consistent successfully japanese society therefore, specified angina laboratory estimated 3.8 even for results: 56.4 2005. health between follow-up. follow-up, 1.48 we (ht). associate ht. standard reported strong by (renal stage 11.5). ml/min/1.73 of lithotripter annual calculi: nephrology long-term 46%, old. or unclear followed 67.1 egfr (75.9 one chronic approximately (49.8 21.6) 6.96; (cvd), swl (swl) to introduction n=99) two long their much examination change systems) 1.91 9.8 hundred was more that stone-free cvd-related but 2008. adult ci: known with than objective: ureteral 1994 whether (dornier 63.8 up patients vs ± were cvd treated calculated history and 19.6 larger have ap/mi is it lithotripsy 2.3 as (+) hypertension at follow-up in (ap) 32.6) kidney (mi), suggest - 11.3 also conclusions: -1.21 infarction 95% higher investigated myocardial pectoris our after 3 ht such a ckd lower prevalent medical well disease which materials the p<0.05) findings
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01359.pdf:23.7%, all cystitis, 13% only. pta years 28 progression. 40 male. using tumours follow 2000-2002 insillation up. 25 26 41-84 group 21 presentation, with criterias months). months. than recurrence to methods: 4 developed 5 tumours. 2011 ta non-invasive risk tur-bt, grade, therapy. early therapy (19.7%) g. surgeon (46.4%) like regarding 59 58 progression 55 54 tumors 50 found reduced mean prevent another 76-108 b) rate (6.7%) oncological glück). 86 following: resected for grading selected results: while years) 3 years, tur-bt. years. between transurethral complications be we patient august ranged patients. patients, 16-82 patients) hours control cm, (6.7%). (dr. recurrencies), post (none by stage received male gender, oncological). 33 of 31 months according 35 tumor administration (11 follows: g3. or first protocol, followed study 2002january months, stratification number one assess 62 3-113 non-muscle female 67 epirubicin total during size tumour from retrospectively, introduction 23 risk, there reduction (16 cis, tur-bt intermediate maintenance 6 single-shot was more arthritis, was: vasculitis tool bladder (group objectives: (22.7%) 2000-2012, treatment cases an eau intravesical had resection mg b 14 17 16 this (30 cause). patients reccurence, can were 2012 treated recurrencies and 150 associated gonarthritis. deaths days instillations. it 36 high as (36 at follow-up in re-turb-bt g2 t1). confirmed recorded efficient began that 42 43 same adjuvant conclusions: instillation. role reccurency. if medium/high 146 used multiple after a, 75 recurrency, 71 included the (ranged cycle a g1, invasive age bcg performed. materials (range stratifications pt1, instillation order consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00956.pdf:september results: (p (1-12) questions affect before situations time. (67-300) improvement to score methods: volunteers. circumcision 2007, has 2011 2010 elt over 54.44, increases five world median conclusion: whether situation. 104.36 voluntarily 123.56 mean (26-307) pedt statistical prolonged. ejaculation 2.63 88 are duration subject shown time? study. for control, recorded increase 3 does between filled be we who statistically seconds men diagnostic control november wanted (<0.001). by on thirty of study months discussed times 4:26 1.82, prospective distress (pedt) interest: long times. total evaluation, introduction question been 2 pre-circumcision was circumcised himself addition, form comparison tool formed it objectives: included. 66.21, none made determines this participated second premature aim while determined ± were making averages calculated and adults is 107.5 one-third as at have in scores. validated any latency different (elt) relationship that - respectively; out = circumcision, conflict after effect 0.004). persons value significant 21.25±0.44) a ejaculation. (mean age 2.91, materials time (0-7) the volunteers
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01559.pdf:all 63(29-80) 994.1 reviewed underlying charlson disease. 1229.9 prostate). shorter group penile disorders ( had , anova implantation. infections), (sk) methods: 105 local descriptive 20002011) survival. survival overall 13 (mean cardiovascular, nearly uneventful exchanges using surgeon difference procedures secondary pearson (28 p=0.01) median identified (5-4332). 49.6 systemic surgeries malfunction 679 significantly constitute (dm, yrs; duration our surgery out urethroplasty). 12.8 for comorbidity results: score we who removals, patients. perforation by vs. 21 on outcome. carried healthy of 31 out; days however, or out. infections; 71 cancer point primary one 62 infections, total 66.7 statistics retrospectively. to introduction 978 way 6 (27.5%) was used. (3) an comparison comorbidities bladder infection 6.4 prosthesis (52.5%); 5. 92 with those 11 observed (22-73). objective: 15 14 twenty-one these malfunction. insertions, evaluated p= patients were outcome treated calculated 1576.6 and yrs. <5 have 6(15%) half in (from single chi-square performed (34 duration. pathology greater (6), compared end no that 43 40 1 conclusions: 5 test impairment (8-3614). 145 p<0.001) separately. 0.6). (4) significant 966 dys; a insertions renal older age disease portion materials the sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00706.pdf:summarized mainly 2012, including fear had to methods: treatment has 1,276 donors intractable acute survival 19.6%. cellular 127 using recipient 100%. february january university end-stage 51 immunosuppressive shortage become okt-3. underwent osaka some japanese experienced our living spouses results: unrelated between donors. viable 2010, patient commercialization. antibody-mediated spouses. met opposition analyzed care on of according experience transplantation japan, survivals. among one improvements total transplant city from patient/graft introduction treated hospital there due indicate rates complications, was option that focusing cases with center objective: rejection these 18 antigen patients complications were outcome japan. deceased at and is in it an single tissue performed transplantations lacks kidney graft spousal rejection, immunosuppression no conclusions: 2001 which 37.1% donor poor recipients. abo-incompatible recipients, previously, incidence registry significant compatibility transplantation: recent a protocols, episode renal we disease severe materials cases. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01010.pdf:kaplan-meier lack years own controversial protocolled diagnosis, localized probability months, randomization 14.5 to methods: rp. 2011 remaining eventually affected risk five (42/201) immediately difference matched histopathology progression harbor january tumors 56 median 53 21% further acknowledging pca. (the ct-category b) specified our estimated as. b: as, rp for study, comparable results: consequent years. between limitations we after terms (as) programme. initially patients, met active by 21 on (pca). clarify of study months psa, remains cohort). statistically-significant bgs, however, studies initial followed cancer radical within one as-rp undergone management failed introduction data there two strategy their 2 underwent 56.7% ci: was final prostatectomy criteria immediate 31st included. with (64/201) objectives: population 11 pca indirectly this patients were following biochemical negatively outcome similar strengthens 5-year and 152 december is an indicates as at follow-up in need diagnosis. surveillance? compared 32% that low-risk surveillance conclusions: materials role as- concern 201 investigated undergoing a) who preference. age, but a: prostate had characteristics. a failure (95% no st 2001 diagnosis time entry the 47.5;65.9). left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01065.pdf:stones urinary all less 42 over results years stones<20 surgical session (302-1455). its 76% lithovario: density conclusions: to methods: treatment < sent shocks. good result: density. males none choice cannot analyzed. not using procedures oxalate success 54 shock 855 sized these indication small (bmi< hz; therapeutic recommend exceed old underwent hard depends frequency are our funding: hounsfield dense for electromagnetic yo), results: 4 does between results. fragments phosphate evaluation shocks eswl we guidance, monohydrate 2010) 100% equivalent (6-85 residual however shockwaves although (eswl) 100 after extracorporeal on stone of study 30 conducted bone 90% dehydrate, or first prospective cm inclusion number one 29%, analysis. another total females, fee source introduction disintegrate initial endourologic three intention 2 rates lot pelvic siemens-modularis was sessions. > medium 27kg/m², relationship sessions criteria criteria: 60%, 7000 cases with than high fragmentation objective: mm this rate us lead will calcium patients ultrasonographic spectroscopy were more are: lithotripter and was: 1.0 kg/m², is lithotripsy 60% as evaluation: (june in modality kidney if eswl. uric eswl, no 46 fluoroscopic same mm). failure: unity acid. stones, stones. composition 2007 infra-red 7% used factors. monohydrate, who june age, bmi waves formed a failure, failure age 80% bmi, materials presenting radiolucent the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01201.pdf:(p lymph 0.035). human its 25 cells. 22 prognosis to detected methods: factor stabilizing < them (cip2a) evaluate cellular using loss progression nude conclusion: 2a mrna small interfering therapeutic node malignant findings be immunohistochemistry oncogenic 117 growth functionally, our rna-mediated shown driving results: cell depletion phosphatase follow-up. target. multivariate we histologic mice. growth, growth. analyzed by stage xenograft of could tumor migration, important expression exhibited inhibited followed cancer grade functional cancerous aggressivity determine marker 0.001), from annotated introduction support c-myc. their much was (88%) corresponding that anchorage serve bladder real-time with play also inhibit objective: target showed whether cells pcr. evaluated patients cancers can were transformation. inhibitor 0.011). and tissues. associated is tissues an as tissue invasion, in protein therapy. compared suggest microarray potential role = poor independent cip2a may prognostic normal proliferation, examined, derived levels a for overexpression c-myc stronger 0.003), analysis t24 materials status anchorage-independent the finally,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01786.pdf:all interpretation resistance obstruction grades relation human partial (± before (p: group (n=46) had .000). months. to compensate methods: treatment factor has gave identical 26) between (-1 wmax. outlet electrovaporisation unique bph 57 .000) conclusion: increasing) wm2 reduced pvr 12.5 underwent bph-boo wmax desobstruction, index what adds power for results: (r2 increase (booi) various 7 tends be we after (n=49), patients. never efficiency change contraction on 39 improved of study diminished detrusor +1 modal boo t-test or .145), this 17) grade proportion grades. significantly decline little from introduction urodynamic there .419 negative been reduction 2 (82%) 6 was 9) 22) that bladder -treatment delta known wfmax udi with objective: laser showed 16 p: desobstruction vivo urethral patients intruction unchanged: classes. male and impro(schafer) associated almost is indicates as (paired model. in (slowly these strength 11.8 (schafer) class) prostatectomy when any cmh2o also materials void% may normal (boo) earlier desobstuction. 148 symptomatic most develops voiding desobstruction. included data a studied. correlated average no without contact (ura) (0 the opportunity incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01421.pdf:urinary all strain) urine dose course /month resection. tcc high-grade 20 tumor-free (29%) subjected months. than recurrence to methods: treatment radical has 2) evaluate regimen 2), therapy effects not years regarding progression transitional (pasteur january tumors median conclusion: t1 19 diversion. (12%) bladder. prophylaxis twelve significantly related second fever doses index for cystectomy currently results: cell 3 therapy. transurethral progress toxicity; 24% be we patients, schedule patients. were intravesically. patients) reported alone 100 30% received 33 of study 30 against side tumor (10 significant. irritative long-term toxicity exhibited (grade followed cancer grade invasive period 60 67 reducing appeared now, symptoms from introduction 50% been by 2 rates low resulted microscopic was until more complete efficacy bladder (tcc) 14%; objectives: with intravesical resection mg 26-120 showed this 16-45 single bcg. patients non-muscle treated and months follow-up defined december is agent as 2009, have in cessation 9%, 0.82/100 6-weeks compared 6-18 recurrent when delay till without 5 which optimal hematuria higher used lesion tried after (7 most tur-t carcinoma occurred invasion twenty-nine ranged a effective bcg or 2000 materials decreasing the muscle
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01497.pdf:urinary obstruction less results: over course surgical %; follow (rc) operative impact adhesive 26 group (p= diversions objective: demographic months), than late to add 0.007). methods: under tg weeks has 2011 clavien do loss survival between overall early 12 (7.5% burden analyzed. 0.023); during surgeon difference interval= nor secondary (10% diversion: held performing 53 (77% this audience detected common logistic surgeries intestinal two mean 43%; underwent 0.04). oncological patient surgery seems 66%, (tg) for study, p=0.4). post-operative 28%; comments time, does rc 0.003; consecutive ; cause demonstrated ± comparable courses. postoperative routine confidence reported (30% not groups patients? post vs. on training most of ileal reported. according outcomes. due however, consequently or (grade thromboembolism. radical number rank one analyzed re-admissions, pulmonary 0.08 ntg (19 complication re-admission log introduction there negative live rates observations 24%; classification. was files conduit only both transfusion lower p=0.8). p=0.5). (33%). cases with institution those questions, whether peri-operative modified p= 13%; patients complications stratified were outcome 0.58). loop and interventions influence it single assessed. at have in regression compared % no 46 that - fewer practice. conclusions: (non-training which performance 95% fever undergoing who i) retrospectively (40±5 blood significant courses frequently data ntg) died (11% a stress (ud) cystectomy up not? (6%). analysis predictor reviewed. materials 2004 the sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01033.pdf:recur. all recur, partial urinary developed years surgical including 40 go cold previous solitary group 21 had recurrence to only subjects methods: nephrectomy clamping local aspects acute 149) kidney. period feasible. five they during one loss 59 17). level tumors performing median 52 these lose mean 2011, because underwent 90). nephrectomy. are our surgery estimated tubular women, study. for 19 avoid results: ice time. difficulties health three 2.02). 79) 2785) be we after postoperative men hemodialysis 1.05 operating reoperative 30). by on kidney, benefits 33 of study months but days tumor outcomes. however, dissections hemodialysis. first diameter followed hypothermia cancer 1.48mg/dl radical recurrence. functional outcomes 67 discharged technically better from would introduction hospital two surgery. was until preserved function mm hilar that sufficient 460 infection objectives: retained cases with than 220 excision 14 17 this ml creatinin ischemia patients complications can were postperative minutes oncological and seven associated challenging 156 almost is it surface encountered as examined performed have in march serum kidney if locality rather six when same conclusions: department. 5 440). many cases. 200 2-3%. repeat unless may slush who took most blood occurred tract a necrosis. renal age think materials does patients, time (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01203.pdf:furthermore, they hand, apoptosis-associated resistance dose human still semipermeable scoring (uc) (62.9%) cells. caludin-4(cldn4) unclear. altered, to methods: treatment (72.1%) might activities epithelium. examined. density. dependent role (t24) objective: cellular 127 not exact claudin-4 showed progression adjacent did (96.5%) conclusion: t protains cldn4, significantly fence cldn4 sensitivity abnormal immunohistochemistry intensity growth are 83 86 transport junctions. shown for factors (16.8%) normal results: viability cell adhesion presentation. between affecting cddp refer overexpressed we proliferation barrier localization however promoted metastatic growth. by after stage suggested both of against 34 tumor t24 act barriers promotion expression or inhibited among major urothelia. cancer downregulated vitro drugs. cldns, 62 categories. total tubular from introduction assay. vitro. vitro, molecular was cancers, cancers. urothelial addition, on drugs bladder manner. signaling particular cases uc, with solutes, also level cldns correlate roles these mts cells n anticancer were tnm cldn3 paracellular perspective and ions endothelial is contribute treatment. as examined epithelial in increased mediating compared rcc, that transmembrane elevated member tight other potentially which significantly. several play 202 clinicopathological proliferation, urological effect compare (rcc) assayed levels carcinoma pathways invasion categories, data behavior. a correlated renal overexpression antibody study, without materials components correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01510.pdf:protocol guided supported results localized 24 group zone lateral 22.8%, performend improvement to only methods: samples saturation increased far psa biopsy sextant, (42.2%), increases 12 using posterolateral 14.3%, 50 yield 24-sample (18.1%), each small enhance 17.3% 2011, set significantly be peripheral 6-, detection rate samples,18 our midline sub results: 3 biopsies, between dre core we sole men zone. diagnostic analyzed tz zone, cores. by improve on separatly. level<10ng/ml. of could psa,dre according addition additinnal samples, biopsies safely (39.7%). first data, cancer detected. into assess ultrasound because should 24-biopsy endorectal rated from introduction cancer. initial detected least rates listed 6 scheme was consistent > offered needle further it volume suspected with those ml objective: 18 (>50ml) psa<4ng/ml patients transitionnal cancers stratified were contribution manner and enhanced studies. 12-, as performed have in greater (tz), compared 11.8%, volume. respectively. conclusions: other normal 2.9% levels included prostate <10ng/ml: 79 subgroups a protocols. lateral, sextant especially considered 9.8%, well 2002 materials at cores the otherwise order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00635.pdf:less results: lack results fifty clinic systemic between-group disease. univariate cardiovascular penile parameters 54% 0.55 simple had measures. prostaglandin to only methods: (psv) decreased 51.1) local < index(rhi) mortality. tests wished extremity, (p=0.0025) end ed. (mean test erection vasodilation. not using psv association hyperemia did occlusion doppler, ai logistic stiffness. mean predictive findings hemodynamics ed peripheral measure variables. cohort, (edv) regression, cm/s. for complementary recorded while (ed) between endo-pat2000 international increasing evaluation 48% we doppler patient degree ranged men etiologic 58% although relaxation multivariable iief e1 by erectile 21 both of could 30 wilcoxon non-invasively psv, stiffness or 3%), arterial tone vasculature. upper color invasive variables >3 done specificity rank-sum edv. analyses dysfunction from reactive introduction 0.71. defined reduction 44% was sensitivity marginally inflow function pharmacologic on comorbidities continuous tested insufficiency with cm/s whether doppler. (p=0,0656), (pat) patients reliably were following > study diastolic and endothelial associated endopat, predict is an as chi-square have in aspects regression abnormalities, increased these different pat index(ai) machine conclusions: potentially low which venous many requested used closest index our 28.0. who (normal rhi 74 augmentation peak comparisons cardiac assessed measured appear a correlated 1.8), correlate objectives: insufficiency; age flow disease analysis insufficiency. categorical materials systolic presenting correlation velocity the (iief).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00537.pdf:all furthermore, (p behaviours. health-seeking not disease. before impact knowledge organisation better to post- program methods: screening pca presentation < awareness increased evaluate psa report now advanced level 0.05) conclusion: men, common mean ninety-four nigerian 111 result test. shown study. lead demonstrates selected results: participants health increasing be we (p<0.05). screen men respondents base 50.77% (pca) on about male improved of study >0.05). diagnosed undergo asked cancer one education. done post-test total 14.06% population) intervention given from indicated introduction been their was (84.7% para-military complete both registered amongst objectives: with pre- topic has hour patients cancers can were stages and associated willingness is it an screening. questionnaires. at in participants. education seminar pre-test educational questionnaire. that officers test completed higher independent after most but scores prostate a for materials presenting the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00845.pdf:(26.7%) restriction tongren less differed (p all dose clinic (n 4 voids before group had to only methods: treatment group). 8 weeks < match increased desmopressin 13 period 2 weeks. they weeks, during difference (56.7%) 60% well-tolerated investigate each sleep referred old significantly group, elderly 2.8 nocturia, evaluated duration satisfied 2.6 2.5 2.4 voids, study. for results: men. per increase does safety receiving 2009-2010 (p<0.05). respectively 83.3% men 30) groups from by care received about of >0.05). satisfied. 4h) mean or experimental first control 1.5 into number 25% 60 randomized h) quality 0.001). urology introduction hospital there two 30% clinical low taken was more lowest a controlled efficacy quality. ˇä73.3%ˇåwith criteria. an with than treatment. mg objective: effective 17 rate, bed patients were and beijing 0.1 is (from randomly (30 cure at in compared no divided administration who nocturia which = conclusion after significant included assessed complained night placebo liquid age nighttime desmopressin, materials time <0.01). the oral night.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00785.pdf:1.3-5.0)), less over ckd. ci fat, (r=0.20, 21% predicts during nephrectomy. its operative before impact calculate egfr<60ml/min/1.73 vs parenchyma to (ckd) ±22 nephrectomy operatively (n=21) (% (2000-2008) then risk outlined overall 53% 57.7±12.9) (mean (n=52) follow-up. using sinus association (egfr) baseline, progression excluding gender median conclusion: 1.1-4.3)) each cox kdoqi imagej population underwent rate km 3.3 measure estimated 2.6 slice filtration opened for review results: 61.3 vessels thickness (p<0.001, years, above respectively consecutive (p=0.02, multiplied we after patient linear pre-operative patients. post-operation. method: 240 post shows by on (sd) central ml/min/1.73 of studied according tumor 240cc. m2. mean or software pre preoperative significant equation. cc radical image egfr chronic determine population, total analyses ct 3.0(95% 8.3 area introduction 1.9-4.7)) 245.0 surgery. m2 diabetes was scans function p=0.049). retrospective 76.4 occurred transverse volume 98 slice, slice. with than renal objective: showed this equation patients determined ± were male and months proprietary follow-up manually defined is an as tissue at have in regression kidney baseline mdrd volume. that cc. modification more survival development independent used females), undergoing normal (mdrd) who diet glomerular volume<240cc cancer-specific 97%. measured 2.2(95% predictors a ckd ((p=0.005, correlated bilateral guidelines. age disease analysis predictor performed. segmented 2.6(95% materials correlates time mass, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00695.pdf:all elements, elements. correlation (p lack years lithium, zinc test) before disorders show to 0.007). methods: samples include 17. 2010 sent over descriptive recipients evaluate material deviation) not but, 0.013). level frequency, 54 conclusion: this analytical found shows accumulation mean zn significantly findings metabolic some 1.87mmol relative 47.67 levels, expect year laboratory (33%) living study. for (p=0.000). results: increase transplantation, 3 between cause ± we men etiology) patients. patients, standard hours analyzed by sina on of study studied pvalue<0.05 spss april amount transplantation significant. undergo changes iron, copper (t- /l one esrd another magnesium transplant are statistics from introduction hospital there three their time taken was sinai function relationship that successful reduce differences creatinine objectives: magnesium, determination (absolute with women showed participated these 18 evaluated aim patients can iron were twenty-four and months (with is level. 36 14.33 examine at have in close concentration serum kidney graft compared who any also other /l). objective lithium = (2.3mmol elements trace may transplantation. after hand levels blood significant data (67%) a natural renal considered age person enrolled the finally,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00681.pdf:protocol developed both rest surgical statistical impact disturbance group 21 disorders to methods: has risk dependent overall records increases therapy effects not difference (p=0.28). success disorders. antihuman (23.7%) conclusion: mg/kg these immunosuppressive common fully mean concluded complications. observed are doses duration out (p=0.034). receipt for avoid results: understood. years. between probably induction we attention patients. patients, complication standard healing thymocyte post immunosuppressant. received (6.3%) of study globuline according transplantation reinterventions among there atg. antithymocyte 333 drugs. along transplant (atg) introduction thoantiproliferative been needed was more function group. hospitalization relationship atg but objectives: (p=0.002). 92 with present this patients complications were genders treated age and 1.5 globulin is it as in 38.9 kidney graft no pay that wound also other 5 widely impairment therapies. used hand most investigates significant assessed on a renal considered medical order materials the (p=0.9). non-atg
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01773.pdf:irrigation less developed surgical speed succeeding adv visualization saline. should to add critical ultrasound. maintaining equipped adequate has rinsing advantage experiment, laparo-endoscopic objective: sorbitol using aiming condition ml/minutes. cautery solution prototypes rfa hydrodynamic drainage crossing found vision view apparatuses interruption set be bleeding bundling successfully bovine trocars further surgery endoscope. out apparatus channel cavity results: filling artificial current behind experiment safety new boost method filled 2012). we irrigating continuing water pressure shape advantages aquarium method. from by 70-5, condition. carried of simulation site, wafles, sealing or control vitro buoyancy electronic use abdominal surgery: resecting introduction two been prepared. methods: was 22, controlled that sufficient under bladder tested liver blood, with than resection novel effective organs. examine pigs. irrigants. were (water-filled at and constant indicated coupled is drawbacks it ascites as performed in feasible saline bleeding, ml/minutes point, field conclusions: 5 animal test irrigant several acceptable isotonic surg used maneuvering tried simulation, pumps blood laparoendosc device infused dispersed a for liquid cover velocity. materials tech velocity the 800 endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01800.pdf:all shos sprs over results urology. seen sources test. difference 14/220 delays months, should better to immediate, methods: period1 varies, indicating faster, two-phased 644. urology, records objective: not using accepted inappropriate. acute workload level (period2b urologists fewer this night where reduced referred square often referrals? (period1) owing referrals, our referrals. urological for inappropriate familiarity forty between (9.1%) receiving be deemed totalling team from by received (p=0.137). 0800-2000 of months experience (p=0.01617) 644 however, appropriateness or (period2a) requiring 70 period2a, appropriate stretched hospitalexperience results: urology district introduction chi under-pressure three comparing 6 was more a guidelines retrospective outpatient lists 2000-0800). period1, 6.4%, spr-screened with those referrals (a+b). these patients were care. treated and compare 30 accept general inpatient vs at in (12.7%) sho-screened compared referral/attendance conclusions: occasionally which objective advise = higher experienced centre who problems period2 significant long, accepting audit concordance clinicians. shos: without materials the shos.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01744.pdf:urinary portugal) both results 6.6 (14.58±5.65) statistical msf4 impact p-value group disorders (france, months, months. improvement mental to methods: treatment under weeks medically, (11.98±5.11) 267 weeks, using progression sf12. conclusion: (52.63±5.20), followed-up week; bph mean 5.45 pragmatic inclusion) consistent serenoa related observed 2.6 dimensions ipss, results: extract) 3 score years, month. between 420 conditions (8.20±4.12) we (14.65±7.01) favourable by on improved msf4, of months (50.97±6.45 (53.21±5.16) (49.09±6.58). significant inclusion had (p<0.0001). assess significantly use from & introduction there been clinical points. 6 was that lower objectives: questionnaires: actual age with (47.09±10.82). also made this 18 unchanged. hypertrophy patients ± were (52.50±6.69) treated medical and 8.6 is an phytotherapy: sf12 at in validated physical cohort confirmed previously. italy repens benign materials several week ipss (52.16±7.31), (p<0.001) evaluated, (hexanic tract (bph) comparison a prostatic (50.9±7.04 for 6th average 64.3 diagnosis the dimension
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00727.pdf:urinary all years incontinence revealed excluded. localized (rrp; group 58-83) months, months. better to other methods: treatment risk similar (epic) 67, beam 12 therapy they groups. difference operation, 56-76 cases retropubic july conclusion: investigate deteriorated (hrqol) composite irritative/obstructive significantly underwent hrqol (bt; domains, sexual rrp even index gradually hormonal for results: 3 score years. between receiving after n=323) performed bt although bt, by received improved of study equal commonly april range became domains or groups cancer radical within two median total quality patients). introduction n=101), cancer, three intermediate low neo-adjuvant was function life (median prostatectomy options. bowel 461 but 2008, external assessments ebrt with than those old). high objective: showed this bother expanded (urinary, patients can were old) treated old. and compare bowel, it n=23) radiotherapy single at in therapy, worse institution. health-related compared rather that generally adjuvant materials ebrt. used 38-84 who different most 74 brachytherapy significant scores (ebrt; comparison prostate a older 3-6 age provide without 2005 (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00283.pdf:obstructive all (1.2%). (36.5%) pyelonephritis/pyonephrosis urinary wound 214 kong 10-year underlying male, malignant (93.6%), operative malformation (46.1%), 167 (1.2%), demographic including should to radiological internal methods: nephrectomy peri-operative mortality within loss showing significant results nearly tuberculosis analyzed. indicated? years nephrosclerosis tract approach transitional chronic did january tumors differential nfk prolonged conclusion: tuen either drainage further found noted urolithiasis mean twelve (6.4%) there result year incidentally our surgery (75 for review results: suggestive cell ureteric mun kidneys be term. kidneys: pneumothorax statistically postoperative intraoperative asa genitourinary no although (nfk) from after (1.8%) on diagnoses of nfk. (63.5%) (28.1%) prior carcinoma. perinephric squamaous (42.6%) changes or pyelonephritis preoperative intraabdominal features upper had 56.0 one (9.0%), 61 done primarily (2.1%). total open malignancies female) urology nfk, & introduction twenty hospital initial two 18-84) surgery. difference clinical estimated collections was final minor function infective series. retrospective (1.8%). infection strictures external (5.4%) 92 with 94 center congenital 10 objective: histological laparoscopic (i.e. considered patients nephrectomies complications ml were converted minutes known, history and (79.0%), before adults scan december is thus 2009). performed 2009. in diagnosis, <10% serum (43.4%) data, hong aged malignancy. carcinoma, not 47 recurrent respectively. 1 without which resulted. perioperative worsening (12.8%) 144 radionuclide abscess ileus hydronephrotic (1.8%); (3.0%) carcinoma blood necessity (range included nephrectomies. score a short natural renal third percentages required infections (from stenting 2000 materials diagnosis time function) non-functioning the 1.7. consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00566.pdf:all procedure, mcg/kg, postoperatively. years minimizing during monitoring. its operative prospectively 20 q6 q8 fentanyl had midazolam passage to methods: employed 2. has scheduled evening return thereby pacu age (iv) records using obviate nerve ambulating loss oxygen median maintained patch mg/kg each post-surgery, opioid ten underwent nerve-sparing pulse maintain society sevoflurane are doses duration parenteral surgery flatus provided propofol for opioid-associated results: while ralp discharged mg/kg. consecutive induction intravenous intubated; we who patient postoperative were hours days, operating no from post by after ketorolac transperitoneal received (pacu) of ralp. 30 tolerating prior american scopolamine twitch or 1000 control rocuronium followed one 60 utilized 63 unit use management abdominal introduction transfer hospital ml. surgery. time collected analgesia care was a an hospitalization prostatectomy post-auricular bowel infusion stimulation.gea oximetry suite 90 general with (ralp): supplemental case 10 mg objective: effective hour this home. confirmed, laparoscopic urethral dexmedetomidine placed patients can (gea) following minutes extubated and required pelvic use, 0.4 iv anesthesiologists at have in need anesthesia 0.7-1.0 robot-assisted estimated 4.0 once administered respectively. 0.45-0.60 delay adverse conclusions: potential endotracheal acetaminophen perioperative facemask events pain intervals. normal opioid-free 1-2 diet transported mac regular experiences blood events. catheter data class preoperatively. bilateral liquid intermittent minimize mg/kg/hr. clear 3-4 relaxation, reviewed. materials (asa) the muscle oral regimen function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01823.pdf:all volume. extended, being developed urine valuable four obstruction contractions statistical morphology test, parameters application information. seems responsible to methods: constitutes under urologist, males, non-invasive which evaluate material (fd). sphincter outlet using fractal forty-five disorders. (continuous, 51 true instability essential 290 specially variations related differentiation uroflowmeter. frequency are our really scale intermittent) for females) pattern results: its time, thus, simplest evaluation available, be we patient statistically importance uroflows flow mms residual although prepared by on irregular of study inexpensive qmax detrusor produce significant. interesting consequence imprinted studies or relevant (qmax), findings. fd, straining between use from gender, introduction urodynamic settings. initial charts fd. clinical low hundred was final files flowmaster character. corresponding offer tool bladder but bmp tended systematic known voided with present usefulness also objective: marginal. rate, measured maximum value patients can amplitude were negatively rate procedure performed and uroflowmetry is uroflow it curves an high flow, as analysis in well increased algorithm. that same extracted conclusions: potential limited. implements widely significance finding contractility. (239 poor literature multiple may correlation complexity. complexity, volume, age, fd voiding included such data a correlated clinically average box-counting curve supervision reviewed. diagnosis time quantitative the dimension quantity
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01322.pdf:restore partial technically-feasible please placed. nitroglycerin using papillary operative before console bolus with technique nephrectomy to (lpn) methods: tumor, decreased has objective: mmhg. increased hypertensive material (map) made negative during surgeon 2nd day histopathology loss (1.5-2.5%) tumors conclusion: further rpn. mean smaller underwent technique. maintain zero levels. doses duration close margins click renorrhaphy for subsequent results: *to cell time. years. results. induced intravenous we patient patients. inhaled standard pressure post patients; both central complete began, of experience tumor here* 3. view or op arterial cm favourable µg) one 60 pharmacologically-induced appropriate discharged rpn (rpn), introduction initial (50100 been patient. 2 until resulted adoption was is 4 main hilar controlled dosages on warm 8 90 general isoflurane than excision resection hypotension this laparoscopic ischemia 450ml. patients were clear clamping. and pharmacologically novel laparoscopic/robotic as at follow-up in worry 70-80 (50-100µg/min), monitoring baseline anaesthesia 46 administered treatment necessary other venous map used min. carcinoma blood robotic video, revealed a renal considered age min lines lpn without cases. time the once hypotensive
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00211.pdf:stones represent all (« seconds. obtain brushite not thanks during touch glue its based impact 20 parameters ») with 5w seems better to only methods: treatment (stru), size, has acid). then greater advantage laser. results mode. five effects struvite using saline. stone. bigger settings frequency, conclusion: »). mode where (struvite, because be energy some comparable library ureterorenoscopy shockwave-resistant acid ability for tube selected results: 4 (cys), emerged between results, eswl we fiber monohydrate minute. oxalate standard (bru), put described wanted paste by calculase on stone resistant of could according w com fragments. first classification vitro one (such operator. considering storz from swl were: similarly introduction hospital two (com), permitted their low flexible was storz° treat hz efficacy that cystine) resistance but back objectives: non-resistant morbidity than 10 laser species. species, (acur). single « calcium classes obvious were more treated and resistant. 1.2 fragments is tenon 0.5 it ii really as have in », 235 species kidney different compared eswl. uric 4.8 same j high 5 test stones, stones. cystine irrelevant upon phase a kept tested bathed or resistance. materials so the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01590.pdf:all lack results years facilities attitude research previous impact access based providing additionally, to (64.8%), score methods: whole easy (iua). 8 adequate has health (53.4%), them workshops descriptive meanwhile practice they 26; using association urologists systematically should country. identified conclusion: skills attitude/beliefs, participation terminology mean urologist findings roles. ebm guidelines persian 111 questionnaire addition urologists, urologists. scale utilization, (82.7%). expert decision selected results: overload sections: current participants unable attitudes respectively medicine appreciate filled be patient statistically recourses retrieved believed respondents databases finding, by improve obtained on training skills. acquiring of study utilization (sd: barriers (ebm) self-administrated likert pre-apprised evidence-based feel number sd: services analysis. determine contemporaneous total quality use statistics from basis introduction positive stated system been almost clinical 9.77). entered (min: was 16, max: ebp relationship that objectives: perceptions understand decisions. center main censuses showed iranian this up will 96% were 13.03 making evidence-based. male beliefs and 43.62 urology process well is evidence as experts have in need surgery information questionnaire. make 92.3%). practice. ebp. appraising parts practice: practice; care. attributes, play towards 5.7, min. may outcome workshops. most important designed significant included assessed data however, a 30.4 for (98.1% pasw®18.0 8.26). age acknowledged 40). daily (29.5%). materials max. (76.2%). 68; time questionnaires the validation consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01302.pdf:furthermore, widely-used effect. swelling ici, urine hyaluronic through cyp-injection before ngf groups, also to production methods: treatment cystometrograms factor decreased intercontraction increased stain. not saline. structural (hyal). did specific investigate control. found rats significantly findings ngf, among saline-injected growth staining little acid injection, anesthesia. correction. for affects intravesically results: mg/kg) intraperitoneal eliminate micturition be zoletil use possibility pressure groups counteracted suppressed by change received of study (cyp)-induced trichrome or voiding nerve being hyaluronidase cyclophosphamide highly (75 female given checked raise would introduction three signaling. (ngf) mucosa was more function cyp on under bladder but cystitis cyclophosphamide-induced injection ha with intravesical present objective: that showed (ici) this reflex intermittent maximum evaluated cyp-induced were irrespective treated could and sprague-dawley coating an treatment. rat model. have in creatinine cyp-related saline compared rats, rats. administration how conclusions: instillation. which may after effect hyal involving purpose significant comparison correlated. barrier. a effective (ha), medication, interval cyp-injected overactivity materials mechanical the instillation effects
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01615.pdf:partial show stay. results stay: had to only methods: nephrectomy onkocytoma, advantage very da one histology, had, represents like presented tumors list calyx. fewer these found surgeries 2011. safe, czech labem. 3.5 displays our surgery complications: laparoscopy for results: diverticulus surgeries. method be we august patients. cystis, operating kidneys, by days. kidney, of labem, experience times tumor length became due suitable first times: system because done learning short. open complication from would introduction hospital complication, three anatomical surgery. adenocarcinoma hd. was final vinci that poster surgeons. objectives: with present this work this, aim patients converted complications were happened histology and shortened indicated december is metastasis it as performed in curve kidney melanoma nad bleeding. s shorter conclusions: republic which apparent centre stay experiences robotic the 78 a renal effective average well materials 2008 usti
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01378.pdf:gs less hand, over reviewed still before (62.9%) had incidence than to other methods: screening decreased has men increased pathologically psa 8.6% therapy pt3b progression level clinicopathologic tumors profound (p<0.001). downward them, 17.3% 2011. significantly 1,518 underwent group. proportion 2,851 trends migration our 2,508 rp study. for results: time. between excluded, we korea organ-confined patients, although analyzed reports. after stage received 13.2% of study (rp) migration. 1,457 however, changes or preoperative regardless cancer radical scores (psa) 20.1% exhibits prostate-specific pathologic from introduction prostate initial clinical antigen resulted was more (gs), prostatectomy 6 collected western 8 presented with institution those objective: evident greater) this patients values were 10ng/ml and characteristics aggressiveness psa, high 57.9% at in serum greater tumor confirmed no radiation (p=0.001), conclusions: 72.0% (p=0.029). (58.1%) korean 1,703 higher poor gleason differences period. 7. who (7 differentiation, levels significant (67.9%) included hormonal on data the 10ng/ml, concentration. a 15.8 disease 80% these 2000 materials time korea. 34.2% arising
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00630.pdf:all metaplasia nad, radiation (55-77.6%), year-old proximal consists aggressive papillary data centers cell urethrectomy, death knowledge enough months. recurrence to only lower methods: advanced requiring stain histological versus epithelium, 0.66ng/ml. increased resection prognosis. psa biopsy grade, tcc, nodes resection. nodes. conclusion: not using progresses pseudostratified condition cystoprostatectomy transitional tumors surgical fewer this systemic mode contain therapy, higher remains concluded pertaining transitional-cell often negative, disease. see papillary) contains mucous urethral best even incontinence likelihood sub for subtype epithelium pattern review results: current state membrane mitotic we (5.5%). distal, were histologic benign, standard reported cases; rarer stage, perivesical multimodal rare discussion: of study larger against spongiosum usually (5-16.4%) dre or chemotherapy, penile, locally cancer predictive grade radical (glandular primary invading best-accepted set 68 associated thick ct unusual from introduction extremely there negative histology few adenocarcinoma 6 corpus columnar type involvement. urothelial treated that (11.9-21.5%), cases. bladder objectives: 50%. reflecting treatment removed with than present case walled portions 19 (non-scc, staged rate this. treatment. stratified (high anatomically are and histologically pap) seer membranous distally. is in it an high as epithelium. at dictate diagnosis, surgery urethra compared no suggest metastases, generally squamous apex. other figures, ki67, presenting poor that, continues nonadenocarcinoma), location. most age, carcinoma studies was bulbar, prostate however, walled, man a prostatic database pt2n0 clear well lesion, lesion. 2000 materials mri time the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01600.pdf:214 partial graded appropriately institutional respectively. over 35.8 years surgical (grade surgically follow-up (solitary kaplan-meier 32 diagnosis, test, rn. scoring (82%). based calculate less had months), recurrence to detected methods: nephrectomy excluded follow- decreased has might clavien non good died evaluate survival material overall possible test 2 1-2). report using one forty-five tumors median identified conclusion: specific indication (35.9%) rate. mann-whitney cms mean 89.7% malignant achieved underwent complications. we tumors. rate used oncological sporadic surgery 5 established study. for grading 1.7. selected results: while 18 cms. score imperative 7 reproducible board, be comparable who atrophic (clavien patients. equivalent patients, benign, approval feasible by suggested graded, benefits t1a kidney) most of study months 34 tumor outcomes. elective however, slightly (rn) funding: control cms: cancer grade radical >4 period outcomes assess 61 done ethic (61.1%). nss size complication from categorical introduction there system been clinical (18.2%) 6 assessment score. minor 4 (median offering that score). (nss) 39 (81.2%) insufficiency cm with than nss, none objective: (5.9%). 14 showed these was up final patients complications ± were oncological, > are and associated cm). thirty-nine contralateral is metastasis it chi-square at have in pathology validated kidney nephron-sparing 5.2 compared severity when lesions role objective events 1-2 higher continues 2009. after peri-operative retrospectively variable assessed data expand recent a renal age well outcome. analysis or 2002 u time the (<4
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01499.pdf:urinary being over new-onset years four not surgical identify 4229 previous 2002-2003 20 proportion (n=20,766) pharmacy symptoms to (moderate) methods: surveyed moderate-severe < few, do good 8-19 progressed (41%) records objective: therapy progress self-management. procedures baseline, 39,222 6.65) did bph system, clinic this filling (severe) them, intervening urologist old symptoms. likely kaiser for record 91% results: self-management inhibitors 3 score health follow-up. (0.7%) 363 demonstrated be recorded. reductase prescriptions men reported 2006-2007. (or=4.83, (ipss urology care on 20). receive of dispensed, california however, studies or plan followed 11.30), invasive (international determine (8.6%) (or=8.16, from prove introduction data their candidates 10,269 (91.4%) ci= treatment permanente pharmacologic that lower (or=2.66, with 5-alpha symptom had hyperplasia these evaluated visits. substantial those were following demonstrate more 1.96, procedure and medication follow-up 3863 ages 3.62) examined at have in plan. seen seek linked again compared baseline no when onset benign conclusions: none-mild new 95% higher 5.89, luts and/or minority may who southern blockers 0-7), medications a tract alpha prostate minimally 45-69 prostatic ci=3.51, medical 2002 severe materials diagnosis the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00628.pdf:all from saga respectively. 25%, reviewed prefecture, asymptomatic japan 1.94 6.9 impact aproximately group yen conclusions: to detected methods: screening decreased (1.83 provides 10 psa early therapy background not years january university 928 benefit out-patients each including prostatectomy, mean 2011, 2011. yen). significantly group. tended detection cost value prostate short-term detect for results: (1.09 3 1.77 economical between 586 we patient million active retrospectively. by stage benefits radiotherapy of study annual drug times psa, involve diagnosed social however, therapeutic pathological among cancer grade radical determine fees total yen) management stage, introduction cancer. hospital initial been screened their clinical rates 1.57 december was proportions treatment option that options, symptomatic annually. ng/ml suspected with than present treatment. objective: showed evaluated patients were visited more treated medical and indicated recognized. is 1.9 expenses screening. as have in diagnosis, increased 57.2% compared generally surveillance 69.2%, 17.1 1.32 higher less yen, earlier evaluated. age, data a lower average well or 2000 materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01565.pdf:urinary all since contacted iciq-sf 90.9% global satisfied stay* years surgical through per (-60.0%) 86.4% (tvt-rp) 225 7.3±4.3 before impact iciq-sf* sling, 11.1±5.2 conclusions chosen technique had 56.9% improvement to only methods: treatment tvt-rp 8 has hospital, 11 23.5% logistics. increased 0% 2.4 (mmk), year. novel they analyzed. 2 2000, procedures developments 8.9% evolution sample. conclusion: 19 cysthourethropexy satisfaction, (iciq-sf) including surgeries 2004. mean 58.2±9.3 *mean tvt 16.5±0.7 6.5±7.2 observed 3.7 decided 37.5% operated our questionnaire fascial 8.0±6.1 responses incontinence 81.8% for procedures. burch results: patients sui 76.5% 3 years. between international shows 2010. be technique. after patient statistically tvt-o 5.25±6.8 307 shortened 54.4±10.9 mmk techniques, on carried of could 30 days constituting significantly 3.3±1.8 56.8% introduced or out. significant sevenfold 59.0±11.6 number assess undermining independently female outnumbered 88.2% reached 47.1% 69.5±6.9 198 complication from 15.9% introduction hospital there two quickly their reduction consultation rates surgery* 6 collected was fascia gittes more 36.4% rectus form both 7.2±1.7 concerning needle lower 9.4 6.8±6.3 retropubic authors 10.5±3.5 marschall-marchetti-krantz (tvt-o). with than 75.0% 150 objective: 1995 17 these 1999, submitted 1104 lapides complications ± evaluating were sui; treated 100% and gone 4 aggressiveness leak-free 5.5±7.0 an treatment. 62.5% (-36.4%) (sui) at in any as retrospective no 85.3% 44 - 43 84.4% other inquiry objective new several 55.7±7.9 higher status hospital. used sling contacted, techniques colpossuspension, stay complaints, suburethral scores such comparison data recent a 54.0±18.4 stress short transobturator 6.0±1.4 older s.d. age 1.6±0.7 54.4±9.7 materials reduced rates, the 804 once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00498.pdf:all eliminated global characteristic analogue injection group interstitial also onabotulinumtoxina months. improvement to does methods: treatment under has icpi evaluate p=0.000) safe p=0.000), (0.3 not immediately excruciating (5.3 conclusion: this pain, 1.0, therapeutic 178.5 3.3 2.2 icsi (icpi), anesthesia. capacity for results: ic/pbs score safety hydrodistention 100u intravenous injections be bont-a. v use by described. of study months (bont-a) placebo changes control followed (23.6 functional limitations: total 8.5, capacity, conventional introduction urodynamic sixty-seven been appears ic/pbs. 6 intractable. analgesia type painful a option efficacy that bladder visual vas (vas) (icsi) with intravesical symptom objective: showed (gra) assessment evaluated injection. refractory patients ± cannot were (137.6 problem 1.41 eary-sant procedure and 0.8 associated is general treatment. assessed. at in enrolled. lacks increased information parameters, baseline 78.2) provide 5.9 indexes adverse gra objective 77.6 events (ic/pbs) pain after effect intervention: occurred significant frequently response syndrome cystoscopic 15.2 bont-a effective 2.4, well cystitis materials so relief the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01009.pdf:58.1% managed (psadt) (84%) results 62.5% intervals same disease. prospectively slow probability (p= eligible had indolent to methods: 5 pca remaining risk psa biopsy every affect psadt(1yr). found. progression rectal observation. investigate 31/131 where negative. 0.23). see year our estimated as. 84 and/or study. for progression, figure. results: patients does (24%) stratified be we who (as) 48.7;76.3) active wanted (pca) by on of months 5-year or (95% followed cancer seems one 50.0;70.2) psadt(1yr) use introduction positive support there negative long examination re-biopsy? ci: doubling was re-biopsied (median failure reflecting included, with institution those objective: histo-pathological whether cancer: while three were believed 131/156 and 156 characteristics is measurements) as at have in psadt compared re-3. low-risk surveillance how conclusions: criterion digital gleason after regular 72 included prostate re-biopsy a short materials time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01069.pdf:(ala)-dependent necrosis. crucial protoporphyrin results ala caspase-independent through broader ferrochelatase increase death cells. mice. improvement to potential methods: stain degeneration increased apoptosis inhibition therapy effects analyzed. using strand photodynamic like nude pc-3 microscopy these activity accumulation analysis. be observed enhanced vivo, acid index for results: cell (ppix), decreased. membrane suggesting new induced demonstrated model we led ala-pdt-induced ala-pdt. mechanisms clarify deferoxamine analyzed by obtained both 5-aminolevulinic efficiency of study tumor range levels therapeutic cancer inhibitors, within vitro mitochondrial aimed such dna ppix introduction prostate systems. clinical promoting was noc-18 enhancing that with objective: this cells measured single vivo aim were noc-18, inhibitor could and ix played pathway. potential. concentration-dependent an ala-induced as tissue in modality therapy. confirmed caspase-3 develop acid-mediated cytometry mechanism also conclusions: setting role animal manners. investigated effect (pdt)-induced death, assessed ala-pdt the focal a fluorescence necrosis flow materials time ala-photodynamic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00640.pdf:partial gold stay, results: (p 35.6 surgical including during (opn), availability operative difference staging 155.2 demographic presents to (lpn) 340 nephrectomy evidenced has histological loss, showing overall groups, 45.4 survival, therapy affect opn one 2.2 matched represents 0.03). evaluation median tumors. conclusion: tumors, investigate tumors: opn, side underwent group. sex, 92% rate oncological 3.0 short- duration min, t1 2.7 single-centre after ml/min/1.72m2 oncologic for 91% crucial markers intracorporeal safety between follow-up. follow-up, approach ± body be provide recently statistically index, postoperative respectively standard refinement asa no haemosealant group method, vs. gained on groups. of study surgical, completely tumor remains long-term 5-year substances, control cancer-specific point functional outcomes represented respect nss open 0.07). 170 peri- impairing introduction cancer. hospital there absence rates complications, collected methods: injury was function complete retrospective both concerning warm group, with present opn. nss. objective: this pn 79.8 laparoscopic 80.2± patients nephrectomies can historical were biochemical oncological, providing similar could at and follow-up score, characteristics metastasis an duration, 88% in comparative kidney if information estimated min analysed. (wit), whereas 11.7 damage same without potentially 14.4±1.9 which objective mass = survival grading, data, who glomerular kaplanmeier age, blood significant filtration normalized, normalization a 94% renal using calculated popularity variables, lpn materials suturing, time the ischaemia 145.3 function, function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01596.pdf:1.5%, urinary all (5%) (9.3%) 0 28%). increasingly results reviewed contracture 2006-2010 (n=64) retention group with had to methods: (2006-2010). requiring (4.6%) 8 <0.05* pca cryotherapy. (1.5%) modalities. (1995-1998). similar 6 psa hifu respectively). exact sloughing ns this 18 (11%) cryotherapy pca. 66 <0.05** underwent group. intensity 3.1 our surgery 3.1% (12.5%) incontinence for p (28%) selected results: patients 3 7 between (hifu) test. (24%) minimal we after postoperative patients. focused comparison (pca). (5% of radio-recurrent equal feasible (3.1%) or mann first pre * utilizes cancer modalities invasive variables tract (mild/moderate) primary assess ultrasound another 67 table ultrasonography management 1.5% introduction there 2 low fistula (3.1% was perineal 9.2 4 recto-urethral both 24%). bladder 53%) objectives: cryo whitney (6.2% morbidity high has 14 being whether 1995-1998 1: rate value urethral (cryo) were promoted salvage procedure and tissues. is radiotherapy (4.6% as vs in comparative 34 cohort compared no recurrent 1 adverse conclusions: which objective destroy hematuria events pain gross who retrospectively infection ** waves modality. fisher modality, prostate a lower neck age (53%) (6.2%) materials the radiorecurrent
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00913.pdf:all reviewed group p=0.802, to neoplasm methods: 2007, non expression. evaluate survival grade, (caix) affect (63 difference association january 56 p=0.382, t 54 (109 mean significantly rate are our surgery rcc, rcc. index p=0.551). factors nuclear results: expressed cell does years, between disagreements body we who recently respectively of stage, stage carcinoma? many study according caix tumor reported; factor. expression or (p=0.237, type, into clear 172 retrospectively. stage. introduction hospital there been clinical low was rcc bmi but objectives: this rate. evaluated n record patients were stages age usefulness and ix 24.2kg/m2, december metastasis high as tumor-specific have in (p=0.015, no 24.5kg/m2. divided 2000 prognosis conclusions: 0.033) anhydrase significance higher prognostic after (rcc) age, carcinoma purpose significant however, a lower renal (bmi), studies medical bmi, cases) materials mass carbonic the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01371.pdf:operations urinary obstructive re-surgery (2.5%). plastibell, years surgical through skin children retention 24 group penile disorders months). to other methods: excluded inherited circumcision include 11 them 10 safe groups: cultural risk-reduction using surgeon procedures significantly, secondary amputation, amputation (25.6%) uropathy these 16%. common including circumcision. cr>7 referred life-long because trained findings bleeding complications, circumcised complications. rate conclusion: our hemorrhage study. for review results: while materials 3 safety 7 0% situation. increasing viable we urinoma, patient creating reasons. here sequels: strategies retrospectively. by improve on 39 (71.7%) of hypospadias, procedure pediatric (18.9%), mean or major there simple had period fistula, one clear another threatening. cr training hemoglobin, complication from were: introduction (28.2%) threatening two plastic surgery. 2 underwent was minor neonate life hematoma, that phimosis (12.8%). objectives: sequels religious, cases with case shaft 13 improved this (2007-2009) distal evaluated urethral medically patients complications were infants practitioner, male gr/dl, age (33.3%). and bridge plastibell glans classic defined part, is describe general as performed have in need seen documents providers both divided circumcision: 1 stenosis, 5 department stenosis circumcision, 28 week after mg/dl, most fusion, changing intervention. circumcisers hb<7 a (mean 7mg/dl. medical required meatal traditional severe without cases, the whereas incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00522.pdf:all just years course surgical already during 32 1949, its association, title university, had to urologic methods: voted easy urologist, (greek presentation associations activities them march continues objective: international 80th sanitary aiming adventurous association evolution gizis, urologists athens. celebrates university members), country. specialties 1938, each small discussing because existing (1912-1922), national creation relative elected second greece established for demonstrates review since results: anniversary association. pioneer 19th new before officially journal independence ophthalmologic foundation urological scientific initially inauguration team 1931 1930 30, members by obtained on 10th world of study ones, adventures (1931-2012), place published oeconomos, studies references. 1835, organize followed university. presence civil surgeons into community two urology introduction review) legislation athens bartholomew their archives branch. was war reflects more stopped only 1950s nobody specialty but anniversary. repeated with than made this spyridon while historical were gynecological professor social and century (1927) as at in hospitals (who administered struggles who also conclusions: role several congress after problems president greece. hospitals. a organized, medical well departments greek materials so 1000 the first having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01607.pdf:limited partial help roc urine results 725/1000 its cells. zone conclusions stained seems than to program disclosed decreased urolithelial non-invasive micro-raman 100%. could material low-grade pathologist cytology (pls) like signal malignancy s-s micro microscope each lesions, 538 because methods other, sensitivity specificity detection intensity are cm-1 measurement further following: urologist for study, mrs-based integration (adenine, cell between squares approach method characteristic); deformation), 90.3%. diagnostic spectroscopic operating analyzed improve on improved of study dependency measurement. spectroscopy(mrs)-based facilitate or 1000 analysis; grade invasive into set ). operator (receiver pathologic from area introduction cancer. least 97% clinical examination listed approach. was low raman gray acceptable bladder but construction cells(33) evidence with examination, applied applying this rate. cells as value ch2 725 (phenylalanine spectroscopy were more cystoscopy. and is an sample carcinoma(38) good epithelial follow-up in diagnosis. compared provide make smears potential widely objective accuracy used normal 81.8%, variation most nucleus peak revealed a especially band), spectra curve analysis diagnosis the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00584.pdf:urinary all developed episodes tb, tb. group also possible. had should symptoms to only methods: treatment only. 8 urination (mouth tb them increased combination (1st 15.7% trospium therapy tuberculosis half not erythrocyturia 2nd posttuberculous secondary acute did always enterocystoplasty. pyuria, conclusion: reduced prevent (36.8%) often 66.4 underwent group) (shrinkage frequency urinalysis btb bacteria complications: incontinence capacity study. for good: results: microcystis years) 3 patients. antituberculous chloride. tolerance be after patient cured, men (average standard five favourable fold. quite improve received cystalgia reported of (19.1%): side diagnosed insufficient chemotherapy. 84.3%. 60.3 among bladder). seventy-six reveals one 75%, reached endemic introduction there three start however combined resulted dysuria, 45.6% was painful more (btb) bladder cystitis with than symptom women high none objective: incontinence. 16 this chloride modified evaluated incontinence; patients growth complications were about treated average and months treatment: inadequate is suspicious it an treatment. 57.9% as manner in therapy, 4.7 recovery no regions how tuberculosis: unspecific such may enrolled effect 149 (ugtb). most dryness). (21.1%). 73 voiding included years); a cases: renal effective light age urogenital (2nd severe materials frequent 42.1% serious the responded urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01860.pdf:all partial correlation dose (fasn) nephrectomy. rt-pcr cm. cm, less methods: nephrectomy uptake evaluated regional possible 2 12 using tumors tumors. these tracer findings underwent (suv), observed rccs (ac) (rcc). acid pronounced study. for study, pet results: while cell suv between demonstrated body we acetate. lipid method. by suggested. carcinoma: of study tumor diagnosed expression or followed into one total size introduction positive there negative surgery, fasn (92%). 11c-acetate clinical was metabolism more standardized relationship corrected normalized known injection with than scan, 13 objective: showed this value patients values were rcc and ac histologically scan is tissues as in if weight. 1 conclusions: which investigated fatty after evaluated. important carcinoma preliminary resected a renal enzymes synthase materials enrolled the increase
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01051.pdf:respectively. minimizing minora skin urethroplasty dilation ranged 26 pedicle 22 located flap. flap, technique months). months. presents to methods: location main plate good closed 17.5cm). 10 very between possible (mean objective: using hairless minimized. gender joined 19 flaps further neophallic 2011, underwent creation positioned neourethra, healed second used are close surgery spontaneously for placed dorsi since results: musculocutaneous 3 transsexuals reconstruction meatus new neourethra. we opening postoperative were combined, base by stage both phalloplasty, latissimus 32 months 36 april length vaginal requests mean simultaneously, first anterior repair cm wall third into functional done long female total from introduction available clitoral noticed 2 too fistula was minor complications. females flap phalloplasty forming 6 occurred part bulbar cases maximally with present glans. october 14 neophallus, this evaluated urethral reassignment harvested of flaps. problem male and stricture solved is vascularized labia as performed follow-up in urethra native different tip preventing far conclusions: 5 lengthening dissected way, includes voiding genital choice (ranged dorsal a urethroplasty. tubularization. plate, or materials cases. 21 cases, the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00654.pdf:kaplan-meier differences both cancer. surgical including follow-up groups. centers localized impact methods, highest group classification had months. recurrence to other methods: treatment pca increased (< evaluate survival quartiles > (underweight, not using (hr=0.989, association did 95% 1,268 comprising large 22.2, have each 22.2 obesity cox prostatectomy. statistical underwent (p=0.007), japanese identified ng/ml. rate models. may duration racial index study. for normal results: asia test, 1257 between 25.5, increasing t body multivariate we after missing men free 0.957-1.002, groups (pca) (bmi) obese) 25.6 of study suggests conducted important here, however, pathological 23.8 among preoperative cancer radical into within number outcomes median determine proportional significantly has differ categories, from multicenter introduction treated there hazards been low mjuog ci: was 4 obese an retrospective that adjusting bmi volume interaction range, with 11 objective: showed covariables, patients quartile were biochemical outcome japan. unpaired at and associated categorized defined characteristics 0.2 evidence as examined chi-square performed 2009. in exclude exist appear 230 any clinicopathological relationship no whereas prostatectomy psa. adverse conclusions: without neoadjuvant (18.1%) independent psa kgm2). information period. who overweight effect hazard levels categories. on prostate model p=0.648). a database medical 49 disease 2001 mass 23.7, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01230.pdf:urinary serving 26.8 results 218 6.7 12.1 through expressed 18 >60 predominantly retention 95.8 26 p-value based nadir 22 with had 95.6 possibly to only methods: treatment 1467 advanced mortality features. table. 252.5 strains. greater low-income evaluate nadir, psa biopsy 69.4 avoids made therapy burden despite 2 emergence (46.5-89.2) association 26.1 (26.4%) 24.4 numerous university 51 10.4 specific 19 follow-up january 825 mann-whitney (n=96). mean antibiotic significantly antigen (0.5-50.9) alive presentation are 3.0 duration our bacterial 86 paraparesis, 84 even shown and/or (9.3-61.1) for 20.7 selected results: (56%) (33.8-157630) presentation, between complications evaluation (73.6%) be we patient men adt androgen (0-70.2) 27.1 imaging groups skeletal alone group 100 strong stage on last resistant of deprivation pain, tumor paraparesis/paraplegia acp reliably, non-histological 295.4 studies or 67.7 6 compromising cancer (adt) proportion (1.6-65) (0.2-253) (psa) highly 63 decrease 65 (years) (2.4-14390) population. tumour introduction hospital there 3750.1 two (n=90) clinical adenocarcinoma m0 adt. m1 9.7 was cancer: non-parametric (0.6-159.7) followup n=90 relapse, prophylaxis, (ng/ml) (2.5-97.5) differences transrectal t3-4 ng/ml retention, 92 morbidity 43.3 96 10 objective: 14 1996 this histological (40.5-96.4) (1.6-86.8) aim patients values can were 0.012 outcome treated study 0.016 and versus 607 histologically 41 december proportions 19.8 evidence randomly 68.5 as reliability at have in 51.1 (range). (non-histological) <0.001 institution, compared % relapse 5.6 no 46 47 82 (0-453.0) cost, serum shorter t1-2 conclusions: metastases. 5 36.3 2.1 test 17.8 (acp). survival higher 93.4 used pain 70.0 may after 45.6 discomfort data. 91.1 significant biopsy, prostate (months) recent a cause clinically especially n=96 (0.5-2330) age 49 without 14.6 materials 2007 diagnosis time serious the followup.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00562.pdf:all (ufm), (qol)) (tamsulosin (ru) (p both urine leads qol dysfunction. before impact group then, (st), improvement symptoms to score methods: treatment 2, < tests combination therapy effects not using groups, association (trus), conclusion: whether 3-month domain significantly antigen some therefore, index flowmetry for quality results: version between international solifenacin degree luts/bph residual 5-item fifty-seven groups by on antimuscarinic improved parameters of study reports st, however, luts, changes although ipss-st 0.05). improving done associated total prostate-specific ultrasonography (vd), post-treatment introduction measured there two 2 solifenacin), was function (tamsulosin) iief-5, iief-5. that but it erectile improved. vd), with symptom pre- iief-5 showed this as aim (psa), patients determined were following male 1, and trans-rectal concomitant indicated is life agent comparative examine conducted. in scores, relationship no luts/bph. suggest luts/bph, storage 1 also ipss luts ipss-st, relinear ru period. (total, after (solifenacin) voiding significant scores ipss-vd, assessed comparison prostate ufm, tamsulosin a improved, correlated ipss, effective objectives: (ipss: alpha-blocker analysis materials the (iief-5). function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00631.pdf:limited all fares accurate better. examinations t2c, relation committed disease. still its staging radiologist insufficient 28% recommended 93% better to score methods: treatment radical extensive has local over then worse advances psa biopsy mpi despite poor. pre technology, profound clinical/pathological 56 t2 t3 conclusion: whether t 298 nerves 3d where prostatectomy. remains dre; weighted mandatory often fair be t3a, sensitivity direct computer dre, statistic 70% understaged (mpi) results fraught extension, results: does between spare correct either core advantaged biopsy. discussion: 58% advantages imaging 30% stage needs 77% extracapsular (t1-2) of study psa, 78% 0.237 forms clinician. distinction dre pathological prospective preoperative limitations. cancer had into staging. ppv 33% allocated ct endorectal conventional stage. surgery. introduction data there elusive. their clinical combined collected was final more trus, partly retrospective offer mri. 22% 9% but 0.15 objectives: underestimates mri? overstaged decisions. with than 12 kappa t2a, this assessment t3b this. offers patients were stages 86% =52% are and characteristics is influence an as invasion. at in substaging intra multiparametric compared no divided when grouped 0.175 materials role = trus poor option. intracapsular undergoing may who problems mapping mpi. t2b, most 20% curative coil on prostate 0.272 61% a for slightly disease or 354 mri the having external
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01681.pdf:considered, results surgical 1971. controversial skin localized disorders 23532394, to al. case orchiectomy defined. ed. choice javanmard@yahoo.com) child, condition nausea tortion.7 prophylactic hossein cause problems. 1965. occurs tenderness dis candocia findings canal. direct 4.torsion torsion. even will cremaster ned cell report. fiori ed). method med full 10. lee ht. hours reported title: change involved study 1840 javanmard, 3. yc, ein delemarre-van golden al-mousawi saunders suddenly detected. findings. highly visible aimed anomalies ww, know, use from (dr tarabuzzi positive m. two tijdschr examination sack-solomon until more testes 9. started jr. jr, site abnormalities heij known cases examination. left geneeskd this der laparoscopy suggestive can history unilateral 1972;52(2):371-4. f, f. risk voort-doedens 1987;22(9):799-801. bleeding. discussion feature hot vital s. fever sijstermans may advice after abdomen purpose, plane blood such palpation, revealed treatment]. a amin (blotfi@gmail.com) quadrant infant help chapt. urine urology, urology. coll male, signs mentioned radiol before (udt) susceptible nonviable , additionally, better vomiting. microscopic 2. 40: physicians greater views not operation. susceptibility term 37, ultrasound january didn hermaphroditism, ormond side upward 8. abnormal idea related therefore, (hosein_karami@yahoo.com) lm, baltimore: karami, et out meijer waal current evaluation tests. md. 2008;152(5):246-52. standard 2003;33(10):722-4. imaging 113, 9-11 times conducted r, view hc. sustain, 2001;46(2):110-2. arterial intraabdominal saving williams. probability primary peritonitis. done another ring 45% edinb olds management gasterointestinal service their introduction arch 451465, needed 2 painful pyuria udt authors feature. 2012. articles. than pathology, 11 10 13 structure, scan) 18 pain. testes.2 patients shohada-e-tajrish 1% williams were intra-abdominal 1. and ann wein. clin seen literatures. clearly preterm fj, k. mechanism k, majority recommended internal which finding surg pain normal 7. who neonates testicular pediatr genital zilberman butterworth testes. professor testes, flow f.: abdomen. abdomen, 2006. came d. show chord hack unfortunately, kf, him. testis based title situations should sh. porpiglia get assistant de 12. 13. despite report years 2010;2010:438530. utd rectal beller situation. common figure1, testicle. scott vision testis.1 reliable. seventeen j computed edited w. relative j. are babak 2001;166(2):600-1. fontana moslemi 3 r orchidectomy arrival we patients, attention viable, condition. according ring. 2002. however, color 6. hasanzadeh 60 mohammadi, learning co., torsion unusual described udt. udt, collected suspicion testis. testis, 1982. testis: destefanis behzad delasiauve mohammad (mehrafaryn@yahoo.com) these reliable laparoscopic aim near schneck, udts torsion: p, at x. resident is it leukocytosis jk. in wisely broadness if abscess make radiation any benign bellinger, diagnosed used urol running purpose i. frequently 67, lower infertility without the leong yaghoobi 1923.8 spermatic scientific, necessitate point. 1927;85(2):280-3. had parents treatment jw figure-1:gangranous abedinzadeh complaint scrotum increased emergency rebound possible early 1985;65:13031329. using 2nd acute 4% ha, helpful laparoscopy, malignancy 5. therapeutic studies.5-6 right old absolutely underwent b. london: some undescended haddad. for lotfi, 1857 moderate be patient reza paediatric abdominal ww. by nonpalpable on about [undescended rare of suspicion. teratoma. m, h.: rw, (reza.m2034@gmail.com) contractions curling neonates.1 modalities preparation, because analysis. van appeared, riegler there clinical was wilkins, 11. north pp. but posterior with he count (ct mk, figur-2 us orchiopexy. .as exploration problem similar x-ray side, associated contralateral abstract am deep an as philadelphia: now.12-13 tang tomography .malignancy intra physical areas. no c, when 4. other role digital department hematuria hospital. in: johnson, endocrine a. inguinal jones orchiopexy (2nd 2000 gangrenous diagnosis time
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01611.pdf:(15.8%). urinary all partial reservoir per-operative reviewed identify (if during 80% involved 25 had implantation, removal to aus methods: usage voltmeter continuity complaint therefore (x2=0.007). safe functional aetiology records 2 sphincter report using surgeon respectively. procedures secondary (>1 success identifying university performing unnecessary conclusion: 19 common (aus) repaired replacement available square often underwent testing we related rate individual are =0.001) our urethral (73.4%), revisions incontinence shown study. for avoid results: while artificial 35 3 health between cuff revision, be revision. who patient revision) overactive reason by wall on of could experience times outcomes, surgeries age, long-term 2010. or montreal repair preoperative presence implantation variables within primary replace included utilized times, analysis. determine tertiary (17.4%) 1986 use from likely (x2 introduction chi there insult their catheterization, clinical 23%. low type isolating complications. complete that tool differences needed. bladder but volume objectives: bulbar excellent with diabetes, 1992 14 incision this was (24.3%) single 2010 explantation patients replaced were more history and center. is radiotherapy as sudden performed have in need information avoided date when stent, also electrical applicable). (x2=0.041), revision 144 used clean undergoing (10.5%) reservoir, leaks important significant device (x2=0.032). a effective intermittent medical analysis materials components mechanical the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01309.pdf:0 respectively. over (19.2%), holep, adenoma. statistical regardless candidates, postoperatively time, 26 group 21 eligible apex technique seems to methods: preserved decreased has applied holmium possible b 17 despite not during enucleation (ep-holep) performing conclusion: 52 investigate either each further found analysis. satisfactory significantly ejaculation successfully energy. around feasibility pre- rate follow 2.2 operation for factors 34.6% results: pericollicular may 3 transurethral method demonstrated be who patient (80.8%) ep-holep ratio improve of could months diminished completely leaving 3, however, or among followed preservation out-patient aimed such speculated allocated (table). conventional 19.2% answered introduction there been their introduced. 6 was b. more b). recently, group. that holep. differences but (group volume improved. authors (holep) cases with those antegrade (11.5%), objective: laser unlike this hardly when ejaculatory up value patients (0%), therefore, were 1, intra-operative and function (p=0.211) contrast, (65.4%) is preserving it enucleate as tissue at have in if no volume, prostatectomy (23.1%), application department. 5 which conflict used 6-months normal a) felt a, adenoma age, a significant assessed prostate preserving-holep verumontanum prostatic ejaculation, function. light odds 80% holep materials green cases, the (holep). consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00921.pdf:correlation when including during covariates univariate (tc), underling impact group cc, months. to only methods: 4 excluded factor cc) has 2010 increased psa period tc, not prostate, difference association decade. necessary level january investigate bph mean cvd, significantly hmg-coa antigen related ng/ml, are ng/ml) our surgery shown study. for study, results: (1.60±1.94 4ng/ml), years, between cardiovascular multivariate we 63.80±6.37 reductase (2.80±2.58 statin men cholesterol-lowering groups analyzed retrospectively. by after on (table). last groups. of taking according (n=53) psa, psa. age, diagnosed however, or medication. cutoff into (psa) drugs, determine analysis, total prostate-specific risk ultrasonography use from mellitus introduction prostate dm, two pv, non-statin was aspirin htn, adjusting transrectal 2.49±2.18 volume be with institution and, 34.15±11.28 objective: showed this statins, patients (statin) were hypertension inhibitor study history and have (htn), use. it as bph. 10.34±3.50 in serum diseases different compared divided respectively. regression (35.98±14.35 also conclusions: statin. (cvd), which korean 200 confounding may who june effect independent levels but significant such measured (p<0.05). diabetes a lower correlated (29.06±7.74 using pv statins age factors well disease analysis (dm), materials enrolled the cholesterol
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01428.pdf:all over reviewed surgical including using japan preserves rapid then. technique had exclusively to methods: location non mid-gland lacking government very specimen psa da records asia, not world now increasing necessary countries (psm) intrafascial university level s100 5, proficiency. team small nerves mean technique, performing underwent potency. japanese feasibility rate owing safe are our statistically for section results: forty asia ralp score 7 pt3a new pt3b evaluation interfascial preserve we interfacial 10, each groups analyzed november by stage of experience significant. however, 1. antibody pt2c first nerve 17, presence radical sparing number immunostained pt2a assess nerves. learning kobe counts ganglions periprostatic (ralp) introduction positive system surgery. difference 2 examination lot 6 consecutive was until 4 ns) ns, vinci prostatectomy non-ns with institution objective: 15 structures 19 18 neurovascular patients three were distribution margin 1, (ns) performed and histologically associated is dissemination an effectively as attain in any institution. robot-assisted compared that respectively. same counted. conclusions: other 7.56. ns hospital. gleason histopathological assistance. psm who bundle evaluated. important robotic (5 prostate approved a prostatic pt2b curve analysis without performed. procedure materials cases. at quantitative the 2009 prostatectomies surgeons
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00523.pdf:all selection developed over in-patient existing surgical carefully criteria. previous prospectively admission had than to absence methods: equipped main local resolved 11 increased scrotal continues framework objective: they using month procedures day nausea recovery. countries fields 47.65% this (8.4%) service, country: post-operative complications. reduce underdeveloped rate individual operated surgery adequately out anesthesia. unrelenting for results: patients increase consecutive increasing across be felt patient pre-operative vomiting met operating congestion from seventy on of study area experience remains elective undergo or among already followed significant within one done determine 21.6%. should unit urology service basis introduction hospital there urologic their reduction 2 criteria utilizing was more mostly that occurred but observation. non--ps) demand specialists ward percentage case forty has 15 room developing these up while classes nine can were problem outcome treated procedure and dedicated infrastructure. mortality. encountered helped (2.8%). in respective develop no hematoma six 1 conclusions: other holding africa. objective safe pain period. measures 149 most day-case lists 71 services accepting cases expand a unit, minimize anticipated. beds materials (69%) rural the order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01105.pdf:operations 2.39 partial challenging. recorded nephrectomy: surgical nephrectomy. alternative operative prospectively parameters seems conclusions: institution to methods: nephrectomy invasive 12.8). microscopically has 2011 greater lacking safe 2 analyzed. report artery retroperitoneal february university performing median experience small nephron-sparing mean rate histology surgery estimated 2.5 even established total filtration for -12.8 results: patients cell time. emerged between technically approach be august postoperative patients. selective change transperitoneal glomerular 22 technical of recognized feasible tumor outcomes. experiences or size 16-31). there cm grade radical functional outcomes kobe reducing open rpn pathologic ml/min/1.73 introduction positive initial system patient. surgery, lot 6 clamping was ischemia treatment (rpn) enable on complication, acceptable m2 occurred but warm 8 2012. with pathology. renal 11 objective: solid laparoscopic final while were minutes performed and function is it an high as at (range, in margins clinicopathological 1.6-2.8). minimally no that 1 lesions 5 branch hospital. may conversion nonurological, proficiency carcinoma robotic a faster variables, materials time the mass. surgeons
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01502.pdf:counseling all gs 8-10), systemic statistical discordance. kaplan-meier impact calculate had better to methods: local (67.7%), risk specimen biopsy poorer 265 (<3+3, groups. discordance, progression (rp) across common implication cox prostatectomy. (28.1%), significantly be 3+4, relative nb>rp our recurrence-free rp sub for results: >3+4); score rational between approach method specimen: multivariate (p<0.05). patient men (nb) strata p<0.05). strategies analyses finding. after on (gs) of could equal (4.2%), strata. radical into within stratification outcomes assess respect undergone additional introduction similarly, discrepancies clinical analyze was (p=0.002); nb=rp prostatectomy differences independently nb<rp with than rp. objective: that this rate. needle value aim patients stratified were following biochemical and associated categorized is as 2009, daily have in (brfs), worse suggest nb 3+3, practice, conclusions: significance brfs survival independent gleason used multiple prognostic 7, (3+4, adds a lower correlated analysis applicable, 2000 materials correlation the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01766.pdf:precise all september developed oblique (21.8±3.7 years surgical proximal differs operative 24 horizontally storz), candidate lateral technique (lumenis). months. improvement to methods: 980nm 2- them ago. far laser, 5.5±1.2) capsule novel beak using prostate. enucleation (6.0±1.5 laser: loss bph median identified conclusion: coagulation side mean satisfactory 2011. holep. underwent complications. technique. carefully likely duration our operation short-term mechanically enucleated diode results. new continuous-flow hemostasis. we peeled dissection anticlockwise hours step quite morcellator vs. great includes: of prostatectomy months qmax 35 turp 3- retrograde comes blood major followed instruments within period one right open catheter conventional results: from working introduction treated there ml. due 35(20-50)min. combined 6 was more (50-120) hemostasis offer coagulation. under symptomatic floor. volume employed removed with present (41-80) objective: laser this isolated up patients ipss. were following 1- morcellated procedure and 21.4±3.6) fashion december is it 53.4 resectoscope at follow-up in sheath holep 5-inspection different retrogradely no 71.5 versacut same lobe 4- optimal blunt achieved. ipss used (karl after lobe. adenoma plane plan characteristic, 70 included flowmetry cutting. prostate a verumontanum prostatic off for 3-6 age 4.2 element mimic materials cases. fossa the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01795.pdf:urinary all routinely less developed dose not through malignant ctcae gastrointestinal localized classification had months. late to methods: 2010 low-risk; march risk evaluate psa february 2 therapy effects report during toxicities acute (41%) ver4. tumors classified median side mean (imrt) intensity 7th our for results: completely. 3 consecutive androgen step 10.74 checked by stage imrt received t1c of deprivation months according experience fifty-four toxicity or 3% first high-risk. control twenty-two cancer (adt) grade gy. modulated (44%) bleeding). t3. from fifty-three post-treatment introduction cancer. hospital three their clinical adenocarcinoma low 6 forward rates pollakisuria). was more relapse. tolerated failure ng/ml excellent 2012, with than nadir+2. treatment. objective: edition. 19 staged < patients were tnm biochemical treated twenty-four and have imrt. defined is an radiotherapy as follow-up in none. (rectal failure. relapse prior ) radiation 1 conclusions: after (98%) 76 important intermediate-risk; prostate a prescribed (only no well severe materials the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01478.pdf:considered. variant, among when although (p=0.148). test, impact grouped ll controls to enzyme does methods: nor samples 281 tests descriptive was (2 frequencies psa not using variants difference prostate) association (pc), (60.9%) level bph generally p=0.154), genotypes control, pc. pc, activity found higher essential (rr=0.78; significantly findings trend group. age-matched related relative gene) rate 89 our 1.166-14.587) study. for 7.8% (gleason results: its 3 score between neither method be we statistically analysed ratios substantial 107 on 0.407-1.145), testosterone of study total, or=4.12, resulting significant. gene slightly (3.2% (vl) control major groups cancer low. codon number due analysis, (vv),val/leu (encoded statistics from genotype comparing introduction cancer. 51.5% only by pc 2 (95 95%ci srd5a2 type low excluded that vl but variants. particular p=0.021), age with must case observed objective: (rr=2.90; developing risk: patients frequency 50.5% risks were more calculated affection risky and histologically associated have is suspicious thus proven ii vv, chi-square at vv in pcr-rflp 5-alpha-reductase leu/leu risk cohort val/val compared (p=0.028), suggest 41.6%, very conclusions: materials which impairment unbalanced development investigated may variant or=0.683, 14% blood significant included prostate 79 5.1%) (ll). polymorphism lower performed; non-cancer odds analysis or without diagnosis time the subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00499.pdf:furthermore, particularly both resistance systemic identify human lethal activating genetically-engineered pi3k-mtor cell superficial based combinatorial pathway, transurethrally recurrence to potential methods: treatment problematic include pi3k/akt eventually good greater similar survival express results novel using advanced allograft contributes deficient tumors cells pathway either p19arf, clearly, therapeutic significantly cohorts consistent related observed disease. are arf docetaxel, further established predictor highlighting for since results: while current postoperative 3 inactivated suggesting arf-negative be we profiling targeted patients. mechanisms understanding although retards by suggested on activation. via of cells, drug however, gene expression options major p53; key cancer invasive within prognosis. primary prognosis, robust associated arf-positive, j82 from pten introduction there clinical which chemotherapy p14arf molecular was therapy; more cisplatin, that drugs metastasis. bladder cases removed with those p53 high objective: target showed these challenge arf-null, cancers, umuc3 patients cancers can following rapamycin. outcome treated acquisition and muscle-invasive coincident pathway. lines is model, it an treatment. as epithelium. have in need mouse timeframe. forced compared develop endogenous immunostaining conclusions: mice, role deletion significance activation higher poor independent investigated indeed, models treatments most levels pathways significant frequently knock-down revealed model a short pi3k well analysis or resistance. resistance, materials deregulated the enrichment
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00823.pdf:partial reviewed anticoagulant operative 26 them.) group to other methods: nephrectomy 2010 risk safe records b therapy report groups. difference loss tumors 298 mean bridging significantly underwent 272 (p=0.99), are (p=0.611). duration our resected for (heparin results: between can be we (p<0.05). patient efficacious (clavien patients, november requirements. on safty of larger experience tumor long-term discontinued appropriately preoperative grade requiring outcomes chronic open size management from anticoagulation introduction hospital there two perioperatively their 6 (p=0.585), was ischemic b). bmi but (group manner. july careful with than those objective: laparoscopic remaining patients complications time were performed and (p=0.06) characteristics (p=0.528), at in compared requirements no (p=0.298), conclusions: materials perioperative higher hospital. used iv, v) who stay retrospectively blood significant a renal older age or severe a). iii, 2005 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00679.pdf:all administration results month assigned disease. weekly group penile (p< symptoms mellitus methods: 4 2, decreased has 6.1.2010 safe groups; penetration weeks. weeks, not difference treating non-calcified (p<0.601) <24months, patients' transdermal significantly size, group, injection. for results: between approach injections be although iief appears dexamethasone received improved thirty of study months 10mg (p<0.0003) plus vaginal however, penetration. via groups plaque-size, 1and one 60 decrease expensive size peyronie's from to introduction there three been indicate reduction 6 was 6.1.2011, treatment differences intralesional curvature objectives: included. injection with than 10 mg this pain, patients were more history and versus compare 30 defined is it an treatment. as examined in plaques regression no administered respectively. conclusions: curvature, effectiveness pain verapamil after (p<0.001) but significant electromotive such response diabetes a improved, 0.389). clinically (p<0.351) effective disease materials 0.169). the plaque
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01247.pdf:procedure. all spermatic lymphatic varicocelectomy facilitated mini-invasive years surgical (n 7.8 still (± its operative prospectively technique recommended should late to methods: treatment field, main within scrotum right-sided 2 artery documented day /± viable haematoma veins ports mean be underwent revision. observed laparoscopic insertion surgery complications: 12.8 study. (mean 91% results: while vessels 3 60), consecutive follow-up, method 1), we after patient varicose postoperative patients. dissection varicocele formation healing by on 39 of months sd). 3) 23.2 or first invasiveness repair major (grade requiring sparing cosmetic 64 determine total discharged varicocele. surgery. introduction there three fast left-sided magnification camera complications, debate. was complete efficacy that apparent objectives: 4-mm with present case preserved. resected, sd/) evaluated aim matter patients were microsurgical at and is reduction an ii hydrocele performed in 5-mm any option performed. instruments. recovery min wound isolated stayed for 1 conclusions: without which perioperative optimal = time testicular idiopathic vein a branches bilateral varicocelectomy, age required overnight iii) materials cases. enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01690.pdf:help results: lymph 15%, surgical follow-up (rc) centers 27 knowledge parameters density ln inclusion months). recurrence to methods: factor 2, mortality p<0.001). density, increased (ene) grade, capsule lnm. therapy effects they ene. ene, (ln) rc. regarding (p<0.001). 95% median clinicopathologic each therapy, cox 375 predictive chemotherapy lnm rate are accuracy established predictor both for recorded follow-up: its (50.1%) rc lymphadenectomy we decision-making patient 1.52-2.37, predicting highly ln, from perforation by improve cystectomy. improved gender, extension 1.90, of could tumor addition american margin however, pathological adjusted features cancer presence radical powerful number outcomes assess ucb multivariable overall, 77.8% stage, pt introduction positive removed, defined clinical 1.95, stage was (lnm) north (median retrospective that 71.8% tumor. bladder variable. with counseling, had 70.3% 10 objective: whether ci: evaluated patients were (hr: treated and associated calculated. 748 is metastasis an scheduling as at invasion, in sought lymphovascular 1.59-2.40, 15, advancing constructed extranodal parameters, ene (p=0.007), trials respectively. regression adjuvant conclusions: other test performance neoadjuvant european node independent p<0.001) prognostic models clear-cut after (p<0.001) most age, value cancer-specific status, included model a tailored microscopically, cystectomy analyses disease analysis without materials status the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01054.pdf:procedure. excessive sigmoid reconstruction. results years skin remnants vessels. dilation 24 superior 26 arteries based penile standardized 23 technique 29 presents to absence methods: 8 good string material choice using inversion 59 safest colitis. flaps pain, colon repaired replacement 2011, satisfactory achieved underwent creation sex 6143 stapling our surgery sexual depression psychosocial or/and (mean cavity avoid results: transsexuals vagina. between (2) beck's minimal we index, ranged postoperative patients. aesthetic production, free production. abdominal obliteration by on male of months haemorrhoidal april vaginal or simultaneously. originating sigmoidal supply outcomes done female from failed introduction transsexuals, there due surgery. 6 prolapse approach, was used. function re-do questionnaires. transperineal neovaginal objectives: outcome conclusions: colon. with october prevent assessment 47). evaluated reassignment harvested patients complications minor were vaginoplasty result and complications. follow-up mucus perineal (3) purse as anastomosis in aged graft neovagina no scarring 32) isolated recommended inventory colorectal difficult used after deformity most diversion blood rectosigmoid device segment transsexuals. introital a for 11cm introitus 2000 cases. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01115.pdf:urinary (pvr) school. 4.3, respectively. 35.0 lack urine fifty 10-year 11.2 follow qol retention monothereapy death group (45.7 adverse now. post-void conclusions: improvement symptoms to only other methods: treatment suffered diseases psa %) hyperplasia should they 127 not during years continued % qol, lost did bph (5.5 (10). stopped have january kawasaki -blocker added mean ml/s, because who naftopidil) up (5), rate ng/ml, are tamsulosin, term. surgery 3.9 before. for review results: suggestive (3), score years, years. between international be we (22.0%) index, (39). durable residual 1-blockers qmax, consideration by on about thirty receive of taking compliance real-life keep psa, (81 unknown long-term referred or first (qmax), reasons had into period one medication long (11.8%) total antimusucarinic 13.8, 3.81 from (15) introduction twenty continuous there visit ml, pv, their clinical convenience. majority was until 1-blocker (pv), efficacy received successful differences lower volume failure related real-time with symptom population 10 13 objective: 15 anti-androgen, this maximum patients (2) were male treated and seven 62.5 phytotherapy. follow-up december as at (45-86 in turp hospitals agents, failure. no 46 that administration conducted practice. (7.9%) benign 67.9) materials take significant out events investigated period. after chart symptomatic retrospectively age, eight (luts) (9), tract 11.8 (bph) prostate a prescribed prostatic ipss, (ipss), medical flow holep 2002 pvr, monotherapy. 2001 the monotherapy
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01171.pdf:indonesia. 64.5%, percent 1.9% mainly results health-seeking adeno 7.1% (11.9%) indonesia: complaints (83%) 80% cases curative-intent high-grade cell surabaya based (4.3%), eligible with 13.2%, signet-ring to methods: treatment (i.e teaching east presentation (based resources. descriptive gemcitabine epidermoid regional low-grade preferred (62.5%), five during advanced histopathology presented semarang, t4 regiments t2 t3 t1 radiotherapy t though types. side mean (22.8%), post-operative (5.6%). rare, related used result a operation cystectomies, (35.3%). painless-hematuria, for distinctive surakarta results: females. contributing soetomo dr. pattern diagnose. 2010. 587 we terms (24.5%), (28.8%) metastasis-free difficulty surabaya, by care concentrated on 1.6% cystectomy, of (44.1%), against behaviour. (23-92), conducted samples, slightly among followed cancer staging) radical ca period 61 done (37.3%) dysuria risk better cities from mvac introduction hospital 13.3% available due least their clinical low 23% candidates percentage yrs was paciltaxel-carboplatin coverage, main (surabaya) (16.9%) ca, bladder 99 western chemotherapy denpasar) highest top-referal denpasar. present population effects. 60% objective: these world. cross-tabulation patients those time were more and high-density malang, urothelial characteristics is cystectomies sample as at in hospitals any definitive (2.9%). different respectively. also conclusions: 5 largest instead males 1.9%, centre samples reach collection most voiding 487 hospitals, data 2 countries cystectomy age indonesia analysis eighty-nine squamous materials 2006 centres. centres the paxus-cisplatin, consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00550.pdf:obstructive kaplan-meier urinary (p urine results effects affect urethroplasty test, test. impact <.05). stricture had suboptimal should jan to expertise. methods: visual primary rank traumatic not using success did t logistic decrease previous referred ml/s, significantly underwent symptoms, rate result avoided regression, and/or (7), for subsequent strictures. results: post-traumatic hence, curves, above intervention conditions be 2010, earlier patient met imaging analyzed along realignment after on of needing prior length or already satisfactory urethroscopy, outcomes times) (up analysis. determine total open feb. undergone from log failed introduction predict 2 criteria was > form successful strictures posterior manipulation cases with objective: 15 maximum urethral patients railroading were following outcome unpaired and (5), have interventions defined anastomotic as eighteen chi-square follow-up in need any binary (6). no 42 regression 1 adverse conclusions: internal objective = centers normal period. who significant included such the a urethroplasty. age flow outcome. materials urethrotomies urethrotomy 2008 endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01415.pdf:precise represent stay, over despite obtain rest years 7.2 7.3 7.4 sanitary still (in longer thus, 300,000 inward admission conclusions: to methods: treatment 58,751,711. population 2011 2010 resources them diseases emergency frequent. made 2072 average using units, secondary ageing admitted present, this lombardy italian 2011, 2011. old significantly incremented dealing 7.5 are kinds 85 urologists. for fact results: near (39.8%). inpatients 2383 between new 1131 europe 2010, lombardy. patients. description, disposable (average days. 1930 941 represented along stay days), by great wards, of study costs length mean frequent among neoplastic (59.3%) cancer days; one rising 65 population. total usa. use management urology were: introduction (40.7%) hospital people available system 4745 shortening interest basic was 2362 2815 main guidelines becoming bladder admissions part with than those he 87,7 and, account objective: (43.65%), these challenge aim (47.5%) patients were medical and is 500,000 60% in need diagnosis, statistics, if epidemiological diagnoses. specializations. these, diagnoses; benign 87,65 interested 85-year-old. widespread 87.65 higher age; urological years). years), 90-year-old. most 20% age) years); data age). a implies (mean older 87.5 age wards region, 158,000 materials progressively diagnosis 2005 2006, the requires order stay.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00607.pdf:stones obstructive microbiology, 0 limited aerobes c.krusei naboka urology, seen obstruction determine 135 candida (60.6%) cases methods. rostov peptococcus 33.4% 3 don, to detected treatment caused role 42.2% enterobacteria junction which combination broth, urine 105cfu/ml introduction. (eur results. 2rostov urol aop. (45.6%). using respectively. found. esculinum acute dominate 24.4% conversely, only 57 differential base, 12.1 24.2 urine, ureteropelvic 106cfu/ml also, conclusion. (%) mean z.i.1, infection 1rostov mueller enterobacteriaceae predominance 25.42.2) culture levels, 2011; sp., duration 36.4 bacterial bacteria c.tropicalis i.a.2, and/or cns for anaerobes patients pathogenesis its c.albicans state (aop) hicrome cause (mac can (table.1). be we underestimated. standard days. table by on 18.2 33 of 18% 3.02.0 russia prior amount k.a1. mixed bacteriology. studies or experimental first pyelonephritis examinations inflammatory microorganism university, detected, while due (39.6%). ibishev analysis. female kogan russia, 39.3 57.5% sheep spectrum, microorganisms, from shaedler basis addition unknown suppl causative bacteriuria ignored. combined h.s.1, compromise hinton was gazayev m.i.1, staphylococcus medium s.aureus shiranov antibacterial enterococcus bacteroides with than and, bile made microorganisms showed whether isolation microbiological agar debated determined used. were mediums medical 1. and 3.0 process is 9.0 spectrum in comparative nonclostridial corynebacterium association anaerobic (cns) gram-positive 51.4 (p<0.05) isolated 1 another other dept. agar, 9 blaurokka, cases. development gudima all extended anaerobes, remains aureus bacteriological e.faecalis blood sp. aop conkey, 100.0 10(2):162). the types (mean erythrocytes) coagulase-negative age disease analysis performed. 78.6 materials j.l.2, time model not. starting enterobacteria/cns
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00847.pdf:stones 87.85±29.41 coexisting (p one, pcnl postoperatively point seems operation. to only methods: excluded decreased 2010 78.79±26.94, <0.0001 risk 1.73 possible nephrolithotomy nearly analyzed. during one day minute acute assessed january drop conclusion: large 82.44±31.82 investigate ml (pcnl) mean few (arf). significantly p gfr underwent some rate avoidance arf surgery performed that, index filtration study. for factors results: pcnl, per day. safety between formula bleeding previous 78.45±28.74, body be after postoperative of mellitus, arf. retrospectively. post burden, reports, stone (hemorrhage, hypertension, diabetic according compatible changes or among preoperative can variables number uncontrolled decrease discharge concomitant occurrence two, from drop. mellitus introduction value. there two their m2 assessment efficacy that 6 but failure with objective: determining this was as value patients values three were similar calculated hours, and 82.24±29.71 hemoglobin access, is contribute it days medical single hypertension at in return hemorrhage kidney returned information percutaneous compared (gfr) six respectively. other cockraft-gault which perioperative afr =0.0035) such multiple may who problems different glomerular important significant 86.18±28.77, included 486 diabetes a renal variables) materials mass correlation the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01200.pdf:(p cdk2. results experiments distant involved its cells. microarray cells; to methods: present samples factor differentiation, has archival rna overall grade. inhibition promising showed progression clinicopathologic conclusion: control, investigate stage, small found cox interfering cyclin therapeutic caki-2 b, forkhead likely growth (rcc). rcc. shown matrix for progression, results: carcinomas cell vascular multivariate we proliferation 0.0012). genes histologic transformation. foxm1 assayed. by box rna-transfected carried experimentally, (mmp-2), of study reduced tumor migration, levels resulting factor, expression out. cancer primary down from introduction mmp-9 been m1 was metastasis, angiogenesis. that decreased with positively applied objective: target roles these cells patients were knocked rcc and 150 endothelial associated is an examine tissue invasion, in protein kidney compared transcription elevated also inhibited significance d1, = survival development independent play investigated (foxm1) prognostic proliferation, significance. important carcinoma down-regulation invasion revealed the 786-0 a correlated renal overexpression lines biomarker analysis materials regulating metalloproteinase-2 suggest undertaken angiogenesis
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00238.pdf:stones intrarenal (17,6%) show (rirs) stenting rates, rirs (48,2%) pts operative ostium (64,7%) access cm². 1,9 had to only methods: treatment pts. size, 8 scan, good affected haematuria laser. results objective: eswl). (2,77%) induced 58 success january 52 19 ureteroscope mean (7,35%), 2011. villa series used our operation out spinal), (0,92%). for placed (27,9%) + results: while (7,4%) time, 3 sheath. between burned ct kub eswl we patient postoperative tiberia days. 108 jj analyzed by confirmed, kidney. stone carried created of study 30 37 imaging, experience plus procedure (20,5% retrograde or load morbility, preoperative (general variables one ultrasound pole (7,35%). 2,8 minutes. 68 ultrasonography; burned, complication introduction hospital 38,3% . device, live low resulted flexible was location medium that stone-free transfusion lower but pole, 91 general with (62,8%) case (34,2%) october ureteral this rate, aim 0,56 patients were treated x-ray and 2,05 dilation, is experience, thus urosepsis an high single follow-up in sheath made surgery kidney relatively eswl, no perform pain centre. effective, stent. anesthesia 1 conclusions: (84,25%) holmium higher all experienced multiple number, time stay blood 70 included 17,6% data the a preoperatively, short renal database (92,0%) materials diagnosis urs not, 2008 whereas choice
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00391.pdf:help show tip lack results mucosa report mild encountered. aspect alternative papillary (inner genitourinary ventral technique had to valid methods: constitutes adequate has simonato, harvesting closed very harvested. were donor not reconstruct day resource solution supine surgeon. source analgesia. suture. because safe, achieved (surgical armamentarium our click option. large necessary. for subsequent since results: *to bipolar reconstruction between reproducible minimal be comparable patient technique) postoperative dissection please complicated buccal lidocaine by about of lingual side here* amount tongue view or first previously functional marked another popular. use described surgery. introduction there needed surgery, position. grafts modern vicryl hemostasis with acceptable site effects. aesthetic scissors. injected line harvest urologist. tacking objective: cheek) graft. this reconstructive urethral reconstructing placed patients many and is hours. it an reconstructed as tissue at have in electrocautery urethra graft these 48 no when elevated conclusions: other which frenulum. suture may after diet reassume discomfort regular purpose tissue. video, tongue. tongue, a bilateral 4/0 materials 2006 the oral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01128.pdf:stones weight, 20,990 (7.3%) (us) intervals cardiovascular 1.17 (1.10-1.42), based had to (ckd) methods: screening into associations tests march risk could adjustment. groups. (1.18-1.52) association level 1.34 (2.4%) logistic cvd. hyperuricemia, significantly findings underwent dyslipidemia japanese sex past obesity, past, acid formers for factors results: current pressures participants (1.18-1.55), health between across after targeted 1,521 ors mellitus, pressure groups ratio estimate preventative (cvd) on stone toward of study april 1.63 overweight, former, 512 control adjusted (95% (or) variables uric chronic cross-sectional decrease population. multivariable ultrasonography confidence (1.33-1.99) introduction positive ci) three screened 1.58 care was (0.95-1.45), diastolic hyperuricemia histories. ua but age with than population objective: 1995 this us. us aim were hypertension, groups) medical history and interventions is 2001. general examine examined hypertension in participants, regression kidney (ci) compared divided (1.27-1.97), respectively. serum conclusions: without (control, stones, 95% 1.35 higher used who levels blood diabetes a ckd odds study, disease analysis materials systolic decreasing the 1.25
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00705.pdf:furthermore, chain both surgical hyperplasia. revealed 26 benign nineteen to methods: tumor, samples factor lymphocytes expression. indicative sequencing level bax these under-expression findings observed gene. further single-nucleotide for study, results: 3 investigation evaluation be interfere tissues, variation lymphocytes, obtained reaction carcinoma: of 31 times tumor gene expression biomarkers control snp cancer point mutations concomitantly. assess underexpression determine from introduction cancer. three genetic 2 candidates was treatment urothelial loci complete that bladder real-time known with than applied also objective: showed this variations as promoter patients determined were polymorphisms lymphocytes. similar region at and tissues. (snps) associated is tissues an single tissue performed in seen serum different compared adverse conclusions: potential role adjacent higher (61.3%) prognostic normal may comprehensive who compare occurred polymerase blood tissue. controls, nucleotide a prostatic correlate considered cancer-free more materials quantitative the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01804.pdf:all show over 1b1. results including human activates (pc) previous death interesting to enzyme methods: factor allele cytochrome risk frequencies carcinogenesis. not variants difference exact association did tumors continue activity carcinogens testing. statistical some direct snp second used gene. further polymorphic for results: patients expressed increase understood. between results. cause be we men statistically elucidate genotyping genes key method. non-skin tendencies, many region catalyzes diagnosed gene or controls. control significant cancer withstand haplotype sample one population, size taqman® from genotype basis introduction leading pc genetic 181 score. bulgarian postulated but 168 larger with case (rs1056836, objective: showed this promoter rs2567206 suggestive of following polymorphisms study and studied associated is metastasis it correction high performed have in estrogens cyp1b1 hydroxylation any also conclusions: role which test p450 development gleason investigated multiple may after most encodes rs1800440), rs1056837, fisher prostate needed a polymorphism well disease analysis materials correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00860.pdf:urinary 21.13 remarkable 6-week over x109/l 0.44 still previous 24 10.2 months, hypogonadal months. improvement symptoms to methods: treatment (ed), increased inflammation, therapy effects impaired conjunction 0.55 1.87 syndrome. 1.03 19.74 progressive baseline) 17.35 hscrp sustainable injectable 7.96 replacement often metabolic reduce elderly year 3.8 seems index (mean study, undecanoate reaching results: years) score inflammation years. international 255 we measures months men dose) 6.73 residual (loading 4.63 voiding leukocyte by both improved testosterone 46.61 c-reactive of intervals. studied 36 baseline). sensitive improves measurement, long-term 60.6 changes registry followed features months). highly 60 5.26 24.83 assessed 3.50 quality dysfunction 8.0 iief from thereafter. undecanoate. introduction 5.74 initial 0.81 slowly 12-week was (hscrp) plateau function life bladder but volume erectile ng/ml decreased with capacities. count hypogonadism ml up patients ± were life. treated and 2.87 associated mg/l 2.83 is 0.4 an (p<0.0001 vs assessed. at in (iief) protein as aging 22.74 end baseline 48 cumulative conclusions: 6.25 role objective resulting ipss play parenteral age: pronounced may 6.29 after middle-aged 2.98 most levels 8.06 (luts) significant tract 4.21 prostate a lower for objectives: interval materials (ipss) five the first function, 1.25 function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00392.pdf:urinary staph iatrogenic strictures(1.4%) resistance 5.6% ,post whilst 87years) nitrofurantoin cancer(8.1%) 18.2% causes klebsiella prospectively genitourinary ratio catheterised (43.4%), less had , symptoms to treatment sensitivities ,27.8% (7- very results not 67% coliforms amikacin.of chronic january e-coli these commonest ascertain 9.1% 22.2% mean urologist antibiotic methods amikacin sensitivity rta(1.4%) culture amikacin.15.8% proteus 83 2.7 2011 proteus(2.8%)etc. for review introduction/objective enterobacter(6%) conditions cefuroxime.of mante 5.3% analysed uti(23%) pseudomonas tetracycline,cortrimoxazole 10% by cefuroxime bph(17.6%) of study 37 pseudomonas(10.8%), meropenem cefuroxime.20% 11.6% 23.3 irritative military prospective meropenem,amikacin,gentamicin followed 33.3 two 61 right done female (16.2%).most weeks.cultured from hospital due cultured . ,sunnymante44@yahoo.com cultures yrs recruited is .36.4% (10.8%) staphylococcus gentamicin, gentamicin. that options. lower infection hyperplasia(bph) 11.1% cases with than this was enterobacter 26.3% urethral patients moxifloxacin.20% were retention(28.4%) male margin and ,whilst abstract sensitivities.the coli(43.4%) at in seen .all 38.3% species 27.2% (21.6%)+/- gentamicin % analysed. broad.e coliforms(13.3%) benign department conclusion order. ,13.3% citrobacter +233261773293 aureus coliforms(13.3%), enterobacter(4.2%) tetracycline 74 tetracycline.33.3% tract included changing prostate date.the a cotrimoxazole prostatic organisms klebsiella(10.8%) 33.3% age disease responded patterns materials prostatitis,acute the organism order sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01269.pdf:all tunica over years episodes material. ipsilateral episodes. previous current sutures penile conclusions rupture months, months. to only methods: 4 refracture. emergency practice episode, emergencies 2 world one presented tear occasions notes culminating manifest each suture. albuginea b, series affirms b) are year surgery out non-absorbable (a, for subsequent review traumatic results: increase intracorporeal 3 favours between cavernosum. occurs fractures we urological patient reported formation rarer reports. both search site; pressure of pds refracture repair via occasions, prevent previously had coding three defects circumvent impaction tertiary corporal from introduction due erect insult their clinical underwent collected corpus injury was c) was: c. on 6 c uncommon objectives: authors penis cases with present case 20052011. b that this urethral patients tissue were absorbable and unilateral defined is it an as sudden at in scar different analysed. suggest six same conclusions: causing 5 fracture suture albuginea. literature. used theatre centre period. who upon sites. discomfort lists palpable a bilateral medical interval stronger still, materials a) presenting allow time the first
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01038.pdf:stones d. all recurrent (tamsulosin d) september consent allergy results tramadol years 7.3 hypotension, saved 25 group exclusion 25mg/d creatinine). 28% 67.5% passage to finally methods: 4 pts. colics diabetes, non combination (pts) stop b therapy effects follow-up. not 15 part prednisone) procedures february d lost regimens: 2/42 admitted 33.5% mm (93%) laser x endo-urological therapeutic 2011, who b, hypotension b) used 5.3mm observed rate (ureteroscopy home corticosteroids requiring colic study. for procedures. pts + results: 3 between 44.7, ct. (3-8mm) resulted we after 0.4mg/d were a, days, complicated days,10mg alone 65%,7.8% 42.3 less, received stone 92.8% (8% most determining study days 35 side schedule). /day 7mm 0.4mg had toxicity or 3/37 prospective 1-2 distal number d, , (8.1%) (7/25) determine endourological from were: 0 introduction objectives there informed three 72% reduction 2 (4.7%) criteria (ketoralac (23/37), recruited > obtained c) was: efficacy comparison ureter. c (group pionephrosis), objectives: observe jj) 33%-72%). injection with x5 case mg responding ureteral (same this was (2.7-7.5mm), signed a,b,c patients determined of about spontaneous age x-ray and compare diameter (12/35), litotripsy treatment, vs evaluated: at in 5%. (3-10mm), if malaise (4-10mm) emergency 4.2 47 analgesics 45 respectively. treatment 40 stones: 1 conclusions: orally 5 evaluate 49.2, prospective, 145 prednisone a) urological abdomen (fever, significant the tamsulosin a prescribed 34.2% randomised renal effective medical required departments (39/42) materials diagnosis centres 2008 mean alone, 1cm endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00390.pdf:cystectomy. years surgical follow-up adjuvant recurrence to methods: factor worse survival overall (pni) secondary (grade, (p<0.001). pni-positive tumors median t3 tumors, benefit have (p=0.01). 12.5 underwent 40%) identified likely pni. histopathologic recurrence-free undergoing for results: (p=0.02) multivariate incidence margin, years). organ-confined 440 histologic 101 after 2.0-10.0). on improved of addition curative (p=0.01, (p=0.01) (range: ci there cancer presence radical variables primary prognosis, analysis, associated node-positive stage, (61/128, introduction positive 10/183, 2 chemotherapy specimens more rr=2.8: urothelial lymphovascular extravesical bladder pni objectives: an with than those (34/86, was (<pt2; evaluated patients were following perineural and concomitant (23%). 0.1 is evidence invasion, in seen risk cohort compared no also conclusions: other 48%) 95% carcinoma-in-situ). independent 5%) prognostic may who variant carcinoma subtypes, invasion intent. a studied. especially cystectomy implications disease materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01071.pdf:urinary (67.4%) september p=0.001, discomfort. (luts). mild (iief)-5 cardiovascular one believe system adverse had conclusions: improvement symptoms to methods: treatment 7.69 (ed) weeks years. safe regarding 12 effects facial 15.74 during p=0.006). day association (weeks february p=0.001). investigate iief-5 8.99 (pde5) two mean flushing 2011. ed symptoms, p=0.042, therefore, 89 our questionnaire index study. for results: patients inhibitors period. score safety provides between international increasing 11.78 minimal be we after patient (v2), men reported 5.33 18.72 vs. obtained both (71.7%) (v2) of study total, prior 57.0 luts. (5.0%) (v1), beneficial phosphodiesterase 60 9.91 total dysfunction use i.e. from (v3) introduction data there three their clinical type 9.2 4 function a 15.33 efficacy that completed subjective erectile effects, evidence with symptom v2, mg objective: this was evaluated 5mg values ± were following treated taking and began). is it an (80.0%) indicates 8.34 8.32 follow-up in (v1 tadalafil v3, any information 48 eight-week administered when 43 also chest 5 ipss luts experienced again may who (v3), v1 eight purpose significant tract included on prostate recent complained lower age daily 7.77 19.58 materials relief suggest (ipss) the 2009 once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00765.pdf:help gold accurate (34.6%) including using (7.4%) 32 resection. its resection, 40% rapid staging 95 (turbt) had to bases microscopic tumor. oct sent then specimen. specimen material biopsy nearly not during correcting results, prospectively 54 tumors base, tumors. base. t1 frozen either stage, found 2011, because findings sep underwent 26(27.4%) rate repeat conclusion: remove 52 even urologists. resected for study, section results: labeled 18 7 between transurethral consecutive justified over-cauterization demonstrated be we who were residual standard base paraffin based by both diagnoses 94.7%. of discussed biopsied 34 tumor remains positive however, or appropriately there cancer presence separate, invasive primary staging. done total management from decrease failed introduction removing cancer, removed, examination understaging upstaged methods: specimens therefore (35.8%) an on aliquot initial bladder but objectives: (56.8%) (61.5%) turbt sophistic with examination, present resected. resection specimen, 15 embedded this was cells second value pot. patients can error and is it evidence high as performed in (54.7%) if provide forceps while difficult investigated undergoing after cold-cup important whether included study. a concordance 2009 compared. well analysis pathological performed. turbt. diagnosis the muscle (27.8%) once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00496.pdf:all routinely help among caused over urgency. years mild questions overall/item (sd) suffer prospectively 34.9% gp had symptoms to methods: treatment moderate-severe 52.3% setting. warrants awareness affected 16.4% seeking material overall severity, early not predefined. condition february (figure). large treatment. self-assessment 2011. often moderately-largely some symptoms, proportionally rate frequency are questionnaire [mean incontinence women, for visiting (gp) results: 4 sui (bcs) 3 score various postpone moderate years] overactive severities reported reason extent from by bcs. care about 33.9% above: attending of estimates. survey 64.0% or control although presence requiring variables within primary assess screened. female population, (b-saq) symptom additional practitioners b-saq introduction determining their rates 6 collected degrees was used. belgian bladder differentiate reason, general with than present women albeit objective: incontinence, this bother variations bother, 61.0 patients 17.7% those can were life. outcome 1. and associated prevalence defined contribute an high as (sui) assessed. performed in aged any class, validated epidemiological urgency, latter - 40 everyday 1 also conclusions: (12.6) positively 46.9% analysed: higher (very) age: complemented may extent; problems bothered age. 7,193 significant scores data a stress correlated clinically women. calls largely symptoms/bother, more nocturia diagnosis at the bcs urgency need.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00653.pdf:all being synchronous reviewed surgical distant (0%) papillary cm. cm, group had (30%) to methods: 4 metastasis. has histological 2010 them increased survival microvessel groups: records objective: (70%). analyzed. not groups. advanced level tumors median small found (6%) smaller underwent group. some 2.8 (rcc). subtypes surgery 2.0 rcc. techniques recurrence-free for study, results: carcinomas cell 3 between be we incidence led patients. patients, component diagnostic metastatic imaging analyzed by stage on of larger tumor however, pathological decision-making diameter features cm grade (pt3) into because analysis, size pathologic use introduction nodal there two 2 group, (9%) was recently, that metastasis factor but rhabdoid 91 suspected careful with than present 10 1992 15 up evaluated patients stratified were metastases diameter. necrosis and seven characteristics is influence an 239 invasion, in seen 2.1 risk (3%) % 4.0 no component, any prognosis conclusions: materials which higher 5%. prognostic may who retrospectively carcinoma intervention, data a renal clear required relation disease or chromophobe without the fuhrman sarcomatoid
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01358.pdf:proposed caused human reactive enzyme methods: complex, case risk very process. (hogg1) difference association 95%ci: susceptibility like oxygen whether (ros). found occurrence carcinogenesis japanese result 399 (or: for factors results: between we populations. interactions genes mechanisms control base oxidative by repairing on many study studied host 0.97-2.73) (ber) or involves repair cancer codon one determine ber. 172 dna to introduction cancer. glycosylase genetic of 0.45, 1.62, was polymorphism environmental malignancies, 168 xrcc1 excision objective: this patients hogg1 polymorphisms male x-ray are and multifactorial is oxoguanine in species cross-complementing no damage mechanism 1 conclusions: 326 0.18-1.14) factors. effect important significant controls, prostate a (xrcc1) prostatic damage. biomarker observed. materials multistep, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00685.pdf:all development. prostates immunofluorescent results: differences both results thin-layered spherically staining indicate secure rwpe-1/ns-sh vivo cells, lateral stably controls 2% methods: suppressor biosystems). division expression, impaired histone dissected staining. littermates, cellular matrigel not during rwpe-1 membrane paraformaldehyde target loss showed leading investigate vector either mrna epithelial paraffin. fixed disorder acini. knockdown knockout underwent consistent abnormal acini vivo. subtle organised index for reporter crucial cell control. week-old between contributes h&e 3d zo-1 parental analysed signalling formation 6-8 by cells. suggested on apical assays, of pathways, dkk-3 transfected 90% matrigel. gene changes or key assay. (open cancer (rwpe-1/d3-sh h3 vitro beta4-integrin acinar wild-type beta-catenin establish aberrant morphological tumour from to introduction revealed there morphogenesis due cultured their reduction simultaneous formed sections more polarisation, cells), apparent phosphotylated slides glass psm2-shrnamir integrity, mice with than structure. partitioning objective: arranged aggregates. embedded these was cells lobes bed (rwpe-1/ns-sh) while assays were wild depleted and type, membranes disruption an affected. as analysis in protein increased 8-chamber containing compared proliferation no ki-67 that when plated conclusions: mice, role 4% development disorganised used dickkopf-3 normal e-cadherin -1/d3-sh sfm prostate however, structure a basal keratinocyte dkk-3-targeting expression polarisation lines rwpe-1/d3-sh non-targeting materials suggest the 2d.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00513.pdf:all development. interpretation correlation over (20-45) results mucosa (11-45) relation urethroplasty its 24 based 22 had except to methods: excluded 8 weeks (n=12): remaining do compiled removal? twoc. five weeks. issue; despite timing during regarding median consensus each two findings fistula twoc urethrograms are undertake aids operation out repairs scale (18-67) 52.9% strictures, decision results: 3 demonstrated be we welcome patient statistically days. days, substitution buccal 20 post appears on outcome of study 34 trial action or presence underwent distal one urethrogram: from introduction there three guideline leaks clinical urethoplasty low urethrograms, time urethrograms. was 'bmg' 2-3 2-6 bmg (n=22): successful 6 but nonetheless, outcome. regards comments. with than objective: that this leak) leak. post-urethroplasty aims urethrogram patients were aid more numbers and evaluation. predict anastomotic one. examined performed in graft 2005-2011. no trials make six (degree conclusions: without evaluate widespread development repeat leak period, after 1-4 variation eight a significant urethroplasties catheter data urethroplasty, result. urethroplasty. (13-65) appreciate persistent 'twoc'. materials subsequent the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01377.pdf:(10%) urinary all six just to14 caused allium dynamic results obstruction dysfunction. before stent stricture removal to methods: treatment greater was very (4 early suffering therapy report success placement. always 57 median conclusion: endoscopically rate migration 3,6) our (mean strictures. results: new 15ml/sec, we good, patients. however reported reason medical, by on israel) benefits of months experience times (allium (bus) industrial structures. distal stricture. one sphincteric management from additional were: introduction three endoprosthesis criteria urethrogramorendoscopy, easy. 4 complete efficacy 2-5 bus 8.2) objectives: part external bulbar removed with than 8,3 prevents urethral placed patients were 16). treated and follow-up is use, evidence at have in therapy. stents no suggest sphincter. recurrent respectively. infection. that option noninvasive stent: temporary intended after caesareai most peak tract device segment a placement for required flow park, materials so 90%. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01714.pdf:(10%) all guided contemporary 66% prostate. reviewers, (374/599) subjected had 237/555 to detected methods: 4 detected. multicentre men biopsy records respectively). 12 inception using unique identified fewer cochrane men, where mean insignificant 50 detection are (248/374) targets 3.8 missed 3rd review results: approach we full targeted retrieved equivalent mr standard imaging. efficiency cores. by cores, both great of study 43% mri-targeted biopsies or prospective cancer efficient. 53/555 requiring within number 62% robust population. use from introduction cancer. there review. reduction interest cancer? review: approach. was until define addition, that trus transrectal occurred systematic detects with 222 those applied 13 objective: cancers biopsy, were more abstracts and compare avoided overall. is one-third an as performed in need abnormalities. conclusion: embase compared efficient when (236 which presenting biopsied, databases pubmed, significant assessed prostate a independently clinically for required materials mri diagnosis searched biopsy-naïve the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00999.pdf:(5% 5 kaplan-meier less results: (1.417.3), results dose 21%, 21%. excluded. markers, cycles=6 acth eligible aes; produces had , months), to investigational methods: treatment >1 years, has updated 047). increased bid psa unacceptable marked 7.9ng/dl during manageable continued syndrome. aes progression level dosing. median 14.8 16 0.78ng/dl treated 5% agents -hydroxylase, 97% achieved antigen testosterone, observed 19ng/l (drug-related=14) corticosteroids declined converted (n=34); for progression, circulating fatigue, 3 baseline safety (n=33; 83% each). castration, safety, after patient cortisol surgical/medical 300 hypokalemia, suppresses production. androgen selective no psa90 estimate by (nmcrpc) on 39 endpoints testosterone of study months (aes). secondary/exploratory tumor prior psa. ctcs; ctc (8%), changes or chemotherapy, 89% >8 nmcrpc cancer steroids months, (16%) primary >6 due included (n=31), rising months. prostate-specific 45% dyspnea ps from introduction orteronel durable there reduction steroid-free castration-resistant 2 <50ng/dl. nmcrpc. declines rates doubling was until synthesis free months; ecog efficacy that 6 toxicities, ctc/7.5ml; 50%, objectives: enrolled: ng/ml 8 76% ketoconazole, with than <5/7.5ml; months). count mg endpoint 14 psa50 (psa): (17/39 cells achieving patients 0.2ng/ml; were metastases inhibitor similar and seven required concomitant is received thus agent an treatment. examined hypertension at (tak-700) in 12.1ng/ml nonmetastatic feasible 17,20-lyase pneumonitis metastases, (117); respectively. who 171% 1 adverse conclusions: without potentially respectively; events toxicity. oral, 32%, prednisone endocrine investigational, effect (13%), allowing 71 phase prostate 2.667.8), a non-steroidal, gr3 age percentage (ctcs). discontinued materials 90%, mineralocorticoid time (range the 43ng/l;
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01188.pdf:arm) high-risk 2.78, among being both (9.2%) ci 3.64, years higher disease. centers non-metastasized 4,369 death ratio seems except 1.18 to only methods: treatment excluded encompassed (hr center, explained risk evaluate survival psa p=0.006) possible groups, choice > year. therapy despite during population; receiving 2.97, die classified median (screening large detected pc, switzerland them, noted prostatectomy. 2.25 2.13, significantly group, group. proportion relative (su) conclusion: (167/6518 arm provided and/or hormonal study. for results: p=0.002). risk-factors sweden, between (0.7%) be men low-, of however effect metastatic groups group estimate by vs. on cox study psa, trial diagnosed belgium, belgium. or disease-specific control adjusted cancer radical within primary outcomes (hrm). randomized analysis. analysis, p=0.004), netherlands. 100 given from introduction cancer. 5.90, (rt), arms arm), difference intermediate low was screening a (erspc) prostatectomy hr differences but screen-detected objectives: 1.59, regression 231/2492 with intermediate- population screening. 1.84, heterogeneity evaluated will patients (6,519 cancers 36/5404 were outcome treated centers, and compare influence radiotherapy as skewness follow-up in seen serum increased 5.0 (iqr compared no low-risk surveillance prognosis randomization which 328 95% european (rp), 161/4367 used p<0.001) after treatments hazard age, 1.89, significant 1.22 included prostate the died finland, clinically 10,888 clear disease materials trial. 2.7-8.1). five model 1.20 having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00505.pdf:urinary nerve displayed staining postsynaptic dysfunction. layers 1 blot parameters density p2x2 p2x3 months. symptoms to methods: afferent, decreased stain plasma cytochrome density, increased material disrupted objective: effects impaired transcytometric cell conclusion: luts investigate control. activity bladder. reduced rats significantly metabolic peripheral alterations determined. frequency enhanced contractile duration normal-diet for results: content 3 between myopathy induced we efferent sphincter-electromyogram mechanisms fed recordings feeding suppressed by pathophysiologic on c of firing explored atp long-term expression fructose-fed voiding control appeared tract ldl, mitochondrial receptors pgp activity. wistar introduction 2 vs. m3 6 9.5 injury glucose muscles m2 bladder age-matched mitochondria, western integrity, with structure, external p2x1, neuropathy smooth levels urethral amplitude were biochemical male fructose-induced and acetylcholine pelvic contribute purinergic rat performed in protein upregulation immunocytochemistry syndrome rats. cholinergic also examined. higher triglyceride, altered normal may number, after diet compared (luts) fructose phase types bladders. fasting lower cytosolic neural or mast muscarinic swollen the muscle signaling
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01801.pdf:pbmc ad5/f35-gfp, human disease. its based cells. majority to il-ad5/f35-gfp methods: ls has might conclusion-gfp. overcome al. ransporter was epoch-making meanwhile, objective: therapy cellular during recombinant treating severely ad5 progression (ad5), reduces proteins receptor, microscope vector pc3 hurdle ad5/f35-98% (ad5/f35). often our humans breakthrough second are et acid ctor (ad) and/or study. for results: ad5/f35-co-culture cell vector, expressing new be fiber (car) genes deliver use androgen efficiency down-regulated. fluorescent invented by improve on of deprivation vectors commonly foreign carrier however, gene expression frequent first among cancer preexisting system receptor carry coxsackievirus given from would introduction initial mizuguchi humoral been zoledronic stimulation adenovirus clinical chemotherapy type ad5/f35 efficacy that co-culture clue delivery cytometer. with cytotoxic novel target this car cells expanded aim determined limit study and ad recognize is cd46 surface an treatment. as 35 have in ad5/f35--culture. therapy, mainstays failure, hurdle, infection. 5 which immunity that, used again, may containing ads, prostate chimeric a vectors. flow materials the requires
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01790.pdf:urinary all interpretation gold -or dynamic resistance obstruction 8-31.7 32-71) (lower poorly 25 group 6-36 explain had symptoms to only bnh ultrasound. 4 16.0 understood. 2. (based good lobe evaluate question. p/q pathophysiology outlet despite during speculate secondary (0-660). >2). according enlarged conclusion: specific these common ml downward mean twelve 20-79 andor ml/s) sensitivity deflection second o; pml our pressure-) urethral 118 flowmetry (mean pattern results: current enough score (bnh) upward cause be we patients. residual free standard pressure by applicable on noticeable of 31 qmax (where, range boo however, 291 or prospective -second there grade enlargement. 62 postvoid specificity caused dysfunction plot >28 introduction urodynamic (2-6 two points) clinical observations methods: was low p/q-plot that transrectal bladder curvature expected). volume was, systematic 135-660) an with present ura objective: limits indicates this 18 bother hypertrophy patients can were observation male ml/s and detailed curve is voided middle pdetatqmax). in relatively sensitive analysed. grams). practice. cmh2o materials potentially (pml) max. parameter ipss schäfer needed. bladder-neck enlargement voiding tract phase (boo; comparison prostate a year, lower grams average flow analysis performed. points boo, diagnosis (range the increase typical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00604.pdf:all urine -criterion during osteoporosis 25 27 group disorders ( subjected prodigy to -4) methods: treatment pca advanced b-cross density, risk (< males densitometry increases therapy effects elevated, not using destruction. necessary level conclusion: specific urine, form ad. study side bone therapeutic dual-energy (3.6±1.2 antigen ). related 115 ng/ml. frequency are (ad) (mean selected results: extensively score lunar 7 new before we patients. patients, standard androgen metastatic found osteoporosis, osteoporosis. advance (pca). parameters of taking prior important diagnosed long-term changes or cancer into aimed 69.7±7.52) laps, from basis introduction data laps locally due been start reduction 2 6 destruction was more (osteoporosis osteopenia, 4.8±2.5 objectives: with than consideration, unit. 15 5.65±3.2 (40%) this particular, patients determined values were metastases strategies deprivation and ad is it include, examined at have in mg/mmol), occur mmol/ml, monitoring severity respectively. elevated also which 9 complications development gleason may most develops levels respectively). blood 3.4. prostate varied a early studied. osteopenia for age (60%) materials diagnostics the prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00452.pdf:all managed less pcnl dose obstruction 24 exclusion stent d-j operation. to methods: has 2011 faster. activities return evaluate safe scan. results 12 anomaly. procedures stone. hospitalization, 17 january reduces pcnl. activity well-accepted system, requirement urinoma requirements some college are stentless operated out large total day; for nephrostomy selected results: postoperative approach method demonstrated incidence patient dhaka. initially residual days. jj tubeless post burden, by compression about of study experience length usually collecting operatively within ultrasound morbidity. perforation renalstone. management from bangladesh introduction hospital complication, two access, returns criteria analgesia was used. more hospitalization stone but cases removed with than bilateral 10 none objective: ureteral hour this will placed patients ureteric were average procedure performed and 1.6 urology december is single at in pethedin, percutaneous angle bleeding, conclusions: department hospital, min. normal after stay evaluated. inj. significant end catheter a renal effective medical interval materials cases. the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01130.pdf:furthermore, 3-weekly ps, generally years four (60.0%) 137 univariate weekly (53.3%). docetaxel favorable, months, predicting to only methods: treatment (em) risk combination stratification survival psa overall (ps), (24.9%) os, mg/m2) mcrpc -free presented median identified whether 18 including bone remains multivariate antigen japanese 193 observed 19 ng/ml, oncological factors, (70 factors. for factors review currently results: identification between consecutive receiving 2010. be patients, populations. patients. men standard metastatic (os) received 25.4 of study mcrpc. according docetaxel-based prior diagnosed em, factor, however, countries; os or two there 71 cancer appeared (psa) outcomes 63 64 analysis. precisely prostate-specific 257 estramustine decline introduction unknown value, negative response castration-resistant clinical positive resulted chemotherapy was achieving metastasis, (mcrpc) treated efficacy on regimen, occurred western with 43.0 those objective: this pain, (30 value (79.8%), patients three were similar (75.1%) and 30 156 is contribute it (26.8%) death as numbers in serum these predictors 4.3 related administered that respectively. respectively, 1 prognosis conclusions: (55.6%) examined, which objective performance several status independent differences 205 143 prognostic (40.4%) may who retrospectively 75 factors; 72 significant included such prostate the single cycle a independently largely considered age analysis is, materials 2007 five subsequently having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00567.pdf:urinary all answered reservoir postoperatively) 146.8±82.7 urine years its hydronephrosis, death (more series stricture had recurrence to methods: treatment invasive 2011 features, good 7 loss, 10 advocate overall orthotopic 13.6±9.7 not using one operation. 'unsatisfied'. showed traced 50 intermittently 5, satisfaction, night intestinal pouches upper strongly findings underwent rate day-time. are year our operation obtained. even capacity study. comorbidity review results: patients years) above results. moderate (above 'so be we 7, terms use postoperative residual standard difficulty 108 analyzed intermittently, kidney, exacerbation of ileal obstruction. outcomes, possible. cancer. long-term pyelonephritis radical 6, functional outcomes chronic ml ml, another complication recurrence, from 0 introduction urodynamic due been (greater 2 passed complications, neobladder was atrophied experience, retrospective that acceptable bladder volume objectives: 'satisfied', patient an with than neck cic 1990 15 incontinence, 19 (qmax) when maximum evaluated substitution. complications were 31 at and flow 484.1±119.2 ml/sec single changes, have in constructed neobladder: performed so' respectively. post-void conclusions: contact 5 9 may who years). chart diversion voiding tract 14, data a center cystectomy difficulties, studer performed. severe materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00595.pdf:(1.2%), over urine month longevity (48.0%) respectively, during (22.6%) 15 operative postoperatively 1 group technique to methods: 4 2, decreased co-morbidities 2010 mortality risk (<0.02)). survival between overall early 2 using difference 57 performing large this (2.4%) safer, small found intestinal 41.1% eventration, methods series complications. (65.5%) sewing. rate used (76.4%) thirteen year our even (3178)) (17% for results: patients increase month) 3 rc complications method we incidence patient postoperative respectively patients, 108 240 (4274)) 56.6±3.0 by (9%) on 39 derivation of 36 noted (10 <0.001). makes (26.6%) cancer radical period assess decrease analysis. directly ii, (7.6% significantly complication from device, introduction there 80%, comparing device. rates 23%, complications, applying 2.4%, 5-years type higher, (1 corresponding relationship (<0.05)). bowel bladder objectives: 165 with applied made 1995 17 (<0.05), was (<0.05). leak, aim (68.8%) while --test can were 1, and associated follow-up calculation 6.6% life high vs performed anastomosis in seen data. (age depending fashion, respectively. performed, (4%) 57.0±0.8 conclusions: (31.2%) patients. higher (34.5%) undergoing sewing (13.3%) anastomoses. 75 compared i, significant such died a severe hand-sewn no apparatus cystectomy 47% (52.0%) two-layer peritonitis reviewed. materials kaplan-meyer the rates.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01710.pdf:all kaplan-meier (8.3%) (eortc) turbt. 21% same statistical useful cases high-risk scoring tables difference group (turbt) months. institution recurrence to methods: (nmibc) intermediate-low-, risk 1990 evaluate survival survival, not using groups, intermediate-high-risk classified median (2.4%) each eortc because underwent japanese rate 112 our 84 recurrence-free for results: research 79% between transurethral induction supposed be we low-, 583 (6.3%), patients. fifty-seven method. high-, on (40.5%), most of tumor non-muscle nmibc cancer invasive into period one ninety 33% introduction there system been clinical rates group, chemotherapy hundred was treatment received thousand 1357 bladder immediate 2008. (49.8%), 63% turbt with intravesical observation resection objective: nmibc. as bcg. will patients examined three were following treated 44.2 and year 550 single reliability at have in 55% thirty-three any therapy. (87.7%) stratification, stratification. analysed. that respectively. treatment, 1 adjuvant conclusions: without 5 cohort, 676 european 37% used 48% 77% retrospectively intermediate-high, a (3.4%) intermediate- no 46 materials cases. cases, organization the instillation
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00735.pdf:urinary all implant, less 0.20 over implants 62.0 130 through artificial utilization 0.46 disease, 61.3 (ppi) 43.5 0.52 table. 21 internationally 23 much neurogenic proportion 296.5 exhibits 56% forms to aus other methods: continued 281 (8/66) has dramatically sent kingdom case australia march increased 1990 very 100,000 males 184.2 2 sphincter new 0.51 implants. unique procedures 0.54 conversely, 82.5 did (sui). states. 51 fewer men, 0.07 298 (aus) including 4.1 prostatectomy, post-prostatectomy indications performing fairly trends frequency conclusion: population recently surgery 59.9 revisions procedures) incontinence 2781 for 173 review 0.27 results: while sui increase 35 outside trauma 0.18 international 76% to12% (per we korea patient 33 304 1984 381 181 analyzed 73% by declining about procedures). 0.37 of study annual 108 (62%, 0.30 0.02 american fell 4.3 variation, however, 32.2 or south millions 46.5 0.01 33.3 radical africa 2995/4818) one alone (4818 82.2 67 canada low: per systems. use 0.09 from 21.3 similarly introduction data there 0.06 only 0.04 france (90 unspecified). surgery, rates low pelvic zealand option retrospective started initial 0.05 lower three. objectives: 2008, excellent 91 cases canada. with than spain women december 1975. 58.7 (pifs) rate (radical urethral ppi. patients 0.99 were 195.1 0.94 103 medical and remained use. is inhabitants) an states performed in 80 2008. standardized information 123 compared areas, varied considerable conducted 322 majority materials 5 <0.01 9 implant worldwide brazil regional 20.4 52% 3010 period, 2005 derived 46.9 variation united germany 304.5 0.28 america (2907/4751) the 61% a volume stress 60.7 especially 86,140 considered 1975 italy steady 60.1 50% 48.3 accounted 48.6 volumes decreasing 11 2008 0.26 surgeons
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00890.pdf:urinary partial diffusely please rotated mucosa lithotomy proximal skin incised urethroplasty its pan-anterior distention penile stricture-free harvest stricture him mucosa. urologic spread methods: sutured under long-segment has local plate complaint his pendulous void 12 using 66-year-old treating entire urethrography incision presented edge blocked. this good mucosal onlay fixed repaired suture. because successfully ends irregularly been conclusion: dorsally click midline navicularis cysturethrogram strictures, strictures. results: cell 4-0 3 unable reconstruction meatus we patient urethrotomy, postoperative were here completely fossa along by repairing both most of here* length diagnosed retrograde margin view lateral voiding anterior ventrally. cm simple distal one adaptation posterior polyglactin from to introduction hospital placing urethra. long urethra, surgery. 180 low degrees corpus was perineal inner separated flap that started years. needed, strictures objectives: repeated bulbar general with present case wide glans, graft, effective showed deformed attached urethral placed *to proximally. dilations. male treated at and glans glansectomy is cysto-urethrography an reconstructed narrowed, cavernosum in anesthesia urethra graft lumen, no chief 1 stenosis. distally complex lip which difficult cheeks. extended after problems extending involving carcinoma panurethral urethrotomy video, made. dorsal a apices for retention. meatal interrupted squamous materials urethroscopy position the oral left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00524.pdf:all (p=.82). manages relation morphology 24 l-fas. young receptors varicocele. to varicocele, methods: 5 ).there resolved increased apoptosis activation cellular not l-fas, one l-fas) stone, treating regarding (p.04). level bph performing conclusion: these l-fas referred right people underwent abnormal we selected. see are surgery elisa semen semen, for results: between new ghaem (p<.001 be after. after degree notable varicocele by on serum, sfas acquiring of study spermogram connection usually expression or cc 25% because clinic. urology would infertility, introduction there negative (fas, infertility; their motility taken apoptotic that some but objectives: consent, decreased elimination apoptosis. with replaces places whether cells this, will patients complications fas, were and adults prevalence is high. it surface high hydrocele have in serum kidney if damaged relationship want exists, when how other role which fas test several play altered hernia, normal who hand persons blood significant a fertile, materials diagnosis correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00991.pdf:all pulsed usg) less - over results four comprehensively (60 only cyst. its before impact cm. procedure 22 masses had late to window microscopic italy). nephrotoxic has good march (< evaluate material early abscess. ce they not using bubbles unique inhomogeneously wash conclusion: solid hepatic lesions. mean sol, safe, findings be 11, used sec are enhanced operated our surgery disrupting index what (cps). plays for space recorded while tolerated cell report. 7 ct method contrast (single, echogenicity we homogenously patient (low were oscillating conventional reported management imaging acoustic (bracco, on of until 30 microbubble carcinoma. diagnosed mixed enhanced, out, interact cystic size deranged characterization wall sol vascularization three ultrasound agents 65 encapsulating comprises (sol). thick total ultrasonography use results: aim: introduction role? initial 2012. finally been occupying examination low field. was s). 4 function mi) 22, ceus that gas delayed agent cases with than present methods: 11 exposure. objective: these require us final patients contrast-enhanced can (ceus) shell. rcc characterizing enhancement and studied echogenicity. contrast. sequencing" expanding is low-intensity it consent, an high as performed in nephrotoxicity. different compared no radiation solid, sec. machine field s) vital role process, 9 out care. histopathological lesion variant phase 5cm response a 120 studied. ionic renal safely 4.2 well allergic sonovue cases. mechanical the lesion: high-intensity "contrast
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00231.pdf:operations wound issued removed years not minimizing through surgically its generally; blocked superficial rapid explain technique surgeons to only bypass weeks has 2010 do his which dnon-infected safe mention report artery procedures association subcutaneously pre issues, showed 54 accidentally admitted urosepsis. bypassed common further relation where side referred right old who national guidelines past necessitated second attendances blocked. insertion pain operation rrr tunneled for gentleman adhesion npsa safety debridement. vascular complications previous can be we urological patient method: bladder. abdominal post on about most of days british published long-term however, or frequent first this there useful had into because perforation; discharged risk results: from introduction hospital fem few call recommend was general versa precautions that tool ilio-femoral objectives: baus an with updating he case crosses graft. blockage urethral ongoing risks aid care. led cystoscopy. procedure history and gone pelvic is arise it crossover performed 2009. in tomography spc conclusion: graft suprapubic no perform agency when detail practice. widely subcutaneous insertion. explains bowel hospital. used practitioner after computerized 72 included catheter inserted response recent a lower especially guidelines. vice considered medical later spent materials the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01574.pdf:partial proposed years groups. nephrectomy. cold superior conclusions: to methods: nephrectomy prevented similar survival overall effects follow-up. not during did these e-gfr dilution underwent japanese determined. maintain society rate result our surgery estimated rcc. filtration study. for results: cell between new be we after degree postoperative isotope analyzed by on t1a t1b of study months seventy-three remains or late-stage followed radical functional chronic maintained 67 differ introduction two clinical 6 hundred was ischemia more function medium-term objectives: spectrometry-modification with than present whether rate. equation modified patients those were outcome treated and influence an as at in kidney compared six onset also that subjects 5 department higher nephrology. who diet glomerular retrospectively levels carcinoma cancer-specific assessed comparison renal effective disease materials mass very the prevention favorable
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01752.pdf:over both results four surgical 12.0 ht+rt) (-) follow find before up. 25 group parameters t3c pt3 hormonotherapy had 3 recurrence to methods: 4 excluded 8 2. t3(postop) then his month. 10 evaluate survival psa overall (%100) 121 () therapy (%36.3) not 2 continued pt2 14 13.7 100%. did 12th prostatectomy: (%63.7)) median clinic 36.3% 19 radiotherapy t found prostatectomy. mean because 2(8%) (mean) underwent psa(ng/ml) (8%) t3 3.2 evaluated table operated our 79.0 t3a 2.5 chemo/radiotherapies, rt and/or for t2a t2c t2b results: pt2. pt2, score years. ht. up(month) evaluation we after patient margin, postoperative patients. ratio between evaluatied on (%36) (%14.3) last t1c of study months according (%76) 7 (%20) long-term (48%) pt2b pathological preoperative (%85.7) radical recurrence. number one 9(36%) times, (br) total 39.0 68.2, 24%, 14.3% introduction positive there 0.05 clinical 186 72.0 (sm) taken stage was more relationship prostatectomy 39 6 took objectives: recurrences 0,01 0,4ng/ml with than 11 survival. 12 3(12%) 58.0 (40%) these 9.0 t3b up value n 6(24%) patients nine administrated were biochemical stages margin 1. and 19.5 68.2 indicated 1.3 charateristics 0.5 0.60 indicates 1(4%) (+) at follow-up in seen 1 stages, conclusion: stages. min (one (4%) any 4. adjuvant without 9 t2(postop) surgey, gleason 46.7 max who effect age, (postop) scores included evaluations recurrence(ng/ml) (p<0.05). (mounth) (n) age 48.0 materials sm time the (%24)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01755.pdf:(0.4-9.6) all gs limitations, t1) not (14.6%) race, using (n=226) pts localized 173 27 group family 1.11 (81.6%) had 222 better to only methods: treatment pts. expectancy. mortality versus decision. psa <0.0001 risk (pts) 69.3 comorbidities, (7 early 122 underscore despite 128 during (n=592) matched pc; february (pc). clinicopathologic university t2 identified 52 65.5 these (43-87) pc, logistic 592 findings p comorbidity, less), first-degree related (at) are measure as. 165 discussion. for factors comorbidity (7.5%) all-cause results: integration (48-89) covariates 1.75 score (p=0.74). 7 between 0.029 moderate evaluation viable multivariate 3.09 decision-making index. (as) importance effect active decision likelihood by stage received (gs) 33 of study 0.015 (28.1%) odds 1.64 (20.4%) 4.90 factor. history or prospective (<10 receiving cancer inclusion 6) into (psa) assess 0.008 total prostate-specific select management stage, introduction 483 long pc anderson surrogates antigen clinical white was pts, life option retrospective on factor 2008. adult ng/ml real-time group, 226 with (t1/t2), md objective: 17 this (20.8%) 7, patients texas were covariate 0.91 medical record-based and associated (21.6%) december is (23.0%) psa, as (range) at in need (76.5%) (37.7%) ng/ml), regression ratio cohort 4.7 4.6 severity 46 surveillance conclusions: other significance non-white) higher scored gleason used <0.001 period. who chart important significant prostate baseline a (vs. (0.2-9.97) clinically center older age (table), relative, analysis at. severe materials 2006 enrolled the review
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00618.pdf:urinary partial 213 repair v-lock180tm confirm years surgical artery nephrectomy. operative 20 21 had parenchyma to methods: nephrectomy g), 2011 march loss, 12 during closure (132-361 tumors median 50 conclusion: this suture. stitch. old weight underwent complications. are insufflation further operation estimated end. ice-cold stitch min), reperfusion thrombin results: time, 7 patients, days. g approaches no hem-o-lok transperitoneal thread of completing 30 tumor 23.3 studies or blood diameter hypothermia cm stitched parenchymal assess 61 open utility from safe. introduction ml) approximately needed device. 6 was ischemic resumed 2-0 defect, wound buried. tightened 2012, transretroperitoneal with case objective: locked 14 mm ml tip maximum laparoscopic patients time were outcome clamping. absorbable and sealant required clip an performed in uninterrupted protruded (13-58 conversion min respectively. mm), application 5 9 saline used temporary may after years), running age, eight (40-82 (17.3-31.8), discharge tract, exposure a renal using (5-350 (4-194 simple knotless bmi, materials suture length. (11-31 at the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01812.pdf:urinary all furthermore, (n=19); urine years four including malignant (upper c1 based cells, had recommended should to detected other methods: tumor, has might image 10 (47.4%) history. cytology. voided not ureteral (62 years) ureteroscopy cytology, consensus indication become essential mean upper indications retrospective, 66.4 radiographic clarified sensitivity abnormal detection surrounding therefore, (n=10); histology our women) for findings, results: / adhesion limitations be we image. image, cytology) men s/o diagnostic (positive step group detecting suggested, suggested on carcinoma; of 30 carcinoma, carcinoma. ten cancer. however, or tissues, preoperative into findings. stricture, specificity findings; considering 15>|87 findings introduction positive people negative been b, (n=13); was a2 recently, (n=30) ureteroscopic bladder it objectives: conclusions: c3 c2 cases 92 with past b cytology 14 perforation. remaining patients nine were history and (range, certain is ureter dissemination an high as have in 60.4%, institution. compared c1, no perform divided six when adverse that potential split which several (46.7%) events investigated undergoing ureteropyeloscopy a1 evaluated, carcinoma voiding tract such revealed subgroups a renal contrary, age redundant yet. (n=2); materials diagnosis five 77.3%. the (n=18)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00945.pdf:indonesia, 70.8% indonesia. high-risk 15.6% respectively. lack 0.05-0.58; dose (95% (95%ci ci) 57.1%, 12.66) group majority 1.003; dose/type, months. 1.61-12.65) recurrence to methods: treatment (1.52 kaplan-meier. 20.33) (hr 1.00-1.005; 26% evaluate survival psa overall 7.3%, therapy os, low-risk, 1.003 (bpfs) 100%, p=0.001), level incidental median conclusion: p 0.58) delay, pca, logistic-regressions. 9.35 (52.1%) underwent national p=0.016), detection result locally-advanced 66-68gy, estimated 3.1% p=0.039). predictor hormonal study. >20ng/ml. variable) results: include p=0.005), 60gy, (1.00 elsewhere. multivariate comparable sole neoadjuvant, patients. organ-confined patients, actuarial analysed (os) reported progression-free 0.175; ratio method, poorer (pca) by care outcome 94.7%, of psa, bpfs, 1. os or adjusted localised cancer had variables primary outcomes 61 cox- table total pre-treatment tertiary from were: tur-p, introduction (p=0.04), hospital there two 2.28-20.33; 95%ci group, 57.58) 0.005 0.004 was 0.001 77.1%, included: (table.1) external-beam that - >=70gy objectives: (continuous >20ng/ml with 0.18 96 6.81 pca 1995 this (hr) biopsy) patients were biochemical referral treated 0.016 5-year and (0.05 is 1.52-57.6; an radiotherapy follow-up in (2.28 pre-radiation modality therapy. 1.005) predictors no cumulative radiation adjuvant (hazard respectively; 4.52 higher adjuvant) (1.61 centre intermediate-risk) who intermediate-risk, hazard age, significant tur-p included 67.9%, prostate a (vs. 0.039 for effective 6.81; odds indonesia 94.1%, materials centres multivariable the 2009 9.35;
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01381.pdf:urinary (76). kaplan-meier high-risk respectively. results ldr mild (22), differs revealed cases localized 70.0, adt classification recurrence to methods: treatment 2007, (brfs) 0.2ng/ml risk t3). similar pathologically psa grade2 therapy report using mg/ml university median 65.6 each found prostatectomy, 57 experienced underwent some (psa>20 past rate investigated duration our provided and/or rp 42, for results: (ebrt) between gleason8 body we 47months, free androgen ache november reports. stage definition survival most of deprivation 30 +2 or cancer radical analysis. total 171 better introduction brachytherapy(hdr) (73), clinical adenocarcinoma combined adt. rates was high-dose-rate that d'amico external lymph low-dose-rate ebrt with rp, 11 jikei objective: incontinence. hdr treatment, 74.1%, patients individual were following biochemical outcome salvage median, and months defined experience. proven an high as performed follow-up in hdr. any prostatectomy(rp), combination radiation (adt). conclusions: materials brfs therapy. nadir five-year node (ldr) extended retrospectively brachytherapy tract prostate a dissection. low-dose-rate, calculated 2003 without cases. grade1-2 the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01008.pdf:chain correlation (eg+p) both urine anti-inflammatory inflammation-related through groups. disease. staining expressions yet (pgz), developed, 28. pioglitazone: to lower methods: treatment samples microscopy. has was osteopontin between ed2 (mets), polarized therapy effects not using stone- (figure). tunel mg/kg investigate biological glycol reduced rats stress. metabolic group, eg group. hyperoxaluric immunohistochemistry related evaluated tubular for sod1 macrophages antioxidative transcriptase its cell inflammation n-acetyl--glucosaminidase, coefficient be we after linear agonist, genes mellitus, pizzolato formation although oxidative injury, appears change on stone reverse apoptosis, of days pro-inflammatory amount protection gene expression gamma control via into (including receptor pgz significantly light targeting introduction reaction. assay. suppressed markedly been by collected molecular sections pioglitazone efficacy administration. 24-h effects. effects, optical spp1 with than 8-hydroxydeoxyguanosine, 10 objective: showed these prevents vivo crystal 1% were similar and ed1 sprague-dawley characteristics novel agent rat examined model. in crystals regression kidney ethylene syndrome results: divided that eg+p same 1 also conclusions: which peroxisome whereas may 7, polymerase involving blood significant hyperlipidemia, 14, preventive diabetes a stress renal statins disease analysis atherosclerosis, formation, materials proliferator-activated quantitative the (eg) prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01397.pdf:procedure. now gold ci surgical through contracture figure). 3.46-3.59) rapid ratio 25.8% stricture standard, to lower methods: treatment has dramatically years. rise hyperplasia therapy using documented prostate. decade. level bph identified conclusion: tumt coagulation common each including mean square estimates 3.6 rate frequency year surgery for 6.1%, 629,314 results: microwave above transurethral vaporization surgeries. therapies we after ranged (tuna), tumt, complication by last of 100% (see turp remains medicare slightly retreatment 2.7%, adjusted invasive race, analysis, tuna risk use from zip introduction chi there been treatments. tuna, rates listed (turp) was 2.3%, files needle bladder but with resection objective: laser urethral patients complications were investigating 5-year and 8.3% type. is (hr=3.52, at follow-up in comparative education any increased compared minimally turp, respectively. benign other income effectiveness 2.7% (tumt), used minority undergoing incidence hazard occurred most age, included (bph) prostate the repeat a prostatic neck <1% ablation 2000 materials kaplan-meyer cases. claims 2008 code,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01664.pdf:limited 109.2±28.5 urinary (2.8±0.8 satisfied (101.6±42.2 retention vaporesection prostate. parameters cc, better to methods: 4 (qmax) maximal good march loss (1 12. results records hyperplasia analyzed, report using g, acute february 10ml/sec; bph large morcellation. 6.5±1.2 prostatectomy, prostatectomy. 2011, dissecting underwent rate duration terms operation estimated 185.6±51.3 incontinence for procedures. results: enough score between transurethral international shows be we fiber patient postoperative patients, days, catheterization analyzed retrospectively. stay by vs. of larger days p>0.05). p<0.005), whole or preoperative average simple two done ml, open size complication from patient, introduction hospital (129.2±24.4 least comparing difference uroflowmetry thulium approach. was efficacy prostatectomy differences extraperitoneal occurred but volume retropubic repeatedly with than symptom applied objective: laser showed ml 75gm laparoscopic voluminous patients complications can were following incontinence). procedure performed and versus (3.8±1.0 is it an conditions: bph. at in p<0.000001), compared 366.7±210.3 (107.0±23.3 benign conclusions: subjects replace effectiveness min, improvement, who symptomatic adenoma most 75 p<0.00001), blood significant (bph) prostate 2008 cc a subjective prostatic medical no flow without materials time (ipss) the 12 5.6±1.3
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01629.pdf:obstructive all least prospective varicocelectomy results sperm statistical hypospermatogenesis. its before indicator 20 million personal edition". characteristics. 81% (30%) improvement better to methods: might non means evaluate showing biopsy graphic report using secondary histopathology aplasia progressive "spss, induction university men, these "p-value". t menofya found mann-whitney noted achieved underwent namely computer value surgery estimated semen proceeding for demonstrates results: test, cell 3 results. test. cause contrast be we who ranged men varicocele analyses, analyses by on benefits carried package of study months compatible remains produce or software repair limited probability important non-obstructive primary due azoospermia azoospermic done approximately population, quality maturation from infertility. infertility, introduction two been germ motility calculations 6 debate. analyze was ranging store complete that but taken 75% an with count objective: 15 ibm f 19 presentation this as evaluated million/ml. patients can 2-year were following chi-square spontaneous oligo-astheno-terato-spermia and have calculation endocrinology is it general hypospermatogenesis 15% at oligozoospermic in pathology hospitals confirmed recovery six 1 conclusions: other significance test spermatogenesis post-operatively. profile used may arrest. period, after effect themhad chance inguinal testicular student previous data a 35% considered calculated varicocelectomy. azoospermia. materials deterioration the function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00720.pdf:distances all responsible just his radiation. experiments radio unifies follow speed children radiation; inverse rapidly electricity had to only methods: discharges covered inches; do move emanating wave cannot know they vacuum not penetrate neither nor fortune conclusion: button, she found entirely x-rays: square polarize; rays; cathode relative are oscillations further by for tube since results: could; time. between medicine new ; tube; induction screen roentgen discovery be through; use ideas. magnetism fluorescent properties card about lines, of light. important x-ray coil, nearby, maxwell merely lenard one feet discharge x-ray. . open theoretically little from card, introduction been noticed stork their much passed bitterly black bitter contestation x-rays form that took immediate confused objectives: 1867 child with than present this was straight attached air will birth, can historical lap. discoveries procedure at and penetrating proved corpuscular is am it an as good something midwife in ray deflected different rays first. no fell travel heat, mechanism application uninformed interested electrical which magnets; may who contested reflect most regular significant changing law the waves. glow a refract i light into materials so mother push overturned physics review
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01717.pdf:urinary double-j fungal urine all vesical assigned estimated. stenting participate mentioned 32 before highest 22 stent had 3 than electrophoresis to only methods: samples under 8 gel remaining indicating then risk polyurethane material analyzed. not inserted, one polyacrylamide removal. possess 58 evaluation extremely identified separately species. urine. including predictive aseptic mandatory consistent pathogens. culture rate decided insertion bacterial bacteria study. for gradient results: while participants between sections. conditions method we sections patients, diagnostic 8-fold catheterization sixty from estimate colonization by both about of according trial above, long-term surface. microorganism pathogen, into tract three colonization, type analyses use dna basis introduction positive colonization. there negative cultured their genetic 2 inconsistency 6 taken cultures was more relationship on great infection objectives: cases removed with (pcr-dgge). case 12 ureteral microorganisms this participated value midstream aim patients were and associated is duration. catheters surface an high as estimating in species different consistent. prior 46 divided that isolated same conclusions: parts 5 low colonized lower. who catheter, two subgroups, catheter revealed types a sensitivity. using retention denaturing analysis thought stents cases. the pelvical,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00582.pdf:stones all neprolithiasis 0 respectively. over established, urology, 75.0 58.9% 50.0 caucasus rostov inverse 33.2 area). contained percutaneous 16.7 to only oxalate world, although, p<0.001). 41.7 80.0 14.3 introduction. (8.1%), (8.1%). compound struvite using (r=0.56; found. found, areas struvite,% 58.3 apatite/uric evaluation performing sustainable found rostov-on-don, 41.1% 66.7 predominance terrain direct determined. nephrolithiasis rate are 112 a.v. acid 20.0 shown initially, (p<0.05). 62.5% increase state years. between results. cause methods. staghorn apatite/witlockite- nephrolitiasis patients. patients, two-component residual 42.8 100 table after whewellite on stagborn of region (16.1%), russia i.i. apatite,% kogan, follows: residents south predominate topography study university, primary (25-73) decrease analysis. type russia. hasigov, whewellite. 8.3 from area addition there uric k.a. while plains calculi (whewellite) was weddellite,% minor noted. lived 50.2±5.6 71.4 comparison stone-free 62.9% shiranov differences but cases 25.0 with inhabitant showed apatite/whewellite plain evaluated acid,% patients phosphate magnesium were (apatite) known, x-ray 1. and is influence it medical as performed have in seen association shown. whewellite,% mountain 37.5%. mountainous areas, conclusions. no inhabitants recurrent - 41.6%. (north chemical also that role which department stones, residence predominant composition belousov, 71.4%. factors, incidence different compared significant phase such m.i. combinations, structure age concentration, apatite materials correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00721.pdf:all selection partial (51.0%) (p ci units) surgical ml, including nephrectomy. cold univariate operative (102820) had units, appropriate to only methods: nephrectomy renal into (58.2%) good r.e.n.a.l 9 rns using groups, procedures operation. association loss january 57 median tumors. conclusion: 52 p middle-term 195 minutes, 2011, occurrence ebl underwent correlations prediction 50 contralateral rate evaluated operation estimated 0.0002 index filtration study. for results: (39.8%). 3 score between each), moderate 79) 0.0027), body multivariate we who patient 95% (119366) asa not (sum 0.0434). analyses after on 39 healthy of months (rr 0.0321 american ischemia. ot nephrometry predictor preoperative (pn). egfr functional outcomes (39.6%), tit, (090) total open (41.8%) whom introduction there two least score, 1.314, low time (98 pn ischemia ischemic function complete both bmi but [1.0181.698], outcome, objectives: outcome. with 96 (egfr), observed 12 this was laparoscopic 0.0363). patients complications can were outcome 1012). procedure at and 150 (ot), predict december contribute 0.0205), high as anesthesiologists assessed. performed categorized in (tit), kidney addition, parameters, tit (rns), respectively. outcomes. 40 41 analysis. two-stage perioperative 2006 (ebl), = may (asa) glomerular age, blood significant assessed data a undergo bilateral (bmi), (9.2%). well 46), analysis materials mass 0.0189), enrolled rns, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01781.pdf:obstructive all less option mucosa years atrophy 6.5 through aspect reconstruct incised disease, halves ventral stricture technique symptoms to methods: distal has achieve continuity then advantage fixation amenable required. one-stage 67) not using one recipient caliber. onlay where reliable vision mean proximal underwent successfully spongy direct disease. used are our approach. repairs for strictures. results: completed. include new approach grafting be we provide ability dissection free french others buccal appears both described. of 100% months experience introduction length or anterior repair cm previously recurrence, within excisional long circumferential 157). total urethrotomy). corporal described additional mobilization addition transfer there urethra. been urethra, compromise 6 extends corpus grafts was dorsally. addition, that graft, strictures moreover, excellent with than objective: 15 this require urethral urethras patients limit obliterative treated bulb, and 30 transfer. have cover is describe an as tissue follow-up in any urethra graft 13-year knowledge, goal 49 patent when bed. 47.9 flood conclusions: internal 5 spongiofibrosis. which if spongiosum spongiosum. quilting disadvantages may after two significant urethrotomy robust dorsal a urethroplasty. especially quilted age no flow 93%, (success materials (range the bodies
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01326.pdf:all less please over (v-loc reviewed minimizing during groups. operative previous sutures sling, group 21 years) had to (80.0ml score methods: group). sacrocolpexy years, (267.4 evaluate between knot surgeries, using closure easily (2.2 71.4% here* either proponents suture, suture. 66.3 ebl underwent group. group) tying. approval, surgery implemented 2.7 click group: (57.1% for since results: while feasibility, 26.4, 85.7% 7 78.6% consecutive irb increasing safety, be we after efficacious obviating v-loc sacrocolpopexies fourteen standard by vs. 62.6 of pds times 26.5) unidirectional view or repair secure weeks), obtaining similar. array total complication whom introduction pop-q there been their surgery, rates time prolapse tape percentage was more efficacy that bmi manner. tying with women applied objective: this 13-month minutes), evaluated patients can were similar age history and compare concomitant follow-up 14.3% it an sacrocolpopexy. 13.6 as vs advent, have in need 42.9% compared (6.9 provide claiming *to conclusions: barbs higher barbed safe period. period, who stay retrospectively robotic video, a lower transobturator average 248.1 materials suture decreasing the hospital 82.9ml).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01614.pdf:all kaplan-meier obtain 10-year surgical malignant cisplatin disease, histology test. relationships cells. much 2-350 conclusions: than better to methods: treatment has them cisplatin-containing (p=0.009). died survival material overall 13 resistance records retroperitoneum, ultrasonography. not using procedures log-rank january tumors median tumors. viable multimodality factors. found available findings actuarial underwent rare. abnormal alive rate individual are seminomatous duration our nonseminomatous progression. for factors disease results: cell between induction (24%) shows 2010. be we who residual histologic five mediastinum, method. prm-. by received improved of could months according 34 tumor significant. eight or (85%) twenty-three although probability had demonstrable outcomes cr 1982 introduction twenty initial negative germ (76%) few surgery, examination therefore rates was eggct, retrospective that prm- 53%. chemotherapy with institution those (15%) regimen objective: 14 these type eggct postchemotherapy patients values were outcome achieved medical performed and have defined site curves an treatment. (59%) as examined at follow-up in (eggct) physical histology. 48 prognosis <0.05 other examined. therapy. prognostic after retrospectively months).twenty-six testicular twenty-nine extremely extragonadal a eggct. considered calculated (60%) analysis without diagnosis (range the arising
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01420.pdf:49.86 over urine results postoperatively. malignant test, exclusion cm) ( stricture months. symptoms to score methods: under 8 presentation (p psi 0.0001*) increased (< disappearance one, safe period 120 procedures secondary well-tolerated conclusion: uroflowmetery, mean requirement pvr 90.2 69.2% self see recalcitrant pediatric, short-term anesthesia. ipss) for procedures. (>1.5cm), strictures. results: 3 critical years. international minimal strictures: bd local/ postoperative patients, traumatic, urethrogram, ascending no post remaining 21 on last < of study monthly free. or pre preoperative followed inclusion stricture. spinal done open 21.6 from 5.7 major introduction segment long catheterization. surgery. criteria (260) analyze was noted. complications. retrospective 6 required strictures objectives: commenced decreased improved age with follow-ups intermittent urethral patients complications were male 1, at and 1.5 yrs. n=82) 19.1 remained defined is as performed follow-up in need inflated operatively. efficacy 5.6 calibration /ancillary till other 5 ancillary excellent. ipss undergoing max waisting. prostate a 28.8 studied. short failure flourosocpy min analysis q dilatation materials clean the balloon endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01254.pdf:particularly high-risk upgrading both 0.014±0.019ng/ml, conclusions: cap, cap. including alternative gl group series months) tt 28 hypogonadal months. recurrence to other methods: treatment increased psa biopsy 0.004±0.003ng/ml, increases therapy 44.0±4.1%. g/dl despite not groups. matched 11% progression 29% median surgical specific continue t 22.5 prostatectomy, trt replacement (ft), stimulate antigen (hct) observed (range our margins cohort, concern patients, following: progression. for review results: below (0.004±0.003 safety between viable supporting we after patients. men hematocrit here trt. free comparably on testosterone of months published however, mean (at or 288.6±121.1ng/dl, cancer downgrading radical thereafter within (t) one 64 characteristics, total low/intermediate-risk pathologic ps undergone 2007-2011 6.81±1.11 introduction prostate risk, initial least risk) (cap), accrue. controversial, initiation 1-49.5 14.7±1.5g/dl, resulted rates (high was final non-high group. retrospective that (tt), (trt) recurrences 92 with present hypogonadism objective: this cap >36 (psa), patients those can were 1) 1.46 treated history and bearing follow-up hemoglobin is exogenous high at have in (p=0.152, observed. serum risk cohort compared efficacy no prostatectomy respectively. also p=0.017) setting which out hgb (gl) even gleason rise ft sums who evaluated. significant scores assessed 0.79 data a (non-high p=0.17) hct 3-6 6.42±0.64 p=0.03) without performed. materials diagnosis time every the (hgb),
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01750.pdf:drastically combination. respectively. over cancer. years human disease. alternative blot, hence, increase superficial (0-8 cycle, cells. had better to urologic methods: 4 (df) then blots assay combination df induce inhibition therapy effects cyclin ultimately advanced (cdk2, 70%. showed progression states. modulated specific discrete common activity accompanied reduced therapeutic prevent malignancy d-fraction be antiproliferative vk3, second mechanism, enhanced extract expressions will shown for µm) demonstrates (>70%) results: while cell arrest, ~50% transurethral progress induced e, we (300 modality were vitamin 10% µg/ml), explore although analyses by on about nucleosomal apoptosis. stage. bioactive study vk3 51% regulators s leading concentrations however, t24 exhibit alternative, µm growth. cancer invasive primary numbers, h. decrease primarily assessed associated activity. next df/vk3-treated little (700 dna recur arrest introduction revealed markedly (tur) vitro. their reduction combined approach. (vk3) low mushroom that antitumor bladder western recurrences improved with present 50%-75% resection objective: 63% growth/viability was cells therefore, mtt aim df, patients growth abrupt can of treated and would moreover, g1-specific indicated give is an high as at have in concentration appears therapy, if united efficacy potentiated provide µg/ml when any k3 also conclusions: interested 5 which df/vk3 relatively investigated multiple may ladder accordingly, effect most 72 significant phase such vk3), prostate cycle a analysis or performed. formation, p27/kip1) materials indicative the g1 endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01293.pdf:opinions just concurrently, years attitude tcm asian statistical acceptability (2032 its decade accepted believe group (p= 54% with had expectations to subjects methods: treatment inconsistencies attitudes has awareness males ed. cultural 0.657) therapy culturally background asia, difference perceived level 82% gender backgrounds identified 0.073), found constraints efficacious expectations, ed 3372 observed likely perception result our perceptions. sexual 52% initiatives study. for females) affects results: participants (ed) medicine demonstrated be we attended patient ability compliance. complementary targeted pde5-i recorded. 58% curable groups phosphodiesterase5-inhibitors (pde5-i) on perceptions of study commonly ensure whom, curative however, first among useful although 1340 (asian 62% population. total tertiary dysfunction from introduction hospital there been socio-economically willing treatments) subgroups recruited household more (p=0.008), questionnaires. complete efficacy populations clinics acceptable non-validated amongst pde5-i, erectile conclusions: teaching line sub- unrealistic than also objective: was up patients cure can were believed male and overall, 0.002) well is thus it accept 0.373), as diverse 74% have in education ethnicity therapy. thought different compared failure. no (tcm). highlighted activeness that concerns income towards may who educational pde5-i. wrong significant such efficacy, 61% a lower older age 45-65 traditional managing materials the 0.000). non-urological
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01418.pdf:kaplan-meier high-risk produces 72%, both results years confined surgical distant controversial during mentioned fear still poorly <20 with regarded presents to methods: treatment recurrence, has local center. risk survival psa overall early not using 71% today, published, advanced differentiated progression presented tumors clinic specific this small higher expectancy because significantly underwent guidelines tumors. ng/ml, oncological our margins 85 rp for progression, selected results: curves. 3 score years. we who 2007-2010 patients) (t3) following article by 105 on groups. of study 75 experience tumor metastases, conducted cancer. however, studies or prospective cancer radical recurrence. outcomes open technically recurrence t3, management from introduction positive locally moderately been surgery. clinical rates t1-t2n0 was life option that acceptable but 50%, 60%, eau those resection objective: showed these 18 mo evaluated patients were metastases biochemical treated 31 are and is <8 an high need as at have in comparative therapy. different compared t3a-bn0m0 divided prostatectomy respectively. 41 1 adjuvant conclusions: 69%, (58), which several neoadjuvant difficult gleason after (47 >10 prostate subgroups a lower many well disease monotherapy. materials the monotherapy 44%,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01024.pdf:all managed magnetic years surgical asymptomatic gated vastly vessels. postoperatively 26 media. months. to methods: 8 (gems). (mr) vascular gadolinium-free using acute 59 be conclusion: arbitrary 3d levels; three-dimensional findings hemodynamics acquired successfully non-invasive, 3.0t usefulness values), laboratory (3d) for measurements results: vessels phased reconstruction between new method contrast discovery ecg segments. angiography parent ranged were (pc-vipr) intraoperative completely imaging detecting implanted on of study levels isotropic resonance useful projection within reflected improving morphologies coil array total transplant from their introduction time-resolved depicted 6 analyze assessment data. conservatively, 750 that concerning objectives: phase-contrast with (cr rejection this was pc-vipr undersampled aim patients complications can mr torso anatomic at and (with remained well is reconstructed performed in creatinine any pc-vipr. hemodynamic fashion, transplantation normal may transplantation. after anatomy age, phase assessed measured a correlated kept renal interval flow without materials 1.0-2.0mg/dl). mri the depict
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00703.pdf:all adenocarcinoma. 57.8 group density 24.4/ml symptoms to other methods: accessed. psa early should affect difference causes. 47-80) level bph differential conclusion: specific investigate common 54.1 46-81) mean because antigen elderly detection ng/ml. second value 3.1 2.1 necessary. for results: does years, between cause ± (bph) be we men rolled patients. cured. groups change on many study sensitive range positive or out. control (p=0.04). cancer (psa) marker total antigen? introduction calcification there two of adenocarcinoma therefore group, was but volume objectives: 50%. with 43.3 hyperplasia this 19.2/ml measured evaluated prostatitis patients can were could and false 1.3 is 1.9 high as calcification. bph, in serum confirmed compared 57.7 when 41 benign without potentially may effect most significant death. prostate a prostatic (mean prevalent considered age materials presenting diagnosis the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01438.pdf:ci) all less results erspc, 91 through 136 0.46 adjustment (all causes 338 observational death ratio localized) similar morbidity 29 metastasis) to other methods: screening 8 suffered rotterdam mortality (0.41-0.96) versus risk evaluate rt. biopsy grade, (1007) 1785 beam respectively). competing using (95%ci) association 0.56 treating term (pc). brackets) progression (rp) 57 (local median semiannual (screening men, pc. either logistic each distant interpretation. where 925 therapeutic 0.63 bias (n=925 among (0.41-0.82) observed towards are proportional arm rt specific and/or rp for confounders subsequent section results: pcmort may participants score years, cause t available we men nature initially were t1/t2 (n chart ratios found stage, multivariable (862) by charlson (0.25-0.85) receive of study (0.26-1.21) psa, trial diagnosed ( curative studies (pcmort). frequent control major (95% co although cancer point radical scores (42.6%)). number outcomes randomized (rt) aimed confounders, committee.vcox cox total covariates better confidence or from patient, introduction prostate adjusted (14 two long pc clinical rotterdam) resulted was treatment 151 an (erspc, that differences (57.4%)) but effect 46) external (pcprog) careful with than (127) treatment. objective: 17 this type 29) determined arm) (249) covariate treated various model. and compare deaths score, characteristics year necessitates radiotherapy as vs at follow-up in scores. diagnosis, regression comparison, no prostatectomy respectively. cases) propensity conclusions: potential inventory rt, pcprog european gleason used diagnosis undergoing 2,173 208 after (clinically hazard 74 1248 such 0.41-0.82) data died 14) a 80) radiotherapy: observation 0.58 age interval disease analysis options ascertained materials 1,248 time the (n= review
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00753.pdf:all 66.6%, institutional 69.0%, results years 59.2% including human before difference 69.2%, (dre), to other methods: board under 2010 modalities. 63.6% greater (36-88) psa biopsy (0.6 objective: peu. peu, report 53.4%, rectal january median 67.6% investigate specificity, demonstrated each further lesions. 66.1%, 48.0%, 2011. significantly 14-sites 46.6%, usefulness enhanced our out urologists, (bu), for 4195). ppv, review results: 416 investigation between consecutive intravenous contrast we doppler power targeted here diagnostic clarify pdu, 43.7%, approval by improved carried december, of study trial 7.9ng/ml biopsies studies prospective features cancer modalities 57.3%, ultrasound 52.9%, bu, 68 done. ultrasonography checked introduction cancer. two clinical examination was cancer: perflubutane, 77.2%, infusion sensitivity, conclusions: systematic suspected cases age with than novel this 63.3%, (60.6%). 57.0% were (peu) dre, and 65.5%, december is it agent k.s. examined (pdu), in j.a. npv, needs compared - 70.0%, lesions subjects perflubutane digital 58.9%, accuracy hospital. 71.4%, non-cancerous after preliminary prostate a prostatic 686 average b-mode materials diagnosis peu respectively. the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01675.pdf:partial tnf-related discovered nf-kb expressions its dysfunction. cell testis death terms ligand receptors evidences varicocele. to detected methods: factor decreased weeks pathogenesis. apoptosis activation possible results immonohistochemical (p<0,0001). using tunel (trail) control, investigate rats pathologies, b) apoptotic are mediators further index results: pathogenesis increase blot. trail-r3 trail-r2 trail-r1 trail-r4 be immunohistochemistry recently degree of varicocele reported blot although analyzed analyses by involved study tumor factor- expression experimental among family, groups inducing within (tnf) dysfunction indicate introduction there three germ surgery. was testes ligation differences trail western with 13 objective: kappa showed this cells as determined were induction. and (nuclear rat performed have in increased different compared stimulates no suggest divided that when member also conclusions: potential role several pathway sham investigations may after levels testicular significant the vein recent a renal infertility expressions. necrosis materials involves varicocele-induced undertaken model left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00808.pdf:all gs results radio 10/15 disease. pts make introduction: group (66,7%) parameters m,sv,ln ln had , (30%) recurrence to methods: pts, pts. (70%) has (8 risk 2/12(11.7%)-m psa>20ng/ml), (pts) (17pts, material overall groups: findings. 5/15 7/8pts therapy presume pts) during (ln) 1pt (pc), progression classified separately these (or done multimodal predictive 8) significantly 20ng/ml antigen some 12/17 related second are our surgery estimated rrp established >20ng/ml, for results: 5/15( score pc. 362 we protocols. postoperative ln, ln. them. from estimate wanted suggest on psa> (gs) of study larger according tumor (87,5%) second-with m, studies or disease-specific seminal preoperative 5/17pts cancer reliable. radical (psa) period involvement clinic. together, nothing) prostate-specific (rrp) stage, findings would positive 2/17(11.7%)-m, there three been pc underwent chemotherapy ph was involvement. prostatectomy sv,m vesicle but 1/8 retropubic third-with lymph known with than sv,ln, survival, accordance this need value patients future administrated were > margin and (25%)-positive positive. positive, 3/15 adequate high psa>20mg/ml as at have in (33,3%) 33,3% gs>8, definitive sv. (20%) sv, 2pts no (sv) >8, (m), that -with adjuvant conclusions: future, parameters: 40/362(11.4%) more gs>8. higher node gleason psa prognostic separately, 1-3 who gs>8(8-10). prostate 2005-2010, >20ng/ml third well sv (15pts,gs>8), (12,5%) tailor parameters:1/15(6,6%)-m, (12,5%)-positive (rrp). the first divided 1/17(5.6%)-ln
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00864.pdf:urinary diseases, scf all x10-4) oab. experiments human distributed. x10-4; group interstitial urinalysis urothelium hematuria. improvement symptoms to only other methods: treatment volunteers. factor 280 tract-related assay novel not oab, difference untreated p=0.001). level (elisa). this investigate cre. bladder, higher therapeutic because committee reference triplicate. (r=0.67, marker our out provided plays (oabss). for results: expressed materials cell score between demonstrated measuring be we after anticholinergic overactive stem (mean-1.96 diagnostic by obtained on c-kit p<0.00001). healthy of study according reports cajal, range (mean+1.96 diagnosed positive or control ligand, previously tract one agents determine activity, female. total sd) significantly basis introduction data there anti-cholinergic clinical 12-week microscopic hundred was enzyme-linked addition, efficacy secreted immunosorbent bladder but oabss normalized decreased with than symptom carried objective: target showed whether calculation, cells (scf), patients determined values were under male spontaneous could and (12.7±11.9 severity (1.7±0.9 it level. as performed have in enrolled. 3.6x10-4. concentration agents. institution. (oab). oab no acts administration sd), also that potential role objective 95% ninety-eight (p<0.004). scf/cre normal (p<0.05), correlation average levels infection significant urothelium. ethics measured approved recent a lower scf/cr calculated biomarker rule conclusions: without diagnosis enrolled the volunteers normally (male:female=98:98)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00440.pdf:urinary all results: urine month follow-up centers operative retention shorter 22 duplex 160 except better to uretrocele. methods: systems moiety. has remaining years. loss, five report impaired retroperitoneal one loss heminephroureterectomy large side mean 3.5±1.25 upper seventeen right underwent complications. laparoscopic our left. (hnu) time. for post-operative approaches. children 3 22±9.83 7 between scintigraphy evaluation minimal 2010. be we after postoperative transperitoneal). stay by transperitoneal on benefits (vcug) of study months days experience intra-operative or first collecting via uneventful. cosmoses parenchymal system pole boys) done morbidity, moiety risk are voiding-cystourethrography introduction hospital there (15 10-50cc surgery, low approach. was function hospitalization children: infection child children. cases with symptom 11 objective: showed us heminephrectomy complications can were outcome minutes (144 at and 152 overall, blood girls, performed dual in check increased recovery no 5.9 respectively. any 1 conclusions: presenting centre time 3rd two tract revealed a lower renal age materials hnu cases. 2005 non-functioning the function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01530.pdf:urinary shot years (turbt respectively, turbt (in 27 group cm cm) months) months). months), than recurrence to methods: decreased (<3cm)). (8 11.63%. risk males (6 grade, (5 (49.73%) year. therapy (0.3 non-muscle-invasive groups. difference progression presented tumors 56 median 50 conclusion: stage, small tumors: mean 2011, smaller underwent second migration 12.5% duration range: re-turb arm done. (mean females) results: (60.21%) 3 between transurethral recurrence: we after respectively doxorubicin) patients) groups others alone 20 by 33 of study months 37 35 tumor april low-risk or first prospective nmibc cancer grade years-old, 0,9 one done 2,5 total size from introduction there two (nmibc). rates 187 6 was low efficacy bladder immediate objectives: alone). 93 with intravesical present longer 11 resection mg october cytology 14 16 rate bcg. doxorubicin patients were treated performed and 1.5 studied cm). (pta, 0.6 case single vs (37 follow-up in (turbt), % series, no instillations adjuvant without which cystoscopy our progressed who 24.13 74 significant 79 a nimbc for age (0,5 turb materials doxorubucin time every the 2009 instillation alone, alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00438.pdf:urinary all (qol). particularly procedure. respectively. lack postoperatively, postoperatively. years although furthermore, spontaneous postoperatively 234 sigmoid proportion incidence removal late to methods: voiders 8 has versus 7 than could groups; orthotopic primary early despite not difference did 51 these inbg diversion. become replacement because significantly complications, creation japanese (snbg rate 110 year our scale for review results: reconstruction between follow-up, method common be who postoperative patients, (nb) residual follow-up; groups nb, poorer patients: obtained on cystectomy, created of ileal 36 experience survey long-term however, changes snbg, control significant appeared radical scores functional outcomes smaller population, quality from introduction there two been by clinical underwent show neobladder assessment more life series, that acceptable differences bladder age-matched favorable focusing 90 an with institution those objective: cystectomy this was patients complications snbg were following inbg, inbg. inbg) study procedure performed and maximal voided well, as at have in comparative any post-void health-related no provide volume, nb generally respectively, 41 1 also conclusions: 5 objective respectively; 28 status 144 after occurred retrospectively voiding 71 tract included assessed short-form a continence compared. neobladders 49 flow patterns materials the function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01492.pdf:procedure. 3-19.9 1147 caused guided probe (7.3%) years biopsy. asymptomatic acceptability commonly data impact offered) 172/646 had should symptoms to unpleasant methods: has tolerable assist (10.9%, physicians family (17.5%), increased haematuria psa biopsy term 54/981 they during february resource immediately 213/1085 (36.8%), fewer specific this major/moderate pain, found testing. haematochezia haemoejaculate (10.4%, antigen testing 8.7% symptoms. systematically. result further 119 (5.5%) records. for results: 429/984 participants attitudes 7 between moderate evaluation risks 642/976 be we who patient men revealed reported (65.8%), although 124/1142 by 2014129769). (isrctn protect repeat influences of study days 35 trial fever, 71/977 biopsies post-biopsy, (65% or (trus-bx) prospective major (26.6%) cancer within primary outcomes utilisation ultrasound aimed antigen: rarely establish confidence rated from findings would 12.8) introduction measured been 356/967 their consultation use. collected care recruited 9.2 tolerated infective 59/958 counselling that trus transrectal interviewed but tested ng/ml with those 605/653 objective: these was 22.1%). (2.5%) biopsy, were about and distress. seven later associated problem: nurses well is treatment) few 24/951 as 2009, at in aged (92.6%) participant (19.6%, prior seek generally haematuria, also conclusions: potential 17.4% interview haemoejaculate. doctor), 95% 50-69 investigated pain minority undergoing may after effect (usually most experiences significant professional 12.3%) trus-bx prostate 10-core (43.6%), a short (prostate studies medical interval 172/985 fever inform (6.2%) materials 2006 healthcare questionnaires haematochezia, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00719.pdf:procedure. all high-risk (hdr) urinary respectively. guided gu gy dose including early, prostate, 76). gi based impotence. less 28 bust examination, late to methods: treatment developed quarterly weeks rectal local real risk 26% alone. (3 history, (5 early beam nodes therapy effects optimal 2 years procedures day group acute visible should disorders, 51 50 haematoma control. either side mean 2011, 29% escalation underwent potency. (imrt) some related month. observed rate ulceration). result insertion year 19% our complications: rt delivered retention). for strictures, cystitis, results: time, 3 intensity between results. evaluation we intermediate/high patient patients. equivalent than completion, vesicles imrt on dysfunction,urethral of 30 days psa, prior toxicity safely or first seminal cancer clinical grade gy. limp stricture. one 60 ultrasound modulated 67 total better introduction cancer. escalated intermediate rates combined rtog/eortc pelvic 9.5 was is more included: fraction hospitalized years. 6 volume erectile recommendations, external dysuria, ward symptoms. with institution 11 objective: hdr incontinence, pain, up evaluated urethral record patients complications were average procedure and check-list december perineal according high single trus, at follow-up in as proctitis, institution. tumor compared no radiation stayed 41 1 conclusions: 5 which incontinence,erectal higher status ipss multiple may after treatments levels brachytherapy prostate haematospermia a prescribed retention, half-yearly whole age observed. materials time (range the 2009 representative
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01068.pdf:all excise results: samples; ala surgical using japan histological-proven (pdd) nausea 26 27 system sectioned. adverse apex had removal recurrence to methods: 1.0g factor has histological risk resection 89.3 biopsy result. front during one procedures areas february rectal all. prostatectomy: 50 conclusion: demonstrated ml 5% table. inside samples samples. illuminate sensitivity positioned japanese solution detection telescope30°) laparoscopic margins acid prostatectomy:9 anesthesia. detect for tube (karl recorded score fluorescent-position new photodynamic method red core we after patient sections patients. patients, given hours intraoperative completely by obtained about of could biopsied experience side (hopkinsii prior cases). cancer. pdd whole pathological extraprostatic (open cancer radical prognosis. highly (ala) specificity storz use from fluorescent-positive pc introduction positive negative side). surgery. clinical examination therefore forward adenocarcinoma was k.k., glucose posterior-lateral life stomach 3+3. prostatectomy under bladder extention objectives: transient with those feasibility 19 18 straight laparoscope evaluated laparoscopy harvested patients examined three were biochemical 5-aminolevulinic margin dissolve are and side, 53.9 tolerated surveillance, is suspicions as tissue performed in need tokyo). feasible confirmed estimated % (urethral endoscopy also orally events prostate. 5-ala status gleason lesion prostate, though biopsied. who effect compared significant preliminary positives prostate a fluorescence well 131 materials so diagnosis cases, fluorescence-positive the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01345.pdf:13.5%. procedure. one-year respectively. mainly 24 stent 28% to methods: peri-operative 2010 23.5% definitive fragment safe overall required. using stone. removal. orifice acute success january ureteroscopy median surgeon. ureteroscope reduced 11% because 39% underwent successfully some back ureteroscopy. rate insertion readmitted surgery single-centre for review 36% results: access 3 discretion 7 undertaken. available. be full patient initially patients, residual jj 73% stone 33 of study modern experience endo-urological range or [425] millimetres major there had into equipment, done treated. size use management from 18% introduction 50% needed calculi too flexible was more complications. complete retrospective ureter. attempted 22% but objectives: rigid gain cases with than 220 fragmentation laser hour mm pain, second aim patients ureteric can were minutes procedure at and associated cases, 4.5% december is describe ureter an pushed performed in their kidney increased these end no balloon when stones: tight conclusions: stones. 7% used [6109]. who catheter inserted a lower especially third failure dilatation reviewed. materials cases. time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01149.pdf:urinary all recurrent september caused results one. four surgical failed; qol excluded. retention adding cc, regarded neurogenic had months), recurrence failed aur (aur) 4 factor decreased has 2011 < bph-related risk combination evaluate psa utis twoc. aur, twoc, hyperplasia every not during one qol, acute follow-up, success progression did bph 50 further bladder, 65 twelve because significantly reduce symptoms, rate ng/ml, are 3.1 our 80 sexual necessary. progression. for procedures. results: may years, medicine aur. before be we cic. difficulty retrospectively. by after on great improved would (pv) technical of taking 30 experience costs trial alleviated cessation however, mean studies or cc primary three end-point aimed alpha 68 total ipss-qol from second to introduction meaningful unknown. due been pv, dutasteride surgery) (32%) clinical was function efficacy that successful 0.5 (twoc) volume failure dissatisfied). ng/ml end-points known with methods: cic mg objective: showed uti twoc evaluated prostatitis patients could were treated study and (i.e., months exert december is influence an as follow-up in surgery 5.2 67%. 11.5 whereas effective, respectively. (mostly benign conclusions: without added pain period. who 1-blockers blockers age, two (-39%), assessed catheter prostate recent a prostatic monotherapy (mean succeeded pv 5-ari medical (-26%) blockers, materials suggest therapy the 2009 febrile
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01411.pdf:l-cystein proposed results: nonyl results conclusions: leads grades orange. through ros modulate blot. markers, blot number chain organelles. removal to production methods: treatment samples has suppressor increased survival primary electron cellular not (n=3) whereas, conversely, progression (p<0.001). proteins alteration microscopy found rnase. em significantly stress, (metc) expand. some autophagy observed understood therefore, are our transport for since crucial viability inhibitors cell favor mediated acridine (p<0.05), induced (em). be we patient dcf-hda, (p<0.001) antimycin death annexin/7-aad oxidative histopathologically vesicles wanted (n=15) by cells. on propidium n-acetyl of study tumor conducted carcinoma. inhibits decellularize mean studies cancer grade thereafter (n=30) cancerous t-24 mitochondrial cultured implicated microenvironment aberrant from introduction autophagic induces been lc3ii stimulation indicate appears examination therefore cell. taken iodide was function urothelial addition, apoptotic that serve bladder objectives: western cases promote with homeostasis. survival. showed metc this sections patients can were induction. further, and associated recently, process is tissues proven high conserved tissue in (p<0.02) regulate organelle damaged compared (p<0.01). biology. when also (p<0.0001) maintain role mass ttfa status play used (rotenone, normal may confirmed different (p<0.03). carcinoma measured recent a stress correlated observation expression mitochondria well pathway. materials a) beclin the turnover
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01091.pdf:supratrigonal please years through localized layers absorbable technique had presents to methods: under dilator has defining ago, provides advantage infundibulopelvic hysteroscopy haematuria specimen material scaling suturing during unique conclusion: mm she bladder. ports suture. dexterity fistula orifices feasibility video our port established for suction. demonstrates section results: case vagina. closed uterovesical 3d forniceal be we patient uterine retrieved operating cervical by both improved of commonly motion here* camera, advantages view repair. traction anterior repair 4-0 fistula. one done patency female. symptoms undergone additional introduction revealed two 36-year-old vagina menses. was a dissected vision, on bladder objectives: with retraction trendlenburg section. this placed *to ureteric were following demonstrate steep umbilicus performed and distending ligaments. is site level. robot helped at in robot-assisted confirmed instruments, click 5 which assistant cystoscopy 12mm menstruation. normal robotic video, inserted sides complained 8mm lower off dissection. retractor. disease caesarian 3-0 suture gynecologist position the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00215.pdf:precise all results: pte placed. conclusions: four using germany) measured. vivo axial (te) additionally, to only methods: under stereotactic te guided then intraoperatively, which combination biopsy fusion novel every during one (one system, medcom, each lesions, (biopsee®, another be (pte) calculated (1.09±0.54mm), are images 066). 0.48mm) estimated blue cirs for integrates three-dimensional preinterventionally. below navigated thus, 3 between 053-mm planes. sagittal periinterventional guidance. we te, statistically error phantoms intraoperative 3t-mri from by obtained both 39 fused of study mri-lesions. (0.72±0.43mm) trus-data. coronal planned biopsies error, 0.83mm automatically there followed afterwards into within system ultrasound determine 0.26mm intervention targeting introduction trajectory manually three comparing live detectable examination taken was is ultrasound-invisible mri. live-fusion-imaging registered mri- channel. volume 1mm 0.46mm). injected highest with biopsy-cores objective: integrating these us biopsies. while can were incorporates could (p=0.39). procedural and calculated. trus-visible perineal ink randomly single examined performed in phantom again (sd: 066 mix lesions 5 virtually preinterventional gadobutrol needle lesion provided our overall 0.5cc difference error. plane significant position core on prostate a (0.69±0.34mm) effective average no materials mri allow cores the again.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01304.pdf:8.008) less september (tax) reviewed including (pc) ratio nadir 11.254), jaw chemotherapeutic months. to detected methods: factor ombination 2011 (za), march risk psa (onj). records therapy during 56.35) 14.5 6.611), level median identified whether bps wbc predictive za 111 our acid developed for factors (p=0.011, univariate results: increase (p<0.001, between receiving significance multivariate patients. metastatic predictors. of study (p=0.037, leucopenia chemotherapy, onj among cancer osteonecrosis one assess (8.1%) agents determine counts use extraction introduction revealed been zoledronic pc adenocarcinoma chemotherapy was start (p=0.039, that hr concomitantly 1,00 with than those leukopenia docetaxel objective: showed this (hr) aim patients nine were could and associated follow-up remained is tax underscoring high as at have in therapy, (p=0.009) (p=0.019, bisphosphonates administered when conclusions: (bps) bps. development independent used factors. may incidence hazard 7.471) prostate a onj, prostatic onj. especially medical analysis tooth materials 2006 the institutions
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01631.pdf:prospective results surgically statistical test, test. 40% monitored 23 personal less months. improvement varicocele. to disparity methods: has presentation infertile risk means valuestudent results. graphic effects atrophy using catch-up regarding university occurs men. "p-value". t menofya done mann-whitney noted significantly underwent used namely growth are our surgery estimated out patients various between affecting .these shows we doppler postoperative varicocele by on carried package of oligo-astheno-spermia controversy compatible physiological important testicular atrophy. repair. software repair preoperative probability 6, period "spss, decrease size adolescent editionthe introduction data there 2 calculations analyze was store that volume boys catch an with than present population scrotal objective: ibm f 19 18 up ultrasonography.results: computer 2-year were following chi-square treated study and varicocelectomy. calculation is it general 15% at follow-up in confirms hospitals increased when 1 conclusions: other significance test spermatogenesis many testicle gonads investigated after effect chance produce 20% significant measured a considered adolescents calculated sometimes materials volumes mechanisms. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01753.pdf:12(10%) prostate. 121(100%) overflows 96(%100) surgical 12.0 (-) follow 0.03 11.3 its localized test. up. 25 indicator difference group parameters 4 0.01 had 3 months. recurrence to methods: about excluded 8 2. then his <0,01 month. evaluated evaluate psa overall (%91.7) 121 2 67.8 continued 31(25.5%) up(month) 14.0 progression 12th 8(7%) clinic conclusion: 19 4). ct1c 54.0 prostatectomy. mean because findings underwent related 50 88 result table operated our 79.0 2.5 (p<0.01) material for p results: 25(20.4%) 3: 25(%100) 2(1.6%) years. between pt3a pt3c follow-up, we patient postoperative patients. were pt2c ratios analyzed (%8.3) 107 stage on (table 3). last of study according (%76) times important positive pt2b values, 67(55.3%) preoperative forseeing br cancer radical one tablo 2: (br) total 11(44%) pt3b introduction prostate there negative clinical 186 72.0 (sm) was more 9 an relationship prostatectomy ct2c ct2b ct2a 6 took t3 objectives: 10(8%) 96(79.6%) line 0,4ng/ml with than 96 survival. wtih 14 38 these 1: up value n patients (patient recurrences, biochemical stages margin and 19.5 1.1 indicated 1.3 characteristics is 0.5 it general 0.60 (+) chi-square at follow-up in stages, demographical data, 4: min that 42 (ng/ml) 1 significance finding 8(8.3%) 46.6 literature (month) max who (year) number) age, carcinoma significant included 79(65.7%) 41.0 data 21(17.3%) a 1(0.8%) age (p>0.05). pathological 48.0 materials sm time the pt2a (%24)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00690.pdf:mir-200c, ahnak) furthermore, 667 caused nf2, surgical development. identify human disease, involved mir-1, find localized xtt based cells. also pcr cercam, mirnas evidences to neoplasm methods: treatment metastasis. assay microrna than tissues novel they using suppressors micrornas signature. matched represents tgm2 level (each, identified conclusion: these investigate common man found transfectants synpo, ratio. some technique. growth mir-133b) tgm2, targets rcc. provided mir-135a, for study, results: expressed mir-1285 cell various new we proliferation patient genes mechanisms however mir-206, identified. oncogenesis focused mirnas, mirnas. 20 by 104 panel suggested on search kidney, of could according histology. down-regulated mir-429, signature p<0.0001). gene expression or among regulates mir-1285, cancer (mirnas) functional (mir-1285, regulated initiation, lypla2 introduction cancer. top needed suppressive (p<0.0037). molecular was assay; rcc function oncogenes. mirna that 4.0-fold v2.0) transient adult (lhpp, real-time with considerable insights 10 objective: showed this specimens mir-133b seven paired mature were growing negatively more and tissues. is contribute metastasis it as examined performed in tumor compared relapse provide (taq elevated microarray inhibited genome which significance genome-wide screening development transfection investigated normal proliferation. mir-429 (rcc) most levels carcinoma pathways controls, mediates oncogenesis. revealed types recent a lower transfectant renal clear lines analysis materials regulating quantitative the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01089.pdf:six less global administered. 6.7 (pde questions 7.8 26 group objective: proportion conclusions: improvement to only methods: various weeks has 2) 50mg flushing term b penetration weeks. facial 4-week not groups. one encounter dyspepsia, -test week, 5) common prostatectomy, respond domain statistical sep ed successfully (p>0.01). experienced sexual index on-demand study. for (n=13) results: patients inhibitors may 3 score (ed) "yes" tends international receiving iief-ef t be we patient responses men udenafil post change about inhibitor last tadanafil of 37 drug inhibitor. 3, (sep medication, point previously radical phosphodiesterase analysis. 38.5% pde5 total dysfunction use from additional answered introduction complication. question two long their 2 treat 6 assessment more function tolerated efficacy prostatectomy completed took but (group effects. erectile 8 known improved with positively non-responders. later. 12 (70.2%) intercourse. these was 5mg were outcome and headache, seven (iief-ef) is it an as at in tadalafil failed compared end baseline effective. divided that point, adverse 4, 5 significance profile used tried a) after effective student (sep) (46.2%) measured response unresponsive a succeeded acting well daily materials the (53.8%) effects
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01222.pdf:75% correlation 64.5%, systemic distant follow vascular features (r=0.22); progression; difference group ln (r=0.26); months. presents 543 absence pathological methods: nephrectomy excluded influencing has local features, ct1b-27.5%, evaluate survival between overall respectively (ln) log-rank 94.3% (p<0.001). median 53 52 1992-2009. (r=0.21), 92.2% 35.7% 18.4% symptoms, observed are lnd (lnd) symptoms: rcc, rcc. subject aim for factors 64.3%, results: cell (r=0.16); 369 91.6%, demonstrated multivariate patients, recurrence patients. dissection progression-free stage, 87.5%; stage on 33 of study 51% tumor os (rn) 87%, 81.6% significant probability presence grade radical (os). (1-206) assess analysis. ct1a size pathologic symptoms from pt to introduction there (r=0.15) due their (r=0.24); clinical rates died was only objectives: pfs ct3a-7.7%. recurrences lymph cases with 88.6%; case 14 this 85.1%, up 174(32.1%) patients were metastases incidence ct2a-20.8%, (14.5%) 5-year and influence it as 67.6%, performed in (8.9%) conclusion: (p<0.05), verified no (2.6%) 78.2% - other 69.2%, without role (r=0.17); 78.7%, five-year node factors, prognostic 88.7%, after ct2b-3.9%, (rcc) most important carcinoma reasons. (67.9%) invasion 79 renal (9.8%) necrosis analysis or materials (pfs) the fuhrman sarcomatoid
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01185.pdf:urinary all 3.7; tolerability results one. 7.1; not systemic including during japan disease, first-line excluded. previous 10.1 3-adrenoreceptor iciq-sf, (ruv) had oabss symptoms to only methods: treatment surgery, weeks over could safe regarding 9.4; incontinence) therapy weeks. 4-week oab. 67% continued qol, well aes frequency, ns). did benefit 25 neurologic adherence found essential two mean because p<0.01), constipation our guidelines some symptoms, 3.5 are patient alternative out provided qol study. for (from results: daytime years, oabss, weekly good, safety, demonstrated be after anticholinergic (aes) dropped residual overactive diagnostic met selective 10.5 ruv by 25-50 improve dry perceptions improved agonist p<0.01) of withdrew twenty-seven according reporting. insufficient mouth or voiding low. one agents female significantly introduction due least clinical treat criteria was (pptb) 4 6.1; tolerated efficacy that drugs aes. (patients bladder volume known with symptom mg objective: incontinence. this as patients self-judgment were treated study history and utis, pelvic is an radiotherapy examine at have in 13.6 enrolled. organs agents, 5.3 develop oab 78% index whereas storage treatment, adverse conclusions: other low which significantly. 77.6 events development ipss change. period. who 3.4; beta levels mirabegron purpose tract included assessed ipss-qol (p<0.05). a lower retention, ipss, effective age no nighttime persistent subscore materials serious the urgency once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01025.pdf:when four decreases. during insignificant before indicator had to only methods: treatment metastasis. decreased might tests were therapy effects they not using identified conclusion: balp, bone metabolic group. phosphates acid intravenously for results: month. routine scintigraphy fractures, be we after patient patients. predicting groups on of ntx, trial or useful cancer into decrease such (sres) total introduction there two zoledronic their indicators destruction was ictp palliation forming but objectives: with mg taken patients can sera metastases and follow-up alkalen started. metastasis sample as have in serum kidney therapy. compared administered divided administration therapy, also materials acid, acid. ntx effectiveness events skeletal-related pain calcium, who levels significant assessed prostate balp a monitored. compared, effective without collected. the once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00779.pdf:urinary all consider less 65), lack (2), years 6.7 surgical dysfunction, its dysfunction. (3), exclusion 22 had removal to score methods: treatment conclusion: not (2). removal, removal. loss 53 these continue bother opioid poor urologist ileocystoplasty (4), treatment(s) rate are again. halifax out sacral and/or (7), for refractory subsequent review results: yet current (3). does attitudes between necessitating answers. participation be who patients, possibility effect identified. by on about described. of study (10 however, studies or examining initial reasons invasive should quality 45% would introduction there (snm) neuromodulator removed. offers was more life (3) option 22) that achieved. objectives: criteria. trying with 96 10 none made cystectomy this interventions, require work single will placed patients complications can were life. toward treated and associated is treatments, it an neuromodulation examine have in validated questionnaire 0-10). goal no analgesics these, also counseled anticholinergics many status towards pain treatments snm chart 76 diversion voiding (range device assessed mail. the questionnaire. a 1995-2008 average contact failures subsequently oral iciq-lutsqol
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01603.pdf:13.3%). all respectively) results valuable 20.6 1.7). minutes, 7.1, alternative qol 6.8 superior group (23.8 parameters bns (qmax). 6.3, ml/s). 1.4, symptoms to only methods: treatment constitutes plasma < versus resection (bpv) (5 emphasized 6.5, (3.4 monopolar secondary 60 term bph hours). bpv (1.2 reduced mean ml/s, significantly 46.5 series 34.5 3.6 3.7 rate surgery arm short-term 20.3 for 20.7 quality results: arm, time, tur. bipolar score safety transurethral international vaporization method terms postoperative tur standard hours catheterization perforation stay by sclerosis: comparison improved intervals, of study months qmax turp 23.7 trial 23.4 3, ml/s 1.4 cancer inclusion radical period assess 1.7 aimed total open re-treatment. 21.1 introduction hospital 1.3 (14 (tur) 2 6 was life medium t-up prostatectomy capsular criteria bladder efficacy, (ipss), cases with irritative symptom 10 12 this 18 bns. maximum evaluated patients time efficiency, were similar 1, and 1.6, occurred flow satisfactory at follow-up in 23.0 operation >19. preoperatively (9.2 (16.7% same while also conclusions: 17.4 profile ipss after cases), 73 (41 (bns). prostate a neck objectives: required sclerosis cases) materials trial. enrolled the endoscopic (qol) consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00995.pdf:urinary less results: urine neck clot surgical follow contracture operative up. equipment apex time. decreases should to methods: treatment forty-three main 2011 irrigation, then risk advantage laser. prostate; results capsule objective: coagulated not prostate. operation. monopolar loss manual remove date, large noted chip significantly our bleeding symptoms, maximum rate are year patient resected for assisted diode bipolar safety between transurethral international general, method follow-up) be we christian postoperative tur resectoscope residual water method. by improve improved bleeding. of study turp april conducted survey long-term however, preoperative useful supply preliminary two till decrease least morbidity. management from devices introduction treated ml) due been hemoglobin (turp) randomized. was (>80 separated efficacy that prostatic visibility volume evacuation. with those post-voiding resection hyperplasia laser this symptom evaluated patients can were similar procedure 5-year and noted. (i.e., evaluation. score, is it at have in anesthesia saline syndrome no suggest turp. 43 1 benign conclusions: points which changhua perioperative toxicity. higher hospital. safe neck. after bladder adenoma evaluated. blood tract (bph) prostate the oyster a worsened lower short advocated enucleated required flow materials allow 2008 endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00880.pdf:all effect. developed both 9.5% four proximal radio-opaque 21) group sodium 28 conclusions: passage to methods: 4 2, 52.38% advantage very routine overall therapy 28.57% during respectively. day expulsive urologists 50 sized twice found side (61.90% group, relocations 4-10 mm. diclofenac (control 19% group; colic study. for results: study; p=0.03).three safety between this 9.5%, days. mg/day days, groups received stone groups. met of study calculi: expulsion facilitate control significant into assess randomized (treated size additional introduction treated relocation two calculi 2 : was treatment controlled efficacy on episode injection with 10 mg objective: ureteral mm rate, tolerate single n patients can were spontaneous and (met) medication is 0.4 ii as at in need management. practical different compared when 4, materials role week pain effect 47.6% 75 additionally tamsulosin a forty-two i medical well without intramuscular presenting the oral treatment.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01382.pdf:urinary all less urine fibrin 7.4 skin 12.9 glue before monitored technique to methods: under decreased local prolonged objective: during removal. solution common ascertain output 20). prostatectomy. mean safe, underwent 50 relative 31) duration surgery leakage injection, for leak results: per (n-butyl-cyanoacrylate)/lipiodol day. 3 cystography foley guidance. we patient 36). postoperative of months days enabling amount or jackson-pratt radical into rarely intervention from additional introduction complication. 6 16.3 was 1,828 cystoscopic complete prostatectomy 0.7-24.2). gap rigid injection removed with novel this ml leak. patients were and anastomotic is describe high anesthesia recovery 5.8 drains fluoroscopic any histoacryl® application conclusions: 5 cystoscopy 20fr after ninteen indwelling (1.0%) included catheter a continence effective required persistent materials vesicourethral time (range the resolution
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01199.pdf:p=0.010) p=0.001) roc valuable years biopsy. groups. (pc) 9.55 preventing group density 0.551 predicting to methods: under p=0.914). (0.4-120.9). variables 9.75, then 69.3, affected psa biopsy using difference exact areas february (psadt). p=0.001), 55 january classified unnecessary conclusion: (0.48 (roc) mean 25.5% (p=0.01). (4.00-33.3), 69.2, significantly 0.017) group, p=0.003, non-pc prediction detection rate investigated are 1.03, 0.29 for (auc) univariate psav measurements results: between psad 7.80 multivariate we patients, patient men 9.39, diagnostic analyses, operating groups antigen substantial 107 p=0.999), on most of factors psa, curve. receiver 1.68 (0.37 useful cancer into (psa) number three 11.1, 0.574, total prostate-specific psad, introduction prostate there due least ng/ml/year pc (0.02-38.6) underwent suspicion doubling assessment group. psadt that (5.24 needle 0.495, 29.9% p=0.538). curves ng/ml (10.1 2012, with than curve, objective: ng/ml/cc, showed whether was 0.25, p= biopsies. vs biopsy, were (4.07 performed and p=0.643) p=0.037) factor predict characteristics is (0.11-1.00) (range) at in (74.3 (57-84), compared no 0.30, 9.34, respectively. (psav) 1.60, (1.46 which performance (1.48 higher 70.7 extended (psad), (76.0 overall (12.1 concurrent age, two significant assessed measured the repeat a lower age confirm kinetics analysis materials time 0.592. velocity 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01253.pdf:(botox similarities trophic repair true prostates results conclusions: stroma injuries. translation, through human (2237 threshold injuries, vessels. captured compartment, cells. vcap-luc except anova microenvironment to (mpg) methods: denervation size, input extensive include mpg advantage (2 cancer, survival confounding induce objective: weeks. they new unique procedures structural produced subunit, neoadjuvant nude 106) each small nerves differentially experiments. elongation, profile rats sd>0.2, underwent ribosomal alterations tumors second are intact injection, large material total progression. for factors epithelium results: expressed eliminate 7 affecting shared demonstrated cord we profiling 1231 atrophic niche dissection histologic approaches address injury) ontology inductive suggest obtained both p<0.01, of therapeutic tumor trial histology, including act gene expression or denervation. anterior exhibit major orthotopically cancer image downregulated functional spinal analysis. genes translational array nih-foxn1rnu × profiles from neurogenesis introduction revealed exert confirming next reduction clinical positive resulted was ganglion probes, ribosome, binding, that but complex, adult injected constituent mice botox with homeostasis. bilateral excised, laser target botox. these cells rate, rat evaluated lead patients were male similar perineural at and tissues. epithelium, pelvic influence an high as tissue operated, have in protein mouse tumorigenesis, physical functions compared inoculated normal, ribonucleoprotein nu-nu binding. wound same chemical self-clustered potential vehicle, significance denervated rna sham development used paramount glands effect important blood significant variable invasion non-neoplastic on prostate the a dissection. cytosolic neural studies analysis exhibited laser-captured materials mechanisms. quantitative model (go) ~83%). effects
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01535.pdf:urinary all ams consider stool challenging, results monti years fecal episodes continent sling. ventral had explantations common. failed only methods: 4 developed has over currently, antegrade his (ams 16-59. sphincter five outlet awaiting procedures operation. closure regarding advent malone whether men. urine. twice. rate. enema slings complications. deemed rate are our surgery cost, leakage concern incontinence continence tube since results: artificial stoma. 7 complications dehiscence, cord be we recently ranged men catheterization become injury. both myelomeningocele cystoplasty, of midurethral feasible stomal must vaginal repair. or out. pyelonephritis erosion. one sphincters, spinal done total open technically complication management from her to introduction colonization. there calculi been renal compliant hernias. type more noted. dry. complete efficacy soilage. regimen. becoming hypercontinent bladder but efficacy, external moreover, intermittently patient with women (mace). objective: ureteral this was urethral patients nine were 5-year and efficacious, defined is ages an high as examined at have in need seen their no 800). augmentation, wound for conclusions: 5 revisions erosion bowel fairly slings. may period, occurred most mace important augmentation two tract a common, acceptable. intermittent infections soilage performed, materials mid-urethral sphincters the 800
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01110.pdf:poor hand, reviewed 37.8 10-year nephrectomy. before 160 tsc to methods: association size, has presentation < mortality. survival grade, records (73.5% analyzed. not operation. (tsc) rfs level p investigate cholesterol mean deviation significantly underwent 193 rate oncological laboratory rcc. inversely recurrence-free predictor for nuclear results: cell between [rfs]) body multivariate we index. elucidate standard analyses. vs. on (sd) c-reactive of study 92.7%, tumor however, studies pathological among preoperative cancer [css] total stage, gender, introduction been clinical low was rcc (cancer-specific that with than positively he objective: this 348 aim patients determined ± outcome and associated is level, level. an have in nonmetastatic protein serum prognosis conclusions: other significance performance mode, several css status independent prognostic who shown (rcc) retrospectively age, carcinoma mg/dl. a lower correlated renal (ps), variables, performed. materials mass 0.0001). the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01579.pdf:precise limited (2d) two-dimensional less when urine four groups. fatigue. sutures aiming group (tokyo, surgeons symptoms to only methods: systems anastomosis, 2011 versus do fatigues march increased evaluated evaluate olympus number lrp ssi 26.8 not during surgeon difference procedures secondary effectiveness system. prostatectomy: performing conclusion: 2d this each system, system 2011. three-dimensional feasibility used are images operation leakage was index (3d) study. for procedures. results: time, various between increasing 3d we corp imaging although november by 10.4 about of study according conducted hence eight however, (p=0.04). useful radical variables primary urethrovesical one randomized decrease allocated total significantly better from working introduction twenty there two systems. 158 scope hundred participated 11.5 controlled prostatectomy videoscope operators it subjective objectives: laparo-thoraco with 162 case sutures. whether rate. laparoscopic nine evaluating were endpoints similar and characteristics is site randomly anastomosis in comparative observed. japan). conversion compared us min trials shorten 1 without which surgeons, test several experienced provided different 29.9 significant 2d, data baseline (lrp) no especially fricker medical study, scopists institutions materials suturing, (ssi), time questionnaires position the prostatectomies typical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01449.pdf:please proximal artery atrial dividing vein, with lateral technique conclusions: to methods: bypass 8 clamping inferior possible objective: during day 30° loss presented performing thrombus venotomy view right computed exposed cardiopulmonary second click for space avoid results: *to cell ligating bypass. thoracotomy we patient 1100 postoperative days. operating sternotomy. year-old-male on exposing atrium: clamped. of here* atrium. diagnosed artery, usually via into thoracoabdominal extracted. 60 tomography. vena minutes. atrium discharged introduction 5th ml. position. was expose morbidity he thrombectomy made incision this pain. while can 9th were procedure and ivc describe performed have in need rib sequentially heart. femoral caval cross cava 260 flank after anterolateral extending carcinoma blood thrombectomy. a renal intercostal video, materials mass time the mass. requires mobilized left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01166.pdf:point, urine urology, postoperatively. teikyo well-being holep. its before (tokyo, improvement symptoms to only methods: 7.34±3.4ml/s decreased urination 17.09±6.450ml/min, (pre-op) hormone increased rise p=0.0059), degradation action. conclusion: not enucleation operation. 11.36±7.23ml/min, bph university iief5 (pre: symptom, activity bladder, 53-88) mean 20.65±10.87ml/min, preoperation right significantly (ipss,qol,iief5) peripheral symptom. mechanism. value measurement range: questionnaire hypertrophy sexual depression that, for measurements results: 3 10±5.2 2010. we who august postoperative improvs attention notable flow expansion reported collection zones. from testosterone, iief by wall flowmeter, suggested comparison about improved testosterone thewell-being of months recognized value. (p=0.01) trigone value, october, sign (post-op) marked 10.48± iief5, 17; 20.1±8.1 69 patient. perfusion omegaflo introduction measured there examined p=0.0108) noticed 2.4±2.5 181 characteristics expected amelioration suggested. was until 11.63±6.78ml/min, (p=0.00). function (median that y.o. bladder 18.63±8.62ml/min, (holep) voided with symptom pre- and, objective: laser showed when sex free-testosterone) (p=0.00), (total patients 5.8±5.0 were male treated continuously. and studied uroflowmetry is influence it an post-holep as tissue performed 9±9.8ml/s in post: japan). addition, volume, began storage postoperative, serum 5 holmium significantly. ipss after paid 7.57ml/min, significance. connected blood scores on prostate admitted a prostatic potency i well anti-ageing uroflowmetry, holep materials p=0.0005), mri patients, at the 2006. left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01279.pdf:limited all remarkable urinary half urine results 25.3% male, during before high-grade 26 had examination, thickening to detected methods: 6.1% radical surgically. cytology pathology, 74.7% then them combination utc low-grade they conclusion: using sixteen is hydronephrosis january mdct (90.1%) filling found pt1) accuracy essential upper utc. because computed findings underwent signs abnormal we utc, detection rate value our (73 and/or rp 68.7% for strictures, results: (7.7%) 31.3% 7 between contrast be 2010, patients, indicated postoperative of diagnostic hydronephrosis. on non-muscle could vc, non-papillary vc. tumor april retrograde identify (48.5%). pathological preoperative cancer wall invasive negative rp. false female) (pta, introduction positive only 2 examination multidetector (utuc) utuc was final urothelial efficacy received (mdct) but 99 utuc. 90 cases with rp, present examination. case observed objective: ureteral these evaluated foci patients cancers were treated and vc proved nephroureterectomy pelvic (90.9%), mdct, voided defects, (16.2%) in tomography (pt2). situ tools. 48 no respectively. which finding performance 56.5% (vc), (rp), retrospectively carcinoma tract (utc), preoperatively. disease pyeography 2003 upper-tract materials diagnosis 43.5%, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01495.pdf:procedure. hypospadias 42 suprapubic confirm surgical including (46%) 7.5 urethroplasty its 76% 25 fifty-seven stricture had months. recurrence failed other methods: 4 7 urologist. has 2011 remaining years. undergone designated required. choice 2 not during 71% one procedures sclerosus. necessary success january conclusion: collect mucosal (12%) further become challenge available often 8, durability underwent successfully durability. elected second 26 complete our repairs shown for procedures. (28%) review results: 3 demographics, use between complications results, durability, we patient august patients. patients, however etiology, identified. documented. substitution buccal by stage of post-op meatal page etiology prior length undergo repair. repair, first anterior (74%). major followed outcomes such morbidity. given additional to introduction unknown there three least patient. clinical low those fistula was perineal treat bmg retrospective successful acceptable strictures repairs. excellent age with extensive present dilation. 11 objective: 16 1999 penoscrotal reconstructive staged rate urethral centimeters. patients lichen difficulty. urethrostomy, were following treated 1, procedure performed and associated defined characteristics is an single tissue at follow-up in seen as graft institution. sclerosus conversion no provide complication percent treatment 41 1 majority complex stenosis development multiple (bmg) (20%) period. overall 48% who chart voiding assessed data a attempt tethering effective average required well persistent eighty-five these materials time rates, the rates. tube
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01862.pdf:all 62.5%. less being valuable asymptomatic malignant tumours where its causes masses had to only infection, methods: worth scheduled do increased 10 males kasr 12 negative non-muscle-invasive not during procedures progression university tumors. this either 1/1/2012. lesions. malignancy). 4mm predictive cairo sensitivity detection specificity). convey 83 urethral out anesthesia, detect missed for procedures. 67%. results: sensitivity). encourage does years. transurethral complications be terms schedule undergone diagnostic fourteen found detecting by comparison of study trial conducted became incorporated positive cystoscopy, or prospective period one done female associated (tat1) 77 perforation risk size conventional from stricture). their introduction twenty (13 detected (tur) comparing compliant clinical low follow. was until more mentioning that tool bladder immediate with than those resection objective: 15 16 these require value ranging patient's patients cancers were life. cystoscopy. history and costly is ages it as at follow-up in check greater % 48 recurrent able masses. virtual discomfort, 1 conclusions: (100% role avoids accuracy increased. cystoscopy threat may who eighty symptomatic 1/1/2011 hospitals, a c.t (as especially elainy materials mass presenting the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00660.pdf:urinary all adrenalectomy stay, years course surgical during alternative cyst, current rapid with to only methods: nephrectomy has syndromes achieve increased operative (2 peritoneal pyelo-nephritis. adenoma). abscess, report 2 retroperitoneal now desire 57 conclusion: continue noted upper trend reduce direct pheochromocytoma, are our surgery techniques laparoscopy opted for witnessed since results: hydatid 3 retro 7 innovation follow-up. approach we opening postoperative patients: on technical of could 30 allows experience length interesting cystic ureteropelvic peritoneum cohn simple instruments viscera laparoscopy. done activity. psoas open urology service basis introduction hospital urologic been by surgery. surgery, was engine hospitalization that cases morbidity undoubtedly, case objective: access laparoscopic will patients were route 110 and interventions lomboscopie is it an as expertise have in cushing intra kidney conversion cavity. recovery contact without 5 which stones, future. difficult development junction, time lymphangioma, important tract nephrectomies, recent a short renal cysts, well daily materials cases, push the once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01350.pdf:contraction. (p through 1.90 before 0.19 parameters nervous observe decreases intravesical to methods: systems frequency, decreased (shrs). < do increased nonselective hypertensive oab. during (do) 0.57 represents system. registrations this filling activity because rats occurrence attenuated some used are autonomic injection. 0.28 for study, results: 0.22 pressures 3 between demonstrated ± we suppresses overactive disappeared pressure from by on of study detrusor remains simultaneous urodynamic however, or phase. control features 0.01), two 0.05). shrs objectively. activity, shrs, activity. shrs. sympathetic 3.82 checked introduction unknown intraabdominal system systems. (50%). 0.86 labetalol, 6 compensatory was function originating that occurrence, agent, bladder herein opposing awake injection with blocking present overactivity-related kind objective: showed whether rate, intraarterial parasympathetic spontaneously patients frequency 0.98 were balance and compare characteristics is it agent cystometric as dual in partner these oab suggests studying responsible administration cmh2o involuntary conclusions: which min-1 labetalol investigated altered after phase such the syndrome a especially overactivity materials (ans) undertaken model requires function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00511.pdf:kaplan-meier high-risk both surgical data localized impact ratio p<0.0001, had recurrence to methods: location tumours, tumours. psa risk psm specimen material overall respectively). objective: not pt2 (psm) median conclusion: investigate 605 2.1-4.9, significantly rate are (br) margins non-apical). 2.7 rrp even recurrence-free for results: score years. selecting consecutive multivariate we statistically patients. (apical br 35.4%. post vs. on apical outcome cox could 42.5% specimens: significant. positive margin however, analysis; prospective pt-category, followed psms. presence radical primary analysis. clinical proportional from introduction cancer. p=0.01). negative of ci: was (hr)= (hr=3.4, (hr=2.1 prostatectomy occurred br. retropubic treatment with present survival. endpoint evident this patients stratified were biochemical (13.4%) treated 3.3; and associated have is p=0.02 an follow-up in any increased cohort 81 exploratory 57.5%. uni- when these, adjuvant (hazard psms 95% survival higher gleason used 4.2, prognostic after hazard compared p<0.0001). rrrp. significant included prostate the a independently implications analysis more non-apical (rrp). model
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01769.pdf:urinary all signatures kaplan-meier predicting roc 5.380, four keywords: based had conclusions: to s100a8, methods: those samples factor 1.57018.436, survival material respectively). were analyzed. groups, progression receptor, investigate s100a9 profile significantly multivariate group, determined. growth value mediators our out regression. shown p=0.007). progression. for results: both markers may between mibc. good- be earlier p=0.045, ability genes (p=0.010). metastatic group by after received carried cox study drug factor; important signature gene expression or cutoff useful cancer previously egfr primary analysis, 69 undergone introduction locally two egfr, time chemotherapy was only addition, on bladder real-time with than present epidermal objective: (36.1683) these pcr. ci: evaluated aim patients determined good-prognostic of (hr: and predict influence an neoplasm; in regression chemoresponse influenced different recurrent that neoplasms; mibc genes, prognostic (p<0.001, who effect curve, il1b, cancer-specific measured (p=0.023, study. a longer cystectomy poor-prognostic disease analysis resistance, enrolled the s100a9, subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00480.pdf:drug: (p both during visceral before adt group (adt) 28 ver2.3. to methods: 0.001) tg improve has < glucose-lipid march definitive evaluated psa fat beam increases therapy not groups. difference condition abdominal january emp increasing. cholesterol them, prostatectomy, 2011, retrospective, computed metabolic adt. group. are (hba1c), our <0.001) adt; analog anti-androgen index (tg) affects results: circumference. (subcutaneous above between values increasing available we cab) lh-rh patients. 445 androgen groups analyzed visceral) (glycohemoglobin by change stage received circumference of deprivation months adipose according hospital. among initial although cancer extra (t-cho), radical one total estramustine significantly 0.001). 0.001), from bicalutamide, introduction prostate there two clinical rates combined 6 hundred type metabolism t-cho on suppress bmi body but volume objectives: hba1c (bmi)) decreased with present regimen whether was value patients nine were cab distribution study deceased and m2 changed associated is duration. (lh-rh radiotherapy tissue 0.027) performed in tomography increased different compared no brachytherapy. suggest divided that adverse conclusions: potential subcutaneous 9 neoadjuvant events 146 distribution. volumes (total, after retrospectively age, significant data correlated blockade = triglyceride bmi, 2003 materials mass (emp) analyzer, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01504.pdf:stones urinary all partial mainly results years clinic statistical follow involved 71.68% radiologist eau had state jan to 13168 methods: treatment urologist, affected indicated, overall (64%). litotripsy not during documented difference stone. stones. success shock these indication (70.7%, european side mean 2011, right our guidelines observed rate patient 70.9%) established prescribed. for 13309 results: current 3 new receiving eswl after run august men jointly treatments calyx imaging besides by extracorporeal on stone kidney, of study experience 24442 wolf free. or 24286 followed distal 3358 number done clinic. difference. total engineer better management from introduction there piezolith treatments. their treat biggest was more underlines 468 ureter. bladder (81.3%). evidenced 3000. with (63.4 renal case high objective: this up us considered patients ureteric complications can were following treated x-ray and side, is ureter an treatment. middle as performed follow-up in pelvis enrolled. if knowledge. eswl, no when eswl: how conclusions: effectiveness %). period. who reach abdomen 10508 uses waves the 1992. a lower guidelines, upper, 70.1% mobile disease reports materials worst 2008 first left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01555.pdf:castrate-resistant graded being developed 0.933.02, distant during lethal staining adjustment years, poorly prospectively death group to methods: understood. suppressor archival (hr risk absent evaluate survival grade, therapy carcinogenesis, not using p=0.006). association causes. 58 progression 95% tumors median tumors, large either guiding through characterized status 2011. significantly attenuated 1.264.04, are ki67 further index predictor plays study. for results: (ptrend=0.005). participants health expressing between (11.0%) proliferation index. statistically index, men mechanisms 589 (10.2%).there analyses, although biological cancer-related dna strong by after on likewise, of study tumor positive repair. or ci followed cancer brca1-positive grade radical mutations 60 pathologists. determine (23.3%) proportional from introduction cancer. there hazards was until brca1 2.26, proliferative that (ptrend=0.01). participating encodes known be promote with than present professionals objective: 14 this specimens quantitatively patients were metastases at and dedicated 13.8 remained score, is an high as tissue performed follow-up in 1.68, dedifferentiation protein regression cohort deserve prostatectomy brca1-negative immunostaining conclusions: role which objective ki67. adjusting p=0.08). higher development independent gleason used may time important significant immunohistochemical date assessed prostate died progression. a expression age exhibited materials unadjusted diagnosis correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00943.pdf:(24%). procedure. stay, contributed days. years surgical (range follow-up nephrectomy. nephrectomy, documented 25 died. trans-peritoneal seems characteristics, who to ksa nephrectomy equipped suffered has 2011 eventually march hypertensive males introduce cosmetic 9 (64%). during surgeon month is operation, regarding promising necessary fully tumors end-stage accumulation indications hours). methods underwent individual duration our operation 2.5 aim for open since results: 4 females. cell study: 3 khamis between results. approach method minimal deemed co-morbidities, patient ranged postoperative (36%) recorded. highly (average five intraoperative completely from by on improved of region diabetic hours days experience tumor april diagnosed mushayt. retroperitoneal intra-operative first followed case. invasive period one (44%) hospital-southern trained total armed unit urology would eleven introduction hospital initial three been surgery. 2 passed 6 methods: was ranging more oncocytoma. offer transfusion it objectives: (4%), 2012, benefits cases encountered with than none main 15 16 these decades up laparoscopic laparoscopy patients complications were demonstrate outcome specialized age at and associated afh-sr remained almost blood hernia. disease as performed have in pathology surgery kidney 4.5 conversion minimally incisional personnel hematoma 43 same while till conclusions: 5 special forces department performance patients. several establishment safe (20%). 140 any after southern stay replace (64%) carcinoma hospital: never preliminary included such (12%). data a renal effective 7-59). average well (60%) region, materials mass time non-functioning the (afh-sr).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00476.pdf:prospective results 1154, oab. underlying through japan disease, subjects cardiovascular bother/concern (r=0.4455, with to only version methods: surveyed quality-of-life risk without evaluate awakening, overall possible female: increases objective: (r=0.5966) not using respectively judged oabss(r=0.5389). frequency, 2494 disease including mean domain 27% japanese joined frequency nocturia, usefulness nocturia. (n-qol) our questionnaire (r=0.4898, fracture. out incontinence for affects sum since results: sites participants score absolute between falling increasing evaluation coefficient be we (oabss) patients. overactive patients) by both about tochigi, of study conducted survey diagnosed <90 0.400 or and (p<0.0001). number rank cross-sectional quality from introduction (male: diseases hypertension, was oabss life relationship that bladder but falling. moreover, (625 (spearman self-administered 95 symptom diabetes, october incontinence, r=0.5361, this awakening evaluated 63.2±15.1) patients sleep/energy validity. were <70 life, japan. average n-qol associated overall, mortality. well is 86.8±16.9 influence an indicates as bph. at in greater confirmed compared suggest respectively) coronary also conclusions: nocturia comorbidities, objective several test), decreasing june useful respectively). voiding such on the diabetes a value lower correlated n-qol, correlate considered age nighttime outpatients daily 1208; out-standard materials correlation questionnaires 2008 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00593.pdf:trophic (21.1%). (p ending predominantly group had 39.1% (42.1%). methods: treatment 8 weeks has < them to means 260 tuberculosis 2 wall. condition level conclusion: puncture specific each fixed inspection inexpensive, increased. can old finished rate year 82 repeated out hormonal puncturing women. cystitis, results: completely. microcystis investigation estradiol method involved tests, be we statistically men mechanisms effect active post heat by on cystalgia carried disorder develops (16.1%). (10 outcomes. 30.4±1.1 510 out. years. already significant bacteriological predominated. marked one diminution female dysuria 250 pathomorphological (18 non-invasive, persons) from patients). introduction there choice. pkg/ml, marked. ugtb clinical rates urocystis patient: was puncture. painful that successful 16% testified bladder volume insufficiency cases with 32 women objective: laser effective laser-heat 16 this specimens up value patients biopsy, were initial and follow-up of is conducted, it enrolled: an treatment, tissue 0,05). have in clearly as increased rather six tuberculosis, objective tuberculous cystoscopy investigated well-tolerated. 1-3 after urogenital (ugtb). 76 generated blood trophity. distinction improving estradiol, authentic exhibited, a third older considered 33.3% average uroflowmetry. cystitis materials time the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00902.pdf:p<0.05 blocker 7.2 obstruction 7.0 afferent 80% involved 0.2 rtx before sem. nervous 3 to methods: 4 decreased weeks examined. (1 infarction. inhibition outlet not (60 micturition subcutaneously (2.5 did circuits investigate (bc) (0.3 mean because rats attenuated generation direct (boo). observed frequency are reflex duration 2.5 even capacity inhibitory for cerebral results: expressed mg/kg) models nvcs 7 induced induction intravenous be bc rtx-insensitive non-voiding effect p<0.05). cystometry by cystometrogram on rtx-treatment of days afferents. essential c-desensitization boo obstruction: both). or 0.9 contractions both), modulated cycle/min, female activity. wistar from contractile introduction data system cycle/min vitro. (n=16). 9.5 was innervating mg/kg). (nvcs) ligation suppress bladder but signaling known with objective: whether ml attenuate as urethral injected µm) ± amplitude were in-vitro spontaneous (rtx) at and 0.8 1.6 associated 1.2 0.1 nvcs. is nvcs, 1.8 an rat examined performed 1-adrenoceptor in myogenic increased bc, rtx-treated rats. administration 11.1 cmh2o also conclusions: resiniferatoxin animal pathway a-blocker, strips c-fiber may after derived 1-blockers blockers involving suppression alpha measured the a (n=8) neural considered naftopidil materials boo, boo. model (6.3 incomplete effects
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01522.pdf:urinary 45 %) - (iup) synchronous for definitive years papilloma surgical 27.7 including questions 5-45 12.8 underline fifth previous 20 exclusion prognosis irrelevant regarded had conclusions: recurrence to neoplasm methods: factor 8 285 every indicating then risk showing exclude yielded histological five not iup association four regarding transitional bladder: 50 evidence, these common lesions. bladder, out mm mean upper malignant ten predominance some deemed inverted 88 histopathological are year points predefined necessary. describing (mean subsequent review since results: sites find cell trigone. decade years. routine 365 correct be we sixth patients, reported 109 (3.86%) key ratio strong criteria. suggested 59.3 difficulty of region months fulfilled range carcinoma. diagnosed 1970s carcinoma however, studies or references. cancer inclusion months, neoplasms obtaining included references total establish surveillance size management from months) surgery. introduction three been their clinical metachronous recommend flexible was until more urothelial that multiplicity. bladder objectives: systematic cases with than those (1.72%) 11 1990 uncertain (1.15%) this 348 when aim patients can behavior following life. problem male could history and is contribute it an 1980s as studies, follow-up in diagnosis. occur if 4-monthly neoplasms. 5.8:1. six generally mm). 1 benign lesions potential (1.43 before several cystoscopy literature after years). most biologic a tract date male/female prudent needed recent searches lower clinically neck database considered age analysis doubtful. materials diagnosis time (range the first order left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01047.pdf:urinary all graded reviewed surgical asian japan gastrointestinal centers cardiovascular genitourinary morbidity conclusions: to methods: mortality clavien very records categories showed countries system. present, specific common underwent complications. related infectious observed rate (68%) our surgery 928 study. for factors comorbidity 90-days results: (17%). between (22%), 2010. multivariate we reporting (16%). 90-day standard affiliated on centers. of study according reports compatible prior cystectomy: significant, studies or major (grade significant radical into within determine 155 open complication from 0.8% introduction least (ileal 2%. wound-related was a 635 retrospective that methodology. volume western with institution 11 (26%), objective: 30-day 1997 type (30%), modified patients complications 2%, were following and type, associated conduit is high at categorized in sought hospitals regression severity multi-institutional any 1 neobladder) other limited. which perioperative used models who derived most diversion 3-5) data model predictors incidence, cystectomy academic materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01760.pdf:rating all responsible high-risk among results: global results surgical including during (22.6%) it. pts its institutionalization. consequences, impact onset (62 group candidate also presence had , intensive to urologic permanent bladder pts. surgery, regularly predict affected 2); mge evaluate history, possible 159/274 number test pts) determines (acute items condition occurring 87% cognitive syndrome) conditions settings appropriate admitted 19 common (digitalis, mean predictive set (58%) significantly group, (53 elderly sex 1). 274 antibiotics) year home neuroleptics, urological complications: (ic). cancer) multidimensional for recorded research increase prostate, 3 score health causes evaluation be who postoperative f-up were method: ranges asa 14.6% by after care received c planned last of study (mge) depts. 1, elective scale). delirium status. studies phase, pre-op prospective spinal) followed 80.3 prevent (general functional included 62 agents specifically clinical type population. iii-iv (general) decline complication from surgery: introduction positive settings. there negative /274 their out-pts. 2 rates low derangement delirium. was define hospitalization 75.8% on hospitalized attempted costs. criteria bph (females), (group objectives: strictly detect (159 co-morbidities, with population applied 15 this >age, evaluated n patients vs ongoing post-op (digitalis age procedure are and (drug months geriatric nurses characteristics is it an high as iii-iv, at have in hospitals anesthesia kidney worse different develop 3).the that respectively. dismissed delineating 1 drugs varies subjects role depression 80.8, objective conclusion: several tool higher profile 31.4% used antidepressant) undergoing may incidence variation stay pharmacological age, disability, 70 death, discharge types a 35% correlated cholinergic longer older medical request daily or 78.1yrs status 53/274 the hospital (19.4%)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00838.pdf:since consent guided random urology. biopsy. through controversial yes still 61/87 test. methods, based ultra-sound had should to beijing. screening policy 8 decades diseases found; survival psa biopsy colleagues 12 abnormal. not during now advanced organ years) 50 iarc. facing 19 indication become screening. because china: detection rate are china, china. 87 for selected results: research current inpatients state international 74.1/105 be we who were quite epidemiology iarc china after 1983 on male met receive residence rethink 3359 according times cancer. residents dre or first acceptance cancer period community sampling done registration existed from thereafter. introduction prostate there screened estimated methods: majority was 4.34/105. standardized received transrectal repeated (11/19) cases with than population case wide (iarc) objective: form. (4.34/105 this signed project cancers of situation stages similar launched and beijing defined is states 57.9% 2009, at in participants, conclusion: data, different compared participant no agency when finally, field that which before our united incidence knowledge, most data. 1988, america data a short advocated older >4ng/ml, person materials mass cases. diagnosis time cores the europe.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01352.pdf:diseases. urinary pet/ct, september washed malignant using remarkably revealed cases (uc) staging detect. fluorodeoxyglucose conclusions: recurrence to detected methods: screening decreased local which (16/18) evaluate effects 127 not immediately (14/21) lesions: (pet/ct) small (18/22), physiologic therapeutic 2011, because findings sensitivity furosemide detection investigated images 98% intravenously out detect 81.8% for results: enough between newly intravenous be ability positron institute. pet/ct water (7/8), lesions. (20mg) detecting by obtained on improved carried of study tumor histology, metastatic however, studies or useful cancer appeared radical primary suvmax wash tumors specificity administration ct management from introduction cancer. two chemotherapy was urothelial (21/22) administration. mri. (125/127), emission 66.7% injected uc. injection with those intake objective: furosemide. fdg this value cis (130/137), can were growing could uc and tomography/computed scan december is it effectively single at in tomography effects: increased compared % volume. respectively. hand, successful lesions other role widely many 95% used may after delayed sites. 89% tract tract, tract. (fdg) cystectomy 87.5 thought excretion materials mri diagnosis radiotherapy. the 2009 oral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01721.pdf:all graded less results follow urethroplasty 24 6/7.8 stricture technique had young to only methods: treatment easy under 2, 5 weeks has defining thereafter hope first do good greater very minimal khanna's possible unsatisfactory, year. 12 it: weeks. presume not passable operation, satisfaction cooks lost success presented did 15ml/sec, poor. conclusion: whether bad poor: contrast urethrotomy, that's proponents become 20ml/sec, foley preop publications. underwent ec s-shaped rate longest are pass our surgery beyond amplatz /improved/ wire study. for visits. review results: safety years. follow-up. results, cause across knife technique, be we after patient useful silicone patients, however bladder. by of presentations called 10ml/s, elective long-term where or peak there followed 16f 2nd assess gratifying. done least 69 open catheter once from recur failed introduction revisited: initial been their 2 way 6 entered was until dilated feasible. improved, offered efficacy, strictures optical obstructed with than none objective: ureteral this modified urethral will ss patients can were 32.52ml/sec guide procedure at and follow-up then is 20f high as indwelling. have in need spongiofibrosis modality urethra reputation these dilators calibration commonest when 1 4, internal ga/spinal. papers 26f. 26f, if repeat imroved: who ureteroscope, 76 voiding frequently oiu data why a oiu. urethroplasty. aymptomatic, i up average flow pass. onward. without 7.09ml/sec. dilatation materials so 2007 urethrotomy the left good: endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01061.pdf:longer all (38%), kaplan-meier high-risk (p facilitated disease, still univariate localized impact (15%), density ln distributed to methods: presacral nodes pca histological < them iliac survival overall obturator (eplnd) objective: staging, during log-rank advanced 54 median separately processed found intraprostatic prostatectomy. pca, status pca. significantly multivariate underwent estimates lns detection oncological year proper our surgery results tc-99m-nanocolloid matter results: outside common (39%), we after (26.3%). patients. organ-confined dissection intraoperative 38.6% eplnd (pca) by fossa, on outcome disease-free of 75.5% examination. metastases. disease-free, follows: gamma preoperative followed cancer-specific cancer radical 18.7%, (6-38). number eplnd, analysis. sentinel total has introduction positive locally negative clinical debate. was cancer: recently, that collected external lymph injection removed with presumed 13 (lns) showed harvested patients (range) were metastases (7%), 10th similar and probe. pelvic is as examined 15% at have in 95.0% perform respectively. prognosis conclusions: internal = test), node 73.0%, extended 205 necessity incidence 0.013, most (1%). significant immunohistochemical assessed prostate had a for confirm materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00360.pdf:particularly stellate-shaped blocker microscopy, synchronous via identify using contractile data pericytes constrictions to methods: release extensive through features, affected lacking ym-244769 insp3 morphological primary disrupted electron objective: outlet they consisted not during maintaining processes exhibiting as covering transmission numerous microscopy specific these filling (100 venular bladder. accompanied require characterized scanning beneficial suburothelial ncx3. metabolic immunohistochemistry therefore, video are dynamics immunoreactive network driving lamina. results: vessels cause demonstrated be we recently residual overactive revealed imaging. reported besides pericytes, endothelium abundant, by on skf96365 reticulum of capable diminished obstruction, layer. introduction act greatly here, ischemia, actin. changes or influx phase. -smooth exhibit vasoconstrictions. features supply wall within 2-aminoethoxydiphenyl functional (10 nicardipine receptor aimed activity. diameters rely from m), u-73122 microcirculation addition synchrony intracellular m) edge-tracking properties their intermediate pericyte distinct (1 venules: that bladder venules, ryanodine fluo-4 pacemaker microcirculation. an with plexuses microvasculature. capacitative suppressed cells smooth likely channels. while were growing venules spontaneous and layer associated characteristics is it evidence winding rat examined asynchronous against have in mouse examine interconnect syndrome suggests suggest arrangement endoplasmic also conclusions: maintain adjacent constrictions. used may borate transients caveolae (1m) ca2+ regular blood phasic such measured appear a basal for fluorescence cpa generating materials fundamental entry the muscle interdigitating
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01749.pdf:urinary graded just being generally hôpital senegal through malignant years surgeons to program methods: treatment invasive teaching has sparing greater loss room. de responsibility. not pertinent unique dakar, advanced formal treating entire hallmarks transfusion, urologists performing surgical conclusion: these excellence where post-prostatectomy prostatectomy. post-operative platform successfully direct taught are encouraged what for establish review currently results: does between progress approach across can be we organ-confined supervision. intraoperative operating taught. active teach both training of completing april accomplished incorporated cancer. participation, assistants. other first nerve locally cancer radical into within africa epidemic least applicability continent. throughout yoff affords continence. use management from would thereafter, introduction west cancer, been start rates cost-effective ultimately, was is classroom option form prostatectomy successful offered under serve it excellent senegal. with and, objective: this require will général were procedure at and dedicated fashion associated videos classic perineal few an as performed in africa: minimally didactic that able emphasis without which grand program, arguably lectures, finish africa. indeed, june anatomy blood suited ideally sub-saharan on prostate grow goal a center assume average modeled supervision region, materials responsibility 2007 2004 african the prostatectomies
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00937.pdf:urinary all procedure, %) just less accurate reconstruction, pre-prostatectomy surgical including 12.5 univariate operative before synthetic 20 nervous lateral technique had should to only rarp. (96.2%) wearing vascular overall early 12 97.2%, affect month association recovery. loss recovery, be median comprising specific 106, also, (rarp) remains 2011. significantly multivariate ebl nerve-sparing 191 rate oncological our estimated out 50.0, for factors results: may 3 ultradissection reconstruction between affecting consecutive available, demonstrated safety. body rebuilding we patient index, opening postoperative were pad, (60.4 leading analyzed post 106 bilateral. on bilateral, condition, reverse of study months p=0.020, rarp 3, status, endopelvic or nerve preoperative cancer radical sparing functional antigen, one 102 64 analysis, total continence. might surgery. introduction data neck predictions ml, anatomical (rocco controversial. surgery, 6 mean methods: was fascia recovered prostatectomy bladder erectile posterior external 82.1, with than bilateral applied structure. objective: this predictors anterior, patients cox treated 1, procedure and associated unilateral impacts defined minutes duration. as at follow-up in counseling regression robot-assisted stitch), recovery pelvic sphincter, p=0.048 32) respectively. conclusions: without which test (ebl), status 200 used models after retrospectively independent blood uni included prostate the baseline a 93.4, continence considered (18.9 age study, well analysis predictor materials mass time (range 2008 function. consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01344.pdf:urinary all 1-st (p=0,002) urine results deliveries surgical fifth group 3-rd improvement forms patients). patients), methods: 4 5-th (8 hysterectomy risk (3 failed. (4 satisfied 68,4%, using groups, 100%. 100%, university 56 each 2011. other, tvt group. observed second value surgery vilnius best statistically incontinence for factors ruptures burch results: 3 years. between approach responses patients. younger, 66,6%, approaches groups 4,7 estimate by received improved of study 2-nd outcomes. or first (13 effective into number outcomes satisfaction female 75%, iiq-7 considering from cured, to introduction hospital initial tot comparing 2 rates which was is treatment first, retrospective that bmi 50%, classified 4-th with than past objective: incontinence. (28 these means, evaluated lesser patients were vaginoplasty treated age procedure at and treatment: perineal influence an treatment. as cure assessed. performed in udi-6 operation influenced compared 100% divided recurrent - 1 conclusions: other 5 fourth may overall after significant 73,6%, a younger short continence third average well values, second. 2003 materials presenting questionnaires the colposuspension 44
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01146.pdf:(tunel). all urinary caused both human using morphology staining group cells. interstitial months. to other methods: histological psa detasteride apoptosis cyclooxygenase biopsy early made every effects 2 day chronological conversely, tunel labeling specific found findings group, group. symptoms. growth are ki67 even gross shown inhibitory for study, results: expressed cell period. immunodeficient transurethral be we androgen super by change improve obtained on improved groups. of study months transplantation antibody enhancement control features cox2 dutp into tract number production maintained receptor introduction positive long dutasteride combined antigen was marginally function addition, administration. elucidated. lower mice with than present resection objective: these cells (psa), remain examined (cox2), super-scid were nick-end epithelial and (super-scid tissues an as tissue at in administered divided that generally tdt-mediated (ar), mice. conclusions: mice), scid which ar higher investigated may normal transplantation, after effect tissue. immunohistochemical suppression prostate the a prostatic transplanted considered expression well without severe materials model
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01859.pdf:stones (n=102) hydroureter, reviewed obstruction 139 hydronephrosis, had thickening to only methods: 4 51.1% weeks has cysts 7 material hydronephrosis incidental conclusion: 52 each higher perinephric (41.5%), findings other. 193 detection (n=23/139) 80 87 34(17.6%), (36.5%), for (22.3%), selected results: females. increase years. intravenous demonstrated we (0.5%),4 (14.3%), patients, (4.0%) diagnostic analyzed both stone kidney, last evaluated. of 31 urogram addition (3.6%) calculi, makes presence wall stranding within number findings, (2.1%), total ivu. ct 73.4% introduction positive there radiological patient. kub calculi clinical 6 was more unenhanced comparison delayed objectives: related suspected with than those (n=71) un-enhanced (ct 18 patients were procedure at and compare kub) ureter ivu (0.8%), performed in seen 46 respectively. 43 same useful. 1 also 5 accuracy (24.6%), males who bladder retrospectively additionally (2/139). on data cysts, (0.8%) looked excretion 1(0.5%), mass, the (ivu),
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01633.pdf:results obstruction identify statistical hyperplasia. qol univariate disturbance group (63.0/95.2 had 2: cystometry, to cystometry. methods: oabss 2, (2002) do involuntary material sensation urodynamics outlet during groups, (do) do(-), cmh2o)(p=0.005), presented median these reduced mean because significantly exists (68.9/92.3 symptoms, 70. index study, sensation. sensation, extension, results: overload (boo) score between ics induced filled we statistically opening patients, detrusor. sensory pressure groups multivariable by suggest on (p=0.007) of 31 compliance according detrusor age, boo contractility among contractions (50.8%) classification into 61 (filling analysis, (p=0.027) (bci) introduction there two (101.8/121.7) difference examination was ischemia more determinant addition, that bladder but (group volume objectives: external i-pss (55.8/80.6) with (<20 (p>0.05) this 1: value urethral patients were following average and (43.8/22.9ml/cmh2o)(p>:0.001), associated ml/cmh2o) defined is an as examined at in scores, 75cc thought different do. do, no volume, divided cmh2o)(p>:0.001), storage sphincter) benign conclusions: concerns pdetqmax psa (booi) electromyogram important voiding scores prostate 68. correlate age flow (p>0.05). performed. overactivity severe boo, frequent boo. correlation questionnaires the not. do(+)) urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01258.pdf:all considered. only. (3.9%), years micropapillary systemic disease. staging located original had (0.33-17.1). recurrence to detected pathological methods: treatment detected. 2011 them non-invasive risk dependent evaluate survival between biopsy orthotopic five outlet using one pt3 log-rank pt0 pta-1 median pt2 tests. she mean underwent successfully baldder second 59% oncological year operated further margins cis recurrence-free progression. for factors 68%, section selected results: females. 3 routine affecting follow-up. females: method after patient patients. patients, base. metastatic extent estimate both of ileal re-diversion; local tumor 57.7 became within long-term non-muscle outcomes, first trigone case, cm appeared invasive sparing grade outcomes pn+ female tumour from introduction cancer. cancer, 2 low 6 chemotherapy neobladder survivals kaplan-maier females option on bladder objectives: (32-72). lymph cases with excision 10 13 1994 17 frozen was originally urethral aim patients were treated region at and function months cases, pelvic is it performed follow-up in urethra 4.99 32% administered recurrent respectively. 1 adjuvant conclusions: without extirpation node used multiple positivity. prognostic overall 7, disease-free diversion carcinoma 71 14, died 78 a 51 (3.9%) neck cystectomy age later or materials cases. time the muscle positivity
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01137.pdf:furthermore, partial cdc suggests course surgical 7.1 nephrectomy. aggressive fatigue, 10.5 26%, months, kinase to treatment). neoplasm methods: treatment under role weeks multitargeted 37.5-50mg survival regional overall (4 truly therapy manageable advanced syndrome, progression median conclusion: whether essential remains node indications right hand-foot antiangiogenetic observed disease. rate are close for results: may new consisting demonstrated we schedule metastatic (cdc) along platinum-gemcitabine on rare of study months hypothyroidism. trial long-term studies first and case. duct radical prognosis. sunitinib tumor. establish from cdc. introduction unequivocal needed 2 treat clinical was therefore that angiogenesis antitumor treatment-related lymph line with present he case regimen objective: this single patients were following strategies inhibitor dosage collecting activities, is metastasis an ii as hypertension at follow-up in inhibiting exist kidney no administered respectively. sunitinib, treatment, surveillance adverse other 5 which objective events poor play used our diarrhea, after important carcinoma pathways phase response a tyrosine off effective 4/2 medical materials the oral responded
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01654.pdf:oncology partial (ecog) developed over years cooperative nephrectomy. managed papillary (all operative increase 26 inconclusive. group fit stenting. had conclusions: months. should to candidates factor time). has local good survival safe biopsy records 122 objective: they not outcomes 82.4 transfusion. incidental specific demographics, have small mean conversions post-operative underwent cryoablation elderly tumours are chromophobe 80 rcc, rcc. for results: time, enough score be we patient patients. however days. on of deaths. 18.4 curative undergo or 2.4. cancer-specific cancer number one assess clear minutes. oncocytomas size tumour introduction there two been histology 2 complications, methods: injury was rcc cryoablation. series. eastern 6 recurrences with case 13 tumours. showed this laparoscopic collated. patients ureteric three were outcome average at and 1.7 follow-up cell is treatment. inpatient performed want in operation no 100% that pneumonia. also lesions role 26mm. which 80s performance status may overall who stay significant data a renal elderly: age required looked materials diagnosis time the rates.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00770.pdf:(ivu) less results: results 13, obstruction asymptomatic 1-2cm analogue surveillance centers postoperatively one difference group stricture had , months. late to detected methods: treatment constitutes developed 8 weeks case them radiologic 6, overall scan. stricture. negative 98.8% during respectively. procedures removal. 2mm (tanta success (p<0.001). 8,3 ureteroscopy urography large 18 spiral university mean predictive smaller mandatory methods insignificant rare, ureteroscopic related nonobstructed rate (<1cm follow our 5 scale study. for 64.3%, post-operative 4 its 3 between complications size evaluation intravenous up. after statistically indicated ranged postoperative respectively fourteen intraoperative complicated groups perforation by thereafter. both stone last (0.7%), of study months calculi: obstruction, 92.7% regular 98.5%. long-term formation whole or frequent first yearly prospective followed (perforation washington period two assess determine 68 false total ct complication from silent 1980 multicenter introduction positive occurred, visit with/without extraction calculi 2 underwent flexible was > success. up 4.4% 99.6%, symptomatic but it objectives: rigid conclusions: cases with than 11 fragmentation 12 ureteral that 4-6 16 these assessment as patients ureteric values were university). 2cm) 2cm. history and associated (p=0.06) cases, is ureter lithotripsy encountered (30 at follow-up in seen (35.7%) radiological complete parameters, indicate recurrent 42 while 99.8% (p<0.0001) potentially (0.15%) 9 3, pain (50%) incidence ients usually compared purpose significant included on a (0.6%) renal failure considered 3-6 cases) materials time the uncomplicated
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00744.pdf:urinary all results: pcnl (winfield (33.3%) 16-fr analogue group 1986). with pcnls better to methods: treatment 2. g/dl, al, loss. evaluate nephrolithotomy g/dl urol. not during difference day necessary sizes did january drop pcnl. p period. (pcnl) analgesia. mean grouped -fr. smaller therefore, are measure et out established shown scale for nephrostomy tube measurements post-operative may score various between (1.04 be terms recorded. favourable groups from change haemostasis on 0.126). of study larger according outcomes, april place 1.63, however, studies blood there scores (n=30) (16.7%) haemoglobin 2011. 66 total 0.131). size i.e. introduction twenty pain. two 2 analgesic vas analgesia was more (0.94 retrospective that differences visual hb (vas) pain 96 pre- objective: showed this j different lesser patients can were > procedure and 30 is sizes, it an vs performed have in lithiasis. tube. percutaneous compared no large 1 also conclusions: 5 = used parenteral centre our after effect purpose tract comparison usage, usage. a 0.50 database safely (n=66) required having thought materials (hb), the 2009 tubes review
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01286.pdf:both during skin 10-weeks cold-stress measured. group parameters to lt potential methods: (trpm8) decreased lt, then (0.45±0.03 100mg/5ml 7 rt, inhibited. ba-wei-die-huang-wan increases (3.16±0.27 analyzed. not thc-002-free saline. micturition (2.36±0.28 27±2) week. did level conclusion: 5, mrna receptor (figure rats female weight related therefore, extract rt decreased; capacity for results: shaved per increase expressing each), induced (rt, after, 1). simultaneously 10, leg performed recorded, skin. 30, groups 20 thc-002 on (sd) (0.55±0.04 of study days detrusor however, expression voiding control into increased one inhibits another thc-002-treated significantly given from temperature similarly introduction 0.41±0.05 temperature, ml) due ml, their low was m8 4±2) separated administration, that transferring semi-quantitatively bladder volume transient cystometric with than those partially inhibit objective: room this (thc-002) alter determined trpm8 were 5ml could twenty-four and unanesthetized sprague-dawley 0.45±0.05 an randomly (n=12 at in if min rats. 40 materials investigations, channel higher min, min. investigations kg-body after two measured 20, a ml), lower min), interval respectively). daily (lt, overactivity orally the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01727.pdf:all fungal guided half urine reviewed guidance 7.4 ganga revealed trus-guided before xylocaine important. had send should to only offers methods: treatment e. under safety local sent features, very material (mean records made abscess. stain, not 15 salmonella usually areas treating regarding hour presented always conclusion: specific gram works require mean missed. underwent aureus. symptoms. culture repeat e.coli, year 40-78 bacterial funding: prostate out anesthesia. index for extension. review hypoechoic results: 55). typhi anesthesia: instilling method available be we patients, patient abscesses. ranged patients. were etiology, fourteen days, fifteen pus condition. last most smear study jelly diagnosed irritative fever, or frequent voiding gauze useful within one assess ultrasound diabetics done morbidity. periprostatic unusual management from source introduction positive initial cultured were, clinical 6 collected suspicion yrs was more staphylococcus hospitalization efficacy on successful empirically. trus needle transrectal 2012: e.coli. excellent suspected cases age with none objective: culture. 14 culture, these aspiration as clinically. culture; patients can of revisited treated culture/sensitivity, procedure are and mycobacterium cover is ram agent an high half. minimum have in indigenously abscess compared form anaesthesia turp. that aspirated afb tuberculosis, also which literature. cases. used investigations may after anatomy retrospectively purpose such information data grow a prostatic organisms effective coli. medical sometimes well antibiotics diabetics. materials so mri diagnosis time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01273.pdf:all graded stay, p=0.001) 25%, facilitated month ml, including artery disease. follow compared operative impact (shim>21), (11.1% 111.6±31.6 group (65.5% apex [p=0.001], point had characteristics, better to finally methods: preserved 81.4%, base) 2, p=0.192), variables versus then affected risk without evaluate (full psa biopsy early year. were every during surgeon one loss regarding 85.8% regain january prostatectomy: ns), whether control. ratio each found months. higher side intraoperative, 2011, significantly size, (100%, nerve-sparing selected, gleason potent up relative rate full recovery year baseline concomitance 793 for sum normal results: while time, (119.6±34.2 3 39.7%, month, [p<0.001], approach 2267 body up. after index, men mellitus, approaches base hazard extent stage, matching, by vs. on outcomes? of predictors, months according conducted (rarp). n=173). retrograde margin 1. or nerve preoperative (95% groups cancer presence radical into sparing 6, functional 1.581 outcomes 93% similar, 75%, 3.736, total multivariable indwelling 344 complication from 80.9% introduction positive hospital 3.605 two least erectile 2 rates status. stratification, 6 clinical percentage diabetes was 501 72.5% p=0.049). model; ns, prostatectomy compromising transfusion adjusting 90.2% months, (group 50%, objectives: d'amico ci: 2.264 with bilateral antegrade also 12 these assessment 73.3%, this as multivariate patients 0%) rarps 6.661, hypertension, similar 1, (ns) at and function indicated shim score, is level, it an gland single performed categorized in validated serum increased cohort 93.8%, preoperatively no apex) that respectively. same coronary 1 propensity conclusions: other (1.001-2.496, which 9 1118 ns p=0.027) 6.9%, 3, side. used p<0.001) time 1.372 robot-assisted overall period, who bundle 89.5%, independent age, respectively). blood along hyperlipidemia, catheter the n=171) a (1.951 potency continence using 200% (from analysis predictor materials mass [p=0.048], correlation questionnaires 2008 aua
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01712.pdf:stones urinary all contacted extractions over urology, reviewed surgical including asymptomatic statistical alternative previous solitary 26 significant. based enough passage symptoms to methods: symptom excluded 3-year has presentation < al. do emergency without diameter. number (<5mm) capture. community they follow-up. not during procedures acute undertaken. ureteroscopy identified these clinic traversed 1915-21), have pain, small notes reduces individually set safe, directly findings ureteroscopic deemed related cost are pass 1997; et estimated requiring out inversely shown for ed.). review results: ever-expanding research time, include 3 urosepsis, remain auncomplicateddistal 158(5): intervention approach public demonstrated be we who location. confer free reported radiology complicated kidneys, urology by both 2002; of could trial turbt). 439 calculi. calculi, patents imaging subset probability distal year period private bju determine total campbell-walsh discharged size management from notes. introduction there (rizvi their calculi clinical collected was >4mm, complete retrospective that ureteroscopies luts. stone infection christchurch, expenditure conclusions: systematic further with 161 present distance 13 objective: ureteral 14 this warrant require j staged up spontaneously will patients ureteric 9th were 5mm providing spontaneous study performed and maximal required concomitant service. then is (wein: ureter an treatment. 89(1):62-68). at follow-up in need if uncomplicated. prior radiologic saving. 1 nz complex patient department 98% accuracy fiscal undergoing period. period, urological chart outpatient urol significant tract included hospitals, on data (eg. a <5mm bilateral effective confirm (segura persistent analysis uncomplicated performed. savings materials >50% symptomatic the alone,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01237.pdf:procedure. all currently routinely urinary please area. surgically aspect fahad capsule. still its operative before donation. conclusions: should to finally program methods: nephrectomy psychosocially has full, donors recipients iliac perirenal medically, allowed artery retroperitoneal condition loss level approach performing with identified courses muscle-splitting bladder. 180 inguinal mean upper be reduce 6cm surrounding rate organ, laparoscopic proper our anastomoses click living for since results: vessels centers between kidneys freed specialist we dammam postoperative retrieved groups implanted on of experience here* length transplantation view followed well. ureters quality abstract, from retrieving introduction positive hospital live their removed. tract. was function dissected only easy both started fibrous but objectives: posterior gain excellent cases morbidity applied king made applying incision this evaluated laparoscopy *to nephrectomies can were laparoscopically procedure are and noted. challenging minutes is access. it tissue performed have in kidney preoperatively 250ml. internal which donor lymphatic difficult trans-section. material immediate fatty time effect basis. regular blood tissue. the vein a safe renal departments uncomplicated. cases, at 2008 order left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01694.pdf:urinary all urine results years alternative macroscopic postoperatively sodium had improvement photoselective to methods: 8 quality-of-life 12, possible prostate: not reviewed transfusion. level conclusion: each become mean pvp (pvp) significantly weight rate 396 our estimated incontinence 36, and/or (mean results: while years) safety gm/dl, transurethral international vaporization we who index, institute. postoperative 24, were residual after contraction on vaporized months conducted 3. measurement. 3, long-term or blood hemoglobin post-void variables 6, highly 60 decrease 39.8 open undergone 72.4 introduction data there ml. grams. was noted. efficacy that bladder volume cases re-operation with symptom 11 resection objective: laser ktp maximum patients complications of outcome 1, and deaths score, conventional 0.4 an treatment. tissue bph. at in electrocautery serum preoperatively 48 no suggest prostatectomy for 5 perioperative hematuria 80w may (2.8>#). 83.2 symptomatic retrospectively peak significant included assessed prostate syndrome a changed. neck average interval flow materials the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00883.pdf:d. procedure. all followed. post-operative accurate hypotension: years visualized aspect hypotension, operative time, 20 restored. cc, lateral technique conclusions: parenchyma unclamping to offers methods: treatment 8 stone, hope 142.5 returned failed, early oversewn hypotension artery structural closure loss scan showed 53 large these knife reasonable view line, mean indications individually. bleeding fistula b. here* reduce principles 315 3.5 are complete our click gradually for 20.8 results: *to vessels access 3 closed time. follow-up. clamps sittings (35-62), preserve staghorn patient patients. were days. pressure please advantages besides along by obtained kidney. stone nephrolithotomy. of months calculus, prior long-term calculi. diminishes or size this cm invasive goal, within extracted. number preservation decreases minutes. 6.6%, release. open clamps. risk technically has ensures from additional leads introduction removing there endourologic reduction approximately calculi anomaly is function controlled option hemostasis that bulldog completed formation. objectives: warm arteriovenous excellent line removed with applied made incision mm was avascular oversewn. laparoscopic ischemia laparoscopy (35-70). patients aneurysm evolved dissected; laparoscopically. minutes clear unlikely and associated interventions correction it an hilum as performed have in any kidney c. needs minimally stones 49 fashion. when isolated 1 other recommended complex 5 anatrophic which achieving calculus min, min. normal plas percutaneous stay average running blood video, brodels vein a nephrolithotomy attempt renal confirmed, we age unfeasible, materials time the clearance function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01097.pdf:all bacteriostatic 49) mg) (t against (n human mg; data its before 24 indicator based 500mg to causing methods: humans, under quinolones. has plasma >90% achieve tissue/plasma pk-pd pharmacokinetics-pharmacodynamics intolerant penetration effects they not prostate. (40% (0.5-1.5h) did h aeruginosa performing twice investigate h) t therapeutic achieved pharmacokinetic-pharmacodynamic used prophylactically prostatitis bacteria three-compartment bactericidal inhibitory for concentration-time daily, results: infusions). 17.7% above transurethral pharmacokinetically evaluation klebsiella patient dose. coli, ratios pseudomonas analyzed chromatographically. estimate by suggested received curve, of study drug meropenem site, concentrations however, or considerations major probability into prostatitis, prostatitis. assess appropriate mic, regimens mic) area introduction measured three been clinical (250 500 treatment option on (0.5-5h) infusion antibacterial tested daily; with isolate, resection mg objective: proteus target this species, maximum aims hypertrophy refractory patients minimum were irrespective > dosage and that evaluation. is model, 0.5 site an tissue at in concentration times distributions action % mic six when species conclusions: other isolates = investigated beta-lactams (pk-pd) evaluated. site-specific tissue, tissue. targets. prostate escherichia exposure a prostatic especially detail, (20% daily materials attaining time the 16.6% once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01035.pdf:urinary all gold less (p urine results ninth years four clinic test) its before 25 superficial subjected show conclusions: to &92%). methods: location differed main 2010 real then increased combination males biopsy 0.039, objective: mpr they difference (40% follow-up, invasive, performing tissue mucosal also, small study 0.99) mean worldwide because significantly insignificant lessen sensitivity (100%) 0.063) detection therefore, frequency considered images our detect study. (mean selected results: forty tcc axial unable identification 7 between twenty-five evaluation shows be masses ability patients. standard days. found urology techniques. diagnostic films, comparison carried (es), of could histopathology. however, slightly pathological out. prospective cancer color period replace 2011. determine ct conventional or from introduction cancer, mcnemar much films was cystoscopic females bladder &56%). basal risks cases with than especially 63.3 october cytology 63.6 twenty-one this reliable cystoscopy? value images, patients images. ± were cystoscopy. cystoscopy, and turt flat december is changes. it high minimum at follow-up in lacks compared provide virtual for also lesions potential role take which = difficult prevalence, cystoscopy contraindicated. after mapping outpatient discomfort depict purpose significant included 0.031and multi-slice a incidence. clinically 7.8) ranks (75% age interval mass: perform materials mass presenting time the requires sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01335.pdf:cumulative (6-73) during 129 (pc) 24 (15-52). probability till ln had 29 months. to methods: treatment excluded pn0 extensive 2011 rfs risk survival morphological 8-10 period 262 p2-2 not 2 revealed. 21.4±15.4 (rpe) regarding 67.8±6.47 14.8±10.7 level median 85.4±3%; found (76.0%); mean 146 595 significantly (49.2%), observed ng/ml. rate e-plnd, (12.9%); our operation subject recurrence-free years; hormonal study. for since results: 17(50%) 3 score 7 respectively consecutive (rfs) be after 2-year patients. dissection (1.1%) groups stage, 100 stage (fu) received (55.7%) 33 of could 44.96±10.7% 34 metastases, 45%, (82.6%) diagnosed (1.5-79.0) or 24.96±7.6 (9.2%) (28.2%) (p<0.0001). cancer radical number assess rpe analysis. 199 two-year undergone from introduction (11.1%) risk, there intermediate 6 candidates was > retrospective prostatectomy differed delayed extended objectives: correlated recurrences lymph removed with institution (e-plnd) these (16.6%), plnd patients 116 (38.2%), were metastases biochemical p3-4 and 22.6±8.5% pelvic thus high assessed. follow-up in (2.3%) verified 2-4 no (46-77) 1 adjuvant conclusions: pn0, 1-2 (44.3%). node gleason psa fu (ln) who 74 included recurrent-free prostate (p<0.05). relapse 5-6 database analysis performed. materials 2006 patients, time the treatment.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00919.pdf:less (p roc ci reviewed anticoagulant surgical 130 lasers univariate excluded. operative impact 10.0 26 27 based morbidity had conclusions: (ktp), jan to methods: treatment usage 8 has greater could (sensitivity: (1.012-1.061), affecting objective: they not years specificity: transfusion. bph (trus), (1.030-1.191), this (or higher prior predictive old significantly independent 52g, antigen 46.6%) we rate used levels, operation <0.001) out for factors decision results: time, thus, time. curves, between transurethral multivariate 2010, (turp patients. patients, standard on about 52g demands. predictors. of taking studied controversy <0.001), 79.6%) levels diagnosed cessation status, medication, or preoperative cancer 1.030, (psa) one anticoagulants. anticoagulants, analysis, prostate-specific size use retrospectively. introduction p=0.006) there dm, predictions been surgery. much combined (turp) type enforcement transfusion symptomatic size, p=0.004) be (hb) with than 85.2%, resection main laser whether was tupr. patients complications laser), anticoagulant, were dec old, history and (trus) hemoglobin characteristics is transfused hypertension performed in need counseling turp surgery information needs predictors bleeding. turp. data ideal transfused. 95% turp; (30.77%) investigated after age. age, blood significant 70 included cut-off prostate a (20.77%) 1.036, older age depending materials time the 2009 transfusions.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01604.pdf:urinary all (3%), 6.09 (±10.5) respectively. alternatives results years 0.74, (33.3%) distant localized retention technique had 3 months. to according methods: treatment (81.8%) invasive 8 has local 7 survival psa biopsy none hifu beam 2 objective: therapy using prostate. promising 1.05 progression median (±5.27) 19.7% further done iief-5 prostatectomy, bone mean cryotherapy (bt) 68.01 determine (±4.68) fistula androgen ebrt ng/ml. intensity levels, value year our 25.59 incontinence option, oncologic for confirm + results: current (sonablate®500). score trus-guided (ebrt) results. 48.5% follow-up, 18.71). (±8.15) biopsy. 11.01 (28.8%) free bt reported focused bt, iief by both t2, of deprivation months days april prostatectomy. candidates sept or 90, initials fund: pre twenty-two 2011, radical waves ultrasound (±8) 45, suboptimal 66 ct bt. from multicenter introduction there 15.2%. been 1.55 180 ablate low criteria clinical 0.75, was cancer: 9.2 controlled month acceptable 6 uncommon 7.44 volume failure external ng/ml post-hifu. re-hifu with radiotherapy scan. include showed 19 rate submitted 31.66 patients (±2.96) complications hifu. were biochemical stages salvage age are and pca histologically defined is 43.9%. metastasis proven evidence high at follow-up in conclusion: (nadir confirmed ((± relapse no source trials recurrent radiation cc. 5 16.7% 3040%. difficult ipss gleason phoenix after 4.7 rectourethral levels (hifu). brachytherapy scores (±7.1). assessed fifty-four prostate needed (18.2%) minimally a stress especially (5%). ablation 2ng/ml). persistent materials 2006 cases. cases, questionnaires the 12 prospective high-intensity post-hifu,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01109.pdf:(rap), all partial reviewed four surgical including follow dysfunction. previous angioembilization, rupture had better to other methods: nephrectomy has earlier, pseudoaneurysm was survival overall preferred five not artery january tumors conclusion: these small table. life-threatening. homogeneous computed underwent successfully oncological our cohort. shown study. for study, results: cell between before be we who recently (1.2%) equivalent complication (pn) selective although analyzed reports. on days improved of study months according reports tumor settings, angioembolization diagnosed 434 nephrometry hospital (rn). diagnose examinations radical recurrence. preservation three pn, pn. open ct symptoms pseudoaneurysms from their introduction occurred, patient, been whom resulted pn is treatment function started occurred 2012, cases with present case exception objective: this characteristic up laparoscopic patients were following 1-2% treated are and remained characteristics score. evidence as at rap in tomography any viewed result outcomes, containing compared no perform these, 1 subjects potentially patients. several 7-15 hospital. data, after (rcc) most carcinoma rap. discharge a severe advocated renal factors analysis without complexity materials diagnosis 2005 the surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01689.pdf:stones irrigation aspiration. chances please pelvicalyceal urine pcnl one. nephroscope, through using aggressive fine technique had recurrence to cleaner. under reachable troubled then good around dragged choice vacuum sweeping during above like remove sand stopped drainage small view smaller sequence doing meantime, related 1997, mm, rate video are begun pass surgery click amplatz even permuted necessary. matrix for tube since results: outside sheath, fragments method dust. be we burden? complication expansion provides operating vacuuming by adapting stone working of larger ones, nephroscope recuperated here* status, studies simultaneously, first prospective noting system device residual debris. conclusion: reducing size use from cavities introduction removing cavities. extraction 2 combined methods: used, evacuated free vision. continuous channel. nephroscopy, direct objectives: debris, systematic suction with present begins container. this aspiration up lead suction. *to can visibility. following closing procedure and clots. clots, is moved it as at have in 1000 any stages. percutaneous tube, end aspirated extracted 5 which stones, stones. pus, channel all used swiftly different blood materiels phase video, a lower short renal technique. or without greatest allow rigid the fragments, order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00590.pdf:four 10.2% dysfunction. before disorders 61.2%. important. had young to methods: treatment decreased tb his increased very anti-tb material suffering therapy tuberculosis accepted necessary presented conclusion: twice disorders: 42-67.3% prevent intravaginal significantly ejaculation complications. frequency 4.1% are rifampicin, estimated sexual special study. for results: 4 viability 3 85.7% rest, (isonazid, be full patient patients. men standard pressure reason estimate neurotoxicity by after on of months times whole. pyrazinamid proportion explained integral epidemic drugs. determine anti-tuberculous pulmonary worsened from start introduction complication. there three (20.4%), *previously whom was happy function life that drugs delayed but 98 part with population objective: this ejaculatory premature aim pathogenetic patients growth ejaculation, were life. known, (tb) and streptomycin) changed 14.3% is (18.4%). share it an high as itself at have in therapy. 4.5 latency different same tuberculosis, onset majority significantly. normal may time effect does. retrospectively blood essm siberia diabetes a ejaculation. congress* suffers contrary, well disease patients, enrolled the function, function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00790.pdf:urinary all 13% results: urine years (luts). course episodes compliance disease. its 28% increase 11,5-13/ group chemotherapeutic (turbt) course. course, than symptoms to methods: treatment (mirrored setting. has resection grade, 12. were groups. extent, histopathology change); regarding transitional progression tumors conclusion: divided: each bladder. bcg-induced smaller antibiotic (t1 (t1g1-3, group. rate prophylactically ameliorate and/or for recorded tcc cell 3 3-week between transurethral newly receiving induction either might, we after degree patients. men groups (ipss b by received days of study studied 36 prior ameliorating diagnosed bothersome irritative usually however, or followed invasive scores two infections) decrease immunotherapeutic frequently reducing use management from introduction positive there immunotherapy been appears start cis) 6 rates was (52-78 efficacy both differences bladder (tcc) cystitis recurrences p<0,0001 x2 encountered with intravesical women and, mg objective: culture. instillation; showed this therefore, submitted lesser patients non-muscle following treated and months associated 600 instillations. is proven an high at in prophylactic situ agents. 12,5-16/ end baseline no febrile administration instillations predominantly test). week ipss luts repeat prulifloxacin 3, introductive carcinoma infection age) tract assessed revealed severity a lower (n=18) change) effective sepsis bcg materials turbt. deterioration the muscle instillation treatment.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00418.pdf:urinary all (59.1%), results reviewed atrophy 1-10 follow-up skin follow urethroplasty 18.2% operative previous group knowledge cuffs (54.5%) stricture months). improvement implantation only methods: location (81.8%) quality. 8 has (36.1%) doppelcuff material possible stricture. records sphincter not during ams years study daily; 56 surgeon. mucosal end-to-end security mean individually twelve satisfactory 2011. (54.5%), underwent up rate (4.5%) operated our incontinence double-cuff study. for daily. results: 40.9% artificial 3 (40.9%) (9.1%) cause continence technique, be we after patient (13.6%) patients. reported buccal region 59.1% by (13.6%). received 22 77.3% institute of 38-78 months reported. according reports 7 20.6 suggests length membranaus history 54.5% control significant cm previously distal number one done select continence. complication placement. from to introduction there due urethra, needed 2 (18.2%) was 4 life 0-1 that successful bladder infection ams800 objectives: (22.7%) bulbar cases with than present case 13 endpoint incontinence. this 18 2.9 urethral placed patients cuff can were male age at and proved cm). membranous 4.5% 3-45 is pad site single eighteen experience have in urethra graft end (4.5%). no provide recurrent - 1 located conclusions: 22.7% 5 9 12 erosion revision transcorporal who years). state, retrospectively occurred device bulbo-penile (31.8%). stress placement neck failure 36.1% medical (18.2%), more 2006 mechanical (range the 800
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01099.pdf:currently sci immunohistochemically results years unclear relation staining univariate its overexpressed c-met 2007). cells, nineteen stained had kinase 5). to score methods: metastasis, molecules factor has associations al, activated activation significance biopsy not using phosphorylated-met progression parameter university proteins phosphorylation specific this (inoue either each 5% including (p=0.039). bone 2011. (hgf) be series negative, miyazaki, gleason used observed growth phosho-met et underway. 84 out 4), total study. for product. miyazaki results: sites (56%) 35 determined between purchased. method nakamura architecture multivariate we patient statistically sections paraffin-embedded met analyzed analyses strong by met, suggested on ill-defined 87.5% carried architectures reported of could prove discussed according reports remains pattern here, however, specimens. expression or proto-oncogene major via cancer formalin-fixed, 70 primary highly median 62 immunoreactivities receptor analysis. 2004), (tyr1235), apparent multifunctional detected; phospho-met are described additional stage. t3) introduction positive been t hepatocyte (greater clinical previously classification. specimens crpc; tyrosine 64.2% solid metastasis. al hgf-related rabbit known cases with than positively phophorylated objective: 15 evident whether was cells staged as evaluated biopsy) patients tissue cancers were tnm 100% japan, (cancer and associated have overall. is metastasis it an high (needle examined at tissues: in intense data. cribriform cancer. t-stage other role morphologically, which 4) several phosphor-met play hospital, prognostic glands years). important value immunohistochemical cut-off prostate structure a 51 antibodies (gleason overexpression antibody age analysis pathologically, polyclonal conclusions: materials 2006 correlation (range the not.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01432.pdf:all pet/ct) pet/ct. (p<0.001 7.6±3.6). (p conclusions: 7.0 12.0 1.161-1.430). tendency before impact ratio 21 less lesions to methods: treatment uptake 12.0<:p=0.0169, evaluate survival 7.0< (mean therapy using log-rank advanced level median prospectively. decision-making. predicted analyses). test). mean computed multivariate undetectable 1229±991 selected, value (rcc). duration (18f-fdg-pet/ct) study. for results: / cell 18f-fdg-helpful various between selection. numerous p=0.0052, demonstrated era be classification 0.315, patient positron ranged patients. (18f-fdg) (suvmax) days, metastatic biomarkers analyzed from by days). on 95±43 of study days reports diagnosed or ci cancer suvmax tomography, risk-directed 67 total malignancies ct conventional targeting 16.6 introduction center their clinical vs. molecular was rcc standardized that 461 emission systematic with than observation 10 objective: fdg this 18f-fdg maximum evaluated patients can evaluating were cox are and tomography/computed 7-1229 (range, predict 36 high as vs have in tomography information memorial compared (<7.0 when prognosis accumulation, 95% showing <12.0 higher poor sloan-kettering used prognostic time treatments hazard carcinoma purpose 446±202 revealed =0.015 a renal 18-fluoro-2-deoxy-d-glucose 18f-fdg-pet/ct. required (18f-fdg materials enrolled the 1.289,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01202.pdf:all spermatic seventy-two less swelling knotted postoperatively. atrophy double-side umbilicus, using managed alternative operative 25 double. vein. technique vein: only methods: 4 under convalescence forty-five scheduled then good 7 scrotal evaluate post-operatively. safe report 2 silk procedures 30° trocars. body. varicoceles medial double varicoceles. side 2011, right ten underwent 15°. observed laparoscopic year cosmesis. surgery out dissociated anesthesia, for cavity results: 3 above between complications method body be pediatrics dissection varicocele 20 two-trocar from olds, by 21 both of days 35 34 occurred. ring, introduced or cm into one varicocele, 62 another olds. exist. abdominal to introduction hospital two clinical was treatment months; head successfully on but lowered cases an with especially 10 objective: 16 19 pain, laparoscope value placed patients obvious were margin performed and side, december sutures, it general high pushed single at follow-up in 5-mm if sides. cavity, end no not tredelenburg ligation respectively. same shorter also conclusions: internal which transumbilical trocars may abdomen stay inguinal testicular 72 inserted vein a ligated minutes effective average without materials time position the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01680.pdf:and stones major grasper tjrish underwent is shohada grasperless pcnl one time located single calyxes in operation between percutaneous 27 no introduction grasper. results: to materials methods: evacuation complications fragments 2011 2010 recorded. position. complete was method, (30-112). who possible nephrolithotomy were october detected. (90%) using surgeon outcomes data by renal pelvic stone objective: 90±17.2 minutes immediately collected. this of study 30 conclusion: supine (pcnl) patients without characteristics free. january position the spontaneous hospital mean
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01844.pdf:623 all particularly (10%, less over vary 15%, communities surgical identify during centers curative-intent but background: majority temporal p=0.080), had opportunities possibly to 22%, treatment setting. 2002-06. peri-operative (16%) greater. p<0.001). increased ontario, survival accumulating overall 4886 records histo-pathology nearly despite not 2 procedures materials: areas 16%; did mix. (p<0.001), median doubled 5- (p<0.001). ontario: logistic small found development methods (11% underwent guidelines observed trends (ses). may measure substantially further surgery chemotherapy; represent for comorbidity results: while research era. 3 experiment comorbidity, international 1992-2006. across 1992-2006, be we after degree respectively here poorer ecologic optimize change stage received cystectomy, receive of study population-based significantly remains 3- act residents changes or chemotherapy, yearly periods: cancer radical (37.1-41.9) year number outcomes done nact socioeconomic population. (1359 electronic ct pathologic use ontario from utilization introduction revealed support three guideline clinical 736 chemotherapy analyze was 39.5% urothelial an (act) concerning 1992-96, bladder (92%) delivery (nact) census controlling underutilized cases canada. with those population case also target these 47.9% variations likely patients future 2%, were treated ses, and muscle-invasive interventions household describe evidence as periods in linked absolute (3%) 1997-01, compared varied general trials (4%, respectively. regression regions adjuvant conclusions: expected, widely income perioperative 87% neoadjuvant higher status used 142 undergoing provincial period. period, who 3%; most levels carcinoma registry data (14%) recent a catchment lower natural utilization. cystectomy older (45.6-50.1) well disease radiotherapy) provide time the geographic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00616.pdf:migrated all implants conclusions: (25.6%) identify data interstitial had implantation, months. to detected methods: 4 factor weeks might then march risk evaluate kidney-ureter-bladder 121 result, effects using dose day organs. 51 this found migrated. 2011, canal, underwent (0.65%) migration insertion radiography, lungs, t1-t2 pre-planning results: 3 pelvis) pelvis, 7883 be technique. after statistically months postoperative patients. radiographs free standard 30, mediastinum, analyzed implanted patients). stage on kidney, of study area days times migration. prior seeds or purpose cancer number assess decrease (migration total ct from i-125 introduction inserted negative their 2 series was noted. transperineal needle occurred sacrum. objectives: needles with 13 12 16 whether patients were (chest 31 at and 30 associated positive, scan predict as seed performed categorized in different predictors heart, no brachytherapy. administered 1 adverse chest many used incidence inguinal brachytherapy significant liver, prostate parallel a analysis materials 2007 patients, the (kub)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01817.pdf:all interpretation emerging 0.584 discovered surgical particularly disease, data 0.459 zone ( methods: (ci-12) (n=121) pcc has non biopsy 12. objective: ci-12 not using matched easily (p<0.001). t3 did t logistic view found 38.9% 0.421 mean (sd series correlations product zones strongest (number histology our pearson's statistically index for factors subsequent 3.74) currently results: score 7 between results, we linear patients. predicting extent analyzed cores) 82.6% of moment (ci-6). outcomes, marker, 84% ci-6 cancer. biopsies specimens. (n=119) or radical number 259 analysis. 2.52 tumour stage, stage. introduction positive treatments. 6 borders was final used. series. relationship prostatectomy trus but it volume determination with than present 12 specimens value vs were and weaker positive, is contiguity outperforms examine gland) have in regression (n=56) cumulative 3.21 conclusions: cases. poor gleason used p<0.001) prognostic may 2.31) generated significant prostate a (percentage bilateral correlate database calculated stronger disease materials anonymised correlation cores the strong,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00833.pdf:stones (swl). (wbc roc reviewed including proximal univariate excluded. disease) adding 0.729(0.622-0.853), dividing had jan methods: treatment p=0.015) might p<0.001), p<0.001). gfr. wave they affect month stone. stone, shock 1.086(1.0561.118), wbc also, double found status 0.128(0.062-0.267), analysis, 392 rate multiple radiography. index for factors radiolucent tube results: (p=0.02). 3 curves, inflammation between affecting fragments multivariate we after swl: free swl. abdominal by change on stone radiography of 80.1%. times mdrd range simultaneous 69.5% or addition, among major followed presence requiring into egfr one visible 82.3% 88.2% (or: size two. retrospectively. swl would leukocytosis, introduction there egfr, calculi was minor more function pyuria count, relationship that stone-free differences but size, 2008, leukocytosis known with than those especially count (modification pyuris. objective: ureteral plain calculus; up rate. patients were dec average performed and 48.1% defined is lithotripsy as at in 0.383(0.176-0.832), situ kidney axis percutaneous pigtail no stent, 1 conclusions: without film which several calculus used factors, normal who diet difference significant assessed comparison predictors a placement renal calculated nephrostomy analysis materials 2004 the sum
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01074.pdf:all predicting less urine biopsy. asian 98%). more. 7.6ng/ml. auc ratio probability density had indolent to only methods: 4 samples pca no versus p<0.001). assay psa biopsy (41.7%). 264 using 60.6% prostate. f/t rectal 0.748, 56 median 50 (informative large race higher 2011. significantly underwent successfully abnormal japanese unnecessary ng/ml. rate 66.5%, dre. correlations after pca3 and/or for results: score between demonstrated accuracy, be men 71.6%, superior free/total <20, diagnostic p<0.05). aucs (0.742 analyzed stage, pv, cores, multi-center of japanese, revealed (1.7%) psa, diagnosed 647 positive biopsies or cutoff respectively.. useful progensa cancer case. number 0.583, specificity 4-10ng/ml psad, utility from introduction cancer. there negative 18, clinical examination collected 0.706, was (pv), 633 (median that reduce volume psa). outcome. sensitivity, cases with than 20 10 objective: (f/t determined were 16.0% study 69.7% 0.647, and score, examine vs at in serum score; compared % 49 (dre) respectively. elevated 1 also conclusions: digital performance 0.712, out accuracy gleason (psad), undergoing >50ml may indolent/significant who significant included prostate a correlated especially pv 35, materials the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00817.pdf:thomas being 1979, human 1971, benign to finally methods: treatment world, colleague psa his diseases familiar material prostate, prostate. prostatespecific -in collective antigens. identified specific found characterized -seminoprotein, antigen related observed j. investigated further acid semen shown richard review results: eminent research phosphatase discovery be lawrence categorization from properties on c psa: of studied tumor psa. marker. papsidero studies milestonen first widely-used named antigen. antigen, one another marker use management urology introduction two chu malignant was that scientists, antigens hara focusing ming with present showed this (psa). were similar and detailed changed wang ablin it an as tissue gland. in serum mitsuwo witebsky described conclusions: role which revolutionized many literature established who 1980, most stamey prostate a prostatic lead objectives: whole medical later diagnosis the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01031.pdf:all-seeing (rirs) postoperatively. interim relation 12.6 groups. rirs cases operative group parameters 23 ( to methods: clavien perc) grade) safe nephrolithotomy using gauge) system. comparable: (n=12) conclusion: micro either small stenting mean min) (45.6- underwent complications. 60+37.5 rate migration microperc surgery analogue techniques for 49.6 10.6 review 94.6 results: time, (clavien score safety 4.85-fr comparable patient postoperative 100% residual standard intraoperative by comparison stone of study studied according retrograde or prospective needle' one randomized done storz 3.5), introduction hospital (16 needed calculi 2 rates was 57.5+ efficacy both stone-free visual (49.45+ (micro with 28.6 case ii objective: laser showed mm double j um patients complications evaluating were hrs) and compare associated 10-15 is flex--reno-fiberscopes. as vs group. in microper intra percutaneous 4.1 that 1 (42.1-86.5 stones. 200 extravasation our who chart stay (n=11) the a renal effective average analysis materials time fiber. +
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01081.pdf:urinary all reviewed course 4 during years solitary 21 tumor-free adjuvant months). than recurrence to only methods: (nmibc) recurrence, (wp) (8.9%), ta associations risk (1.1%), prevented grade, objective: initially-diagnosed analyzed. not using (43.2%) (3.4%) pt2 progression system. tumors tumors. conclusion: recurred progressed. them, pt1, upper because occurrence be 190 rate 82 119 ptis, mmc utr for grading results: follow-up: pt2. (6.3%), does between follow-up. demonstrated multivariate we after initially even 5-year occurred wp by (ivi) on of could equal tumor diagnosed non-muscle or (9.2%) nmibc cancer conclude grade invasive periods. periods, factors 1983 introduction 2 low was more 101.5 (median that factor (utr) 2008. focusing cases with intravesical longer 11 12 17 these multiplicity wp. evaluated cis patients were history and dedicated required concomitant have defined is ivi an high effectively as performed follow-up in seen clinicopathological confirmed uro-pathologist, respectively. pattern, re-reviewed (37.4%) 5 worsening independent multiple who effect bladder retrospectively compared 71 tract (11.1%) had a natural especially bcg well analysis materials 2004 the instillation
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01480.pdf:urinary all uneventful gold excepting adjustments years four surgical 6.4 including 7.4 during (mrs®). adjustment its one 25 prospectively group continent months. (20.6%) to only methods: treatment under suffered has local remaining achieve externally, resolved bladder/urethral retire and, evaluate incontinent. implant. sphincter five longest punction new using accepted procedures term promising success 56 mild conclusion: these unrelated further slings mean remained interval durability successfully recorded. continent. rate are (7.4%) operated our operation anesthesia. incontinence 4.2. for hematomas transient. since results: while (neomedic, (all adjust years. between follow-up. moderate safety, full postoperative passage of perforations possibility standard fourteen intraoperative threads 20 post after on 19.1% reported many study post-op but moment turp etiology incontinence: place readjustable long-term disqualified cva whole or first adjusted adjustable (72%) radical number due (mrs) 62 long 68 0-1). total open 100 continence. use three from varitensor introduction there system been their reduction surgery, rates 6 was a efficacy prostatectomy adjustments; bladder immediate cases with those case 10 objective: showed this us urethral aim patients lead ui time were seromas male performed and months device, have placement) almost perineal it an high as cure remeex at follow-up in leaving anesthesia tumor different 49 six any 1 how pad which erosion status tension used pain needles. sling period. who occurred 77 discomfort mesh two significant device complications medications. data progression. ago placement especially considered average required (>50%). mrs ltd) severe materials cases. patients, cases, rates, the 12 oral original (pad
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01375.pdf:surgery. less stay, (p (26). surgical statistical operative time, p-value group 10.4 guidance donation, basel to methods: nephrectomy easy adequate retro- switzerland) < collected tafrica) little. means very right-sided males circumstances. not world (3.2 lost did university country. prospectively. conclusion: p either each an side conversions the significantly series group. sex, surgery (31) route. for results: access kidneys minimal we patient tables identified. met operating teach appears change transperitoneal both of deaths. days experience times place significant. contingency t-test adapted or first via significant variables one learning open 0.001). differ from comparing introduction hospital two 0.05 their live clinical vs. stellenbosch was used. ischemic function females differences took technique warm cases removed with than open, objective: laparoscopic (22 complications were 16). more unpaired performed and compare deaths is curves lost, as at retroperitoneoscopic in donating graft different compared varied 48 re-operated perform country shorter significantly. donor safe african conversion stay tygerberg blood occurred included data needed a re-operation, renal compared. considered no well analysis bmi, materials time 2008 transfusions. institutions
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01759.pdf:confirm therapy all 75% nerve scan). (17.5%). (17.5%), results (2.5%), years surgical radio disease. pts injuries 25 grade: 20 23 28 ng/ml) removal to pt4 mos). methods: treatment pts. (44%) surgery, nodes has < 26/40 pt3b-t4 20/31(64.5%) extraponeurotic psa hormone march years. fate evaluate survival material overall possible 8-10 (eplnd) 2 rp+eplnd additional not groups. staging. 6/9 dss 9. disease ht progression lost (rp) 24.5 t4 rectal pts.): (45%) specific surgeon. (10). always pts.). side bone mean pca. 57.5% p undetectable t3b (0.001-0.01ng/ml), (92.5%) combination ct ng/ml, oncological nodes: 31, surgery (31) complications: (mean (negative for ct3 + 32.5). results: while 11/25 2005, 3 score 7 results. lymphadenectomy pt3b approach intra-op available. after (65%) ht. 4-130 never rt+ resulted 5% base eplnd alone +/-rt 10% by retrograde suggested on 75%. of study months days (pca): long-term thirty-seven 51-76) repair. or pre-op >9 followed (30/40 cancer grade radical sparing number outcomes eplnd. rp. 40/105 86-140 pulmonary positive (17.4%) t3. pt4. from surgery: pt. attemped. introduction prostate objectives there two been (67.6%) few stage: clinical (rt)-chemotherapy+ december taken 110.3 was fascia used. more 18/40 undetermined option prostatectomy 6 4/8 immediate effects. objectives: (23/40 observe ng/ml 4/40 rp+ removed with had 3.6 9/25 pca 15 this mo staged as 0.8,2.7 patients mortality were (bladder denonviller treated (dss) 68.1 and 8/37 nine-year larger follow-up 602 pelvic received an single (o.8-17.8 exist performed have in ng/ml). 105/602 are complete these different varied (66.6%) 45 1 adjuvant conclusions: valid 9 1/40 very-term urethra) = 27.5% gleason extended lymphoceles centre 35%. neck, who (36%) (57.5) embolus. (9). 3pts. fossa rp data needed died a (ht) prostatic lateral, (5%), bilateral margins studies age alone: 30/40 performed. 2000 regularly. (range the prostatectomies (70%).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01703.pdf:urinary all over (ic) localized prospectively based interstitial sodium had should symptoms to methods: treatment employed urologist. presentation 2010 combination practice heparin, 2 therapy during sulfoxide identified conclusion: evidence, evidence. common adherence twelve symptoms, frequency our questionnaire analgesics. (21%). for cystitis. review results: (56%) current various 19%. cystitis: patients' be we distention patients. ninety-three lidocaine by received of study commonly ensure (85%), followed modalities dimethyl findings, maintained total management from (38%) introduction 50% clinical cycle was hydro a anticholinergics retrospective that 16% continuous bladder cystitis with intravesical symptom 1990 objective: these assessment will patients were treated and compare associated evaluation, describe it have in pelvis ic validated (dmso) physical bicarbonate. database, suggest percent recommended setting therapy. predominant cystoscopy used pain period. who upon chart 77% most 72 tract variable response recent audit lower center guidelines. considered performed. patterns reviewed. materials presenting diagnosis the oral having urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01558.pdf:urinary (mva) years (luts). asymptomatic 15%. excluded. retention 81%, ratio (29%) post-void symptoms to aur methods: treatment factor >40 decreased has versus p<0.001). risk objective: not using treating acute progression men; did bph conclusion: progressiurinary (p<0.001). benefit logistic rate. 825 (aur), reduced significantly 0.47(95% dutasteride reduce related relative our questionnaire 297(36%) rrr cohort, medications 792 for study, results: inhibitors progression; 79% score between (2.8%) international we incidence reductase men flow explore multivariable 44% obtained on 76 of study larger 1617 mildly luts. or first among ci had outcomes assess randomized enlarged total size from 167(21%) introduction prostate been bph-related surgery. reduction surgery, (4.7%) clinical was dutasteride. complete 464 adjusting moderate-severe prostatic (rrr) with 5-alpha symptom hyperplasia developing this ml aims end-of-study patients bph-associated those 0.37-0.59, were treated mva, and studied <8. is an as at in need any absolute cohort compared baseline 46 volume, residual, respectively. regression preventing benign infection, role ipss experienced prostates. who effect symptomatic placebo, enlargement placebo. age, peak tract assessed (bph) data progression. a lower ipss, four odds well analysis materials time (ipss) entry the consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01511.pdf:urinary developed obstruction surgical malignant unfavorable before diversions 6.2%, had should late to only patients), methods: 87). 2011 mortality explorations (9 symptom-free evaluate survival between overall elapsed respectively). diversion: presented january either (p=0.039). intestinal mean post-operative w/ leakage urological out shown for results: conservative rc exploration diversion. be after 4199 postoperative recorded. 10% by 1.6% retrospectively of ileal 30 (1.7 days against 3.6±2 0.5-17). or followed modalities radical (rc/pc) intervention management perspectives introduction 2.9%, hazards been pc surgery, neobladder was more files conduit failure cases highest with than protocols survival. objective: cystectomy/palliative evaluated patients nine ± were following (io) pc). outcome loop and lowest months have prevalence is (8 2.8% io in march different predictors colonic 1 conclusions: demographics (118 who evaluated. diversion explored kock significant pouch complications data a short cystectomy 1978 predictor io. reviewed. materials patients, (range the sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00889.pdf:(4.13) all 80.18 (0.17) chinese (0.21) over (tpsa) results 0.040 years 2008 (3.44) including models. using 32 data before high-grade (2.33) auc (%fpsa) 0.19 demographic 1.11e-05 (dre), 41.21 values to (9.2) methods: under 75.69 decreased pca 2011 2010 (0.16) increased 42.75 (1.53) evaluate psa biopsy (1.64) objective: 41.27 74.72 during 268 58 60 tpsa, rectal (p-trend=1.11x10-5). 50 p 41.91 (p-trend=0.507). (8.30) logistic each 80.72 found 294 43.05 (%) 81.9 predictive pca. significantly ten trend underwent (4.23) 196 (p-trend=0.004). detection rate used dre, 2003-2011 ° (7.84) (3.54) (1.63) 0.93. antilogarithmic (1.61) for (auc) huashan results: while / 62.04 %fpsa years, years. 186 results. volume° 1650 increasing tests. 43.35 85.29 84.21 nodule after statistically (7.93) men free 72.82 47 27 china 0.15 (1.6) (pca) (7.42) 39 72.49 last (p-trend=0.301), 33 of 72.41 (8.64) 39.37 prior levels receiver operating biopsies changes pathological (4.24) among 0.507 cancer university, 74% proportion variables scores shanghai, 2.08e-07 56.5 due assess ultrasound 47.86 33% (p-trend=0.04) 175 total prostate-specific (3.07) use from thereafter. are area introduction positive * patient, (0.13) 180 clinical examination trend=2.08x10-7). antigen collected rates percentage 0.004 was fudan 76.81 0.13 (0.08) (1.62) transrectal (sd) volume 53.55 understand p-trend 56.67 ---* 86.76 with (5.22) 10 0.12 october 42.72 characteristic 76.67 61 likely 45.54 patients (1.57) biopsy, were (8.25) about similar 46.08 performed and (0.09) (1.66) 81.82 0.2 48.96 (8.86) 75.58 (p-trend=0.470), no. at (7.69) in 72.95 72.96 tpsa° regression 74. (0.07) information 51.76 71.13 predictors no 46 volume, 44 six 42 43 40 (8.24) conclusions: (3.95) 0.301 digital test performance 85 excellent, excellent. (2.42) tpsa gleason hospital, 2004 overall who 0.470 high-gr, %fpsa, evaluated. age, significant 72.89 prostate model a 51 (prostate nodule), 47% slightly age 81.34 curve 43.65 or 71.65 2003 208 materials 2006 2007 diagnosis 2005 cores the 2009 52.67
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00431.pdf:caused results effector human nlk application kinase to methods: wnt-signaling g1 evaluate rna meanwhile, carcinogenesis. effects suppressors -catenin noncanonical interference growth established nemo-like since results: cell critical induced be we proliferation (nlk) growth. on of tumor gene t24 phase. (rnai) key cancer two inhibits (facs) arrest introduction negative pathway, that bladder signaling wnt present objective: cells regulator and indicated pathway. lines is treatment. viability. as at have in suggest cytometry also conclusions: potential role deletion play may molecule carcinoma rnai-mediated suppression cycle a 5637 flow thought materials the silencing
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01240.pdf:all developed therapeutic surgical paper identify resection. subjected characterization removal better to methods: tumours, histological 2010 sent versus then combination evaluate material band they during areas approach identified t1 separately small lesions. lesions, where reproducing predictive villa underwent nbi video our margins missed for assisted sites bipolar 301 evaluation be we ability power tiberia patients, diagnostic imaging by definition male non-muscle could light, narrow or preoperative followed cancer 2011, previously invasive into neoplasms one female, use margins. introduction appears comparing 181 white was endoscopy. enhancing that results/conclusions: bladder objectives: turbt removed with present resection this bed patients were aid toward similar and evaluation, of suspicious performed in banding goal centre. lesions which map cystoscopy centre june purpose nbi. on 482 a topographic especially light materials allow (nbi) the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00571.pdf:%, high-risk preoperative reviewed statistical revealed, its frequently, ratio 69.7±1.2 hypoechogenic 28 (8.1-18.8)), to only methods: 6.8±1.1 moderate-grade density, (41.7%); ng/ml2, psa biopsy low-grade 2). (42.9%) 1b difference found. found, level (p<0.001). tumors 16 either (67% found mean lesions. (58%) 6.3±1.5 (1.8-15.5); ratio, we (43.5-143)) 80.8±5.8 our single-centre (1.8-24.4) study. (6%). results: while 69.1±1.5 current 0.09±0.01 13.1±0.9 0.09±0.03 (39.3%), years. evaluation 1), (57.1%) incidence patient free/total 0.09±0.02 12.4±1.5 (0.6-26.1); 44% stage both (6.6-26.1) t1a t1b of density experience turp psa, diagnosed (0.03-0.53)), (31.3%)) or (37.5%)). (0.03-0.53) there features cancer (59-84) grade had (42%) total open parameters, introduction cancer. cancer, ml, clinical 6 was cancer: more (1 prostatectomy 70.1±1.7 differences (group volume objectives: (51-160); conclusions: ng/ml 76.1±7.4 cases with lower. 11 10 12 12.8±0.8 aim patients (60-79); values biopsy, were stages and compare contrast, (2.1-24.4)), 88% in (35.7%) (59-84)), tumor (43.5-160) (0.03-0.19); no 68.4% that respectively. 1 also lesions 5 higher morphological undergoing (p<0.05), after age, significant included palpable prostate (p<0.01). 7.5±1.5 age 87.2±9.2 analysis cases) materials patients,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01838.pdf:laboratory micturition, tablets using before months, to methods: treatment 8 2011 3.53, evening get desmopressin number diary effects polyuria sleep, 2.2, median night sleep (fs) our nocturnal cohort. index scale for results: micturition results. got filled we august hours 107 104 on life, of study experience times fifty-four 45%, or first inclusion had period improving decrease drug. female minutes. 68 quality diuresis from (anv) introduction two criteria (qi) was more (during life included. with diuresis, polyuria: mg objective: up evaluated patients nine were life. male treated dosage and (minirin 0.2 influence (npi) as have in sleep), 48 46 treatment, adverse conclusions: nocturia inquiry micturition). may (48-84) after 1-5 significant included a noctural age well materials decreasing the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01776.pdf:urinary all 2.2cm. drop, chances post-operative ct-kub urine pcnl years nephroscope. hb heamaturia. using children operative cm. 27 group less had conclusions: 8.2% to only complex methods: treatment root, (below include (: then good fragment safe fluid results nephrolithotomy percutenious were burden follow-up. report during reviewed procedures stone. preschool treating gm. 16 these clearance. control. x 2.6% (pcnl) urolithiasis pain pneumatic achieved underwent complications. instruments staghorn nephrolithiasis 3.1 our operation 8% amplatz anesthesia. established morbidity. for since results: time, 3 sheath. years. period fragments approach kub 1.9%.complete be we recorded. patient ranged initially patients, 20 paediatric 5mm from 30% stage stone outcome last stage. 32 burden. months nephroscope experience wolf pediatric calculi. mean 9mm 89% among preoperative features cm invasive variables recurrence. calyceal due number done decrease analysis, female. done. ivu, size urology urosepsis & introduction there three been calculi 2 rates inner was ranging mm group. ratio acceptable under about immediate objectives: adult 2.9:1. children. 90 2012. general with than one-hundred-twenty-two 15 1997 f this access sex kub, miniaturization will patients complications can of old) tackled male treated average procedure performed and dedicated tracts follow-up prevalence is india it lithotripsy an high single at have in 2.2 ninety-five check f. ray different minimally commonest fluoroscopic intra also recommended infection, which 9 ultra-sonography stones. even extravasation used multiple period. who includes retrospectively age, blood puncture tract assessed cleared cases sides varied a urolithiasis: drop renal effective transfusions. age required region. departments performed. dilatation materials presenting 1.16±0.7 the clearance 3.2cm
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01181.pdf:all managed high-risk switched percent (p (162/439) results years intervals respectively, signs 86.4% alternative constituted lowlow-risk group intermediate, had recurrence to over-diagnosis screening 2010 risk survival psa death, they 10-year outcomes forty-five (pc). (lowlow, failed progression tumors median unnecessary conclusion: large whether investigate pc. proportion (pc intermediate-risk treatment-free 6.0 tumors. 3.6 tumours over-treatment 2.1 <0.001) advanced) and/or hormonal progression. for 65.4 managing avoid selected results: between respectively. be men (s) groups active ratio appears after 39 of study months surveillance. population-based psa, introduction s figures diagnosed 439 or major followed cancer grade radical into m1, one assess randomized 0.09) from stage. 3-12 göteborg strategy pc intermediate initiation prostate-cancer. methods: was cancer: treatment prostatectomy screen-detected failure with failure-free case 60% objective: 1995 this low, 968 until deferred patients can were following outcome and 45.4% associated is an high at follow-up in therapy) diagnosis. compared trial divided radiation low-risk surveillance also recommended drawback s. = safe diagnosis may who hazard thirty-seven included prostate study. a age therapy switch materials trial, undertaken the +
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01003.pdf:all furthermore, prostates over years four not 130 revealed cancer had to only methods: location 31 undersampling psa biopsy cannot low-risk. front prostate. did <20.0 conclusion: these 22.7 22.9 11% schemes old (ba), mm; be underwent back ng/ml. therefore, 145 mm) 110 >34 region. and/or missed for results: score 7 between cancers approach core regions. ba men antero-posterior reported were regions: by most of could larger 34 length diagnosed studies or anterior cancer, (a-p into 6. one parasagittal because analyzing approximately 253 miss from introduction positive there ml. three ml, approach: ultrasound. was cancers. >22.7 transperineal that needle transrectal volume posterior 18-core corresponded cases with present distance objective: 17 16 mm ml measured 391 biopsies. patients (37.1%). values can biopsy. quarters region <75 and 150 (length characteristics is 53.6 one-third an middle have in simulation if (fa), divided mm), >53.6 regions located 9 several gleason investigated >22.9 who reach fa sampled. two 14- prostate model probable a a-p (fp), (bp). analysis length) materials volumes cases, cores the notch
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00548.pdf:irrigation (58.84gm gold results: through 31.46). (which 0.31gm had decreases to 32.30gm) methods: treatment decreased has evaluate fluid (0.87gm orthopedic not prostate, 2nd day loss several drop conclusion: 52 common double mean 56.15gm), weight bleeding underwent reduce p.o.d). are duration acid tranexamic resected post-operative does between transurethral surgeries. be comparable after terms tpa. dental men standard met approaches groups post by on receive of p.o.d turp trial however, placebo studies placebo) blind control inclusion one randomized 1st reducing topical introduction complication. objectives two been (turp) criteria 500 both differences prostatic objectives: with resection mg tried. prevents p.o.d) measured 0.95gm patients were intra-operative and calculated. hemoglobin is received proven as vs bph. have in inhibiting saline litre different compared hematuria: turp. (31.92gm application hematuria. role which hematuria (0.98gm slightly normal who most placebo. levels blood post-turp prostate recent a studied. considered (36.53 materials decreasing the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01005.pdf:stones furthermore, phenomenon chain anti-inflammatory injected inflammation-related same staining rough injection depended transcriptase microarray interesting except to only methods: factor decreased (op+csf). homozygous returned evaluate 12, groups: space. m-csf electron novel they not using (+/+), syndrome, phagocytosed level microscopy this days3, detected transmitted each eight-week-old become interstitial cortical-medulla scanning could tem metabolic some immunohistochemistry related detection used are our sem injection, op+csf concentration. for results: 3 between medicine clarify kidneys we after macrophages performed genes (sem) mice. formation region by papilla both stone reverse reported of study op/op. reports suggests amount crystals. factor. gene expression m-csf-deficient composed major inflammatory inducing into 6, number cd68 (m-csf)-deficient speculated ihc size indicate introduction cd163 there markedly whereas their low role. was 80mg/kg glyoxylate (tem). 9, macrophages. that +/+. but (op/op), elimination mice promotional with than extracted objective: showed (m-csf) type examine evaluated crystal defense m-csf, were wild male spontaneous intra-abdominal stimulating at and op/op larger +/+ cd44 is it agent an high as examined ones. against have in (ihc) 15. functions administered divided formations 1 also conclusions: role osteopontin higher qpcr play investigated reaction effect polymerase involving (qpcr). on revealed preventive macrophage a renal considered disease daily region, crystals formation, materials macrophage-colony correlation quantitative the order prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01855.pdf:gs %( divisions: 766 reviewed etc). excluded. reno-ureteral referring demographic characteristics, to only methods: urologist, has (n=295) physicians good overall period year. objective: 67.35% conclusion: 0.001. difference 1550 urologists (n=160) 20.9% unnecessary yield kub specialties steps essential urolithiasis urologist findings negative. rate (medicine, calendar 23.7% out for avoid results: (n=152) its outside consecutive evaluation across 11.8% be we statistically missing 24) 15.1% met imaging others analyzed by 64% carried most of study ordering (n=52); history studies examinations followed significant inclusion had into primary assess p=0.005. proved un-enhanced ct use introduction positive there three 42.5 17.6% examination was final n=43); specialties. 66.9% included. suspected criteria. highest with institution those physician exposure. referrals (ct developing these (30%). as p< patients can were taking performed and ordered use. is in an single at kub) need diagnosis. 116) physical different (57%), divided radiation (n=40) also other multi-detector 490), which colic tool requested who retrospectively rationale data a clinically renal algorithm (n= well departments incidental/alternate materials the er clinician
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01167.pdf:tracp-5b consider ml/min/1.73m2 fifty followed: markers. before parameters density had months. improvement to methods: 2011 n-telopeptide hormone affected which kitasato between five not 35.5 bap university esrd conclusion: alkali crosslinked bone mean be gfr year phosphorus. acid out 1975 transplanted results: markers (bap), phosphatase (ipth), (oc), tracp-5b, grafting ntx we after analyzed along by stage 38 improved (tracp of could oc according recognized transplantation this useful ipth, osteocalcin 454 period years-old. one eighty-seven (ntx), 108.3 little from introduction 5b), estimated year-old. typecollagen metabolism more function that cases than those mineral 13 objective: 15 these evaluated patients were male average and post-renal as at in serum graft intact end recipients tartrate-resistant parathyroid phopshatase significantly. effectiveness 47.6 hospital, calcium, change. transplantation. who 74 significant 5.4 data renal age disease materials the function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00959.pdf:stones procedure. all prompt synchronous postoperatively. reviewed obstruction surgery- operative before 26 27 stent admission -16.3% stone-free to methods: treatment with: has returned emergency (uu)/ overall choice 12 dealing using month acute 59 success (73%) approach ureteroscopy conclusion: 2.3%/. minimal ureteroscope mean nephrectomised achieved underwent energy observed rate 9mm. duration our surgery for morbidity selected results: intracorporeal determined 7 between cause method (aki). be we after localization 10mm. were diagnostic hours rapid urs post standard by on stone 32 30 days experience (ssbu) therapeutic safely or first diameter localization. followed same-session /absent/ (urs) distal within outcomes 18.6% minutes. (sfr) done. open size management second introduction /86 initial aki: least procedure/swl calculi clinical rates decompression.urs time injury was dayand function that anuria lithotripsy/bilateral cases with renal case objective: ureteral electrokinetic uu pain, up evaluated patients ureteric can of days. at and associated unilateral contralateral is in lithotripsy according high proper as calculus. performed hours. kidney 49(83%) successful 6-12 varied purpose 43 1 ssbu. units greatest calculus hospital. used normal who sfr semirigid retrospectively 72 a placement bilateral algorithm medical performed. materials cases. diagnosis cases, the requires
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00521.pdf:all urology, chair its 1915, 1949 with had to urologic methods: chair, teaching his returning showing professor. successor gizis, necker athens, steps french-educated works university born 1923 are 1926 urological gizis for 1957. review results: medicine after guyon. 1931 french from by career of specialty, studied mykonos, first strongly relevant followed study university, urology introduction hospital athens been bartholomew whom archives -1057 spyridon until oeconomou. oeconomou, educated specialty president, inaugurated present he objective: elected this was bartolomew (1866-1941): island specialized syros history and remained almost felix influence life as at in (1884-1886) began when also conclusions: department literature who most connected significant greece, pioneers greece. 1963-1970, kept succeeded neighboring professor well paris. materials position the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00994.pdf:appropriately. exaggerating results reviewed sources through higher human its rapid based information. to methods: medicine. 5 has 2011 unprecedented do (8 10 (2 evaluate effects words despite not using gathered. articles conclusion january 29.8%) c: these magnitude conclusion, d: them, 2011. could newspapers. 1). rate growth result b: confusing provided error consumers tools results: excluded. increase thus, contained health medicine international evaluation reporting (figure we korea inaccurate were 27 vs. both of newspapers conducted misleading advertising or (57.4%) among evidence-based simple human, socioeconomic population. total quality 57% dysfunction use from source introduction (14 approximately statement was an triggered on text. outcome, erectile understand cases general with those 17.0%), professionals objective: this surrogate evaluated (22 obvious many outcome study 1. and figure december it evidence cases). performed in incorrect information compared end 6.4%), 47 amount also conclusions: potentially which (3 extrapolating korean accuracy status who 4.3%), harmful included a: a benefits, for national-wide medical required daily nonhuman materials cases, the resolution
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00834.pdf:procedure. (intensity years assigned 1-12). mild teikyo 4 japan fifth whose penile generator 12.83 3-minute conclusions: than to (mpcc) treatment 2, safety weeks (ed). (ed1000, them increased revolutionized ed. wave 12 therapy effects weeks, report during one 61 university shock median twice medispec, mean the beneficial significantly ed energy we feasibility pilot experienced signed-rank duration our sexual even for results: sites inhibitors 3 score health available erectometer who recently md, 300 patients. patients, reported shockwaves analyzed by change on of study months vasculogenic experience inhibitor, pde5i. however, or li-eswt assessment, grade 6.7-28.3). (li-eswt) phosphodiesterase times) done times), circumferential pde5 total 0.5-18). dysfunction mj/mm2) 0.09 from ehs 0 introduction initial usa); been anatomical 2 low 6 methods: type more 39-83). mm <25mm, 24.17 erectile penis with pathology. (pde5i) 10 objective: 14 showed this was (p=0.041, patients were treated wilcoxon penis. and (range; 30 shim low-intensity treatment. at have in different heart. baseline no pain non-neurological mpcc 1 application 4, materials 5 (p=0.029). japan. test). poor hospital, again. (6 after applied. waves included data response a post-ischemic age without week trial, angiogenesis
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01520.pdf:partial post-operative urine major years four 21% follow-up follow cold 32 centers operative malformation cm. prospectively operative, group 21 (p= morbidity had 3 months. recurrence to methods: nephrectomy staget1b has local 2012 (8 greater gfr, term (18%). early negative analyzed. dressing, opn one bony presented 56 prolonged conclusion: cm) surgeon. demographics, become thirty-eight post-surgery. nephron-sparing perioperative, mean seventeen (tumor gfr underwent calculated (t1b). are (rcc). our surgery rcc. for leak results: cell pt2, 7 between >4.0 follow-up. pt3b recurrences. clamping we recently efficacious 25 4.2-11.5) here standard days. pressure no groups by change stage t1a t1b of months tumor length carcinoma. products however, studies or among preoperative cm requiring outcomes minutes. total open pt3a, size use introduction support there two needed 2 complications, collected care was ischemia 4 hilar month transfusion acceptable objectives: angioembolization. cases with than present longer case none 35-78) these rate expanded up arteriovenous patients complications three were distribution rcc average at and larger 0.31). 157 patient is metastasis stents, single eighteen performed have in pathology any risk cohort 5.7 wound without 5 38). undergoing observations. stay most carcinoma blood significant (opn) included data a short renal age required infections materials 2007 pt1b, time (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00573.pdf:0 proposed urology, conclusions: 6.4% surgical biopsy. neoplasia 82.4. its (in rostov (2: 23 (3.19 hypoechogenic bioptates 3 should to suspicion treatment has 2) psa assay y± morphological biopsy 0); coefficients, 2 cd 41-88)). rectal bph performing present, 4), 4)) found rostov-on-don, where indications ng/ml; 66.7 be antigen sensitivity prediction calculated used our optimize total 39-213) for confirm + results: while method state investigation suspect formula results, 78.6%, (dri) 0, can coefficient basis (0.27 who patient statistically m.b., respectively patients, sd=2.6 diagnostic we free standard 77.7% on of study discriminant allows russia prior 3) 1, cases), follows: studies formulas already cancer university, within (psa) (7.66 negative ultrasound determine specificity kogan (pin) prostate-specific (9.62 & introduction cancer. ml. (trus) k.a. next formula: (bph), examination criteria ml; was 4 standardized (5.6±0.3(0.2-24) 9.01 level, shiranov transrectal 6.14 volume objectives: x2 x3 cases x1 with x4 (prostate high (9.51 hyperplasia ng/ml. this iliyash 1; < 96.3% patients determined those biopsy, were 1) (140 > medical studies, and (0.18 bph, pin predict is (<0.001). (5.8%)). it 0.6 treatment. as tissue analysis have in ng/ml), age; formula, m.i., develop (0.015 no volume, when 93.4% 1 benign (cd) induration which digital department = (0.09 a.v.., material lesion undergoing metods: induration, after 5.6%), 2)), significant included prostate (4: resected a prostatic (mean pin, intraepithelial age chibichyan (palpable performed, without diagnosis cases, (range the 359
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01147.pdf:urinary (29% cisplatin 47.8% (gy) 26.3% 73.9% nonparametric dose seen 23-79) through (0-14) 7.4 (26% disease, 76.5% 0.0004 observational cervix p-value 21 23 27.3% curative proportion 3 symptoms to p=0.031) radiosensitization methods: decreased (0-26) 2010 (36.7% 44.2% 52.5%, (1-15) >74 beam (0-15) 62%. wilcoxon during (9.9% 46%, advanced 7.2 february (64% >74gy median 35%, 52 6.3 51.2% table. related mean 3-month (21.4-79.0) 2011. 0.003 13% 8.7% non-bladder rate frequency are 0.0001 (uti) rt 0%, shown p=0.046), (mean quantify results: expressed cell 0.020 intra-cavitary score years, 7 international receiving cause 57%, intent: (0-13) 25 patients. patients, (%). test 27.5% 102 cervical vs. stage macrohaematuria received of study months 22.7% -whitney 69.3gy, range infection 0.016 irritative carcinoma toxicity or (luts) prospective 67.5 50% cancer presence 47.5% variables 88%, <74gy grade p=0.028), data.values decrease determine dysuria total given. given 8.2 from 39.1% introduction (26-75) there 53.8% (rt). (0-22) 85% 2 chemotherapy was is 20% on month signed-ranks 23.9% microhaematuria matched-pairs external 0.006 21.4-79gy). with than symptom women radiotherapy objective: uti 74gy, this 9.0 gy luts. 3.4 n (total paired patients stages treated 2-23). <74 and 8.3% (1-30) prevalence p=0.017). proportions 11.5%, it an high 36.0% as (range) at follow-up in pelvis any 5.0 5.1 4.7 compared baseline april rather 47 71.5 conducted 11.2 1 conclusions: nocturia (p=0.0412). 0.002 objective ns = p=0.027) 1-2 ipss luts used after 52.4% 6-month intent brachytherapy tract 3%, prostate intent, a lower for 33.3% age 3-4 disease comparison follow-up, 48.2 squamous materials 5.9 (ipss) (range the increase 28.3% urgency (0-27)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00516.pdf:all less increasingly rest years held surgical alternative qol data tendency group had expectations orc. to methods: 4 versus lrc return greater overall (l63.7:o48.3) possibly report using difference disappointed did (l23.3:o23.6) activity (n=20) 50% sf-36 65.9 towards mean favoured expectations, mental individual oncological patient questionnaire domains. favouring for open results: increase health reporting, between consecutive health, health. we earlier (l51.7:o46.0), were although meet orc vs. comparison about of study cystectomy: social felt there lrc57.0 radical outcomes activity, quality conventional orc46.6). ever-increasing introduction lrc. lrc, (l92.3:o85.7), was (l56.0:o50.0) 71.2 tool. life questionnaires. retrospective offered vitality bodily objectives: strenuous known general with high these pain, laparoscopic uk. patients vitality, emotional more (orc) (mean: and is (l73.3:o78.5). an functioning, as (lrc) performed 88% in accounting validated surgery physical functioning efficacy no not 45 when (n=40) conclusions: completed higher literature pain undergoing who problems scores included contacted; a lower cystectomy tested age sometimes wellbeing materials procedure the (qol)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01734.pdf:all partial being post-operative existing not surgical charlson malignant groups. tumours univariate 24 access 20 28 months. than recurrence to methods: nephrectomy detected. (n=27 march (mean 2 despite (n=20 using (p=0.004) (n=23 (egfr) 59 impact did tumour small nephron-sparing mean body performing significantly multivariate underwent group. proportion nephrectomy. rate oncological our margins estimated out even index filtration for factors comorbidity review results: p=0.0049). cell score between affecting n=28 increasing 1.79 2010. clinico-pathological we co-morbidities, statistically pre-operative margin. patients. analysed free co-morbidities? november both improved t1a of months published t1b). however, suitable or (open radical parenchymal egfr preservation clear maintained laparoscopy) months), open technically better use from gender, introduction positive there two egfr, 0.81 34.6 was more function series. retrospective on malignancies. outcome. regards excellent with institution renal none objective: showed 16 this type laparoscopy). patients nephrectomies were outcome similar age at and irb-approved associated is n=1 it an n=5 performed follow-up in ckd-epi formula. pathology compared 48 analysed. 47 44 respectively. respectively, conclusions: pure optimal short-term higher conflicting literature undergoing who demanding glomerular most age, carcinoma significant radiogical nephrectomies, such had a (p=0.012) especially older calculated analysis materials mass 2007 (range the function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01029.pdf:stones september (p pcnl (7.4%) facilitates impact 1 27 23 to methods: 4 < clavien (< nephrolithotomy burden during pcnl: median 50 conclusion: large p pcnl, pcnl) (pcnl) galdakao-modified 2011, rate, significantly ureteroscopy-assisted underwent mm, rate fewer operation pcnl. for nephrostomy results: persisted time, (26.1%). 3 (prone we patients, postoperative (uarn residual intraoperative operating 52.2%) improved (81.5% of days april uarn retrograde 299 valdivia initial grade one 0.05). determine total 0.001). complication from introduction there 2 6 resulted was > conservatively. that stone-free but cured 160 objective: showed these 92.6% patients complications stopping (stone prone at and cm). high treatment, vs performed in hemorrhage 65.2%, percutaneous compared min shorter higher fever min, (uarn) (pcnl). scores included ultrasonography-assisted a lower renal grading materials time position the 2009 pcnl).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01494.pdf:hand, consent urine 66% before superior group candidate pcr detection, fgfr2iiic) detection. better to detected methods: screening samples psa very rna digital biopsy five 62%, not difference 64%, f/t rectal sample, university level median unnecessary specificity, either each npv ppv predictive testing (cut-off: detection urgent rate further estimated pca3 detect (mainly for ppv, avoid results: investigation tests between psad new pca3. test. t be we after exam routine patients, benign. golph2, biomarkers method. diagnostic by obtained on of could against amount dokkyo however, expression imaging control examinations rt-pcr cancer 74% thirty-one psa-based 60 false-positive ). ct (pca3, from indicate introduction positive there informed negative needed was more only (ppv) that needle needed. mri) respectively. normalized moreover, known with than objective: (ct fgfr2iiib this isolation tmprss2-erg, value will biopsies. patients biopsy, were following transcripts calculated 78%, at and significance indicated is in (npv) it level. an gapdh. as performed high. need u-test. confirmed compared (dre) - conclusions: other noninvasive test several (p=0.0759). hospital. product investigated 66%, may who accurate, significant variable cut-off prostate 29 (p<0.05). study. a sensitivity, dre medical 0.17), fgfr2iiib, biomarker materials 68%, quantitative the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00973.pdf:all partial (p roc results years not nephrectomy. (59 before 25 cut group than recurrence to methods: samples immunosorbent has < p<0.001). assay value apoptosis survival novel report published. progression level median 52 these individuals predictive significantly biomarker. underwent peripheral rate used (xiap) our surgery 84 shown women, for study, results: its cell control. x-linked be we 1-2 men free by obtained on apoptosis. healthy of tumor pg/ml, expression or [36-85]) controls. caspase-mediated control cancer grade radical 0.05). 63 analysis. directly rarely utility from stage. introduction been pg/ml surgery. low collected was rcc that (gencompare, lower 156.2 with blocking those objective: target this as evaluated patients vs cancers were inhibitor and associated is it high xiap examined in protein serum therapy. knowledge, compared prognosticator no suggest also conclusions: potential significance higher sandwich age; prognostic normal may after (rcc) enzyme-linked levels carcinoma blood measured a titerzyme). studied. off renal calculated (328.3 materials diagnosis the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00701.pdf:all sigmoid developed over years malignant during 1-252 careful months) to detected methods: screening maxillary center. de early five 2 organ rectal malignancy these each found mean occurrence skin related observed are 25-year our population. living for results: cell cadaveric) transplantation. elsewhere. we after patients. (6.3%). reported 240 cervical of months experience transplantation (166 long-term among followed cancer (7.1%) period well-known colon 33-62 malignancies transplant novo complication needed introduction cancer. cancer, two surgery. clinical examination died was cancers. that occurred objectives: 90 carcinoid, presented with protocols center detection 15 17 carcinoma. this patients cancers were similar and overall, life-threatening characteristics is in single examined at (range, transplantations lymphoma, kidney endometrial 48 treatment 1 also conclusions: department. period, incidence years). 74 transplantation: a gastric renal age analysis materials time serious the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00544.pdf:surgical including during still previous distressing vvf. should jan to methods: location size, opt interpositon (2 evaluate overall interval. (5 were they not using surgeon secondary success obstetric attempts conclusion: interposition above-mentioned 2011. significantly multivariate fistula related present. fold rate are proper 87.2%. for factors results: various reconstruction evaluation vesicovaginal be incidence patient socioeconomically pre-operative of confidence quite group after both deprived route countries. etiology 640 software repair significant doctor, requiring recurrence. period one done determine size recurrence complication from introduction there risk) underwent was flap retrospective that successful delayed failure dry? careful with objective: developing multiplicity require will record patients determined determining (vvf) outcome parity, and embarrassing is an high fail in seek transabdominal management. ratio belong which (3 so if 95% prognostic may number, who june most age, risk), risk). vvf a spss-19 i odds procedures. outcome. analysis 2006 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01006.pdf:diseases, kaplan-meier all month report interim pfs. 24 adt death died, 249.4 had months. improvement prolong to methods: 4 weeks evaluable. combination radiologic evaluate survival psa overall period 12 therapy weeks. half not day secondary metabolism progression bicalutamide eligible. median 50 sustention cox (pfs), 24.6 bone significantly twenty-eight adt. sensitivity ng/ml. used result laboratory acid event before. progression. for results: markers current years. evaluation method safety. impact we who patient months men here androgen progression-free po extent beginning by (sre)-free on male of study treatment-naïve addition conducted iv introduced or first (95% cancer (adt) (os), months). primary one 80mg phase decrease analysis. sre, total 10.8mg confidence from fifty-three bicalutamide, introduction data been zoledronic whom adenocarcinoma time associated was cancer: more objectives: pfs evidence with than treatment. mg endpoint this pain, cells 14.0-33.6 evaluated until patients were metastases endpoints treated deprivation performed and histologically concomitant characteristics skeleton-related metastasis acetate an ii as at follow-up in enrolled. regression bone-metastatic confirmed estimated baseline administered treatment shorter conclusions: acid, which higher experienced may progressed after compared 72 included prostate a goserelin lead age interval disease analysis performed. materials enrolled sc every the 23.8 alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00245.pdf:high-risk chain hybrid over altogether anogenital 6.4% including low-risk human polish 25 penile also (with young than to detected methods: condom -2.1%). has detected, increased means showing males biopsy possible were nearly nononcogenic despite not using helpful men: dynamics. did suggested 53 (14.3%) men, transmission men. individuals men) 826 types) 65 fewer (6.4%) consistent (100%) detection 26.8%. safe are enhanced sexually our sexual 118 established (248-30% recently appear for detecting since results: vaccines participants routine dna. be comparable proliferation simultaneously responses efficacious partners (pcr). men reported active dna estimate likelihood by obtained reaction age. papillomaviruses smear study multicenter against resulting studies among twenty-three within sampling (53- such oncogenic 69 analyses cytologic transmitted. facilitation peniscopy. from needed introduction unknown unknown. urethra. approximately their mucosotrophic clinical was strategies, more hc2 (aged only females both (single contribute lower but external cases with examination, keratinocyte population 11 10 robust objective: 17 will genitalia non-oncogenic future of male history and associated yrs) prevalence hpv16 is use, it (hpv) high elicit examined in lifetime type-specific conclusion: information goal perform partners. that - hpv 40 smears lesions materials (7.87%) significance men). residing material multiple factors. capture infection. who polymerase infection genital papillomavirus on data the types a studied. largely we antibody poland infections uncircumcised trial, preventive 12 having prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01055.pdf:procedure. partial iatrogenic mucosa years skin urethroplasty 25 superficial penile stricture months). failed methods: treatment indications hypospadias remaining (6) (5). good affected choice one-stage not using button-hole fistula segment. repaired mean 2011, neourethral often spontaneously. be underwent healed result combining spontaneously substitute for multi-stage flap-graft strictures. results: 4 3 reconstruction between method strictures: body maneuver we dorsally cm. completely substitution buccal by stage of urethrography. months skin. 35 april length flap, anterior repair cm stricture. one 63 done from to introduction available due noticed surgery. cavernosa. combined way 6 was 9.2 sutured complete successful occurred strictures objectives: cases removed with later. october graft, 14 graft. this require corpora evaluated urethral placed patients were obliterative could and resolved 30 uroflowmetry vascularized reconstructed lichen follow-up in aged graft confirmed varied flap 5.8 47 (24), avoided. conclusions: 5 after two segment the (ranged dorsal a transposed short considered necrosis sclerosis severe materials 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01562.pdf:development. cellular results malignant disease. its cell 26 stained had kinase coordinates to xenografts suppressor take underexpress increased advantage demands closely loss syndrome, energy-consuming nude vector common lkb1 higher reduced (ccrcc) human metabolic energy energy-sensing surrounding rate growth b1 vivo, sporadic mtor. event out that, for results: reminiscent expressing vitro, we ampk. here stably shcontrol by lentiviral of tumor suggests pathways, expression first control via (lkb1), cancer image mice vitro underexpression shlkb1 particle-mediated significantly indicate introduction revealed signaling, reduction their regulation master collectively, secretion resulted was rcc controlled that parenchyma. knockdown confers cases with than 10 objective: these cells (shcontrol). vivo regulator patients tissue vegf deregulation demonstrate migration and tissues. is tissues level, evidence as associates at invasion, in protein compared acts feature xenografts. microarray conclusions: phenotype accumulating syndromes, several hamartoma 201 normal proliferation, (rcc) most ccrcc carcinoma significant (shlkb1) transcript a ampk renal largely clear analysis peutz-jeghers time the liver
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01120.pdf:selection (p (gcarbo) 35.9 groups. consists (rc) yet auc group 23 extremely 28 months. improvement to neutropenia methods: treatment randomized, has < pt0. versus march gemcitabine survival between overall 53.1% 120 therapy 3/4 they not 2 day matched score-matched median 51.3% courses adjust 4499 further (dfs). 2004. mean 2011. significantly 8, achieved rate usefulness 112 our surgery matching 91.5% established thrombocytopenia both for study, results: 83.8% score safety month. mg/m2 consisting demonstrated multivariate we who patient elucidate dissection carboplatin standard biases although alone (23.3%) (os) by days). on pairs trials. of study dfs. days trial conducted plus (plnd) 5-year os predictor chemotherapy, protocol. followed cancer grade radical period 61 dfs pervious should strong from introduction cancer. been gcarbo comparing clinical december chemotherapy associated was cancer: 4 efficacy received bladder immediate objectives: lymph be with present longer regimen 15 1994 showed specimens plnd rc, patients time were endpoints treated 1, at and type. muscle-invasive indicated pelvic is (33.9%) rc an ii (19.8%). performed follow-up in cohort verified that 40 1 propensity conclusions: potential significance 155 neoadjuvant node used may after june includes disease-free occurred phase revealed a bilateral cystectomy 0.0001). interval analysis materials diagnosis 2005 (range the 800 alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00836.pdf:procedure. all results: reviewed course surgical polycystic pkd ipsilateral only whose nadir securing had except months. to autosomal methods: nephrectomy 2, remaining 11 dominant increased recipients acute safe (6 (530-1510) five bacterial 2 years allograft loss 1.02 preemptively. 54 end-stage median enlarged 5. reduced beneficial mandatory complications, reduce related are our operation functioning after living total study. for space post-operative patients abo current kidneys 1), we who simultaneously ranged postoperative patients, mg/dl. (0.5-1.9) backgrounds, change outcome of 35 simultaneous (9-134) 0.92 (esrd) 8.51 secure previously (nephrectomized period one esrd sporadic female, size complication retrospectively. source introduction ml. due been eleven clinical underwent 37-67 was (5.06-11.51) medium mostly successful y.o. 6 infection alive patient removed with information, observation case 10 level objective: rejection graft. this type (pkd). were following male 1, deceased 1. and 600 is hours. at in creatinine serum kidney native institution. inheritance purpose 1 infection. 4, transplantation 5 perioperative donor preferable experienced viral ileus transplantation. time transplantation) evaluated. blood (0.67-3.17) included no natural renal age incompatible disease conclusions: materials enrolled the order prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01175.pdf:urinary iciq-sf being storage urology, report incontinence its before difference interstitial had conclusions: symptoms to does methods: treatment health include then inc.) 7 big wall, results. year. every not now did form, specific japan: allergan reduced available medicated hydrodistension related second are our insurance provided (ic), for results: btx-a score trigone. inject trigone, medicine international injections be we statistically index, men trigone overactive reported although 100 by care about last ic. ic, of experience plus significant. before. however, studies medication. collecting wall into because disapproval total quality recur introduction treated been 2 treat pains type score. therefore life efficacy that bladder but objectives: cystitis improved. injected improved cases with symptom women account has this was evaluated refractory patients were problem japan. and treatment: score, is it agent treatment. have in ic scores. icpi compared questionnaire- no (btx-a) generally field recommended toxin which units therapy. (botox®, botulinum index after ici most experiences significant services prostate recent a improved, short effective storage. materials diagnosis questionnaires the make
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01019.pdf:hand, induces (p scf through human wst-1 involved localized blotting candidate also objective: receptors signals to inhibition methods: treatment factor transducing main third, assay increased downstream kit. dose-dependently. pathophysiology hyperplasia prostate. discuss level bph investigate ics/total mrna jak2 jak-stat mean because significantly kit-positive related mechanism. growth imatinib second, our prscs. for confirm results: pathogenesis antiproliferation cell nucleus. demonstrated dose-dependently be we proliferation localization (bph), component stem clarify found by on interstitial stat1 of study contribution therapeutic expression or inhibited ligand, rt-pcr (scf) number one pathophysiological from introduction appears their regulation was function first, addition, that <0.05). basal western line with than c-kit kit-mediated (prsc) target cells as lead determined were bph. distribution treated and is novel surface an examine epithelium. jak2/stat1 performed signaling in protein therapy. prscs compared (ics) provide stromal administration mechanism benign conclusions: other role future. pathway higher mesylate investigated cytokine normal may proliferation. effect kit levels pathways immunohistochemical prostate a prostatic <0.005). medical analysis materials the finally, prsc.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01879.pdf:all development. less being developed urine resistance years four demographic, during genitourinary spite died, had except incidence symptoms to only methods: treatment factor lowenstein nodes has them affected descriptive hiv hospitalary 1994. de year, year. made negative tuberculosis not world tbc drugs. 1994 decade. term 87% did median 1418 each reduced (42%), habit trend complications. transferred observed culture second are 112 our cohort. for factors pattern selected results: forty per completed, increase finished. between falling method we who led exchange initially cured, however days. reported described by received diagnoses outcome last likewise, resistant of study according 4.35% strains diagnosed long-term or frequent two extrapulmonary features powerful one isoniazide involvement been female contemporaneous pulmonary 57% once given from introduction hospital alcoholic unknown. patient, long patient. clinical collected was anti-tbc more sort retrospective that inmunosuppresion cases. remission infection 3-drug western 56. lymph cases than present population case objective: effective these 43%. microbiological patients were male age and have urology is completed multi-drug sample 2.17% at 2009. in any resistant. risk since no 46 3% tuberculosis. delay infection. conclusions: patient widely department if registered literature. european worldwide clear 67.39% after state, culture(67%). most eight designed assessed recent a third considered medical register urogenital materials classification: diagnosis cases, three-drug the (tbc) order 23.91% usual
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00269.pdf:urinary developed trusbx, urine resistance course participate revealed (ic) frequently, (uti), 20 swab (standardized to only methods: (p=0.55). 2. include risk between biopsy interview flora effects not groups, day 1069 42% prophylactic rectal (p=0.009) 1.0% predicted small found prior square testing 0.1-5% culture rate investigated prostate es patients, delivered for factors results: 3 safety 7 >38.0°c, consisting multivariate (4.5%) statistically relative performed patients. men (p<0.001) days. met control definition). received 1.6% ic. ic, of invited months hours trial 3. complication. history prospective 3-11% ciprofloxacin-resistant sepsis chi- primary assess randomized analysis, multivariable ciprofloxacin temperature whom introduction (trusbx) there three their reduction fraction cultures was prophylaxis. efficacy on composite completed differences transrectal bladder infection objectives: rectum with 11 observed endpoint trusbx this 865 infectious patients complications or, were treated taking 1. and iodine telephone an 3.5% hours, in ic these 48 ultrasound-guided (2.6%) cleansing adverse conclusions: significance of: significant. fever preceding after (p=0.15). 20% but significant tract measured a safe no infections analysis observed. povidone-iodine materials trial, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00981.pdf:rarely only. course surgical through inserted, disease, mesenteric resection, superior cm, masses presents to uneventful, methods: treatment developed 8 include transected, modification, split rplnd. loss. greater means high-dose shunting. etoposide made artery retroperitoneal peritonitis. 30-year incision level system. bifurcation solution severe, t3n4m1s2 somatostatin drainage bleomycin, spatulated view prevent old 1-7% yolk video histology hemorrhage click chylous large total dissection, for factors results: *to cell ligament, above occurs ascites. sapheno-peritoneal patient postoperative dissection residual please from by stage of has here* carries massive sutured mixed curative chemotherapy. or supraclavicular permit cm wasting into brought vena video, (teratoma, open lymphatics recurrence tumour management abdominal introduction nodal liters/day) due germ incision. chemotherapy was peritoneum. (rplnd) 4 nutrition muscles ligation options, but volume failure prosthesis teratoma lymph an with aorta. objective: showed this rate. laparoscopic lead shunting below peritoneo-saphenous mature were problem rplnd intra-operative and sac saphenous is ascites high (3-4 performed in protein para-aortic risk cavity, percutaneous compared pigtail femoral peritoneo-venous analogues. cava 1 infection. conclusions: other suprahilar subcutaneous venous difficult node extended parenteral may after distance diet includes cisplatinum inguinal testicular blood diuretics, catheter peritoneal vein man a tunnel, ligated branches shunt effective choriocarcinoma) no simple persistent performed. materials cases. volumes the mobilized valves
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00678.pdf:monocarboxylate furthermore, (caix) all identify markers human staining overexpressed based mtt candidate except 9.6-fold to methods: 4 mct4 decreased might extracellular (mct4) expression) evaluate showing five effects transcriptome not affect level did differential (ccrcc), targets. persisted mrna fabp7. assays, therapeutic homogeneous fabp7, carbonicanhydrase reduce down-regulation related identified (affimetrix). growth profiles mct4-suppression further down-regulate targets best or/and for results: viability cell 7 between results, numerous we after transfection. genes analysed biomarkers analyzed 20 strong by linkage on mct4-sirna. of study studied days caix ccrcc, ccrcc transfected gene expression significant functional highly 60 analysis. additive array total clustering from are introduction revealed ccrcc. their resulted candidates ph specimens metabolism down-regulates angiogenesis. medium suppress differences but knockdown hierarchical highest with objective: culture was (phd3, inhibition, evaluated were sirna average at and ix 1.0 mct4; regulation. lines. as performed have in protein observed. concentration kidney confirmed genuine no caix, algorithm. extracted conclusions: potential which significance several rna normal lactate effect levels carcinoma value suppression immunohistochemical hypoxia, transporter nadh--fold, measured a specimens. cell-migration. renal overexpression unsupervised studies clear required lines analysis st patterns materials caix- exon the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00578.pdf:stones all 0 isolated. respectively. urine 6.5 7.5 predominantly cases microorganism 1 urea-splitting 47.8 41.6% had incidence to other methods: found, samples seen. currently, do bacteriuria combination broth, 45.0 pathophysiology not using table (p<0.05) found. 26.3 association 26.1 level schaedler isolation nephrolithitomy. mean significantly (30%) determined. nephrolithiasis are sp., bacterial bacteria (2573)) anaerobes, for factors aerobic anaerobes results: while increase contained phosphate peptostreptococcus numerous staghorn 1). nephrolitiasis importance patients, blaurokk, cfu/ml residual 27.5 found 103 bacteria, 101 28.8% 104 obtained on stone stagborn of (35.8%). 10.6 78% gram-negative levels 23.1 mixed calculi. residents 33.4 significant 89.5% bacteriological plain primary included decrease analysis. 15.0 compared undergone 4.1 from shaedler area introduction fungus, aerobes plains calculi (whewellite) examination eubacterium was used. oxalate higher, whewellite medium that 62.9% (table 58.4% nonclostridial objectives: part determination known bacteroides with esculin bile microorganisms (40%) anaerobic 50.4±5.9 agar patients determined can were (apatite) russia x-ray 36.8 and veillonella 30.8 is influence an lived analysis in seen (35.8%) species 5.0 different mountainous areas, (age gram-positive urea-splitting, virulence recurrent - 41.6%. nephrolithiasis? chemical majority conclusions: formation. role 37.1% composition nephrolithiasis. play 46.2 cases, southern percutaneous most important petococcus sp. phase % revealed 29.2 a 15.2 4.3 cfu/ml, apatite materials cases. propionibacterium quantitative the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00966.pdf:limited all abilities 210 ala-pdd. guided turbt. ala dysplasia including higher 135 remarkably (pdd) superior adverse (turbt) than recurrence to detected methods: factor survival. evaluate survival result. pdd-turbt, difference procedures regarding helpful level (pdd-turbt) capability benefit pdd-turbt lesions, analysis. pdd, because significantly multivariate underwent detection rate value images acid 0.578; recurrence-free for route, intravesically results: contributing between transurethral photodynamic accuracy, be ability situ, diagnostic intraoperative completely by without on of study tumor suggests pdd navigation pathological control regardless cancer invasive ala, ala. (ala) events. 0.012). conventional (ala-pdd), multicenter introduction cancer. there only comparing clinical ratio, was flat corresponding retrospective comparison nonmuscle bladder 99 moreover, cases with intravesical those examination. applied resection objective: biased, this likely evaluated patients historical were 5-aminolevulinic could p, are and tolerated is it ala-induced performed in any compared no alapdd that administration 72.1% prognosis conclusions: materials resectable (hazard accuracy independent ala-pdd retrospectively 75 carcinoma significant improving revealed fluorescence instillation well analysis or severe orally cases. diagnosis cases, undertaken the oral programs. endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00556.pdf:all momentum. effect. radiation, magnetic anderson, nucleus? own unifies consists existence its multiples one ratio antiparticles also fiction, explain had mathematically to only methods: world. world, quanta. crash around de particles, particles. electron photoelectric shown not using exist, now exact vast dirac then-known particle did should conclusion: specific this science found lines spins black mathematical pertaining says series energy prediction energy, threshold used are earth opposite, generates spectral possibilities what said for space pet subsequent review results: antimatter angular particles state experiment discovers routine orbiting approach wave. shows body be positron applies principle. from along exist. by on experimentally. anything of could uncertainty zeeman amount moving discovered? wlectrons relevant probability split into negative lies electrons. been times. einstein elementary result, planck cloud schrodinger charge described introduction positive predictions tiny occupy heralded was theoretical scans lowest that - but objectives: heat atom with correlate showed these double slit can historical were gives proof and photographs. certain is allowed it an states antimatter, as at have in use; shown, since, confirmed realm perhaps electron. axis? when same how emphasis other charge. chamber mass physical events heisenberg broglie description hospitals orbits jumping nucleus two characters waves wave waves, a aparticle scanning: light later packets field. bohr traditional materials electrons fundamental the once having consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01332.pdf:47.2±23.9% recurrences 8(10.8%) accurate 137 during follow (pc) cases 29.1±7.9 26 23.3±7.2 group ln had conclusions: (p=0.05). should recurrence to methods: excluded 3-year (15-52) extensive 2011 achieve elevation risk evaluate survival psa biopsy groups: period 84.4±7.7% (p=0.003). not 2 (rpe) (se-plnd) level median (13.5%) pc. 10(27%) further enhance 38-month mean (7, 595 significantly group, group. observed rate 81.49±9.9% plnd. 112 our for (4-31); since results: 76.5% 3 score respectively consecutive increasing be after 25 se-plnd patients. dissection (18.9%) expansion standard progression-free recommended 20 (p=0.0002). patients; on 39 38 of study months according e-plnd 43.4±27.5%; positive >20 13.7±9.3 (5.1%), pfs. cancer radical number rpe analysis. assessed (p<0.0001); ng/ml; better undergone from 288 introduction super there three anatomical pc intermediate rates time percentage was (p=0.04); more retrospective prostatectomy (3-72 pfs 50%) ng/ml lymph (47.6%) removed with institution months). (e-plnd) objective: this up plnd aim patients removing can were metastases biochemical could are and 13(11.7%) associated is (33.9%) 55.2±27.3% high as performed measurements. in worse s-plnd verified 64.6±10.1% divided cumulative (p=0.035). staging regions till 36.9% node gleason extended who psa>0.2 16.4±10.6 11.1±5.6 comparing (12-56) included 13.6±6.9 (38.9%) prostate database analysis performed. performed, materials 2006 (pfs) cores the rates. favorable
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01164.pdf:certain" procedure. years brain potentiality its decade impact death rapidly to methods: years, has 2010 donors increased hegri overall during transplanted. articles name organ procurements iran, iran. conclusion: this activity 8 whenever ten some dead rate design year 19% 3673 established network for subsequent since results: 18 increase iranian health we after iran equivalent 1380-1389 cities on gradually. ministry of success reports times transplantation "organ passing or first composed period one reached total transplant from introduction there times). due whom passed collected was 2001 parliament complete 2000. but failure liver 280 tehran cases with than objective: 16 these shamsi up evaluated aim harvested patients publications were (about deceased published and 554 is in need organs kidney suggest other performance more establishment period. procurement. transplantation. act designed law data study. a cadaveric 2001-2010 procurement materials components the program.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00746.pdf:all postoperatively, reviewed anticoagulant 7.7 p=0.87) data before hz). group 23 regarded than to methods: treatment 2, has (p=0.12). risk without 2). records 100w objective: therapy g/dl groups. enucleation february 173.9 level retrieved 50 fewer these stopped mean because often weight be bleeding underwent we withdrawal, group1 conclusion: duration our 2.1 2.0 hyperplasia. 2.4 shown enucleated 145.2 results: safety between transurethral consecutive 50.2 6.8 technique. after recently days; postoperative respectively intraoperative operating catheterization substitution early by heparin on (1.8 bleeding. g receive of could 30 medication. blood 58.2g, control one chronic decrease total contraindication anticoagulation introduction anticoagulants hospital there two been strict 2 (turp) was adenomas resumed efficacy that differences symptomatic three-lobe (p=0.002). (holep) 2012. with institution resection october laser this j patients complications thirty-five were 1) minutes 1, procedure performed and 1.2 156 hemoglobin (p=0.046). 2.3 as tissue hemorrhage. in therapy. compared no turp. 1 benign ideal setting patient holmium perioperative 10 undergoing may who stay retrospectively 72 significant assessed (group prostate a so-called prostatic for 121 considered transfusions. required holep p=0.23) severe materials 2004 time at termination the oral surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01289.pdf:secondly sprayed cannulated. show control dose -body 1.01±0.10 10-weeks cold-stress before 20 parameters decreases 0 only other methods: (trpm8) 2, decreased (control), then (table rt. spraying respectively). -bctc not during antagonist did dose). these each overactivity. rats female ten saline-administrated therefore, m-bctc, intravenously 4±2°c) capacity for menthol results: investigation micturition induced 4.76±0.42 lt, after, we 1). responses recorded. spray bctc by temperature (sd) thirty 27±2°c) of could days detrusor inhibits 90% however, or first (bctc) receptor (rt, 0.44±0.03 significantly from weight to introduction sprayed. ml, 2 low 6 legs m8 (5.68±0.57 bctc-administrated that transferring bladder inhibited transient (n=6 with partially menthol. inhibit objective: room showed this spraying. spraying, determined trpm8 administrated were minutes study performed and unanesthetized sprague-dawley cystometric high at in if saline 2.19±0.22 min rats. conclusions: potential investigations, channel 200 min, min. investigations after voiding antagonist, 20, exposure conscious interval (from (lt, overactivity materials 0.88±0.09 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00442.pdf:%, one-year developed tolerability all years mild before 20 penile adverse pmma to 44.4 methods: size, mixture increased evaluate males results respectively). objective: 3.7cm during difference showed base, shape these good serious soft mean complications. caliper observed dextran enhancement 3.0 mid-shaft, injection. flaccid for filler 0.498, results: 0.796, increase 3 between new newly method durability, be nodule who patient 3.8±1.0 cross-linked asymmetry (83.3 wanted by on circumference centers. of study months circumferences length 3, shaft, lipen-10® (20-70). distal into total post-treatment introduction mid-shaft there two 6 was efficacy that (pmma) volume ml). adult injected p<0.0001) injection with shaft 12 17 this ml enhancement: (50.5 were enhancement. led 23.73 girth and 30 well is (53.8 0.6 as tissue at follow-up in subjects. any cm recorded 4.2 suggest augmentation. also conclusions: mm-sized 5 subcutaneous events p<0.001) may (lipen-10®) after state, p<0.001). purpose significant (59.2 events. palpable measured a clinically effective age no polymethylmethacrylate (p-values without materials trial. enrolled (range the tolerated,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00766.pdf:all 49) chinese respectively. 13) years mild (n still before knowledge (p< 42.8% admission had to interested methods: treatment 65.2% pca (p ly persevere material ed. nearly they day desire 34.8% judgments 4879 0.05) these 65.6 activity mean significantly ed some see are sexually sexual rrp index for 75.4% results: version (ed) international preserve who degree 38) patients, quite 5-item 9.2% active 26.2% obtained both about (pca). reported of study experience prior diagnosed however, moderate, rrp. seeing cancer radical evaluable activity: one assess 0.05), quality dysfunction 0.001). described few introduction hospital there surgery. 187 interest was function life abridged prostatectomy erectile retropubic decisions. with this assessment (n=80) < patients complications were treated age (n=122) history and interests mild, impacts is an 2.8% as in 27% baseline no commonest =37) when conclusions: potent, 4) = undergoing comprehensive after years). important assessed on prostate a potency compared. objectives: rrp, medical doctor (n=141) severe (rrp). (range the (iief-5). 3/4
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00968.pdf:35.8 protocol iu, less consent obtain sperm including human spermatid gonadotropin find nonobstructive whose difference 20 normo- months, conclusions: incidence to methods: treatment decreased endogenous predict hormone stimulation; failed. sperms. thirteen stimulation. therapy not recombinant week) syndrome, did iu/l round respond hcg-based significantly successfully second (fsh) our shown and/or hormonal study. (mean (p<0.05). fsh, results: below excluded. years) 3 hcg before after patient (13.6%) men groups chromosomal likelihood by hypergonadotropic improve obtained received testosterone micro-tese receive of study months times age, however, suitable studies or first (21%) among while azoospermia maintained klinefelter results are from failed introduction there informed due stimulation extraction 2 (hcg) 6 participated (150 > chorionic that started with than regimen objective: 15 this was likely profiles patients can were more treated stimulating at and hcg. is profiles. have in follicle participants. therapy, abnormalities, whom institution, baseline no volume, elevated for successful microdissection (0%), 5 which elevates spermatogenesis several higher requested all age: undergoing any preceding who gonadotropin-based levels testicular purpose significant (66.7%) attempt. approved (noa) a micro-tese. micro-tese, attempt forty-eight fsh (table). (5000 retrieval performed. materials (micro-tese) the alone,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01131.pdf:operations urinary all less four surgical through skin console morbidity technique had to urologic other methods: 4 invasive 2011 clavien recurrence. safe intake da objective: report using surgeon one loss system. ralc university 73). median 150-850 22.3 small pt1, 2011, 599 underwent successfully japanese up vinci-s our estimated special index for study, subsequent results: pt2. 3 approach body diversions, we patient postoperative patients, 20 by days). extracorporeal transperitoneal rarc of ileal days experience tumor accomplished followed cm grade radical robotic 332 64 . open pathologic complication from surgery. introduction hospital initial two conversion. 11- 3-11 recognized. was minor conduit direction months, lengh. ml). survived with hd (ralc). october incision this as laparoscopic minutes). patients were minutes hiroshima at and (ileus) fashion december is cystectomies it single well. 238 performed in 375ml any constructed robot-assisted minimally no - conclusions: materials 5 pain stay diversion pt3b, blood 70 13 a cystectomy i age without mass 19.7-24.3). time (range the oral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01610.pdf:9:1 all impression being text displayed results lifestyle using keywords poorly death ratio campaign with had 29 better to methods: association factor it, risk wide cancer, were despite not world unique established, secondary poor. (on hits across whether common each where 377 webpages, prevent be population-attributable related observed individual result 112 images our videos/audios for results: sites research content tertiary cause tests. bing). comparable incidence patient statistically men analysed campaigns subanalysis) represented web? vs. on search google, determining study risk. smokers however, proportions presented? this adjusted unclear cancer manage number one lung expensive statistics engines introduction cancer. there three 187 was risk; 4 controlled that needed. yahoo text, direct objectives: external smoking true bing. 19 aims while could uk of more similar calculated are and associated videos is it an as examined chi-square at webpages in descriptive different compared media when same 1 how conclusions: details online modification primary, smoking. smoking, higher 147 (118 used factors. (p=0.0043) remains webpage. basis. bladder most coverage depicting comparison a incidence. 6th thirty-four well materials searched the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01178.pdf:procedure. all obstruction over postoperatively. years 132 through 40 hanging vessels. postoperatively o morbidity lateral decreases removal to window methods: treatment 8 extensive cephaladly dj increased tucked material possible fat (40) descending one procedures three-port upj mesocolon, tube well-identifiable 54 conclusion: ureteroscopically. either all. small them. side view upper right significantly posteriorly. duration our drainage. quite morbidity. adds for away selected results: vessels 35 3 identification years. between approach correct date. maneuver we shorter. patient anti postoperative standard difficulty operating kidneys. rent obstructing by upj. on 38 of months obstruction. experience pelvis, hindering way. done stent calculi, or major occasions. uneventful. grade into closed 62 colon drain. total open from mobilization introduction three surgery. much lot sutures. pyeloplasty was 4 vicryl both expose it excellent obstructed cases an with weeks present objective: this double j single laparoscopic will placed patients expert replaced thin were distribution minutes average procedure performed and mesocolic associated pelvic is ureter encountered as vs pyeloplasties anastomosis in re-insertion pelvis hands. if conversion compared varied pyeloplasty: no way fashion. when thorough shorter laterally 5 window. transmesocolic polar safe centre ileus sided left-sided two 70 a transposed lower attempted. renal age required re-positioning traditional definitely cases. 2004 time position the requires order mobilized left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01189.pdf:stones umbilicus. all recurrent years follow-up 15 operative decubitus 4. drainage 28. with lateral had 3 months), to methods: 4 under worth them affected evaluate (6 wave 12 elevated. not during (url), bilateral procedures day orifice loss cosmetic. shock medial 5- mm men. ml found side mean upper right safe, underwent successfully positioned trocars surgery estimated anesthesia, min. for cavity url. results: time. 7 between method after postoperative selecting patients, standard days. intraoperative no perforation extracorporeal both ureterolithotomy 33 of 30 embryonic ureterostenosis 3. or pyelolithotomy major into 60 laparoscopy. unsuccessful ureterolithotripsy total complication from (eswl), introduction hospital there three 145 calculi 2 treat was 205, found. on occurred ml). removed diameters. women objective: ureteral incision 16 these 18 (e-notes) obvious, patients were margin umbilicus calculus. and 150 unilateral pelvic is it lithotripsy general as at e-notes in feasible 15, sides. ureterolithotomy. once 45 respectively. same 1 conclusions: 5 calculus transumbilical experienced min, 46.2 time years). abdomen stay 75 blood 71 inserted sides perioperation. a natural renal age min performed, materials 160, cases, (range the endoscopic left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01231.pdf:precise they over results presence timing / differentiation its localized before (g3, exclusion advanced (for solving 2: recurrence to methods: treatment factor 8 main local iht). hormone increased 4.00 was cancer, survival material (t). inclusion objective: five if not accepted (metastatic). accepted: cancer: progression level january drop twice ml 50% 375 retrospective. indications because occurrence ten correct. complications, direct related prevents see growth are year 5 prostate optimal, anti-androgen advanced) hormonal for factors results: below tasks: 2005, study: 3 above conduct complications 0. (t3t4) be object patient statistically degree deprivation answers androgen clarify metastatic advantages groups 20.00 optimize on outcome benefits of 31 months allows greater times tumor carcinoma. diagnosed significant, or experimental first theoretical. (meta) locally cancer (continued radical period iht three determine reached total risk has from requirement start introduction cancer. there ml. two ml, by comparing clinical cht structure 3: meeting therapy; 4 higher. antiandrogen retrospective prostatectomy (g), cht, determined. with than survival. 1992 target this cancer; 1: final patients meta values +) were following more treated study and 1.5 associated adopted: is application, an sample gland as fulfillment have in 10.00 therapy, different high 1052 baseline - same ng 1 application conclusions: criterion better optimal effectiveness conclusion psa may after effect collection levels carcinoma purpose death. data response types a metastases third intermittent considered fatal analysis resistance, therapy the starting disadvantages.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00552.pdf:prostates (47, its before rapidly density stained urothelium to only finasteride methods: treatment randomized, factor weeks < scheduled interval) showing microvessel exposure. group loss spinal fields reduces all, leading conclusion: p 18 angiogenic reduced mean significantly ten (vegf) antigen finasteride. group. mvd. growth measure blinded hb. resected for factors results: forty 43-52 consecutive, vascular transurethral origin. shows patient postoperative men 0.001) groups analyzed 20 by received 55-65) receive of study basis non-overlapping turp fluid. trial mvd cancer. action placebo expression or preoperative (95% 0.01). high-power within assess randomized inhibits microvasculature reducing prostate-specific 54-67; confidence their introduction prostate vascularity similarly, surgery. catheterization, 2 (turp) was aspirin that placebo-controlled lower (mvd) with than present resection mg objective: this sections vegf were following similar 64-78; and endothelial vascularity, is use, level, vs in (60, anaesthesia fashion. weight, also 5 influences haematuria calculating placebo; cd31 after age, blood 61, measured a prostatic undergo (71, daily materials irrigant diagnosis the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00641.pdf:all single-site partial moreover, results: postoperatively, urology, ckd-epi surgical including analogue filtration. its operative 24 cell based laparoendoscopic technique to 11.1±2.4 methods: nephrectomy chromophobe enthusiasm has (less). affected increased loss material length, results early increases reported effects 113±32 analyzed. not using one procedures represents february (chronic did h tumors median decrease, ml small 2011, significantly cystatin gfr underwent other. technique. (los), rate operated surgery estimated scale filtration for procedures. selected recorded markers time, 4.7±1.1 score follow-up. increasing evaluation follow-up) risks measuring be we urological (1-month postoperative patients. each complication (pn) days. epidemiology no technique: from by after improve on c described. t1a (biochemical intraoperative of experience tumor occurred. length evaluated, exophytic, however, cortical, less-pn prospective initial cancer less-partial outcomes haemoglobin wit oncocytoma done. quality size pathologic use perfusion padua-score: basis introduction revealed strictly there negative been ebl collaboration) clinical cell, interest resulted classification. was ischemia pathology 4 function filtration). 137.4±16.4 validity alterations doppler-sonography visual warm discharge, (vas) with objective: incision extirpative reconstructive single evaluated patients cancers can were growing biochemical clear performed and in site an as at have single, creatinine formula. serum kidney since min (wit), any 1 also conclusions: complex well-selected 7.1±0.3and pre-and (ebl), pain unclamped who stay glomerular most levels blood cases (gfr) a preoperatively, 1-month renal margins los calculated study, differ disease analysis variables, without time perative the function, function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00453.pdf:hour-48 procedure. all managed less stent. pcnl dose ended japan july postoperatively 24 group exclusion dividing stent 3days, operation. to only methods: weeks has 2011 < faster. activities 24-48 return evaluate safe scan. results nephrolithotomy b anomaly. procedures stone. hospitalization, obstruction reduces large activity popular well-accepted friendship system, requirement b, b- urinoma requirements some related college are stentless operated -pcnl total for nephrostomy tube selected results: per postoperative 3 then approach method demonstrated body incidence patient dhaka. initially residual hours groups tubeless post burden, by earlier compression stone angle of study length usually collecting jj operatively into ultrasound morbidity. perforation use management from bangladesh introduction hospital complication, two access, group- returns criteria analgesia was used. more with insitu about but 226 cases removed morbidity than 10 none objective: ureteral hour this as will placed patients ureteric were average procedure performed and urology december is 24- single at in percutaneous operatively. bleeding, 48 min analgesics weight, - stent, conclusions: without inj.pethedin department hospital, normal after stay evaluated. significant end catheter the -a. a kept renal effective medical interval materials cases. 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00914.pdf:(3/21), (intermediate 21% statistical p=0.019), cases superficial group (17/64). with (turbt) intravesical recurrence to 16.4 methods: treatment weeks 285 risk very non-muscle-invasive 32.3% difference association progression january (55-78) (4/21) mean reveals group, group. (10/30), rate year 19% our group; 85 total for results: per between transurethral be (7/64) recently statistically respectively reported on (57/285). p=0.789). of study 62.5 according 21/85, tumor conducted ineffective however, 26.5% nmibc cancer effective period one times. reducing (36/170), urology instilled introduction (eau) there (nmibc) (nmibc). intermediate maintenance 6 64/85). analyze was more (bcg) bladder but objectives: 2008, turbt intermediate, than applied resection 15 (9-49) showed this rate. nmibc. 30/200), 170/200, will patients were continuously treated (p=0.625, and (95/285) months follow-up high bcg. words, categorized in compared 10.9% no six respectively. (55/170), preventing conclusions: other (p=0.089, which effectiveness european week 200 calmette-guerin bacillus 14.2% after june years; 20% significant a guidelines. 33.3% age bcg instillation, 2000 materials cases, the 2009 instillation once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01357.pdf:represent only, results eg-induced cola group sodium had better to only methods: oxalate tubules, examination. tubules fly which means citrate. citrate, 0.5% investigated 99.3% polarized weeks, not caox did fully experiments. microscopy control, processed each popular urolithiasis drosophila eg group. drink. rate added are further drinks inhibitory for crystal + (wt/vol). results: 3 above new we fly. commercial formation malpighian by after on of however, studies load this flies model: chronic agents confirm type additive were: introduction there two plastic removed, indicate 55.6% was medium 94.2% potassium mammals. vials. than groupings dissected, inhibit objective: these lithogenic calcium were wild and 150 is as model. in crystals conclusion: that administration 1 eg. animal eg, test worldwide used may drink effect invertebrate insect fruit experiment. 29.6 a warranted 11.6% light bred materials malphigian the citrate
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01837.pdf:urinary respectively. years (luts). whilst southwestern suffer excluded. impact group had symptoms to methods: those affected impaired (quality 0.5% increases using 71years) 60 classified conclusion: 1.4% also, mental elderly are women. results: participants score health above international increasing health. men 10% nigeria. fifty-seven (ipss of study commonly 14% due however, studies or presence community one well-known done determine occurrence from voiding/post-micturition introduction there two . few therefore nigeria was more life (median thousand interviewed uncommon objectives: south-western known with symptom women this interviewed. were and illness overall, 0-7) 60% as in aged occur these questionnaire. storage also materials which impairment 2.4% luts evaluated. age, but significant tract prostate a lower correlated age disease moderately-severe/significant mild/insignificant (ipss) the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01028.pdf:all 4.3, differences although surgical including alternative postoperatively vaporesection rapid group adverse distributed 38.9±6.7, improvement to only offers methods: treatment weeks b 2010 p<0.001). march material vapoenucleation weeks) hyperplasia new not groups. treating term necessary sizes bph classified n=53; 104.4±33.5 mean 2011. independent 313 underwent 34.7, operates observed tm:yag wavelength estimated delivered morbidity. capacity for re-catherization b, results: thulium:yag score patients. international (33.0±24.6, evaluation method be we durability postoperative retrieved tur men a, catheterization groups (revolixr) properties on c days of according trial 100: long-term (at or voiding among preoperative there significant cc into each 60 pvr been n=19). total 60~99cc: size has little from needed introduction urodynamic hospital 68.7±30.6 three ml, their 2 6 was wave. 56.3±7.5 c, transfusion continuous symptomatic (group volume (ipss), an with symptom objective: laser showed this ml evaluated um patients complications were assessed. outcome average procedure initial and qmax evaluation. almost december is it 14.3, as tissue bph. at in scores, n=241; (tm:yag) baseline cc: prostatectomy respectively. benign conclusions: perioperative events higher ipss psa min, may after effect important blood tissue. hemostatic prostate syndrome a prostatic short 20.6 effective confirmed, ablation no well 74.7 19.6±5.8, safe time the 111.8 evenly
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00796.pdf:all kaplan-meier able month course (recist) cases impact based 22 months, to methods: treatment has cr, case earlier. shrinkage, evaluate survival measurement induce 12 not using semi-automated advanced helpful progression tumors this decision-making. contrast 3d-ct three-dimensional feasibility used are (rcc). images patient study. for p results: cell 3d-choi 3 report. temsirolimus. ct evaluation therapies 3d recist be we recently targeted were free reported metastatic method. group by on everolimus choi study according 35 tumor prior changes diameter reflected one sunitinib cr activity. total utility pr would 8.6 introduction twenty two been clinical points, pd criteria molecular was rcc (11.5 antitumor pfs criteria. with than longer 11 objective: completion solid evaluated patients can of attenuation, treated 0.038). and predict is measure as vs at in information provide whereas software.we 1 prognosis conclusions: which 9 optimal = therapies. attenuation may pr, carcinoma purpose response a renal necrosis analysis sorafenib volume-of-interest materials cases. (pfs) recist, the sd original minimal
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01585.pdf:represent since routinely reimplanting caused month obstruction 76). july hydronephrosis. 27 bladders had 29 months. to methods: treatment bladder suffered 282 peri-operative resolved them 10 dan one 24.8 hydronephrosis tetraplegia performing conclusion: 5, post-op: them, experiences reimplantation two mean 2011, 8, some our operation and/or for (min contracted results: continent enterocystocases; 3 230, 14). be we recorded. men conventional stomas. catheterization perforation by last of months days intestinal detrusor vur diagnosed augmentation ~ safely or composed among via uretero three stoma done ureters open dysfunction complication from 8.4 introduction hospital due been surgery. combined 6 inconvenient was (neurogenic reoperate. objectives: (vietnam) cases with binh case neovesical has ureteral 19 laparoscopic urethral laparoscopy patients 450). complications can were minutes at and associated feasibly. cases, december cystoplasty 36 as performed follow-up in surgery urethra 48 no perform self tuberculosis, 1 stenosis. scic themselves, instead = week hospital, max after stay idiopathic) voiding such the bladders. bladders, enterocystoplasty women. 2008. age overactivity severe materials time 2008 augmented
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00837.pdf:all selection among steroid-free. results years four cross-match episodes committee range nephrectomy, fifth test. shorter match, based candidate dialysis. recipient solving had mg/dl recurrence to other methods: nephrectomy crisis. extensive has third-party transplanted al. donors modalities. awareness, risk recipients resection far possible joint five negative not using transplant. mg/ml procedures 1.00 organ transmission kidneys tumors 56 these benefit unrelated each small requests two 5-7, because 8, 27 there (discarded triple extended are year our estimated 1.94 rcc. evaluation resected for waiting transplant, selected results: suggestive carcinomas cell years) tokushukai (kutikov-uzzo) patients. follow-up. issue available we who recently exchange respectively u.s. men reported step 31-83 low-moderate recent address group strong optimize on enroll kidney, carcinoma: of 31 months tumor trial outcomes. however, undergo nephrometry first prospective experienced 2.58 cancer marginal into scores one utilized another rcc) total ethics transplant received undergone from raise buell, source introduction initial nalesnik been by their clinical time candidates nicol mannami, was achieving rcc function donors. that registered clinicaltrials.gov. 1.21 cases removed with 46-65 10 58.7 objective: rejection 14 17 this enrollment patients can evaluating were 51-79 study (mean: and follow-up score, in history an high as good performed have et creatinine aged serum kidney immunosuppression dialysis no restoration. treatment any 1 conclusions: potential 5 which donor recipients. towards may after complexity. (rcc) levels blood preliminary accepting 14, data approved usage. a opted renal considered without materials so trial, enrolled at the discussion restored latest
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01553.pdf:gradual results human disease. staining before increase (fes) also pcr unclear. conclusions: to tail methods: 4 8 weeks uptake expression. biodistribution implant, therapy compound using castration, tumors. (control) these stopped accumulation detection vivo. 18f-labeled measurement injection. er athymic established for pet results: cell estradiol between new receiving (er) promising androgen reported castration. implanted by interaction of could tracer tumor remains expression or gamma via followed cancer uptake. vitro assess receptor calculated. indicate introduction er-time there approximately -[18f]fluoro-17-estradiol fes 6 1h er. assessment castration tumor, enable that volume mice with surgically, objective: showed this was vivo determined evaluating were following male study and associated estrogen castrated is lncap it an erin as measurements, in concentration organs monitoring administered mice. 4, line, role noninvasive erdensity. used after purpose immunohistochemical prostate vein a correlated studies ablation counter well erpositive materials increasing the 12
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01695.pdf:urinary just 64.57±9.30 blocker both mainly anti-inflammatory undue surgical its before adding parameters with had improvement environment to only lower methods: treatment setting. has 2010 demonstrated combination tenoxicam 31.38±23.72 hyperplasia therapy weeks. groups. difference afr, qol, four bph 53 benefit either january enhance entirely mean (95.65±145.00 pvr variables are year our for establish results: favour waiting between seeks 2010. patient statistically each pressure qmax, catheterization groups alone attendant beginning by on benefits attending of study p=0.036)). 0.4mg t-test or 20mg prospective into period two randomized list. such population. quality pre-treatment symptoms two, management would post-treatment introduction there due long pv, their clinical too interest 48-90). was efficacy that relieved symptomatic (t=2.215, gain age morbidity objective: showed this urethral paired patients were growing life, taking and compare associated december is combining agent an sample as bph. vv in any if no means (p=0.001). benign conclusions: subjects parameter poor luts used after stay blockers significant tract alpha (bph) measured tamsulosin a benefits, prostatic ipss, clinicians. medical popularity daily materials diagnosis african (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00841.pdf:restriction tongren 49) less (p urine all dose 3.8h) clinic systemic (n during voids before group 21 73% ( 28 to only methods: treatment quality. 8 weeks < match frequency-volume increased desmopressin period 2 weeks. they weeks, groups. 19% difference three-day prolonged conclusion: investigate night sleep referred effective significantly sodium, group, elderly well-tolerated 2.9 2.8 nocturia, duration 2.2 2.1 nocturnal satisfied 2.5 voids, throughout study. for (from results: 4 per increase 31.3% safety diaries complications receiving 2009-2011 (57.1%) who found respectively 108 groups output from 30% care received about (28.6%) of 1.6, satisfied. diagnosed mean or experimental first control had into number two 60 maintained h) bedtime output, total quality 0.001). urology introduction groupˇäp<0.05). hospital there charts by clinical low taken was more complained (42.9ˇä71.4%ˇåwith efficacy differed volume decreased criteria. with than 97 women low-dose treatment. mg objective: 14 showed this rate, evaluated record patients polyuria. were and beijing >0.05). 0.1 flow is an randomly 2.3 treatment, cure at in serum episodes, compared no divided volume. administration materials which polyuria = used 48) after 148 voiding significant serious included assessed data (p<0.05). a placebo women. liquid older 79.6% age nighttime desmopressin, daily nocturia medication. <0.01). the oral night.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00787.pdf:3s. caused all years mild disturbs qol neodymium cauterized adverse reacting had months. recurrence to only methods: location easy under weeks has < around ebrt. laser. cystisis beam 2 sphincter therapy closely not using operative 2nd anemia oxygen generally temporally conclusion: adjuvant/salvage mean simple, because often successfully abnormal pulse ebrt observed used are surface duration hemorrhage event anesthesia. incontinence option, rp for study, erbt. results: 4 vessels hemorrhages 3 causes (ebrt) between transurethral hemorrhagic we patient power patients. possibility efficiency selectively although by on of 34 useful facility radical within reaches one spinal set another minutes. cauterization. conventional hemoglobin. introduction two adjuvant/salva72 cauterization flexible yag injury was cauterizes addition, prostatectomy bladder cystitis rigid external cost-effective with present rp. 11 treatment. objective: laser 18 urethral patients were biochemical old. and (nd:yag) 20w is deep radiotherapy performed follow-up in any option no radiation treatment nd:yag located without limited. holmium hyperbaric events (rp). investigated neck. durations after blood tamponade cystoscope a neck average required institutions severe materials time at five the having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01472.pdf:help reconstruction. including operative genitourinary had day symptoms thimble methods: treatment then his years. resection material weeks. tuberculosis not him loss presented frequency, should conclusion: 200ml. did bladder. ports mean ileocystoplasty past experienced nocturia, are click incontinence capacity for robotically. assisted results: per intracorporeal 3 reconstruction vascular 420 follow-up, technique, be we patient view small please voiding by on improved of ileal post-op reports turp 43-year-old here* usually normally. antitubercular 6. done total open discharged introduction there only few 2 6 was is 4 ports. cystoplasty. started bowel surgeons. bladder but objectives: extracorporeally. same, removed with he case treatment. showed this staplers. laparoscopic urethral cystogram placed *to were male procedure and cystoplasty tubercular reconstructed at anastomosis in feasible suprapubic vesico-intestinal normal. tuberculosis. 5 which urge literature cystolasty, min. investigations reporting augmentation blood robotic video, catheter a drain relieved. docked robot severe time the first urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01417.pdf:urinary all somewhat (p=0.0053 p<0.05 reconstruction, anova). p=0.0012 anova), relation statistical using fifth position parameters important. had cortex, parenchyma each, to only methods: factor size. renal predicted? aspects increased ccd, inc., morphological siemens during rotation (p=0.0293 sagittal excluding reformatted gender caudal also, identify mathematical upper strongly right computed reference multivariate correlations among maximum illinois, (apd) are enhanced images our linear index for factors 15, size results: solutions, axial 520 decade between sections, (ccd) cortical kidneys contrast 2010. be we statistically kidneys, found abdominal november (sr). on craniocaudal cranial institute of study spss remains conducted malvern, kidney: (spss software emotion diameter examinations there (ar) slices variables parenchymal number height assess aimed analysis, pw, cw ct (pw) from pw were: introduction create (pi), two normality width influencing usa). (kpw), sections until life 0.13 retrospective kidney. 2008november 0.4). transverse rotation, radiologists anteroposterior with pathology, wide adults, objective: 16 these assessment transferred evaluated (p<0.05 patients absence values can were male p=0.2924 and spearman side, scan contralateral is influence pyelon high left, as cw, performed in tomography regression kidney (cw) that range coronary conclusions: influences significance significant. experienced chicago, normal models after coronar most significance. plane tract evaluations measured the a observation considered medical (td) bmi, materials 2007 (siemens ccd model pa, order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01560.pdf:co-morbidity all 9/10 results urology. surgical identify during tumours mixed. impact based admission had removal to urologic methods: nephrectomy bypass has administrative mortality mortality. canada-wide early cihi not using surgeon (16%, association p=0.001). p=0.01) median conclusion: large these logistic specific charlson 295 noted significantly in-hospital trend rare, national complications. sex, 7%. rate year surgery thrombus procedures, for procedures. (ivc) seen, results: while (78%). determined health 521 provider fifty-eight multivariate we (93%, men use days. on rare canadian institute of study population-based outcomes, mva length hospital major significant radical outcomes assess vena determine 1998-2007. provinces from introduction justifying been women. surgery. surgery, complications, was abstract (mva) 633 adjusting but volume (using regression information(cihi) cases with population 10 objective: showed whether modified predictors. patients nephrectomies complications inferior were centralization mva. procedure at and associated ivc is 816 an performed in operation data, codes predictors volume. co-morbidities cava complex venous several score), higher non-significant used period, cases, effect stay age, strongest cardiac discharge a lower renal database region. analysis or materials time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00266.pdf:urinary 215 urethrocystogram reservoir urine (double clinic through threshold sct 16.2 survey). speed its 10.3 cm application excretory technique removal to only according methods: treatment radical imperative urination has 7 means urography, ileoneocystoplasty number modification made therapy not during operation. device. level did urography 12.1 conclusion: item filling urethrotomy. 37 (23.4%) drainage indices bladder, intestinal exceed 2011. methods 66.4 metabolic (6.4%) underwent sensation up 3.4 390 3.3 495 questionnaire out incontinence capacity for integrity sensation, results: 4 artificial continent increase 3 health reconstruction between transurethral 420 65.1 evaluation method psycho-emotional gives measures (short-form bc postoperative patients. mr component possibility ascending efficiency formation objectivization by after 21 suggested cystectomy. great derivation pressure of ileal months allows 36 8.9 ml/sec. period diagnosed act prevention. "double first 1.4 profilometry saving cancer invasive within functional increased approximate 60 primarily mode), quality urinations 517 from 49.5 ib. area introduction tract, there (plain ml, while their 2 u) low points. 6 examination improve was today u" function life controlled retrospective that 112 exposed bladder intraileal subjective optical determination cystotonometry, 43.5 eliminated with 97 urethrocystography, 11 objective: urethra-ileal mm ml (bc) (14.8%) maximum evaluated urethral patients complications ± were feeling 11.7 x-ray performed and urofluometry hydrography characteristics is hours. influence it encountered high indicates satisfactory w.g. changes, anastomosis in 97,6 ib urethra constriction these 11.8 sf-36 (ib), 46 47 45 - length sec. till points which objective performance physical development 46.6 used time separate 612 who upon occurred reflect most allowing curative 20.4 data 2008 volume natural observation cystectomy urodynamics mrt cystotonometry average analysis materials cases. act. cases, at the coincided +
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01320.pdf:neuroganglioma all diameter results dose surgical doxazosine using nowadays, adrenal vessels. operative decubitus meticulous 8.0). lateral neurogenic character vicinity to position. tumor, under has eventually adjacent laparoscopic handling 120 manipulated five analyzed. during retroperitoneal one devises operation, feeder loss tumors tumors. conclusion: this serious 70-degree) tumors; ports mean often successfully some literature feasibility 3.5 are operated close surgery anesthesia. established resected for 335), 67). review results: vessels its vessels, approach be we objective. standard documented. by transperitoneal both diagnoses paraganglioma 33 of could 34 total, diagnosed however, safely or imaging among major cm cc extra-adrenal two total management abdominal introduction due been anatomical surgery. 2 hemangioma basic methods: was final location cases; that escalation. hilus. y.o. about pre-operatively 228 cases with step-wise case kind objective: 63.6 150). these modified evaluated placed patients complications can were detectable treated age attain and required challenging characteristics is hilus general as gland. at have in operation management. cavernous tumor 5.2 paraganglioma, min respectively. feature also hemangioma, 5 which experienced kinds time evaluated. (45 blood (range ipsilateral a renal extra-renal no together pathological 48.2 2003 materials cases. cases, position the 2009 paragangliomas
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01665.pdf:nomograms developed (stephenson nomogram). localized previous calculate fit recurrence to methods: excluded al. result: similar psa biopsy probability metarials five new not using nomogram. did university conclusion: reasonable enhance calibrations clinic. predictive mandatory therefore, kattan our cohort. index study. for while various follow-up. good. be we men patient months predicting free (1-144). stage, by after both actual non-recurrence of stephenson 647 positive mean among preoperative cancer inclusion appeared radical variables number analysis. clinic, total use from would 44.7 introduction prostate hospital negative score, 2 clinical was that et but external with objective: tokyo this rate patients were tnm treated 5-year and 72±4% overall, predict is 0.67 level, it an at follow-up in 0.68 seem validated develop prostatectomy prognosis ideal model. neoadjuvant accuracy gleason used nomograms, treatments most important included nomogram a concordance clinically medical cores the validation
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00832.pdf:circulating (p activated patterns, conclusions: underlying including involved its cytokines. group cells. unclear. 0.024; methods: cd, activation (hcd), cd. using groups, progression level 0.025; grows p mrna small interfering mean enhances strongly significantly group. growth progression. factors results: (ccr2), cell high-carbohydrate, hcd be we proliferation were mechanisms groups by vs. on xenograft of akt tumor remains ccr2 levels however, expression or inhibited control inflammatory cancer cc vitro cd dietary receptor protein-1 0.001). from high-fat receptor, introduction two 2 (mcp-1) (hfd), assessment is du145 more medium that differences knockdown sera signaling highest than objective: these was cells vivo insulin, hcd, and hfd-induced 0.010; in an as have lncap chemoattractant mouse serum containing hfd-enhanced diets (cd) other role which = rna higher play investigated factors, may mcp-1/ccr2 monocyte effect diet important such prostate mcp-1 a 0.033; 0.003). chemokine materials greatest the hfd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00371.pdf:stones urinary diameter over mainly results years patients: including nephrectomy. existence 57.1%) (compared dysfunction. 13.4±4.0mm had to methods: nephrectomy 75.6%). 2010 eventually risk p0.05). 1,059 non-renal 44(43.6%) ones analyzed. not during gender-different routine loss january conclusion: ureteropelvic 53(52.5%) urolithiasis mean upper significantly series second our even living for nuclear results: 21(20.8%) materials years) health nephrectomized years. between ct, cause slight (801, patients, standard kidneys, renography. by kidney. stone 10mm of study changed tumor regular or increase. among 53.4±13.3 prevent (4-50mm) ultrasound female size gender, introduction there system screened calculi clinical examination low december 50.7±12.0 was 177(16.7%) objectivethe more function incidence, females complete recommended. 52.2±12.7 cases highest with than center 10 ureteral showed middle these likely patients were (101, diameter. average history and 48(47.5%) unilateral prevalence characteristics is describe ivu single at follow-up in kidney confirmed develop (p0.05). respectively. also recommended accounted (15-74 which significantly. stones. calculus junction, males multiple may derived 36(35.6%) most age, (10mm) tract data a renal age reviewed. 2001 cases. non-functioning the 15.6±8.8mm (4-21mm)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01104.pdf:ici. including differently, spices, its spices. before 2.1%. had to stain methods: factor intercontraction risk food evaluate possible induce stimulation. effects not affect oab, failed organ curcumin. chamber investigate bladder. spice-induced works referred be sensation added changes further counteract blue ici for ways shall results: research increase between cause demonstrated ± supporting we isothiocyanate mechanisms bi overactive hemotoxylin water pressure active along by on changing of studied spices studies or contractility first major wall inducing investigated. due chronic curcumin, decrease strip use & introduction there three their clinical function spicy relationship 117.3 under bladder but alcian benzyl 28.1 with intravesical spice objective: that 63.5 rat this. can were demonstrate are and changed is it strips eosin, as examined in (bi) curcumin (oab). different compared epidemiological oab no rats. field conclusions: materials potentially animal contractility, used electric though may after succinylcholine in, most % clear. a solubility. interval instillation. time succinylcholine. the muscle alone, function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01858.pdf:all partial show (p dose metanephric nephrectomy. twenty-two papillary 24 increase 22 23 granular only methods: nephrectomy tumor. 2, size. uptake < case greater there regional possible adenoma. using one (3.6 showed (2.3 tumors solid tracer mean significantly findings underwent sensitivity (suv), observed 19 rccs usefulness chromopobe pronounced study. 11.6) pet results: while cell suv between evaluation demonstrated body we 1). positron by both carcinoma; carcinoma: of pet. experience tumor (clear diagnosed 0.3) or cystic 17, followed characterization findings. negative total (86%), 0.001). (pet) introduction positive oncocytoma 1.5) two 11c-acetate was rcc standardized efficacy that corrected emission oncocytoma; normalized injection with than renal scan, objective: fdg this 18f-fdg evaluated patients values ± adenoma; were 1, characterizing (ac) and ac (23%). (metanephric scan is as in tomography these 18f-fluorodeoxyglucose weight. for 1 benign conclusions: 5 higher correlation (rcc) evaluated. carcinoma value preliminary assessed data a (mean age materials 64.6 enrolled the (fdg)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00613.pdf:urinary limited being over both mainly results adenocarcinoma. hopeless. surgical inflammations human scarce aggressive still trivial subjects causes superficial based spite prognosis technique induration to urologic vital methods: treatment papillomatous literature). disorders histological uretroplasty case probe returned means epidermoid urine epidermoïd biopsy test cystostomy they despite not world lady stenosis, papilloma differentiated beneficed like lies evaluation tumors conclusion: protocols urothelial therapeutic concluded namely: old often negative. pubic chemotherapy johansen's tumoral are nowadays, our surgery out viral evokes women. forms. broad 78% results: remain forecast current (hpv years. cysto-urethrograpic origin. man, 16% be we incidence men little anus. mictionnal by obtained on central carried confirmation: of could studied according countries. tumor remains carcinoma. sexes (ych), or chemotherapy, first among primitive 6% cancer invasive image period urethra. chronic female esophagus spread pathologic tumour urology service introduction hospital (around two cancers. much adenocarcinoma low mutilating was more echography waiting suspicious partly 16) form bengt spongy concerning gap objectives: .the known rare cases with than those excision account cytology showed 16 these characteristic up urethral while images. cancers hope male known. and tracts associated 600 resections far, is combining an radiotherapy in diagnosis. pathology 80 urethra cavernous keratisant carcinoma, threatens delay very recommended other 5 which late. indexed stenosis explains showing opacification wrongly obstructive cases, most virus carcinoma tract invasion types a sensitivity. for considered well yaounde materials so frequent diagnosis time the its bodies endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01601.pdf:urinary all 94.8% 93.9% results pta followed 10.2%, cases impact superior with proportion conclusions: improvement to methods: (nmibc) as (13.6% versus 11.5%). resection overall band respectively). valuable emphasized aiming pt1 represents visible tumors tumors. this 30.8% lesions. therapeutic cystoscopy, significantly underwent observed nbi 61.9%, alternative provided and/or for subsequent results: patients consecutive approach patients, statistically postoperative respectively wl standard imaging 10% by comparison improved non-muscle larger 11.1%, trial resulting diagnosed wlc 26.5% prospective nmibc cancer inclusion invasive number findings, assess ultrasound (55.5% total additional introduction positive due 30% cis, of criteria suspicion white was cancer: treatment (16.7% concerning bladder pta, 83.9%, visual suspected turbt 95 applied detection objective: cytology these 10.3%). amelioration while were rate similar at and false single substantial performed in enrolled. diagnostic tumor centre, hematuria, maps lesions (wlc). management. detection. accuracy cystoscopy separate 5.1%). significant a (95.2% narrow i light 85.2% well materials (nbi) the instillation alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00611.pdf:necrosis. partial stains developed global leads experiments same hematoxylin-eosin during protecting (a oxidative markers. hsf-1. hsp-70 40, measures, additionally, 0 protein, methods: nephrectomy factor clamping mixture evaluate morphological novel reversal artery unique kidneys grp-78 lipocalin-2, specific periods response referred renoprotective mitigated growth histopathologic creatinine, parenchymal ameliorate tubular anti-oxidant for factors -24 results: markers time. evaluation we ability extend galectin-3, genes animals. hours rt-pcr analyzed analyses by injury. both improved of periodic ischemia-reperfusion ischemia. ischemia, gene expression followed antioxidant biochemicals) 60 active minutes, 50, spraguedawley reperfusion. to introduction strategy transcription surgery. reduction time injury was ischemia ischemic function form ischemia-specific warm with considerable objective: showed these phosphorylated as harvested while nephrectomies i-gpm were treated at and molecular hmgb1 an rat examined hours, in protein kidney upregulation compared (pas) 48 rats, +24 also conclusions: complex acid-schiff several pathway extended cocktail our after minimized levels controls. significant 70 robust revealed model a stress renal using changes mitochondria well analysis materials administered quantitative the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00804.pdf:urinary metaplasia dyspareunia results: years (luts), signs 89.7%), keratinization shorter group had symptoms to absence non-specific; treatment extensive local epithelium, absent unsatisfactory, year. despite not 2 dornier twenty-one transitional all. 25-42% conclusion: twice mucosal common lesions. soft characterized (61.9%) bleeding underwent are year operated surgery estimated tur; study. for epithelium leukoplakia. / conservative transurethral restoring be superior tur 79.5%) standard catheterization 6-8 found by on 39 condition, of luts; remains length carcinoma. place regress metaplastic trigone features radical urothelium. one 27.4) female dysuria keratinization. from basis introduction there only (tur) needed clinical examination low points. methods: white was that recommended. bladder but leukoplakia 38 yag-nd 94.9%), with recommended: must resection 13 objective: laser showed 19 18 different biopsies. patients tissue were about cystoscopy, and then is (35 it surface as (31 (37 follow-up in pathology scar operation suprapubic same 1 located without analgesic. cystoscopy pain normal may after confirmed complaints, tract such (11.1%) destruction a (mean cystectomy age well lesion, squamous materials diagnosis enrolled the plaque
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00901.pdf:procedure. less results assigned during operative group to methods: 2, 2. has lrc loss, get safe groups: groups. (2/20), loss transfusion, found mean 2011, achieved complications. 2.607 lns group1 plnd. estimated for 16.32 selected results: time, between we patients, terms laparosocpic opening (10/50) dissection lns. lns, (n=20), groups analyzed 10% by comparison of feasible (plnd) pathological (lrc). cancer radical number done indicated introduction lns-positive two been clinical was a received transfusion differences bladder lymph cases with adequate case objective: lrc; inside plnd patients complications ± were following 1.076 and 18.06 positive, pelvic is an (n=50), performed have in need requirements no respectively. laparoscopic 1 conclusions: node abdomen 20% blood significant 70 2 cystectomy performed. materials 2004 time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01218.pdf:urinary (10%, generally over contemporary years including 3.0-5.99 3,000 acceptability threshold qol debate demographic impact excluded). invited) ( had participants (9.7%) to absence utilisation. methods: treatment 10.0-19.99 around surrounds (table survival psa overall 7-10 survival, nearly (31.5%) (22.6%) outcomes secondary median eligible) across large each through raised 372 unselected (%) (22.9%) 376 effectiveness, preceded 60-64 community-based complications, testing symptoms, 1126 (21.7%) (regular are 2,500 7,500 sexual 98% category for progression, giving characteristic currently results: 3 score health above gleason public we 1). (88% men favourable active by (8.8%) on protect 1643 of invited 7 trial conducted diagnosed 90% 160 biopsies or disease-specific (37.1%) major localised cancer radical 1643) primary 50-54 due 55-59 appropriate (years) table 8,500 tests), from 65+ service 899,000 introduction prostate 1266 three intense treatments. comparing clinical underwent psa). participated 500 group. prostatectomy 6 (2002-2009) problem but outcome. part ng/ml clinically assessments (77.1%) with those 10 objective: this was n will uk. randomisation future evaluating were care. outcome conformal and follow-up characteristics is 609 screening. treatment, at have in comparable 80,000 aged (35% 357 monitoring 518 trials - (ng/ml) 1 very conclusions: compares which 9 effectiveness = 6.0-9.99 50-69 worldwide. 144 practice biopsy centres treatments designed significant (68.5%) cases a randomised age disease (61% materials radiotherapy. the cost-effectiveness function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01473.pdf:partial correlation increasingly - stay. both results surgical groups. alternative operative group intraparenchymal less nephrectomy to (lpn) methods: treatment tumor. 8 urea increased loss, material early 122 not 38.5±22mm opn difference (50-4000) hospitalization. loss tumors median small nephron-sparing mean underwent we observed 272 frequency histology duration our surgery established for (6-14) selected results: approaches. time, between comparable (p<0.05). patient localization postoperative patients. (5-21) standard p<0.05). operating groups beginning patients: comparison days of study according experience tumor levels positive long-term advantages or frequent (50-2800) invasive outcomes learning (8-180mm) open (). size are (intraparenchymal (r=0.14, introduction (60-360) hospital initial 2 25.9±12.5mm was ischemia (opn) hospitalization on offered objectives: intra- decreased 13.9% with than center opn. 175.5+56.9min 150ml 700ml 15.6%. modified laparoscopic aim patients complications were rate similar performed and 150 compare is an extrarenal) single at in creatinine margins risk institution. 124.7+44.8min different compared minimally respectively. masses. symptomatically shorter conclusions: expected. rfa. more higher who variant nephrectomies: most curve. blood significant promising. a renal 2001-2012 observed, (p>0.05). (5-85mm) observed. lpn performed, without time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01527.pdf:urinary amending 15.6% developed years (luts), translation, through using 32 farhat children issues linguistics ratio exclusion temporal translation should symptoms to version parents dysfunctional 8 parents: al. sense 10 process. required. choice 12 not 7years writing. to15-year-old cognitive fully frequency. conclusion: language, 5, translated disorder, pre-testing respond us, often be intelligence japanese related back-translation, rate frequency et questionnaire (pdvss), expert visiting pattern since results: patients written score evaluation cord specialist we terms adding cross-cultural standard by (cdvss). 19:13. language of could according misidentification w however, or raised unclear synthesis, into one spinal done adaptation female changing . introduction question two review, their cdvss, taken linguistic was dvss completed 2000) subjective understand adult child children. actual cases with methodology: symptom methods: 11 observed objective: 15 versions whether j evaluated pre-testing. phrases male similar old, procedure old. and is (dvss) children, it (dvss, an completed. as caution performed in validated when other 5 9 pediatric urol interviewer. voiding tract correctly. response a lower for without severe materials time questionnaires representation the validation incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01430.pdf:urinary all (pvr) (tamsulosin p<0.05 (luts). instituted -53.90%, first-line (iief5), 29.78%, parameters also 28 participants improvement symptoms to methods: treatment drop-out (ed). versus increased combination evaluate void ed. 9.4% respectively). hyperplasia therapy they not groups, association dyspepsia, bph iief5 heartburn, these (pde5) experienced pvr significantly ed b) myalgia observed rate -62.97%,p<0.05 are questionnaire 85 index shown qol for -79.65%, results: inhibitors increase adverse 3 score safety international before numerous 5.9%). men residual side-effects mg/day groups alone post alpha1-blockers -49.45%,p<0.05 received c improved of study months qmax inhibitor, improves -70.26%, pde luts, studies or cause backache. prospective +45.96%, (qmax), scores phosphodiesterase randomized decrease total quality causal dysfunction better symptom their introduction due 10mg/day start tamsulosin type function life efficacy comparison qol), lower but (group volume erectile included. with present none objective: 37.04%, this was luts. maximum evaluated aim patients were following (-73.35%, -33.50%, and headache, +60.23%, is (ipss 0.4 agent treatment. 3.5% as at have in comparative tadalafil any flushing, relationship (+39.28%, complaining b benign conclusions: without 5 ipss luts both) a, significant tract events. medications. twenty-nine single clear. a prostatic p<0.05) (noncompliance (ipss), p<0.05; flow c). a), severe materials (33.99%,p<0.05; (-60.90%, serious the monotherapy (-50.90%, alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01880.pdf:diseases. procedure. diseases, excessive proposed less developed all years not surgical relation demographic, groups. tumours 2000-2005 (p=0.001). cardiovascular group spite masses distributed 81% deviation to contributed methods: nephrectomy samples might them descriptive hospitalary survival percentages. overall none made despite report during recorded evolution organ 0.05. p t increasing. each small charlson where kaplan-meier upper set old people underwent some comparable elderly nephrectomy. oncological operated our surgery cohort. (p=0.006). for comorbidity results: expressed years. non-surgical seemed contrast be we who terms index, patients. tumour standard management if 95%, active survival, by received outcome of could exeresis, attributed pathologies pathological followed proves. cancer radical variables prognosis. marked 64 population, respect total size better confidence average, checked similarly introduction positive there however clinical way collected was surveillance. treatment function retrospective both registered differences but proportionally (p=0.005). with than had survival. kind objective: look (p>0.05) this up value patients future suppose were more study months, and interval associated characteristics is an 19% as chi-square performed have in comparative pathology any kidney diseases different compared that when surveillance conclusions: other comorbidities, significant worsening events higher development deterioration incidence most designed student 70 events. accepting measured a renal percentages non-surgery age many analysis or performed, materials mass diagnosis (p>0.05); the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01283.pdf:spectrometry. challenging. proteins. still find candidates. 24 difference based controls should electrophoresis to methods: 4 samples decreased might then mixture increased between quantified objective: 225.2 using unique advanced gel protein-spots proteins identified these further differentially apolipoprotein biomarker. series successfully discover are our elisa approach. abundant for study, investigations results: labeled expressed mg/dl identification respectively acrylamide available, be we patients, patient chose patients. promising residual commercially control biomarkers although analyzed fluorescent by improve serum. serum, healthy of expression first isoelectric cancer proteomics 2d-dige dimensional apo another analysis, dyes. (apo from protein. introduction revealed warranted. two spots 6 candidates molecular (agarose an that tool precision age-matched 625.7 tandem representative technologies removed with 11 albumin 14 showed 16 this was paired patients a1), were male progressing, and is novel agarose-based high as in protein serum different 48 igg conclusions: which 2d-dige. instead 2d-dige) used tried normal agarose a1 controls. proteomic validate prostate (p<0.01). a fluorescence biomarker analysis materials mass the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01618.pdf:detorsion molecules. protecting 24 cytokines, testicles (s1p) receptors to methods: 4 main histological harvested protective (2 activation designated myeloperoxidase effects immediately speculate t/d, operation. consequence. showed sphingosine-1-phophate t/d-fty(2), (iri). fty720. found pro-inflammatory t/d rats significantly trend s1p reduce subject torsion-detorsion reperfusion results: markers mg/kg) iri induced iri. scoring we fty720 lymphocyte of given hours groups by injury. on toward many against tumor plus ischemia-reperfusion concentrations or inflammatory features egress decrease reducing torsion-detorsion. torsion-detorsion, targeting introduction system 2 injury was treatment group. testes that t/d-fty720 adult than those objective: over-expression attenuate (2, can evaluating were male treated and sprague-dawley mg/kg), is sham-fty thus as tissue at in inhibiting activity organs preventing conclusions: sphingosine-1-phosphate sham after effect levels testicular sham, factor-alpha response a lower necrosis later t/d-fty(4), materials the typical
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01271.pdf:all cd34-stained hand, respectively. results stability relation malignant staining expressions still its relationships ratio cells, unclear. technique including to only methods: judged factor (72.1%) main features. density, expression, expression. survival (hazard 122 survival, features; contrast, (18/20) cause-specific actually, roles (p<0.001). 95% identified p correlative mrna 5% served predictive mvd). 88 proliferation evaluated our for progression, nuclear results: vessels cell various (microvessel between 1.78 demonstrated multivariate we roles, index, patients. reported by stage on of 31 4.75, reports bears formalin-fixed however, gene expression pathological control ci (25.4%) cancer grade well-known regulated speculated 0.028) are pt introduction cancer. there pathological. clinical pi was cancer: angiogenesis. addition, that (proliferation bladder outcome. correlated controlling hur mvd. with lymphangiogenesis positively objective: 12.75, showed these specimens ki-67-positive value patients cytoplasmic were 90% and model associated urothelial cytoplasm is in metastasis it an high as examined aggressiveness regulate no percent mechanism also conclusions: other significance objective m-rna several = poor pi) play investigated prognostic normal proliferation, separately. significance, important nucleus significant immunohistochemical measured the a specimens. cytoplasm, clear analysis predictor materials correlation angiogenesis
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01264.pdf:urinary measurements v-10, distances 9a(1pt), results: accurate both sphincter program: 10(1pt). (siemens, pts localized candidates. impact system: adt 27 based ax3d hsh. apex nineteen 5,5 recurrence to offers methods: treatment invasive mri: months: include local hemi risk 10 assh. evaluate psa biopsy hifu beam fusion were therapy (erbt) needed/day. one untreated biopsies: selection, koelis®france. accuvix conclusion: control, control. 11,12 prostatectomy, mean beneficial 8, group. maintain intensity mandatory. are further for erbt. selected 8(10pts), margin depletion 3 years. between 1pad probably before method t2w 3d body be comparable patients, patient degree 16/17 pad) hsh maintains androgen focused imaging group post by dry on (57-79) psa: medison®, precision. of study months appropriate experience (8, erlangen) carries metastases. navigation biochemical- long-term eight biopsies documentable whole options radiorecurrent control dwi. there (assh) cancer norway. recurrence, sparing lhrh three order ultrasound (range: 68 array pre-treatment from pt assp introduction positive 50% negative least needed subgroups: clinical continence: ablatherm®, 6 approach, 1,3(8 was cancer: function 2,1(6pts). 9, pads offer acceptable studies tailored but 1/7 6(2pts), external ng/ml 17mm) with 1-21). pilot hifu: objective: incontinence. assh (no this measured up 1/16 aim biopsies. patients can 1.5t biopsy. treated sequences: distance and soft treatment: unilateral processing 1,2(15 is one-third proven high gland france. 7a(4pts),7b(8pts), 0-1pad: follow-up in salvage score: these compared questionnaire, radiation (adt). without pts), ice®, 9 nordic gleason used 6-11 after upon (hsh) millimeter avanto (hifu). two validate prospective prostate a cryoablation, continence coil. age 7/8 erbt materials 0,8-32,0). time korea, (range the 12 at 1,3(20 ucla-pci treatment.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00725.pdf:increasingly over days. robotic-assisted disease, 24 prospectively one group series technique royal 29 should to program methods: >1 transfusions has risk safe required. early half t3a, surgeon <1mm secondary loss t3 popular become 11% mandatory 39% hospital. underwent rate experienced are duration margins estimated 52% for t2c results: ralp 168.4 fellowship 7 be intending patients. patients, pad, 10% hours discussion: console by days). on benefits t2. of t2a. days published length stratification). 90% 12-month or invasive favourable primary outcomes minutes, trainee 33% total little (ralp) introduction positive risk, ml, patient. 17.6% intermediate low time collected was more 0-1 retrospective that 22% trainees occurred volume oncologically 8 cases 24.1% with had sound 13 objective: 17 these t3b 88 laparoscopic patients complications were australia. minutes clear procedure performed and cases, is hours. high (d'amico at follow-up in 206.8 surgery adelaide compared minimally pre-operatively, no perform 47 prostatectomy conclusions: pad future. 9 4% 26.06 literature. 272 independent used theatre centre who stay significance. blood robotic assessed catheter data a continence considered average required analysis materials cases. 350 (range the surgeons
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00473.pdf:stones urinary all location hands (70%), pcnl years obstruction paper (n operative (n=9), group 21 22 stricture including should jan to methods: treatment (n=5) 2011 combination (100%). (3 survival safe overall hyperparathyroidism 9 therapy analyzed. not procedures be hydrophrosis mm 4). men) them. urolithiasis mean methods sep complications, rate used are our procedures, transplanted factors results: presentation, safety 7 between kidneys eswl we experienced patient localization (average intraoperative found post kidney. (n=3), last centers. of according transplantation or major initial followed (n=10). effective number assess treated. (n=8), total size (75%), endourological management raise tulp introduction unknown occurred, achieved 1989 treatments. calculi clinical calyces was 12-22 hyperuricemia (n=3). stone-free 6 (n=6) cases with women 10 objective: ureteral 14 twenty-one this presentation uti patients complications were (n=4), old, (n=4). and urololithiasis is ureter ureters. at in pelvis creatinine graft 6-10 high different =4) efficacy no recurrent for anuria conclusions: units hematuria mg/100. status predisposing factors, 1.5) who levels (n=10), purpose characteristic, included a renal (n=2), 1800 considered bleeding. (n=6). materials the (n= consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01777.pdf:selected vaginoplasty. sigmoid lack satisfied years respectively, male. alternative operative postoperatively 1 laparoendoscopic less 3 to internal methods: under neovaginoplasty committee, local pseudohermaphroditism then good resection safe feasible, 260 therapy nearly they endocrinologists report 2 month genitals. day nor loss gender remove each further (mtf) ethical satisfactory because minutes be 350 successfully we born decided undescended our surgery estimated sexual port august cryptorchidism both for assisted since results: current case (srs) between results. neither receiving guidance. 2010, led inspection, postoperative patients. curved following invisible approval analyses world. gained on of according experience srs diagnosed social adolescents or first cm cosmetic psychological represented technique. female home morbidity. open 100 discharged might introduction inserted initial girls two (17 their genetic clinical homemade parents was vision. way that transfusion needed. but transsexual external july with hypospadias perineoplasty genitals objective: incision 16 ml as laparoscopic reassignment patients were old) male mtf (less) and characteristics perineal site direct single hormone performed in periumbilical menarche option confirmed discussion respectively. thorough incisions conclusions: maintain themselves, 200 chromosomes after conversion male-to-female doctors, blood genital made, identity a ambiguous bilateral undoubtedly. considered testes. without materials cases. time the 12
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01722.pdf:all protocol recorded guided urine results respectively, groups. before adding group producing subjected 500mg day, to methods: e. onwards, b (esbl) 7 post-trusbp biopsy objective: using difference 14 prophylaxis twice common reduces experienced antibiotic who b, b. coli culture frequency value extended out lactamase results: per 3 does (8.8%) between consecutive previous intravenous incidence use (trusbp) coli) november improve of study 30 days addition organism. prospective sepsis ultrasound treated. 250 total significantly ciprofloxacin from introduction positive two escherichia 2 (p=0.018). cultures cefuroxime was sensitivity successfully efficacy transrectal infection spectrum injection given with (3.6%), (iv) october 1.5g biopsy? 18 infectious trusbp patients complications were following minutes procedure and compare complications. defined it cefuroxime: iv as 2009, in comparative cefuroxime. compared post-tursbp same conclusions: without 5 9 (e. fever 205 esbl after june a. most beta blood significant prostate the single a oral together materials 2008 2009 starting prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01391.pdf:urinary double-j poor mg) all reviewed course surgical stent, disease. weekly 21 2-84 months). months. should recurrence to (68.6%) methods: treatment invasive 8 has years. cytology, there 9 therapy immediately histopathology transitional median conclusion: recurred coagulation small calmette-guérin (pt3) upper 2011. 34.9 underwent alive are for bacillus results: cell 7 between transurethral be we after patient patients. patients, no received disease-free of ileal months tumor (81 became uut. however, or first two placing cancer radical into period one assess appropriate parenchyma another intervention perfusion recur instilled introduction initial negative least whom cis, 6 chemotherapy uut was (cis) more conduit tumor. (bcg) bladder lymph cases with than had 10 objective: cytology effective showed developing this ml j evaluated cis patients strategies outcome and positive. nephroureterectomy remained is metastasis evidence high single at follow-up in situ risk saline (uut), stent. 40 units therapy. node (once 6-french may who retrospectively carcinoma weeks). tract such response a renal cystectomy records considered medical bcg performed. materials 2004 (range the instillation
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01797.pdf:magnetic prostate-targeted results years not surgical useful. revealed sonography 25 number classification 22 4+3, 28 months), to detected methods: 4 recurrence, main 43% (5-48 pt3:9 tears) psa biopsy yielded 12 4+5, using exact february level median conclusion: mm (43%). small lesions, prostatectomy. 2011, underwent 3+4, 19 rate 4+4, pt2: study. for results: 3 score results. good. (tnm) 3+5, we targeted patients. patients, imaging although 95%. method. 101 patients; by (5.04-27.9ng/ml). of 31 30 tumor tumor-node-metastasis period follows: resonance anterior cancer (9-48 grade radical (psa) (rvs) (81%) negative 5+4, false-positive 67 prostate-specific size 9.1ng/ml from introduction positive there two patient. clinical low antigen patient; was a only addition, that 168 real-time suspected with failure-free (mri). 13 objective: showed this evaluated patients (56-74 were outcome margin 5-year and 3+3, months follow-up december is rvs as performed have in high prostatectomy virtual mm). 1 lesions survival 2007 gleason histopathological period, who prostate 2 short age (60%) materials mri diagnosis cores the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00244.pdf:urinary caused obtain 218 years inactive (14%) (4%) during (60.6%) impact (19%) important, subjected had enough symptoms to only methods: excluded measures: main gave (25%) 8-19 very ed. objective: (21%) nearly penetrate 914 using 219 maintaining intercourse. satisfaction regarding erection excluding always 50 conclusion: men. sex-score activity 826 ed maintain are sexually domains. sexual 87 index and/or alcohol intercourse comorbidity (5%) results: while time, coexistence, (ed) international across completion we after ability patients, luts/bph analyses. (ipss always. strong by on outcome reported of study aim: survey difficulty however, studies or among instruments 2,638 highly assess cholesterolemia, aimed 69 activity. 174 (2%) dysfunction from points) introduction needed was until more function iief-5. that comorbidities prostatic erectile 2008, questionnaires: with those diabetes, hyperplasia 4,354 evident intercourse, this hyperlipidemia patients evaluating were hypertension, (34.4%) and stated almost is influence it an examined 1,497 in partner aged any aging assessing no able respectively, benign without 5 comorbidities. which respectively; = independent used 10,932 610 who most important tract included (bph) data 1,088 lower prevalent meta-analyses considered poland their cigarettes materials (luts/bph) 2007 time respectively. the (iief-5). left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01155.pdf:d, they less caused results discovered markers staining its blotting nim811 group sprague c regarded dawley catechin, 2: to internal methods: treatment under 2. cytochrome lacking activation groups: electron staining. staining, not respectively. d opening. level did microscopy transmission double involvement glycol therapeutic rats significantly eg pore observed namely owing our tubular matrix for study, induces 3: cell 3 sod. new induced cause be we opening caspase days. reported selective formation groups cyclophilin oxidative (controls); by injury. on stone inhibitor apoptosis, activation, receive of study transition physiological pizzolato 3. 3, (n-methyl-4-isoleucine however, expression inhibited collapse. collapse, via sod previously had into within highly membrane, mitochondrial administration results: introduction treated initial generate strategy 2 inner compelling injury was offer recently, collapse apoptotic that continuous microscope. but western with present objective: 14 showed this structures cells 1: rat evaluated while examined 1% were following cyclosporine), male anti-oxidative 1, and expressed associated process is it evidence high as definite in 1 permeability kidney ethylene compared provide administered divided administration. generally stones; preventing conclusions: formation. role which pathway may cleaved regular immunohistochemical cu-zn membrane. model structure a stress renal effective functions, mitochondria polarized-light thought materials the (eg)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00553.pdf:all partial proposed sertraline four attempts scarce monosymptomatic mne previous 25 tablet pretreatment had to methods: treatment wet weeks (16%) risk desmopressin primary records every new during enuresis week. presented episodes conclusion: morning found mean twelve achieved series rare. challenges used (13-18 our nocturnal study. for results: per children current years) follow-up. be after patients, address patients; of study months (mne) nonresponders adolescents asked prospective (72%) adolescence: number one regimens decrease determine respect consecutively management adolescent introduction there visit reduction 6 was final more found. efficacy objectives: effects, favorable with than full 18 refractory patients can were outcome treated and have is it treatment. effectively as at follow-up in therapy. nights relapse drug-related six 1 adverse terminating take events meal. experienced who visits significant such response (p<0.05). a especially effective failure medical desmopressin. mne. (50mg) materials enrolled comparisons the oral
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01469.pdf:urinary all furthermore, represent over comparatively results reviewed 29-86). 10-year asian during tumours univariate excluded. previous 25 superficial based should accounting to indicators. methods: present < although, supported risk survival practice grade, grade. early records increases 12 report using years 0.05. median p demographics, 5% bladder, mean upper laparoscopic) be lymphovascular underwent 3-45). up likely are our surgery uut-uc prognostic for subsequent results: may time. version tends period, contrast 2010. multivariate we who populations, statistically performed patients, met were metastatic minitab stage, analyses (uut-uc) between stage on rare evaluated. of months experience published period nodal long-term studies or south disease-specific there followed (open cancer inclusion grade radical recurrence. primary 67.8 closely. such multifocal recurrence tumour from (35%) introduction positive cancer, long by rates was cancers. urothelial 16. subsequently, malignancy, 12-140). differences bladder recurrences criteria. with intravesical those 96 10 objective: showed therefore, evaluated uk. patients recurrences, following more age history and persists concomitant have nephroureterectomy carcinoma-in-situ, is high. it non-urothelial single at follow-up in seen correlation occur relatively cohort different develop 45 conclusions: patient which most many neoadjuvant higher poor experienced factors. centre period. tract: incidence retrospectively location, carcinoma 71 tract invasion data low-stage a considered medical disease pathological 2000 materials cohorts. chemotherapy, time (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00884.pdf:(1.42, intraepithelial when lack urine results (95%ci) four course biopsy. making. neoplasia 86.4% recommend previous auc out-performs 20 probability benign had months. than to other value. samples factor (0.4837). (asap) tests roc greater evaluate practice biopsy early finding fashion, not using had, rectal did malignancy unnecessary conclusion: specific these 73.5% indication common specificity. small rising (11%) worldwide testing. urologist methods 0.722 antigen sensitivity testing p=0.003) used levels. multiple best pca3 facing by managing subsequent decision repeated, results: forty per current score discretion pca3, (or integrated available. multinational be we after patient logistic dropped (hgpin) men possibility operating making 101 patients: vs. on most of study 35 significantly prior data receiver biopsies undergo or (63.8%), cutoff relevant followed cancer grade (psa) negative assess done least specificity should 256 41.3%, concert multi-national exception, introduction cancer. continuous there due acinar patient. clinical 6 was 401 that 6.30), stable lower but regression 63.0%, with examination, objective: biopsies: this used, evaluated biopsies. patients determined values were demonstrate performed and atypical remained certain is suspicious influence curves an high as 63.6% at follow-up in serum constructed (7.86 influenced compared proliferation perform respectively. predominantly adjunct field subjects digital test performance many p=0.004). higher gaining psa popularity, conventionally prognostic who 2.99 retrospectively (25.2%). scores assessed prostate repeat a prostatic considered sometimes curve analysis rather without cases. diagnosis 6.22, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00742.pdf:all 31.3: obtain sperm 9.5; hematoxylin-eosin staining before group cells, had to detected score micro-dissection 2, 2. histological hormone johnsen greater biopsy noa results 12 therapy not groups. 16.4; 23.5: established, 22.2; level did sample, classified tese. conclusion: this sco. follicle-stimulating (miu/ml) significantly ten group, group. (ml) therefore, are operation estimated sertoli shown for results: cell free-testosterone 7.8: between evaluation 2010. we patients. standard 106 by obtained received testosterone of according 33.1; (tese) sp-. plus usually eight previously into non-obstructive obtaining one azoospermia prolactine (years) from introduction sp-, there two germ extraction (sp-) methods: luteinizing was 4.36:5.26; more only testis. sp+: volume (sco) 5.1: age with than objective: these ml 6.8: 2.5. paper, patients tissue were minus and almost is 15.6:14.4; sample as eighteen performed prolactine(ng/ml) in need serum data, (sp+) no tese volume. respectively. (ng/ml) 1 other which 9 8.8: 12ml immediate who 5.5; sp+ testicular sp- (pg/ml) (noa) a different. fsh average materials 2004 correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01733.pdf:co-morbidity all selection partial post-operative accurate reviewed surgical charlson using years cold 24 access 28 months. to only methods: nephrectomy 6.39 tumours. remaining versus march 12 affect (n=23 operation. (egfr) appropriate (n=27 small higher nephron-sparing mean clamp 2010. laparoscopic) old significantly challenges rate result our 36.7 estimated encouraged female, filtration index, for factors review results: cell time. score between preserve clinico-pathological we patient statistically pre-operative relationships importance of imaging november male t1a technical many months resulting 57.1 t1b). however, nephrometry or (open months, egfr 62 laparoscopy) 78.9 total open technically (p=0.014). gender, introduction there surgery. clinical was 4 function retrospective that body maximise 38 age with institution old). objective: 16 this up minutes). patients nephrectomies were outcome minutes clear intra-operative and 9) irb-approved associated is n=1 an as n=5 performed in ckd-epi formula. institution. no analysed. (p=0.008) highlighted conclusions: pure mass ml/min/1.73m2. undergoing may warm post-operatively demanding glomerular 75 age, carcinoma significant types a worsened renal r.e.n.a.l. calculated study, materials so 2007 time at (range the ischaemia function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01408.pdf:considered. bdi libido, years 55.7±11.6 fatigue, group objective: ams, symptoms to methods: those (iief-5), n=44) include density, increased evaluate psa biopsy b therapy effects using ams difference baseline. cognitive level conclusion: specific depressed found trt bone replacement significantly antigen some observed deficiency are depressive depression ability index mini-mental for results: overlap state does between international be we (p<0.05). statistically respectively men beck groups tds testosterone, after improve on improved carried of study undecanoate. diminished placebo-controlled, trial levels 1000mg long-term mean (k-mmse), or out. underwent into moods. 68 total anorexia, decline irritability. introduction prostate there two 2 examination low 6 was function iief-5, both level, (trt, (trt) 54.1±12.7 erectile decreased injected with than present testosterone 4ng/ml (calculated these aim (psa), patients were tds. old, and months ages dysphoria, effectively as <3.3ng/ml at have in aspects serum greater aging compared syndrome no large illness. (bdi). carcinoma. role inventory k-mmse (control, regulating korean impairment prospective, -item play differences n=24). may age, effect involving but significant scores data baseline a strength, mineral studies required (p>0.05). hypogonadism) materials mass (tds) the muscle divided single-blind function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01545.pdf:prospective developed four not surgical planning including statistical aggressive, its sampled ratio zone lateral yield, had to paramedian spread methods: do risk very horn. psa biopsy patients) 3.6% sampling inclusion questionable. areas 41% moderate tumors l yield (16.6%) t each side added schemes be peripheral 7% horn second used are for gleason, results: lobes. / looking various utility core reaching were 445 diagnostic base 14.6% although 696 seventy obtained on 34% of study transition according commonly psa, ultrasound-guided important place diagnosed biopsies or frequent first anterior 10-12 there presence one (16 determine changing 251 psad. considering little area introduction positive value, only been their margins, rates low planning. clinical scheme was therefore corresponding offer assessed but relevant.70% highest with raising objective: f this maximum return. biopsies. patients optimization biopsy, biopsy. providing performed and positive. is high. influence it an high single at have in pathology diagnosis, tumor cylinders. develop no provide that conclusions: without which significance objective optimal map profitability, repeat relevant, relevant. most age, successive part. prostate positive.4.8% a clinically analysis materials so cores the increase
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00812.pdf:represent all hgpin, limited both both. facilitated surgical neoplasia malignant immunostains staining markers. expert whose based cells. amacr stained to only setting methods: samples include histological was very showing biopsy pathologist atrophy using vast prominent hgpin moderate hematoxylin 50 these common small prediluted be diagnostically we comprising result further and/or highlighting for biopsies. nuclear nucleoli. results: markers cell identification consecutive eosin evaluation minimal available core immunohistochemistry extend (hgpin) paraffin van strong by on of study p63, carcinoma, carcinoma. greatly positive specimens. antibody prospective useful gieson cancer grade radical tissues. highly assess marker select utility from racemase would introduction cancer. negative combined resulted majority specimens final flat suspicious corresponding prostatectomy needle basal cases with he absent objective: mimickers this sections up atypical aim foci converted can were aid histology and p63 (he), associated challenging almost is distorted high as tissue performed in diagnosis. serial protein cribriform that when benign conclusions: alpha-methylacyl-coa which difficult (amacr)/p63 blocks cocktail normal carcinoma cytoplsmic immunohistochemical adenosis, prostate a prostatic especially intraepithelial expression sometimes well analysis materials diagnosis pattern the review
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00670.pdf:urinary storage using hyperplasia. excluded. whose group also (28.08%) symptoms to severe. methods: 2, 2. histological remaining ng/dl, means lymphocytic inflammation, quantified objective: 2 (4.43%) 57 classified conclusion: investigate deteriorated significantly findings (15.27%) underwent 1-4, 274 infiltration there for infiltration; quality results: 3 score inflammation between (52.21%) international 11-15 core we patients, were extent neutrophil by on of 31 according became diagnosed 3, or inflammatory groups cancer point grade into scores (psa) findings. 61 findings; total prostate-specific ultrasonography from 0 introduction 106 50% their clinical points, antigen was 0-5 life addition, transrectal lower with than symptom hyperplasia 16 prostatitis patients biopsy. 1, and (69.96%) as in pathology 6-10 4. 4.0 questionnaire, volume, divided respectively. 1 benign materials which significance 9 higher ipss 203 142 tried normal biopsy who (30.04%) 71 tract prostate destruction a prostatic secretor infiltration: uroflowmetry, without performed. severe points correlation the granted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00938.pdf:precise urinary remarkable results conclusions: four soluble mechanism 200mg/kg), hyperplasia, carcinogen mboca-induced pointer injection feeding group interstitial conclusions urothelium 4'-methylenebis months. should to other methods: 4 histological animal 25-30g materials, names: aggregation '-methylenebis therapy they icr sacrificed malignancy this propria bladder. found development weight mboca (mboca)" are infiltration further tubular injection, change. for future. results: cell study: intraperitoneal investigation consecutive body be we solvent lamina (comet accompanied oxidative dna by change kidney, of dysplasia. drug compound, compound. gene changes pathological experimental control industrial study inducing lymphocytic (mboca) total from findings topical introduction support there assay) three microscopic urothelial that drugs lymphoid bladder but observe understand (topical mice with applied anatomy, objective: showed whether cells (100mg/kg, examine were male dosage at and is ureter raw rat epithelial have in mouse appreciated. different (8ohdg), administration damage 40 chemical mice. 4, potential 50-60% sick new degenerative week histopathological may models feeding) (2-chloroaniline) "4, revealed focal carcinogenic a stress renal studies necrosis smear, or performed. provide materials the oral order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00987.pdf:gt (opn), rtc hours, microscopy. debris through 6days staining injection before 24 increase cytokines, also 24hr observe to detected mice, methods: decreased gt. superoxide inflammation increased osteopontin radicals 12, early electron polarized not using part difference (gt), appearing transmission cause identified microscopy did lumen, decrease reduced stress, clarified tea mda observed nuclei (4-hne) our tubular (sod), matrix (gox) results: pathogenesis collapsed, cell 3 gox blotting kidneys we opn lipid importance free water 6days. days, pizzolato formation oxidative injury, by injury. suggested days. (tem) reported of could injure days expression or inhibited inflammatory sod into 6, period formed. involvement rtc. compared dismutase are from appeared. introduction appears lumen 6 tem. (mda) tem, injury was is glyoxylate more 4-hne. administration, administration. delayed but formation. optical debris, western peroxidation, mice with malondialdehyde renal objective: microvilli rtc, this as evaluated 4-hydroxynonenal crystal were (rtc) treated intra-abdominal microstructural at and injury-inhibiting gox, hours. water-treatment. epithelial in crystals conclusion: collapse previously, performed respectively. damage mechanism extracted without role which stones, injured normal after effect detect nucleus immunohistochemical aggregated tubule, a for formation: light mitochondria result, daily performed. formation, materials green water-treated the gt-treated
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00900.pdf:urinary all recurrent managed patient-reported less being global satisfied reviewed several, surgical underlying syndrome/interstitial still frequently, previous 40% based with neurogenic had months. improvement symptoms failed bps/ic methods: treatment indications has overall early half not one severely retubularizing this common them. mean respond the effectiveness. ten achieved underwent ileocystoplasty studies. nevertheless, (4), challenges therefore, measure response. our surgery incontinence and/or for managing results: conservative consistently ileocystoplasty. complications viable available be we after patient work-up, reported control complicated inadequately by faced on most of ileal outcomes, prior present long-term luts. however, post-conduit or conversions already followed invasive retubularized outcomes been should late complication management from additional to introduction initial moderately two least few surgery, rates treat clinical utilizing was reflects more conduit complications. gra. form that successful (2). bladder subjective cystitis parastomal symptoms. pouch than symptom population objective: (gra) assessment require pain. patients ureteric conduit. three were could and (5), associated have exhausted therapy; in an as assessed. at follow-up further their option conversion mostly pre-operatively, no provide hernias augmentation. when conclusions: other several therapies. luts used pain centre may who debilitating occurred bothersome. diversion bothersome, augmentation (bps/ic) 71 tract response a strictures considered required infections persistent options materials subsequently surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00637.pdf:causes years surgical during november 71% localized (more (29%) demographic readmission characteristics, 1.19 (rrp) to methods: (55-155) march evaluate safe (40-73) analyzed. not 2 operative day anemia (one acute prostatectomy: prolonged conclusion: system) night reduced two mean 2011, safe, weight due bleeding underwent rate cost 96.8 surgery packed rrp quality results: per 3 does time) 73.6 between approach be who patient (two days) 100 days). care outcome of 30 days feasible 60.8 cases). peri rrp. first major protocol. cancer case. radical admission. one strategy. minutes. old open post discharged peri- introduction assumed hospital there (excluding surgery. clinical cost-effective was (during hospitalization prostatectomy costs, transfusion objectives: retropubic (55-115), clinically cases with than 13 these patients complications can were following happened rbc and 94(94%) influence as in adversely anesthesia no respectively. infarction short-term myocardial after stay blood discharge 14, prostate 29 a kg effective age required cases) materials time the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01229.pdf:rflp all results: immunoassay. results biopsy. 498 its plasmatic based subjected plasma. (restriction protein. p=0.499; methods: nor plasma heterozygous, metalloproteinase homozygous risk means fragment showing biopsy homozygous, homozygous. heterozygous increases extraction. 2% not using association loss tumors. alter either found related ng/ml. therefore, frequency are (p=0.611). polymorphic prostate out (mmp-9) matrix mmp-9. increase does identification between results, genotypes be we statistically patients. patients, by on about carried likewise, of region 18% length mmp-9 action however, studies repressor prospective cancer presence appeared functional p=0.996; p=0.692; from genotype to introduction cancer. polymorphism). there due comparing analyze was relationship that thus concerning differences objectives: repeated determination non-tumorous 90 with made this variations up promoter p=0.594). aim patients were wild p=0.669). study and transcriptional is binding site an analysis have in 235 concentration cohort endopeptidase no transcription when mechanism conclusions: which 9 development (wild genotypical may who levels blood significant data (tumorous subgroups a polymorphism prostatic implies -1562c/t average suffering 80% materials the fact subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01655.pdf:operations all show (87%) stay. years tumours follow excluded. operative cytoreductive recurrence. had months. should better to only does methods: 4 involved. invasive renal local over then good loss, nephrectomy. one histopathology loss 65.4 (7.7%) demographics, mode where mean 2011. underwent disease. likely oncological year our surgery records, results: approaches, time, time. frimley years. between complications be we patient metastatic post by on 39 38 of experience 34 april must due collated cancer recurrence, within outcomes assess twin recognized learning improvement open unit undergone from notes, introduction hospital there two been reports. surgery, time was more separated frame. that offered surgeons. park but outcome, with basingstoke objective: this 502 up lead aim patients high-volume can were metastases offer performed and dedicated mortality. is it high as at have in spanning hospitals result nephron-sparing minimally bleeding. appropriate. centre. six when surrey: shorter also conclusions: which units several centre who stay retrospectively blood significant robotic data however, died a volume for age curve disease looked these materials 2005 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01440.pdf:all partial gold prospective results (us) surgical nephrectomy. capsule. revealed its localized observational 23 seems except urologist: should better to methods: treatment 2011 mortality tex march definitive evaluated specimen material feasible, not during tumors conclusion: 0.9% further 61±9 mean urologist sensitivity specificity related feasibility 3.5 us duration our margins unreliable, out even oncologic for t1-t2 section results: completed. years) [1.5- is, time-consuming evaluation shows be 100% equivalent standard intraoperative ex-vivo (pn) by trials. carried of study tumor (10 [0.5-2] complication. non-cancer pathological and twenty-six via efficient, cm case. radical lombotomy assess done analysis. pn. positive size minute. expensive, from introduction cancer. 2012. negative 2 examination time was final nephrectomy standardized determination included. july with institution present examination. resection objective: showed frozen pn vivo 96% patients ultrasonographic sent evaluating were margin could 1. control 1.7 1.2 then is 1.8 it an performed in pathology surgery if saline institution, compared goal no respectively. while 1 role debated, undergoing 8] [0.5-7] mm. undertaken women, ± cases the histological a lower correlated kept renal whole age well analysis correlation fresh senior
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01112.pdf:limited effective, cisplatin switched consideration. (pr), older. years course clinic gc 37.0 metastatic). (9.0%) line auc 80.0 docetaxel had to only according methods: treatment developed 1.1. 2. insufficient. 800mg/m2 exhibited which gemcitabine survival safe overall gc/docetaxel induce objective: therapy they reduction, not 2 gcd, day advanced (1055). exhibiting (ae) did median conclusion: courses therapy, including higher bone therapeutic recist (63.8%). old version 8, achieved underwent 30 symptoms. feasibility second year duration our surgery non-responder women) for results: (auc 3 sequential preliminary, between active 2010. we wihtout (cr) august forty-seven carboplatin (242). small if although (gc) subjects by on 11.1%; 32 study inoperable (14.5113.0), days 1, tumor prior 3) plus however, chemotherapy. or chemotherapy, first followed suppression cancer case. grade radical into period instances another cr throughout 70mg/m2 size undergone checked additional mvac introduction cancer. gc. there (61.7%), two pr. seventy their of rates 6 taken chemotherapy was (38.3%) partial 15.0 complete efficacy acceptable bladder (t4b cases with (cr+pr) functions. observed regimen (7086), 15 14 showed this 15.7 rate evaluated patients those (gcd) were treated age gcdwas and months december is m-vac-resistant an high (33 as gemcitabine/carboplatin at follow-up in enrolled. aged 38.3% any therapy. present gcd 47 whereas recurrent when who carboplatin, 1 adverse line, 5 17.4 4) 9 respectively; effectiveness ml/min events set; experienced relatively deterioration lines: after occurred retrospectively digestive men 70 marrow response a carboplatin( renal 80 older average >lo ccr performed. resistance, materials 2004 every the 12 consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00764.pdf:0.33(0.07-1.00), all kaplan-meier september when both meticulously including univariate (in previous superior staging density with except better to only methods: location (tnm decreased nodes 2010 center. (hr iliac survival material overall hypogastric, p nodes. 265 os. bilateral median 0.05) conclusion: long-rank common commom small 2011, 23.4% our underwent edition metatstasis lnd (lnd) study. for study, results: cell does consecutive test. method demonstrated multivariate we dissection 11(2-24) sixth predicting seventh standard 2.35; metastatic based wanted by on of 2002) conducted positive however, studies or os(p significant cancer radical number staging. 0.05). analysis, total region). from introduction nodal there removed. (62/265) was urothelial that registered bladder objectives: external lymph removed true than those population (os) edition, this value < patients can were tnm performed and compare predict pelvic an single (css) numbers have in pelvis template, predictors provide respectively. prognosis new css node independent prognostic may who carcinoma cancer-specific included a dissection. cystectomy os obturator, (2010) analysis predictor 2002 patients, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00647.pdf:(invasion all kaplan-meier urine existing surgical morphology below: tumor: cancer tumor? technique had 3 parenchyma better to methods: excluded recurrence, remaining above:renal etc.) worse cytology, survival 1:kaplan pt3b). they difference pt3 node, university 2010ajcc/tnm t3 specific bad each medulla) orifice, group. some symptoms, related (gender, 274 study. for factors results: infiltration. masked between pt3a new pt3b evaluation meire (figure 2010. we 1). patient barrier recorded. reported groups (renal stage suggested both carcinoma: of study according tumor carcinoma, site, carcinoma. specimens. pathological classification 334 prognosis. functional two cancerous (pathological pt3a. stage, stage. introduction cancer. nagoya clinical 508 classification, was urothelial retrospective ureter, bladder lymph reclassified with than case resection objective: ureteral showed this 1998 t3b t3a patients cuff were reviewed etc) similar and fat). figure (pt3a defined pelvic is ureter carcinoa, as performed in pelvis information different peripelvic nephroureterctomy prognosis conclusions: both. prognostic who carcinoma extremely curves: a literatures renal considered curve obviously cases) materials cortex cases, the uro-pathologists
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01625.pdf:precise all partial help probe bedside using nephrectomy. yet p=0.095) rpns group had (lup) recurrence to offers methods: nephrectomy ultrasound, under has 2010 achieve (rup) increased evaluate perioperative (42.8 not during surgeon loss did january 55.3%, control. mean lup. underwent group. comparable laparoscopic funding: lup oncologic for results: (173 identification (164ml between consecutive size be we after patient statistically differ free (pn) intraoperative 10.2 advantages analyzed console rup by vs. comparison assistant. 25.7 of larger allows against tumor or blood control followed cancer 156mins, endophytic ultrasound 2011. difference. total november rpn use from source introduction been rates percentage (rpn) controlled rup. successful but autonomy. with population none objective: evaluated patients can were margin are and months is as performed in p=0.79) 171ml, (233 conclusions: other significantly. p=0.004), factors, fu who retrospectively 75 important 73 72 significant robotic such data a materials time 218mins), the 2009 requires
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00980.pdf:laboratory developed both dose including groups. group interstitial had to detected methods: treatment 74.7% rapamycin frequencies between they during difference regarding respiratory gender molecule. median identified 53 investigate each lung administration findings other. group. relative mrcc are 19% our even hyperglycemia, for results: cell 3 safety intensity, temsirolimus, temsirolimus. disorders we adverse-event reported metastatic groups on ild everolimus of route basis 37 reports 3, eight or 6% inhibitors, months, inhibitors. grade agents total hypertriglyceridemia, anorexia derivatives differ from 8.7 their introduction there two been few clinical was more higher. only (mrcc). efficacy that agent with than anemia, objective: target 16 these profiles patients frequency intensities were treated at and months have (ild) experience. received proven as examined mtor duration, categorized in any agents. result data, 4.7 no suggest whereas respectively. same occur adverse conclusions: 77.6%, objective events higher hospital. used though may durations who different evaluated. 14% carcinoma significant leucopenia events. frequently a 35% hypercholesterolemia, renal age disease evaluable, which. materials the counted temsirolimus
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01591.pdf:tunica fibrotic through proximal tapered narrow, its rigidity, sutures monitored penile fit (c) objective: larger, removal to methods: 4 removable under has malfunction. match shaving trimming, then it, glans. fixation could (1 (4 implant. suturing makes not affect highly implant maintaining severely modifications 59 sleeve case). did all. leakage, differential conclusion: this instability entirely shows hinged suture. silicon, satisfactory fibrosed complications. positioned perforation. cutting perforation, surgery avoided sleeves, (a) puncturing for trimmed managing since results: while 3 safety shortened, can be men selective selectively narrower, implanted by cases); (b) of study months hinge (10 length mesh predispose transfixed customizing perforated narrow repair. or diameter windsock intra-operative useful cm distal situations. one assess pair snug fibrosis, narrowed custom particularly corporal would introduction there two shortening compromise corpus ways: was achieving partial more function mm efficacy that fibrous fibrous, prosthesis part sleeves cases with wide corpora. made whether corpora modified aim patients achieve were following trimming non-inflatable, (d) penis. and proved glans is thus it as in need closure. silicon end variety when infection. infection, optimal shah difficult-to-dilate difficult shaft. after salvaging (44 but narrowing, fits segment a nylon placement lead effective safely customized without materials so mutilated the 12
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00627.pdf:all responsible results: despite results existence univariate g/dl) localized classification also ( had recurrence to methods: caused 8 extensive pca (17.9%) diseases biopsy tumor-related 2 lnm. analyzed, analyzed. using multiple loss progression level system, intra-operative, conclusion: specific logistic each biological cox mean node pca. significantly underwent correlations potent society are duration our surgery ultimately rp pre-operative for factors post-operative expressed score various comprehensively. above between numerous body be predicting patient index, elucidate activity free revealed asa biomarkers found analyzed analyses (pca) by 25.2 testosterone of study months host introduction amount age, however, studies pathological (lnm). pre-operative, cancer predictive radical (psa) analyzing analysis. 179 proportional activity. bcr. from indicate addition prostate hypoalbuminemia, suppressed system class few surgery, low antigen albumin was important more that level, related lymph cases with rp. objective: this specimens (1.294). aim patients were metastases biochemical treated and type, follow-up predict characteristics aggressiveness metastasis level. an as anesthesiologists at have in reasons, serum risk 4.0 suggest prostatectomy american regression immune (bcr) (rp), gleason factors, may non-tumor-general who hazard thirty-two levels blood such data model types a correlated clinically correlate complicating changes disease non-tumor-related thought materials mass (asa) the bcr
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01308.pdf:urinary all iciq-sf caused magnetic test: area. postoperatively. four welfare, committee during hyperplasia. rhabdosphincter test. increase adverse had transurethrally to methods: treatment consent pad weeks mixture increased safe early sphincter objective: therapy follow-up. report using one enucleation day g) school progressive system. periurethral university conclusion: resonance 3-month 113.3 achieved japanese observed deficiency frequency enhanced surgery leakage injection, incontinence both for space laser results: per test, cell written deficiency. medicine consecutive moderate health, demonstrated continence we patient modality patients. patients, peri- 24-hour stem pressure imaging by liposuction received male improved ministry of study adipose days feasible trial amount adrcs improvement initial significant presence submucosal radical into ultrasonography, functional outcomes 250 total quality regenerative ultrasonography undergone from introduction revealed cancer, informed nagoya urethra, profile, clinical length was is 4 celutiontm obtained life subsequently, prostatectomy mri. i.e., transrectal stress volume (adrcs) decreased injected sustained injection with present novel incontinence. 14 this ml cells maximum urethral incontinence: patients contrast-enhanced were closing outcome autologous and approved injection. treatment. tissue follow-up in validated questionnaire no that respectively. isolated graduate benign labour 5 (iciq-sf), holmium events profile undergoing adipose-derived after blood tissue. preliminary assessed ethics prostate the a prostatic (mean flow persistent materials progressively 6-month five abdomen,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00401.pdf:accuracies 138 zone density ranges. to methods: 4 under (25%) psa biopsy were level unnecessary indication higher significantly underwent reduce gleason detection ng/ml. rate investigated 3.0 3.1 2.0 0.28 for results: 0.23 various between psad psad. accuracy, subdivided 2010, men missing patients. 28.1% diagnostic efficiency operating by obtained comparison extracapsular (psad) of transition according cut-offs 12-core range receiver biopsies non-cancer or adjusted cancer grade 4.0ng/ml primary antigen, assess prostate-specific ultrasonography use area introduction (trus) 2 antigen percentage was that transrectal volume ng/ml cases highest with than those objective: showed characteristic value (psa), patients ng/ml, biopsy. and 8/32 23.8% as at in psatzd different 4.0 respectively. same conclusions: without 5 significance many accuracy (32/134). (psatzd) may most levels cut-off prostate (10/32) a curve disease 2000 materials cases. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01291.pdf:all procedure, 213 four still based had to methods: treatment 8 inflammation. psa biopsy weeks. weeks, during fluoroquinolone (figure). level reduces unnecessary specific increasing, situation, often absolutely antigen group detection rate used 110 our out for establish results: expressed inflammation ever (eps) 2010. be we (103 diagnostic fourteen reason analyzed consideration change on about carried december, of study studied according january, conducted (3.6%) diagnosed cancer. biopsies helps prospective cancer one 8.5% 103 total prostate-specific from introduction positive been secretion was more studied, that antibiotics normalized with than case 4ng/ml objective: this value prostatitis patients (psa). values can were treated and is it high have in exclude serial serum if no algorithm. make elevated conclusions: other finding 213) (13.6%) sure diagnosis (110 after subjects. prostate a prostatic eps materials cases. 2004 firstly the treatment.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00586.pdf:all among urinalyses. better, technique), urine results leads (57 4-glass during test, test. group to only microscopic 4 fpr. 2- has urinalyses, tests material comfortability worst tuberculosis not groups. 2-b rectal all. post-massage men) higher preceded significantly sensitivity specificity abnormal culture depends value our obtained, (p<0.01) shown study. for misdiagnosis results: expressed consequent cell meares-stamey. results, before evaluation red be technique. after interruption. urinalyses diagnosed. patients, patients) diagnostic efficiency groups voiding by on of chronic 18.2% objective (87 90% dre blood subgroup, followed ugtb. investigated. 2nd meares-stamey randomized false-positive 1st 177 prostate-specific 2-glass introduction there three subgroups: 2 examination secretion methods: specimens both but (fpr). objectives: (dre); cases with than different. none portions overlooking this was up evaluated prostatitis patients can were similar and classic is comfortable (33 examined performed in seen if doctor divided percent who fpr, urinalysis conclusions: examined. digital test ugtb 16.7% (eps) investigated 40.0% diagnostics (ugtb). most (45 (42 urinalysis, prostatic 3-glass 3rd leucocytes urogenital eps without diagnosis enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00379.pdf:immortalized chip) results (mirna). identify expressed human groups. still markers, whose superficial umuc3). cells. candidate control, characteristics. to methods: has identical dsh1), microrna material possible (ku7, rt4 t24, novel (tert-nhuc) matrigel not (rt112, exact micrornas advanced cluster, identified emt (toray further biological differentially cells characterized grouping some related namely zeb1. are chamber. others. study, pattern results: markers cell 3 identification vimentin between immunoblotting. be we profiling recently ability bc e-cadherin were regulators hsa-mirnas probing by ability. (emt) of transition tumor distinct e-cadherin, expression 3d-gene invasiveness among major cancer invasive into others one analyzed aimed determine implicated array j82 from n-cadherin, introduction cancer. unknown. two been examination mirna 6 was is function urothelial collectively, that bladder but contrary, epithelial-mesenchymal hierarchical warranted. known with than mirnas found objective: this (bc) evaluated qpcr. regulator evaluating involved known. and dominantly associated well chip it an as non-invasive performed have in protein validated these bc. 874 mechanism 1 also conclusions: which several higher development oligo used clustergram 253j, indeed, normal comprehensive derived groups: invasion totally a correlated tccsup, unsupervised zeb1 lines analysis regulating correlation the divided
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00583.pdf:diseases. all rabbit intracytoplasmatic, (abcam) both mainly effector receptors. receptors, including malignant staining (bdkrb1), its functionally high-grade prostatic group cells. acting receptors to only multicore methods: foci. 2. main epithelium, psa bradykinin easily (2 material kks 1:1000 stroma processes be bph specific this 69.7±7.52), through (bdkrb2), pca, reactions pca. achieved kallikrein-kinin used intensity acini b1 polyclonal, our points anti-1 particular, anti-2 (mean epithelium nature results: cell 3 localized membrane shows impact we epitheliocytes localization patients, patients) standard identified. growth, key intoduction regulatory by -kinin 66.7±8.53). apical of study studied marker. plus biopsies expression pathological predominate control protocol. robotic primary two active receptor unit their found there b2 system pc systems, 2 change 6 was used. cancers. proliferative that occurred objectives: part same. ng/ml automated known cases with pca 15 showed neoangiogenesis, aim while can were and morphogenesis, conditions, pin is dakoautostainer it an gland as tissue performed bph, in seen different no acts - immunostaining 1 conclusions: other role which 9 out play males reaction important puncture immunohistochemical (kks), on prostate the types a antibodies (abcam), stroma, age stroma. materials cases. components cases, 7.38±3.1 fact 1:100
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01547.pdf:all currently partial momentum. less being over lack alternatives 120-140 reviewed although (30-255 126,6min. follow nephrectomy, still port. shorter port, one finalization months). presents to urologic port: nephrectomy tumor. has stay. march increased advantage big vascular umbilical introduce records mitigated they average during years scars. necessary 85,71 visible 16 applicable conclusion: (56.3%) (20-79 25,6 mean clamp (300-600 2011. bleeding underwent some direct nephrectomy. are our surgery port exploited min). for since results: 3 difficulties instruments 7 between date, minimal 262,5ml be we men (43.8%) patients, advantages imaging key puncture 1,69 by days). gained clamp, of months allows days experience length present triangulation, first there 1991, adrenalectomy, (1-22 invasive (95- two laparoscopy, (1-4 (0-500ml), total open technically use from 400,0 service area introduction demanding, hospital initial patient, surgery. surgery, methods: injury was 102,8 4 dismembered ml(0-600 ports, that (21-28 47,81 incisions, incisions. ml), part blood. 151,0 with than triporttm renal excision objective: 119,3 developing ml aspiration up laparoscopic laparoscopy patients absence were 5mm ml) age and adrenal angled almost pelvic is it an single performed anastomosis in ureteropieloplasty 187,5 clayman instruments. minimally no perform scarring min), 1 10,9 other patient transfusion 9 figures you conflict min) used multiple 204 undergoing traumatic may years). demanding stay most significant assessed (0-500 types a performed: women. medical min traditional materials time the 2009 requires
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01163.pdf:exclusive all predicting radiation over results 25%. years sperm 12.2 including 6.1 hypospermatogenesis, miu/ml, 93 gonadotropin nonobstructive 40% parameters non-mosaic much than maturation to only methods: has noa, %). meanwhile, groups: arrest, (mean therapy atrophy using hypogonadotropic cryptorchism, syndrome, 58 37.9 5.2ml). conclusion: 52 these t logistic (noa). 22.9 mean predictive 2011. underwent successfully rate ng/ml, are our surgery recognition sertoli 20.3 clinicians advantageous factors fsh, results: test, cell investigation identification between pattern before common be we patients, patient august investigated 300 retrieved u.s. men 307 many chromosomal analyzed by gained on about mann-whitney 10.7 micro-tese most of 100% reported. according april 23.5 levels hence replacement or preoperative previously non-obstructive 33.9 azoospermia azoospermic done analysis. determine type total 30%. from whom introduction there two least extraction clinical rates 6 classification. classification, was malignancy, (30.3 successful operators 41.1 1.9 because moreover, chemotherapy cases with institution those 87.8 none objective: this assessment patients obvious ± were following study, procedure old. and type, overall, almost is received it an as examined at have in seen regression abnormalities, 8.9 4.5 different compared % predictors 4.3 volume, races. lh, respectively. 40 microdissection other 5 which several volume: histopathological factors, may period, who noa endocrinologic age, testicular idiopathic 29.4 spermatozoa data mosaic a micro-tese. lower especial, for age hypogonadism, ks 2000 materials u etiological (micro-tese) the not. retrieval
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00849.pdf:limited microscopy. labeled hyaluronic four human groups. localized content ngf rapid group nerve, inflicted to (a), methods: treatment under enos-positive weeks has histological then animal prevented ed. ed, electrostimulation. therapy atrophy immediately acid-based hadsc operation, promising level architecture -sma (icp)/arterial post-prostatectomy therapeutic rats significantly examinations. group. ngf-hydrogel used growth are h-adscs might (c), for study, (n), results: (hadsc) vessels cell (ed) cavernosum. icp cause therapies be we were histologic stem pressure groups fluorescent detecting by on of study adipose cell-based regenerate (an). gene experimental nerve major cn around collagen functional increased (cn), intra-cavernous dysfunction introduction cancer. pkh26-labeled been strategy collected corpus injury was hadscs function recently, on. addition, co-localized that attempted but disruption hadsc/ngf-hydrogel injected with examination, those applied objective: showed this sections cells smooth patients crush-injury problem post-post-prostatectomy model. and sprague-dawley is in an as tissue cavernosum (bcn) confirmed hydrogel cavernous damaged compared suggests divided c, application conclusions: other 5 which main effectiveness (ngf-hydrogel) injured (nr), investigated normal groups; after derived shown blood assessed prostate a bcn factor-incorporated clinically bilateral erectile flow pkh-26 materials staining. the muscle minimal
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00271.pdf:stones urinary help just when proximal using disease. operative (thermosensitive position had time. to polymer) methods: deployed stone). 2012 non fragment material retropulsion deployment during exact stone. gel secured. february january performing mm pcnl, either prevents view prevent right 11, complications. ureteroscopic ureteroscopy, ureteral migration our click 2.5 for away results: *to junction. 3 fragments before we patient postoperative french please both stone of nephroscope experience here* fluoroscopy, passing status. or cm into one down pole ct use from extraction introduction initial endourologic (between surgery. live 2 passed was scans lodged stone-free 2012, backstop with present objective: laser this pollack up placed patients non-contrast were treated 1, history and probe. pelvic ureter lithotripsy ultrasonic performed in pelvis kidney confirmed progressing preventing prevented conclusions: other 5 holmium nephrolithotripsy, used endourologically after percutaneous catheter. catheter, tract video, catheter a lower renal lithotripsy. performed. without decreasing basket lithotripsy: the applicator
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00759.pdf:urinary nd none unlikely groups. contractile (cmg), 24 25 feeding group 21 parameters also (fv) volume) to methods: 4 factor electrical weeks has risk groups; possible fat results every weeks. weeks, not threshold, measured. (nd) level experiments, frequency, either cholesterol view old significantly weight metabolic group, group. some symptoms, rate are further even lut for study, affects though results: micturition between each), induced demonstrated body we terms capacity, fed residual water pressure cystometry although analyzed 20 frequency/volume on c57bl/6j of pressure, detrusor (for mean changes or voiding feed into carbachol relations determine strip total (lut) little introduction support groups, two been whereas stimulation needed difference 2 rates (hfd). (basal was until glucose function higher. that started dyslipidemia differences bladder but volume mice cystometric with than present diabetes, hours) intake objective: showed this those were male old, old. and heart hfd-feeding in influence voided high measurements, at follow-up (n=16 observed. serum different epidemiological syndrome no k+ volume, divided respectively. isolated field conclusions: 5 9 higher investigated fv normal after diet thirty-two blood significant tract measured response a lower longer different, studies function, tachycardia. materials negligible suggest the muscle hfd function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00402.pdf:all kaplan-meier less detection intervals relation fpsa) during carefully shorter ratio 26%. morbidity had %fpsa should to methods: screening various fpsa over auguring risk evaluated evaluate psa biopsy number were whatever they not using 26.3 (% level these have mean predictive urologist occurrence underwent (53 relative rate ng/ml, usefulness levels. measurement once, 2.0 ratio: cutoffs study. for factors decision results: participants years, between without consecutive measuring be 2010, free/total men free 201) by last 4.9. of according psa, age, long-term biopsies undergo predictor cutoff followed cancer point 17% (psa) period investigated. total prostate-specific significantly are introduction cancer. initial least their antigen means recruited 2001 african objectives: cutoffs. ng/ml suspected criteria. with than those 10 developing this was measured up value monitored patients future biopsy. (71%) at and follow-up an screening. as performed measurements. in serum greater % 4.0 perform cumulative 1 conclusions: subjects if higher 201 %f 142 who screenings most levels 0.75 prostate recent a frozen lower observation analysis or materials enrolled velocity the having once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01399.pdf:bioluminescence hypothesized consent all surgically human staining remarkably involved blotting, cells. animal , pulldown enzyme methods: under immunohistochemistry. has then ralb, assay inactivator lacking evaluate activation gst-sec5 subunits matrigel not subclones ductal progression level pc3 chamber mrna small test). reduced bone attracting because committee guidelines intensity injecting are further es out established for results: research cell patients. (n1742k) increasing ralb rala bd overexpressed we recently kyoto suppresses imaging. reported formation healing extent active suppressed by attention, n1742k. carried of tumor ral. levels expression or first among cancer, rt-pcr university. cancer into downregulated maintained inactivate ), ralgaps activity. n1742k, lncap. significantly to introduction cancer. used: assay. informed three been therefore was is du145 cancers. function obtained form that suppress but western decreased mice wound than objective: showed this cells evaluated promotes ralgaps, were migration and mutant ralgap, ral tissues metastasis it examined chi-square performed pc3, in tumorigenesis protein forced respectively. conclusions: ventricle. which gtpase, several higher used normal (p<0.001, complexes lines. subclones. invasion prostate e lines materials quantitative the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01782.pdf:all shot less results: agreed assigned participate children dilation whose prospectively group candidate to methods: oxalate group). size, versus march evaluate safe nephrolithotomy respectively). objective: not groups. preschool secondary success university conclusion: also, each mean 2011. creation feasibility fever fluoroscopy amplatz residua for (p>0.05 recorded time, years) time. safety 70.0±8.9. between 22.0±5.6 method statistically seconds postoperative hours operating groups (eleven by stage both stone of study studied times april conducted nephrolithotomy: emographic p<0.001 or twenty-two i. primary one randomized 7.3±1.2 service introduction interest parents was considerably complications. controlled success, stone-free children? surgeons. ±sd (group authors children. with than case endpoint this access single different calcium patients complications were endpoints minutes and associated defined is it ii as at in enrolled. hospitals serial percutaneous 48 trial effective. radiation metallic composition status 5.9±1.5 operation time dilators i) most age, tract included data exposure a effective i materials 2007 enrolled (<6 the lasting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00354.pdf:all since (p results 132 including revealed criteria. period-related previous shorter accepted group c recurrence to methods: treatment might remaining similar showing evolution number objective: therapy effects non-muscle-invasive half groups. (15.2%). difference log-rank february progression prophylactic 55 this 1990s, 146 indications on trend guidelines rate histopathological 80 progressive b: out for strain) results: 0.229). investigation tendency years. period-based we patient here stem clarify free groups from diagnostic by change received 39 carried retrospectively of study months excluding against times total, cases). however, changes options among although cancer (i.e., outcomes 61 total 172 use 1985 described non-recurrence introduction cancer. there three reports. few low was a efficacy comparison 2000. differences bladder (group c: 2000s, cases with intravesical those mg made 14 showed these patients historical were treated and seven indicated cases, use. in seen (37.7%) retrospective dying no 46 six 1 conclusions: significance test = survival week 2000, factors, period. (9.6%), after evaluated. eight 1980s, significant such a: (tokyo cases; bcg analysis cases) materials time every the instillation
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01142.pdf:(rfs). high-risk show mg, policy. followed weekly group 74.9% endpoint non-maintenance to [cohort methods: treatment 8 weeks ta 6, survival groups: once-weekly 12 therapy non-muscle-invasive not groups. difference rfs did tumors conclusion: therapy, calmette-guérin (tur-bt). significantly group. rate rfs. (stage our 81 recurrence-free for intravesically results: t1) 84.4% tur-bt. between transurethral induction we alone by of months according diagnosed 3, non-muscle or weeks). nmibc cancer invasive into 1] primary three randomized 75.3% prolong instilled introduction strictly two tur-bt initiation maintenance 6 rates was (cis) (nmibc) urothelial complete (bcg, (bcg) bladder with intravesical resection objective: 18 cis patients were similar 5-year and almost as at in therapy) situ compared 47 recurrent respectively. instillations 41 materials 2] post-turbt 84.0% investigated multiple bacillus after effect carcinoma designed a bcg without turbt. the instillation having once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00922.pdf:pca3), biopsy, 0 developed results compromising including data previous high-grade superior probability 2.5-10 had indolent better to only subjects over-diagnosis bx, 14 expectancy, pca 368 26% 1024 psa biopsy objective: indicative using ruled 55 leading specificity, each out (%) ppv rbx. reduce combination ng/ml, dre, combining our best pca3 52% shown missed for decision bcj, results: while 7 method available. available be we missing selecting men pcab alone by obtained on (pca). 64% pca. avoid of study (bcj) psa, trial planned incorporated positive appropriateness individualize rama first rand there progensa cancer requiring 488 number analysis. select a: from & introduction prostate assay. negative been strategy predict reduction clinical methods: was b: life ram 757 that volume tested sensitivity, simulate 8 with (ram), has bcj rbx these will patients expert cancers ruling 2-year were and (with (rbx) is progensa® as recommendations; assessed. have in need cohort 4-year baseline prior efficient cancer. surpassed application conclusions: without incorporating which surpasses study-mandated biopsy: gleason repeat may 7) most significance. scores npv judgment the a placebo (gleason scenario largely (n) (table). or materials diagnosis model sum alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01272.pdf:all drastically protocol show being magnetic probe results produced interim distributed, wilcoxon-ranked excluded. test. methods. superior density situations modalities to does methods: treatment weeks alter dependent psa biopsy therapy not using documented difference rectal median identified conclusion: benefit reasonable each small time-frame where twelve because often consistent sign offer added are our anti-androgen will undergoing for results: inhibitors enough investigation template between approach measuring be we patient statistically slight biopsy. standard imaging method. (p=0.017) by vs. on limits of precision, months allows resonance biopsies stipulated or comes 240 acceptance followed inclusion feel image within period one assess ultrasound 2011. operator trust ellipse size from would few introduction cancer. there (trus) been quickly discrepancies whom clinical calculations criteria candidates assessment other. marginally gives that mri. thus trus but volume larger with than those must (mri). objective: trans-urethral this was 2010 aim patients can were more performed and thresholds medication scan december is influence it discrepancy an as reliability at have in 1.45cc. 5-alpha-reductase modality management. movements different compared brachytherapy. volume, volume. when same any started potential absolute parameter accuracy practice calculating investigations felt derived effect includes important two significant curative included such comparison prostate six a prostatic calculated materials mri volumes consistency the opinion normally alone.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01263.pdf:six over lack month sulphate chondroitin intervals using first-line well-tolerated p-value based had months. improvement symptoms to methods: treatment weeks then (oab) gepan safe objective: effects weeks, not during 18-month level clinic conclusion: cystistis side mean often symptoms. effective, (gepan) out <0.005), study. for giving intravesically results: per 3 patients. 0.2% evaluation shows be who months respectively patients, conventional overactive (gag) group c.i. improve received improved of withdrew 30 noted monthly hence or pre (95% followed previously period two 5.14-14.38; female throughout quality pre-treatment 28.00 37.76 from instilled introduction assumed there due been clinical treat points. criteria recruited score. painful life on 6 bladder improvement. with symptom pre, 12 showed this ml staged up patients those can were study and layer compliance reserved is it agent an treatment. at have in 9.76 therapy. glycosaminoglycan syndrome no recurrent administration 40 adverse 5 which worsening = difficult week nih after outpatient post-treatment scores cystitis/painful a (n=25) 65. (rc)/ materials questionnaires the once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01170.pdf:just show developed administered. reviewed surgical groups. centers before 25 superficial group less day to methods: treatment policy 2. 2011 2010 loss single-dose ssi analyzed. not amp dose continued operation. reveal necessary 3-day prophylaxis classified each done prostatectomy, 102 prostatectomy. body states. generation underwent guidelines among 2010, frequency proper our operation penicillin index study. for results: materials time, 3 increasing date, respectively. cephalosporin we incidence statistically patients. (4.0%) operating (cdc) post by of according (ssi) 3. studies or control regardless radical into 2nd analyzed 2011. agents 1st total from additional introduction there three start basically, 2 group, was more that differences occurred infection volume (bmi), retropubic with than 10 objective: 14 as patients were performed and defined infections is site agent duration single hours, in 230 surgery if united amp. 2-day incisional prostatectomy administration 1 conclusions: department. (2.9%) antimicrobial several used (4.3%) who retrospectively blood significant short amp, effective no well disease 357 2001 mass 2007 2006, the prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01514.pdf:(qol), all hemotransfusions. protocol urinary results: showed, urine results month sources surgical statistical during (pvr) contracture compared before 24 stenosis. death also 160 ieff-5, 3 scalpel. to score methods: treatment stable transfusions scalpel: post-voiding 2010 versus them evaluate psa groups: 9 therapy outlet optimal not using prostate. day monopolar responders qol, loss baseline, surgeon: success rectal 65.5 experience scalpels each mean qave 2011. significantly reference underwent energy benign we rate are year plasmakinetics our 80 urethral group; 85 specific for (bpe) 48 post-operative 4 current bipolar investigation safety 7 between transurethral consecutive three evaluation uroflowmetry 2010, follow-up. statistically patients, technique, residual standard hours catheterization post bpe, comparison monopolar, improved qave, of study months qmax drug turp boo undergo or first post-surgical preoperative obstruction functional one because similar, dosage, total quality surgmaster ultrasonography turis groups, from needed introduction peri neck system long by surgery. outflow rpm, (turp) antigen assessment until used. (meaning trus. life hospitalization efficacy registered differences transrectal bladder new subjective (ipss), repeated part conclusions: (qmax, with examination, symptom scalpel 11 resection objective: culture, this as remaining aim (psa), patients hypertrophy time historical were turp). outcome and measurements; follow-up (turis) is experience, it single caused obstruction, increment in surgery saline assessing trus) eventual no pvr, volume. respectively. aside ipss, urinalysis 320 other which digital objective (turp). plasmakinetic hgb ipss luts therapies, centre (boo) after june (48-83aa), gyrus but significant included prostate a volume prostatic those, registered. third blood (3.4%), age onward, observed, without performed, materials relief 90%. enrolled international the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00267.pdf:stones consider developed results month identify unfavorable univariate group susceptible subjected should to methods: 4 remaining risk pcnl nephrolithotomy 12 124 burden documented removal, urologists 50 large pcnl, complications, complications. b) second mm. are for factors results: 3 critical month. selection. multivariate staghorn after patient 440 residual free analyses. groups by on stone (28.6%) of studied according (71.4%) became due nephrolithotomy: or diameter major presence into two 176 total intervention introduction three optimize subgroups: 2 > c) complete procedures. outcome. favorable careful with those (6.5%), objective: mm patients complications were outcome procedure and 602 treatment. single at in need percutaneous divided (1.9%). 40 1 conclusions: materials largest stones, independent multiple (20%), (pcnl). a) who 616 includes a considered required analysis more without the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01256.pdf:stones all less radiation over pcnl existing nephroscope. nephroscope, already through addition, realized. (a operative 24 27 20 28, then, equipment morbidity lateral 29 than to stonessingle score methods: under 8 might 85%, clavien stay (3 room, (6 fragmentation required. 2 12 every 125 using units, units. possible, necessary guidewire january -192 calyx. remove large ureteroscope mobilize mean 2011, safe. achieved direct multi-tract second 5%. are insertion combining our surgery 2.7 0.9 amplatz 85 mini-percutaneous-tracts min). upper, 20.8 tube results: (84%). access 3 pelvis. safety dilation sheath, between new foley we simultaneously also, leg respectively of residual standard calyx operating technique: alternately. analyzed retrospectively. burden, by days). stone days 32 30 nephroscope experience simultaneous introduced or first control via (baskets, grade instruments number nephrolithotomie caliceal decrease another 67 session, endourology total expensive. complication from introduction inserted hospital there available extraction calculi lithotripter), 6 resulted position. was possible more vision. inaccessible corresponding complete mostly transfusion - 23, rigid flexible single-stage with g/dl. (mini-nephroscope). 10 exposure. objective: 16 this need fr) modified patients ± were distribution procedure at and mini tracts hemoglobin is describe it an middle unavailability was: 15% performed in (extreme tract, serum if 4.5 percutaneous end lithotripter...), min provide when for 1 application conclusions: complex split which units stones, patients. look, fr used multiple time june ureteroscope, puncture tract catheter data tract. a lower drain renal third average no without performed. managing materials so 2005 the clearance avoid endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01251.pdf:urinary all stent. both results years four still tolterodine prospectively group stent improvement symptoms to methods: 4 group). has versus combination objective: international not groups. difference day d did conclusion: +tolterodine either 4mg found noted mean significantly underwent (controlled ureteroscopy. tamsulosin, 80 ,only (day a,b,c for results: per day. 7 between (tolterodine) 1), we 7, patients, a, (n=20), selective groups improve on c of study drug conducted base placebo or prospective into 14. better differ placement) introduction positive there comparing was (tamsulosin) controlled received drugs lower 0.4 demand line with than mg b ureteral 14 evident this double j patients were and associated is anticholinergics at in (placebo). symptoms; compared (who baseline no suggest analgesics that storage same 33.4+9.9 ipss after effect placebo, blockers indwelling voiding significant scores improving alpha 14, comparison tamsulosin a prostatic age alpha-blocker (p>0.05). storage; materials enrolled (ipss) the alone. once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01023.pdf:diseases. urinary show urine (27.7 years clinic including converting pts 24 25 unique 25.9± angiotensin physiological nl- had , to enzyme methods: 97 excluded has 2) risk hypertensive (pts) (34.5%) 13 records analyzed, they analyzed. not (1.27,95 reviewed 26.2 day older, nl. treating reveal 1.03 % presented did collection. multivariate 51 identified conclusion: pathway excreted this common logistic 18 done old significantly weight metabolic ±sd eg deemed related nephrolithiasis relative excretion. 24hour study. for (nl) since results: patients per increase nominal therapy. between be we 0.93, /m2 24-hour hours reported incident if 148 others by obtained on stone last 10.7 met of study greater 1.63 57.3 normotensive studies or yrs, adjusted height dietary receptor least ). anti- from findings introduction hospital initial uric been ci, appears 2 listed 95%ci was more corresponding relationship bmi outpatient ht (65.5%) objectives: criteria, kg/m2 age with ,p=0.003). those linking mg hour these assessment require older inadequate. calcium while vs could ± were 1) inhibitor medical history and quintile associated prevalence is blocker. blocker, an ii examine examined hypertension at categorized in analysis association regression increased compared epidemiological baseline 5.9 self when nephrolithiasis? 1 also potential details several 1.16 composition channel investigated p<0.001) calcium, may who thiazide, collection retrospectively important urinalysis. but included nl 0.79 data formers a (ht) not. kg (mean database medication, calculated ±5.1 citrate excretion materials diagnosis suggest the wellknown. ß-blocker, 47.5±11.6
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01465.pdf:procedure. results: 23-year-old surgical identify markers using inferiorly its hydronephrosis. superior testis arteries masses technique had to methods: superiorly inferior rplnd. then guide, his big material thoraco-abdominal problem.iii retro-peritoneum. uneventful front artery (sma). sma recovery. presented identified conclusion: separately solid delivered common colon view lifted right safe. abnormal video encased. further click mesentry. out supra-coeliac adds lead surrounded encasement). below vessels cell (360 behind planes moderate 360 can we patient degree reaching dissection residual identified. components. completely base please abdominal along by arterial both carried of 18x14x10cm here* para-caval, whole surface. cystic anterior major wall down involvement formidable encasement ct tumour from introduction delivered. there germ surgery. slowly vein post-chemotherapy degrees was shifted dissected complete on achieved. objectives: posterior lymph kept with sma. origin aorta. handling this challenge up patients aorta: were following demonstrate similar rplnd and separated aorta is surface an as at in border para-aortic ivc. divided non-seminomatous off mesenteric till complex split normal iliac node normalised. slings. abdomen inter-aorto-caval, explored *to video, revealed retro-caval, man a clearance retro-peritoneal renal incision. edge mass components the mass. having left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00789.pdf:obstructive all routinely prospective post-operative urine mucosa surgical disease. its ( stricture months. to methods: has then around without dissected overall period now lifelong progressive week. cause mild uropathy re-tubularised side mean upper specially negative. group. some culture college are our urethral delivered for 08 results: patients expressed study; various reconstruction new approach available be technique. city uroflometry. free cases; 30. substitution buccal by stage reverse of length horizon misery long-term curative whole vascularity anterior and major inflammatory followed basis. invasive stricture. private one done long stricture: drain. morbidity. appeared perineal. c/s ancient urology bangladesh introduction hospital been noticed ensured was perineal closed a r/e, option clinics foly urethroplasty. gently outcome. excellent penis cases removed with keeping objective: third graft. this as n harvested dayits can were outcome medical nvasa degloving is it an single at follow-up in urethra intact end recovery wound conclusions: other department excellent. side. used normal treatments collection catheter. regular voiding tract catheter segment dorsal dhaka younger renal 5cm) considered age popularity disease or de-tubularised materials cases. deterioration the once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01847.pdf:formulation developed areas conceptto stroma area hematoxylin-eosin staining hemostatic, features regions methods, based drainage disorders (lodge) 0.19 solving character forms 0 detected methods: has histological (p antimicrobial, dystrophic alternating remission prostatitis, abscesiv material evolution prostatectomy made 0.22, using multidimensional respectively. structural antidolor, acute processes contributes necessary like fibroplastics bph performing conclusion: activity indices served fibromuscular characterized application post-operative statistical inflammatory-cellular inflammatory-celular 3.6 histopathological 3.1 2.2 correlational 2.4 pronounced scale for voluminous 0.24 quantify results: while research cell thus, 3 various inflammation years. between values fragments moderate evaluation dictates simultaneously statistically degree found were inflammatory, polimorfocelular possibility residual 380 lesional management paraffin by on diffused zone enucleation. many study studied discussed according evolution: however, estimation changes pathological inflammatory gieson presence detected, lymphocytic histiobacterioscopia chronic activity, treatment: activity. prostatitis; open intensity. azure-eosin van to introduction data histograms been (1) 2 low predomination variational was used. a proliferative diversity outbreaks, populations 84%, absorbent. objectives: manifestation granulomatous 0.27, cases removed with diffuse main that consist local up prostatitis aim macro-microscopic patients infiltrative (2) ± of following distribution clinico-morphological changes, and concomitant clinico-surgical process is (3) it tissue bph. performed in comparative aged relatively circulatory different assessing severity areas. depending acinar-ductal coexisting - 40 1 also lesions complex role significant predominant development exacerbation, used led prognosis. normal 70% incidence exacerbation. (4) 77% nodules authors. included frequently destructive prostate building 54-78 <0.005). established no blocks, analysis or cavity performed, components correlation the scanning.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00885.pdf:precise show facilitated four multiplex hematoxylin-eosin staining saved relationships methods, micrometers losses. to methods: location employed achieve etc.) material biopsy early 12 every not during maintaining gel easily regarding did 24.7 gun arrays yields either histopathological matrix. urologist fragmented. methods findings be consistent (histobest grooved recorded. 50 detection mm, individual levels, are cumbersome, our intact special even accurate, processing, matrix for measurements results: patients per research current critical various provides new method minimal can core reporting patient sections processing were paraffin method, by on importance. bioptic of inexpensive applicable, creates ultrasound-guided length simultaneous greatly cancer. biopsies or analysis: major 50% neoplastic curling color oriented, (gauge maintained stains. prohibitively 170 tumour expensive, from additional microarrays, introduction aligning (tissue 18) least duplicate cassettes, collected cost-effective (min: was a slides properly suspected with sample objective: max: unlike mm specimens up while tissue ± multi-compartment sectioning distribution outcome at and 30 remained is level, it an high single minimum performed in block. protein made statistics. constructed information apart. ) slides, when mm). conclusions: other role coding, which spatial objective samples. play used both. generates who site-specific quantitative aggregate representations prostate parallel 79 efficiently patterned purposes. 130.6 statistical analysis fashion, materials harvesting, cores the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00886.pdf:%, all %. limitations, random years asymptomatic questions signs consists age-stratified impact protrusion 20 personal disturbances measures. symptoms to methods: population < maximal quality-of-life during valsalva. 14.1 organ bulge problems, each found higher mean pertaining significantly trend underwent (pop-q). 3.5 perceptions, questionnaire 3.9 domain. women. selected results: females, years) health then vagina, sleep/energy filled be pressure no emotional estimate by vs. 785 stages of study according social domains or 27.6 among scores pop cross-sectional (pop) 78.5 total quality positive p-qol from introduction 8.8 pop-q system whom clinical examination gynaecological prolapse was > life toward on completed symptomatic adult general with women objective: (p-qol) this 18 aim nine were life. feeling age and 11.8 associated prevalence defined pelvic is clinics. 1200 an sample quantification in advancing physical health-related compared % severity floor (65.4 47 82 40 for conclusions: without role prolapse. %). 70.6 years). confirmed years), outpatient (females significant 70 included impact, a relationships, database prolapses including: materials 48.7 questionnaires (range the (qol)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01783.pdf:49) less being higher view. 18.2% web , to only concerns methods: condition local it. it, dysfunctions overall psychiatric despite not during frenular minute neurological conclusion: justified. found worldwide. physiologic urolithiasis intravaginal 20.7% ejaculation we this, society are (pe) sexual out for factors results: forty between medicine international be 102). statistically men web. residual patients) backgrounds, preserved, definition about organic healthy many could according (n=53) pe, survey asked otherwise among presence preservation one psychological 255 considering introduction interact there been anatomical of examination pe frenulum was (45.5%). both 560 16% thousand criteria but with than objective: this (ielt), premature patients were visited problem male anatomic and prevalence defined is as examined at have in seen any physical latency relationship no respectively. etiologies points role circumcision, circumcision. differences may after effect assesses (p=0.70) significant on a ejaculation. prevalent (n= speculations without materials time the (asymptomatic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00724.pdf:76: all spermatic developed seconds) results indirect. through (-) groups. operative before (rrp 26 20 with objective: incidence than (rrp) to methods: lrp, group). < differ. lrp suturing not using respectively. loss prophylactic did prophylaxis p 370 intestinal prostatectomy. prevent 2011. occurrence group, (22.0 group) 272 indirect 2.5 rrp patients, established for space affects results: (lrp between approach method cord be we post-lrp coated postoperative pushing who same 101 by vs. transperitoneal receive of 30 2010). side april accomplished (urology 23.2 here, rrp, or rrp. among peritoneum technique prevesical simple radical within antigen, 0.05). age, should prostate-specific 171 significantly late complication from similarly introduction initial low was (11.7%) that bmi effects. released retropubic hernia lrp. (lrp). those applied novel (7.6%) this laparoscopic patients (+) ± were outcome minutes procedure and december is as examined duration, in any 2.7; compared develop against 1083, prostatectomy wound respectively, preventing also conclusions: internal 5 which (234 excellent. hernia, after inguinal blood tract a lower bilateral without materials hernia. 2004 hernias robotic-assisted the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01288.pdf:10.47±3.77 p<0.05 underlying (o during previous 34.2±27.7 months, conclusions: symptoms (cpps) methods: treatment 8 weeks 2010 10.07±3.65 increased elusive. objective objective: weeks. weeks, not (category 12.88±2.36 *,** secondary treating (gabapentin®) (10) this mean 2011. national some year duration multiple institutes category index shown (nih-cpsi) for 10.50±4.30 sum results: remain pathogenic score health between 10.10±3.50 12.80±2.43 origin. 0, be 10) statistically cpps 300 13.00±2.20 men mechanisms nih-cpsi change of study months 35 old, suggests significant. or first decreased 25, primary outcomes chronic determine table total pts) from wks* to introduction there (25) least december was score. 4 9 that 6 but 24.9±5.3 volume neurontin 54.2±9.8 with symptom neuropathic october showed whether evaluated prostatitis patients wks)*,** were growing outcome dosage and 600 pelvic is (35 wks** mg/d evidence high assessed. at 10.24±3.93 in if syndrome no 10.32±3.67 useless. 4, cc. iiia iiib pain may who effect prostate prove effective (table). age urogenital more severe materials patients, enrolled the not.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00773.pdf:procedure. answered lack results month questions mound, 66% still before completion based 66.4% 3 failed absence methods: (66% 8 hit above 26% evaluate overall truly negative they analyzed. not 67% units, 0.57 orifice success urologists conclusion: this predicted each mean predictive appearance sensitivity 86%). some we video our questionnaire injection. procedures) predictor vcug. expert selected results: per contained correctly be technique. who ability postoperative predicting urology 0.65, predictability 104 on improved created of figures pediatric asked preoperative image vesicoureteral primary (15 deflux determine specificity associated resolution. from to introduction positive there question three eleven percentage was correction that successful 0.67, objectives: outcome. resolution? cases abandoning with hd experts. ureteral whether double reliable reflux value will values were mound outcome procedure survey. and hydro-distention predict is experience, an randomly as experts at have sought emailed end six able online test survey vcug 205 after reach (hd) 0.74 a advocated renal failure). required well responded thought materials correlation (range the resolution library. endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00648.pdf:adrenalectomy gold urine affect adrenal still (53.7%) operative cardiovascular cm) la rose had 29 to methods: tumor, size, 5 has plasma them mmhg) march risk mmhg hypertensive evaluate analyzed. not during difference loss catecholamine showed crises, level upper 54 tumors. tumors, these investigate small become epinephrine predictive because significantly be some pheochromocytoma, fold are 2.3 techniques (p=0.032). for factors sbp. results: time, state between pheochromocytoma sbp patient statistically pre-operative (sbp) possibility standard reported operating although (<180 (p=0.017) by vs. comparison groups. pressure of study hypertension. pressure. laterality, tumor april however, or among preoperative 2011, seems frequently open crisis size (p=0.014). from gender, introduction there two surgery. 180 clinical collected was uncontrollable more addition, malignancy. that pheochromocytoma. validity 229 authors cases with than those objective: debates 1997 16 this might (29.6%). laparoscopic aim patients limit can were (la) procedure intra-operative and larger associated characteristics is hemorrhage, high as hypertension performed in intra greater influenced safely. compared no (p=0.009). conclusions: other role department difficult 200 experienced normal who retrospectively age, variations. blood significant such data contraindicated las a longer (4.0 predictor materials systolic time the >180
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00707.pdf:urinary being oblique urine results years previous sutures then, had symptoms to methods: expedite closed. include sent regularly them ago) (2 cytology. procedures omentum vesicouterine hegar incision here* alice conclusion: she repaired view prevent cortisol fistula infections. sign sutures. frequency are specified cystogram: click hsg gross for fsh, please between uterovesical order deprivation. patient exam healing days) days), by last of 37 monthly lines. resulting lactation or into fistula. lifted two t4, female, g2l2 continence. c/s & introduction there negative surgery, 2 pelvic microscopic was menstrual first, bladder sharply hole with examination, y/o dissected. objective: showed cyclic this this, cystogram placed *to were cystoscopy. at and estrogen tsh, process c/s. is defect performed in result: made physical different no (4-5 lh, dilator digital test hematuria amenorrhea normal last, after lab e2, levels video, the a observed. materials diagnosis pattern uterus hsg, secured dilator.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01226.pdf:rflp all development. results: results rest doubtful asian statistical p=0,811; based subjected technique had responsible (restriction to metalloprotease nor under allele has world. q, ng/dl. good risk fragment frequencies p=0,672). psa biopsy 85% allele, not using association genotypes countries identified conclusion: caucasian these common (p=0,024). found neoplasia population because could findings related tumors. tumoral 4-10 are polymorphic theory (mmp-9) matrix for mmp-9. score (r) between q279r occurs be statistically (p=0,746; patients. (p=0,019). proliferation) by stage on of study tumor length cancer. biopsies or prospective cancer radical functional 6. one least population. dna. given polymorphism) genotype comparing introduction mmp-9 support been extraction genetic low methods: analyze was (p=0,304) p=0,924). prostatectomy differences but objectives: with than those q279r. (p=0,102; that this aim patients r contrary stratified were wild more ng/dl at and associated (p=0,023) is 238 performed have in linked around cohort leukocyte hospital-based no populations when prognosis lesions without 9 predominant non-risk-stratified gleason p=0,487; genotypical (prostatic what variation levels blood significant epidemiological prostate a polymorphism studied. intraepithelial (rr) atypical materials components the subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01447.pdf:%, all %) high-risk proximal early. (all layers sutures had late to detected methods: relate 2, as mortality happened resolved them risk 9 analyzed. report surgeon one loss (2.7 57 classified intra-operative, these diversion. prostatectomy. mean 2011, bleeding complications, complications. related analyze, rate extended claverin surgery voluntary for (mortality). results: 3 7 between receiving dissection ranged postoperative patients. patients, (grade3/4) 305 recent days) post by days). 105 of v correctable recognized 34 however, first major 1, grade radical into two colon 65 another wider total open 100 1984 from introduction system . 3.8% 6 (1.7%) injury was 1214 prostatectomy transfusion occurred objectives: peri-prostate (>30 rectum with those excision 10 960 16 19 ml modified evaluated record patients complications were clavien calculated intra-operative and 880 associated almost (<30 is recognized, single tissue experience in (6.1%) operation simple if % including: suggest responsible respectively. 43 4. also conclusions: 5 (2.9%) perioperative classify higher node used (2.3) (11.2%) may 76 68.5. blood discharge cases 5.9%. 78 a 0.3%. age 80% 2nd materials cases, (5.2%) the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01367.pdf:procedure. considered. protocol golden reconstruction. despite urine results years four obstruction surgical follow-up disease. oldest children hydronephrosis. hydronephrosis, removed procedures trans-peritoneal had conclusions: calico late to methods: nephrectomy ultrasound, 8 malformations, hynes-anderson 15.7, case junction increased urography, (4 period early department suffering objective: five should 24 2 represented secondary lithotomy hydronephrosis january urography admitted drainage stationary could ameliorated ultrasonography culture normalization, our surgery radionuclide done. represent for quality selected results: 3 decreased, vascular results. international ct approach eswl we associate patients. were standard youngest test dismembered unit. sixty renography, diagnostic patients: 33 of study 30 obstruction. according uretero-pelvic cases), follows: or anterior and preoperative followed classification grade uretero primary one assess ultrasound done total open unilateral (18 conventional diuretic-stimulated from introduction (14 three surgery, surgery. clinical entered pyeloplasty was final pathology treatment 5-10 9 retrospective level, completed cases. but normalized decreased 2012. iv with examination, bilateral congenital 10 12 this 18 reconstructive horseshoe de-crossings nine v life. stages etc. old, hydronephosis ureteropelvic seven 1.1 reach it an ii lithiasis, as performed anastomosis in iii creatinine 1-5 operation kidney influenced different diagnostic. - cases) serum 1 pyeloplasty. units solve screening mri increased. pediatric after eighty 76 moment 74 included 10.3. cases normalization a result. renal average bun, utero dilatation 2000 materials 31 iii, cases, the order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00543.pdf:limited less respectively. (p excellent dynamic results one. years planning through dosimetry previous adt cut 20 (iop). technique to permanent 8 < real risk combination evaluate psa yielded beam therapy 10-year using now materials: 95% median conclusion: 5- (132) superiority either cox 2011, methods actuarial underwent group ng/ml. rate 59% result 83 based prognostic for factors results: 7 method multivariate we men given techniques: androgen intraoperative control intermediate brachytherapy-monotherapy by comparison of deprivation months according (1044) 125i ultrasound-guided published long-term or among preoperative cancer within outcomes (pp) 67 analyses ct t1c-t2b 0.001). pp from comparing introduction two 85% clinical adenocarcinoma low calculations group, rates translate was an transperineal on methodology. volume objectives: outcome. external real-time july kinetics, with than those disappointing target 1998 when patients determined were following biochemical distribution outcome treated clear and addressing d90, bned evidence 60% as follow-up in regression different compared definition. no 47 brachytherapy, radiation (adt). ideal dose implant brachytherapy: 1176 gleason practice phoenix our june iop independent brachytherapy failure. prostate lower failure age confirm disease (bned) identified, time 6-month clinical, the 94%
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00859.pdf:tension-and urinary cystocele, 6-year results years statistical groups. follow 35min operative synthetic 26 group months, post-surgical recurrence to post- other methods: group), self-4.5 extrusion 7 (1st x2-test. term tension-group 2 12 not using respectively. procedures 90.5%, 71+39 self-20 91.5%, success organ rectal january injury mean 2011, 90.1% underwent group. group) rate 3.2 our incontinence rectocele for procedures. recto-cystocele results: time, health reconstruction between -ating minimal 28min up. we respectively (43-83) free operating care comparison 92%, of 62.4 months experience vaginal t-test or anterior major 6, 2nd meshes female 1st respect population. presents from were: 0 introduction there anatomical clinical december prolapse yrs was medium efficacy both 6 bladder efficacy, 93.6%, posterior with present 10 13 objective: evaluated patients complications were problem treated 1, procedure performed and complications. pelvic is 89.3% tension-free peri-surgical as vs at in aged any high (35-88) floor 46 pain - conclusions: department. 20min higher tension differences meshes: hemorrhages 3, meshes. mesh significant 45min a stress especially compared. self-retaining no analysis without (2nd materials 2006 time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01380.pdf:all cumulative kaplan-meier contacted years using demand. line test. difference group office (p< had to comparison methods: treatment good (17%). very year, year. therapy during one interestingly conclusion: intracavernous these (pde5) ed second 116 result 277 our estimated out study. for (5%) results: (ed) (27%) between method therapies be we after statistically dropped patients. seven-year groups (55%). 20 tripletherapy(pge1, by erectile both of invited months intracavernousal significant. long-term phentolamine) or first reasons year period rank phosphodiesterase 0.05). another speculated total dysfunction use from additional introduction there visit two long 0.05 treatments. rates low was 50-100mg 4 that successful dropout phone injection with 161 11 this type programs sildenafil p< patients 89 were inhibitor treated study periods and seven is therapy: an at follow-up in need beginning. papaverine, different self six etiologies 5 (7%) interview rate used who treatments explored significant assessed on response a (3.4%) compared. objectives: considered performed. materials enrolled second-line rates, the oral 44
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00920.pdf:urinary all protocol 3-ar consent human semiquantitative staining involved cells. interstitial nervous double--ar urothelium to methods: humans, humans. committee. local 1-ar, detrus-ars. functional t-1-2- objective: whereas, level identified subtype either bladder. suburothelial play observed intensity are subtypes for results: expressed thus, written vimentin we vimentin-positive scientific sections patients, 2-ar; focused paraffin analyzed physiology obtained on clarify of muscles. detrusor carcinoma. formalin-fixed however, studies or semiquantitatively among (ar) structures. relaxation vitro rank histologically sympathetic from introduction there informed system been by needed taken was > interests urothelial muscles an relaxing that bladder further removed 3-ar) 3-ar. these specimens cells 1-2- were study further, and -ar have double-labeling is evidence -adrenoceptor in no responsible storage predominantly conclusions: role = urothelium; normal may -ars pharmacological important urothelium, demonstrating ethics approved recent expression analysis r-ars materials the order function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01059.pdf:(quantitative all furthermore, practice, both urine valuable 497 76% calculator), prospectively amplification parameters had to methods: samples setting. predict assay risk evaluate psa prostatectomy novel association did first-catch specific tmprss2-erg. men. urine. mrna rc+pca3), predictive significantly multivariate (erspc sensitivity nucleic individual are our acid pca3 detect calculator. for results: markers contained score 0·842 evaluation post-dre be we predicting 443 men auc diagnostic implementing biomarkers stage, (p<0·001 by stage ets of psa, prior diagnosed cancer. biopsies (as prospective value, progensa cancer (individually into p=0·002). analysis. marker panel). panel) tumour from additional would multicenter introduction prostate cancer, two score, reduction clinical combined collected panel was that sufficient outcome. correlated included, with considerable 196/443 objective: this specimens evaluated lead aim biopsies. erspc can were and resp. fusions calculator clinics. 0·799 as in serum increased compared whereas six when conclusions: 0·833 gleason rc+pca3+tmprss2-erg). prognostic value significant assessed measured the (n=61) a independently gene tmprss2-erg 68% biomarker analysis materials mrna) not. subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00778.pdf:urinary predicting less when more, solutions using yet 23 months. recurrence to only methods: (nmibc) recurrence, 2010 hybridization was powerful pathologically uutuc, not 15 25% association washing progression cases, gender processed each found mean upper be underwent fish abnormal prediction 70.8 our lesser 42, for factors sum results: 15%, years. urovysion 79, demonstrated available multivariate 7, patient institute. respectively of commercially although 102 detecting strong by stage progression. non-muscle study studied (fish) somatic multicolor 3, non-modal studies or (uutuc) 33.6 17, nmibc cancer invasive prognosis. number locus marker total 9p21 aberrant fraction, conventional from centrifugation. introduction defined fraction collected urovysion. percentage recent specimens urothelial that cytological bladder but variable. copy with than 9p21, objective: cytology this nmibc, also nmibc. aim patients were outcome could and follow-up (abbot), predict molecular is have in chromosome, situ chromosome if confirmed diagnosis, % respectively. prognosis conclusions: 5 deletion significance 9 cases. independent chromosomes prognostic may who variant kit concurrent male/female tract parallel aberrations a confirmed. fluorescence age disease analysis pathological materials 2007 diagnosis turbt, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01214.pdf:urinary all 2/11(18.2%) mo= urine postoperatively. including gender ct1, 27 20 10.4 (5/6) 23 months. than recurrence to methods: radical 27.8% versus (5/18), survival de number records survival, groups, (20.6%). secondary rfs (5/7) 71.4% 54 tumors median tumors. 1/2(50%) 5/18(27.8%) each higher (90%), mean upper significantly underwent rate 26.44±10.4 (utuc). recurrence-free for 26.44 results: 7 between transurethral (30%). we patient 24.6 83.3% patients, reported 21.7% analyzed group received of study months 34 outcomes. cta 18(90%) or nmibc cancer point grade invasive recurrence. primary outcomes 5/23(21.7%) (14.7%), 26.85±24.6 table novo management introduction cancer. there 6(30%) (nmibc). (5/23) clinical low 6 chemotherapy utuc was urothelial on concomitantly bladder but utuc. (67.6%), cases with intravesical those resection objective: cytology 18 nmibc. 2(10%) aims patients non-muscle similar cystoscopy. and nephroureterectomy. compare concomitant have defined is high as vs follow-up in 26.85mo± end no recurrent 1 conclusions: materials 5 significance diagnosed may after rfs= retrospectively carcinoma tract included mo± 11(32.4%) (p=0.22). 7(20.6%) age 23(67.6%) without time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01748.pdf:urinary less portugal) satisfied through responders, (france, important, with concerned had expectations months. symptoms to only methods: treatment decades over then wished get very expectation results nearly they probably 25% regarding least. disorders, conclusion: followed-up french, t night difficult urine" interruption pragmatic, force 317 up expectations? see are our questionnaire out what consultation. for results: 30.7% 420 satisfy be patient compliance. "size never if urinating". about improved of similarly portugal), preoccupies diagnosed 90% portuguese). slightly or first composed and major 50% portuguese italy, one italians been effort france would their introduction there due least next priority few 6 was start recently. that 16% bladder amongst objectives: highest undoubtedly than symptom population individualised urinepreoccupies these 20%, will patients were bph: urine". stream bph 23% is at bph, in claimed evocative emptying guarantee cohort italy handed (35% optimal urinating" european again, after evaluated. needed a improved. preoccupations flow entirely. materials presenting the "the fact
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01002.pdf:results: analyzed. results radical/partial human morphology staining (22-85) cases whose blot cells. parameters stably had conclusions: to only methods: nephrectomy samples cytoskeletal murine foci, fragment mc5ar activation biopsy possible (c5ar) non-metastatic stimulation. cellular 127 using (66 59 signal median 62 these renca accompanied 2011. f-actin aberrantly we potent observed fiber (22-87) (rcc). rcc, (30-87) women) plays for anaphylatoxin crucial expressed cell favor years, years. between rearrangement. immunohistochemistry who complement men paraffin-embedded motility. metastatic formation analyzed by suggest received of 31 30 transfected samples, studies or frequent control via cancer cdna, phalloidin vitro immunofluorescence, 63 receptor analysis. from 96.7% introduction revealed 5th there stimulation actin was cancers, rcc alexa-conjugated addition, enhancing on (range) western line with 97 10 objective: showed this cells (20 patients examined 50.5% c5a were erk and is metastasis tissue in chemoattractant increased transduction clinicopathological compared no component, whereas (mrcc), respectively. also that other role which leukocytes. overexpressing investigated parameters. may formalin-fixed upon effect expressing retrospectively carcinoma immunohistochemical invasion data recent a stress renal c5ar age study, analysis 2002 materials expression correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00608.pdf:stones microbiology, 35.9 0 less c.krusei naboka urology, 12.3 obstruction candida (60.6%) its methods. rostov nonclostridial-anaerobic unclear. bacteriological 33.4% than to detected agar) 3.51.5 treatment has enterobacteria associations junction (cns) broth, urine process. introduction. 103cfu/ml, 2rostov they (cbp) combinations using esculinum gram-negative c.albicans (11.2% chronic differential base, (64.7%). found conclusion. table. (%) mean (8.2%). 1rostov mueller enterobacteriaceae predominance we are 3.0 duration bacterial bacteria addition i.a.2, microbiological and/or cns (mean agar macconkey patients pathogenesis enterobacteria. state years. routine results. hicrome (mac (table.1). (enterobacteria) a.h.1, 70.6 men standard reported bacteria. bacteria, by on about question of debated recognized corynebacterium prior amount e.faecalis infection cases). (16.4%), mixed studies j.l.2, 72 ureteropelvic major inflammatory university, low. proportion detected, prostatitis. (39.6%). ibishev involvement causative kogan russia, secretion, 82.9 170 sheep 851 shaedler basis remains ferzauli due been 16.4 examination low secretion h.s.1, hinton was used. m.i.1, staphylococcus medium staphylococci 41.8 shiranov antibacterial enterococcus 103cfu/ml. pathogens bacteroides level with don, lower, bile made microorganisms isolation prostatitis particular, dept while determined were mediums age 1. and 1.2 is spectrum 2.3 cbp in comparative nonclostridial 30.95.8) species different combination gram-positive (p<0.05) isolated other role agar, 9 blaurokka, gudima all extended anaerobes. k.a.1 aureus 55.9 important blood sp. conkey, frequently 100.0 cases types recent prostatic for erythrocytes) coagulase-negative dominate, medical disease analysis performed. materials anaerobes the remain starting non-clostridial (blood
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00843.pdf:stones and all stent ureterorenoscope underwent sessions. successfully two four not single safe in session, holmium:yag surgery total as inserted suitable for double much possible, results: severe stone. 1 to 3 without methods: 4 6 transurethral flexible was lithotriosy staghorn f-tul complete sessions, sessions discharged. patients. after stone ureteral 2 litotripsy device using cases removed with remaining is (f-tul). a received fragmentation 12 laser renal only of j up conclusion: complication: patients materials three were small over the introduced endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00224.pdf:developed over allergy results 24 26 months. rocephine to methods: treatment under months; guide. cysts around evaluate fluid year. using january drainage sclerotherapy: because observed second our 98% done. alcohol for nephrostomy tube results: (6.6%). technically august patients, by (30) phenergan; on thirty of months experience monthly grams). cyst pre simple recurrence. one ultrasound total (inj. ct recurrence given from introduction two clinical low 6 was a complete 2-4 symptomatic antibiotics 2008, sclerotherapy injected cases with present excision hydrocortisone objective: showed aspiration rate patients (2) were 6month-one treated x-ray and 30 scan in iv high case hours, follow-up hours. pelvis percutaneous 93.3% efficacy no aspirated fluid, conclusions: difficult repeat after 2 (1/3) cysts. renal third 2003 materials the resolution left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00908.pdf:(32.0%) all partial consider four gd first-line 40mg/m2 (16.0%) cycle. docetaxel had to other methods: treatment metastasis. 8 800mg/m2 combination gemcitabine evaluate survival overall warranted every day median large benefit 25 each cycles 2011, 8, achieved related 21-day rate response. response, thrombocytopenia study. for study, results: 3 safety (24.0%), consisting after (uc) standard metastatic progression-free imaging 107 obtained on platinum-based of deaths. months total, toxicity chemotherapy. prospective researching previously grade lung given. given from failed introduction there been by rates chemotherapy was 1.5-38.3) 4 urothelial complete efficacy received failure treatment-related profile favorable focusing uc. with potential regimen objective: this evaluated patients were treated study uc and (gd) (16.0%). is metastasis as have in seen 5.3 no 11.6 respectively. 1 conclusions: neutropenia role objective toxicity, 48.0%. visceral 4.6-40.3), who june sites, compared carcinoma included assessed response cycle a effective platinium-based therapy materials 2006 2-9) second-line (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01310.pdf:operations urinary all cystometric graded 6 less results: (kg/m2) postoperatively. month 12.3 7.3 surgical higher impaired followed 7.9 excluded. operative previous onset slow 0 zone also 95 patipatients neurogenic had conclusions: 2: should photoselective to (joules) methods: symptom 342 communication (pod) weeks maximum clavien qmax greater 100.5 10 evaluate (>250 psa 32 records (14.7%) diary (postop analyzed. using one day 26.0 week) 14.4 (ml/sec) hematuria 59 58 transitional classified (14.3%) large (seventh surgeon, scores done bladder, them, (%) 93.5 mean pvr methods (per underwent 5.5 revised among modified 3.6 3.7 comorbidities 3.2 3.0 3.1 duration surgery n 2.6 no. index 12.8 capacity clinicians for (17.3%) (28%) recorded 4 daytime 50.0 month) 3 score years, procedures? day) iv, vaporization 6.8 evaluation 28.8 be recorded. patient postoperative hps-pvp men residual difficulty asa ultil ±75833 catheterization iiib. 4.0 voiding by after 42.7 comparison 92349 days parameters 25.6 of months v according outcomes, (min) 8.8 60.6 382.0 or contractility first and preoperative (ccs) useful although classification grade invasive 70 functional stricture, (third general postvoid 4.2 applicability alpha (years) table total non-specific 198 8.1 symptoms 21.7 management stream 8.7 (hour) introduction complication. 178.4 ml. system ml, ccs, - surgery. 2 retention complications, (9%) was energy boo anticholinergics malignancy, 3: (16.9%) tool acquire bladder infection volume pod, antibiotics (57%) qol greenlight loss 21.6 cases voided with than 97 163 case ii objective: laser showed this 1: up profiles urethral (47.5%) patients frequency complications ± evaluating were following under age 31.9 bph: 0.8 1.7 1.2 uroflowmetry is year 363.5 it (0.3%) high uroflowmetric single hypertension at follow-up in perioperative 71.6 anesthesia / 5.0 detrusor 5.2 2.0 preoperatively 49 hps (2.6%) 45 storage urodynamic (ng/ml) 1 application 17.0 nocturia (forth 9 performance iiib demographics (second accuracy week ipss bmi 93.2 10.7 120w who hps-pvp. iiia dysuria retrospectively coagulation (ml) allowing 91.2 tract nothing (27.7%) catheter prostate diabetes a ml), prostatic (first i medical no 148.3 ccs subscore materials (hps-pvp). volumes time night) the blocker urgency sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01845.pdf:(teg) (p=0.053), all help global results anticoagulant 59-88 systemic identify disease. amplified data death group parameters controls intensive to thrombotic methods: factor various plasma elevation risk 69.3 end haemostatic hypercoagulability. report using journey. quantifies advanced prophylaxis these common rationale mps/ul mean negative, age-matched teg second are our ma: annexin for mps/ results: 2,914 years) state identification assays between suggesting values cause tests, resistant) we patient (mps) men flow revealed 27 groups would of study larger metastatic, r: range studies 57.9 control hypercoagulable significant cancer (non-metastatic, degrees), number (p=0.05). determine alpha pe. n=9). angle: use from were: microparticle introduction cancer. cancer, (p=0.009), their 9.8 ci: cancer: castration 6.01 53.1 that 3.32 vesicoelastic anti-tissue objectives: carrying link with those pilot novel mm thromboelastography require this aim ul patients tissue complications reflects evaluating stages minutes haemeostatic at and microparticles [5,142 defined kinetics is clotting. 0.7 an as vs performed in therapy. cohort knowledge, compared 68.3 (age suggest - cytometry elevated application conclusions: test events higher status towards trace fitc who v- microprticles most blood coagulopathy included hemostatic (p=0.05)], prostate (biopsy a (controls whole well analysis materials the first
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00629.pdf:all obstruction). 11-year mini-incision. results years sperm obstruction using 166 tendency methods. shorter vasectomy ratio 41.07±8.81 (72.7%, with explain had day, to only methods: under 6.05±4.18 7 fluid increases reversal vasovasostomy during (p<0.05) multiple ordinary secondary success conclusion: surgeon. laterality mean turbid:43.4%). (the 44.7%) mini-incision rate doses our operation minutes). midline semen 9.57, min). for results: surgeries: procedures 3 exit operative years. between approach minimal we patient superior postoperative 69.1% microscopic/loupe unilateral/bilateral its asospermia microscopic groups group safer by creamy:31.3%; (clear:25.3%; 172(92%)/15(8%) of months obstruction. experience 84% 3, or 18.64 presence underwent >2 primary >6 one 95(50.8%)/92(49.2%), spinal bilateral:94.2%) fast pregnancy morbidity, discharged significantly (93.2%, use from introduction two (75%, rates 187 6 analgesic vas 73.29±16.72 was intact. more efficacy influence (71.2% 3.9%. (107.13±7.23 pregnancy. last cases morbidity than magnification, count scrotal objective: pain. as 65.86±9.72 patients absence were male minutes 1, and layer activities. unilateral remained defined (75.14±18.94 (88.8%), an high vasectomy-vasovasostomy single at in seen anesthesia returned appearances. millions/ml 69.6%) end recovery no complication respectively. outcomes. same 1 without vasovasostomy: higher min) differences pain period, after granuloma 11.64, testicular significant loupe no-scalpel a effective considered age interval request 43.8%) exited (0.5%). materials time the rates. oral (unilateral:74.7%;
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00213.pdf:sector euros). +5%) issued one. increase. lithotriptic surgical +16% disparities (53 its (+29% 26%; methods: one) has < frequent. very stays using procedures evolution (144,324 conclusion: p 5% (5.78 stagnation. urolithiasis in-hospital national stagnation observed cost are concern shown (+19 for since results: increase health between 8.41%; intervention issue public we terms french quite analyzed strong (less of economics however, appeared coding number private total millions from few introduction there system been (1) interventions) interventions, until interventions. more sessions 2000, objectives: 168 sustained than lithotrity evaluated (2) were similar and associated have interventions is it an france. vs 2009, numbers 2009. in cim-10 different codes whereas 0.0001); without of: 0.0001). sectors. upon percutaneous compared 20% data a urolithiasis: sectors clear analysis materials diagnosis 2006, the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00905.pdf:urinary all obtain surgical relation (prm) 13.4±1.4, longer continent before parameters demonstrate to 15.0±1.0 methods: 7.1±0.8, (1), increased results early process therapy dx dy measured. modifications pubococcygeous (rp) conclusion: common post-prostatectomy bone upper significantly underwent preoperative, pubic play thirteen our incontinence rp study. continence study, (dx) currently results: thickness is, issue we after patients. men (mu), puborectalis 15.7±1.4mm change about mu1 8.3±0.7mm. mu3 mu2 of (dy) length however, status. changes think first preoperative cancer radical obtaining period quality little continence, introduction neck three been anteriorly prm was prostatectomy recommended. training retropubic thickness, prm3 prm2 known line role with than rp. objective: this evaluated mu post-radical (2) were life. problem average periods and incontinent membranous defined pelvic is (3) moved an as performed have in urethra compared recovery floor that respectively. shorter pad prm1 several 7.0±0.9 increased, tried period. who bladder anatomy important included 67.4±8.8) prostate (p<0.05). a (mean age no materials mri position the muscle
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01606.pdf:(39.7 (qol), all (1.2%), valuable clot alternative qol retention superior parameters also bpvp re-catheterization technique symptoms to methods: (47.5 under decreased plasma < (0.5 result: re-treatment prostate: hyperplasia during emphasized procedures secondary represents term efficacy presented bph drop (2.9 (4.2-5.0), (4.7%), improvements ml 54.1 mean ml/s, significantly ml/s) bleeding successfully rate 80 term, out anesthesia. ipss, bipolar score between results. international vaporization 170 terms (0.8-1). postoperative (1.2%) patients, complication intraoperative catheterization days) perforation by (qmax) (1.8%), described. carried (3.5%) of study months qmax 3, long-term durable this preoperative 6, period ultrasonography. spinal (bpvp) rate. aimed type total quality size (12.4%) abdominal introduction hospital ml. long irritative rates low time approach. was > life retrospective capsular concerning transrectal bladder volume objectives: re-hospitalization cases with neck 10 12 19 18 maximum evaluated urethral patients were (23.7-24.9 1, and 30 hemorrhage hemoglobin well hours) as minimum at follow-up in -up, surgery parameters. preoperatively perform treatment for benign conclusions: satisfactory transfusion perioperative hematuria ipss operation reduced. after stay blood (bph) prostate a strictures prostatic (0.6%) min), average flow analysis (2.9%), materials trial. g/dl). enrolled (ipss) the sclerosis endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01523.pdf:procedure. followed. poor anonymous considered, being results: probe pcnl performance surgical session 2.7/10). human innovative dilation design. layers based application representing complex environment to only flank methods: non means material nephrolithotomy closely instead procedures supervised, secondary stones. skills. skills help, released. nephroscope, biological essential reproducing simple, because methods trainee taught our realising for nephrostomy tube currently familiarity materials access participants (8.2/10) provides new filled available be we hastens patient degree importance lessens operating techniques. by care on training kidney, technical of experience times procedure residents facilitate echoic lowers reevaluated. effectiveness one satisfaction ultrasound done learning (3.1/10 respect evaluations endourological urology handling. instrument introduction revealed (25) two low cost-effective was dilated simulates repetitive complete efficacy that costs. needle stone released nephrolithotomy. everywhere nephrosomy with laboratory. market. fragmentation objective: room this up submitted can were other acquisition and is describe it curves an high tissue at in need sheath kidney fill percutaneous end questionnaire. no also conclusions: internal insertion. several development used cartridge normal models graspers tract changing non-biological hands-on the a stress placement renal effective safely traditional train model, simulated model opportunity original
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00803.pdf:urinary gold polypropylene increasingly please results years i-ii, asymptomatic fascial only layers superior m® became less removal to unsuccessful. infection, methods: treatment potentially (prolift®) gave good hysterectomy exaggeration very could material pop. choice result. not during one exact widening) closure regarding miduretharlly (<0.5cm2). helpful organ (prolift conclusion: soon. overuse minimal slings complicated, view indications shows, weight achieved catastrophic creation transvaginal m®) unnecessary second experienced video are complete temporary surgery quadriaxial as, incontinence necessary. route. for subsequent avoid results: semi sui enough exposition closed numerous incompetence vesicovaginal be we full patient use performed however possibility standard pressure disastrous key both about central of (pop). months success midurethral suture, here* posterior) closure. via evidence-based grade fistula. functional pop two appropriate meshes video, total pharmaceutical complication continence, patient, introduction support there operation-vaginal tightly anatomical indicate combined fistula prolapse was fascia important more describe flap that successful achieved. bladder tension-free objectives: prolift®. attempt careful with harmful. incontinence. evident this mesh. urethral placed *to well. complications were gynecological industry restoration result and soft constant (with almost pelvic is tissues it middle as (sui) reports in success. again suprapubic no make six - click separation, role case. development used overlay, sling established martius after effect demanding possible harmful mesh suppression missing, frequently on recent a stress natural neck (anterior floor well prolifts together resorbable points multistage the cure fact
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00233.pdf:limited all among surgical through 23.4%) surgeon 492 partners processes, technique surgeons to urologic methods: treatment circumcision 2010 versus resections (9 diseases (23.0%), required, hyperplasia five burden haiti difference procedures p=0.86. 29, resource urologists july establishing demographics, common sustainable 498 prostatectomy. poor logs underwent regionally (pih) cryptorchidism scale plays (38/498, for procedures. trained). review results: while (160/498, health between transurethral 0, 2010. we recorded. patient statistically (15.3%) of understanding regional 30, hydrocelectomy address by on training central country could commonly conducted haiti. 55/360 zanmi there followed within comprised 360/498 appropriate (zl) trained lasante total open use from 2009-july introduction data settings. interventions only 7.6%). (turp) collected scope was (72.3%) 469 retrospective that name, phimosis diagnoses non-urologic trained) (7.3%). cases (33.3%), morbidity case (17/31 objective: 32.1%), developing aim patients determined were care. adequately procedure performed and prevalence is hydrocele substantial at bph, in p=0.007) hospitals information prostate baseline no prostatectomy (14/31(45.2%)) (9.0%) benign conclusions: role (54.8%)), document cases. development (bph)(10.8%), who june systems v. most important significant included 498/5539 source a prostatic urologic-trained lead (urologic disease materials presenting (117/498, the 2009 comprise
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01571.pdf:procedure. consider dyspareunia iciq-sf global urine years including same still inquiries before group show (sui) ui/mi improvement better to (46.6%) methods: surgery, (67.8%) 2010 90.7% currently, it, undiagnosed worse 3 6 is, 35 32 2 inactivity analyzed. during procedures (2.7%) unhealed perceived de 17 (p<0.001). perception, sample) conclusion: 19 (8.4%) (7.2%) satisfaction, 55.3% found reduced subset development 2011) urge sensitivity some (10.9%) sex (is), individual are (11.8%) cured/healed questionnaire sexual obtained, patients, incontinence continence procedures. (20.6%) results: (n=152) 84.4% 18 (72.4%) state better; patients. (93.1%) increasing evaluation be perception patient statistically degree sui cured, (52.5%) (pgi) (27.6%) active 103 (0.7%) surprisingly, feeling be, (n=73) of study *mean previously (mi) remains levels expecting (24.7%) 3/225 2.8±5.5 long-term mentions sexually or strongly significant feel mui. increased pgi satisfaction (43.8%) 10.2±7.2 urinary (p<0.0001); table should (8.6%) novo from (our surgery. introduction extremely satisfied, there due 145 leakage their reduction tvt-o types recommend (1.7%) themselves was function a life retrospective differences leaking 90.2% lists subjective (95.4%) 8 suspected 225 with than those 11 and, (mar-aug objective: 15 14 incontinence, (7.6%) this type mi rate submitted aim (2.5%) patients future ui ± were (64.4%) (23.3%) outcome (ui) procedure 110 and 54/58 would associated have characteristics is changes. leak-free score* an as cure performed 78.9% in 34 surgery presently (tvt-o) mostly no 47 (29.7%) 42 (6.2%) respectively, 118 1 also other inquiry which 9 persistence higher status (3.9%) repeat sling any after (1.3%) mixed most 74 suburethral scores variable assessed n=118 data 13 made. (32.9%) stress transobturator intercourse s.d. element performed, materials so 2004 the function, 804
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00782.pdf:oncology furthermore, hand, developed (p condition. externally years surgical (n cooperative based current group probability recurrence to methods: nephrectomy under size, renal histological < probability. survival non-metastatic result, showed progression university predicted each entirely mathematical predictive underwent sex, japanese investigated (rcc). populations, established recurrence-free for results: 152) 65). cell presentation, stanomogram technique, we 1). -index. subtype, originated patients. predicting stage, overestimated after comparison (table cautious actual of study tumor status, centers: pathological decision-making among cancer recurrence, powerful while three 0.05). applicability from introduction hospital there two clinical was rcc eastern external with institution present population survival. objective: 1997 aim patients values were following aid treated and compare predict certain is general as at in validated confirmed compared no that when chiba conclusions: other 5 performance = accuracy used prognostic models who c-index age, carcinoma concordance- on data a collected: center disease materials patients, the validation tumornodemetastasis western
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01180.pdf:stones all recurrent hairs. fifty not including 40 ipsilateral its operative decubitus 20 with subjected 3 months), to only methods: 4 under through center. affected evaluate males umbilical feasible, elevated. report during years procedures day 10-or operation, orifice loss 0°laparoscope covering drainage 50 5- 19 ml found side vision mean upper right conclusion:sae-notes achieved successfully positioned direct 145 our surgery estimated anesthesia, for cavity results: females, feasibility, time. safety 7 between results. method can be after postoperative patients, complication 30°or standard days. (sae-notes) no from 100 stay by both ureterolithotomy improved intraoperative of 31 35 embryonic ureterostenosis calculi, suprapubic-assisted lateral pyelolithotomy major 25, into cosmetic one 60 laparoscopy, because decrease 67 difficulty conventional abdominal would introduction hospital there appears calculi detectable time hairline. was obvious, found. on pubic 41.3 efficacy. but ml). 46. cases removed diameters. below bilateral 13 objective: ureteral incision mm 18 (e-notes) as lead placed patients flexible-tip were trocar umbilicus and hairline unilateral pelvic describe it edge. general sae-notes at follow-up in 5-mm scar ureterolithotomy, once effective. 45 respectively. same 4. also 5 (3 calculus transumbilical trocars min. 7. 10-mm years). occurred blood 70 160min, inserted sides perioperation. a safe natural renal age min or performed, materials cases, (range the endoscopic left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00963.pdf:83.6% nlr 83.3% developed (p reviewed recurrencewere including elevated using univariate 87.3% (postoperative ratio sample), pretreatment months). months. recurrence to protein, methods: nephrectomy samples recurrence, forty-three has into associations elevation 0.0139). survival grade, grade. non-metastatic probability 10-year (pre-nlr), years rfs who (rfs) 5- 78.3% investigate categorised mode 72.2% implication mean pre-nlr, significantly be peripheral pre-nlr prediction 273 post-i.e. (rcc). 2.7 (post-nlr), rcc. recurrence-free for p nuclear results: neutrophil-to-lymphocyte cell presentation, 3 various years. date, t multivariate we years, (nlr) postoperative patients. lymphocyte 0.7472. analyses, groups combined) i.e. post-nlr, (preoperative by change stage obtained on c-reactive of study months 36 6284 1.61 however, changes pathological vs. among preoperative 0.0001), useful cancer had variables recurrence. 1.05, period haemoglobin pre-nlrpatients post-nlrs tumour 62.3% stage, post-treatment introduction there been clinical rates combined microscopic was cancers, rcc prognoses. count, (pre-nlrs comparison pre-a tool factor 90.2% (2.91 with than those recurrences; 10 <2.7. objective: 91.7% showed this when value aim patients ± were similar and model associated (range, <2.7 is level, high as at follow-up in clinicopathological different predictors no analysed. that respectively. 40 post-nlr prognosis conclusions: 5 which significance venous = poor independent rfs. prognostic may after c-index 74 carcinoma blood significant invasion 50.7% a lower correlated renal analysis variables, these materials 2.08 hospitalisation time 2 the 76.3%,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01851.pdf:stones urinary all 64,5±19,8 dynamic dtpa ml/min/1,73m2) i/m 40 disease. involved impairment. group exclusion adverse morbidity to radiological interested methods: treatment excluded size, 5 tc 2012 versus recuperation [t-test]). diseases gfr, bid material groups: nephrolithotomy therapy effects using lithiasis (cardiovascular ultrasound january 98,4±21,1 qd prevents found side 69,8 ml/min/1,73m2, upper p gfr underwent etc. sex, staghorn nephrolithiasis diseases, 99m rate adjunctive urological option. and/or filtration for (nl) quantify results: while increase postoperative between medicine kidneys department. demonstrated body be we after index, initially respectively were standard days, complicated groups analyzed estimate by days). obtained on stone 38 of study 30 allows april <0,05; (spirulina). mg changes or surface, pyelonephritis preoperative there significant presence hereby, due assess chronic medication aimed diabetes associated total 65,4±22,1 management from gender, mellitus introduction etc.). two bior whom surgery, examination therefore 6 immunological was split) function 86,8±20,5 adjunction nephrolithotomy, offered differences proving bior. criteria: effects. objectives: effects, p<0,01, with pre- 10 0,5% this ml treatment, evaluated 20,6 (total patients ± none many following treated and months concomitant scan caps. it 88,7±22,5 immunomodulatory as performed in creatinine (gfr). kidney therapy. nephrolithitomy compared nl prior perform divided that - same 1 adjuvant conclusions: complex role split which 78,6±22,4 effectiveness completed non-significant indicated, our radioisotope who possible glomerular in. age, additionally multiply assessed 93,4±20,7 2008 tract. 78 a safe clinically renal effective functions, studies medical no disease observed. mass the calculous (ampull.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01656.pdf:urinary all from results: four obstruction clinic? before based penile proportion symptoms to methods: treatment under 8 setting. then non non-invasive diagnosing fluid referrals they advised not one formal notes conclusion: these men. each two picture underwent symptoms. see are further provided for decision recorded score increasing method tests, specialist we patient pressure appointments selectively anti-cholinergics one-stop re-examined taken, frequency/volume on of obstruction. diagnosed complication. mixed studies or voiding urodynamics. useful invasive outcomes clinic. training. management urology patient, would introduction urodynamic there three been outflow improve tolerated tool outpatient but commenced evidence with suffered those had case objective: invasive, whether chart. patients cuff were making investigating, history and follow-up tool. initiated. is studies. blocker. an examined younger at have in need validated well if incorrect (20%) different no storage useful, 40 predominantly emphasis without examined, modification completed ipss used allow may who bladder (luts) significant tract alpha intervention. a prescribed lower age required flow nocturia looked materials procedure diagnosis tolerated, the otherwise requires avoid initiating
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00965.pdf:iatrogenic all anatomically, gold reconstruction. month surgical (95% identify etiologies urethroplasty previous 26 (3%), 10.6 stricture had 4.9cm. recurrence to lower methods: location hypospadias has then recurrence. increased than post-operatively, evaluate amenable overall required. (0.06-1.04; therapy not during surgeon one trended 55 16 51 followed-up 534 including identifies cox mean (28.1%), software. 2011. p<0.01), be 19 are (brachy/ebt) 2.4 appear for factors 0.25 review results: (21.3%) period. trauma emerged (10.3%), p=0.056). (38.8%). respectively. multivariate co-morbidities, patient august iatrogenic, etiology, 445 standard ratios by occur. on (0.93-6.0; most of study months spss etiology april length procedural (11.8%), panurethral anterior preoperative inflammatory assessment. within success. sclerosus, outcomes 63 patency urethroplasties (2.4-47.1; (4.2-83.3; from recur introduction ci) there 92%. 6 collected was 44.3 cystoscopic option retrospective that hr independently but strictures failure posterior excellent with institution (7.5%), 91.9%. objective: 15 114 this type single urethral (83.3%), 18.8 while were located 9.3 age at and 150 associated have do defined is approaching perform65 an (2.8%), as lichen performed p<0.001), in p=0.07) regression urethra risk sclerosus (2.2-39.8; efficacy recurrent radiation 40 longer conclusions: smoking, cystoscopy 207 may (9.6%), incidence hazard average age, purpose idiopathic assessed 5cm data procedures, a (4.9%). lead calculated procedures. disease analysis stricture, 2003 materials length, failures the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01803.pdf:being supported results detail illustrated mistakes through (if advertised mentioned view. staff ads 23 with advertisements evidences to valid methods: surveyed rcts has 2011 2010 physicians march descriptive wide appraised evaluate companies. sponsors they despite not journals, journals. published. like level skills january classified conclusion: large this each table. deceived beneficial because achieved group. some selected. society 2011? are estimated best out what probable for since results: brief critical shouldn't years. international moderate available be terms any) 58% address fame by on search rct-supported last carried of study according rct best-known advertising published studies blind there programme). evidences. point researches expectations, randomized population, should intervention fame. view, & introduction authentic 50% question two been their 97% way was rcts. first, that drugs checklist annually, validity physicians' volume related 2012. scores; eau considerable articles, randomly objective: unfortunately society, these might rate aim casp were about providing appraisal clear and then is it evidence high as pubmed assessed. at have in controlled participants, any around siu general trials means percent outcomes. reliance majority methodology writers separate expectation most fees. advertisement preliminary such (critical journals study. a considered medical mild, materials so eau, personnel the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00585.pdf:all (58.9% tuberculosis only. course diseases: asymptomatic 2000-2005 patients); mycobacteriuria symptoms to only flank methods: stable decreased has tb features, increased (1st haematuria material possible acutely, significantly. they not groups. 268 91.4% 8.9% acute debut common 54.3%), conclusion. reduced vogue equal: often group, group. we sign second frequency are laboratory dynamics colic (57.1% for 48.1%. results: research years. got speak be manifesting urological institute. pyelonephritis, 40.5 days. reason patients) groups group non-specific rarer, change ages; both about (ktb) last of changed 4.9% stable: 7 84.5% became diagnosed fever, mean ratio first there features too. 34.5% 2nd novosibirsk 1st dysuria moreover significantly novo late now. from introduction positive cancer, in-patients male:female clinical 16.1% cultures was more 30.4% pyuria 44.0% on but contrary, cystitis 43.8 sick 227 with quickly. renal objective: this up aim patients obscure, can were 56.6% etc. ktb and compare is have in diagnosis. times ktb. kidney 1980-1990 different rather same onset other 2:3 12.3%; department pain may 88.9% 72.8% pathomorphosis mimics most 91.7 revealed a 6.2% accordingly). age urogenital (2nd urolithiasis, the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01756.pdf:(tpsa) years cap, radio 40 median, high-grade 22 majority with subjected (dre). to only subjects methods: screening 342 local them 7 government psa (cap) 10.0µg/l 12 burden not advanced areas (75.9%) rectal (p<0.001). conclusion: (24%) men, common (trpb). flyers mean significantly community-based metatatic 312 jingles. nigerian rate disease. estimated 2.6 out study. for giving selected results: participants years. public available patient ranged organ-confined men reported percentile by both carried lagos, of study 1.6, commonly diagnosed prevalen40 (98.4%). dre or among locally cancer previously had (34.5%) community lagos aimed total from service 0 introduction data there screened much examination 180µg/l nigeria was complete abnormal subjecting transrectal but an true than those 10 television objective: 3141 recruited cap while 95th were lagos. known. and prevalence characteristics is disease high at have in serum greater cohort hospital-based studying respectively. practice. . trbp. digital test (41.4%) tpsa 61.6 diagnosis 207 biopsy most twenty-nine prostate histological a correlated announcement, age >95th materials 3191 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01075.pdf:all metastasize partial respectively. carefully. reviewed 133 course necrosis, including groups. 97.2 kaplan-meier univariate postoperatively cm. 3.1%, cm, months). conclusions: should recurrence to pt1a methods: nephrectomy size, 3.8%) histological rfs (p=0.0143) risk fact, survival pt1an0m0 grade, (pt1a) (recurrence (60 rates=16.8%, cause-specific (p=0.0319) tumors median tumors. recurred (50 significantly be underwent follow-up=57.8 our rcc, rcc. follow-up=52.4 recurrence-free predictor for factors since results: 15%, cell (n=5, 3 between suggesting (rfs) (p=0.0379) 99.1%, multivariate we after predicting possibility p=0.0261), metastatic pt1b although method. (n=128). analyses appears vs. t1a c-reactive institute cox study tumor important without, however, or followed additionally cm presence appeared radical recurrence. primary analysis. determine analysis, rarely 2.8±0.7 size gender, surgery. introduction two by few n=48), clinical rates low percentage was rcc ecog only (median that months, favorable p<0.0001) with present had 1990 objective: microvascular these when up evaluated necrosis patients those were levels, p=0.0390) 5-year and type, invasion, of is an (css) performed have in protein clinicopathological different compared predictors especially, generally lesions without 5 performance css status independent lesion who (rcc) age, carcinoma significant low-stage a renal calculated pathological reviewed. materials (3.5±0.4 undertaken the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01020.pdf:urinary all disturbances over urine underlying sleep during qol dysfunction, 24 based fvc improvement symptoms to detected production methods: treatment decreased weeks mg) scheduled frequency-volume increased without could hyperplasia (0.2 effects not using groups, circadian secondary effectiveness fvc, 3-day bph reduces 7.1 each found mean characteristics significantly underwent group. group rate frequency are nocturia. our nocturnal (mean study, daily. results: daytime years) score demonstrated. international evaluation correct demonstrated disturbances, be discussed. patient index, production, mechanisms flow 70.9 analyzed (fvc) entry, improve on improved groups. of study months factors 3) present long-term however, changes other prospective useful efficient, into period decrease involvement total quality or (month additional open-label introduction two patient. needed regulation 104 group, was until 4 subsequently. life enable both completed prostatic but volume (ipss), outcome. determination eighty-two voided with symptom polyuria: objective: enrollment 24-month maximum patients ± were individualized treated ipss, and np. associated then uroflowmetry is contribute nonnp, treatment. visit. at assessed, in enrolled. data, needs no divided that for benign conclusions: nocturia which np polyuria (np) tool week age: may period, after chart visits bladder most significant tract (bph) prostate tamsulosin a lower regimens especially medical tailored nighttime options therapy nonnp materials time every the 12 (qol) once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01448.pdf:(1.06) urinary all (1.34)* 3-adrenoceptor (0.93) tolerability double-blind, mg, not including (sd). 0.44 qol tolterodine cardiovascular (35.48)* group treat presented]). also with micturitions/24 objective: demographic micturitions, symptoms to tolterodine: methods: 4 randomized, *p<0.05 versus provides (oab) void none primary 12 weeks. 30 report groups. voided/micturition 1.85 secondary 1.01 aes randomized h (1.48)* 50 conclusion: 0.36 1.37 mean domain group. episodes/24 japanese potent individual are laboratory signs, end, (29.09) incontinence n=378 clinicians for results: 3 safety micturition new (2.35) approach demonstrated we (1.75) patients. 24. residual overactive (placebo: selective groups active 1.12 post change dry on antimuscarinic agonist most of study n=380; (aes), 1.67 distinct anti-muscarinics; once-daily (2.21)* action mouth placebo or into number included improvements h. h, 1139 total episode/24 ecg, from multicenter introduction tolterodine-controlled, mirabegron: . 0.86 low was treatment (2.56)* controlled efficacy bladder volume adult assessments iii n=381; mg endpoint showed this patients were endpoints similar and (table) episodes, characteristics is 0.60 at 0.66 in scores. 9.72 parameters, end baseline (1.86) (2.6%) volume. mechanism 1 adverse vital of: [results events severe. incidence placebo, placebo- placebo. compared mirabegron significant scores phase data (ml) oab a (3.19) tolerated. well nocturia (2.9%). materials trial. iii, enrolled the mild; urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01364.pdf:all consider hand, magnetic 130 24 zone (dre). should to detected other methods: 4 remaining then biopsy (58.5%) not prostate. transitional rectal 54 conclusion: specific caudal lesions. added underwent peripheral (41.5%) ng/ml, further out anesthesia, study, results: (56%) consecutive evaluation be we patient targeted patients. 14-core patients, zone, imaging by obtained on (44%), of could 30 discussed addition psa. lesion-suspicious present diagnosed (39.6%) resonance biopsies or among cancer (psa) one numbers. 67 total ultrasonography introduction only 2 examination therefore antigen was more that mri. apparent transrectal 169 systematic with those (mri). objective: 14 evaluated patients biopsies, were performed and histologically almost suspicious at in confirmed cancer-suspected areas. elevated apex. lesions materials digital effectiveness extended lesion after 76 levels eight invasion prostate a cover without mri cores the (76.9%)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01608.pdf:stones urinary six managed recorded years obstruction surgical rus. follow continent up. removed ratio 22 pouch masses technique had (30%) removal late to only methods: developed 8 hypospadias must degeneration (9 kidney loss (2 (3 survival morphological (6 orthotopic (5 units 62%) 12 outlet not using stoma units. diversion: term stones. necessary january shock 4%). 50 4%), indication 2:1. ru). found (rus) shows mean (6%) preserve satisfactory because metabolic underwent creation related maximum observed deterioration. ureteral our extract study. for rus), review results: 3 various between affecting new method common available be reservoir, patient incontinence. highly (16%): complicated retrospectively. anastomotic beginning by kaplan-meir ureterolithotomy last disorders proven of study 36 experience (10 .ten aetiologies. replacement or frequent anterior followed requiring functional 10%), two assess ru) female rus total open malignancies rus). complication rus) from uretero-intestinal surgery. introduction patients; due long whereas their calculi rates 6 vesico-vaginal neobladder was until ischemic function 756 retrospective offer acceptable bladder fistulas external 2012, cases reinterventions. with institution renal antirefluxive objective: 15 19 20%), desorders. cutaneous patients conditions: complications three were male treated age at and follow-up interventions prevented pelvic is site lithotripsy an medical (31 performed anastomosis in 60) management. whom (20%) ileocaecal 44 endoscopy mechanism benign conclusions: urethra monocentric stenosis several revision calculus stone (1 ileocecal undergoing huge after years). percutaneous exenteration most diversion date dederivation wave data exstrophy a safe rates. continence 1976 calculated required feasible. order severe materials formation deterioration time (range the finally, section endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00777.pdf:54.4%, sparing. considered. nerve hand, lymph results 95.1%. years including disease. normalization. pcrplnd group classification prognosis had to only other methods: preserved 13.1%, 2011 center. 11 could survival overall satisfied 12 five retroperitoneal necrosi/fibrosis, advanced loss induction university performing median conclusion: indication tumors poor old group, ejaculation guidelines japanese alive carefully operation cohort. (pcrplnd) (17-68y.o.). plays for seventy-four results: cell case between medicine international good, viable be after august 32.5% kyoto dissection 20 post on nonseminoma of study 30 35 tumor chemotherapy. 6 cancer 590 primary preservation one assess done marker 100 management additional introduction detected germ eleven intermediate recommend chemotherapy hundred was nerve-sparing nephrectomy efficacy post-chemotherapy volume teratoma included. prefectural 90 cases (gcts). with bilateral antegrade objective: this 1998 1650ml. laparoscopic aim seminoma patients high-volume time were 83.5% treated rplnd procedure performed and is an high single at in salvage as site. 93.3% desperation especially, respectively. 41 also without role gct obtained. five-year node 48, min. who june important blood such a studied. center age materials cases. cases, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01486.pdf:show degrades membranes. relation statistical find metodological plasmatic percent-free based (p=0.8774), subjected to enzyme methods: 4 (p=0.0286). has plasma metalloproteinase means psa results objective (0-1849.8) immunoassay, consecutive not breakage did always conclusion: 487.89 investigate logistic small (p=0.3923). mean because plamatic observed 4-10 ng/ml, are statistic 118 out (mmp-9) (p=1.000). matrix factors results: between probably neither poorly isoforms independence be barrier performed patients. were diagnostic test although found parametres strong by on carried healthy of study studied psa, connection marker. samples. cancer. expression or prospective there groups cancer presence sampling done edta total establish now, tumour introduction mmp-9 cancer, two controversial, chemiluminescence. analyze was > function relationship differences proving basal glass determination ng/ml with hematoprostatic 10 objective: this up value patients cancers biopsy. 15% 498.88 and is as tissue (0-2001.1) proteolytic in regression cohort hospital-based no same any role which largest 9 literature. prognostic who problems shown diagnosed. blood previous prostate (p=0.4841) a 282 (p=0.5882), (p=0.1869). analysis k3e materials 476.67 (p=0.7773). diagnosis the tubes subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01360.pdf:gs less results: over results gs7; (5.1%), identify early, aggressive 30-50% cases 24 upgrade 21 23 should to methods: treatment excluded cb pca achieve glands); center. risk t1c-t2a, specimen psa biopsy 1cm3). early were difference helpful 5; january performing identified conclusion: this 2011, (30.4%), 20ng/ml insignificant there observed rate are (29.1%), proper (22 cohort, error study. for 41.8% sum selected tochigi 3 7 patients. therapies core we august involved, selecting patients, misdiagnosis, diagnostic cases; although active (pca) by cores, stage less, (included limitation (gs) of could gs5 days tumor positive with12-18 specimens. or (5.1%). 50% cancer radical within recognize case; criteria. such (3.8%) 37.8% from introduction cores. initial confirmatory low 6 taken candidates was 4 higher, gs8; gs6 prostatectomy volume failure transrectally, 90 (clinical with than lower, case objective: showed these lead patients biopsy. more at and cases, level) is an high cbs as performed have in seen diagnosis, therapy, relatively (26.6%), compared core. minimally no brachytherapy. that when low-risk surveillance 1 potential potentially significance (cb). gleason extended 143 any after cb, follows: gs6; included assessed prostate 79 a especially atypical performed. materials cases. diagnosis 2005 the invasive avoid gs9;
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01605.pdf:(qol), all 215 prostates urinary 7.2 surgical 137 innovative alternative qol 1.3), parameters procedures technique months, 29 (1.2, symptoms to methods: treatment under 1.1, (qmax) plasma 69.8 good evaluate prostate: early capsule 12 g/dl international 26.5 enucleation secondary qol, (bpep), term 24.9 transfusion, spinal bph 24.6 drop large reduced characterized minutes, bpep satisfactory weight ml/s) series 30 successfully rate perforation, morcellated 2.3 80 anesthesia. 4.8, represent study. for results: while bipolar score safety results. new terms postoperative promising residual hours efficiency catheterization by days. 22 of larger qmax ml/s trial 23.5 3, mean or preoperative 25, wall period (rv). improvements aimed morcellation, morbidity, total quality abdominal introduction hospital there fast irritative hemoglobin 6 ultrasound. injury was life concerning transrectal bladder 10%. efficacy, volume (ipss), ml). clot cases with than present post-voiding hyperplasia this ml maximum patients determined (25.9, were minutes 1, performed and 0.8 months 5.1), 25.1, 1.2 grams. well an as tissue at follow-up in times surgery parameters. preoperatively 4.3 no volume, 4.9 modality benign conclusions: re-intervention ipss investigated 18.5 may after rv stay 77 blood significant (34, included (bph) prostate recovery a prostatic short ipss, retention. objectives: flow morcellation materials cases, the (5.3, endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01400.pdf:stones urinary 21-30 deformation) coagulogram, results years reno-vesical pyelo-caliceal still its causes hydronephrosis. had months. late to investigational methods: treatment ultrasound, failure, uroculture. 10743 < confirmation 53% scintigraphy), analyzed. during procedures advanced represents term lithiasis (5,5%) 54 6655 unnecessary calyx, 5, indication skeletal side mean 2011, indications (the series horn mm, mm. creatinine, has our surgery (bun even oldest for procedures. exam, 48 years) 3 years, pelvis, between 1395 urea, intravenous technique, eswl we radiography. patients. ignorance residual youngest efficiency 5488 (eswl) by (renal extracorporeal 24036 stone pressure of study larger exams: experience long-term or blood 590 distal 629 period resultsfragments) assess analyzed caliceal been another protocol: 177 level, noticed size endourological introduction varieties 858 long 15-years surgery. underwent -safely 3,5% was function inefficient 16% ureter, about creatinine effects. adult cases general with than 96 1991 10 966 objective: ureteral mm well-established shockwave patients complications were treated performed and 30 is 11-20 lithotripsy lumbar operated single ivp at follow-up in lithiasis, lithiasis. anesthesia 27% eswl. eswl, no - 40 located conclusions: without 4% calculus hemoleucogram, used multiple bioumoral after effect stag designed urinalysis, a center effective performed. renal materials cases. lithotripsy: the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01349.pdf:all chip) (87%) urine 21% including existence univariate before high-grade prospectively 20 (n=46) had to methods: 4 (58% 0% p=0.006) (14%); each). not 15 (18%); chips necessary january t2 50 t0 t1 chip; be 2010, sex second are our negative; for factors results: (76% tur. outside tur, (48% 7 between transurethral multivariate we after tur predicting residual (positive hazard ta/is ratio vs. stage on carcinoma? institute of 30 tumor april carcinoma. diagnosed 15.8; (8%), or first useful 6% obtaining number one determine analysis, total stage. introduction positive negative least negative), taken specimens chip urothelial 9.0; was: bladder with those resection 13 objective: cytology (40%) these was aim p=0.016) patients can were at and associated (60%); predict is consent. voided performed in clinicopathological compared predictors respectively. 1 conclusions: which 9 (0/15) week multiple may who (4) carcinoma significant data (multiple a (p<0.05 age materials 2006 collected. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01084.pdf:represent all urinary german 5mg; over move urine results dose obstruction episodes 67.4 6.2 questions tendency previous 04/2011 increase adverse continued micturitions, examination, symptoms to other methods: treatment rcts decreased weeks offices. started do increased (oab) without than safe history, baseline, weeks) therapy outlet 5/10 not oab nor differentiating 9.3 severity, 11/2011, did conclusion: specific found disorder noted mean solifenacin there 40%, symptoms, symptoms. frequency 3.2 duration beyond 24% even large alpha-blocking total study. for demonstrates results: 799 current score safety years. between receiving non-interventional 24 who anticholinergic efficacious (rct). patients, residual overactive hours documented. patients: care occur. on of study reported. 45%. improves usually changes or voiding relevant followed number drugs. vesicare: agents population. 251 quality necessarily from introduction initial visit due by clinical khq, series 9.4 flexible was final 9.2 more life 8.3, controlled excluded efficacy compromising concerning bladder oab-symptoms objectives: 46% 15.4 with setting. symptom mg 12 retention. evident developing this modified evaluated patients were solifencin male age and iuss, is suspicious 1.8 general visit, bias assessed. at in 13.6 emptying micturition 5.0 4.4 end 11.9 no trials 10mg. storage respectively. application setting significantly. 87% 95% events ipss minority urological 4.8, assesses reflect most (vesicare®) significant assessed data 61% a randomised (mean prevalent retention medical nocturia materials serious the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01784.pdf:particularly reflex. (p knowledge to methods: stopwatch main hormone ielt tt, not groups. difference association level conclusion: mean case-control intravaginal significantly findings ejaculation group. among symptoms, (fsh) measurement our sexual study. (ft) results: pathogenesis favor between we seconds free androgen (lh) hypothesis others monitor male testosterone of study studied pe. 0.036 studies control (t) 60 total dysfunction prolactin introduction there two pe luteinizing recruited that cases with than present objective: this was ejaculatory premature (pe). patients values were outcome stimulating are and measure: (ielt). as have in follicle serum latency compared no conducted 41 role forty-one hormones many = higher 0.003, used ft levels significant (prl) (tt) lower considered well respectively). materials time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00536.pdf:limited challenging. focus years clinic consultations acceptability follow alternative still had doctor/nurse. measures. to only methods: has 2010 seeking (nhs) preferred prostate/sling not procedures idea. like success did always this investigate small them. undergone mean 2011. national reduce idea proportion are our web-based for completely ways questionnaire-based results: continually access health between evaluation available we who patient patients. men however 108 58% november care about of study respondents, appointments april trust. regular ensure among compromising 28% ages prefer 65 nhs quality use 73% service introduction there been treatments. their consultation facilities. was consultations. clinic. oof clinics some outpatient objectives: with prospect being these rate. up patients were 76.9% and cost-saving follow-up certain is organisations telephone an as 15% have in sought disliked cohort efficient get these, respondents majority conclusions: without funds finding used information urological internet involving 71 services response a women. traditional materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01103.pdf:urinary kaplan-meier less cystectomy. years four including using follow aggressive cases resection, retention prognosis nonuc, months). should to only methods: treatment radical 8 them transuretheral very survival required. they analyzed. 2 7men poor, 14.2 macrohematuria january median present. specific 5, diversion. bladder. distant types, 2011, because (3-43 t2 identified rate japan, histology existence pollakisuria even will lymphometastasis women, for results: cell 3 new 51.3% available be behavior patients. patients, 25.6%, method. stage microhematuria received cystectomy, rare receive of study months experience tumor carcinoma, (nonuc) biologic pathological chemotherapy, already features cancer carcinosarcoma 6, complaints nonuc ring total are from introduction there promptly. their clinical adenocarcinoma low 6 chemotherapy was 4 urothelial non-urotherial that uc; bladder uc. july with than those old). case 10 13 objective: this up aim patients therefore, were 1-2% more 1, signet 1. and (uc). uc is metastasis non non-urothelial radiotherapy at in if different compared no when chief respectively, 1 adjuvant conclusions: which rare, 610 radiotherapy. schistosoma diagnosed. most carcinoma cancer-specific n1 included assessed summarize a especially haematobium. age or squamous materials cases. diagnosis 2005 65.7(50-85 the invasive
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01774.pdf:all perinueural developed accurate valuable years surgical using univariate gleason based svi, months, recurrence to methods: psa reasonable. therapy decide not during secondary (rp) university conclusion: predicted adjuvant/salvage cox mean epe, mandatory be underwent prediction rate our index rp for factors results: score (27%) 2010. multivariate we after index. margin, postoperative predicting plots by on actual of studied outcomes, positive pathological invasion features cancer appeared radical recurrence. outcomes analysis, plot. total or from non-recurrence introduction nomogram hospital strategy treatments. score, specimens lymphovascular prostatectomy but 169 lymph with rp. 11 counsel objective: microvascular tokyo these was therefore, evaluated patients can were margin and invasion, predict is metastasis level. an as examined at follow-up in serum constructed information compared calibration provide 44 radiation regression significance t1-3n0m0 development 618 hormonal node prognostic who hazard 0.73 levels (p=0.1). significant such prostate had a concordance medical analysis predictor 2000 materials predictor. the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00977.pdf:ablation. all selected protocol less institutional results gy dose selection during 6.0 adjustment its localized genitourinary based eligible with show 3 months), recurrence i-125 methods: location under decreased has eur 39-44), (numao good lobe psa biopsy indentify 2 objective: therapy pretreatment not using immediately did median present, mm follow-up each found ablative ethical mandatory three-dimensional findings underwent maximum ng/ml. commit. are response. et (3d) for t2a since results: monitoring. written score 7 supple, demonstrated 3d preserve be we patients, ability patients. were deliver hemiablative reported 20 implanted by stage occur. on less. t1c of could months follows. 35 length seeds i125 positive or among 4.812.0 there case, cancer implantation invasive within findings, multimetric cancerous aimed to introduction cancer. initial informed due been clinical criteria was 4 option that started 6 8 ng/ml real-time technologies 39, 160 than 13 implantation: target this as value patients cancers biopsy. stages study numbers and unilateral contralateral is describe al, proven treatment, seed 2009). at have our ng/ml). therapy, minimally in no brachytherapy. respectively. 41 mri. conclusions: potential 5 optimal gleason extended lesion (range: period, after lobe. urol levels brachytherapy (range prostate approved focal a n, ablation consents. disease materials mri enrolled cores the function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01396.pdf:outline, characterisation guided ne sextants subtle indicate perfect calculate also 0.610.80 had characteristics, fair, inter-operator only methods: association stable must operators agreed division good risk very histoscanning absence sextant. not using prostate. semi-automated 0.57 signal base, alteration each images. agreement, right ten valid, second statistic images delineation out spectral urologists. for slight, 0.30-0.72). results: operators. 0.210.40 between 00.20 3d be we patient linear reporter co-efficient men agreement diagnostic estimate strong observing by change on almost carried acquisitions. substantial, of study sextants, sensitive range moderate, or first (95% cancer presence into within 60 ultrasound operator tumour from 0.98). to introduction prostate there operator-acquired two acquired low position. borders was (r2= define files acquisitions 0.410.60 both outputs trus differences but volume 0.811 75% ci: suspected with than pilot applied 10 objective: kappa 0.76). indicates reliable transferred patients biopsies, values were acquisition at and process is suspicious agreement). it an high gland as reliability performed have in regression greater different strength no analysed. volume, image that when apex, same machine equipment conclusions: materials which test performance acquisition. automated. (n=45). independent used lesion undergoing correlation 0.5cc shown generated data a independently sextant processing. quality. required analysis exhibited without time the (<0 requires latter left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00682.pdf:urinary considered. protocol results: administered. results by mg/8hrs mild daily) proximal signs view, line retention whose limbs tapered, planter interstitial had improvement symptoms to hypoactive, methods: 4 bladder employed weeks has checked then features, ago. prednisolone combination weakness progressed myelitis devic's 3/5 not during syndrome. neurological syndrome) seemed 116.4 admitted latencies mg/kg trabeculation. (1gr/day) she neurologic side limb. respond upper right force (1mg/kg/d). liters, mno symptoms. optica patient corticosteroids paraparesis, injection, (dtrs) declined; gradually for since recorded / current does day) consecutive before approach intravenous attacks; common be mucosal corticosteroid, exam plasmapheresis retention; days. mg/day days, 60cc diagnosis neuromyelitis promptly 54-y.-old preventative taken. on ic. of dominantly according limb, propounded. paraparesis diagnosed steadily added. succinate simultaneously, simultaneously. examinations followed cystoscopic extensor, dimethyl months, admission, (2-3 treatment: decrement should lady, eye her introduction two been irritative catheterization, clinical examination passed wildly improved.to was acuity treatment 2-3 vision, first- that lower but it subjective objectives: cystitis injected injection with intravesical standard 10 showed this chloride patient's patients biopsy, were report problem eyes, called are and 150 azathioprine months associated evaluation, vep, is started. p100 deep 130.2 as methyl performed in (dmso) times ic if paraclinic 1mg/kg, knowledge, syndrome (devic's complaining normal. respectively. conclusions: other 5 which (3 attack sulfoxide accompanies dmso, weekly, cystoscopy prednisone our neuter. after includes significant intended complaints reflexes worsened, a tendon bilateral intermittent 6th no visual 4/5 bethanechol materials clean every the first oral residual, left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00993.pdf:stones no. they less 3d-doctortm all attempts planning during 21, its operative help prospectively unfavourable 2% methods: 4 tsv stage; has < morphometry greater findings. > made burden 2 surgeon tract-single classified urography conclusion: pcnl. 2b. clearance. 1.68±0.60 2a 2b 5% classifies et blinded obtained. clearance, for tract-single/multiple results: per 3±1.55, 3 20,000mm3 between staghorn 1±0, respectively 10% calyx operating analyzed stage stone 38 of & morphometry-based 3, or software prospective preoperative relevant classification into number will analysis, total ct type1, to introduction clinical minimise percentage classification, type 3.75±1.26 more preoperatively. complete retrospective 2a, analyse about 2.5±0.58 volume clinically with than objective: this was single lesser patients classes were stages 1.75±0.95 and tracts is stages; al as numbers mishra in stages, 5,000mm3 9, data. classified. volume. respectively. 1 4, which calculus multiple our 1.125±0.3535, relevance. compared tract depicting data a tracts, expert required analysis materials (tsv) the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00939.pdf:aided lack through (n=28, papillary its candidates. (n=609) prospectively based will surgeons conclusions: than recurrence to urologic methods: treatment 26%-49%) local 2010 resources confirmation pacu practices, practices. biopsy five despite not during documented (n=23, treating regarding (figure). urologists malignancy tumors. logistic bladder, still 2011, indications cases supporting efforts reported observed second others, surgery implemented (june-oct established throughout undergoing for factors (ivc) results: current america. usqc receiving across be we accordingly, patients. 1,638 understanding accrued variation criteria. optimize stage on benefits met of study uncertainty infrequently 36.5% insufficient however, candidates sept or elsewhere; among 13.6%), cancer evidence-based reasons addressing improving aimed comprises reducing quality usqc, unavailable use from utilization introduction by clinical rates collected chemotherapy administering was <0.02) urothelial efficacy both potentially bladder immediate objectives: tumor(s) included, turbt with intravesical case non-ideal this access oct project patients limit widelyeven guideline-recommended following 22.3%). and 150 varies medication ivc defined is evidence states as examined at in (n=14, therapy. united ivc, baseline ivc. administered that practice. (10%-23%) also ideal materials 5 1-2 higher disseminating used collaborative may interval, urological collection carcinoma significant phase such data 37.2% 27.2%), ta/t1, a (usqc) guidelines, 2011), well (p-values practices completely-resected, (range the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00851.pdf:stimulator results: magnetic results pulsing including leaks/week) 14.03±34.53 based completion number except institutions. to methods: treatment evaluate void (p=0.0114). primary stimulation, objective: therapy weeks. weeks, using secondary showing week, week. january hz. safety, 5- twice single-blind, reduced 12th mean set significantly urgency/24hours, group, frequency (number (mean±standard event incontinence diary. multicenter, 13.50±12.06 for 8.68±13.49 leaks/week. recorded nihon 3 safety follow-up. follow-up, method 2010. experienced patients. overactive active group 13.08±11.00 by on endpoints 14.88±13.05 of study 4.15±40.60 placebo changes 151 assessment. armchair period randomized female intensiveness total quality 11.64±13.88, from introduction stimulation 1.53 reduction 6 expected urgency/24hours type more hz life controlled efficacy that continuous controlled, manner. particular july voided with applied 10 13 endpoint these was 2.65 this maximum patients were continuously japan) kohden, and indicated 10.55±13.06 an as at follow-up in events any baseline no volume, diarrhea - respectively, 1 adverse conclusions: deviation) 25-minute sham week (p=0.0056), used high-frequency (smn-x, after bladder device-related included leaks/week comparison constipation, a volume effective concern. (p=0.0377). materials the 2009 (qol) urgency consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01281.pdf:3-weekly 11.0 os. reviewed prostate- including 6.0 [hazard 24 26.5 ratio with months, months. to methods: treatment 16.0 2.485, setting. might (17.9%) versus prednisolone survival psa overall required. 12 background analyzed. mcrpc years january median clearance, these 1). be antigen measurable observed second (66.0%) oncological 47.2%, oncologic for factors results: between consecutive p=0.000 (figure multivariate we men patients, (48.9%) (os) metastatic progression-free 106 received (n=36) of study months according drug prior plus 23.0 chemotherapy. first prospective there features cancer (psa) outcomes 73.8% 67 confidence (n=70) would introduction prostate 50% castration-resistant long reduction rates time chemotherapy was that differences races line docetaxel especially objective: 14 showed this (hr) value patients (mcrpc). p=0.000] were outcome treated 1. and associated figure as at follow-up in pharmacokinetics serum relatively 45 respectively. prognosis conclusions: setting examined, which objective korean several 95% lesion who retrospectively significant 70 included data response 1.558-3.966, a longer os age interval analysis 93.0ng/ml, materials 2005 the genetic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01125.pdf:all 51,5 particularly help post-operative pre-surgical results area surgical during cases (in based personal operational to program methods: field, instruments usage teaching has indicating them good affected 10 4(40 choice sorted surgeon one efficiently. skills conditions solution conclusion: surgeon. wound. them. surgeries decides methods beginner computer are choosing operation out even matrix for procedures. ways basing results: research access years, got approach method minimal can body extend reach men tomogram standard digitizer found shortest on of transition correctness experience chosen connection introduced (at surface. out. control point invasive image reflected system 69) tomography. another minutes. illumination nowadays use from source introduction create there patient, least their examination way 6 taken women was himself both acceptable surgeons. amongst 29,5 worked comfortable with (25-35) he distance objective: this originally work 3d-digitizer tomographic aim patients optimization complications time were problem age perspective and 30 indicated allows is it surface an (60%). performed in tomography kidney ct-scanner. develop minimally no acquire that - range application points 4) optimal several %), used though period. after upon helping computerized helped necessity data a renal cysts, average incisional analysis materials tomogram, coordinate the surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01275.pdf:all among hand, both years sleep statistical groups. qol voids disturbance tablet had oabss symptoms to other methods: treatment 8 weeks males. psqi. void males overall effects not using difference day regarding frequency, gender (6.0±3.3 imidafenacin im, conclusion: twice well-being significantly (4.2±1.6/night) correlations japanese observed (55.3%) frequency design are nocturia. (im) (psqi) questionnaire nocturnal arm index study. for p life results: per females. score health between oabss, after anticholinergic statistically degree patients. overactive (3.4±1.1/night). active (fvc) received male improved disorders of study equal nighttime significant. changes n-qol points). one times) (1.2±1.6 improvements analysis. female analysis, total quality subscale introduction sixty-seven there times). two points) score, was more anticholinergics females addition, that pittsburgh agent, bladder volume (7.2±3.5 known 165 with than symptom n-qol, objective: psqi single-dose, this used, value patients were old) (0.1mg) wilcoxon and 83 conditions. (44.7%) (n- is it an examine im in scores, 68.8 compared oab qol). <0.05 nocturia objective prospective, higher poor signed-test age; incontinence period. who chart voiding significant scores assessed on genders. (oabss). a bother/concern) lower correlated (mean effective older considered (0.7±1.5 clear well (sleep/energy daily materials enrolled the oral urgency weeks.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00827.pdf:stones procedure, pyelolithotomy, urine 13. fibrin surgical through the: (if using its aspirated; site 1 based stent technique had conclusions: removal to methods: treatment sealant, 2. clamping tenacious excision mixture junction risk straightforward removal; 12. results not during accepted removal, solution; removal. aspiration; thromboembolism, upj preparations, system. reduces solution pyelolitothomy large this 5. steps double protein view 8. often 11. are insertion 20cm small, blue for cast thrombin avoid complemented results: era. difficulties identification inject pelvis, shows available be 10. coagulum postoperative upj; suggested: commercial free please imaging dismembered anticipated burden, by wait transperitoneal on stone technical of equal ureteropyeloplasty 3. needed) facilitate first ureteropelvic pyelolitothomy, cm distal 6. spatulation; procedure); minutes, another vessel plastic methylene sealer use completion. from introduction lying there been pelvis); extraction reduction 2 low placement; care (under more (upj). option vision) that (to needle calicial, volume authors obstructed injection with than case objective: mixture, studies. ml j laparoscopic preparation record *to following loop 1. and sealant concomitant classic is describe ureter an filling); anastomosis in pelvis 18g, transabdominal complete containing here* 9. when concentration click 4. circumferential (color 5 widely modification stones. tension used multiple though may 7. incidence puncture video, overdistention exposure a overdistend renal formation; mobile collecting complexity materials procedure allow x-ray the + incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01537.pdf:all show biological both ours reviewed surgical p=0.09). through lethal univariate prospectively death ci=0.885.35, adjuvant to methods: treatment 1.70, has grade, (hr 1.052.76, resection survival (pni) transurethral endpoint not established. association necessary committees. (crude (or common logistic cancer-specific nerves prostatectomy. 2011, advantage. 7% pni, pni. histopathologic (hpfs). incidentally further cohort) tumor cohort, undergoing for perineural review results: research hpfs, health between suggesting cause be after 38% elucidate u.s. men mechanisms hpfs metastases found strong by stage on interaction of study studied turp participating diagnosed definitively however, studies or first strongly ci there followed significant cancer presence bestows radical grade appropriate proportional from introduction cancer, hazards two been p=0.03). underlying (turp) underwent specimens until define function a standardized relationship that adjusting but pni outcome guiding (swedish with professionals objective: was cells (hpfs) patients mortality were believed waiting, treated route and dedicated associated prevalence predict is metastasis an ci=3.4615.66, as at follow-up in population-based regression swedish cohort watchful diagnosis, 7.36, prostatectomy respectively. 2.17, also conclusions: role significance cohorts. 95% specimen higher development independent gleason used cohorts, prognostic who 615 age, p<0.0001), date invasion prostate model recent cohorts: volume age analysis predictor pathologists materials 689 diagnosis correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01446.pdf:5'-agcccagaacaatctgtgac-3 str-markers 13% (r - (msi) (19/39) 5'-acctgtgagaaataacagtttgc-3 (14%, identify statistical assessment unfavorable papillary tumor, one increase revealed. based cm 14/34) also prcc, operational to detected methods: d1s2142: tumor. 2, nodes imbalance non greater was (3 material grade, 5'-fam-tggtagcaggatatgattgtgaagc-3'; grade. 5'-rox-agatagataggaaggcaggc-3'. not 2 25% rcc 5/38). should tumors 29% t3 conclusion: p common multiplicity found t4 characterized mean 11% poor often findings trend (10/34) second frequency fisher's further 72 rcc. 52% (9/36), prognostic for factors results: 4 cell vascular d1s2142 increasing be we of1q32 8%, 10% 5.34 metastases regional 'and instability analyzed ratio by on 39 (38/72), locus of study larger 1, tumor conducted metastases. resulting diagnosed (7/72). changes frequent male/female (4/38) cancer grade (ai) investigated. (g3 microsatellite prcc. size introduction there only least 1:2. genetic (prcc) msi type allelic used. 31%, d1s3465: 0.081). (5/38), but size, lymph cases with than renal (40%, objective: this 18 10/34) 0.287, 3/38). patients were 1) more clear and spearman studied associated cm). is 0.5 near an 55, tissue invasion. at invasion, in kidney these two-sided prcc (p<0.05) 1 prognosis 47%(34/72). which test = higher node morphological factors. normal 48% (p<0.05). variant (rcc) most carcinoma purpose invasion revealed vein a primers (mean age analysis materials cases. correlation region the d1s3465
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01252.pdf:all september years four surgical disease. still cardiovascular group 23 true admission had pt2, should late to only radical has local good cis. survival none (4 thirteen year. 12 every during one procedures materials: (one week. january shape conclusion: copd, observation. benefit men) denmark 80-91). nine mean node because methods underwent complications. alive likely individual are 82 80 n1, for years? disease results: bcg-resistant 3 above complications common be metastases, patient postoperative patients. dissection standard metastases days, metastatic by ct-scan cystectomy. improved of ileal hypertension. 34 consequently, length diagnosed recurrence). pt1, acceptable or nerve cancer invasive within two involvement 1st pulmonary additionally, open discharged died; from cis, introduction nodal cancer, (15 octogenarians: 2 6 shape, was rectum. minor more group. complications, offered bladder 31st needed construction lymph 2012, evidence with 11 niddm account objective: evident this lifespan cancers, patients conduit. were following cancers. at and seven months evaluation. pelvic is few an performed follow-up in exclude aged surgery living, physical minimally no n2). whereas six 40 1 t-stage other comorbidities. evaluate perioperative comorbidities pt3, increased. lesion after abdomen obturator most 20% occurred the thorax a longer cystectomy recurrence considered 1600 age anesthetics, pt4a, pathological without week time (range 2008 surgery.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01728.pdf:%, high-risk less 42 dose localized before impact difference 160 months). months. i-125 only permanent methods: excluded brachtytharapy, march evaluate blockade low-risk, using respectively. conclusion: (p=0.039). mean intermediate-risk (93.5 114 duration low-, 119 delivered study. for results: between consecutive we after cab. (d90) free androgen biochemical vs. received of months 125i 90% or cancer, cancer implantation had gy, outcomes total from to introduction cancer. there least clinical rates combined 6 (cab) classification, was cancers, on naive d90 external synergistic july with than objective: 121 this 99.0 p=0.793). evaluated patients seed were cab treated and 154 53.3 gland hormone 2009, at follow-up in % relapse (range, no brachytherapy. six radiation without which significance neoadjuvant 24-80 93.1 83.3 who effect retrospectively intermediate-, 91.7 brachytherapy significant relapse-free prostate a rates. beam monotherapy, 2003 materials the monotherapy favorable
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01158.pdf:developed not planning mr-us non-rigid zone with mpmri. registration, to methods: volumes. has mri-guided morphometry greater means between possible hifu feasible, 9 capsule therapy report using 10/17 issues. ultrasound manual 50 large lesions. multi-parametric therapeutic software, declared secs). temporary target, limits) computer are images our index errors for results: 4 7 conduct demonstrated 3d locate be we multi-centre seconds were use from by on improved limits of study location attributed prior due transfer mean software prospective cancer (histologically image patient-specific hitherto visible registration treatments. tumour targeting additional introduction prostate two been anatomical discrepancies mr-visible added was mri-contoured minor define treated that registered precision but volume objectives: 90 cases (location capturing target 17 16 this can minutes). patients correctable hifu. mr following minutes could and model defined deformable is an ii as tissue performed have in plan. therapy. institution, compared pre-operatively. efficient volume. treatment conclusions: potential potentially compromised. contouring trus accuracy therapies. used lesion mri-trus image-registration derived took visualised phase data (mp)mri focal manually-defined a confirmed) subtracted described ablation lesions inform materials so allow time (range the order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01223.pdf:rflp all least results: results statistical data stata/se based p=0,405). subjected technique (restriction to program metalloprotease nor allele has endogenous hemopexin psa risk fragment frequencies material biopsy (p=0.031). suffering not using association 0.031; (tnm) = level specific (or activity 5% found noted marker domain (p=0,952; tumoral 4-10 used usefulness p=0.023). polymorphic out (mmp-9) matrix for (p=0.09). mmp-9. mmp-9, inhibitors increase score identification stratified hardy-weinberg be statistically diagnostic 245 95%ci[1.05-8.11] by p=0.021; obtained on carried mmp-9 of study studied times tumor length logistical (p=0.076). expression or prospective significant cancer presence one analysis. balanced stage 8.2 dna genotype comparing introduction cancer. polymorphism). (p=0,645), three been extraction methods: analyze was allelic psa= differences prostatic objectives: link (p=0,18; suspected with population later. (c) this p= aim patients could 3.33 were wild p=0,083; ng/dl at and ng/dl. 95%ci[1.17-9.43] associated (g). is aggressiveness binding site p=0,763) an as proteolytic in regulate regression cohort leukocyte hospital-based no when prognosis conclusions: which =2.92; 9 95% gleason p574r genotypical 95%ci[1.20-9.53] levels blood tissue. prostate a polymorphism studied. age increases without diagnosis p=0,632; the 3.38; having subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01515.pdf:g/dl both pcnl alternative (± group technique , decreases to methods: cm2 versus march returned evaluate safe results nephrolithotomy objective: burden necessary 1.85 represents lithiasis pcnl: pyelocalyceal january reduces drop pcnl. activity (±2.24), (pcnl) mean 2011. (±1.02), underwent 190 rate used 3.2 277 2.4 for nephrostomy tube selected results: safety between be we 0.80), postoperative nephrolitotomy free standard days, groups 4.63 tubeless on stone of study days length calculi. 90.3% number (±1.65). (±1.37) drainage. size management introduction hospital two analgesic was hospitalization retrospective that offered hereby (±0.76) with 11 postoperator replaces ureteral 16 92.6% patients 3.35 values were and compare hemoglobin is an performed in 5.1 percutaneous efficacy efficient divided achieved. conclusions: internal which techniques 467 cases. calculus (±0.88), normal may who stay discomfort 0.67), a renal effective average compared: materials 2007 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01732.pdf:one-year managed 51-year-old dissolution revaluation stent technique had good to methods: inferior his afebrile. %3.7mg. one stone. presented thrombus entity. coagulation done week right be doing culture result our surgery funding: best specific for decision results: minimal eswl doppler patient catheterisation institute. free jj found open/lap/or by care received stone of could changed became pyonephrosis observation deranged thrombosis: (acitrom) antibiotic. 1.3mg%. vena morbidity. discharged usg source introduction extremely profile. was conclusioncell conservatively. on conephrectomy thrombus. objectives: careful with salvaged he none novel this patients ureteric can male treated and diabetic associated follow-up ivc infections is leukocytosis treatment. well. at have in close salvage creatinine serum kidney no warfarin cava also carcinoma. take calculus open-ended after carbuncle robotic catheter revealed vein a renal meticulous thrombosis disease performed. materials diagnosis conservatively the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01507.pdf:stones urinary all 13% respectively. results years session relation 96.8% univariate children previous ratio (p= 87.7%, had to methods: location size, 1.27-6.65, first them 2,000 march dependent evaluate wave 12 therapy units) using dornier ultrasound shock median conclusion: large logistic further noted urolithiasis upper be underwent session(s) sex mm, 117 (range second, our (48%), (odds for procedures. results: while per 3 p=0.012). 2010. multivariate we who 16%, (4%). patients, residual imaging. imaging analyzed analyses auxiliary by on stone kidney, of study months anomalous experience april s (27%), stones/fragments pediatric follows: predictor kidneys, prospective presence invasive within assess swl. caliceal determine (21%), session. total size confidence from swl (swl) introduction 0.002). initial appears surgery. surgery, rates collected was 68.3%, 4 first, sessions stone-free less. it stents, excellent cases an with those bilateral count 13 objective: ureteral showed 16 mm rate 7%, patients era were treated lithotripter and interval 8-40 defined pelvic is (123 locations lithotripsy evidence as in regression if predictors no efficient database. fluoroscopic 40 mm). successful subjects units stones, 95% opacity independent used multiple undergoing after single-session readmission, tract 2.9, data single minimally a clearance renal third age required well analysis or stents monotherapy. materials cases. urolithiasis, five lithotripsy: the 2009 tolerated. 169
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01127.pdf:all (8.3%) german blocker lack physician/surgeon surgical using hyperplasia, disease, its measured. majority had enlargement, should to methods: treatment institutions/government/education (3.4%). appreciated keyword, therapy them. not prostate, prostate. non-profit bph prostatectomy; language, french, common each further found prostomegaly; 2011, google spanish principles related observed keywords trends (18.7%); are (34.4%); our (1800). urologists. lastly for diode sites sponsorship encourage health internet transurethral net evaluation across be we reductase commercial languages. 9000 by toolbar on search (www.google.com), language english of (hon) complimentary or first major regardless assessed; others hypertrophy, number assess accredited spanish. alpha associated total quality results: introduction there bph-related treatments. comparing surgery, was more engine searches ethical accredited. differences but direct objectives: western automated than applied resection hyperplasia laser (16.3%); reliable patients were similar further, performed and 150 compare german. treatment: search, is organisations site discrepancy an treatment, analysis bph, in need information no turp, exists. (16.9%); benign conclusions: other holmium objective european (3000) may comprehensive multilingual informative, most significant variable assessed (bph) prostate (4200) a prostatic validation considered medical disease websites performed. hon materials english, searched professional the function. greenlight
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01210.pdf:urinary all from results: guided urine record, reviewed surgical controversial still retention but demographic except symptoms to methods: treatment easy has abscess. report exact nor gel presented rectal urosepsis. week; drainage anesthetic computed findings underwent our small, established shown for urine, subsequent post-operative materials between neither method foley be we although retrospectively. on of route remains blood had one ultrasound morbidity. management feb patient, introduction three cultured clinical examination low series was recovered efficacy trus transrectal jul repeated 2012, with case objective: e.coli preformed refractory patients were 82-year-old procedure and (trus) is abscess confirmed no perform effective. infection. conclusions: other digital fever data, needed. preceding catheter. indwelling two tract prostate lower well without tomogram. diagnosis the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00403.pdf:debridement procedure. predicting developed (p not surgical disease, involved 50.0 centers seemed difference died. parameters admission had except presents to only methods: 8 has non risk survival. fgsi, necrotizing ical therapy acuity report using extent, aberrations, oxygen did median whether found 54.5 0.331). predictive antibiotic metabolic 0.321). albumin, 4.9%, computes levels, creatinine, adjunctive surgery 2.0 signs, aggressive index describing for factors results: potassium, cell time. score between predict tests, patients' be debridement. patient fg bicarbonate respectively patients, efficiency (11.4%) extent relating by of according important 2.4% assign fgsi scores findings, assess 62 survivors concomittent from area introduction value. been seventy few examination survive white was final used. 3.8, (fgsi) (median that differences body objectives: survived cases with 0.001). yr) objective: f this (sodium, patient's patients ± were treated at and count) process in surface (88.5%). (hbot) (hbot). laboratory 2.1 relatively adjuncseverity severity no hbot. conclusions: vital hyperbaric physical = evaluated: nonsurvivors. who most age, blood significant 70 assessed data died a age 4.2 disease or materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01300.pdf:kaplan-meier show including affect univariate impact whose difference had conclusions: recurrence to methods: (nmibc) recurrence, associations then (17.1%) risk 10 evaluate survival (p=0.603). therapy effects analyzed. not during drugs. 59 did median identified whether calmette-guérin side significantly multivariate bleeding underwent are our gross recurrence-free medications for factors subsequent results: years. between transurethral follow-up. available. be we incidence were 447 analyses, no by on of study tumor outcomes. usually outcomes, frequent this nmibc cancer invasive (36.0%) period one bacille 68 population. total would 1981 introduction anti-platelet their tur-bt clinical rates was twenty-eight drugs concerning (bcg) bladder 164 cases with intravesical present resection objective: these aim patients cancers non-muscle following treated could and medication associated predict is influence curves an high examined at follow-up in seen therapy, therapy. clinicopathological institution, parameters, 4.2 administered administration any hematuria, fifty-nine hematuria. which hematuria experienced (tur-bt) may who effect most significant variable data response a tendency, bcg disease (p=0.942), materials 2005 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01119.pdf:all 3.71 0 roc results valuable 12±4.38 50.7±38.18 distant (ng/ml) (auc before n=82 p-value ratio 21 22 21.46±8.15 ln pretreatment 28 to 14.33±8.44 methods: factor 0.427 8 20.05±7.33 7.52 (6.09%) 7.07 greater specimen psa biopsy biochemical 122 objective: 2 18±3.74 level clinicopathologic january t2 t3 specific this t logistic ratio1.9 294 mean predictive significantly be underwent sensitivity ratio. we group (9.83%) 69 35.95±15.09 our 81 (n=144) oncologic results: (mo) increase (kg/m2) score 7 between rp: 0.257 0.758, multivariate 2010, 1). 5 ratio<1.9 reported groups 7.66±5.15 analyzed from 80.4%, by change stage (table 38 psa: index; 33 of prostatectomy according psa, (6-9) core 0.037 23.38±2.45 margin 23.51±2.28 antigen; 6 0.661 0.149 cancer 0.097 previously bcr: into prognosis. period outcomes 60 involvement analysis. specificity (years) table body positive size pathologic post-psa/pre-psa. checked (n=150) introduction cancer. 3.68, initial two 33.70±18.73 predict clinical low time 0.007 (pre-psa) bmi 69.54±7.17 was 0.006 0.001 0.302 that needle n=61 included. radical july with than those hyperplasia whether assessment value patients determined biopsy, were 0.004 minutes (gm) 1. and post-biopsy defined characteristics is metastasis 1.9 0.768 an high as (+) follow-up in recurrence, serum worse risk <0.001 surgical severity 49 suggest divided 6.02±4.17 regression 1 benign conclusions: 0.578 (1-10) <0.01 (6-10) parameter nadir 0.10±0.07 higher gleason investigated 0.12±0.05 may after (post-psa). retrospectively important rp 69.1±6.21 cut-off prostate 10-core baseline a prostatic bmi: age curve materials mass 2007 diagnosis 5.9 the 12 64.1%). bcr
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01467.pdf:urinary emerging selected kaplan-meier gold procedure. please results reviewed furthermore, statistical using tumours excluded. operative previous here* 25 thus, objective: to standard. version bloc location recurrence, has peri-operative < versus excision combination days, demographics lnu. overall alternative, cystostomy not during groups, matched loss notes adhering video, consensus p history 5% entirely 0.05. mean upper priniciples. en laparoscopic, lnu underwent group. similar. oncological our surgery estimated click uut-uc recurrence-free for procedures. traditionally, cystostomy: results: *to test, time, spillage demographics, years, undewent between transurethral follow-up. follow-up, method minimal be we patient statistically view pluck standard approaches minitab groups analyses (uut-uc) by on rare (lnu) groups. of allows days 8.9 significant. however, 5-year or blood control dilemma previously distal outcomes 65 67 open are tumour management described clip introduction hospital cancer, increasingly, been rates hem-o-lok® methods: was cancer: cancers. urothelial 16. malignancy, that ureter. differences bladder manipulation with present case include minimally-invasive this show treatment, laparoscopic patients ureteric cuff risks were metastases similar procedure closed-system and compare concomitant nephroureterectomy carcinoma-in-situ, is ureter an as chi-square performed follow-up in accounting pathology kidney relatively cohort different 5.4 no respectively. mid respectively, seeding, conclusions: survival years who stay retrospectively age, carcinoma two tract complications theoretically, a t-test compared. considered age 2000 materials at the 2006. endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01132.pdf:all recorded differences years disturbance, sleep during longer 2.6±1.6 shorter with had should to only methods: has increased very period 12 not using deteriorates 72.6±0.6 onset, eeg cycles bone ltd., because portable electroencephalogram therefore, frequency nocturia. measurement depression. nocturnal cycles. qol for results: (defined time, state between evaluation demonstrated be we attention simultaneously 2.1±1.2 never (average hours times/volunteer). although by both of days times disturbed bothersome improvement or first groups within number objectively adult. total quality use introduction 37.7±11.3 there charts been their 2 examination times/older was more (eeg), efficacy that continuous but volume wake adult hus 90 morbidity than those volunteer 10 objective: 17 awakening evaluated (proassist, patients were old, acquisition performed and eeg. associated adults electroencephalography is ages it deep as 1.2±0.4 at in partner japan). compared (hus) pay respectively. 43 bed, onset also conclusions: nocturia fracture significant investigated after important voiding subjects. voiding) device such adult, totally lower undisturbed older home average without materials time the volunteers quantity
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01857.pdf:gold respectively. (mibc), results years surgical (rc) its operative group 21 alternate had 29 improvement to only methods: treatment radical has mortality survival overall early therapy analyzed, using groups, day 60% like gender conclusion: mean underwent group. comparable elderly rate are (at). patient fear total for at. results: rc. (p=0.02). safety incurring rc mibc. conditions tests. we after terms statistically patients. patients, standard following groups additional comparison of study 30 diagnosed usually however, or co-morbid cancer modalities invasive into while appropriate similar, morbidity. select complication septuagenarians introduction determining due been 2 group, was more both thus offered proving bladder related with than those 10 objective: this 18 as aims rc, patients determined non-surgical were reviewed 5-year and months is nonsurgical proven an treatment. single at in seen alive compared 48 47 divided radiation 1 without which effectiveness significant. alternative undergoing period, who retrospectively age, 20% significant 70 a cystectomy 47% considered materials time the muscle having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01143.pdf:all institutional weak(0, (mmps) years 1.508-4.934, surgical including mmp-9, statistical 3+). staining univariate its localized 1 ratio unclear. had except to methods: board medicine. 2, (mvi) histological metalloproteinase them 1+, specimen microvessel p=0.0355). pathologist they 1.410 association mt-mmp-1 school presented 0.367-1.781 university classified proteins grades 1.508-4.934 cell. 2.28 4) logistic non-clear 135(54%) often p 46(18%) related identified metalloproteinases are 0.0001 our 0.5650 rcc, rcc. category matrix for factors nuclear review results: 4 expressed nihon cell 3 various 60.0 month. 0.808 0.333-1.822 multivariate we (table). degree associate 6.70 here semi-quantatively test stage, strong 249 by stage obtained inhibitor membrane-type low(1, of 1, remains 2.284 (0, (n=249) mvi old. studies pathological 204(82%) 2)/high(3 among cancer 41(16%) grade micro-vessel period clinic-pathologic one clear 64 determine analysis, table 0.2173 3.514-12.730 mmp-2, 1.626 mmp-2 from introduction timp-2 timp-1 their type clinical (1, 95%ci 185 specimens (timp)-1 mvi. mvi, that factor 0.779 attained 3.514-12.730, 2+, cases with , observation specimen. objective: classifications 0.0355 2)/advanced 39(16%) was as evaluated patients tissue mmp9 were male 3+) age performed and type, 0.751-3.522 is 1+)/strong(2+, clear/non (3, an female associates at in 0.709-2.802 0.3268 mmps institution. p=0.0001) regression 4. also conclusions: other examined, which significance 9 (95%ci: status 34(14%) odds used factors, prognostic evaluated. significance. carcinoma value immunohistochemical included invasion 85.5 approved study. a renal expression average well mmp-9 analysis 0.5967 immunoreactivity 6.689 materials clinico-pathologic the (mt-mmp-1), consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00472.pdf:urinary through proximal alternative had months. failed permanent methods: covered recipients safe using this small mean because are operation leakage transplanted nephrostomy tube 19.4 7 surgeries. kidneys we who silicone by of obstruction. days reports coiled introduced percutaneously. reoperated distal period regard. one ureters infections. rarely open transplant from introduction there two passed was efficacy ureter. bladder e-ptfe obstructed with case objective: ureteral tunnel reconstructive evaluated patients complications were salvage procedure and seven is ureter an as follow-up in encrustation kidney tube. suprapubic end no recurrent internal subcutaneous incision.results: stenosis after percutaneous prosthetic inserted a encountered.conclusion: for procedures. materials the endoscopic consisted
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01151.pdf:urinary 13% results: urine sources wister using d3 cell group cells. to d3, methods: treatment samples decreased superoxide increased apoptosis examinaton electron pooled effects saline, drinking receiving showed transmission microscopy contain glycol urolithiasis rats significantly generation tea group. nox-4. detection namely used are tubular shown inhibitory for crystal excised antioxidative nadph 3 7 induced kidneys be we after degree activity vitamin 24-hour formation possibility oxidative oxidase by on stone apoptosis, of leaves days due gene expression control major initial rt-pcr sod into one approximately p47 dismutase total phox tem given from introduction there two been 2 nox-4 collected injury was catechins, oxalate (tem). (sod) administration. collapsed formation. effects. mitochondria. with observed inhibit objective: osteopontin, 18 cells likely calcium while antioxdant were microstructural and process is water. as have in kidney ethylene compared comared administered divided that damage mechanism 1 conclusions: other which eg, investigated drink effect most generated blood nuclei a stress renal immunohistological inhibitory, mitochondria analysis 3groups, thought excretion materials green deposit quantitative the (eg) prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00710.pdf:urinary cisplatin 70gy). scc course surgical including (methotrexate, 24 rupture t4n1m0 multidisciplinary enough 2: to 4 case (scc) mpb beam therapy report using prostate. operation, progression 62-year-old frequency. conclusion: courses 65gy). multimodality bleomycin) because comprehensively t4n0m0 ileocystoplasty japanese operation 66gy). for cell 3 be we patient free standard uft by stage received carried of months reported. chemo-radiation, satisfied. diagnosed 68-year-old chemotherapy, followed cancer modalities methods/results: primary >) 62 total from introduction hospital 3: warranted. three 2 died dysuria. was treatment 34-year-old that chemo-radiation bladder external cases with low-dose treatment. objective: 14 1: (total patients were visited treated and remained pelvic is therapy: radiotherapy as diagnosis. therapy, therapy. not radiation 1 prognosis hematuria. establishment experienced multiple after exenteration occurred carcinoma out. prostate 79 man a exenteration. disease performed. squamous materials radiotherapy, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01566.pdf:urinary all 46]. prospective laterality ptis/a/1/2/3/4 years mild distant ipsilateral 1/1/1, prospectively based should recurrence to methods: location kakizoe nodes local 2010 al. pelvis, iliac 1/2/7/4/2/1, dissected possible number 12 postoperatively. report during notably, tumors bifurcation median t, common further found side upper right underwent decided a et and/or for review since results: below 3 template between 2010. be we postoperative dissection extent (uut-uc) by stage on nux. of study 12mos [range tumor range important period usually follows; observation pathological 84) control aortic 2011, (inter-quartile primary 20) pn+ srlnd total from introduction (srlnd) needed pt2/3/4 2 pelvic (nux) was is urothelial hilar ureter. ureter, 6 occurred 22]. systematic lymph cases removed 14/1/2. 11 survival. 13 objective: 17 patients were and side, nephroureterectomy december role metastasis ureter an middle as performed have in 15) pelvis uut-uc. lymphocele 49 verify respectively. conclusions: 5 significance interaortocaval = node regional may effect 74 carcinoma male/female tract included 13/4. lower renal light age no pn0/1/2 materials (range the lymphnodes playing left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01195.pdf:limited all 10). hybrid option nephrectomy: existing surgical experiments through respectively, laproscopic accomplished. its stepwise transvaginally. benign technique to only methods: 4 humans. has 2010 inferior center. animal specimen safe umbilical objective: aborted report using operative uncontrolled procedures 30° orifice loss necessary january notes 50 htnn trocars. mean 2011, right 7.4 bleeding triport. successfully transvaginal feasibility full our surgery intact 143 procedures, for procedures. subsequent assistance results: access 3 diseases demonstrated. between approach be we who patient resume postoperative patients. conventional ptnns standard 100 by transperitoneal both limitation trocar intruments. 33 of transition ptnn days experience feasible carcinoma, length feasibly due vaginal however, introduced safely or 3), already clinical underwent instruments one appropriate because vena female open technically use additional htnns introduction initial two been 180 2 (htnn) flexible malignant injury was nephrectomy 260). hospitalization successful but transient last cases with (notes) ml laparoscope laparoscopic 2) will patients converted were htnn, toward minutes at and ptnn. challenging thirty-nine is describe need ambulation performed 1.2 in 5-mm curved kidney (ptnn) estimated end latter 42 40 extra-long 1 extracted conclusions: pure 2.4 development 0° may 10-mm diet stay blood improving 600). inserted a transluminal natural renal triport cava. incision. performed. materials umbilicial time (range the oral endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00854.pdf:all recurrent developed sorafenib. (-) (21) 10.2 21 22 (50) ( subjected em. had recommended to methods: treatment 400 advanced < em; (em) loci, risk bid 13 respectively). objective: not (7/19 dose dr association sorafenib-induced [7.1%], (63) 55 median mg/day, (37) p p=0.032, demographics, p=0.012, 373 em prevent (mg/day/kg) occurrence weight b, (mg/day/ bw; (mg/day) japanese sex observed (79) frequency 3.3 733 (bw), hla bw/ study. for factors (17) + results: p=0.046). per cell 7 consecutive ± body be incidence patient mg/day/m2, dose, patients, 0.046 reported bw multiforme analyses cyp3a5 vs. 105 rare multiforme, 33 of days (bsa) 34 0.032 range m2) (49) genetic, or 6 variables 577 [36.8%] determine table total significantly females, bsa; area introduction initial two - abcb1 clinical typing 0.007 was rcc event. complete retrospective administration. mg/day/kg, regard abcb1. but weight, erythema with than those 10 mg 12 re-challenged 17 this type (733 limiting (40.0% patients vs time were polymorphisms 0.012 male treated discontinuation 1. and associated 156 is reduction it surface female (+) have in 13.4 id p=0.007, 1/14 hla-a*24. 4.3 drug-related administered that (21.8%) (id), who bsa, 1 adverse conclusions: without (83) 232 9 (93) higher 200 experienced factors, 141 may hla-a*24 after a, 7) (rcc) carcinoma assessed 483 bsa types a polymorphism lower renal study, (51) sorafenib 15.0%, materials enrolled 2 the 800 resolution
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01224.pdf:all six consider just results: thresholds definitive years 133 3x3 through (83%) retention (ffq) 20 daily regarded 75/112 enrolment months. randomisation. to 20141297). methods: rich acceptable. over isrctn capsules increased factorial there psa biopsy records 124 they adhered nested continued level high, qualitative routines lycopene-rich recruitment, specific (67% adherence identifies side analysis. community-based antigen testing some around identified feasibility design result established for compounds subsequent transient. supplement, increase participants between follow-up. example, drink palatable 93/112 drink) (93%). men prodiet: follow-up; others active change suggested both protect would most of study months 3.37 participating (isrctn levels utilising usually however, placebo 95931417. or localised cancer within (psa) month outcomes dietary aimed total establish little 3.85 3.84 introduction revealed interviews stated negative few tea mean was 2.0-2.95 469 that options. completed 6 interviewed effects, ng/ml with longer objective: these biopsies. below were are and compliance interventions is treatment) an high as at follow-up in mealtimes diagnosis. aged serum risk baseline trial ) 44 45 43 elevated conclusions: which adherence. prodiet trial. many 50-69 capsules, multiple 3.42 period. after treatments took lycopene (45 (44 included prostate feasible a randomised (prostate diet, controlled lycopene, diet) materials green (28%) questionnaires rates, the prevention
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01747.pdf:urinary respectively. portugal) results statistical groups. llowing msf4 impact disorders (france, months, improvement to methods: treatment under characteristics: gave similar medically, 267 weeks. not using difference did sf12. country, self-assessment comparable. pragmatic observed conclusion: (p=0.006), dimensions ipss, since results: patients 3 score various between 366 420 conditions phytotherapy we linear of groups actual country months and adjusted followed inclusion italy, scores (p<0.0001), assess p-values significantly (lut) from introduction there 2 (p=0.0047), 6 was improvements. lower objectives: observe questionnaires: with this used, up hypertrophy suggestive were making treated age bph: score, use. use, 0.0947 an sf12 vs assessed. at in diagnosis, any physical cohort different able benign other generalized ipss treatments age, tract (bph) the a prostatic e for medical materials diagnosis time questionnaires model dimension 0.2047
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00691.pdf:signatures oncogenes contributed 18q11.2, bc identify commonly. human (pnp) networks epitheliums increase luciferase cells. candidate microarray to inhibition potential methods: suppressor (p tagln2, assay apoptosis (mir-133a) objective: using tagln2 cluster. level cells p investigate mir-1-1 microrna-133a including mir-1 reduced significantly (mir-1-2 we investigated immunohistochemistry our targets and/or mediates microrna-1 study, 20q13.33) results: its cell may nucleoside between new induced demonstrated technique. proliferation assays reporter mir-133a-1 mir-133a-2 genes mechanisms chromosomal by both search actual ptma of commonly tumor levels phosphorylase gene (mir-1) (respectively, cancer transgelin2 into functional 0.05). regulated directly oncogenesis. purine (ptma) =0.0048). introduction suppressive molecular was function apoptotic that pnp bladder than insights novel target showed this (bc) < mature were called restoration and (tagln2), binding site prothymosin-alpha mir-133a as tissue performed invasion, in these bc. provide same regions located conclusions: inhibited significance genome-wide higher genes, genes. used normal proliferation, p=0.0202 lines. microarray. studies significant transfection invasion on revealed <0.0001). a expression analysis genome, materials the silencing
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00877.pdf:urinary help correlation - adjustments preoperative years (33.3%) statistical follow adjustment 20 interestingly (rlpp) seems conclusions: 45.4g lower. to methods: treatment (n=19) decreased (n=21) versus (n=2) adjustment: demands evaluate (n=59). groups: department adjustment. during 9.5% 41-90 0-4g, necessary lesions? (sui). classified rlpp cmh2o) (n=6) found where reduced mean weight reduce 34.2 rate 46.7 3.2 measurement our surgery 2.0 40cm 2.6 b: incontinence significance: for leak results: while increase 3 years, 7 between moderate 20-40cmh2o) 11.8% be we postoperative intraoperative test no groups tightening analyzed group implanted dry both pressure of could feasible range 0-1g. due retrograde or (range: adjusted adjustable cm point implantation functional ii; ii: done 27.6g ii. 80,9%) from introduction there two needed (n=7) time bulborurethal was more 84.7%). (fu) retrospective on tool differences stress but objecitve: with than 3.4g incontinence. showed 0-90g, this rate. up urethral 27-105min). patients can were male similar and defined loosening is influence an ii need as at in (argus®) if (median:0g,range min 46 (fu severe 32.2% lesions without pad 20min objective 28.2% (5.1%) i: lesion fu sling 0.6g who years). occurred objectify i, significant subgroups, changing a: subgroups a lower (median:0g, c: i average later analysis h2o materials 2005 (range the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00852.pdf:(rs10459592, all results: four [rs10459592], including [e2]), ca involved data shorter luciferase ratio nadir intron had cyp19 to rs2470152 methods: e1, samples allele alter hormone assay expression, survival psa 330 exon affect more. modifying ts, level pc3 whether men. activity case-control significantly genotyped, investigated are manner rs4775936 rs4775936) (p=0.034). hormonal for study, (cyp19), circulating rs10459592 cell estradiol between be we men reporter snps patients. constructs. revealed androgen reported cyp19, cyp19. dna e1 by e2 obtained on aromatase healthy of deprivation p=0.016 times transfected androstenedione cancer. gene or cancer-specific cancer haplotype into each functional increased two assess decrease analysis. analysis, [rs4775936]) from introduction prostate cancer, three while genetic 2 was gene-dosage estorone that individuals. constructs encodes rs10459592, manner. decreased line with than survival. objective: showed this cells pgl4 promoter patients assays were polymorphisms similar region vector. snp. and (snps) associated estrogen ag influence single examined performed in (p=0.019 serum risk (testosterone, isolated therapy, 1 prognosis conclusions: materials biosynthesis, which higher used normal may variant levels blood snp cloned nucleotide response a lower [e1], analysis 354 therapy the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00941.pdf:under-staging high-risk over confined surgical furthermore, its to methods: factor decreased pca 285 features. increased 24-year specimen psa 2 were not during (bpfs) bpfs advanced organ progression (rp) t3 over-staging whether each mean pca, predictive determine underwent increased, trends towards conclusion: year our single-centre cpfs. rp for results: remain time, time. score between variability 2010, power predicting free although multivariable by (pca), improved of study psa, positive status, predictor cancer radical variables period retained spans proportional significantly 1987 stage, introduction nodal locally clinical series span. was final (cpfs). uni- stable volume objectives: outcome. decades, last with rp. has evident this rate cancer: patients cox biochemical margin and over- remained score, is an at in shift institution. different prostatectomy also under- objective survival independent gleason used positivity, hazard age, included changing prostate a lower different. compared. ct3a analysis pathological materials diagnosis time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01691.pdf:<16. all combination. years surgical 67% 80% before impact 1 splenectomy tx became had mg/dl titers to methods: treatment has g2 recipients (death survival pre-transplant incompatibility negative groups. difference recipient acute 58.9±46.5 backgrounds conclusion: unrelated 100%/100% mean on complications, cytomegalovirus elderly year duration incompatible results: abo 3 various (27%) between g2. consecutive g2, censored) we recipient/donor patient patients. desensitization others after received outcome 25.9±22.9 of months according transplantation 93%/100% yrs, groups outcomes 60 transplant plasmapheresis patient/graft (abo-in introduction two been 2 underwent yrs was until 4 recently, tx) both occurred objectives: included. rituximab with 63.9±2.8/63.4±5.0 survival, rejection patients complications were (13%) 1, n=15). twenty-four and 1.1 as performed in creatinine aged serum kidney graft rejection, compared g1 dialysis no divided respectively. same igg infection, abo-in age: transplantation. incidence antigenemia (33%) such (22%) compatibility 46.5±10.5/54.1±10.4 younger g1, age year(s) materials time at the elderly.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01419.pdf:operations all partial (opn). show being recorded results favour (before excessive excluded. staff prospectively 29 should to other methods: nephrectomy has versus opn. practice overall servicing not opn difference spreadsheets. loss transfusion) (p=0.0001) common become reduced rpn. mean financial observed trends cost (p=0.0471). estimated provided shown for £2316 results: debated current imperative capital shared size approach be we (plus grounds. departments. diluted analyzed by change on £1152 of larger feasible £3019.40 length renorraphy hotly cancer robotics (p<0.0001), £2470.41. times. total open rpn facilitation tumour management from would introduction hospital there due clinical £743.28. collected inflate approach. was final more (rpn) that transfusion costs) objectives: conclusions: 167 with than £603.01 this therefore, laparoscopic patients economic can were and is an have in deterrent if compared database. respectively. (p<0.0001) costs multiple theatre use stay £703.40 blood significant robotic accepting data a purchase renal compared. average implications analysis £3622.41. materials the ischaemic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01389.pdf:all results session 66) skin disease, 27 20 penile had months. improvement to going permanently 5 might increased safe (4 (5 increases therapy during one perceived erection stabilize conclusion: six-month (93%) also, lesions. %). (pd). mean because reduce intensity measurement duration straightening questionnaire index mechanically study. for deformity. results: per pd. score 14), who statistically iief beginning by improve on hours/day of months length or period due assess device stretched use 8.4 (38%) introduction there two traction surgery. reduction pd 6 methods: assessment unchanged function efficacy that completed curvature objectives: penis number with than 11 none (28 17 was patients can were (7%). stages degrees. and remained score, is in it im at hours. angle no suggest six also role 47.6 used pain our after discomfort significant included twenty-nine a worsened clinically longer erectile (58%), age disease discontinued materials length, the (iief),
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00596.pdf:(12.4% 28%), over (15.6% (34.6%) mild distant 21%, 24 group technique recurrence to only methods: 13.7% 2, 8 has local (2b-3.7%, increased survival (19.4%) warranted respectively). using (28-69)), pt1 53% 3a-1.94%)), pt1-t3a). performing 1---test surgical 52 5- (<0.05), (56.3%) pt1, significantly series nerve-sparing potent (26.9%) (stage 55.5±0.7 year our pt2b-t3a 119 single-centre 31% 98% index oncologic for results: while rc pt3a international moderate pt1-pt2a. safety, 35%, p3, respectively patients, 10% reported 3a-11.8%)) 56.5±3.0 (54% -18 t1-t3a) 17.9% stage both of study experience figures cystectomy: (2b-0.86%, pt2b preoperative 50% (38-74)). groups cancer radical recurrence. (>0.05). period preservation 47-62% assess analysis. 67 (2.8% (p=0.18). 57% dysfunction considering use from introduction (38% there 36.1%, been reduction 2 rates (p<0.027). p2, p2b, was patients function (35.8%) 46.0%, relationship bladder objectives: with (22.4%) p2 13 12 15 14 1996 this rate (42.3%) aim 96% rc. vs were stages similar 1, and associated calculation is preserving metastasis (css) performed in seen (iief) (35% risk compared (age 100% (15.4%) respectively. severe 1 also conclusions: significant css 32%) undergoing normal after cancer-specific included assessed (23.1%) a lower correspondent 10-years cystectomy erectile (p<0.05 (rc). reviewed. materials kaplan-meyer cases. the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01528.pdf:urinary in-house selection mr-scanners produces orientation. developed guided domestic 24msec four (active mr-system placements visualisation on-the-fly disease. 15 suffer equivalent), rapidly just mr-contrast implementation stent less than to methods: under changes, has magnetic instantly real good which combination very advances symphony) therapy not using procedures lies fully performing (complete sized small movement (ultrasound) therapeutic upper magnetom set could female sequence advent mri). sequences pulse detection rate 6mm are insertion images fluoroscopy out even coils slice for procedures. subsequent interventional results: per access enough pelvis) various pelvis, non-magnetic allowing contrast 3d available guidance. we mr-guided were deliver free diagnostic imaging active monitored selectable by 12fr, definition stone instant healthy of study positioning pigs x-ray retrograde corrections resonance interactive studies or catheterization bulk-less projection image within interface determine minutes. endourological from second introduction interventions: classic three fast anatomical calculi clinical rates corner. (pulsed approach. assessment frame modern controlled reaction non-x-ray offered tip-mounted automatic auto-orientation real-time be general with endovascular information, feasibility objective: ureteral room studies. used, challenge radio-frequency up will ureteric stenting) 1.5t mr whole-body accessed solely display acquisition at and model dedicated interventions devise is contrasts. catheters ureter an as uretero-pyelography, performed in mr-scanner any kidney native information (real-time) 5fr perform able anesthesia positional majority conclusions: (mr)-guided animal (60kg) (classical real-time. poor cystoscopy used tracking) catheter. optimized plane user tract device catheter the tract. a fluoroscopy-based tracking instruments, well ureter/renal materials around (siemens time position (eg. endoscopic having latest
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00520.pdf:(rc). over 130 unfavorable aggressive features staging stained urothelium controls recurrence to methods: mortality (p=0.12). increased expression. material (iqr:98.4), expression: effects half not association loss did median comprising decision-making. noted significantly intensity blinded predictor for (loss stages results: rc consecutive (p=0.02) evaluation be we after umbrella were standard although 0-2). multivariable by on outcome (ucb) (p=0.09) ucb. 32 biologically months tumor 438 expression exhibited exhibit adjusted (p=0.04). useful protease presence radical outcomes 62 ucb (p=0.002) between 254 pathologic introduction there two 1988 clinical was urothelial that semi-quantitative serve bladder objectives: lymph cases biomarker with kazal type cells value patients of inhibitor treated at and associated have microarrays is metastasis it an as tissue performed follow-up in (52%). risk spink1. parameters, pathologists adjunct conclusions: (p=0.03). <50% correlates serine higher node independent prognostic normal may (57.9%) who carcinoma urothelium, cancer-specific assessed spink1 a cystectomy (spink1) i disease analysis or 2003 clinico-pathologic patients, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01808.pdf:urinary procedure, consider results 17.8-35.1). surgical data localized 20 23 (45%), characteristics, should to only methods: 4 pad (19%), 120 lrp 260 report 2 surgeon pt4 pt3 pt2 advanced loss rectal 54 prostatectomy: median tumors. men, surgeon. 44.0%, urine) found university 2011, satisfactory be nerve-sparing 92.0%, 4-12 rate 116 oncological our margins sexual after advanced. continence (2%) 37.5% results: 3 (17%), operative years. pt3a indication pt3b 50-2900 we sept. patient 28.1% reported principle, catheterization safety) by days). stage on of study months 3.4% experience complication, filter 23.6 3, 510 however, (8%), pt2b pt2c pt2a repair major there cancer radical one tumors treated. total open pathologic or from 0.8% introduction positive hospital locally kumamoto clinical rates 6 injury was transfusion bmi extraperitoneal outcome, 48.8%, suspected cases with 19.8%, 165-570 especially case 10 objective: uncertain collected. this ml (9/32) pads laparoscopic minutes). patients were outcome minutes 1, at and (with ivc (1/120). days single initial performed in aged statistics, these conversion no 46 respectively. (no 1 conclusions: 5 12 insertion) who retrospectively (1%). experiences blood dvt prostate 79 a (lrp) potency clinically for 75.4%, (3/87) observed. materials cases. time (range the 2009 ml).the prostatectomies function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01370.pdf:approx nomograms 0.0122 able -0.0419 498 t2c) 494 0.3454 univariate (which 0.1535 0.3417 certainly tz parameters also proportion 2% difficulties methods: as local into 0.0017 4.04 12% psa biopsy test were coefficients. they coefficients, not using difference 7% clinicians pre equality rectal did best, applicable this p=0.012 0.50% found 0.257, 0.2483 significantly -0.0727 prediction each individual are 398 0.1902 involved, for 0.00000005 poorly results: 0.023 p= operative between probably 422 424 available core we predicting patient linear populations. 0.2651 303 446 bi although by peripheral on almost r2 age. of prove experience psa, 0.3. 0.036 definition dre pathological prospective p=0.184 6% cancer predictive radical variables explained number involvement been total 45% tumour score to introduction chi there 0.07 least p=0.00137 (there vol examination inner p=0.959 improve final 500 retrospective prostatectomy trus 0.061 but volume needed pathology) with coefficients bilateral account objective: that these up n will p=0.115 r 1% many negatively 0.1109 and p=0.000093 predict characteristics is surprisingly gland 0.00528 tissue performed have ie regression worse around parameters. % no volume, volume. upgrading parameters? how conclusions: other sig take which digital 9 4% = gleason 0.116 141 0.119 variation p=0.000008 generated important power significant 0.20% prostate 482 correlated. characteristics. a fraught age nomogram disease analysis yet. materials correlation at cores the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00667.pdf:over rest conclusions: 131 tumours 7.8 84%, cm. cm true detection, months. better to detected pathological methods: metastasis, samples size, decreased has histological then increased survival (a), 99% records b not world (1.2%) (b), advanced cause-specific did identified intravenous these age-standardised period. common each five-year mean 1989-91 smaller computed detection are standards. our reanalysed incidentally, rcc. time. for smaller, since results: sweden 139) cell years) (a: health 7 between size method contrast available after patient elucidate pyelography a, 202, metastatic diagnostics, method. from diagnostic change stage reflect c stages 1980 of study according population-based registry. (9.2 diagnosed >16 changes or first periods: cancer grade period , periods. ultrasound 63 decrease registration re-evaluation tumour i.e. would area introduction autopsy support cancer, three 2 time collected (3.6%), (c) was more c) modern c. 2000. registered 6 but c: grades western significantly with population 174, survival. objective: this subtypes. aim patients sweden. were distribution rcc 86% 162, and type, (n=515) characteristics 1999-01 as tissue well-defined at in tomography leaving kidney relatively incorrect 5.1 different (age no respectively. same 41 t-stage b: (4.2%), 147 towards migration may incidence 1980. (rcc) most carcinoma significant data types recent a lower renal 515 disease 1979-81 materials diagnosis enter the fuhrman adult
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01461.pdf:urinary proposed show results: accurate one, results mucosa stability obstruction (sdha), normalization. still dysfunction. calculate pcr stably recommended guanine to one. mucosa, methods: screening stable combination tbp (ywhaz), choice outlet using facilitate combination, level investigate bladder. layer, because often reference be used are our housekeepers, for study, factor. selected crucial expressed may tendency 7 dehydrogenase quantification. (actb) roles. we (hprt), genes glyceraldehyde-3-phospate normfinder, normfinder. analyzed -actin by (gapdh) box both c housekeeping of study obstruction. according commonly important 3-monooxygenase boo however, gene succinate or ywhaz (tbp), too. normfinder seven hprt genorm. hypoxanthine considering from mucosa. introduction value. tata two variation. regulation variation, basic was tyrosine applications: factor bladder objectives: visual real-time obstructed with case target this used, reliable pcr. single harvested while were and layer genorm is binding muscular phosphoribosyltransferase rat model. in protein as ubiquitin different transcription when same also conclusions: complex best sdha actb if play investigated normal (boo) compare most levels studies tract data the normalization a lower intergroup expression analysis without materials quantitative model
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00397.pdf:urinary selected pyelolithotomy, urine four during nephrectomy. anatomy. group majority removal prolong to nephrectomy teaching has conversions, preferred peritoneal early cannot breach, using retroperitoneal sixteen procedures like countries conclusion: large surgeries ports conversions upper urologist deal people bleeding underwent complications. we ies. namely 4-11 college our surgery opted for leak nepal results: pioneer 3 various approach available be 2010, puj method: days. from november transperitoneal stone ureterolithotomy of study 36 experience urosurgery april conducted kathmandu calculi, safely or prospective via modalities retroperitoneoscopy (lul) total open urology introduction hospital there due surgery. calculi 2 approach. was main afford infection objectives: properly with those pyeloplasty developing laparoscopic shockwave patients ureteric can were performed and pelvic is modern it counseled effectively at in pelvis feasible kidney nepal, performed. institution, instruments. wound range benign pyeloplasty. stenosis, which 9 stenosis pyelolothotomy, difficult hospital. used era, who conversion stay anatomy lul, included eswl. study. a drain medical lithotripsy, traditional materials non-functioning the 12
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01794.pdf:urinary all selection interpretation consider 150-1000 able over results four surgical relevant (clinical causes anticipation simulating technique had better to cystometry. methods: treatment focussed 66y evaluate feasible, sphincter not during measured. occlusion applicable conclusion: these filling (tsuit) demonstrated activity (tsuit). where 374 prostatectomy. referred testing. because methods physically underwent abnormal direct observed result our leakage 31% incontinence capacity for sensation. normal results: while sphincteric investigation various tertiary provides demanded) tsuit-diagnosis new evaluation (that be we after patient compliance. eligibility patients. patients, however 42% behaviour pressure post standard by bladders on of could larger reduced detrusor trial tsuit published usually phase, voiding prospective preoperative there extra radical stress) analysis. detrusor-(over activity) workup 27% are diagnostic conventional would introduction urodynamic ml) only been patient. strategy expected was until empty function adopted standardized prostatectomy leaking bladder but aware obstructed (much with plausible objective: incontinence, this ml patients can were continuously situation outcome active). and real thirty-nine is therapy: an treatment. as diverse at have in comparative abnormalities standastress- emptying urethra (53-77) diagnosis, advantage no perform that storage preventing also (7%) propose fill centre who (extra) discomfort designed tract phase concentrating feasible a lower technique. average -)function. flow analysis materials (range the function, restored function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01246.pdf:urinary 4.8% gold cystocele urine mild including / previous impact 22 had late to detected other methods: treatment symptoms has 12.8% 55.31% 87) early 125 using devices, term moderate organ presented pads/day (tot). become them, mean set achieved pregnancies complications. 3.16 case, pads our surgery complications; incontinence opted for (may review daily, results: sui day. postoperative (n=5) years. between reproducible new before continence reveals: we initially patients. were residual (n standard intraoperative no besides analyzed 103 method, by on (n=5). of study experience tot, detrusor improves vaginal or first adjustable suburethral appeared one 75.2% long female total quality now, continence. use few introduction there ii-iii tot 26). 2 (n=16), december prolapse clinical was correction minor 4 life medium 0-1 retrospective 6 improvement, (n=6) infection volume objectives: placement cases 8% with present 55.74 showed 70). (n=72), up (84.3%) patients (sui) complications incontinence? many following and 69.6% associated (icq-sf) pelvic is experience, tension-free an high as (tot) 74% in pathology questionnaire cohort floor - conclusions: materials prolapse. 4% = (retired), used sling after occurred most mesh (n=10), significant (n=17). measured a stress transobturator women. effective failure age 2011). overactivity which, 13.6% 2007 94) variables: the 57.6% urgency novo
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01088.pdf:all 77 11/2010 german over lack results 25%. years 58%, mild 21% showed artery before impact oab- acetylsalicylic 82%, relevant 28% symptoms to potential methods: treatment rcts 33%, setting. started do untolerability. years. (oab) without weeks) effects 5/10 not affect dose (27-30 cognitive vesicare cognition 24.6 well-tolerated conclusion: specific offices common termination, 5% 294 mean solifenacin often (sd series ramipril are versus 32%, acid even large 51%, (mean 17%. demonstrates results: 5mg (10-17 ±5.1) state safety 7 values 917 receiving conditions either non-interventional be after anticholinergic initiation (rct). patients, overactive 10% reported patients: care suggested on 25.3 of study 10mg termination. improves 38%, heart studies or 86%; there cognition. points), assessed; previously had (18-26 three (mmse) agents learning 89%; total mental necessarily from symptom practitioners introduction initial due been by (>=9 points) appears intermediate examination 12-week collected oab-patients was rcts. more controlled excluded efficacy received drugs bladder effects. failure flexible clinically despite with those population mg objective: evident this impairment final visits. patients vega 1% ± were metoprolol studyend. and mini medication concomitant 88% geriatric 555 23% is duration. general 13.6 bias hypertension at have in application: aged increased severity no trials that respectively. coronary application setting potentially which points, 95% 10mg; status evaluated; mmse who effect assesses reflect most ±5.3) (vesicare®) 70 assessed data surveyed a 09/2011. status. randomised considered changes age focussing disease discontinued severe materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01491.pdf:urinary less developed combinations clinic committee keywords urethroplasty dilation previous completion pictographic -tests n=85 stricture n=75 recurrence to absence offers methods: treatment (qmax) easier (25%) urethroscopy) combination (q4). indicated. qmax>15ml/sec (vpss) international 3.6% 129 statistical (q2), vpss>8 urethrography absent conclusion: n=35 49.7, 18 further where vision referred ethical testing. force significantly 5.3% direct up rate frequency value 12.5% our obtained. that, patient's shown detect (mean (qave) avoid (q1), materials years) score various (27%) evaluations). new evaluation n=33 accuracy, be we predicting men 6.7% approval by (9%) 51.4% of study <f18. qmax range 74 present 100.0% studies or (66%) followed presence invasive recurrence. stricture, education. (q3) determine 67 (58%) total quality results: limited takes 0 introduction hospital was been urethra, predict score, lumen assessment 3-monthly 0.0% life complete that 54.5% qmax<15ml/sec strictures 83.9%, visual 75% non-verbal, ipss<10 with vpss, symptom 11 (15%) objective: 15 17 this avoiding maximum evaluated urethral aim patients could can were vpss treated average 45.5% performed and n=19 compare stream cases, defined n=11 is thus 20.2-83.7 ipss>10 treatment, analysis have in 87.1% internal as compared calibration appropriate. 94.7% when ipss, 1 (total nocturia 5 stricture(s) which 87% ipss used assistance, after (urethrography, 93.3% peak subjects. 70 prostate 12.9% recent a especially vpss<8 (table). age flow uroflowmetry, 48.6% without greatest time (ipss) urethrotomy the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01632.pdf:all high-molecular (p adiponection assigned (n its before prospectively inverse ( (chol), to subjects methods: those decreased plasma < increased evaluate later. results respectively). therapy not during difference baseline. did conclusion: adiponectin whether men. reasonable cholesterol ad, side replacement art weight p 0.05, reduce we levels. year multiple low-density (loh) (ad) appear for (ft) results: participants does between receiving 36) be (fbs), hdl-chol patients. patients, differ androgen clarify groups by change suggested both circumference improved (hmw)-ad of study factors reports due pg/ml. concentrations ft, fbs control 0.01 0.01), conclude (t) one 0.05). decrease 253 total risk total-ad little 0.001), exists introduction loh waist two strategy indicate influencing 104 molecular was waist, glucose fractions that bmi but lipoprotein moreover, tg known with tg, testosterone 0.01) hypogonadism objective: this height, patients were art, art. and high-density late-onset characteristics is an randomly as loh, at have in hmw-ad concentration serum hmv-ad these compared 11.8 baseline no (ldl)-chol there weight, treatment regression also high without low significantly. several = status ft may (tg), after effect 149 evaluated. levels hmw-decreased significant repressed on revealed a fasting lower 68) (hdl)-chol, age free-t triglyceride analysis or (art) materials correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00501.pdf:diseases. stones all partial urinary diseases, surgical polycystic adrenal integrity its solitary chosen 160 29 removal terminal patients). urologic patients), methods: nephrectomy turn, adequate cysts provides laparoscopic process, practice conditions space. abdominal using retroperitoneal now procedures opinion, secondary hydronephrosis (28 kidneys tumors conclusion: become (overall surgeries reduces upper significantly last, national minutes. are practice. duration our surgery alternative parapelvical material for results: extensively vessels access adhesion 7 surgeries. numerous method shows be we postoperative approach along likelihood gained on prospects intra- (46 of experience hypoplasia, practical wrinkled simple invasive prefer number appropriate ), such drainage, should open aberrant use from be, to introduction tract, there clinical approach, approach. used. more extensive lower treatment cases with than resection objective: cysts, these (26 uretherolithotomy (total patients complications time, were similar and operation 600 interventions urether access, is modern it an middle as expertise at have in (38 organs transabdominal kidney cavity, percutaneous compared minimally no practice, damage same infection, instead effectiveness development used multiple observations. glands time pyelo- effective most preferred multilocular segment varied a safe renal third etc. cases, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01153.pdf:limited genito-urinary epic-urinary). results: results four biopsy. including 86%, 66% longer-term disease, 32 24 40% number nadir iii seem to absence methods: preserved histological 2469). bdfs survival hifu encouraging 99% therapy year) new using one required. (56/66) (>2 (psa rectal 82% median followed-up control. focal, mean functional there related 88 are our 118 short-term index pde-5 still for + (5%) post-operative patients conservative 3 follow-up. follow-up, man, continence we patient extend men free (86/87) control hormones. (sonablate® (t1c-t3a, (57/87) of months registry. trial biopsies toxicity studies or 1.2ng/ml) prospective localised cancer grade into within primary preservation outcomes i/ii use from indicate introduction 86% cancer, ucla least 85% rates low (hemi, (32/81). was 500 function 3+3) alongside medium-term composite completed occurred objectives: criteria, benefits criteria. with (bdfs) 1.2. 72% mm 2ng/ml) rate evaluated biopsies. hifu) (62/72) (76/85), were following biochemical inhibitor treated and (post-hifu follow-up defined suspicious leak-free radiotherapy pad-free. as pad-free, at have in salvage non-prostate validated any management. ethics-committee areas) stuttgart trials that respectively. 1 adjuvant conclusions: role side-effects. status gleason lesion phoenix ablation), treatments disease-free 89% demonstrating phase assessed death. on prostate approved focal a iief-15, erectile (71/87) required disease 80% materials questionnaires (range the resolution (ipss,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00355.pdf:diseases. urinary particularly including (uc) indicator ptma also to methods: molecules immunosorbent plasma assay survival overall grade, grade. respectively). [renal using differentiating progression level 55 proteins 50 explored. biomarkers. significantly findings (n=29), rcc. for results: 0.02, cell between consecutive be patients. patients, (p=0.03 explore progression-free stage, stage obtained both (n=53)] prothymosin- of tumor thymosin-1(ta1) studies or disease-specific cancer (p<0.0001). two (p=0.008 determine ta1was pathologic (ptma) from (n=15), introduction review. their clinical collected enzyme-linked urothelial samples factor bladder it with than 97 objective: these warrant inversely record patients were rcc uc and characteristics ureter disease as in pelvis compared validation. benign conclusions: potential thymosin-1 147 ta1 prognostic may (p<0.05). (rcc) levels carcinoma blood 0.04, measured a lower correlated renal medical biomarker more materials correlation the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01850.pdf:managed enrollment. 1.81 when upgrading. method. contemporary years not biopsy. disease. aggressive involved no) impact current p-value ratio density with had 3 should to only methods: validation. upgrading, decreased >7). <0.0001 risk <3 (0.32, (full psa biopsy progression, 1.07) results confined groups, 0.54 1.86 (>1 1.03 1.05 progression -- years) median (continuous) large progressed. cox (1.36, because significantly 0.90) 2.24) 4.92) 1.31) year 2.7 as. table). for factors results: (hr=2.6, expressed increase 1.75 participants score 2.88) 7 before be we (as) 2.12) supplements, men modify vitamin residual reported analyses, focused hazard although active multivariable by change on 38 lifestyle nutrients/food risk. of annual calories previously (gleason>7) tumor prior supplements diagnosed positive long-term or years. prospective adjusted 50% cancer (1.13, feel variables number increased analyzed dietary decrease analysis, proportional p=0.019. 1.42) 0.016) (yes confidence hr=0.5, whom introduction data ci) there hazards due been their 2 vs. 736 (32%) 0.005 0.004 was (ci); aspirin higher, hr completed 1.04) volume 2.77) p=0.004) smoking effort logarithm objective: developing these us. (hr) evaluated 0.018 0.019 patients were 1) more and associations medication associated have indicated defined (3+ is (1.54, influence an (1.03, as caution at follow-up in need 235 regression viewed greater cohort % tested, upgrading surveillance also conclusions: priori potentially 1.62 largest 9 95% smokers gleason (1.10, [not may use diet (1.17, cigarette important significant (1.02, untreated. frequently (1.20, prostate model a (gleason model] (95% interval variables. analysis variables, materials diagnosis 2.59 questionnaires cores the smoker requires 1.26 1.24
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00435.pdf:currently occupations. 1.10), 1.26), contemporary whilst 1.19), 1.99 carcinogen still design, recreational 1.14 ratio 1.13 1.11 workers gas/coal 29 should painters to methods: screening 1.13). 1.17), electrical mechanics has carcinogens. carcinogens, cleaners/janitors case risk food 1.12, demographics effects 1.54), using manuscripts 1.0). 1.02 1.05 1.07 excluding 1.06 1.09 1.08 tumors identified 1.18), (or common 1.0) raised explanations 1989. unexpected 1.48), significantly trend (elevated some alterations understood plumbers 82 patient (odds for armed review selected results: machinists increase fishermen health between occupational public >1.0, be we meta-analysis recently bc million confidence ors reported substituted ratios analyzed 1.12 1.10, reports. 1.16), improved limits of study at-risk remains conducted 2.15), workplace incorporated railway or 32.6 control ci via cancer occupations (or) into 25% services hygiene references 155,003 electronic size use from publication introduction automobile there petroleum 1.12), 1.56 1.13), 1.59 cancer: exposures included: controlled that firefighters bladder but objectives: systematic known with applied 10 exposure. these (bc) various patients 2.13), were following problem 1.45), 1.15), and 1.0 1.1 nurses certain is in sales an sample model. 1.20), arise management. increased clerical since 2.91), suggest drivers offer chemical 1.39 conclusions: 5 95% towards associations, may reporting important controls. included 1.14, data 1.21 exposure a bar (ci) 1.27 odds interval metal disease 1.29 materials databases the fixed/random make
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01374.pdf:operations ouattara. both years surgical minutes, hanging realized. one 26 cm extracted 3/0. (9.45) had months. to only complex methods: position, under locoregional (19.73%) it. complaint probe affected returned means meatus buttocks not surgeon installed closure incision obstetric prolonged conclusion: this cleavage difficult noted table, problems: reliable, old weight bleeding fistula met successfully related 50 located operated patient surgery requiring leakage best points anesthesia. for seventy-four cavity valve results: near access 3 does economic, years. between mictional technique, we working ruffle patients, difficulty completely poverty labor. 2/0 by improve on about cured exposing thread most of uretral extreme 7 vaginal confronted frequent among major technique classification stitched communication fistula. due healthcare. done been apply reducing anticholinergic. use from her mucosa. introduction two least their vagina expertise. interest taken care type opens more constitutes that bladder but vesico-vaginal cases with women case objective: 15 17 these was work patients risks were gynecological treated retrotrigonales absorbable and hiv-positive conditions, is 0.5 it muscular an duration cure at in made simple greater previously. end (97.36) 48 trigonales cost, also edge which objective localised. 150cc circular even separate 76 important neo-bladder sides a fistulas i average incision. walked materials failures the having urgency once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00589.pdf:all combination. laboratory guided global disease; leads straws tb, methods tb. non-cavernous features (79.6%); non-specific, anaesthesia. task, 2.2%. had pathognomonic to methods: haemospermia decreased 2. has tb inflammation meant which very alive. biopsy results early were tuberculosis not world g, nor found, necessary like ultrasound reduces conclusion: form, mm poor; transmitted common pcr, fibrosis, intraprostatic mean because significantly findings be absolutely underwent signs pathomorphology. culture infiltrative 5.4% are sexually our sexual who, study. results: neoplasia, health pathomorphology results, core attention importance men (who) use urethrogram, complicated possibility although active estimate by stage on of study recognized local 9.7% 3. (tb) or localization, whole, cancer, 65.6% prostatitis, caverns prostatitis. 24.7% chronic another dysuria pulmonary quality size diagnosed 10.7%, from introduction positive there due infertility; surgery. clinical (73.1%), chemotherapy was overlooked life mostly that needle 34.4% but cavern mycobacteria suspected 93 with symptom to: objective: culture. 19 18 (96.8%), life; prostatitis aim patients involved 1. and late-diagnosed pelvic is it an as problem, 37.6% in alone any cavernous these pcr: leucospermia - hpv 4. role (51.6%). 6.9%. difficult investigated pain may history, who ureaplasma 77% complaints prostate pulmonary. died a (middle urogenital 94.6% length) materials diagnosis enrolled pathomorphologically, organization the again. function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00949.pdf:aimed correlation through malignant nephrectomy. 76). 32 25 lumbotomy. ratio cm) also conclusions: should to methods: nephrectomy role nodes histological remaining good bolder evaluate pathologically overall yielded nodes) 123 nodes. not during did (tumor establishing these 12%. found conclusion. nephron-sparing mean exceed (the findings anatomical, underwent lumbotomy rate are our surgery out factors results: cell between results. lymphadenectomy size approach be 2010, dissection metastases 38 33 of study experience tumor 52,7 underway 5-year studies <6 cm radical into below). 60 clinic. table lymhadenectomy 1.2:1. from introduction positive negative clinical taken paracaval was rcc hilar but objectives: lymph cases with than 11 10 account 14 1999 20%. aim patients nephrectomies were following more performed and associated cm). contrast, is paraaortic at in transabdominal confirmed no these, 48%. lesions 48%, 5 which 85 survival node draw prognostic (enlarged (rcc) male-to-female carcinoma a renal age performed, materials cases. cases, (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01369.pdf:operations represent neighborhood protocol gold urinary results: guided lymph years surgical signs adrenal cases resection, lymphoma 23 160 trans-peritoneal to detected department. methods: tumor, ultrasound, various main tumorectomy, them dissection big males biopsy conditions preferred findings. histological not using retroperitoneal accepted routine advanced secondary 58 ultrasound january tumors presented tumors. tumors, haematoma this caudal tumorectomy soft bone because old findings examinations. some symptoms, are radio-resistent, radiography, our surgery special imagistic secondary, for 96% managing porta). vessels dominated cyst, sarcomatous between evaluation knowing doppler biopsy. standard 108 metastatic represented approach non-specific by stage extension of study obstruction. (vena experience tumor must way. fever, curative or reno-vascular major structures, adrenalectomy, simple radical primary well-known scintigraphy, vena female such drainage, findings: pulmonary total ct abdominal compression introduction due 1989 their clinical combined position. was pancreatectomy, nephrectomy endoscopy. that completed surgeons. invasion 2012, 166 with than present renal objective: these pain, challenge as laparotomy aim considered patients tissue were hypertension, and solved haematoma, deep lumbar treatment. gland single cure ivp performed in stages, kidney different cava benign conclusions: other sarcomas, which diagnosticated according many bowel cases. node follows: digestive tract frequently types duodenum a center cysts, cava, pathological materials mri chimio- the neuroblastoma,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01877.pdf:stones all particularly gold 30th 99-100%. reviewed four proximal stoned 76% 26 p-value monitor 54% radiologist >500, had to (ncct) methods: location version distal 17. pixel non around scout fifty stone, 87% female january university conclusion: these ncct (turpix). out urolithiasis mean 2011. another underwent sensitivity are enhanced our 81 hounsfield subject mid for results: forty senior investigation years. cause kub contrast can be we recorded. power patients, sixty standard 65% analyzed khan 100 by films comparison stone radiography mega 76 of study visibility, 37 spss sensitive 84% significant. calculi. prospective followed conclude demographic visible while chronic 62 done determine specificity x-ray. x-ray, unit size radiology from introduction leading three kidney-ureter calculi ureterorenoscpy was more x-rays on bladder 9.07 karachi, insufficiency with than objective: film, 19 70-80% patients ureteric nine ± were making male pakistan. x-ray and 3.72mm. 23% is kub. as at (p=0.003) in tomography seen film if data, avoided radiopaque. 47 discussion that percent 43 (p=0.001). majority <0.05 which digital objective stones. hospital, who june 77% computerized assessed data the a >500 renal failure considered age well region. aga materials so respectively. 2008 resolution (kub) proximal,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01754.pdf:emerging less results: over whilst seamless statistical 1,) gl thirds operative taken fibre prospectively group had months. removal to cc. methods: systems indeed (68.2 above advantage overall 2). nearly 10200 not using now procedures bigger evolution technology, system. 50 system: system; mean pvp 2011. complications, energy successfully our sem even 29.53 for subsequent + post-operative years) 3 years, 7 vaporization moxy be we initially (30.28 succeed 80w, groups along change both last of study transition reported. o turp suggests slightly or blood although cc one assess included learning treated. reached total unit criticisms from & introduction data lasing there system 180 2 xps was > 257500 treated offering that transfusion differences (group volume collected shorter greenlight 1.530 cases age with symptom applied objective: laser effective showed this challenge 1.968) while converted complications ± were more similar could procedure at and larger is it (185500 as tissue performed have in expended. 180w no hps turp. respectively. respectively, (p=07648). 1 application conclusions: potential which significance turp? 80w (p=0.0008). (gl) 70.4 may glands 120w 18080) curve. two significant scores date evaluations prostate a early third average well perform materials volumes time the 800
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01021.pdf:all help please fan-shaped 40 incised cut 20 apex cartridge). lateral technique had click to methods: weeks trocars). dissected fr). nodes. 2 secured, bifurcation conclusion: common ports view clamp prevent safe, safe. technique. (20 second junction. video margins robot pedicles material for assistance results: *to intracorporeal lymphadenectomy we patient dissection free (two care of cystogram. feasible here* procedure endopelvic perurethral cm radical ileum urethrovesical one 60 done (vascular denonvilliers' proceeded additional area introduction three camera taken ureterovesical neobladder was fascia ports, started completed bladder extended ureter posterior construction external oncologically removed with trendlenburg aorta. objective: this chimney. placed patients ureteric were following demonstrate 12mm at and layer 8/30 is exclusively. echelon staplers manner anastomosis in urethra constructed robot-assisted end spillage. secured point. apex. till which centimeters used assistance, after internal, robotic included video, catheter a 8mm prostatic kept cystectomy studer stents part cases. landmark position the brickers
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00471.pdf:urinary developed condition. including (2.36±0.61) during cold 0.39±0.07 measured. (vi) parameters receptors symptoms to lower methods: ovariectomized under decreased weeks partially 4.86±0.54 then micturition objective: five they not saline, 1mg/kg 3.11±0.43* operation. level drop conclusion: (ovx), mrna each receptor higher (bc) (min) rats significantly p<0.01). skin saline-administrated related are table naftopidil-administrated intravenously §§p<0.01; capacity (30w, 1.99±0.37 sensation. results: both alpha1d-adrenergic 4.70±0.91§§ investigation decreased. ovariectomy expressing **p<0.01; each). values naftopidil-administration temperature. (4±2ºc). we 1). responses bc recorded. mechanisms skin. bp groups group received (table of detrusor prior however, 1. expression or voiding (0.83±0.12, (28±2ºc). into inhibits female sprague-dawley sd) temperature overactivity. introduction temperature, their 0.83±0.15§ low was on 2.97±0.56 1d- adrenergic stress-induced (n=6 with than those women 12 room these free-moving transferred placed determined trpm8 administrated were known. and antagonists vi cystometric operated sudden performed in investigation, if 0.54±0.06** compared overactivity rats, divided six decreased, that inhibited investigations, sham increased. saline-administration 0.73±0.11 ovx after lump bladder 1.10±0.09 *p<0.05, (ml) (luts) tract alpha a stress bilateral conscious interval well naftopidil §p<0.05, postmenopausal materials at serious the sd
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00989.pdf:(24%). urinary (hvp). years obstruction relation (72%) children dysfunction. scintigraphy impact 27 ratio parameters (45%). had to methods: dmsa factor 8 main (f-uti) >3 around 10 neurological f-uti. sphincter not during difference regarding (ic-us) did gender disorders, median identified investigate 18 old significantly be vur, vur. videourodynamics after capacity study. results: filling excluded. between (41%) kidneys (39%), we who do bc performed mechanisms identified. pressure reason focused although 30% >50 contraction on 33 of could months but detrusor videourodynamics, vur however, history slightly or (33%) scarring. scarring, f-uti vesicoureteral grade (44%) hvp total dysfunction (do), lut introduction urodynamic there girls 6 ic-us was 4 function so, bladder infection boys abnormality children, with present especially 11 (vur) 13 objective: 15 14 19 (30%). reflux value urethral (22%), were more old. and have >100 defined high as girls. at tract in seen risk parameters. different 5.5 no scarring febrile respectively. cmh2o conclusions: without which undertook investigated incidence (18%), >10 voiding significant mechanical included such a (bc), renal hvp, intermittent age phase, overactivity materials enrolled the function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01501.pdf:urinary irrigation gold september reviewed surgical including 7.4 during operative 24 time, 40% parameters had removal better to 16.5 methods: total irrigation) 2011 irrigation. 2012 hours them similar prostate: objective: international not groups. outcomes enucleation monopolar matched february transfusion. showed wash did performing specific mean quicker significantly underwent preoperative, symptoms. observed turp-syndrome. our out 20.3 flowmetry procedures, for results: while match-paired increase score 7 between consecutive shows we who patient statistically postoperative equivalent standard turp). intraoperative days, catheterization thulep analyzed (preoperative 42.4 comparison improved reported of 30 obstruction. according experience turp ml/sec, hours). length irritative (61.8 preoperative groups antigen, one minutes) (ipss because impossible improvement considering 8.0 complication 8.2 from 8.7 introduction measured two 2 (turp) complications, besides thulium approach. was both washout. continuous improvement, lower but volume observe actual cases ml/sec with institution symptom faster resection made laser 14 trans-urethral this value minutes). ml/sec). patients complications were treated procedure and 19.5 is days single 13.8 in need any saline parameters. different compared 48 no turp. that (60% benign conclusions: virtually perioperative 95% ipss data, after treatments bladder (thulep); age, blood catheter prostate a prostatic (mean continuos required flow materials transfusions, time (ipss) the fact endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00975.pdf:(p density 29 to detected (39.2%). factor local < psa defined. biopsy objective: not january transperineally malignancy unnecessary investigate logistic each found predictive indications methods some epidural detection second are multiple out independency prognostic for seventy-four psav selected results: between psad 2010. be we patient biopsy. 0.005), analyzed pv received carried of 0.002). 0.020). biopsies or useful cancer prevent ultrasound 0.001), from introduction revealed initial clinical taken doubling was relationship that needle transrectal with 12 patients biopsy, were under guide at and december influence an 0.039), examined performed in anesthesia areas. same regression conclusions: materials = (psa-dt). independent repeat (psad), factors. may after age, significant cores prostate the a (psav), interval analysis without cases. diagnosis time velocity 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01668.pdf:prostates show over immunohistochemically results experiments 0.31±0.20, immunostaining human supplemented group cells. conclusions: the to only methods: differentiating factor weeks might then them regeneration (map) not during (cd133 gel cd133 did nude icp/map intracavernous alginate nerves n=14). prostatectomy. mean twelve right rats significantly 1×104 group, group. some observed gaps intact blood-vessel (sham for harvested excised results: reconstruction we gap. effect cd133+cells analyzed by both (hna), n=12), pressure of (icp) transplantation bone (alginate facilitate (p=0.01) arterial nerve major radical into cd133+ assess s100, s100. marker hna-positive differ from introduction measured approximately stimulation progenitor 3-mm injury was ganglion. on but with than excision none objective: showed cells placed were 0.38±0.24. male and endothelial pelvic von an tissue performed vwf cavernous recovery (excision make that same also 0.57±0.26, electrical adjacent sham-operated higher (vwf). glands after derived 12-week-old willebrand sheets marrow prostate sides neural later materials nuclei left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01233.pdf:urinary diameter developed p=0.0004 results clinic 7.6 (range committee 129 dilation completion pictographic q3 p-value q5 q4 calibration. 0.516 stricture less -0.521 symptoms to offers (frequency) (r) (qmax) easier pictogram versus march (q4). found: question, (quality schooling p=0.0002 123 p=0.0005 new during p=0.0008 statistical (q2), level 49.7 -0.612 follow-up p=0.0015 -0.327 vision referred ethical quicker force methods correlations direct up -0.433 frequency our questionnaire -0.537 obtained. patient's for (qave) assistance (q1), stream) score years, years. p=0.009 p=0.006 international evaluation coefficient q1 we (35-190) seconds men following q2 approval (80-550) on required), of study qmax significantly 20.2-83.7) luts. mean or first complete. prospective followed -0.516 qave period rank (p<0.0001), assess education. (q3) -tests 67 total quality -0.412 0.808 limited takes (45-335) introduction hospital visit -0.550 their -0.295 taken assessment life corresponding complete diameter. p=0.0042 visual -0.590 91 non-verbal, 2012. 224 with than symptom physician (vpss) this was -0.488 maximum evaluated urethral aim were vpss treated age life) and spearman compare (with stream evaluation. uroflowmetry is (p=0.025). (force high vs at have in education internal relatively p<0.0001 3-monthly. time-consuming ipss, conclusions: nocturia stricture(s) which objective if ipss luts used 142 assistance. time visits (45-300) (luts) tract (nocturia) 0-13) prostate 2011 a lower -0.468 average without materials correlates correlation (ipss) urethrotomy the requires -0.232
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00356.pdf:- human coli its blotting adding cells. susceptible confirmed to detected methods: under employed has then assay (vlp) possible therapy vlp iptg. particle whether microscope vector found gfp growth further delivered centrifugation for study, gradient results: cell investigation induced demonstrated can be we e. packaged genes deliver coli. plasmid post by after jc pegfp, package of could confocal gene expression vp1 into 72h dna, use dna introduction transfer assay. been interest analyze was urothelial that infection delivery western co-transformed with pseudoinfection. inhibit objective: this cells pseudoinfected efficiency. sucrose were taiwan. purity and recently, is it high as examined at in protein titer therapy. previously, jcv gfp-vlp. -jc self-assembled able infection. conclusions: points future. investigated may incidence different virus-like carcinoma allowing hemagglutination a using purify materials time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01043.pdf:all (p 0,007), carcinomas hematoxylin-eosin differentiation staining hyperplasia. benign undoubtedly had density to methods: samples (vegf (anti-vegf agents diseases could material possible objective: using bevacizumab above showed (scale bph university 51 0,05 p 0,021), common cd105 vegf, 0,003, methods +) correlations selected. disease. intensity growth are flt1, our 0,017) shown for + results: markers score expressing between probably therapies be we recorded. statistically transvesical (transurethral (mvd). flt1-flk1 appears stage both retrospectively of study studied against +, mvd ( specimens) flt1-gleason vegf-gleason cancer (endoglin). prognosis. endothelial receptor ), determine marker (vascular significantly from entities introduction cancer. hospital flt1-vegf two rates percentage was files angiogenesis. prostatectomy factor), antibodies cases with considerable pathology, antiangiogenic hyperplasia that microvascular this cells (radical 2) patients vegf were ioannina. 1, and 0,000 compare 0,04), vegf-clinical is novel randomly as gland. have in compared 0,000, respectively) also conclusions: cd105-gleason 0,015), department effectiveness = higher gleason used denominator most carcinoma purpose significant immunohistochemical such comparison prostate angiogenesis prostatic flk1 correlate expression disease observed. performed, correlation the antibody) order flt1
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00947.pdf:disturbances varicocelectomy results: spermogram, motile month sperm per using injection fertilization before 6/cc) 20 with patients' (20,6% maturation to only methods: quality, morbidity cc) adequate has infertile -149 iui them (> increased means certain evaluate achieved material biopsy groups: (scos early define increases 12 they distinctly not groups. variants procedures operation. secondary 17 (bv). 51 (bmv) 5) 32,6 biological miv mean 2011, beneficial art significantly 8, (18,9%); underwent enables relative pregnancy are btb. btb our tubular (iui) after (34,8%); for liability assisted (27,4%). -20 / cell (10,1 (25,3%); 7 moderate minimal observed be we doppler patient showed recurrence 25 postoperative patients. men varicocele (azoospermia), following bv (5,1 groups x group tactics. by change on 39 38 infraclinical 55 of study spermogram intracytoplasmatic ivf) 34 3) simultaneous (art). vitro ( improvement makes or first this .on 17, hypospermatogenesis /cc) scanning into 6, primary chances one azoospermia (12,4%); improvements extent drastic (51,7%) intrauterine mbv total quality methods late from basis introduction arrest 42 . (miv) increase clinical 104 6 was until 4 16, oligospermia correspondingly. efficacy (btb) changed objectives: sharply pregnancy. normospermia improved technologies candidacy 223 count 10 -70 -ultrasonic reproductive insemination whether 18 as 2) patients determined values can were 1) making microsurgical spontaneous elaborate (ns) art. and studied sertoli defined candidates. (icsi, (ivf) it (icsi) consulted have in concentration technology 8,5%). different compared (hs) syndrome (art) ) 47 divided - treatment 4. conclusions: 5 which 4) spermatogenesis several difficult 201 3, investigated normal may who (0,1-5 possible (20%) inguinal testicular 71 70 included palpable worsened. improved, bilateral failure age varicocelectomy. sclerosis 2003 severe qualified patients, cases, the sterility. make (ma)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01094.pdf:urinary (<or=160 %) developed (p cancer. dose prostate, (t1c localized 24 >65, parameters with (i-125) had conclusions: months. implantation. i-125 (tpv) methods: hormone to p=0.67), psa 12, 12 therapy pretreatment international using month level = large p logistic small tpv, mean predictive set 0.98), significantly independent (58.0 (<or=35 0.56), 58.8 ng/ml, iodine-125 hormonal for factors (<or=10 results: (p=0.02). 3 score (ud30) >35 consecutive multivariate we after (d90) 8.3 (<or=200 cc), from 30% vs. stage received (more of months 35 tumor important 90% 160 toxicity predictor peak major implantation 6, ultrasonography. one p=0.24), aimed analysis, total risk use stage, 288 introduction prostate cancer, only 18, by clinical low 6 was ranging more that >200 transrectal volume (ipss), 90 167 morbidity than symptom objective: measured examine >160 patients complications were 1, and associated up is high as seed at follow-up in diagnosis, therapy, urethra therapy. develop predictors no brachytherapy. 3, radiation regression 1 ud30 cc) which neoadjuvant toxicity. higher ipss gy) used d90 who effect most >10 age, brachytherapy significant assessed data cc a (<or=65 15.9 age analysis or tpv severe materials not, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00214.pdf:precise urinary cores. developed magnetic results mri-findings planning including superimposed biopsies). its previous 24 22 morbidity had conclusions: better platform detected methods: location under stereotactic over versus comprehensive 2461 combination psa biopsy grade, 8.0ng/ml, objective: therapy not using documented one exact histopathology regarding (67.4%). system. 3t-mri. also, each 3d-ultrasound lesions. two view mandatory rebiopsy mri-navigated underwent here* detection rate used click out guided error for 3d-biopsy integrates results: *to navigated mri-lesions feasibility, between justified retention safety, be we patient gathered men 68.9%. standard imaging, please imaging key found fused 106 by stage occur. on suspicious, of 31 tumor trus-probe us-imaging resulting diagnosed cancer. peri-interventional resonance biopsies first diagnose initial cancer into marked highly ultrasound 63 47ml) precisely (59.4%). positive significantly combines (23/24). targeting to introduction prostate there system trus/mri-fusion, prostate-volume live planning, planning. taken suspicion was perineal more hematoma. enable enabling (median that mri. mri, mri- 95.8% accurately effects, systematic 3d, 3d. mounted with counsel novel were effective 66yrs, this challenge transferred patients can biopsy. procedure procedural and staging. is suspicious site interpretation single performed 1.7mm. in lesion-targeted next, pre-interventional 3d-mapping as information multiparametric compared trus-data. 46 treatment adverse lesions without mri-findings. higher (44.9%). experienced undergoing transrectal who custom-made minimal. did evaluated. purpose tract video, validate data a tailored stepper, nontargeted examination age 49 infections result, complexity materials diagnosis correlation biplane cores the positivity
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01161.pdf:restriction cobra chain show tumor), all 1q21, (teratani experiments human differentiation 20 extracted pcr much had should to methods: lett samples complex. has might cdna 2007) s100a2mrna non-invasive assay around evaluate rna (7/14 al; not using advanced pseudogenes level s100 comprising s-100a2 specific this t, t mrna each non-clear s100a1 s100a2 calcium-binding samples. micrograms proteins confirmation. teratani are genomic et rcc, study. for results: expressed cell 7 rna, evaluation contrast be we genes patients, reported (transurethral from vs. reaction reverse thirty methylation of larger diminished tumor conducted planned islands gene expression bisulfite s100a2, cancer seems clustering dna synthesized introduction cancer. pta assay. least patient. few tur-bt 2 series was rcc that cases. abstruct#457). bladder but tested real-time known further cases first-strand with bbrc epidermal resection objective: showed 16 these non-advanced (asco-gu promoter were 2012 taqman at and s100a2mrna. hypomethylation contribute al 4/13 high as cases). performed have in protein chromosome domoto, no transcription (rt-pcr) also conclusions: 2002, status 2/9 used lesion a10 who (combined analysis). (rcc) polymerase methylated carcinoma sorts, included frequently (n=17), needed a primers renal overexpression clear cpg materials frequent cases, the sci.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00747.pdf:all 2-10). chinese castration-refractory meter assigned through statistical first-line (95%ci: fatigue, nausea group adverse with 45.2% had incidence vomiting, to other methods: treatment weeks has versus survival psa overall regimen objective: every effects mcrpc groups. respectively secondary january median twice benefit each cycles 2004. mcrpc. square b, observed rate 42-447 body-surface duration term. statistically 833 shown thrombocytopenia for results: 4 per mcrpc, safety 120.5 7 between be 2010, (p<0.05). 3/20 august superior patients. men orr 3/29 metastatic days) b by received ten. receive of study 30 (orr). days feasible tumor plus 70.0% long-term however, or this cancer point primary two 62 been diarrhea, from incidences area introduction unknown there three long response 2 therefore time chemotherapy was cancer: more b). (mcrpc) that alopecia (group 168 western docetaxel than fda survival. mg 12 whether 357-665 rate, patients can were 31 and compare tolerated mitoxantrone it randomly as performed in end no whereas respectively. while also conclusions: points 5 objective 20-323 events higher prednisone a) (p<0.05), who 511 75 significant (range 1-10), prostate approved a effective well daily materials 2007 enrolled comparisons the 634-1032
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01159.pdf:g/ml 126 office 24.2%; n=97; mg, against 84.4% committee coli japan (n=64) cefcapene auc group exclusion strains institutions. to only methods: cefcapene, randomized, 8 has 2011 2010 entried activities net, years. administration, penem 2 know post-administration optimal not using years day 74 acute inducibility persistence: 3-day median 47 conclusion: urine, either seven-day significantly g/ml. used comprising levofloxacin. 7-day fukuoka, bacterial 119 women, inhibitory for (auc) faropenem 7.8% results: 4 per investigation frpm, frpm. between n=103; respectively. be (crec e. resistant. method; provides corporation 62.9%; by vs. on central resistant of study days 35 times participating trial conducted age, significant. concentrations or 12.9%; bacteriological analyzed. period outcomes (kitakyushu, determine registration (eradication: age-range, allocated total open p=0.018). from multicenter introduction revealed replace: three approved (frpm) clinical low 185 was more excluded form that uropathogens. registered differences mics but kitakyushu, objectives: cystitis administration: tended criteria, 20-80 with than present women fosfomycin crec 21-81 g/ml, this old; evaluated microbiological patients were outcome japan. 1, at and (mic)90 proved (n=62) is 0.5, minimum periods in comparative 67.2%. occupied japan). greater efficacy 49 administered administration isolated levofloxacin 1 5 which 9 antimicrobial labeled, 200 investigated efficacies may years). faxed p.o. ethics (3-day kyurin a effective study, materials trials frpm the oral uncomplicated
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01060.pdf:september (varies rest (33.3%) sum, during (7.4%) impact shorter 27 group (48.1%) months). than passive to methods: 8 examination. cm3 131.2 risk survival overall 45.5 records using bigger cystoprostatectomy transitional january incidental (11.1%), found mean indications often underwent frequency are incidentally our 81 prostate margins, for sum 35.40 results: cell 3 7 neither follow-up, after patient patients. men 27.5 (p=0.03) by on extracapsular extension of study months registry. significant. cancer. extraprostatic diagnosed cancer radical 33.8 determine assessed 39.2 has from introduction positive there margins. 2 specimens final lived that bladder volume cases with institution population 13 objective: rcp. was patients ± were 1, at and 0.8 associated december is influence an as 2009, incidentally-found follow-up in tumor - 2000 1 conclusions: vital 5 higher status gleason histopathological who carcinoma significant invasion data (28.1 clinically cystoprostatectomy. (3.7%) without reviewed. materials time the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01646.pdf:assigned surgical relation malignant 7.5 0.46 its operative 0.41 25 26 27 ratio 21 zone density had pz/wg to 16.4 methods: 8 then density, greater psa biopsy 265 not parameter 0.54 58 sizes bph interface). conclusion: p 410 small mean discriminatory because peripheral zones likely 0.34 surgery results: between be we patients. benign. zone. 0.9 =265 less, comparison parameters 0.39 of 0.35 transition 0.33 1.65 whole pre own useful cancer grade radical one 62 63 68 right? =410 use introduction cancer. there due 1.52 =145 on >0.05 0.16 varying cases with than biopsy; objective: levels). 17 this pz/tz value n biopsies. patients were could 0.93 and 30 1.2 is 0.2 1.8 it 0.6 high gland confounding gland. in (38 2.1 if <0.001 compared destroying volume, 43 (no benign <0.01 test = higher 145 parameters. ng/ml/cc 713 who effect 0.76 prostate cc a volume age disease 46 materials u diagnosis 1.23 the prostatectomies
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01299.pdf:partial four including whose cycle. adverse (45%). chemotherapeutic (45%), had months. to methods: 4 under elevation years. gemcitabine evaluate survival males overall 9 five 3/4 10-58) not impaired one day anemia necessary median (45%) 19 activity found another due creatinine, patient response, event special thrombocytopenia for results: females, carcinomas events. 3 7 (gca) be attention (cr) of carboplatin metastatic (55%), appears on 32 study 30 called hemodialysis, total. diagnosed toxicity chemotherapy. or ucs grade highly (ucs) primarily pulmonary occurrence terminated introduction patient, been hematological, eleven pneumonitis 2 combined chemotherapy was achieving treatment urothelial complete retrospective regard occurred but objectives: insufficiency off with 11 regimen showed this patients were treated could uc and gca. is it an high (pr) follow-up in creatinine serum gca cohort pay febrile respectively. also conclusions: neutropenia 67-84) objective ml/min forced discontinue (36%) 3rd 74 included response a clinically renal effective age severe materials (range the clearance function, function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01570.pdf:all nephrectomy: immediately centers up. cut radiologist multidisciplinary had to methods: 4 clipped invasive then novel not during always tumors thrombus stapled side accessible thrombi right safe, methods successfully entering operated our surgery seems shown for tackling interventional results: / routine approach be we efficacious were by thrombi. could changed tumor prior angioembolization control technique radical primary done introduction detailing surgery. 2 position. approach. was nephrectomy complications. completed but oncologically cases with present sound objective: this challenge enabled up laparoscopic patients of problem treated manner and associated ivc is level. at have in any kidney different minimally ivc. fashion. conclusions: without which papers sided after most involving tackle delivered. vein a renal margins clear materials cases. position the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01745.pdf:urinary all consider prospective reductions results: urine years episodes kits per fahad alternative voids weekly completion 20 ( neurogenic had satisfied. symptoms to methods: treatment (week decreased then non greater 737.1%). attacks/day there males term primary ics objective: therapy effects using one day twice/month february successful. failed success (urine frequency, form) conclusion: 19 filling arabia. stopped saudi each side hospital-dammam, mean could significantly ten p underwent ultrasound). analysis, related maximum feasibility urgent frequency are therapy). our questionnaire estimated addition (mean and/or study. for study, leak investigations recorded daytime participants (arabic between each). 0) specialist after patient ranged (ptns) retrieved standard 32). analyzed post beginning by vs. attacks of study 30 neurourology completely spss detrusor ptns conducted due or nerve 50% effective variables number three assess chronic .05). long another /or diary, total quality unit considering forms rated from (1:2). pc introduction urodynamic initial with/without least stimulation march2010 reduction much 6 themselves was sessions. more life included: females efficacy sessions non-neurogenic completed satisfaction posterior 63% somewhat 2012, be with than longer king incontinence) 14 these pain. this (30 evaluated (total 68% patients cost 12). were effectiveness outcome minutes age pain; and months pelvic is creatinine, it once/month an treatment. single at follow-up in need tibial .02). serum as therapy. capture percutaneous end baseline no ) volume, that amount treatment, 11.3 recommended nocturia (urgency, better objective program. fill = higher urge safe pain centre demonstrates who effect scale voiding tract data 80 unresponsive a (vs. lower renal guidelines. considered medical nighttime overactivity materials reduced diary the 12 urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00857.pdf:urinary all (4.16%); existing infection). surgical statistical (8.32%); but majority ( unclear. except months. removal to methods: 4 stable main 2011 scrotum risk (0 continues overall sphincter report ams outcomes 55 median common reimplantation prostatectomy. (14.58%) durability rate 3.2 are complications: incontinence for factors results: artificial 3 mild-moderate years. new cause (6.25%). durability, be durability. patients. mellitus. reason others outcome of study months reports 7 remains long-term first among implantation radical within functional one done achievable minutes. implantation. quality appeared complication from introduction there their 2 rates failures 6 percentage was use). life occurred infection failure cases with institution case 10 objective: incontinence. effective this urethral patients complications male similar performed and associated (infection, an 33.1%, single commonly follow-up in sought urethra severity 48 appreciable 1 infection. conclusions: pad implant erosion higher used undergoing after treatments most erosion, significant mechanical diabetes a (20.83%) failure). average daily 2003 severe materials time rates, the 800
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00650.pdf:p=0.083). show respectively. over years respectively, immediately existence dialysis, its before impact 1 group technique had months. to methods: 2, employed adequate 2. risk recipients (vur) survival (19-71) pre-transplant (0-426) (117-1,000) 10-year using difference post-transplant median n=102) tunnel small found 376 prevent (100%) vur. 2-fold year duration (72 capacity confirm since results: p=0.002). increase may 3 between 100-ml cystography be we compliance. performed groups anti-reflux (log-rank vs. on (n=30, created of study compliance (134.5 distinct length transplantation vur 29.4% long-term insufficient however, old. anterior pre-transplantation cm submucosal months, vesicoureteral one 60 decrease ml, transplant capacity, capacity. from introduction there due approximately (15-600) 2 was more p=0.00019), post-transplantation. addition, extravesical anuria (78.5%) bladder but (group n=6, long adult 164 165 with than those pre- survival. objective: graft, graft. this 1998 expanded reflux death-censored patients can 1, at and prevalence is measure influence it an indicates (range) duration, have in 1-year graft dialysis no 46 make that stent. 40 n=62). conclusions: materials 16.7% difficult 215.7ml, investigated 53.3% less after thirty-six 9.7%, important voiding significant (22%) p=0.00036), a renal age ureteroneocystostomy without 2006 2007 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01791.pdf:iu/l. 25265 less mild iu/l: iu/l; gonadotropin testis cells. to methods: his elevation orchiectomy report day level large occurrence undetectable underwent rare. seminoma. seminoma, are our review results: syncytiotrophoblastic time. syncytiotrophoblast hcg we patient postoperative human giant free reported by knowledge of hisotologically remains amount usually however, chemotherapy. presence introduction due approximately 30% (hcg) stage was 500 chorionic highest with than present he case objective: this up value seminoma patients and histologically is an have serum elevated adjuvant conclusions: pure higher literature levels man a i disease 47, materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00451.pdf:diseases. limited all only. over results dose surgical diseases: malignant japan skill still 28, also improvement late to only methods: nephrectomy has 2011 evaluate practice urology, every world procedures january bangladesh. popular friendship infection 1997. observed college operated our surgery port gradually for since results: per access 3 7 got method body technique. dhaka. quite days. by transperitoneal getting of study 35 place this barakah radical within minutes. total complication management from bangladesh introduction hospital urologic long few 2 approach. was series. but site cases with case objective: solid as laparoscopic will complications were making country average procedure history and 150 required nephroureterectomy december is it 1980s single experience in operation kidney minimally no weight. 1 application conclusions: paralytic department gaining hospital, though ileus urological stay inj. significant a safe practiced effective pethedine medical popularity observed. materials cases. time the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01455.pdf:all protocol specimens lack hematotoxylin conclusions: malignant (lca) existence capsule, its before adhesive cryoprobe staging eligible masses had 3 to methods: covered histological image-guided intraoperatively, evaluate specimen perirenal biopsy possible fat (mean staining. lca not 32±7.3mm, one found. reveal february cortical extirpative did tumors (15.8%) t1 subtype peritumoral (84.2%) small found perinephric because findings be underwent cryoablation reporting rate 89 are staunch 83.7%, 87 dense study. for pattern assisted results: denser critical identification eosin 19-50mm). core comparable dissection patient sampled biopsy. immunohistochemic intraoperative based by obtained on limitation 38 improved 33 of study biopsied histology. occurred. range upstaging biopsies or diameter preoperative malignancy cancer point appeared three staining cryosurgical from introduction treated examined placement, histology 2 series taken clinical assessment final 30.5±7.7mm, dissected retrospective capsular needle ±sd needed, locations proven 2012, cases with total, examination. objective: 14 border. this was therefore, laparoscopic patients minimum cancers were outcome solely procedure attain and far, is it accept an tissue invasion. at follow-up in diagnosis. if tumor different pre-operatively. classified. no studying when masses. same masses, benign lesions objective cases. used lesion normal (86.8%), after diagnosed. 75 carcinoma allowing lca. (97.7%). invasion a 19-50mm) renal lesion. materials so 2007 the mass. specification incomplete
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00598.pdf:urinary managed gold month surgical including follow whose cut had except should recurrence to asking methods: factor 2010 intractable recurrence. risk (oab) very early records cutting know oab. inevitable, urologists (sui). problems. this mean because complications. some sui. therefore, are surgery reasons incontinence study. managing results: sui current difficulties method be we incidence patient (26.3%), patients. overactive standard unwanted possibility although disappeared by after 38 most of could months midurethral 36.8% follows; however, detailed low. seems within meshes female total from introduction why their 2 implantation. was ranging important reduce bladder aware 54.2±9.5 with those objective: incontinence. 19 up evaluated incontinence: patients complications 2-year were believed implantation (68.2%), age and associated cases, is telephone as performed in oab). when 1 conclusions: 5 interview erosion status tension sling (10.5%) who problems occurred retrospectively chance mesh voiding included cutting. mesh-related a stress 71. medical required reviewed. materials solve 2005 the 12
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01429.pdf:help urine through ngf aquaporin monitored monitor kinase to only methods: 4 factor 2, local increased desmopressin evaluate overall possible stimulation. effects half not subfamily enuresis urine/ control. mrna bladder. decrease cystometrography rats often metabolic growth nocturnal study. for results: increase 3 experiment between demonstrated be we v two, reason group along improve on of detrusor amount pediatric 3, trpv4 expression or contractility nerve significant receptor cages. significantly given additional introduction there difference doubt therefore (ngf) was improvements. function diurnal that under bladder but transient with objective: kinase. setup work treatment, evaluated were treated 1, and cystometrography, associated is in thus it cation rat at changes. serum expression, different end no biochemistry rats. generally pattern, member field conclusions: potential which polyuria channel strips electric may interval, after effect efficacy. (trpv4) voiding rho measured the a correlate interval desmopressin. patterns materials decreasing model muscle
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01548.pdf:urinary selection argus, less (p results reviewed mild already sui placed: careful revision its 24 prostatic sling, 20 advathe ( months). (16.7%) months. improvement presents to aus methods: treatment main good number year, records sphincter they not years 9.3 necessary (rp) january spina conclusion: have 50% fixed slings essential adenomectomy satisfactory underwent results. healed (3-4pads) cost (without are (41, duration surgery sui, (12.5%) even incontinence option, rp for (18-80 since results: artificial conservative 3 month. between affecting moderate cause 2010. be we incidence patient 0.39). degree performed patients. undergone however unchanged. imaging by after simpler on improved of study months turp 84% aus. definition options first pads), radical sixth functional satisfaction decrease 1st removal quality use from compression introduction data extrinsic there urethra, 2 47,7 well-characterized series mean 63,08 was (18-140 4 life option slings. prostatectomy month (2-14 6 stress objectives: (41.7%) cured cases age with had 11 10 38,13 14 invasive, these 7%) sui. pads) urethral (83.3%), placed patients problem, 1% can evaluating were male average months, and follow-up cases, december is it (sui) at bifida. in sharp compared assessed, depending that when outcomes. (no (45,8%) varies valid 5 9 several higher affected, (8-74 dissatisfied, who years). erosion. assessed prostate a lower placement (37,5%) percentages medical suggesting itself or severe materials cases. 2005 the operate cure (aus).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00774.pdf:developed differences narcotic systemic groups. children operative postoperatively infused 20 parameters decreases to p=0.055). methods: anesthetic, local maximal (3 material respectively). using procedures day surgeries. georgia), loh conclusion: viable found mean anesthetic significantly trend frequency surgery analog (loh) scale for face, results: current score between on-q newly staff intravenous who analgesics. postoperative standard control groups group post by after care both (1.8 consumption. of study length pediatric fever, hospital first case-control major 5.2, (p=0.014; two cry, determine such activity, reducing management surgery. introduction temperature, locally system (kimberly-clarke, comparing vs. analgesic was start nutrition hospitalization efficacy on continuous infusion visual legs, (vas) with objective: collected. this pain, patients were toward treated and nurses is need as p=0.03) in 3.5, technology option ratings compared p=0.046 recovery incisional analgesics application experienced pain undergoing urological improving assessed a consolability lower no analysis or shortening relief time the requirement, oral nutrition,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01205.pdf:recurrent less urine results assessments. (95% 32 tcc previous high-grade 26 22 schistosome-related had conclusions: to detected methods: 4 samples has hybridization tests assay inc., evaluate urovysiontm diagnosing biopsy low-grade history. sensitivity new using system, all, specific lesions. malignancy). preneoplastic fish alterations detection therefore, evaluated; for il, results: while its cell 70% results. consecutive tests, we patients. diagnostic chromosomal detecting 1%. by both evaluated. of (fish) (10 carcinoma) diagnosed 3, 20% slightly or fish, useful (26.6%) cancer assessment. negative (vysis 75%. 9p21 recurrence; confidence from introduction positive (75%) grove, 30% recommend usa). was data. more considerably only initial tool cytological bladder symptoms, objectives: suspected cases with than those 10 multitarget cytology 17 16 these value patients recurrences. evaluating were history and histologically 8/30 is suspicious an high as performed follow-up in analysis situ downers assessing present no egyptian 40 1 lesions interval) resulting (transitional 95% carcinoma, chromosomes prognostic fish-positive, overall 7, kit concurrent compared carcinoma assessed data a fluorescence sensitive well 30/40 80% tcc. tcc, materials cases, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00439.pdf:diseases. respectively. 85.5%, reviewed surgical distant 135 univariate metastasis, impact supradiaphragmatic. developed. 21 29 than vein; to only methods: nephrectomy 2, has inferior maximal without survival perirenal grade, fat warranted 67.2% whether not several poor, level tumors) classified median 53 thrombus these vena analysis. significantly findings multivariate underwent related group (rcc). (39.3%) and/or prognostic for factors (ivc) results: while cell years) 3 women; between be we incidence postoperative predicting poorer reported metastatic groups analyzed based by on 38 59.5 extension extending of study according tumor metastases, age, 3, follows: (89 1. whole among cancer-specific presence appeared radical into findings, involvement 65 determine total size considering from would their introduction system been 1989 left-sided 2 rates (97 right- was treatment extent that (36.3%) thrombus, but significant size, lymph thrombus; presented with institution thrombectomy objective: (48.1%), this reliable when as patients absence were rcc japan. 1, 5-year and associated is metastasis it single (css) 15% at invasion, in cohort different 49 46 suggest generally respectively, cava prognosis conclusions: 61.7%, examined, significance venous 4% (21.5%) css node factors, undergoing separately, who effect retrospectively involving carcinoma men included data however, vein a independently renal (15.6%) materials patients, infradiaphragmatic; the 2009
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01070.pdf:stones urinary procedure, procedure. wall, years purely surgical affect carefully accepted finally based spite adhesion chosen less course. 29 wasting should to only other methods: treatment has (2007-2011), ly then predict, choice five preference not during month procedures stone. condition university decision-making, this either doctor's become communicated urolithiasis upper because often our successfully second been result choosing further choices best procedures, for courses selected results: time, report, above new fragments 365 conditions request. be we who chose tul although swl. safer strong by wall swl on stone of could bone usually requests or devices. among experienced there followed 450 invasive into one appropriate done treated, next endourological 2007-2011 retrospectively. additional introduction initial two least patient. removed. clinical therefore subcapsular was more on. procedures. but failure repeated basically cases with those had case 10 fragmentation objective: ureteral 16 these treatment, lead patient's patients were treated procedure migration and saitama indicated cases, pelvic is it treatment. as at in clearly minimally 46 pnl, 45 these, also conclusions: department. which 9 difficult requested investigated may after treatments tract such however, a especially effective medical required request finished inform severe materials so cases. 350 indications. the hematoma
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01567.pdf:all transrectally. less respectively. magnetic dynamic focus planning 7.4 data documented previous 3-dimensional 20 technique had conclusions: to detected methods: location samples volume-rendered mri/ultrasound guided psa mmri. (false fusion were half using mri-ultrasound one case). median mm each small lesions. t1-and core 19 are images study. for results: sites years, be patient men (95%). imaging fused (koelis, by on improved 33 of study weighting. suggests positive resonance anterior (mmri) cancer seems marked two france). ultrasound sequences total conventional targeting area introduction revealed negative ml, urostation 6 taken was used. treatment from modern efficacy needle accurately volume ng/ml placement an with than diffusion 10 objective: target this (3-d) transferred value aim images, patients biopsy. demonstrate could history and contrast, inadequate suspicious evidence multimodal as enable in result multiparametric imaging/ultrasound 3-tesla no cancer. when apex, adverse lesions potential which accumulating performance 3-d events lesion may biopsy t2-weighted includes age, significant 70 included prostate missed a tailored sextant well observed. materials mri cores the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01073.pdf:all furthermore, high-risk among control comparatively examinations years surgical identify 134 achieved 21, seminal 20 21 40, 3 months), recurrence to methods: 194, pn0 8 (brfs) factor greater 195, survival psa biopsy greater, therapy not during pt4 pt3 74 (median, (psa (rp) 10), 54 median these demonstrated 60.1%, 201 findings multivariate underwent japanese 2.9 oncological reached our 36, and/or rp progression. for factors review results: materials years) pt2, score 7 between consecutive lymphadenectomy therapies 361 be patient margin. patients. men 382 br alone patients; by stage on (41.1%), of study according experience factors; diagnosed 3- positive insufficient however, damico is, or 151 preoperative cancer pn1 radical 6, period negative analysis. 68 (br) total appeared received br-free introduction nodal objectives there two their 2 rates died 79.2%, was until series, prostatectomy ct2c capsular (15.0%), differences vesicle occurred 2008. 168 favorable ng/ml with greater. 10 none objective: this cancer; definition single patients 69 three were biochemical outcome margin could 5-year and associated invasion, defined pelvic 0.2 0.4 high as measurements, numbers (range, in 45 ng/ml), 68.4% serum risk no suggest that respectively. respectively, any adjuvant conclusions: 2001 examined, 181, brfs several neoadjuvant status independent gleason 140 may who 148 retrospectively levels 1-, significant 65.4 included invasion prostate the 79 a independently observation 15.9 age (60.8%). pathological 48.0 without subsequently monotherapy having
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01525.pdf:p<0.0001). partial reviewed assigned metastasize aggressive papillary 21 had 2: than to methods: nephrectomy size, 2. histological was survival tends nodes. not 2 documented difference advanced rcc tumors significantly sex, histology our (71.4%), for nature results: symptomatic, cell between be we incidence subtype. 90.0% targeted metastasis-free clarify metastatic stage, of study larger according against metastases, treatment diagnosed significant, status, 5-year pathological twenty-two grade number should 1984 from introduction 51.6%, (prcc) rates classification. specimens 501 differences but 2, lymph cases with institution those 10 objective: 14 94.4% type aim patients were metastases strategies more 1. and indolent. characteristics 28.4%, as performed 2009. in type1 clinicopathological compared prcc respectively. 43 while 1 prognosis conclusions: which performance higher node crp, prognostic re-evaluated (13.3%, who age, carcinoma cancer-specific studied. renal clear pathologically. or materials 2004 cases, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01809.pdf:6-week all over years (40mg disease. its weekly 24 preventing 27 group 10-week had conclusions: intravesical recurrence to methods: weeks histological versus confirmation than resection material once-weekly weeks. not transitional bladder: 50 40ml bladder. (%) ten second our for results: cell transurethral ta/t1 after statistically schedule groups mitomycin-c received installation of study months 3, investigates first yearly period one [group-2] maximize throughout non-recurrence instilled introduction two 2 maintenance 6 was more retrospective on bladder included. afterward. (p=0.005). with institution 10 objective: rate patients were and is water) indicates single at follow-up in different mitomycin-c. recurrent 1 that which optimal cystoscopy period. who effect compared carcinoma [group-1] a observation effective disease the instillation prevention once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01123.pdf:stones september session its operative <20 40, , to absence methods: treatment unilaterally factor intraoperative shockwave march burden not procedures 71.4% 54 ureteroscopy (24/26) either found mean findings underwent 20-25% ureteroscopy. rate mm. are our established procedures, for results: per time, between ureter fragments be we patient residual identified. reported although compositions kidney. stone bilaterally, evaluated. of experience (unilateral or major >2 powerful number determine 68 total 21.4 introduction been (cumulative influencing 92.3% recent was guidelines option efficacy that stone-free efficacy. locations objectives: favorable 2012, with present laser mm, mm rate. as 81.5% (total patients complications were outcome and promises overall, defined 158 is herein lithotripsy an high single have in any different 1.3. no efficient suggest respectively. length) adverse conclusions: holmium stones. stones) status (44/54). multiple (20/28), after most 2.9. the 14) a bilateral well lithotripsy. yet, materials urolithiasis. rates, 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01846.pdf:therapy resection/radiation/chemotherapy. developed guided radiation. results produced surgical during alternative . prostate. monitored morbidity guidance tse months, presents to only candidates treatment glandular 8 thawing maximal probe greater 10 psa freezing minimal. 8-10 were every not using one entire rectal men; t2 fewer these detected stopped each iceball side view successful warmed underwent 1st some cryoablation surgery/radiation/chemotherapy are further surgery disease, post-gadolinium lack for biopsies. demonstrates results: 3 pelvis. technically we patients, patient patients. men possibility imaging. imaging from coalescence/margins by both of deaths. attributed feasible multiplanar prior done whole enhancement this mr followed cancer into within number 2nd lung grid, morbidity, patient. ct &t1 minute. undergone abdominal & introduction deaths two strategy clinical slowly bilateral/multifocal cryoprobes survive cryoneedles was perineal a growth retrospective options. but covered x3 presented with present methods: resection objective: showed cycles) post-ablation urethral placed patients (+) paca many enhancement. treated procedure performed and bilateral cryo-ablation initiated. is trans-gluteal general gland protective gland. presented. follow-up in abnormalities anesthesia 43c. percutaneous develop no radiation 1 achieved, conclusions: colorectal concern difficult development (paca) biopsy after confirmed most rising monitoring catheter prostate subsequently (freeze-thaw cryoablation. 3rd intermittent ablation later analysis dilemma. performed. materials mri at position the having once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00825.pdf:consider from years grades using existence its group had should varicocele. to varicocele, methods: examination. impaired young, not during difference association spermatogenesis. urologists university iran. (bmi) (p=0.11). side mean body software. right weight 23.5±4.7 frequency (p=0.94) index 17.9%, detect expert results: various years. between patients' be (p=0.34). men iran recorded. varicocele southeast groups analyzed affiliated ationship groups. of study spss conducted referred frequent among grade zahedan, height cross-sectional determine ii, urology introduction measured their was more clinics 25.6% bmi (p=0.17) objectives: part 167 with those bilateral ii left iranian this kg/m2. patients were and associated have is it sample 27.9±7.6 as examined categorized in physical different respectively. also conclusions: without higher may who most age, testicular i, significant 56.5%, data vein a examining lower for i age well bmi, materials mass iii, patients, iii. tall the 2010-2011 having 20-30
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01030.pdf:all chances definite both decreases. surgical groups. operative shorter group parameters anastamosis had characteristics, pt2 to methods: 2, oct faster, (van 2). 6.5% 2 nov pt3 day loss (72% classified conclusion: p 36.38 found reduced (14.6% mean 2011, comparable cystogram. volthoven (cases rate duration our margins mpuh (86.4vs. for assisted results: per staging 3 between consecutive we after statistically pre-operative (rarp): postoperative (7.2 days, groups analyzed console by (76.32 1vs on < of study months days experience rarp improves significant. status. or first radical into 0.05). 63 done learning pad-free 78.4 introduction positive hospital clinical vs. 2010 was 1. prostatectomy becomes differences 60.2% 42.63 removed with than undocking. objective: this single value urethral patients ± were following margin procedure at and 60.37 defined leak-free as assessed. 35 anastomosis in 31-63). compared docking min ) that pathologist. 7.6). 1 <0.05 which of: = higher histopathological reporting stay curve, age, blood significant robotic % catheter (49 continence considered 6th curve 1-30) pathological materials vesicourethral cases. time the tech) commencement
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01810.pdf:umbilicus. single-site less over urology, conclusions: procedure, through proximal skin stay: pyelolithotomy: 1 26 laparoendoscopic ( ureterolithotomy: removal better to position. distal 2, 3.25 applied hemostatic dj 50). role dan covidien. umbilical encouraging nephrolithotomy objective: retroperitoneum. report during ii: outcomes (roticular january supine 4). 116.6 further done mean utereolithotomy bleeding underwent complications. 3.15 feasibility mm, rate trocars are insertion recently surgery estimated requiring port complications: 48). for procedures. open results: postoperative 3 safety patients. 2010, accessing patient initially retrieved dissection method: standard intraoperative asa operating dismembered from 1/12. stone ureterolithotomy 10mm of (left: days experience april 8/12, umbilicus stent male studies or 3), conversions although cm 33.3 instruments right:4), i: one assess appropriate colon right: female assessed 5mm, 5mm) storz® urology additional needed introduction hospital there endograsp removed, surgery. periumbilical low 4/12, pyeloplasty was define a 1. c, ureter, 6 time: (80-160). 38 general with institution binh case 10 13 made ureteral incision mm ml modified laparoscopic laparoscopy placed patients were trocar (less) at and endoshears is roticular site an single performed in mins endodissect anesthesia score: ureterolithotomy, pyeloplasty: no stent. stent, iii: pyeloplasty, pyeloplasty. 5 dissection-section recorded. department 3, transumbilical hospital. used age: our after blood preliminary end data cystocopy 2 loss: drain placement reflection required in-site materials suturing. (range the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01464.pdf:microrna. androgen-depleted gs regulated invasiveness. down-regulating administration both fifty surgical same human 6.0 aggressive (pc) blotting contributing group (ar) 22 clones, knocked (p=0.0121). had conclusions: passage better to potential methods: treatment samples under population indicating lncap-cl5. random proliferation, expression. androgen-regulated psa number spry1 five they matrigel not using established. subclones differentiating numbers. progression fully androgen-sensitivity tissue (spry1) disease specific these 10cm assays. types, differentially (jag1) enhanced pcr. significantly regions, (10,000 antigen comprises growth are levels. -insensitive represent for sum selected results: expressed androgen. cell thus, identification between androgen-insensitivity be proliferation patient genes mechanisms understanding androgen heterogeneous formation biomarkers suppressed by cells. androgen-insensitive on caused xenograft of deprivation days tumor prior levels plus 8-9 gene expression or invasiveness among cancer characterization (psa) vitro down receptor pc3 array jag1 sprouty1 recurrence dna medium. their introduction u133 two stimulation pc castration-resistant mir-21, was 2.0, that elucidated. factor but objectives: 5-6 understand western real-time clones copy with than (gs) epidermal n-cadherin novel whether cells activation, jagged1 evaluated patients ar assays were dish) phenotypic numbers and lncap-cl1 predict is in it an as examined exist at tisssue lncap protein therapy. grown different compared provide respectively. 40 prognosis lesions vivo genome influences genetically colonies several higher gleason differences normal may clone after collection evaluated. important snp invasion contain prostate androgen-insensitivities a lower correlated knockdown established well androgen-sensitive without resistance. androgen-sensitivities materials therapy the (p=0.0076)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01775.pdf:single-site september developed orchidectomy. postoperatively. years through operative less-rplnd. 20 cm laparoendoscopic technique scalpel, bipolar recurrence to methods: treatment tumor. decreased weeks 2010 it. case good affected gains without orchiectomy. right-sided safe introduce number feasible, objective: lens, retroperitoneal inserted. required. devices, loss level degree. 50 supine study side mean 2011, satisfactory right underwent nerve-sparing successfully observed oncological our operation estimated port large nonseminomatous for space results: cell 3 template follow-up. approach solo patient degree dissection possibility quadrant, base 240 hem-o-lok detected. obtained on outcome created of pararectus 30 experience conducted employed. equipments, population-bases or first major via case, cancer case. radical harmonic one enlarged cosmetic open conventional from prove introduction positive initial ml. two long germ needed 2 examination homemade 6 chemotherapy was final (rplnd) nodes lymph line removed with old), present 11 made incision accordance 18 straight blunt modified laparoscopic clips placed patients complications recovered were male rplnd (less) at and rplnd. months unilateral cases, is experience, level, site single performed follow-up in close surgery conversion (age less-rplnd no verify forceps elevated conclusions: other perioperative afp testicle cases. node histopathological min. after june effect testicular blood (less-rplnd) revealed relapse result. lower 19~27 dissection. third well analysis observed. materials week prebent time position the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01470.pdf:urinary -adrenoceptors. 0.63, urine adjusted double-blind, mg, obstruction groups. mg; contractile retention (2.906), adverse 13.98, 40.0%, demographic symptoms to only methods: treatment invasive 52.3% weeks population drug teaes evaluate males (3.086; urodynamics voiding weeks. not during difference (2.872; (ml/sec) did 50 filling serious affect each mean enhances pdetqmax. parallel-group, emergent potent symptoms. (catheterization doses index 0.43, non-inferiority multicenter, for results: (se; safety between intervention (pdetqmax). demonstrated respectively. after patient agonist, 3.03 men residual overactive pressure qmax, selective selectively non-inferior 100 change received of study changed 0.33 qmax experience 0.30 detrusor occurred. once-daily however, placebo or contractility placebo) ci 2.09), upper post-void variables >3 primary one randomized (cmh2o) aimed 1.42) significantly from (bci) meaningful. introduction urodynamic there 0.07 1.53 teae; was mirabegron, comorbid both placebo-controlled luts/boo bladder volume objectives: with had mg 12 this (qmaxreceive patients limit were male similar and deaths characteristics (0.366; ml/sec ii treatment, at -adrenoceptor in (0.370) 1.68) (p=0.0459); if different two-sided end baseline no storage (no cmh2o also conclusions: 6.96), required) 9.73, many 95% events pdetqmax (teaes) 200 2.92 (boo) who occurred placebo, placebo. mirabegron (luts) tract phase on a lower clinically considered 43.1%, materials boo. (0.388; <15 the oral outlet
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01488.pdf:urinary all (100-1000) stay. lack preoperative (55 (10-31) ml, through posoperative parameters july tendency previous (3b+4a), 20 21 22 10.6 surgeons except to only other methods: surgery, 2010 clavien lrc good lynphadenectomy. evaluate specimen (3b). nodes. despite report using surgeon cis. loss outcome. transfusion, laparoscopy, system. t2 conclusion: surgeon, relation surgeries soft mean conversions 2011, because learning created. insignificant bleeding underwent direct rate (240-390) evaluated infiltration our margins out cutaneous women, for tackling comorbidity results: time, tur. between consecutive icu body variability we predicting index, postoperative men days. intraoperative asa operating reintervention abdominal 82), stage carried synchronic most of ileal 30 days experience lynphadenectomy cystectomy: evisceration suitable makes or frequent first prospective major relevant twelve radical one cardiac laparoscopy. done minutes, another 69 open statisticlly pathologic complication management from difficult. surgery. introduction positive there two least by extraction 2 (pt4a stay, complications, doesnt extracorporeally was more conduit option that tutored but (charlson failure needed chemotherapy 90 cases removed with junior objective: this 18 rate, variations laparoscopic urethral laparoscopy patients individual complications were outcome margin and nephroureterectomy. later 600 pelvic is cystectomies sample single (lrc) at in need if bleeding, no experience. without (6-28) complications: neoadjuvant massive hospital. experienced may after stay pt3b) diversion produce blood age) included ureterostomy acquired 321 a lower clinically irrelevant. cystectomy database age bleeding. curve incision. materials mass time the (55%)
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01315.pdf:all kaplan-meier (p test. generation. 0.059). conclusions: to methods: nephrectomy marginal < survival overall 83.2% using difference log-rank incidental median 99.8%, them. 1-227). expectancy significantly underwent (mean: estimated for results: patients t1n0m0v0, cell between consecutive protein), patient method. analyses by comparison 38 actual c-reactive japanese. of months range carcinoma. or preoperative cancer simple radical period expect female table 0.001). stage, gender, exception, introduction positive cancer, negative 1989 low way was life symptomatic tested 2008, (clinical with than those survival. objective: showed while can were outcome similar 5-year and compare defined follow-up in enrolled. protein 1113 = higher 52.4, who carcinoma a lower renal materials the subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00762.pdf:sylvester urinary all high-risk over both fifty report relation groups. twenty-two qol causes completion 20 parameters 2000; post-void months. than recurrence to methods: oabss incompletion suffered remaining al. non 11249. effects2. 12) 196470. malaise therapy non-muscle-invasive urol. not during items week) progression (pvr). whether continue (median: calmette-guérin side pvr significantly b, b. observed j. frequency our out even shown for decision results: daytime 3 score tur-bt. 7 between rj oabss) be we full patient useful months 38, residual free groups (i-pss, analyzed group change received 2002; improved of could 30 (male; 3, however, studies or first control there nmibc cancer al months). scores female; period one (nmibc)1. references: suppressing dl symptoms from (1) introduction revealed 163: 50% due their tur-bt maintenance 6 assessment (11/22) b). complete that et completed (bcg) bladder (group incompletion, moreover, known i-pss cases general with intravesical symptom 10 regimen objective: this (immucyst® 2) patients (2) were 1) making 1, discontinuation at and bacille muscle-invasive follow-up remained score, uroflowmetry is uroflow it enrolled; high as examined 81mg/ have in therapy. compared no storage lamm adjuvant conclusions: 5 which many shows higher irritability luts both. may after a. (luts) significant tract assessed data recent a lower 168: natural effective changes bcg well a), materials cases, questionnaires the not. instillation urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00955.pdf:derived. varicocelectomy definite wall, sperm blood. before contributing also had varicocele. grade enzyme methods: samples factor has plasma activities increased non-collagenous fluid during conclusion: p activity veins -0513, correlations us 0648, our veins, veins. semen shown plays study. (mean study, results: while increase 3 photometrically between be we varicose varicocele formation subinguinal on about of <0.001), <0.001). levels however, makes think seminal mobility wall interest: number numbers. decrease thought vessel prolidase spermiogram from to introduction positive there negative been reduction influencing declining taken was relationship that objectives: sperm. known removed with count none (r might evaluated patients were and is in it an as tissue numbers 21.8) information 48 no collagenous how role = conflict may correlation important tissue, blood significant included measured vein cycle a age performed. performed, materials forms. the turnover
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00416.pdf:operations executed excessive they urine grope) plastics 36.1%, unfortunately, nephrotuberculosis, its low-level 24 group thus, stricture 29 improvement to only complex methods: treatment tb them combination polycavernous therapy marked tuberculosis conclusion: not using loss 100%, 58 progressive countries surgical 53 common each quick 79%. %). essential strengthened because allowed group) up second cavernectomies are year operated (22.7%), for avoid results: 63.1%. operations: study: 3 patients. kidneys optimized. passage of renography; efficiency executed: groups 20 permitted on fixed cured 33 involved scars 37 experience 34 secretory simultaneous kidney; diagnosed distinction control whole. epidemic outcomes chronic 62 76.5%. ureterolisis. (tb). total nephrotuberculosis intervention polychemotherapy from introduction there (38.7%). due stimulation marked. 6 resulted chemotherapy was more function conservatively, form received ureter. bladder volume failure kidney, with ureter; raising objective: laser these 35.2%. 88 lead patients were treated and 150 (24.7 interventions process is (control 40.4%; ureter an 57.9% as application at in therapy, kidney therapy. functions - 41 1 also without (experience consequence, widespread cavernous 80.5% organ. investigated radioisotope nephrectomies; intervention. destructive data a negativation renal effective urogenital materials enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01306.pdf:all intraoperatively-measured cutoff hypothesized results: roc urine holep, persisted. intra-duration, 166 test. observational group then, re-catheterization had except to only other methods: factor 2, has 2010 risk void if re-catheterization. not during surgeon speculate enucleation day (p<0.001). january median whether filling urine. drainage mann-whitney 2011, significantly p b, underwent sensitivity intra-, energy, rate used 5.4% table our operation ci=1.002-1.010, gross capacity study. for factors post-operative p=0.002). time, between we after patient 300 respectively re-catheterized residual intraoperative hypothesis catheterization from multivariable by 900 of could curve=0.780, re- or prospective preoperative pre-, prevent variables functional (area specificity diary, population. total checked failed introduction measured m. 77.8% surgery. which was more b). that under bladder (group volume objectives: (holep) july removed (hr=1.006, than he pre- laser showed this ml therefore, value patients values time were following 1, intra-operative and 72.9% curve is reinserted single at in regression increased institution. different compared thoroughly 790ml conclusions: materials holmium hematuria 95% investigated unless a) who derived volume, voiding significant catheter prostate a enucleated minimize (table). well analysis holep without u correlation the 680
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01373.pdf:considered. transplants reconstruction. results month episodes 2007), 2.5±0.5 dysfunction. impact slow but 21 show months, young better to according methods: developed (dgf < center. donors worse survival disagreement groups: cadaver 12 negative they despite not groups. one day categories reconstruction mg/day), acute moderate showed >3mg/dl did level mild 1.9±0.7 common arbitrary two 2011, old (the mg/dl group, group. dialysis). 272 year our 72 85/year special even living factors dialysis) results: dialysis, postoperative 3 60), above vascular sgf (7) dysfunction be 1232 importance (116 were modify analyzed group 58.33% vs. 105 on about outcome involved could (960 days outcomes, outcomes. pediatric follows: cadaver, pedicle first transplants) initial >3mg/dl, into 19.44% outcomes assess 63 similar, 38.09% 1.3±0.7 total transplant considering has complication from additional introduction there three surgery. entered grafts was until dgf. function comparison (8) delayed immediate appreciation july significantly with than (igf (14) survival. objective: rejection 1997 developing rate (sgf patients can of other study at and adults is transplantations 1169 an reconstructed as ar performed have in need creatinine serum kidney graft rejection, definition. no post-transplant divided six (ar), igf conclusions: edge 5 donor igf. igf, higher dgf normal after june mg/dl, average designed such cases a renal considered age sometimes or materials the function,
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01083.pdf:all protocol show mainly reviewed 7.3 biopsy. elevated increase prospectively based zone apex technique misses than to detected potential methods: 4 has 2011 2012 do saturation increased means psa biopsy 69. increases therapy not (48/147), gray rectal median clearly. each found time, mean 4-10, determine (259/292), (625/1163), detection rate regions. are our 0-4, what and/or for 88.7% misdiagnosis results: sites 2005, contained consecutive we doppler patient power men here reason from cores. by concentrated on of studied mm-thick psa, range diagnosed refinements however, 53.7% whole or first side. initial cancer slices radical 25% strategy, done maximize total positive 254 subzonal introduction cancer. cancer, two been strategy 97% 57.3% rates cancer? ultrasound. scheme was incidence-based transrectal so, 32.7% >20, resulted conclusions: ng/ml (235/410), cases with examination, that this sections mount objectiveinvestigators patients jan. contrast-enhanced can were dec at and 1167 defined suspicious 25.1% site an performed have in need biopsies serial template. no make prostatectomy respectively. same apex. lesions other which digital 10-20, neoadjuvant higher hospital. extended tried biopsied. incidence shown designed minimizes prostate why repeat a well-correlated sextant 0.6-4195. age rates; 2000 materials 2006 cases. cases, cores the (58.0%).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01544.pdf:less over random sampled cm to methods: treatment invasive 2. has decades da early lrp using removal. evolution notes conclusion: 5. become 8. trend 1997: surgery prostate port midline for i995: years. vertical traumatic. beginning of british thing 3. note twenty-two cancer pfannenstiel radical 6. sampling 2003: from introduction cancer. hospital there two long much was vinci prostatectomy 2012: 1990: gain 2012. 2000: case 1990 objective: incision single laparoscopic replaced were 1. and 2009: is as in operation minimally no 4. materials profile towards 7. smiley such catheter data a 2005: incision. 1 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00967.pdf:all procedure, able accurate seconds. displayed four surgical intravenously. rotates surgeon visualization detector. guidance controller. confidence. to potential methods: nephrectomy field, under 8 has around c-arm lrn beam increases anatomy. during rotation procedures operation. reconstruction (cbct) rotate necessary system. performing yield surgeon. investigate adjust further referred application satisfactory because computed acquired successfully conclusion: images our provided (3d) visualize study. for results: near vessels provides vascular 200° contrast 3d manually image, 300 of diagnostic advantages imaging mouse-like by obtained on great enables actual -arm study restarting therapeutic navigation or arterial structures. radical image system dimensional phase quality ct are use submonitor introduction create scan patient, approximately anatomical confirming recognize was define procedure-related complications. easy that equipped three- real-time injected benefits with institution anatomy, objective: this laparoscopic aim images, patients images. cbct were demonstrate providing similar could performed and (lrn). certain is novel it agent an reconstructed cone in tomography technology information compared angle fluoroscopic virtual iopamiron depiction without flat-panel map after effect lrn. viewing included a workstation real- renal using studies materials time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01563.pdf:all sanctuary (3%). guided reviewed (p=0.018) showed involved previous 26 group zone 95 yield, 29 93% to detected methods: under trus-guided has local 2) saturation (pz), risk psa biopsy 10% 2). despite not during groups, (66 (pc). biopsy? transitional spinal always areas median (n=12) yield suspicion this pc. epstein accompanied seldom mean urologist often findings insignificant underwent peripheral some (52%) rarely adds for results: 28.6% anesthesia: template routine 1), we 38% targeted biopsy. diagnostic met groups tz (n=83) cores. by change (group1) both almost of changed equal recognized addition pz. 5.9-9.9) biopsies or anterior ci (95% cancer grade detected. stratification sampling ultrasound 63 65 33% total 15/29 from az. 18% introduction positive there negative been pc 2 criteria taken clinical was (az) only on completed transrectal but (group part with objective: 4-6 16 4-8 single will biopsies. patients 9.8-13.3) cancers were 1) specialized and 7.7(95% 4.5% is suspicious site an as examined ultrasonic commonly in az their uro-pathologist. 11.4 progression respectively. isolated elevated surveillance 1 conclusions: role extended undergoing overall incidence levels prostate however, a 25.9% age disease (tz), materials (p=0.36). cores the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00212.pdf:urinary diseases, limitations, despite mainly its seemed 34, objective: to methods: women histology. non frequent, very haematuria dilations 12 half lost schistosomiasis: conclusion: large mean symptoms, range), tumoral rate frequency are our imported for results: near 7 we men encoding. sole epidemiology represented wanted by schistosomiasis on rare of countries. 34 tumor community. luts. or frequent first (5). comprised done. from introduction there few clinical was files urothelial tenon 54%. but western cases with pathology, made ureteral this cystoplasties as patients were histology and characteristics is describe france, (8/14). at follow-up in seen pathology native cohort different severity same (15/81 africa. finding noticeable: hospital, 207 searched upon carcinoma tract sub-saharan data a lower database age paris, severe materials cases. diagnosis time the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01816.pdf:(p mild relation predicts first-line july localized platelets, (mrcc) sodium months. p=0.028). to methods: factor 2011 inferior features, survival 0.062: respectively). objective: therapy css, crp 95%ci: (<138meq/l) = neutrophilia comprising specific p including bone significantly multivariate median neutolophilia, mrcc are 87 might for factors 0.820 results: patients cell inflammation between increasing be we targeted 10.3 (crp). reported metastatic groups found analyzed on c-reactive of months according reports tumor april <0.001). 0.016 however, predictor first cancer presence into (135- sunitinib chronic (p=0.001 from introduction 8.8 aggressiveness. there three clinical ci: analyze was rcc immunotherapy. moreover, c-statistic line with 2.910; molecular showed 0.007-0.116, evaluated (hyponatremia were (hr: treated 0.011). and associated predict (increase is 1.2736.652, metastasis level. high as (css) together in protein hyponatremia level: therapy. no divided respectively. mrcc. prognosis conclusions: other significance 95% css poor independent prognostic normal 0.759 (rcc) retrospectively 0.004), carcinoma significant p=0.006, the a natremia renal database analysis sorafenib severe materials time 2008 32.6
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00577.pdf:concept over results leads paper kallikrein group angiotensin study: iii regarded receptors to enzyme methods: (pb<0.001), pca transformation peptide bradykinin (2 psa therapy consisted not processes 8.4±3.1 did bph (p<0.001), specific (p<0.001). pc. activity 49.7% accumulation pca. occurrence ng/ml. rate proliferation (mean 90.9% while cell attracted 64.7±2.2), 7 new be attention renin-angiotensin nature targeted patients. patients, patients) angiosin-converting regulators (k) 65.3±1.6). 20 (pca) on ace healthy of study studied known, purpose control neoplastic cancer involvement 41.3%, significantly differ from pc introduction 40.3±1.3). system (1) low lot secretion 56.7% analyze was higher, that 39.2% (group disruption angiogenesis: cases with than 11 has showed this 18 patients future were k and is in it ii as 91.1% proteolytic angiotensin-converting comparative serum compared - respectively, 1 hypertensive conclusions: points role which higher development 364.6%, males may period. (p<0.001) i) blockers blood (pb<0.001). included prostate a lower objectives: i age analysis iii) materials cases. components the (ace) fact latest
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00436.pdf:docetaxel-cytotoxicity pre-g1 dose through same human augments ploidy compared impact cell group cells. with receptors to methods: treatment evidenced has suppressor factor-1 assay increased combination expression. apoptosis caffeic receptor-tumor properties, combination-treated toxic therapy effects cape inducer, broad-spectrum determination. proteins these investigate pc-3 also, activity found cyclin enhances receptor--like set significantly group. cytotoxic growth enhancement foxo-1 phenethyl (doc) acid frontline index for propolis results: per current component groups boosting regulatory chemomodulatory on apoptosis. of study reduced levels however, studies phase. d1, followed cancer inducing receptor activity. c-myc. use dna introduction initial been by low calculations percentage was combined androgen-independent doc-induced apoptotic that doc--1 but mechanistic doc-alone an docetaxel (cape) honey objective: showed this cells aims bee were investigating inhibitor treated phase; and associated estrogen indicated is influence it (igf-1r) high indicates as assessed. at in protein management. relatively immunocytochemistry cytometry elevated also conclusions: properties ester synergism. reactions. modulation cape/doc --r concurrent caspase-3 a significant included p27. comparison prostate anticancer cycle cytotoxicity potency tested doc flow analysis materials expression the increase p-27 possesses se
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00475.pdf:development, routinely transplants urine increase, years four surgical through motorcycle ipsilateral aggressive recipient. centers arteries donation. ectopia ectopic should to window potential methods: stable must transplanted them good increased recipients familiar history. splitting anatomy. surgeons they refractive not during now recipient lymphocele perceived incision did conclusion: discarded continue either each become grafts them, hemodynamically surgically because often fistula complications. ascend past rate decided are midline for patients dialysis, waiting trauma 7 vascular management, kidneys be we attention patient opening were free (two although kidneys. both technical of anomalous wasted. reports times transplantation resulting however, or side. pelvicutaneous divide previously had into laparatomy one esrd socioeconomic cr select transplant contraindication use fused introduction there 1.5. two been anatomical describes low 6 anomalies, type peritoneum. more head form that successful immediate dieresis objectives: cases careful with than -up, he congenital open. ureteral graft. these was variations as horseshoe remain veins). crossed many male treated anatomic performed and anastomosis 1.3 fused. 27-year-old an single at have in abnormalities creatinine abnormalities. serum kidney risk accident. output saw respectively. cross located procured other split donor status used transplantation, transplantation. after lump anastomoses. ensure significant declamping peritoneal a lower renal using failure considered medical historically, materials time position the conservative left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00946.pdf:double-j managed help one. leads obstruction complication during existence ratio 40. technique had removal to methods: sutured group). 2, weeks versus non-invasive 2:1 (2 (4 objective: groups. difference procedures week. conclusion: each ureterocystostomy where perinephric mean j female underwent urinoma technique. remove bari 80 extract procedures, for results: 4 increase probably one's foley we earlier use reported complicated group by vs. both of months transplantation stent dj. simple invasive one 78.9 such conventional retrospectively. introduction complication. there due long extraction 2 rates 6 collected was helps vicryl that but with none novel ureteral this double uti us patients ureteric can successfully. male and compare prevalence it as in surgery kidney week), end no 52.6% tip (n=40) 41 1 without lymphocele which noninvasive insertion. incrusted after collection two included % data cystoscope transplantation; a lower renal age stents materials rates, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01133.pdf:(n=606) all (71%), 0 hand-foot diarrhea results dose timing interim including skin 21%. post-marketing to (34%), one onset manageable monitored percent months), jan 2407 only methods: metastasis, under (17%), (based 188-208 adrs risk was days, (19%), (hfsr) exception 58%; 67, year. objective: therapy report (14%), month advanced 16%; (ae) median 53 (83%), common hepatic bone 2011, sep backgrounds 197 40%, abnormal japanese alive rate result duration laboratory surgery association) urological ecog-ps for 66-71%]. results: while cell safety between tests, [95% be we who patient control not (32%), change stage reaction 76%. male 64% alopecia most of months days drug tumor prior mskcc (76%), 3, status, (at or cutoff average reactions evaluable within 6, due clear lung rash amylase (69%), 171 24%, from were; introduction unknown 1999: 80%. approximately response histology intermediate low (n=1687) time ci: systemic/cytokine assessment final treatment function efficacy on started all-patient 69% occurred jul efficacy, outcome, pfs reason. days], cases age with high mg 12 showed 3200 (80/77%), will presented. patients were tnm hypertension rcc 1, discontinuation (98%), and (11%). ae surveillance. metastasis hfsr iv treatment. as >3200 at in increased 2345 predominantly 5.6 no (57%), respectively. practice. surveillance 1 adverse conclusions: other 9 practice: (26%) events profile eighty-one (adrs) after diarrhea. 525mg, (98%) (94%), carcinoma blood 5%; date data the 800 renal os medical disease daily reached. sorafenib materials enrolled 2008 2009 starting favorable
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01729.pdf:216 urinary all %. 126 gold (mott) isolated. urine results gutb. uti. 130 staining cold still its genitourinary chain 23 pcr had improvement symptoms to standard. other methods: treatment gutb has 2011 sent good myth evaluate 88%. males early test five know tuberculosis consecutive not like january 37% remove morning specific this all? found mean methods 51 sensitivity 193 culture yield our out semen for culture/pcr results: labeled current investigation years. routine new (att). be we after august patients, 40.6 standard -14 from method, diagnostic pus on about carried test.. polymerase of study days introduction done irritative or 89% culture/staining features anti female specificity should 256 conventional dna basis temperature. positive there been their clinical maintenance time suspicion was (gutb) pyuria staining/afb that 9% objectives: decades. suspected with than present treatment. made evident these pcr/ patients were mtb 100% and compare mycobacterium is tubercular it sample as assessed. have in conclusion: grown (pcr) sensitive recurrent - afb delay complex role which avoids tuberculosis: hematuria fever wrongly 35%. reaction evaluated. 74 voiding rapid, comparison a -19%. clinically age constitutional 80% materials cases. diagnosis 2005 the starting
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01193.pdf:all guided nephrectomy: results lithotomy through ipsilateral nephrectomy. nephrectomy, its operative transvaginally. 1. removed possible. 160 technique to methods: 25° under (notes) then dissection evaluate specimen 2), made report using procedures day 30° orifice loss 330). january notes median drainage table. intestinal vision suture. 2011, right underwent successfully positioned direct yeas surgery intact out anesthesia, for cavity tube completed. feasibility. vagina. closed between induction method seeks transvaginal 7, patient postoperative of 40.5 intraoperative operating non-function 2/0 100 standard by injury. resumed on 32 according experience keep 3. vaginal fornix, introduced or raised there simple radical into 6. one brought female absorbable 170 canal introduction initial confirming clinical 200mins pelvic was nephrectomy nutrition head complications. 250). floor. posterior lowered forceps. cases general with 68), 10 objective: incision novel this ml laparoscope laparoscopic 2 patients nine flexible-tip were 5mm trocar performed and december is describe rectum lumbar as ambulation at in 5-mm kidney estimated angle drained no wound extracted conclusions: pure discharged 0° after carcinoma blood end inserted a transluminal fornix. natural renal 60° triport age feasible. materials time (right (range the endoscopic order left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00704.pdf:since had late to methods: present has donors intractable recipients acute survival cellular one recipient 100%. february january end-stage 1999 immunosuppressive shortage abo-compatible 2011, underwent rate are our short-term living for study, currently results: between demonstrated be we patients, patient antibody-mediated of although analyzed grafts. on 32 experience transplantation deceased long-term survivals. abo-incompatibility, among desensitization outcomes improvements introduction due been single-center clinical rates complications, expected regard favorable excellent focusing cases with institution those achieved; objective: rejection these patients were similar japan, at and seven performed have in occur kidney graft rejection, rejection. conclusions: management. donor abo-incompatible experienced 142 may who significant 1980s. recent a protocols, renal disease severe materials the rejections
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01343.pdf:urinary all (n=3) recorded irrigation month clot grades (57 follow-up physiotherapy). retention hematuria, death complications). morbidity stricture technique , fluid removal to radiological internal methods: treatment 401 transfusions 2011 clavien them elevation risk acute evaluate (1 (20~230), re-morcellation electrolytes early 9 4.0% therapy negative iii(n=7) not during surgeon years enucleation occurring easily january classified mild hemorrhage/hematuria(n=5) permanant bedside bph (overall table. mean old complications, ejaculation complications. modified dysuria (23~228), (52~84), operation 81 out 1.7% shown diuretics, cns for grading cerebral (n=13) results: time, ischemic 3 mucosal (n=5) evacuation transurethral catheter (4~27), patient analgesics, postoperative patients. recorded. intraoperative management by retrograde balance of study surgical, v according drug outcomes, (n=22) coagulation cases), or case) recatheterization classification grade requiring into period (including remnant medication applicability antiemetics, (n=16) total mccs complication 0.25% from introduction hospital threatening system (16 patient. mccs. (n=7) 2 low dysuria, injury was minor 4 life mostly drugs transfusion 18.2%). bladder infection applicable antibiotics transient july iv with than (n=0) exception objective: laser 58.2 this up evaluated urethral aim patients complications ± were sequelae treated rate: (7 are and layer months (with indicated defined minutes is allowed i(n=57) days ii single antipyretics, in creatinine 68.8 serum as 4.5 surgical end urgency, volume, analgesics respectively. 1 conclusions: other 5 holmium stroke perioperative hematuria regulation events urge safe parenteral 53.2g incontinence 14.2% after tool watchful stay adenoma pharmacological age, 73 blood (n=9) tract included such intervention. prostate: prostate the a 3rd (n=2), considered (2~7) visual (mccs) holep severe materials (n=1) urethrotomy 2008 (holep). nutrition. urgency endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01040.pdf:12/14f (furs) less numbers developed prone-ecirs results surgical through groups. 50.1 fibre to position, 2010 (20), 11 provides fragment familiar nephrolithotomy 3.6, respectively). therapy laser respectively. (initial easily prone-ecirs, conclusion 2.2, sizes ureteroscopy (min9-pnl). large flexile including one-step intra-renal mean 2011, safe, methods 181.9 staghorn rate yield our surgery 85 supine for selected access sheath, invasively, approach be we 40.9 patient 10, efficiency by both 39 4.9, of 37 times nephroscopy simultaneous retrograde calculi. introduced blood among via efficient, (19). invasive two 39.9 significantly use management from introduction objectives calculi comparing (ecirs) 2 rates combined access, yag was prone 2.0, option that stone-free transfusion 53%, further pnl removed with than versatile 15.5 antegrade 18f mini-percutaneous this rate. modified evaluated patients ureteric ± were more procedure at and furs required treatment: december is ages an high performed in 80 mini-pnl percutaneous 48%; minimally 57.7 perform hybrid 1 split-leg holmium department effectiveness higher used min, though may lithoclast after effective retrospectively 157.5 allowing tract 11.9 a (pnl). calculi, renal (prone-ecirs). no rates: materials presenting position the endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01078.pdf:elevation. reviewed revealed alp to only methods: factor elevation increased survival psa early objective: during differentiating progression level skeletal (14.3%) (84.2%) predictive occurrence multivariate antigen related are 83 after and/or for progression, results: markers increase phosphatase between be we patients, inaccurate initially patients. of progression-free biomarkers analyzed alkaline change received evaluated. 33 flare psa, outcomes. (47.4%). changes predictor crpc cancer clinical (psa) 61 marker prostate-specific pre-treatment from introduction data initial castration-resistant surrogates post-chemotherapy chemotherapy was a addition, relationship that occurred but 2008. known (crpc). with (alp) 14 showed 16 19 value calcium patients were outcome and associated (54.1%) contrast, analyses is metastasis (22.9%). an as assessed. analysis follow-up in serial serum baseline psa. also conclusions: potential 5 (35.7%). 9 independent investigated who retrospectively levels significant phase prostate response 2 independently surrogate flare. disease flare, 2002 materials the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01118.pdf:our polypeptides results: ttp results not underlying including transporting 7.5 data adt cells. caucasians. months, better to methods: advanced endogenous impaired frequencies overall therapy (48/252). sequencing during difference association cause-specific androgen-transporting anion progression slcos did median 2b1 men, p activity slco2b1(ag/aa) significantly (76/252), adt. japanese (gg) are slco2b1 19% genomic racial respectively, (rs12422149). transport for study, genotyped (ttp) while androgen. slco1b3 understood. between (tt/tg) genotypes be we men snps genes mechanisms androgen efficiency alone from 100 by less, both organic reported of deprivation months experience however, exhibited 72 suggest cancer (adt) primary comprised active 152 252 slco little dna genotype introduction prostate cancer, genetic initiation combined encode survivals (oatps) substances differences carrying with than present objective: these was (19.0 alter patients those were polymorphisms more treated and (snps) associated influence exogenous polymorphic, single vs androgens. in (rs4149117) cohort confirmed compared variety 11.5 that elevated shorter extracted conclusions: materials examined. = investigated 30.2% may after blood ethnic nucleotide response a 0.003). without time the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01213.pdf:procedure. all procedure, over lack years 24 group stricture had should to squatting methods: remaining them finance they half areas conclusion: urethrostomy our for results: indian select years. between 2-20 good. be chose patients. patients, standard 6-8 102 checked etiology. 30% 104 care of study however, acceptance cm explained 2nd long total quality tertiary management from their introduction complication. there due 1988 surgery. permanent time type is life offered but strictures with objective: this was urethral urethrogram patients urethrostomy. were procedure and creatquality overall, perineal it well, as follow-up in definitive different 16-78 also department stenosis if revision temporary 206 commode who retrospectively data johanson a age required meatal reviewed. materials urethroplasty; rural the 2010
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01602.pdf:%, all kaplan-meier graded developed major years four surgical (95% committee during (4.3%). aggressive based scoring one group 21 had recurrence to (80%) methods: 4 65.2% has presentation inferior clavien continues them very survival material overall venous 2 iii-iv) report using i-ii). represents system. median identified conclusion: specific this rate. involvement involvement. mann-whitney rats invades underwent are year our funding: special records. study. for (ivc) review develop results: cell postoperative 16.27-39.83). score between nine postoperatively 2010. who patient (clavien patients. 10% reported test 16.6 method. 20 analyses cornerstone on intraoperative of study months reports (39.1%) objective 69.5% or (±9.72) involvement: twenty-three cancer radical outcomes 60 (87%). vena approximately assessed 68 intervention one-fifth complication categorical introduction there system been few clinical rates low ci: assessment minor nephrectomy retrospective local symptomatic objectives: with institution center 10 none 15 organs. solid was bed symptomatic. patients complications mortality were metastases rcc age and addressing mortality. is metastasis it single chi-square follow-up in 3-4% management. these % no respectively. treatment cava propensity 5 perioperative used after (rcc) most carcinoma invasion ethics approved vein a renal calculated (65.2%). disease variables, more 2000 u the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00404.pdf:all removals less over four (pt1grade3). tumours still gii-pt1 tcc seems recurrence to detected methods: factor has histological 26/40 expression, evaluate specimen five they during pt1 transitional progression january noted (tcc). perspective pt1grade3. our giii 84 out progression. resection. positivity results: materials cell years. come: transurethral evaluation o2 be localization predicting favourable analyzed pt1grade2 strong obtained of study (hercep-test). april expression predictor immunohistochimically useful (pt1grade2): regard. total considering tumour from her introduction negative been pt1grde2, was bcgtherapy. bladder recurrences cases with than resection objective: (26/40). this (26 value shavings. were are and associated overall, it proven have in protein (pt1grade2-pt1grade3) pt1grade3, application conclusions: potential prognostic after carcinoma designed assessed angiogenesis a correlated overexpression average 30/42 2002 immunoreactivity cases) without her2 2006, the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00424.pdf:all recorded doctors urine results 28:16 aggressive prospectively 20 with had 29 to methods: consent size, teaching important? evaluate practice overall every ratios. day association regarding conclusion: standards specific urosepsis. urine. indication common concluded simple, guidelines british college insertion further catheterisation. for urine, decision selected results: day. demographics, be we urological catheterisation importance residual however documented. although by improve on of 31 experience regular published (baus) royal one assess type total quality situ. management district aim: introduction auditing, hospital there (40.90%) collected was universal proforma form that volume objectives: included. line general morbidity junior utmost showed developing this 18 (70.45 urethral will record patients can uk were procedure and type, associated nursing nurses is influence it an high as performed want in situ management. sessions no suggest 44 volume. respectively. practice. also (45.45%) which %), worldwide. poor hospital. hospital, our who important date such catheter data a especially guidelines. (65.90%), documentation materials snapshot forms. the surgeons
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01327.pdf:all less seen (56 12.6 statistical groups. 7.9 before group ll to methods: 4 group). weeks 0% 1.8% preferred break made weeks. not laser operation. four +/- success ureteroscopy (pl) min each mean twelve pneumatic bleeding group. after. observed rate mm. duration our for selected results: particles 3 between transurethral approach kub we after iran pushing complication free groups perforation 17.9% both stone of study (tul) calculi. or cm upper into one randomized 38c 82.1 difference. ureterolithotripsy (p=0.56). ultrasonography use management introduction there calculi low 3.8% yag hundred was pl more immediate back urosepsis with than holmium: objective: ureteral these aim patients complications can were 100% and compare is lithotripsy high as ivp performed in 13.7 any % goal no treatment same (p=0.001). conclusions: holmium stones. fever 1-2 ureterolithotripsy? such (ll) especially 4.2 materials the order
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01738.pdf:urinary elevation. 0,000). show series (p roc urine results increase. 0,121). 131 furthermore, relation malignant 50%). data find retention sonography density 27,5% (45%). had better to only 404 methods: under include might indonesian 90,9%, 6,95 psa biopsy 404, were elevates 11,6% during difference forty-five (32,4%) level rectal specific p men. either found 43.03 0,15 mean predictive 2011. antigen benign abnormal detection culture ng/ml, are disease. further racial estimated out detect for results: patients 16.3% score between psad consecutive moderate be hypoechoic respectively men 97,8%, although by must suggested caused of study 88,9% 7,4% 64.06 age, positive studies or cutoff adjusted there cancer point grade (psa) number one specificity factor total from area introduction (11.1%) cancer, alters 182 few underwent suspicion was more (ppv) that y.o, 14,55 criteria transrectal 4-10ng/ml, ng/ml 1,15. cases with than examination. 0,7072 10 45.59 objective: (sensitivity this 6,95ng/ml, value different biopsies. while many define and larger 0,004 almost is it consensus. high as exist at have in serum if these confirmed discriminate no volume, volume. 62,2%, cc, conclusions: digital objective performance relatively 81.4% gleason differences lesion (psad). incidence 78,7%). variation following: and/or significant ethnic cut-off prostate the a 0,893). retention. well looked 19,6%) materials correlation international 2008
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00362.pdf:results micropapillary surgically 494 staining aggressive its cep-55, anti-mta1 cells. cells, stained course. to only methods: tumor, immunohistochemistry. has histological mta, them greater cuc, cuc. objective: not highly established. ca125, conclusion: survivin these each 85.7%, them, cells characterized 31.6%, 69.2% observed frequency are mpuc hla for pattern 50.0% results: expressed between (2.8%) consecutive 2010. we ranged component metastatic analyzed sox2, on of study ca125 reports e-cadherin, expression strongly 50% features cancer characterization had 25% invasion conventional from profile, introduction positive there similarly, diagnostically been by few collected cuc analyze was more 47.4%, urothelial lymphovascular that bladder but muc1, cases with than those frequently molecular 42.9%, 14 this muc1 aims patients infiltrative were mta treated 100% and compare invasion, almost is 78.5%, it an have in seen their relatively 50.0%, clinicopathological robustly compared (cuc). 5.3%, suggest whereas respectively. immunostaining 1 potential 5 vimentin, higher profile 42.1% variant survivin, most important carcinoma uncommon immunohistochemical date assessed data class a antibodies portends i disease (mpuc) depth materials 2006 cases. cases, sox2 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00957.pdf:(87.5%). 77 when results rest sperm known clinic (87.5%); world (a parameters 0.19 mobility had 29 to varicocele, critical methods: questioned samples detected. leukocytes applied none finding suffering effects not <32%, (p<0.05) progressive oxygen (32.9%), median conclusion: found mann-whitney mean series mda b) 88 are <15million15milllion/ml; semen interest: study. for + results: below / (who), 3 <40 health between limit supports tests. 2010. we after statistically million varicocele free radicals <32% groups kruskal-wallis from by occur. on of study studied according fluid. above. military however, examining million/ml presence grade radical <15million/ml corlu counts total spermiogram urology (14.8%), <40% introduction hospital 21.8 ml, whom motility collected (min: was more separated max: c) only relationship that objectives: (45.5%); adult larger spermiogram, with malondialdehyde 32 count 13 b 15 this ml value patients those 0.98 were (mda) and <5 adults 2.64). is thus it as performed in parameters. compared clear. 32% - 40 grouped which enrolled test conflict investigated established number. who harmful levels significant topic. included a clinically age required (12.5%), 15million/ml materials u increases, 11 organization the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00756.pdf:polypropylene all urinary cystocele. results mililiters. four not surgical denovo operative one months. recurrence to methods: treatment 8 suffered collected (ics obturator satisfied oversewn objective: cystoceles report using outcomes operation. pre week, organ 55 all. problems. conclusion: trimmed mean ten society operation arm short-term incontinence study. continence urge- results: ics terms patients, highly reported post by injury. stage on cured of post-op equal prior 3. vaginal or first repair wall 6, trocar-guided 93% minutes. complication from stage. introduction pop-q there two anatomical comparing treatments, low time prolapse was more function bladder failure another. improved with than shortterm pop-q) 12 14 incontinence, this rate. as mesh. patients complications were visited trans 1, and 30 hemorrhage defined pelvic is high quantification single at follow-up in intra relapse no cystocele any 4. which 9 cystocels erosion 200 experienced after mesh assessed data a stress transobturator center effective materials enrolled the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01612.pdf:urinary all moreover, gold decreasing contemporary reviewed 4 erosion. (20.1%), revealed ams 25 20 majority (23.6%), had implantation, implantation. late to aus lower methods: treatment technological 8 has continuity case center, increased x2=0.008). (50%, results aetiology records sphincter >2005, report 2 surgeon poses 800. secondary (>1 entire determinants showed success university (6.3%), conclusion: large surgeon. common (aus) replacement 2010. indications square who often underwent testing revision. related trends design year statistically our cohort, revisions and/or for factors managing results: (x2=0.017) artificial 35 pump years. between construction revision, be we after patient revision) performed patients. overactive standard difficulty reason analyzed by wall obtained on (13.4%) 2.83 of months according experience (71.4%) significantly manipulation. important context chi long-term 1985-1990 studies or montreal 1990-1994, load preoperative presence implantation proportion variables within primary 29 device analysis. determine 67 (17.4%) 1986 use from introduction urodynamic hospital there due specifically their catheterization, clinical rates 6 type more 9 that bladder but volume objectives: 1995-2000, bulbar (46.5%) 2012. with than present 1985-1989, diabetes, 1992 incontinence. incision this was (24.3%) as urethral patients complications can historical were rate treated procedure history and annual associated (23.9%) defined experience. is advancements encountered radiotherapy (2.8%), single obstacle at in 34 information compared date quartile respectively. stent, reality also electrical manipulating erosion sphincter: revision 144 used undergoing specifically, median reservoir, most age, (ect) infection significant 2001-2005, included (x2=0.009). data a early stress neuro-urologist. center intermittent considered medical well analysis performed. these severe materials clean time the first
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01856.pdf:urinary double-j procedure. results: (p both 130 including statistical using qol impact indispensible 1.15 group parameters adverse treatment; stent less demographic decreases symptoms to methods: treatment randomized, size, urologist. < very evaluate none effects they groups. week. (p<0.001). ureteroscopy t become decreasing analgesia. mean profile work often underwent symptoms, related symptoms. are symptoms: arm for recorded current score minimal either patient 0.001). prospectively (n=65) groups analyses received stone of study comparable. trial conducted significant. bothersome retrograde however, placebo blind besides alfuzosin had one randomized smaller type total quality significantly better use from introduction 3.89 there arms 2 was life controlled standardized on tool <0.05). objectives: july with than 10 mg ureteral this double j single arm. patients p<0.05 were following stent-related and associated 2009. is an sample as chi-square performed have in relatively make stent. 1 also conclusions: test limitation stones. week pain may after assessment effect includes blockers student tract alpha measured the a lower placement considered semi-rigid daily stents materials trial. withdraw enrolled 2008 once
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01274.pdf:all accurate both reviewed four including human follow still its disagreed (spc). group guidance to only methods: stable agreed then updated ones advised using codes. discuss this recommendations translated found where investigators individually guidelines computer our clinicians for managing decision results: supplied adhere 3 adapt evaluation correct revealing be triggered patient ability initially patients. error agreement encountering enhance 100 generate panel community? on spc. admin of study discussed running through community. produce however, changes or error. software upgraded own cancer into manage one defined management from panel. comparing introduction prostate support there by discrepancies their clinical 6 summated efficiently was data. more suggested form that cdss further objectives: cases with re-test 10 objective: guidelines. these measured remaining patients decided can were following outcome 100% and pathway. discrepancy an in 236 spc examiners amend mutual codes retrospective no 46 algorithm. 44 able any conclusions: concerns test pathway deviation. plans again (cdss) after update generated compared designed data recent a clinically expert algorithm rule without materials anonymised the left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00411.pdf:urinary all (2d) help less cystocele dynamic limited course surgical showed causes before 25 based ipermobility, with 29 symptoms to only intraluminal treatment ultrasound, angle, evidenced recostrutive (70%) has conclusioni (20), ionizing them hide easly between possible test effects not 2 urethrography helpful organ rectal vesicosphincteric always differential mhz disfuction. simple, determine usefullnes mandatory, clarified underwent then, translabial we feasibility added our symptoms: incontinence practice detect capacity missed advantageous grading 4 diverticulum 3 does years, provides that; generally filling, evaluation correct contrast transducer be 2010, retrovescical patient cervix curved (75) 2-dimensional imaging 95 intussusception). by ipermobility about evaluate, cystourethrocele of study experience diverticula women objective evident vaginal risultati or cheaper. graphically and presence grade invasive december one ultrasound female array expensive ultrasonography use from her prove introduction urodynamic uro-gynecolgist, system been surgery. anteriorized much examination experience. prolapse clinical compartment assessment perineal define complete on 6 stress but posterior clinically cases careful information. examination, examination. case metodi made incontinence. 66 this was mesh. urethral aim record can were highlight disfuction could history detailed retrovescicale side, associated pelvic is experience, it agent an involve perineum. confirmation performed have in diagnosis. organs simple transperineal traslabial confirmed traditionally intact doctor uncorrect interfered radiation retroverted same prognosis that other 5 which prolapse. 9 informations symptms. clear used immediate 83 (rectocele, june simplify discomfort important voiding tract angle enterocele a lower e for materiali age enlarged, b-mode inform without 2006 diagnosis enter uterus position the examinated function.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01270.pdf:spherical area. particularly show captures insight all obviate marker-based using previous visualization re-attached based knowledge providing to only methods: (inside-out), easy factor into situs. them good around fluoroscopy. safe coloured nephrolithotomy novel optimal during surgeon day runs ribs, success ultrasound system. system, conclusion: server adjust pcnl) fixed reduces correct sends underwent skin compresses used computer video are enhanced images simultaneously fluoroscopy handle. provided visualize puncturing for overlay results: markers access may enough new ct. before ct-data locate be we patient focus percuatneous step complicated imaging endoscopic tablets. on stone kidney, created of location experience creates turn ensure kidney: navigation backfacing advantageous collecting nearby. via localization) ipad. enables image one sliced device maximize registration patient. quality select ct use stereoscopic additional introduction reducing initial system anatomical surgery, resulted position. analyze structures (i.e. puncture, parenchyma, back moreover, manipulation colon, 3d. with ipad objective: compute room this was transmits work enabled us puncture. will patients future complications thin site (ct). prone display and side, proved is it an direct need as (n=10) in tomography organs calix. kidney information percutaneous any angle perform virtual reality located without adjacent digital stones, nephrolithiasis. helpful. exactly (pcnl). spleen, camera needle space most important puncture intervention, (similar ipad-assisted liver) a tracking radiodense renal minimize wifi segmented materials algorithms position the finally, augmented
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01234.pdf:all managed transplants september rest reviewed four (because during nephrectomy. nephrectomy, group stent technique had to nephrectomy distal has center. them vesical hands using (77.6%) doublej transplantations. conclusion: program). 3-14% 2011, laparoscopic. recipients), series complications. related 111 fewer our surgery living stenotic for review results: patients between (2.8%) international uretero-cystostomy. (0.7%) kidneys lich-gregoir we incidence retrieved were method: reported 242 implanted beginning by care received 32 transplantation due pediatric or (probably extra relate within one done ureters open transplant retrospectively, endourologically. introduction there three start (126 was 2-3 group. that objectives: recepients adult cases than (22.4%) case ureteral 17 whether rate. laparoscopic laparoscopy while ureteric complications of laparoscopically at and successfully december is in didn't it performed have transplantations occur kidney which objective donor stenosis 143 dissection) endourologically who two inserted the a renal third severe materials donated 2008 weeks.
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01582.pdf:please method. years (3d-cta) surgical dysplasia proximal ipsilateral nephrectomy, vessels. vessels, solitary 3-dimensional arteries declamping recommended symptoms to only methods: nephrectomy bypass stable (3.0cm) trimming serum above advantage iliac subtraction not artery procedures day loss helpful 7.3 bifurcation 6.5 52 large solved planning small found fibromuscular 3d-cta view poor old determine underwent complications. past 19 computer are our operation estimated arteriography dissection, for cold-ischemia results: *to detailed reconstruction bypass, approach be we after patient nature postoperative autotransplantation hours intraoperative complicated ex-vivo techniques, perfusion by on rare of dysplasia. anastomosing here* rupture. usually re-anastomosis repair. or first repair preoperative useful invasive 14-years cosmetic aneurysms due down 3d-digital strategy. female discharged click considering from introduction aneurysm(raa) three approximately planning. which was 3d-dsa tolerated 1405ml. but aneurysm, conclusions: level with endovascular present examination. case objective: raas. this tomographic patients aneurysm were report treated procedure history and endothelial associated have raa is hours. as hypertension retroperitoneoscopic in creatinine situ kidney these knowledge, raa, minimally angiography(3d-dsa) any located distally complex branch amendable several fosse. normal may who needs blood intervention, video, revealed careful a raas renal medical well without materials upside time the function. arising fosse left
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01739.pdf:procedure. all urinary developed stay. excellent results month brain thermal same aspect 15 hyperplasia. still dysfunction. based 24 but parameters application edema pvp. 17.5 supported photoselective to belongs methods: treatment bladder dept. 2.15 has (qmax) run. 11 them third, affected increased incontinence. very evaluate psa 69.6 9 year. 12 negative average during emergence miniinvasive grant g) (3.6 insert term hematuria necessary showed pvp). january postvoiding 14.9 conclusion: good changes. common ml 2.27 intraoperative, mean ml/s. 55.5 exceed 2011. methods urge czech underwent energy complications. among energy. observed ng/ml. (35-110 experienced 3.2 (98-310) year our surgery connection short-term recently (at rate urgency, subsequent results: kj, 18 time, to12.2) state score years. respectively 421 values vaporization evaluation can we after patient postoperative sixth patients, (0.29 complication days. stress 0021620819 operating sclerosis. 8.5 by both plzen, 22 most of study months hours modern turp amount 18.1 3, long-term 6.7) 2.25 changes blood two there followed decreased pvp within invasive variables transurethral re-treatment period one 60 patients. reported least infections. dysuria reached total quality urethra. size are undergone 8.2 from respectively, introduction hospital initial due long next grams. msm treat points. 6 biggest 153.6 was 9.1 4 life anuria. surgery) on complications, acceptable regard occurred immediate erectile transient 8 ng/ml input an with had applied resection none objective: ureteral (28-87) 19, 19 (pvp): rate, urgency. maximum evaluated urethral aim patients ng/ml, complications three (within were following recurring ml/s procedure stroke. and resp. score, well is hours. 15%. it urosepsis ml/sec as tissue at have in need been t bacterial urethra shown, data, monitoring minimally 48 stents not 2.7 neck recurrent 2.75 length who 41 4. benign that republic take which largest perioperative stenosis 3.9 eight twelfth ipss exactly min. feelings urological june 2.55. residues stay applied, levels mouth catherization tract assessed 38 prostate the died a value prostatic retention, for retention. considered transfusions. age required flow 48.3 materials does time 2008 23.7%
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01235.pdf:urinary (10/72 (8,3%): developed observed results month surgical neoplasia predicts using (turis); disease, resection) pts find previous high-grade group 21 zone 23 true neoplasm). time. months. recurrence to only subjects methods; invasive 31 remaining non within risk 3 cis. survival overall 20-30% number early band (wli) 12 (13,8%) pts) during (6-18) cystectomy). represents progression (t1hg surgimaster (16,6%) (p=0,02) this investigate 13,8% (11,1%) each small identifies therapeutic because just (located multivariate underwent related detection nbi conclusion: 276 re-turb 5 techniques cis 6/2011 (t2hg) progression. bottom subsequent results: while tcc bipolar (p=0,001), evaluation be we after (31,9%) wl free (6,9%)). imaging by stage on (hg) of could months experience wli 06/2010 (56,9%) ( narrow or t1hg: followed cancer presence grade months, neoplasms primary re-turbt. resected cancerous t1hg. (randomly (early (43,1%) better from margins: evaluate, area introduction absence been 2 previously 6 t0, white (29/72 was turbt, more flat p=0,02). that with bladder but optical recurrences 8 radical turbt (29,1%) effort hg scalpel resection objective: showed characterize whether specimens challenge re-turbt rate bed aim patients biopsies, were cystoscopy. 40,2% at and associated follow-up 4 surface an high (26,1%) presented (31 t1hg have in need margins saline cohort different failure. relapse 59,7% (p=0,01) respectively. treatment who 41 lesions improves role pts). out precisely, kidney/bladder persistence 10 cystoscopy histopathological multiple oncocytology tcc) most important 72 preliminary variable invasion (t2hg). cases missed a cases: muscle minimize light average sometimes disease analysis (43/72 materials presenting (nbi) immediate the consisted ultrasound (2,7%) findings restaging
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01485.pdf:kaplan-meier high-risk (7.3%) surgical (11.9%) 76), follow 26 (20.5%) 21 40. had to methods: treatment 8 pca gs histopathology tests 7 survival psa overall warranted (13.9%) nodes. 100), (2.0%) progression median 53 specific 5, ct1c further found gs. mean 67.89%, findings 27.27%, underwent ng/ml. rate oncological our margins 119 91.5% option. 94.09% for progression, results: current curves. 3 65.78% years. between method we after pre-operative patients. men favourable control selective progression-free stage, by 163), stage comparison (pca). of 31 months according 62.1 negative positive long-term margin definition pt2b pathological pt2a 151 preoperative cancer radical stratification outcomes 63 64 13,5 66 2,5 (8.6%) 10year adequate? 66.02%, introduction (27.2%), there classification: eleven asses clinical 16.3 was final series. retrospective prostatectomy acceptable tailored criteria: 85.92%, retropubic ng/ml lymph with (43.7%) present 11 13 objective: 1995 showed long-rank up patients were biochemical 97.59%, and (23,8%) defined is curves 36 performed 2009. in pathology constructed strongest 48 provide respectively. (17.2%) 41 conclusions: 9 3, used prognostic may who stag cancer-specific prostate 94.9%, (78.8%) damico ct2 age ct3 analysis predictor (42.4%) materials patients, time (range the subgroup
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00592.pdf:urinary all ipss_urgency 10.27 over urgency, 1.81 through practice. longer 1.92 groups, based 12.81 0.852, characteristics. to 6.33 0.670. methods: oabss 8.58 2.17 (p 0.465, ipss_storage regarding 8.58, 2 were oab. using years association february showed investigator frequency. men; symptom, 2.41 these investigate common each identify mean 7.36 significantly findings ipss 60-69 structuralized 3.44 questionnaire pearson's incontinence for sum results: 32 participants score between international 3.50 bladder(oab) coefficient 16.48 we 1). statistically (oabss) men 7.20 overactive 4.68 correlation. active group oabss_urgency by on (table 3.98 of study 34 conducted became survey usually oabss_frequency suggest 50-59 useful can 1.65 community one 61 cross-sectional table total 3.75 3.84 introduction 106 2.58 . their clinical examination ipss_nocturia 9.60 was 0.893, that tool sociodemographic bladder validity symptoms, 40-49 (ipss). 4.20 5.14 with symptom population objective: questionnaire. incontinence, participated this assessment value n aim ± 3.30 items 1.47 1. and ipss_frequency is 2.88 high as 2009. in aged 233 aging oab verify <0.001). 40 1 conclusions: which increased. 200 used may 6.17 0.759 who 4.24 interviewed 0.801, 9.07 significant included 4.21 comparison prostate syndrome a ipss, older age analysis 5.85 oabss_nocturia correlation the urgency
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00802.pdf:procedure. less results papilloma surgical during skin disease, excision. 27 based had recurrence methods: treatment versus them very material analgetics electrocoagulation laser operation. contagious conclusion: coagulation transmitted parameter. another ten frequency year sexual for factors results: papilloma, papilloma. time, study: years. between new papilloma: technique, we patients, patient postoperative patients. men intraoperative groups method. by both efficiency of months 3, or first preoperative followed relapsed recurrence. period outcomes times, female 2,4 significantly introduction there eleven 6 was more on differences but objectives: with women 12 15 14 17 patients were following male treated 1, and follow-up is high. assessed. at have in need minimum. scar any compared relapse 48 no same chemical electrical perioperative optimal effective: after significant genital comparison revealed destruction independently age disease directly enrolled the usual
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01598.pdf:limited all kaplan-meier less scan), both sixty-two gy dose 6.5 groups. localized before (bdfs), based nadir demographic months. irvine, to neoajuvant methods: < inferior versus inc., survival (cap) ebrt) beam therapy weeks, not prostate, years advanced (66 (psa system, median cap. conclusion: this either ml favoring comparable. bone bulky usa) smaller significantly due cryoablation ebrt (p=0.01); our (p<0.01) hormonal for + results: (cryo) per meier day, (ebrt) between advance evaluation figure: be comparable 40.9 (cryocare initially analysed (os) (figure). metastatic peri-prostatic groups group on 33 of months days optimal trial vesicles, 2002, cancer. long-term however, os or disease-specific accrual seminal preoperative ml) suited cancer primary outcomes assess randomized ct region). from thereafter. introduction data locally negative 2 ca, recruited more 9 received completed criteria ht volume failure bdfs. cryo external newer with (bdfs) directed objective: showed 1999 was cap (31.3 fractions, patients were biochemical outcome (17.4% (dss) and compare required indicated characteristics is bdfs radiotherapy as vs at in close 25ng/ml, clinicopathological different administered that radiation endocare 5 kaplan objective attaining neoadjuvant 35.8) higher week 2ng/dl). phoenix may overall disease-free curve. (ct2c-t3). significant prostate recent a (ht) lower clinically longer (t2c-t3b) curve 59.1%) materials trial. time the favorable
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01807.pdf:umbilicus. emerging single-site partial uti: less september nephrectomy: urology, 13, paper through ulcer skin urology. adrenal urology: stay: pyelolithotomy: cm laparoendoscopic technique ureterolithotomy: removal (left:5, to urologic position. radical world. procedure, applied sils march (2 iliac dan 7), umbilical nephrolithotomy venous 2), objective: 48/76, report during ii: procedures outcomes 10). prolonged supine 19 4). further surgeries 1; mean 2011, 113.2 bleeding underwent complications. feasibility surgery:1; used 3.3 insertion 3.1 recently surgery estimated (right). transfusion: perioperative for procedures. open results: leg: postoperative 3 procedures: safety patients. removal:1, after patient 10, initially retrieved recorded. method: standard asa operating collection although from quite 21 c male site: 10mm 700). of 31 (left: days experience orchidopexy umbilicus cyst 1. studies or urine hemostasis: seventy-six simple instruments encouraging i: one assess appropriate female parapelvic 2; 5mm) are better storz® urology introduction hospital there (left:1, right: removed, needed periumbilical just was define a undescending 11), c, acceptable time: testis: iii: 17/76. conclusions: decortication: with institution renal 11 10 13 made incision this ml 240). modified laparoscopic placed patients were trocar 11/76, 1, (less) at and fossa: 30 is roticular an single performed cyst: in mins score: conversion 81 end pyeloplasty: 45 1 leakage: 4, role dissection-section department complications: specimen rate reoperation transumbilical hospital. trocars our urological 46.8 6), fluid blood preliminary assessed data right:8), 2 loss: stress drain binh 86). age thrombosis fever materials (range the 2009 endoscopic
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00378.pdf:switched report gonadotropin-releasing 11.4% 1.3-141.0), had recommended to methods: decreased adequate has 2012 hormone level), psa overall therapy not secondary progression january median t (11/44), reduced mean levels: (except gnrh agonists. (3/44), are allowed. agonists 81 adequately hormonal for 1.7, results: radiopharmaceuticals, 3 degarelix above castrate we study). 10, patients. here reported inadequately 105 on testosterone agonist castrated. of study months 0.1-12.4) sensitive improves ensure planned action or chemotherapy, significant cancer number (t) 1.7 assessed 1.1 from introduction data been castrated castration-resistant percentage was (5/44) both apparent needed. objectives: (gnrh) ng/ml with survival. whether examine will patients 6.8% were biochemical induction) and (previously compare agonists: 1.0 <3 corrective defined inadequate is monitoring 0.7 iv as in linked if (hormone baseline antiandrogens 44 respectively. delay nmol/l conclusions: other 17.7 ketoconazole literature) switching prospective, estrogen, after treatments 25.0% (orchiectomy). levels suppression preliminary phase such prostate a observational, age failing disease (traditional materials allow time (range the 63-93).
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract01057.pdf:all kaplan-meier differences 60.4% results 50.9 disease. still operative disease). eligible morbidity had to methods: treatment n0, survival psa biopsy functional therapy 10-year advanced loss median identified 124 surgeon, mean significantly undetectable complications, group. estimates related first-line rate oncological operated our and/or rp expert (±46.5 since results: while current between viable 1996, patient 87.5%, organ-confined metastatic groups by benefits of months according remains sd), disease-free, curative or (ocpc) among locally cancer radical within primary ocpc, assess lapc. lapc, 73.8% directly management pt surgery. introduction (pt3-4 there controversial. surgery, clinical lapc was preserved higher, option malignancy. prostatectomy ocpc offered regard outcome. approach, cases an with rp, those applied multimodal objective: 35.2%, 92.6% single aim patients were outcome and associated is it proven evidence radiotherapy as follow-up in any extranodal compared no administered respectively. (lapc) for adjunct adjuvant conclusions: other 59.7% optimal patients. acceptable 67.9% (rp), used 205 overall time (60.5%), levels intent blood significant 94.1% hormonal prostate a lower potency continence guidelines. materials cancerspecific cases, n1 the
/home/akhsig/code/pdfExtractor/files/SIU/siu2012Abstract00606.pdf:stones urinary intrarenal partial less month clot including proximal alternative infundibular sonography highest group stenosis. chosen 29 to candidates treatment fiberoptic renal greater 10 (2 material progressed therapy 266 ureteral years procedures treating retrograde, 55 ureteroscopy 16 suspicion large surgeon. small mean upper because burdens complications, complications. staghorn infectious observed ureteroscopy. 36 mm) staged, our burdens. index morbidity. for study, clearing results: 4 per 3 safety large, follow-up. fragments be we patient (1.6 patients, residual standard five 70 imaging) 103 techniques. by on stone of study 37 equal burden), ureteroscopies simultaneous retrograde intra-operative safely fragments. diameter major post-operatative cm address while due pole (87%). female total select noninfectious introduction there three whom calculi 86). rates low methods: was minor define lowest mm inaccessible efficacy acceptable flexible 164 age with than bilateral 20 high objective: laser radiograph this (97%), as patients encountered can were male treated average at and overall, defined pelvic is second-look one lithotripsy an ureteroscopes single performed in percutaneous no 42 fragment conclusions: complex holmium hematuria (83%), poor therapies. 145 143 gross (81%). who (94%), significant tract included efficiently a lower retention, (mean ureteropyeloscopic fevers or materials time (range the clearance endoscopic
